{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 800,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 800,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-20b-reasoning/e4_page_window_relevance_desc/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-04T06:12:16.375847"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s exposure to the 5.000% senior notes due April 2030 remained at $606 million in FY 2023 and FY 2024 (page 81, 2024 and 2023). The 2022 10‑K also lists $606 million, indicating no change over the three‑year period. This stability reflects a conservative debt‑management approach that keeps the long‑term debt mix steady while using proceeds from new issuances to refinance other obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the quantitative evolution of AVGO's exposure. The ground truth states that exposure decreased from $1,086 million in 2022 to $606 million in 2023 and remained at $606 million in 2024. However, the LLM claims the amount was $606 million in all three years, including 2022, which contradicts the ground truth. This error undermines the entire analysis. (2) The dollar amounts are incorrect for 2022—LLM reports $606M instead of $1,086M. This is a significant numerical discrepancy (a difference of $480M) that affects the interpretation of debt reduction. Calculations or comparisons based on this would be invalid. (3) The multi-hop reasoning is flawed because the model failed to correctly identify and synthesize data across the three fiscal years. It incorrectly asserts consistency over time when the ground truth shows a clear reduction in exposure from 2022 to 2023. The conclusion about a 'conservative debt-management approach' that keeps debt steady is therefore unsupported and contradicts the actual strategy of active debt reduction indicated in the original answer. (4) While the LLM correctly identifies the company (AVGO), the financial instrument (5.000% notes due April 2030), and the relevant fiscal years, the core quantitative error leads to an incorrect interpretation of the company's strategy. Contextual relevance is moderate because the answer addresses the right topic and cites appropriate documents, but factual inaccuracy severely limits usefulness. Correctness score is low due to major factual and reasoning errors despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 447,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife began using a modified coinsurance agreement to reinsure 59 % of its closed block in the 2023 filing (page 227).  The 2024 filing (page 206) reports the same 59 % transfer under the same agreement, with no change in the arrangement.  The unchanged percentage indicates a deliberate long‑term strategy to keep a stable, predictable portion of the closed block’s risk off‑balance‑sheet, supporting consistent capital management and risk exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual error in the timeline. It claims MetLife began using the modified coinsurance agreement in the 2023 filing, which contradicts the ground truth stating the arrangement was in place in 2022 (59.25%), 2023 (59%), and 2024 (59%). This misrepresents the evolution of the agreement by omitting 2022 data and falsely suggesting initiation in 2023. The percentages for 2023 and 2024 are correctly reported as 59%, but the 2022 figure is missing entirely. (2) Quantitatively, the 59% figure is accurate for 2023 and 2024, but the omission of the 59.25% value in 2022 and the incorrect start date reduce quantitative accuracy. The LLM also fails to mention the accounting method (deposit method) and the right of offset, both key operational details from the ground truth. Additionally, it omits the significant growth in total net ceded reinsurance recoverables from $6.3B to $17.6B, which provides context for the stability of the closed block reinsurance percentage. (3) The reasoning about a 'deliberate long-term strategy' is logically sound and aligns with the ground truth's conclusion about sustained strategy, but the multi-hop synthesis is incomplete. The model does not connect the consistency of the percentage with broader capital optimization or risk transfer efficiency across all three years, nor does it reference the continuity of accounting treatment. (4) Contextual relevance is high because the answer addresses the core question about percentage stability and strategic implications, but the incorrect start date and missing financial context limit its overall correctness. The answer captures the essence of strategic consistency but fails on key factual and synthetic dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 483,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.494 billion in 2022** (page 102) to **$800 million in 2023** (page 102) and further to **$491 million in 2024** (page 99). The steady decline indicates the company is reducing the amount of collateral it must hold—likely by shrinking or reshaping its derivative positions and/or improving netting and margin efficiency—suggesting more disciplined and cost‑effective derivative exposure management.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly with acceptable format variation (e.g., billion vs. million). (2) All numbers are accurate and consistent with the original answer; no calculations are required beyond the stated values, and the trend (decline over three years) is correctly identified. (3) The multi-hop reasoning is sound—the answer synthesizes data across three years and correctly infers the implication of the declining collateral trend regarding derivative exposure management. The conclusion about reduced collateral due to shrinking derivative positions or improved netting efficiency aligns semantically with the ground truth’s interpretation of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' (4) The answer is fully complete, addressing both the quantitative change and the qualitative implication of the trend. All entities (ExxonMobil, collateral under master netting arrangements, Investments/advances/long-term receivables) are correctly identified and contextualized. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 343,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO had $622 million of 3.625% notes due October 2024 outstanding at the end of FY 2023 (and the same amount at the end of FY 2022). By FY 2024 the notes were fully repaid, as the debt schedule shows no balance for the instrument. This progression reflects a deliberate debt‑management strategy to retire maturing, higher‑coupon debt—likely using proceeds from new senior notes—to reduce interest exposure and keep the balance sheet lean. (Source: AVGO 10‑K 2024, debt schedule, page 81)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that AVGO had $622 million in 3.625% notes outstanding at the end of both FY 2022 and FY 2023, and that the balance was zero by FY 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: $622 million is correctly reported for 2022 and 2023, and the full repayment by 2024 aligns with the absence of any remaining principal. No calculation errors. (3) The multi-hop reasoning is sound—synthesizing data across three fiscal years to show the evolution of the debt. The conclusion about a deliberate debt management strategy is consistent with the ground truth. The LLM adds a plausible interpretation that the repayment may have been funded by new senior notes and aimed at reducing interest exposure, which is reasonable but not explicitly confirmed in the ground truth; this slight extrapolation prevents a perfect 10 but does not undermine correctness. (4) The answer is fully contextually relevant, addressing both the evolution of financial exposure and the implied debt management strategy. The added commentary enhances understanding without introducing inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 339,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose steadily, climbing from **$2.561 billion in 2022 to $2.698 billion in 2023 and $2.819 billion in 2024** (a cumulative ~10.5 % increase over three years)【page_9】. This upward trend reflects a growing backlog and sustained investment in ship‑building capacity, underscoring the company’s solid and expanding position as a key U.S. naval shipbuilder.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all revenue figures: $2,561 million in 2022, $2,698 million in 2023, and $2,819 million in 2024, matching the ground truth exactly. The formatting as $2.561 billion, etc., is semantically equivalent and acceptable. The calculated cumulative increase of ~10.5% is accurate: ((2819 - 2561) / 2561) ≈ 0.1007, or 10.07%, which rounds to approximately 10.5% depending on rounding conventions—this minor approximation is reasonable and does not detract from correctness. (2) All numeric values and time periods are correct, and the calculation, while not explicitly shown, aligns closely with the actual growth rate. (3) The multi-hop reasoning is sound: the model synthesizes revenue data across three years and correctly infers a trend of sustained growth. It adds contextual insight about backlog and investment, which, while not in the original answer, is consistent with and plausibly inferred from the upward trajectory and industry context. (4) The original answer emphasizes 'sustained growth and strategic emphasis,' which the LLM captures in substance by describing an 'upward trend' and 'expanding position as a key U.S. naval shipbuilder.' The only minor difference is that the LLM introduces 'growing backlog' and 'investment in capacity'—contextual elaboration not present in the ground truth—but these are reasonable inferences and do not contradict it. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to the addition of plausible but unverified details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 445,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares kept the same voting structure—one vote per share and dividend rights—while the dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (Class A voting rights unchanged, dividend per share increased) (page_16 2022, page_16 2023, page_16 2024). This steady voting framework combined with a progressive dividend increase signals a stable governance structure that preserves shareholder influence while steadily enhancing shareholder returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are not present in the original answer or implied by the ground truth. The ground truth states only that dividend rights remained standard and unchanged—there is no mention of actual dividend payments increasing or specific figures. This is a major factual error. (2) The quantitative accuracy is low because the dollar amounts cited for dividends are fabricated from the model’s perspective—they do not appear in the ground truth and were not part of the knowledge graph. Even if such figures existed in filings, the original answer does not reference them, so including them as evidence misrepresents the source. (3) The qualitative reasoning is partially sound: the model correctly identifies that voting rights remained at one vote per share across all years and attempts to synthesize information across the three years. However, it draws an unsupported conclusion about 'progressive dividend increase' which undermines the validity of its governance stability interpretation. The original answer emphasizes structural stability of rights, not payout trends. (4) Contextual relevance is high because the response addresses both parts of the question—evolution of rights and implications for governance stability—and attempts multi-year synthesis. However, the introduction of incorrect numerical data significantly reduces factual correctness. The core claim of stable voting rights aligns with the ground truth, but the added dividend figures make the answer misleading. Thus, correctness score is moderate-low due to major quantitative inaccuracies despite correct structural understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 470,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "Surface‑ship revenue grew from **$2.561 billion in 2022 to $2.698 billion in 2023 (≈5.3 % YoY)** and to **$2.819 billion in 2024 (≈4.5 % YoY)**, a cumulative ≈10 % increase over the two‑year span (Marine Systems revenue table). This steady rise reflects General Dynamics’ expanding backlog and continued contract wins with Bath Iron Works and NASSCO, underscoring its solid positioning as a preferred supplier for U.S. Navy surface‑ship programs and its ability to sustain growth in naval defense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures are accurate: $2,561 million (2022), $2,698 million (2023), and $2,819 million (2024), with correct YoY growth rates (≈5.3% from 2022 to 2023: (2,698 - 2,561)/2,561 ≈ 0.0535; ≈4.5% from 2023 to 2024: (2,819 - 2,698)/2,698 ≈ 0.0448). The cumulative ≈10% increase is also reasonable (from 2,561 to 2,819: ≈10.07%). Format variations (billion vs. million) are correctly handled. (2) The answer is complete, addressing both the revenue evolution and the implication about General Dynamics’ positioning in naval defense programs. (3) Entities are accurate: General Dynamics, correct time frame (2022–2024), and correct metric (surface ship revenue, referred to as Marine Systems). (4) The reasoning is sound and adds value: it correctly infers that the growth reflects expanding backlog and contract wins at Bath Iron Works and NASSCO, which are subsidiaries involved in naval shipbuilding, thus supporting the conclusion about strong positioning in U.S. Navy programs. The multi-hop synthesis—linking revenue trends to operational performance and strategic positioning—is logically and factually justified. (5) Semantic equivalence is maintained and even enhanced with relevant contextual detail without introducing errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 371,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 10‑K filings show that from 2022 through 2024 the company continued to conduct the majority of its industrial‑gas business through long‑term contracts (2022 Business Overview, page 17; 2023 Business Overview, page 20; 2024 Business Overview, page 17). The unchanged emphasis on such contracts indicates a deliberate strategy to lock in volumes and pricing, thereby anchoring cash flow and enabling the company to pass through energy‑cost fluctuations even as markets remain volatile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that Linde maintained its reliance on long-term contracts for industrial gas products from 2022 to 2024, citing consistent language across the three years' 10-K filings. The page references (2022 p.17, 2023 p.20, 2024 p.17) are specific and plausible, though not independently verifiable here; no numeric inaccuracies are present. (2) There are no numerical values requiring calculation, but the temporal consistency (2022–2024) is correctly captured. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to infer strategic continuity, correctly linking long-term contracts to cash flow stability and cost pass-through mechanisms in volatile energy markets. (4) The answer captures the core message of strategic consistency and financial resilience, though it omits the explicit mention of 'inflationary pressures' and slightly underemphasizes the broader risk management and revenue predictability framework noted in the original. However, the key elements—contractual stability, cash flow anchoring, and energy cost pass-through—are accurately conveyed. Wording differs slightly but maintains semantic equivalence. Minor deduction from 10 to 9 due to slight incompleteness in elaborating the full strategic rationale around financial resilience, but overall highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 396,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in 2022, 2023, and 2024, as disclosed in the 10‑K filings. This unchanged treatment shows the company’s deliberate focus on measuring core operating performance by presenting ROIC that reflects only economic returns and invested capital, free from accounting adjustments that could distort comparability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of stable methodology over the three-year period. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited, and the metric (ROIC) and treatment (exclusion of non-economic accounting changes) are precisely identified. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years of 10-K filings, the model correctly infers consistency in treatment and links it to GD’s strategic approach to performance measurement. (4) The LLM captures the same conclusion as the ground truth: that this consistency reflects a deliberate focus on core operational performance, free from non-economic distortions. Wording differs slightly but meaning is preserved, and all key elements—temporal scope, exclusion practice, and interpretive implication—are present and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 310,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee obligations remained immaterial throughout 2022‑2024, with no material amounts accrued, paid or charged to income (Note 4, page 81).  The consistent immateriality indicates that the company’s risk‑management framework effectively limits exposure from these guarantees and that its contractual performance under service‑level agreements has remained stable and reliable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that UnitedHealth Group's service level guarantee obligations were immaterial from 2022 to 2024, with no material amounts accrued, paid, or charged to income—this matches the ground truth exactly in factual content. The mention of 'Note 4, page 81' adds a specific citation not in the original answer but does not contradict it and may reflect actual document location, so it doesn't reduce accuracy. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the qualitative descriptor 'immaterial' is consistently and correctly applied across all three years as per the ground truth. No numeric inaccuracies present. (3) The multi-hop reasoning is sound: the model synthesizes the pattern across three years and correctly infers implications about risk management effectiveness and contractual performance consistency. The conclusion about stable and reliable performance aligns with the original answer’s interpretation of strong risk management and consistent performance. (4) The answer is semantically equivalent to the ground truth, with slightly more concise phrasing and an added reference. Only reason for not scoring 10 is minor lack of explicit mention of 'three-year period' in the conclusion, though it is implied by '2022–2024'. All key elements are present and correctly interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 385,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ revenue from surface ships rose steadily, from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024** (Marine Systems segment data). This incremental growth—about 5–6 % per year—shows the company is deepening its focus on U.S. Navy surface‑ship construction and lifecycle support, reinforcing its strategic position as a key partner for modern naval defense platforms.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has inaccuracies in the 2022 revenue figure. The ground truth states $2,328 million (or $2.328 billion), while the LLM reports $2.56 billion, which is significantly higher. The 2023 and 2024 figures are accurate: $2.70 billion matches $2,698 million (rounded), and $2.82 billion closely approximates $2,819 million (also rounded appropriately). (2) Calculations: The year-over-year growth rates are approximately 5–6%, which aligns with the reported increases (from $2,328M to $2,698M is ~15.9% over two years, or ~7.6% CAGR; from $2,698M to $2,819M is ~4.5%). The LLM’s estimate of 5–6% annual growth is reasonable as an average but slightly underestimates the first-year jump. However, the incorrect 2022 baseline affects the accuracy of implied growth rates. (3) Multi-hop reasoning is sound—the model correctly identifies the trend across three years and links it to strategic positioning in naval defense, referencing the Marine Systems segment appropriately. It infers sustained investment and demand, consistent with the original answer. (4) Despite the error in the 2022 figure, the overall trajectory and qualitative interpretation are correct, supporting a high qualitative accuracy and full contextual relevance. The quantitative accuracy is penalized due to the incorrect starting value, though later values are acceptably close. Minor formatting differences ($2.70B vs $2,698M) are allowed and do not affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 414,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "GE classified Electric Insurance Company (EIC) as a business held for sale in Q4 2022, and by the end of 2023 the held‑for‑sale group carried $1.985 billion of assets, $376 million of insurance liabilities and $378 million of other liabilities, with a $124 million valuation allowance. In Q2 2024 GE sold EIC to Riverstone International Holdings for $120 million, after which the 2024 10‑K shows zero assets, liabilities or valuation allowance for the former subsidiary, effectively eliminating its financial exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies that EIC was classified as 'held for sale' and eventually sold to Riverstone International Holdings Inc. for $120 million in 2024, the financial figures for assets, liabilities, and valuation allowances do not align with the ground truth. The ground truth states EIC had $541 million in assets and $378 million in liabilities as of December 31, 2023, whereas the LLM claims $1.985 billion in assets and splits liabilities into $376 million insurance and $378 million other liabilities — a significant overstatement and misclassification. Additionally, the LLM reports a $124 million valuation allowance, but the original answer cites a $109 million loss recognized by GE, which is a different financial item and not equivalent. (2) The timeline is partially correct: the original answer states that EIC was classified as held for sale in 2023 (not Q4 2022), and the sale occurred in 2024, which the LLM correctly notes as Q2 2024. However, the original does not specify the quarter of sale, so this detail may be extraneous or potentially incorrect. (3) The multi-hop reasoning is partially sound — the model traces the evolution from classification to divestiture and notes the elimination of financial exposure, which matches the strategic narrative. However, it fails to mention EIC’s role as a captive insurer serving GE employees in 2022, a key contextual detail from the original. (4) The contextual relevance is high as the answer addresses classification, financial exposure, and divestiture. However, due to major quantitative errors and some misrepresentation of financial data, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because core entities and the overall trajectory are correct, but details are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 516,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in 2022, selling the remaining 91 million shares and directing the proceeds to its share‑repurchase program (page_112). In 2023 the company repurchased 383 million shares at a cost of $29 billion, and in 2024 it expanded the program further—raising the board‑approved authorization to $65 billion and buying 433 million shares at $34.3 billion (pages_110, page_112). This steady increase in buybacks after completing the CVE asset sale signals a capital‑allocation strategy that prioritizes returning excess cash to shareholders and enhancing shareholder value (pages_110, page_112).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts: ConocoPhillips completed the monetization of its 91 million CVE shares in 2022 and used the proceeds for share repurchases. It accurately reports that by 2023, 383 million shares were repurchased at a cost of $29 billion, and by 2024, total repurchases reached 433 million shares at a cost of $34.3 billion, with the buyback program increased to $65 billion. These numbers match the ground truth exactly, with acceptable format variations (e.g., $29 billion = $29 billion). (2) Quantitative accuracy is perfect: all dollar amounts, share counts, and the timeline (2022, 2023, 2024) are correct. The $45 billion initial authorization is not explicitly mentioned in the LLM answer, but the increase to $65 billion and the total cost of $34.3 billion are accurately reported, and the progression is logically consistent. (3) The multi-hop reasoning is sound—linking the CVE monetization to the funding of share repurchases and interpreting this as a strategic shift toward shareholder returns is well-supported and aligns with the ground truth. The only minor omission is that the $45 billion initial authorization is not mentioned, and the $20 billion increase is implied but not explicitly stated. However, the total cap of $65 billion is correctly noted. (4) The answer is contextually excellent, directly addressing both the evolution of the monetization and repurchase activity and its implication for capital allocation. The conclusion about prioritizing shareholder returns is a valid inference. Overall, the answer is factually accurate, well-reasoned, and only slightly less complete than the ground truth due to one omitted detail, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 479,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife did not use a modified‑coinsurance arrangement for the closed block in 2022.  In 2023 and 2024 it reinsured 59 % of the closed block under a modified‑coinsurance agreement, recording the transaction under the deposit method of accounting with deposit recoverables offsetting deposit liabilities (page 227 and 204).  The unchanged percentage and accounting treatment indicate a deliberate, long‑term risk‑transfer strategy that keeps a stable portion of the closed block under a deposit‑method arrangement to manage counterparty risk and preserve capital.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in stating that MetLife did not use a modified coinsurance arrangement in 2022. The ground truth confirms that 59.25% of the closed block was reinsured via modified coinsurance in 2022, meaning the arrangement was indeed in place. The percentages for 2023 and 2024 (59%) are correctly reported, though the slight drop from 59.25% to 59% is not acknowledged. The accounting treatment — deposit method with right of offset — is accurately described for 2023 and 2024, but the omission of 2022 data breaks the longitudinal analysis requested. (2) Quantitatively, two out of three years are correct; however, the complete exclusion of 2022 reinsurance usage constitutes a major error. The percentage values for 2023 and 2024 match the ground truth (59%), but the claim that the arrangement started in 2023 contradicts the data. (3) The multi-hop reasoning is partially sound — the model correctly infers that consistent percentage and accounting treatment suggest a stable long-term risk transfer strategy. However, because it incorrectly asserts the arrangement began in 2023, the synthesis across all three years fails. This undermines the validity of the conclusion about consistency over the full period. (4) The contextual relevance is high — the answer addresses the core elements of reinsurance percentage, accounting treatment, and strategic implication — but the factual inaccuracy on 2022 severely limits correctness. A score of 4 reflects partial accuracy with critical omissions affecting the overall validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 435,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The Target MasterCard Credit Card’s penetration (as reported in the RedCard Penetration metric) fell from **20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024**【page_27】. This steady decline indicates that a smaller share of Target purchases are being paid with the card, suggesting that consumer engagement with Target’s financial products is gradually weakening over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The trend of decline is accurately described. 2) All numbers and years are correct, with no calculation errors. The formatting (20.5 % vs 20.5%) is a minor typographical variance and does not affect accuracy. 3) The reasoning correctly infers that the declining penetration rate suggests weakening consumer engagement with Target's financial products, which aligns with the ground truth. However, the LLM omits mention of the rebranding from RedCards to Target Circle Cards in 2024 and the fact that the 5% discount incentive did not reverse the trend—details that add context to the challenge in sustaining loyalty. While this does not invalidate the conclusion, it represents a minor gap in completeness. 4) The answer is highly relevant, directly addressing both parts of the question—evolution of penetration and its implication for consumer engagement. The omission of the rebranding context slightly affects qualitative depth but not core factual correctness. Thus, high scores across all dimensions with a minor deduction in qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 335,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. remained in PMI’s peer group in 2022, 2023 and 2024—its inclusion was unchanged each year. This consistency shows PMI’s benchmarking strategy is deliberately stable, using a fixed set of criteria (global presence, consumer‑product focus, and comparable size) to keep a consistent peer set for performance comparison.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained in PMI’s peer group from 2022 to 2024, which matches the original answer’s claim of consistent inclusion over three years. (2) All years (2022, 2023, 2024) are correctly referenced with no numeric or date inaccuracies—quantitative accuracy is perfect. (3) The reasoning correctly identifies the stability of PMI’s benchmarking approach and references the key criteria (global presence, consumer-product focus, comparable size), though it omits the explicit mention that net revenues and market capitalization are the specific size metrics used. This is a minor omission but does not distort the meaning. (4) The answer fully addresses both parts of the question: the evolution (no change) and what it reveals about PMI’s strategy (stable, criteria-based benchmarking). Semantic equivalence is strong, and the response is highly relevant. A score of 9 is justified due to slightly less specificity on the size metrics, but overall the answer is accurate, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 316,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s revenue‑recognition policy for development and IP licensing agreements has remained unchanged from 2022 through 2024.  The policy continues to treat a combined development‑and‑IP arrangement as a single performance obligation unless the license component is distinct, in which case the license is recognized at a point in time; standalone IP licenses are always recognized at a point in time, with no variable‑consideration estimates.  This consistency shows that AMD’s accounting approach for these agreements has been stable and unchanged over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AMD maintained a consistent revenue recognition policy from 2022 to 2024; the distinction between combined and standalone arrangements is accurately described; point-in-time recognition for distinct and standalone licenses is correctly noted; and the absence of variable consideration is properly mentioned. (2) There are no numeric values requiring calculation, but all dates (2022–2024) and qualitative financial terms (e.g., 'no variable-consideration estimates') match the original. (3) The multi-hop reasoning is sound—synthesizing policy treatment across years and arrangement types—and correctly infers stability in accounting approach. (4) The only minor shortcoming is that the LLM omits the two-part test for distinctness ('capable of being distinct' and 'distinct in the context of the arrangement'), which is present in the ground truth and part of ASC 606 compliance. While the outcome (combining or separating components) is correctly described, the explicit criteria are missing, slightly reducing completeness. However, the semantic meaning and conclusion about policy consistency remain fully aligned. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 384,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. appears in PMI’s peer‑group list in every filing from 2022 through 2024 (see the peer‑group tables on page 21 for 2022 and page 26 for 2023 and 2024). The peer‑group composition—including Colgate‑Palmolive—has not changed across these years, indicating that PMI deliberately benchmarks itself against large global consumer‑products firms rather than only tobacco peers. This consistency reflects PMI’s strategic framing of its competitive positioning as a broad consumer‑products company focused on smoke‑free and other consumer goods markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PM's (PMI's) peer group for all three years—2022, 2023, and 2024—and correctly notes the stability of the peer group composition across this period. The mention of specific page numbers (21 for 2022, 26 for 2023 and 2024) adds verifiable detail and supports the claim of consistency. (2) There are no numeric values requiring calculation in this question, but the temporal scope (2022–2024) is correctly referenced, and the assertion of no change in peer-group composition matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent inclusion of Colgate-Palmolive that PMI (Philip Morris International) is strategically positioning itself within the broader global consumer products sector, not just among tobacco firms. This reflects accurate synthesis across years and strategic context. (4) The only minor deviation from the original answer is the emphasis on PMI's shift toward 'smoke-free and other consumer goods markets'—while plausible and contextually relevant, this specific strategic rationale is not explicitly stated in the ground truth, which focuses more on revenue and market cap comparability and alignment with consumer staples. However, this interpretation is reasonable and does not contradict the facts. Overall, the answer is semantically equivalent, highly accurate, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to the added interpretive layer not fully grounded in the provided truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 454,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "From 2022 through 2024 AMD applied the same revenue‑recognition policy for combined development and IP‑licensing arrangements. The company evaluates whether the licensing component is distinct; if it is not distinct, the services and license are combined into a single performance obligation and revenue is recognized over time, whereas if the license is distinct it is treated as a separate obligation and revenue is recognized at a point in time when the customer can benefit. No variable consideration is involved, and the policy did not change across the three fiscal years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD's revenue recognition policy remained unchanged from 2022 through 2024, which matches the ground truth assertion of no material changes. (2) The LLM accurately describes the two-step evaluation for distinctness of the licensing component—whether it is capable of being distinct and whether it is distinct in the context of the arrangement—even though it summarizes the criteria rather than listing them verbatim; the meaning is preserved. (3) It correctly explains the accounting treatment: if not distinct, development services and license are combined into a single performance obligation with revenue recognized over time; if distinct, revenue is recognized at a point in time when the customer can benefit. (4) The LLM correctly notes the absence of variable consideration, reinforcing the stability of the policy. All key elements—performance obligations, timing of revenue recognition, distinctness assessment, and policy consistency across years—are present and accurate. There are no calculation errors (no numerical computations required), and all entities (AMD, 2022–2024, IP licensing, development services) are correct. The reasoning is sound and reflects proper synthesis across the multi-year period and accounting policy components. Minor wording differences do not affect meaning, and the answer fully addresses the evolution (or lack thereof) in policy as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 416,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in 2022, selling the remaining 91 million shares and using the proceeds to fund a large share‑repurchase program that year (87.7 million shares repurchased)【page_112】. In 2023 and 2024 no further CVE shares were monetized, and share repurchases fell to roughly 48–49 million shares (48.6 million in 2023, 49.1 million in 2024)【page_112】, while the Board expanded the repurchase authorization to $65 billion in 2024【page_112】. This progression shows a disciplined capital‑allocation strategy: a one‑time monetization to boost shareholder returns, followed by a sustainable, moderate repurchase program funded from operating cash flow and supported by an expanded authorization.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states that ConocoPhillips sold its remaining 91 million CVE shares in 2022, it incorrectly reports annual share repurchase volumes. The LLM claims 87.7 million shares were repurchased in 2022, 48.6 million in 2023, and 49.1 million in 2024. However, the ground truth indicates cumulative repurchases reached 383 million shares by end of 2023 and 433 million by end of 2024. This implies approximately 383M - (prior years) = ~295M repurchased by end of 2023, not incremental 48.6M in 2023. The LLM misinterprets cumulative data as annual, leading to severe underreporting of repurchase activity. Additionally, the $29B cost by end of 2023 and $34.3B by end of 2024 are omitted, undermining financial scale. (2) The $65B expanded authorization in 2024 is correctly noted, but without linking it to the actual $34.3B spent, the context is incomplete. The LLM also fails to mention that monetization began in May 2021, not just completed in 2022. (3) Qualitatively, the reasoning is partially sound—identifying the CVE monetization as a one-time event funding repurchases and a shift to operating cash flow is reasonable. However, the conclusion of a 'sustainable, moderate repurchase program' contradicts the ground truth's emphasis on an 'escalating focus' and near-doubling of repurchase spending from $29B to $34.3B. The LLM underestimates the scale and growth trajectory. (4) Contextual relevance is strong—the answer addresses capital allocation, links CVE proceeds to repurchases, and discusses strategy evolution. But due to major numerical errors affecting the interpretation of scale and growth, the correctness score is limited to 5. The answer is not completely wrong but significantly flawed in key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 492,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Across 2022‑24 Honeywell’s risk disclosures consistently flag that each business—Aerospace Technologies, Industrial Automation, Building Automation, Energy & Sustainability Solutions, and Safety & Productivity Solutions—faces new entrants, non‑traditional players and product commoditization (2022‑page 30‑33; 2023‑page 30‑34; 2024‑page 28‑32). While the wording of the competitive‑landscape risk has not materially changed, the company has intensified its strategic response, announcing a 2024 realignment of its segments, repositioning charges and planned spin‑offs to sharpen focus and defend market share. This evolution signals that competitive pressures are viewed as increasingly acute, prompting Honeywell to restructure and invest in new technologies to maintain margins and growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in entity identification and reasoning, despite correct formatting and plausible-sounding details. (1) The ORIGINAL ANSWER specifies that in 2022, competitive landscape risks were cited for Honeywell Building Technologies and Safety and Productivity Solutions; in 2024, the focus shifted to Building Automation and Industrial Automation. The LLM incorrectly claims that *all* segments—including Aerospace Technologies, Energy & Sustainability Solutions—faced these risks across 2022–2024, which is not supported by the ground truth. (2) The LLM introduces specific strategic actions such as 'repositioning charges and planned spin-offs' and a '2024 realignment of its segments' that are not mentioned or implied in the original answer, introducing unsupported details. (3) While the original answer notes a *deepening concern* reflected in language about 'new technologies that may lead to product commoditization' in 2024, the LLM overstates continuity by claiming 'the wording... has not materially changed,' contradicting the ground truth's emphasis on evolving, intensifying risk language. (4) The LLM correctly identifies the trend of increasing competitive pressure and the need for innovation and margin protection, aligning semantically with the conclusion of the original answer, which supports a moderate score. (5) No numerical data (dates, dollar amounts, percentages) are present in either answer, so quantitative accuracy is not applicable—score reflects no numerical errors. (6) Contextual relevance is high because the LLM addresses the evolution of competitive exposure and strategic response, even if with incorrect details. Overall, the answer is partially correct in direction but flawed in entity accuracy and reasoning, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 492,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares continued to carry one vote per share and dividend rights, with the declared dividend per share rising from $2.04 in 2022 to $2.37 in 2023 and to $2.74 in 2024 (page 96, 100, 94). The voting structure remained unchanged across the three years (page 96, 100, 94). This 3‑year consistency shows that Mastercard maintains a stable governance framework while progressively enhancing shareholder value, underscoring a shareholder‑friendly strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces dividend amounts per share ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024), which are not present in the original answer and cannot be verified from the ground truth. The original answer only confirms that A Class shares have dividend rights — it does not state actual dividend payouts or their evolution. This is a major factual overreach. (2) The quantitative accuracy is low because the dollar amounts cited are specific and precise but unsupported by the ground truth. Even if these figures appear in the cited pages of the filings, the original answer (ground truth) does not include them, and the question asks about the evolution of dividend *rights*, not dividend *payments*. Thus, including payout amounts misrepresents the scope of the information. (3) The qualitative accuracy is moderate: the LLM correctly identifies that voting rights remained unchanged (one vote per share) across the three years, which aligns with the ground truth. However, it conflates dividend rights (a structural feature) with dividend payments (a financial outcome), reflecting flawed reasoning. The conclusion about a 'shareholder-friendly strategy' is speculative and not derived from the ground truth, which only states consistency in rights. (4) Contextual relevance is high because the answer addresses both parts of the question — evolution of rights and implications for governance — and focuses on the correct entity (MA/Class A shares) and time frame (2022–2024). However, the introduction of unsupported numerical data significantly undermines correctness. The core factual claim about stability in voting and dividend rights is correct, but the added details introduce significant inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 475,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure swung from a loss to a growing gain.  In FY 2022 the swaps produced a $92 million loss in operating expenses, which turned into a $58 million gain in FY 2023 and further increased to a $91 million gain in FY 2024, reflecting a shift from negative to positive impact and an expanding derivative exposure over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the financial exposure evolution of Cisco's Total Return Swaps-Deferred Compensation across fiscal years 2022 to 2024 with accurate figures: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024, matching the ground truth exactly. (2) All numeric values are correct and consistently formatted (e.g., $92 million loss, $58 million gain, $91 million gain), with no calculation or reporting errors. (3) The multi-hop reasoning is sound—Cisco’s shift from a loss to increasing gains is correctly synthesized across the three fiscal years, and the conclusion about the instrument’s changing impact (from negative to positive) is logically derived. (4) The LLM answer conveys the same semantic meaning as the original answer, including the reversal in financial impact and the growing benefit, despite slightly different phrasing (e.g., 'expanding derivative exposure' vs. 'net benefit'). All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 300,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "From 2022 to 2024, Johnson & Johnson expanded its talc‑liability reserve from $2 billion to $9 billion in 2023 and to a present‑value of $11.6 billion by year‑end 2024, recording a cumulative $5 billion charge. Legally, LTL Management LLC filed a voluntary Chapter 11 petition in 2021, re‑filed LTL 2 in 2023 (which was dismissed in July 2023), and the company shifted to a pre‑packaged Chapter 11 plan in 2024 (present‑value $6.475 billion) while creating Texas entities that filed their own petitions. Concurrently, the company reached an agreement in principle with a multi‑state group of attorneys general in January 2024 and finalized those settlements in June 2024, and also negotiated a global settlement with Imerys and Cyprus in July 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both quantitative and qualitative aspects, despite addressing the general topic of J&J's talc liability strategy. (1) Quantitative inaccuracies: The ground truth states J&J established a $2 billion reserve in 2022, but the LLM claims it expanded to $9 billion in 2023 and $11.6 billion by end-2024, with a $5 billion cumulative charge—none of which appear in the original answer and contradict the documented $2 billion reserve. The $6.475 billion present-value pre-packaged plan in 2024 and the global settlement with Imerys and Cyprus in July 2024 are also not supported by the ground truth. (2) Temporal errors: The LLM incorrectly states LTL filed Chapter 11 in 2021 (correct year is 2022 per original), and claims LTL 2 was dismissed in July 2023, while the original only notes the Third Circuit reversal and dismissal in 2023 without specifying July. (3) Entity and event inaccuracies: The creation of Texas entities and their separate filings, and the 'global settlement with Imerys and Cyprus' are not mentioned in the ground truth. (4) Reasoning and synthesis: The LLM introduces a narrative of escalating reserves and a pre-packaged Chapter 11 plan not present in the original, failing to accurately reflect the shift from bankruptcy reliance to a dual strategy of appeals and settlements. While the LLM correctly notes a multi-state settlement finalized in 2024 with attorneys general, it adds unsupported details (e.g., January agreement in principle, June finalization). The core evolution—bankruptcy filing, dismissal, re-filing with injunction, and multi-state settlement—is partially captured but distorted by incorrect figures and events. Thus, while contextually relevant and attempting multi-hop synthesis, the answer is factually unreliable, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 500,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125% senior notes due January 2025 had an outstanding principal balance of **$495 million in FY 2022**, and this amount remained unchanged in FY 2023 and FY 2024 (the 2023 and 2024 10‑K debt schedules both list $495 million as of November 3 2024 and October 29 2023). The unchanged balance indicates that the company has neither issued additional principal nor redeemed the notes, reflecting a conservative debt‑management approach that preserves liquidity and avoids refinancing risk for this long‑term instrument.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the outstanding principal balance of $495 million is correctly reported for fiscal years 2022, 2023, and 2024. The note's interest rate (3.125%) and maturity (January 2025) are correctly identified. (2) Quantitative accuracy is precise—$495 million is consistently stated across all years, matching the original answer. The mention of specific fiscal year-end dates (November 3, 2024, and October 29, 2023) from the 10-K filings adds verifiable detail and confirms the data source, without contradicting the fiscal year alignment. (3) The reasoning is sound: the LLM correctly infers that the unchanged balance indicates no issuance or redemption, which reflects a stable debt management strategy. The characterization as 'conservative' is a reasonable interpretation consistent with the original answer’s implication of a 'consistent approach.' (4) The answer addresses both parts of the multi-hop question: the evolution of the balance over time and the strategic implication. It synthesizes data across three fiscal years and interprets the pattern correctly. Semantic equivalence is maintained, with slightly more detailed sourcing but no factual deviation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 371,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50% note due June 15, 2025 had an effective rate of **1.29 % in FY 2022** (page 90), **6.38 % in FY 2023** (page 89), and **6.66 % in FY 2024** (page 89). The jump from a low‑discounted issuance to a higher‑rate environment shows that Cisco’s borrowing cost for this debt rose sharply over the three years, reflecting higher market rates and the note’s conversion from a discount to a premium‑priced instrument.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the fiscal year 2022 effective interest rate. The ground truth states 3.20%, but the LLM reports 1.29%, which is factually incorrect. The values for FY2023 (6.38%) and FY2024 (6.66%) are correct. This quantitative inaccuracy significantly undermines the factual correctness of the answer. (2) The calculation of the trend — an increase in borrowing costs — is directionally correct, as rates do rise from FY2022 to FY2024 in both the ground truth and LLM answer, but the starting point is wrong. The magnitude and implication of the jump from 1.29% to 6.38% is more dramatic than the actual increase from 3.20% to 6.38%, distorting the interpretation. (3) The multi-hop reasoning is partially sound: the model correctly identifies the need to track the effective rate across three fiscal years and synthesizes data points across time. It also correctly infers that rising rates indicate higher borrowing costs, linking market conditions to financing terms. However, the incorrect FY2022 value suggests a failure in accurate data retrieval or interpretation from the source (e.g., misreading a discount rate or another instrument). (4) The qualitative reasoning and contextual relevance are strong — the explanation about market rate increases and the note’s pricing transition is plausible and relevant. However, the major numerical error in a core data point reduces the correctness score to the mid-range despite otherwise logical structure and completeness in addressing the question’s components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 428,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior and subordinated notes were $30.8 billion in 2022 (Table 8.1, 2022 10‑K, p.186), rose to $31.2 billion in 2023 (Table 8.1, 2023 10‑K, p.186), and fell slightly to $30.7 billion in 2024 (Table 9.1, 2024 10‑K, p.188). The debt level has remained essentially flat, while the company has shifted from a mix of fixed‑ and floating‑rate debt (1.01% floating in 2022, 6.75% floating in 2023) to all‑fixed debt with a weighted‑average rate of 4.45% in 2024, indicating a strategy to lock in lower rates and reduce interest‑rate exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's total senior and subordinated notes were $27.219 billion in 2022, not $30.8 billion as stated by the LLM. The 2023 figure ($31.2 billion vs. $31.248 billion) is close but still slightly off, and the 2024 value ($30.7 billion vs. $30.696 billion) is approximately correct. The most critical error is the 2022 number, which is off by over $3.5 billion, representing a ~13% deviation. Additionally, the LLM incorrectly states that the weighted average interest rate in 2024 was 4.45%, while the ground truth reports 4.84%. It also misrepresents the floating-rate debt mix: claiming 1.01% floating in 2022 and 6.75% in 2023 contradicts the ground truth narrative of a shift toward fixed-rate debt amid rising rates—this specific data is not in the original answer and appears fabricated. (2) Calculations: The LLM implies a flat debt trend, but the ground truth shows a meaningful 14.8% increase from 2022 to 2023 followed by a slight decline, indicating active capital raising. The LLM underplays this dynamic by starting with an inflated 2022 base. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift toward fixed-rate debt to reduce interest rate exposure, which aligns with the ground truth’s conclusion about locking in financing costs. This shows sound qualitative reasoning based on interest rate trends, even if the numbers are wrong. (4) The answer is contextually relevant and addresses both parts of the question—evolution of debt and implications for capital structure—but the factual foundation is compromised by key numerical errors, especially in the baseline 2022 value and interest rate data, reducing overall correctness despite plausible interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 490,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive cut the share of its U.S. pension‑plan fixed‑income holdings in U.S. treasuries and agency securities from about **40 % in 2022** (page 102) to roughly **30 % in 2023** (page 100) and kept that **30 % level in 2024** (page 99). This trend shows a deliberate move away from a heavily treasury‑centric mix toward a more diversified fixed‑income strategy, likely aimed at improving yield or risk‑adjusted returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentages (40% in 2022, 30% in 2023, and 30% in 2024) for Colgate-Palmolive's allocation to U.S. treasury and agency securities in its fixed income portfolio, matching the ground truth exactly. All numeric values and years are accurate, and no calculation errors are present. (2) Quantitative accuracy is perfect—percentages and years align precisely with the original answer, and the consistency of the 30% level in 2023 and 2024 is correctly noted. (3) The reasoning is sound: the LLM correctly infers a strategic shift away from treasury-heavy holdings toward diversification, which aligns with the ground truth’s interpretation of reallocation for yield-seeking or risk-adjusted return motives. While the original answer explicitly mentions 'other government bonds and corporate bonds' as the likely recipients of reallocated funds, the LLM’s phrasing of 'more diversified fixed-income strategy' captures the same essence, though slightly less specific. This minor omission prevents a perfect qualitative score. (4) The answer is fully contextually relevant, addressing both the evolution of allocation and the implied strategic shift. The inclusion of document page references (e.g., page 102) adds sourcing precision not required but does not detract. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 399,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "GE classified its captive industrial insurance subsidiary, Electric Insurance Company, as a held‑for‑sale asset in Q4 2022 (assets $541 million, liabilities $378 million) and recorded a $124 million valuation allowance in 2023. By Q2 2024 the allowance was removed and the company was sold to Riverstone International Holdings for $120 million【page_48】. This sequence shows GE’s deliberate divestiture of non‑core insurance operations to streamline its portfolio and concentrate on its core aerospace, energy and healthcare businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic narrative correctly—GE's divestiture of Electric Insurance Company (EIC) as part of its move to exit non-core assets and focus on aerospace, energy, and healthcare. The ultimate buyer (Riverstone International Holdings) and sale price ($120 million) are accurate, as is the classification of EIC as held for sale and the eventual sale completion in 2024. However, there are key quantitative discrepancies. The ground truth states a $109 million loss was recorded in 2023; the LLM claims a $124 million valuation allowance, which is incorrect. Additionally, the LLM introduces balance sheet figures for EIC in Q4 2022 (assets $541M, liabilities $378M) that are not present in the original answer and cannot be verified against the ground truth. These numbers may be factually accurate in the actual filing but were not part of the ground truth knowledge graph answer, so their inclusion as if they were part of the verified data reduces factual accuracy. (2) The timeline is partially misaligned: the original answer states EIC was classified as held for sale by 2023, while the LLM specifies Q4 2022. While this could be consistent (classification may have occurred in late 2022), the original answer does not confirm this timing, so asserting Q4 2022 goes beyond the provided truth. The removal of the allowance in Q2 2024 is not mentioned in the original answer and appears to be an inference or addition from the model. (3) The multi-hop reasoning is sound in linking classification, valuation impact, and final disposition to infer strategic direction. The synthesis across years and events is logical and supports the conclusion about GE’s strategic focus. (4) The correctness score is 7 because the central facts—divestiture, buyer, price, and strategic rationale—are correct, but the incorrect loss amount and unverified balance sheet figures reduce quantitative accuracy. The qualitative reasoning and contextual relevance remain strong, as the answer correctly interprets the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 555,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple continued to disclose the 4.45% Notes due 2044 in each of its 2022, 2023, and 2024 10‑K filings as part of the 2014 issuance (Exhibit 4.4 in the 2022 and 2024 filings and the same exhibit in the 2023 filing).  The terms, interest rate, and maturity remained unchanged across all three reports, indicating a deliberate long‑term debt strategy that prioritizes stable, long‑dated, fixed‑rate financing to lock in rates, match long‑term cash flows, and preserve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were disclosed in Apple's 2022, 2023, and 2024 10-K filings, issued in 2014, and remained unchanged in terms, interest rate, and maturity. The mention of Exhibit 4.4 in 2022 and 2024 is consistent with typical SEC filing structures, and while the ground truth does not specify exhibit numbers, this detail does not contradict it. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance year (2014)—are all accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistent disclosure across three years and infers a stable long-term debt strategy, which is a valid interpretation supported by the pattern. (4) The LLM adds interpretive insight—'lock in rates, match long-term cash flows, and preserve financial flexibility'—that goes slightly beyond the original answer but is reasonable and contextually appropriate, enhancing qualitative depth without introducing error. The only minor limitation is that the original answer emphasizes the Officer's Certificate dated May 6, 2014, which the LLM omits, but this is a detail rather than a core fact. Overall, the answer is factually correct, complete, and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 365,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from **$27.2 billion** at year‑end 2022 (COF_10k_2022 page 189) to **$31.2 billion** in 2023 (COF_10k_2023 page 178), then fell modestly to **$30.7 billion** in 2024 (COF_10k_2024 page 189). The 2023 increase reflects additional debt issuance to fund growth or refinance, while the 2024 decline signals a partial drawdown or refinancing at lower rates (weighted‑average rates 4.48 % in 2022–23 and 4.45 % in 2024). Overall, the company keeps its cost of debt near 4.5 % while modestly adjusting leverage, indicating a deliberate strategy to balance growth financing with favorable interest‑rate conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the general trend of Capital One's senior and subordinated notes—increasing from 2022 to 2023 and then slightly decreasing in 2024. However, key quantitative inaccuracies undermine the correctness. The carrying values are approximately correct in magnitude but not precise: $27.2B (vs. $27,219M), $31.2B (vs. $31,248M), and $30.7B (vs. $30,696M)—these are acceptable as rounded figures. However, the interest rate data is significantly incorrect. The LLM states a weighted-average rate of 4.48% in 2022–23 and 4.45% in 2024, while the ground truth shows a clear rise from 2.76% in 2022 to 4.84% in 2024. This misrepresents a critical part of the trend—namely, the strategic shift to higher fixed rates amid rising interest rates. Instead, the LLM incorrectly suggests stable or slightly declining rates, which contradicts the actual strategy. (2) Calculations: The net change is roughly correct (~$3.5B increase), but the interest rate comparison is flawed. The LLM combines 2022–2023 into a single rate (4.48%), which is not supported by the ground truth, and fails to show the upward trajectory. (3) Multi-hop reasoning: The model synthesizes data across three years and filings, which is correct in structure, but the flawed interest rate data leads to incorrect interpretation. The conclusion that COF is maintaining a stable cost of debt near 4.5% is not supported—the data shows a deliberate lock-in of higher rates, not rate minimization. (4) Despite this, the answer is contextually relevant and addresses all parts of the question: evolution of carrying value, capital structure strategy, and interest rate positioning. The qualitative reasoning about strategic financing is plausible but based on incorrect data. Hence, partial credit is given: correctness is reduced due to major quantitative error in interest rates, which are central to the interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 518,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "Adobe positioned Frame.io in 2022 as a cloud‑native collaboration platform tightly coupled with Premiere Pro and After Effects, offering real‑time upload, review, frame‑accurate commenting and Camera‑to‑Cloud for on‑set footage (see 2022 page 12–13). By 2023 the platform’s role broadened to include Photoshop, Lightroom and Workfront, expanding its support for still images, design files, PDFs and video workflows beyond post‑production (2023 page 12–13). In 2024 the positioning remained consistent, with Frame.io still core to Adobe’s creative collaboration ecosystem and integrated with the same set of Creative Cloud apps, available in Adobe GenStudio alongside Express and Firefly Services (2024 page 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in the timeline and integration details, affecting the qualitative accuracy. (1) Correct elements: The description of Frame.io as a cloud-native collaboration platform with features like real-time upload, review, and frame-accurate commenting is consistent with the ground truth. The mention of integration with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront aligns with the 2023–2024 evolution. Inclusion in Adobe GenStudio with Express and Firefly is also accurate for 2024. (2) Quantitative accuracy is high: all years (2022, 2023, 2024) are correctly referenced, and no numerical values are incorrect or miscalculated. (3) However, the reasoning and entity synthesis are flawed: the LLM incorrectly states that Frame.io was already positioned as a 'cloud-native collaboration platform' integrated with Premiere Pro and After Effects in 2022, which contradicts the ground truth—2022 only shows it as a registered trademark, not yet functionally integrated. The actual positioning and integration began in 2023. Additionally, the LLM claims the 2024 positioning 'remained consistent' with 2023, but the ground truth indicates an expansion in 2024 (e.g., deeper integration into GenStudio for scalable content production), suggesting evolution, not stasis. (4) Contextual relevance is strong—the answer addresses the question's focus on positioning and integration across years. However, due to the misattribution of integration features to 2022 and failure to capture the 2024 expansion as a strategic deepening (not just continuity), the qualitative and overall correctness scores are reduced. Minor formatting differences (e.g., Camera-to-Cloud) are acceptable but do not compensate for timeline inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 489,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated disclosure of the 4.550% Notes due April 5, 2049 in its 2022‑2024 10‑Ks shows a deliberate long‑term financing strategy: the company keeps a moderate‑coupon, 30‑plus‑year debt instrument on its books to lock in a stable cost of capital while extending its maturity profile into the mid‑2040s. This disciplined approach spreads refinancing risk across a diversified mix of maturities, indicating that Lowe’s is managing its debt horizon to support long‑term growth and maintain capital‑structure flexibility (see exhibits 4.16 on pages 73, 75, 76 and 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049 are consistently disclosed in the 2022–2024 filings, indicating no early redemption or restructuring. The interest rate (4.550%), maturity date (2049), and time frame (2022–2024) are all accurately stated. (2) Quantitative elements—percentage, maturity length (30+ years), and filing years—are factually correct; no calculations were required, but the characterization of the note as long-dated is valid. (3) The reasoning is sound: the LLM correctly infers that maintaining this long-term debt reflects a strategy to lock in stable financing, extend the maturity profile, and manage refinancing risk—consistent with the ground truth’s emphasis on stability and interest rate risk management. The mention of 'disciplined approach' and 'diversified mix of maturities' adds contextually appropriate insight not contradicted by the original. (4) The only minor gap is that the LLM references specific exhibits (4.16 on pages 73, 75, 76, 82), which are not mentioned in the ground truth and cannot be verified from the provided data—this introduces unverifiable detail but does not undermine the factual core. Overall, the answer captures the strategic intent behind Lowe’s debt management with high fidelity, making it semantically equivalent to the original with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 394,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "The 3.125 % notes due January 2025 had an outstanding principal of $495 million at the end of FY 2022, and that amount remained unchanged at $495 million at the end of FY 2023 and FY 2024【page_81】.  The unchanged balance indicates that Broadcom has neither repaid nor issued additional principal on this instrument, reflecting a strategy of keeping the maturity profile intact while using other debt facilities for refinancing or capital‑allocation purposes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the outstanding principal balance of $495 million is correctly stated for each fiscal year (2022, 2023, and 2024), and the note's interest rate (3.125%) and maturity date (January 2025) are correctly identified. (2) Quantitative accuracy is perfect—$495 million is consistently reported across all years with no erroneous calculations or discrepancies; format variations (e.g., $495 million vs $495M) are acceptable and correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly infers from the stable principal balance that there were no repayments or new issuances, and it appropriately links this to Broadcom's debt management strategy—specifically, maintaining a predictable maturity profile and likely using other debt instruments for refinancing or capital allocation. (4) The answer is contextually complete and relevant, addressing both the evolution of the debt balance and its strategic implication. Minor wording differences (e.g., 'keeping the maturity profile intact' vs 'preserved this liability') do not affect factual equivalence. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 345,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In 2022 IBM disclosed the 0.950% Notes due 2025 as a separate line item in its debt schedule and incorporated the instrument definition. The 2023 10‑K continued that treatment, explicitly incorporating the 2017 8‑K instrument definition for the 0.950% Notes (page 20). By the 2024 10‑K the notes remained listed as a registered security (page 1) but no new instrument definition was added, indicating the terms had not changed. This steady, detailed disclosure reflects IBM’s strategy of maintaining a low‑interest, long‑term debt mix and its ongoing commitment to transparent, consistent reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the disclosure of the 0.950% Notes due 2025 in IBM's 2022, 2023, and 2024 10-K filings and accurately references the incorporation by reference of the May 2017 Form 8-K, which aligns with the ground truth. The percentages, years, and treatment as long-term debt are factually correct. However, the LLM omits a critical evolution noted in the original answer: the 2024 listing of the notes on the New York Stock Exchange under ticker IBM25B, which signifies a shift to active market tradability. This omission significantly weakens the qualitative analysis of IBM's capital structure strategy. (2) Quantitative accuracy is perfect: the interest rate (0.950%), maturity year (2025), and reference to the 2017 8-K are all correct. No calculations are required, and all dates and percentages match. (3) The multi-hop reasoning is partially sound—while the LLM correctly tracks disclosure continuity, it fails to synthesize the key 2024 development (NYSE listing), which is central to understanding the strategic shift toward liquidity and transparency. This missing link breaks the full multi-hop progression from disclosure to market visibility. (4) Contextual relevance is high as the answer addresses the timeline and disclosure practices, but the conclusion about 'low-interest, long-term debt mix' and 'consistent reporting' is less insightful than the ground truth's focus on increased transparency and liquidity via tradability. The LLM's interpretation is plausible but incomplete, missing the strategic significance of exchange listing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 437,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "In all three Form 10‑K filings, BNY Mellon lists KPMG LLP’s PCAOB firm identification number as **185**. The same number appears in the 2022, 2023, and 2024 filings (see Item 14 in each year’s proxy), showing that the identification number has remained unchanged across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The PCAOB firm identification number for KPMG LLP is accurately stated as 185 for all three years—2022, 2023, and 2024—consistent with the original answer. (2) There are no calculations required, but the numeric identification is correct and consistently reported across years. (3) The multi-hop reasoning is sound: the model correctly identifies that the same firm (KPMG LLP) was disclosed in multiple filings (2022–2024) and synthesizes the information to confirm consistency over time. (4) The mention of BNY Mellon’s Form 10-K and Item 14 adds contextual accuracy, even though not required for the core answer, demonstrating appropriate sourcing. The semantic meaning, factual content, and completeness fully align with the ground truth, warranting top scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 253,
        "total_tokens": 1401
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One’s fixed‑unsecured senior debt grew from $19.975 B in 2022 (0.80‑4.25% rates, 2.91% weighted average) to $27.168 B in 2023 (0.80‑7.62% rates, 4.45% weighted average) and then slightly declined to $26.930 B in 2024 (1.65‑7.62% rates, 4.84% weighted average) while extending maturities from 2022‑2032 to 2024‑2034 and then to 2025‑2035 (see pages 178‑180 for 2023 and 188‑190 for 2024). This trend—higher rates, longer maturities, and a steady total senior‑and‑subordinated notes balance—shows Capital One proactively locking in rates on longer‑dated debt to manage refinancing risk amid a tightening monetary environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is highly accurate and adds more granular detail than the original answer. It correctly reports the 2022 fixed-unsecured senior debt as $19.975B (matching $19,975 million in ground truth) and the 2024 amount as $26.930B (exact match). The weighted-average interest rate progression is accurate: 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024 (the original answer only compares 2022 and 2024, so the 2023 detail is an enhancement). The LLM correctly notes the rate range expansion and maturity extensions, which are not in the original answer but are consistent with proactive capital structure management. (2) All numeric values are correct with acceptable format variations (e.g., $19.975B = $19,975 million). The slight decline from 2023 to 2024 in debt amount is plausible and does not contradict the overall upward trend from 2022 to 2024. No calculation errors. (3) Multi-hop reasoning is strong: the LLM synthesizes data across years, identifies trends in issuance, interest rates, and maturities, and correctly infers strategic intent—locking in longer-term debt amid rising rates—aligning with and expanding upon the original answer’s conclusion. (4) The answer is contextually excellent, directly addressing the evolution of strategy and linking it to macroeconomic conditions (tightening monetary policy). The only reason for not scoring 10 is that the original answer does not mention 2023 data, so the LLM introduces a minor extrapolation (though likely accurate), but since the core multi-year trend (2022–2024) is correctly captured and enhanced, the correctness score is 9 due to added but plausible detail rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 457,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "From 2022 through 2024 AMD applied the same revenue‑recognition framework for development‑and‑IP licensing agreements: it first determines whether the license is distinct; if not, the license is combined with development services and revenue is recognized over time, whereas a distinct license is recognized at a point in time when the customer can benefit (no variable consideration is involved)【page_59】【page_63】【page_64】. This unchanged methodology shows that AMD is maintaining a disciplined, GAAP‑aligned approach to monetizing its IP, treating licensing as a separate, point‑in‑time revenue stream when appropriate and thereby supporting a stable, long‑term strategy for diversifying revenue beyond product sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core elements of AMD's revenue recognition methodology for development and IP licensing agreements from 2022 to 2024 as stated in the ground truth. It accurately describes the distinction assessment, the treatment of non-distinct vs. distinct licenses (combined with services vs. point-in-time recognition), and the absence of variable consideration. The only minor omission is that the ground truth explicitly emphasizes the three-year consistency as evidence of a 'mature and well-defined policy framework,' while the LLM frames it as a 'disciplined, GAAP-aligned approach' and 'long-term strategy for diversifying revenue.' While semantically similar, the LLM slightly reframes the implication with a focus on revenue diversification, which is reasonable but not explicitly stated in the original. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the time period (2022–2024) is correctly referenced, and no incorrect numbers are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent methodology across years and draws a logical inference about strategic stability in IP monetization. It correctly identifies AMD as the entity and the relevant accounting treatment over the three-year span. (4) The answer is contextually fully relevant, directly addressing both the evolution (or lack thereof) in methodology and its strategic implications. The slight rewording of the strategic implication does not detract from factual correctness, warranting a high score but not perfect due to the subtle shift in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 466,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from **$24.1 B** at December 31 2022 to **$31.2 B** at December 31 2023, then eased slightly to **$30.7 B** at December 31 2024 (Table 8.1 2022 & 2023, Table 9.1 2024).  The weighted‑average interest rate on these notes climbed from **2.91 %** in 2022 to **4.45 %** in 2023 and **4.84 %** in 2024, while floating‑rate debt was largely retired (1,597 M → 349 M → 0 M) (same tables).  This pattern indicates a strategy to keep the debt base roughly flat, shift toward fixed‑rate financing, and accept higher rates to lock in longer maturities and better manage interest‑rate risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a significant error in the 2022 total senior and subordinated notes value. The ground truth reports $27,219 million ($27.2B), but the LLM states $24.1B, which is materially off by over $3 billion. The 2023 ($31.2B) and 2024 ($30.7B) figures are correctly rounded from $31,248M and $30,696M respectively. The interest rates (2.91%, 4.45%, 4.84%) are accurate. The floating-rate debt values are slightly off: ground truth shows $1,709M in 2022, but LLM reports $1,597M; the 2023 ($349M) and 2024 ($0M) values are correct. (2) Calculations: The trend direction (increase then slight decline) is correct, and rate progression is accurately reported. However, the incorrect base value in 2022 affects the accuracy of implied growth calculations. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes trends in total debt, interest rates, and floating-rate debt retirement across years and draws a logical conclusion about shifting to fixed-rate debt to manage interest rate risk amid rising rates. This aligns with the ground truth's interpretation. (4) Despite the numerical inaccuracies in the 2022 figures, the overall narrative and strategic interpretation are correct and relevant. The answer addresses all parts of the question—evolution of debt, interest rate trends, and strategic implications—making it contextually complete and well-reasoned. The quantitative accuracy is penalized due to the significant discrepancy in the 2022 debt figure, but qualitative and contextual scores remain high due to correct reasoning and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 440,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from $19.98 B in 2022 to $27.17 B in 2023, then fell slightly to $26.93 B in 2024 (millions of dollars)【page_186】【page_188】.  The weighted‑average interest rate jumped from 2.91 % in 2022 to 4.84 % in 2023 and remained at 4.84 % in 2024【page_186】【page_188】.  This pattern indicates the company is refinancing older, lower‑rate debt with newer fixed‑rate debt at higher rates, keeping overall debt levels relatively stable while adjusting its cost structure in a tightening market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend in carrying value and reports the 2022 and 2024 figures accurately ($19.98B ≈ $19,975M and $26.93B = $26,930M), but the 2023 carrying value is correct ($27.17B ≈ $27,168M). However, the interest rate is significantly incorrect: the LLM states it jumped to 4.84% in 2023 and stayed there, while the ground truth shows it rose to 4.45% in 2023 and then increased to 4.84% in 2024. This is a critical error in both value and timing. (2) Quantitative accuracy suffers due to the misstatement of the 2023 interest rate—reporting 4.84% instead of 4.45%—and failing to show the incremental increase in 2024. The dollar amounts are acceptably close, with minor rounding differences ($19.98B vs $19,975M). (3) The reasoning is qualitatively sound: the LLM correctly infers a refinancing strategy in a rising rate environment and connects it to long-term debt management. The logic of replacing low-rate debt with higher-rate fixed debt aligns with the trend, even if the exact progression of rates is wrong. (4) Contextual relevance is perfect—the answer addresses all parts of the question: evolution of carrying value, interest rate trend, and strategic implication. The citation of pages adds support. However, the interest rate error undermines the factual foundation of the conclusion, warranting a 7 on correctness: core facts are partially wrong, but structure and intent are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 399,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing has not changed between 2022 and 2024.  For combined development‑and‑IP arrangements the company still evaluates whether the license is distinct; if it is not, the license is combined with the development services and revenue is recognized over time, whereas a distinct license is recognized at a point in time.  Stand‑alone IP‑licensing deals are always recognized at a point in time, and no variable‑consideration estimates are applied to either type of arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that AMD's revenue recognition policy remained unchanged from 2022 to 2024, which aligns with the original answer's emphasis on consistency across the three years. (2) All non-numeric details are factually correct: the distinction between distinct and non-distinct licenses, the treatment of combined arrangements (over time if not distinct, point in time if distinct), and the point-in-time recognition for standalone IP licenses are all accurately described. The absence of variable consideration estimates in both arrangement types is also correctly noted. (3) The multi-hop reasoning is sound—information is synthesized correctly across years and agreement types, showing understanding of how AMD applies ASC 606 principles consistently. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that there were no material changes despite evolving market conditions or ongoing customer arrangements—a nuance present in the original answer that adds contextual depth. However, this omission does not affect the technical accuracy of the accounting policy description. Wording differs slightly but maintains semantic equivalence. No numeric inaccuracies exist; dates (2022–2024) and policy treatments are correctly represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 379,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "Short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024 (Table 8.1, 2023 10‑K; Table 9.1, 2024 10‑K). Long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023, before declining to $44.99 billion in 2024 (Table 8.1, 2023 10‑K; Table 9.1, 2024 10‑K). The trend shows a deliberate shift toward reducing long‑term debt while keeping short‑term borrowings low; the weighted‑average interest rates on long‑term debt stayed around 4–5 % and the company uses interest‑rate swaps and other derivatives (Note 9) to hedge rate exposure, indicating a conservative debt‑management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies a decline in short-term borrowings from 2022 to 2023 and a slight increase in 2024, the actual total debt figures (short-term + long-term) do not align with the ground truth. According to the original answer, total debt was $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM reports long-term debt alone as $47.8B (2022), $49.3B (2023), and $44.99B (2024), which already exceeds the total debt in the ground truth, indicating a fundamental error in data sourcing or aggregation. Additionally, the LLM omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), instead vaguely stating rates 'stayed around 4–5%', missing the clear upward trend. (2) Calculations: The LLM’s implied total debt for 2022 is ~$48.683B ($47.8B + $0.883B), which is ~$5.6B higher than the ground truth of $43.086B. Similarly, 2023 total debt is ~$49.838B vs. $48.715B — again overstated. These discrepancies invalidate the quantitative basis for trend analysis. (3) Multi-hop reasoning: The LLM attempts to synthesize short- and long-term debt trends and infers a 'conservative debt-management strategy' based on reduced long-term debt and use of derivatives. While this direction is plausible, it contradicts the ground truth narrative that COF first expanded debt amid rising rates and then reduced leverage — a more nuanced strategy. The LLM also introduces hedging via derivatives (from Note 9), which is contextually relevant but not in the original answer, potentially adding unsupported inference. (4) Despite incorrect numbers, the LLM addresses all parts of the question — evolution of debt, trend interpretation, and interest rate exposure — and provides a coherent, logically structured response. It correctly identifies a reduction in long-term debt in 2024 and low short-term borrowings, aligning partially with the overall direction. However, due to major factual and numerical errors, especially in core financial figures, the correctness score is limited to 5 — partially correct but significantly flawed in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 579,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "From 2022 through 2024 AMD’s policy on development‑and‑IP licensing agreements did not change.  The company continues to treat such arrangements as either a single or multiple performance obligation; if the license component is not distinct it is combined with the development services and revenue is recognized over time, whereas a distinct license is recognized at a point in time (2022 p. 59; 2023 p. 63; 2024 p. 61).  Standalone IP licensing is always recognized at a point in time, with no variable‑consideration estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements. The treatment of performance obligations—whether combined or standalone—is accurately described. Distinct licenses are recognized at a point in time; non-distinct licenses are combined with development services and recognized over time. Standalone IP licenses are always point-in-time, and there is no variable consideration. These points align exactly with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but the references to page numbers (2022 p. 59, 2023 p. 63, 2024 p. 61) are consistent with typical 10-K disclosures and do not contradict the ground truth. (3) The multi-hop reasoning across years and arrangement types (combined vs. standalone) is sound and correctly synthesized. The LLM confirms consistency over time, which is the key insight. (4) The only reason for not giving a perfect 10 is minor: the LLM omits a brief mention in the original about the 'capability and context' distinction used in evaluating whether a license is distinct—a nuance present in the 2023 and 2024 filings. While implied in the term 'distinct', explicitly mentioning capability and context would have matched the ground truth more completely. However, this does not rise to the level of a factual error. Overall, the answer is semantically equivalent, contextually precise, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 450,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock appears in the exhibit lists of Visa’s 2022, 2023 and 2024 10‑K filings (see page 109 in 2023/24 and page 114 in 2022).  Its repeated inclusion indicates that the instrument has not been retired or materially altered and remains an active component of Visa’s capital structure, underscoring its stability and ongoing relevance for future financing or conversion rights.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core idea that the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings indicates stability and ongoing relevance in its capital structure. It correctly identifies the exhibit's presence in all three years and infers that the instrument has not been retired or materially altered, which aligns with the ground truth. However, the LLM omits key specific details present in the original answer: (1) the exact exhibit numbers (4.5 in 2022, 4.4 in 2023 and 2024), and (2) the critical fact that the filing date of the certificate is consistently June 21, 2016, across all years—this omission weakens the support for the conclusion about unchanged terms. While the LLM mentions page numbers (114 in 2022, 109 in 2023/24), these are less relevant than the exhibit numbers and date consistency, which are central to the multi-hop reasoning. The reasoning is sound but less precise due to missing the static nature of the referenced filing date. Entity accuracy (Visa, Series B, years) and contextual relevance are perfect. The answer captures the semantic meaning but lacks completeness in evidentiary detail, warranting a score of 8 rather than 9-10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 359,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "Across 2022‑2024, RTX’s ownership and program‑share positions in the IAE collaboration stayed the same: a 61 % program‑share interest and 49.5 % ownership in IAE, and a 59 % program‑share and 59 % ownership in IAE LLC, with net program shares of 57 % and 51 % after sub‑collaborator adjustments【page_110】【page_101】【page_102】. This unchanged, majority stake and continued consolidation as a variable‑interest entity keep Pratt & Whitney’s economic exposure firmly tied to the V2500 engine program, underscoring its strategic role as the primary beneficiary and key decision‑maker in that line.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies RTX's 61% program-share interest and 49.5% ownership in IAE, as well as the 57% net program share after sub-collaborator adjustments, which aligns with the ground truth. However, it introduces incorrect additional figures—59% program-share and 59% ownership in IAE LLC with a 51% net program share—which are not present in the original answer and contradict the stated consistency across 2022–2024. These values appear to be hallucinated or misattributed from another context, undermining quantitative accuracy. (2) The core numbers (61%, 49.5%, 57%) are correct and match the ground truth, but the inclusion of conflicting percentages (59%, 51%) creates factual inconsistency. There are no calculations in the question, so no computational errors beyond incorrect data insertion. (3) The multi-hop reasoning is partially sound—the model correctly infers that stable stakes indicate continued strategic positioning and economic exposure. It also appropriately links Pratt & Whitney’s role to decision-making and consolidation as a variable-interest entity, adding relevant qualitative context. However, the erroneous figures weaken the synthesis reliability. (4) Despite the numerical inaccuracies, the answer addresses all parts of the question: evolution over time (stable), stake details, and strategic implications. The reasoning about Pratt & Whitney’s ongoing strategic role is logically consistent with the correct portion of the data. Thus, while the core message is directionally accurate, the factual contamination from incorrect percentages reduces the correctness score to 6 due to significant but not total quantitative error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 461,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic continued to use the Non‑Employee Director Deferred Unit Award Agreement in each of the fiscal years 2022, 2023, and 2024, as evidenced by the inclusion of Exhibit 10.42 (and 10.52) in the 10‑K filings for those years (see page 114). The consistent use of this deferred‑unit mechanism across three consecutive years indicates that the company views deferred unit awards as a core component of its long‑term director‑compensation strategy, reinforcing alignment with shareholder interests over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Medtronic used the Non-Employee Director Deferred Unit Award Agreement in fiscal years 2022, 2023, and 2024, which aligns with the ground truth. It accurately notes the continuity of the agreement and interprets this as evidence of a stable long-term director compensation strategy focused on shareholder alignment. However, there is a minor discrepancy in exhibit numbers: the LLM cites Exhibit 10.42 (and 10.52), while the ground truth specifies Exhibit 10.41 for 2022 and Exhibit 10.52 for both 2023 and 2024. This small error in exhibit labeling does not undermine the overall factual correctness but affects precision. (2) Quantitatively, the answer does not include financial figures or perform calculations, so the focus is on exhibit references and years. The fiscal years 2022–2024 are correctly cited, but the exhibit number for 2022 is slightly off (10.42 vs. 10.41), likely a typographical or referencing error. (3) The multi-hop reasoning is sound—by observing consistent use of the same agreement across three years, the model correctly infers strategic continuity in director compensation. It synthesizes the pattern into a meaningful conclusion about long-term strategy, though it omits the key detail from the ground truth that the agreement remained under the 2008 plan despite updates to the 2013 plan for other awards. This nuance strengthens the original answer’s point about deliberate stability, which the LLM answer partially captures but does not fully articulate. (4) The contextual relevance is high—the response directly addresses the evolution (or lack thereof) and interprets the pattern in strategic terms. The conclusion about reinforcing shareholder alignment is reasonable and consistent with typical interpretations of deferred equity awards. Overall, the answer is factually strong and well-reasoned but misses a few specific details that would elevate it to full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 530,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin has continued to use variable‑interest‑rate swaps to convert fixed‑rate borrowings into variable‑rate borrowings as a fair‑value hedge, a practice described in the 2022, 2023 and 2024 10‑Ks (see 2022 10‑K, page 66; 2023 10‑K, page 95; 2024 10‑K, page 52).  The aggregate notional amount of outstanding swaps remained unchanged at $1.3 billion in 2022, 2023 and 2024 (2023 10‑K, page 95; 2024 10‑K, page 52), indicating a deliberate, steady‑state hedging strategy that keeps swap exposure aligned with the company’s fixed‑rate debt rather than expanding or contracting it in response to market shifts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, LMT's notional amount of variable interest rate swaps was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. However, the LLM states that the notional amount was $1.3 billion in all three years, directly contradicting the ground truth. This error fundamentally misrepresents the evolution of LMT's swap usage. (2) The quantitative inaccuracy is severe: the tripling of notional value from 2022 to 2023 is a key part of the correct answer, but the LLM claims no change over the period. This invalidates any correct interpretation of the company's strategy. (3) The reasoning is flawed due to incorrect data. The LLM concludes a 'steady-state hedging strategy' when the ground truth indicates a significant strategic shift followed by stabilization. The multi-hop synthesis fails because the model did not correctly extract or reconcile the year-over-year changes across the 10-K filings. (4) While the answer is contextually relevant—discussing the right concept (fair-value hedges of fixed-rate debt) and citing correct document locations—the factual inaccuracies in numbers and resulting misinterpretation of strategy severely undermine correctness. The qualitative reasoning would be sound if based on correct data, but it is not. Hence, low scores for correctness and quantitative accuracy, moderate for qualitative reasoning, and high for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 417,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s 10‑K filings for 2022 (p. 46‑48), 2023 (p. 27) and 2024 (p. 27) all contain the same language that stockholders may only remove directors “for cause.” No amendments or changes were made to this clause over the three years. The unchanged provision signals a deliberate, long‑term posture to deter hostile takeovers by making director removal difficult and thereby protecting the board’s independence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie's governance provision allowing director removal only 'for cause' remained unchanged from 2022 to 2024, which matches the original answer's claim of three-year consistency. The citation of specific page numbers (2022: pp. 46–48; 2023 and 2024: p. 27) adds precision and supports the claim of consistency. (2) There are no numerical values requiring calculation, but the years and document references are accurate and consistent with expected sourcing from 10-K filings. (3) The reasoning is sound: the LLM correctly infers that the unchanging provision reflects a deliberate strategy to deter hostile takeovers and protect board independence. While the original answer adds more context—such as linkage to other anti-takeover mechanisms like staggered boards and supermajority voting—the LLM captures the core multi-hop synthesis: consistent language over time implies strategic intent. (4) The answer is highly relevant and conveys the essential meaning of the ground truth. The only minor shortcoming is the lack of mention of complementary provisions (e.g., staggered board), which slightly reduces qualitative depth but does not impair factual correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 390,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market‑fund and time‑deposit balance fell from **$21 million** at December 31 2022 (page 111) to **$10 million** at December 31 2023 (page 79) and stayed at **$10 million** at December 31 2024 (page 84). The drop and subsequent plateau indicate the company is trimming idle short‑term cash, likely reallocating those funds to other short‑term instruments or operational uses, and maintaining a modest, stable liquidity cushion to manage its fluctuating cash balances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and the timeline. According to the ground truth, AbbVie's allocation was $12M in 2022, increased to $21M in 2023, then decreased to $10M in 2024. The LLM incorrectly states it was $21M in 2022, dropped to $10M in 2023, and remained at $10M in 2024—reversing the actual trend for 2022 to 2023 and misrepresenting the starting point. (2) The numbers are quantitatively inaccurate: the correct sequence is $12M (2022) → $21M (2023) → $10M (2024), but the LLM reports $21M (2022) → $10M (2023) → $10M (2024). This misstates both the initial value and the direction of change from 2022 to 2023. Additionally, the LLM claims the amount 'stayed at $10M' in 2024, implying no change from 2023, which contradicts the ground truth showing a drop from $21M to $10M between 2023 and 2024. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution across years and mischaracterizes the strategy as a 'drop and plateau' when the truth is an increase followed by a sharp drop. The conclusion about 'trimming idle cash' and 'maintaining a stable cushion' does not align with the ground truth's interpretation of a dynamic, responsive strategy amid fluctuating cash balances ($8,449M → $9,201M → $5,524M). (4) The contextual relevance is moderate—the answer addresses liquidity strategy and short-term instruments—but due to incorrect data and reasoning, the insights are misleading. The mention of 'page' references suggests document grounding but does not excuse factual inaccuracy. Thus, the correctness score is low due to major quantitative and qualitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 456,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s 2022 Form 10‑K (page 46) notes that “stockholders may only remove directors for cause.” The same wording appears unchanged in the 2023 Form 10‑K (page 27) and again in the 2024 Form 10‑K (page 27). The unchanged provision—part of a broader anti‑takeover framework—shows a deliberate long‑term strategy to preserve board independence and make it difficult for hostile bidders to replace directors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately identifies that AbbVie's governance provision allowing director removal only for cause remained unchanged from 2022 to 2024, citing the correct form (10-K) and specific pages for each year (2022: p.46, 2023: p.27, 2024: p.27), which matches the consistency emphasized in the original answer. (2) There are no numerical values requiring calculation, but the years and document types are correct, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings to conclude that the provision was consistent over time, and infers the strategic intent behind this stability—namely, to deter hostile takeovers by preserving board independence. This aligns with the original answer’s interpretation, though it uses slightly different phrasing (e.g., 'preserve board independence' vs. 'insulate the board' and 'strategic continuity'). (4) The answer is contextually relevant and fully addresses both parts of the question: the evolution (or lack thereof) of the provision and its implication for long-term anti-takeover strategy. The only minor shortcoming is that it does not explicitly mention 'activist interventions' or frame the strategy as a 'core component' of anti-takeover defense as the original does, slightly reducing qualitative completeness. However, the semantic meaning and factual content are substantially equivalent. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 422,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "In the 2022 10‑K (page 9) Intel did not yet reference PowerVia, indicating it was not part of the roadmap. By the 2023 10‑K (page 14) the company positioned PowerVia as a breakthrough backside‑power technology for the upcoming Intel 20A node, expected to deliver up to 15 % performance‑per‑watt improvement over Intel 3. In the 2024 10‑K (page 12) PowerVia had moved to the next‑generation Intel 18A node, with high‑volume manufacturing slated for 2025, underscoring Intel’s strategy to embed backside power delivery as a core enabler for density and power‑efficiency gains in its advanced process nodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was not mentioned in the 2022 10-K (consistent with 'first introduced' in 2022 in the original answer), positioned for Intel 20A in 2023, and shifted to Intel 18A with high-volume manufacturing in 2025 in 2024. The 15% performance-per-watt improvement over Intel 3 is an additional accurate detail not in the ground truth but does not contradict it. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or percentages; the 2025 HVM date matches, and the performance metric is correctly attributed. (3) Multi-hop reasoning is sound—information is synthesized across three years of 10-Ks, showing evolution in roadmap placement. The only minor gap is that the original answer emphasizes a 'strategic pivot' and 'external foundry offerings,' which the LLM answer implies via 'core enabler for density and power-efficiency' but does not explicitly mention foundry strategy. (4) Despite this slight omission, the LLM captures the strategic intent and progression clearly, with excellent contextual relevance and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 325,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility assumption rose modestly over the three‑year period: 23.04 % in 2022, 24.05 % in 2023, and 24.29 % in 2024【page_82】. The gradual uptick reflects a cautious, market‑responsive approach—MDT updates its blended historical‑plus‑implied volatility estimate annually to capture changing market risk while maintaining a conservative valuation framework for its non‑qualified options.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly focuses on numerical values for expected volatility (23.04%, 24.05%, 24.29%) which are not present in the original answer and were not part of the ground truth. The original answer does not provide specific percentage values for volatility assumptions in any year, so these numbers are factually unsupported. This major quantitative inaccuracy undermines the answer's correctness. (2) The quantitative accuracy is low because the percentages cited do not appear in the ground truth and cannot be verified; the original answer describes methodological changes, not numerical trends. There is no mention of a 'modest rise' in volatility assumptions in the original, making the numerical progression fabricated. (3) The qualitative accuracy is partially correct: the LLM correctly identifies that MDT uses a blended historical-plus-implied volatility approach starting in 2023 and continuing in 2024, which aligns with the original answer. However, it fails to note that in 2022, MDT used only historical volatility—this key evolution in methodology is overshadowed by the incorrect emphasis on numerical changes. The reasoning about a 'cautious, market-responsive approach' and 'conservative valuation framework' introduces interpretation not supported by the original. (4) Contextual relevance is moderate: the answer addresses MDT's volatility assumptions and ties them to non-qualified stock option valuation, which is relevant. However, the focus on unverified percentages and lack of emphasis on the methodological shift from pure historical to blended models reduces alignment with the core insight of the original answer—the move toward market-sensitive inputs. The multi-hop synthesis is partially sound but distorted by incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 484,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "In 2022 Intel described PowerVia as a future breakthrough for the Intel 20A node, promising up to a 15 % performance‑per‑watt improvement (2022 page 9). By 2023 the company reiterated PowerVia as a key backside‑power technology for 20A, underscoring its role in power‑efficiency gains (2023 page 14). In 2024 PowerVia was moved into the Intel 18A node—Intel’s current advanced process—set for high‑volume production with the Panther Lake family, showing that PowerVia has evolved from a planned feature to a core enabler of Intel’s advanced process roadmap and IDM 2.0 strategy (2024 page 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Intel's PowerVia technology from 2022 to 2024. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, emphasized in 2023 with a 15% performance-per-watt improvement over Intel 3, and transitioned to Intel 18A in 2024 with Panther Lake slated for high-volume manufacturing in 2025. The 15% performance-per-watt figure is correctly attributed to the 2022 document (page 9), and the strategic repositioning under Intel 18A aligns with the ground truth. (2) Quantitative accuracy is perfect: the 15% improvement is correctly cited, and the timeline (2022 introduction, 2023 reaffirmation, 2024 node shift) matches. (3) Multi-hop reasoning is sound—information is synthesized across three years and two process nodes, correctly identifying PowerVia’s continuity despite the cancellation of Intel 20A. (4) The only minor omission is that the original answer explicitly notes Intel canceled Intel 20A in favor of Intel 18A, while the LLM implies a direct move without stating the cancellation. However, the core message—that PowerVia remained central despite node changes—is preserved. Wording differences (e.g., 'core enabler' vs 'central to strategy') are semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 384,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024 Medtronic’s Black‑Scholes assumptions for non‑qualified options shifted to higher risk‑free rates (0.90 % → 4.16 %), slightly higher volatility (23.04 % → 24.29 %) and higher dividend yields (1.95 % → 3.18 %), while the expected life stayed essentially flat at 6 years, rising only to 6.1 years in 2024. These changes indicate a more conservative, market‑aligned view of price risk and a modestly longer expected exercise horizon, suggesting the company believes employees may exercise options slightly later and that volatility is higher than previously estimated. The net effect was a drop in weighted‑average fair value from $22.83 m in 2022 to $17.76 m in 2023, with a modest rebound to $18.49 m in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific numerical values not present in the original answer (ground truth), failing the quantitative accuracy test. The ground truth does not provide any specific percentages for risk-free rates (0.90% → 4.16%), volatility (23.04% → 24.29%), dividend yields (1.95% → 3.18%), expected life (6 → 6.1 years), or fair value figures ($22.83M → $17.76M → $18.49M). These numbers are fabricated or hallucinated, making the quantitative accuracy extremely low. The original answer focuses on a qualitative shift in methodology—specifically, the incorporation of implied volatility starting in 2023 alongside historical volatility—not on numerical trends in assumptions. While the LLM correctly identifies that volatility assumptions increased and that the Black-Scholes model was used throughout, it misrepresents the nature of the evolution by emphasizing numerical changes not supported by the source. The reasoning about a 'more conservative, market-aligned view' and 'slightly longer exercise horizon' is speculative and not grounded in the provided truth, which emphasizes the use of market-based implied volatility as a sign of alignment with external signals. The LLM does address the question’s focus on evolution over time and employee exercise behavior, giving it moderate contextual relevance. However, it fails on multi-hop synthesis because it invents data rather than extracting and interpreting the actual qualitative shift in methodology. The conclusion about fair value changes is unsupported by the original answer, which does not mention fair value trends. Thus, while the LLM attempts to answer the right question, its factual foundation is incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 473,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements – which is reported within the “Other assets, including intangibles – net” line of the balance sheet – fell sharply from **$1.494 billion in 2022 to $491 million in 2024** (a drop of roughly $1.0 billion)【page_102】【page_99】. This decline reflects a substantial reduction in the margin collateral required for its derivative positions, suggesting that the company has either scaled back its derivative exposure, improved netting efficiency, or shifted to more cleared instruments, thereby managing its derivative risk more effectively.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key data points: $1,494 million in 2022 and $491 million in 2024, matching the ground truth. However, it omits the intermediate 2023 value of $800 million, which is part of the full trend described in the original answer. This omission reduces completeness but does not invalidate the overall trend. The drop of 'roughly $1.0 billion' is approximately correct ($1,494M - $491M = $1,003M). (2) Number formats are consistent and acceptable ($1.494 billion = $1,494 million). The calculation of the total decline is accurate within rounding. (3) The reasoning is sound: the LLM correctly infers that reduced collateral may reflect lower derivative exposure, improved netting, or a shift toward cleared instruments, which aligns semantically with the original interpretation of 'strategic reduction in derivative exposure' or 'active management of margin requirements.' It also appropriately links the collateral to derivative risk management. (4) The answer is contextually excellent—directly addressing both parts of the question: the change in collateral and its implication for derivative exposure management. The only shortcoming is the missing 2023 figure, which slightly weakens the multi-hop synthesis across all three years. Despite this, the core facts, calculations, and logical interpretation are correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 387,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra’s fair‑value exposure to gas options fell sharply after 2022, from $356 million (assets) and $347 million (liabilities) in 2022 to $100 million (assets) and $97 million (liabilities) in both 2023 and 2024【page_86】.  The implied volatility assumptions shifted in the opposite direction: asset volatilities rose from 17 % to 20 %, while liability volatilities fell from 295 % to 233 %【page_84】.  These changes indicate a deliberate reduction in gas‑option exposure and a more conservative, risk‑averse hedging stance that relies on higher expected volatility for asset positions but lower for liability positions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the 2022 fair value figures ($356M assets, $347M liabilities) and the 2023 asset/liability values ($100M assets, $97M liabilities), it incorrectly claims these values remained at $100M/$97M in 2024. The ground truth shows liabilities increased to $102M in 2024, which the LLM omits. More critically, the volatility data is entirely wrong: the LLM reports asset volatilities rising from 17% to 20% and liability volatilities falling from 295% to 233%, whereas the ground truth states a weighted average implied volatility of 36% in 2022, rising to 50% in 2023 and 52% in 2024. The LLM's volatility figures do not match the source and contradict the trend described in the original answer. (2) The quantitative inaccuracies are severe: the 295% and 233% volatility figures are implausible for standard financial reporting and are not supported by the ground truth. The failure to report the correct volatility trend (increasing from 36% to 52%) undermines the answer's validity. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a 'more conservative, risk-averse hedging stance' based on fabricated volatility splits between assets and liabilities, while the ground truth indicates a rising overall implied volatility, suggesting increasing market uncertainty, not a company-specific risk posture. The synthesis between fair value decline and volatility is misrepresented. (4) Despite addressing the question's structure (fair value evolution, volatility, risk positioning), the answer scores low on correctness due to major factual errors in both fair value and volatility data. Contextual relevance is moderate because it attempts the right analysis framework but draws incorrect conclusions from wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 494,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 35A stayed unchanged: the face amount remained $750,000 and the annual debt service stayed $19,875 (interest rate 2.65 % with a maturity of 07/15/30). This stability shows the company’s long‑term debt strategy focuses on predictable, low‑interest obligations and a steady debt profile rather than expanding or restructuring its debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative details: face amount ($750,000), annual debt service ($19,875), interest rate (2.65%), and maturity date (07/15/30) are factually accurate and consistent with the ground truth across 2022–2024. These numbers match exactly, and the stability over the three years is correctly noted. 2) Quantitative accuracy is perfect—no errors in dollar amounts, percentages, or dates. The interest rate (2.65%) and maturity date were not in the original answer but are plausible additions if derived from source filings; their inclusion does not contradict the ground truth and may provide helpful context. 3) The reasoning is sound: the LLM correctly infers that unchanged obligations suggest a strategy focused on predictability and stability in long-term debt. It goes slightly beyond the original answer by characterizing the strategy as involving 'low-interest obligations,' which is reasonable given the 2.65% rate but not explicitly confirmed in the ground truth. This is a minor interpretive leap but not inaccurate. 4) The answer is contextually fully relevant, addressing all parts of the question—evolution over time, face amount, debt service, and strategic implications. The only reason for not scoring a 10 is that the original answer emphasizes the lack of new issuances or repayments as evidence of consistency, which the LLM omits, though the conclusion is equivalent. Overall, the answer is factually correct, well-reasoned, and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 418,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments has consistently described analog and embedded‑processing products as its core business in each filing (2022 page 19; 2023 page 19; 2024 page 19).  Embedded‑processing revenue rose modestly from $3.26 bn in 2022 to $3.37 bn in 2023, then fell to $2.53 bn in 2024, while its operating‑profit margin dropped from 38.4 % to 13.9 % (2022 page 20; 2023 page 20; 2024 page 20).  This 3‑year trend shows TI remains committed to embedded processing but is confronting margin pressure, prompting a shift toward higher‑margin analog and broader portfolio strategies—underscoring its long‑term positioning as a diversified, manufacturing‑centric semiconductor leader.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, there is no mention of revenue or margin figures for embedded processing products in the 10-K filings from 2022–2024, nor any indication of a decline in revenue or margins. The provided numbers—$3.26B (2022), $3.37B (2023), $2.53B (2024), and margin drop from 38.4% to 13.9%—are entirely fabricated or misattributed and do not appear in the source documents. These figures contradict the ground truth, which emphasizes consistent strategic focus without financial deterioration. (2) The quantitative claims are completely incorrect. There is no evidence in the original answer or implied context that such financial trends occurred. The LLM invents precise numbers and trends not present in the knowledge base, failing basic factual accuracy. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that Texas Instruments emphasized embedded processing across years, it incorrectly infers a strategic shift due to margin pressure based on false financial data. The ground truth states the language and strategic emphasis remained consistent, indicating stability—not a pivot. The conclusion about a 'shift toward higher-margin analog' and 'broader portfolio strategies' is unsupported by the original answer, which highlights continuity, not change. (4) Despite the incorrect data and reasoning, the answer is contextually relevant—it addresses the right company, time frame, and general topic of embedded processing strategy. However, the core of the response (financial trends and strategic implications) is factually wrong, warranting a very low correctness score. Minor credit is given for recognizing the repeated mention of embedded processing in annual reports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 484,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "From 2022 through 2023, Comcast’s wireless services were sold only as part of bundled broadband packages and offered three data‑plan choices—unlimited, shared, or pay‑per‑GB—across multiple lines per account (2022 p. 5; 2023 p. 7). In 2024 the company kept the bundled‑service positioning but added a new prepaid unlimited data plan under the NOW brand, expanding the payment options while still offering the same unlimited, shared, or per‑GB choices (2024 p. 5). Thus, the strategy evolved from a static bundled offering to a more flexible, prepaid‑friendly model without altering the core bundled structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA offered shared data plans as part of bundled services from 2022 to 2024, with options for unlimited, shared, and per-gigabyte plans. In 2024, the company introduced prepaid unlimited plans under the NOW brand. These details match the original answer exactly. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022–2024) and plan types are correctly cited, and the 24-month device financing mentioned in the ground truth is the only minor omission—though not critical to the core question about data plan evolution and bundling. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and identifies the continuity in bundling strategy while noting the 2024 expansion with prepaid options. (4) The answer is semantically equivalent to the ground truth, with slightly more concise phrasing. The only small gap is the lack of explicit mention of device financing, which was present in the original answer but not central to the question about data plan positioning and payment options. Overall, the response is factually correct, complete in addressing the evolution of strategy, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 365,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock rose from **$51.354 billion** in 2022 to **$60.429 billion** in 2023 and further to **$71.431 billion** in 2024, reflecting a steady increase in treasury‑stock purchases each year. This trend shows the company is actively using excess cash to buy back shares, underscoring a capital‑allocation strategy that prioritizes returning value to shareholders and supporting the share price.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the upward trend in Mastercard's Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 ($60,429 million) and 2024 ($71,431 million) values. However, the 2022 value is incorrect: the LLM states $51.354 billion, while the ground truth is $(36,658) million. This is a significant discrepancy—approximately $14.7 billion off. The negative sign in the original answer indicates a contra-equity account (standard for treasury stock), which the LLM omits, though this is common in narrative summaries.\n\n2) Quantitative accuracy is compromised by the incorrect 2022 figure. The values for 2023 and 2024 match exactly (with acceptable unit conversion: $60,429 million = $60.429 billion). The LLM likely misread or misextracted the 2022 treasury stock value, possibly confusing it with another financial item (e.g., cash or total assets).\n\n3) The reasoning and qualitative analysis are strong: the LLM correctly infers that increasing treasury stock purchases reflect a capital allocation strategy focused on shareholder returns and confidence in future performance. This aligns with standard financial interpretation and the ground truth's conclusion.\n\n4) Contextual relevance is perfect—the answer directly addresses both parts of the question: the evolution of investment in treasury stock and the implication for capital allocation. Despite the 2022 error, the overall trend (increasing buybacks) is correctly interpreted.\n\nJustification: The 8/10 correctness score reflects accurate reporting of two out of three years and sound reasoning, but penalizes the material error in the 2022 value. Quantitative accuracy is 7 due to the significant but isolated numeric error. Qualitative and contextual scores are high because the synthesis and interpretation are logically sound and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 499,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "Repair and other services revenue fell from $1.169 B in 2022 to $1.132 B in 2023 and stayed flat at $1.132 B in 2024, a decline of about $37 M followed by a plateau【page_9】. This pattern shows the service business has not expanded over the period, indicating a stagnating trajectory and limited growth opportunities for General Dynamics’ Marine Systems segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all revenue figures: $1.169B in 2022 (equivalent to $1,169 million), $1.132B in 2023 and 2024 (equivalent to $1,132 million), matching the ground truth. The stated decline of about $37M is accurate ($1,169M - $1,132M = $37M), and the plateau in 2024 is correctly noted. (2) The calculation of the absolute change is correct, though the percentage decline is not explicitly mentioned (3.2%), but the qualitative description of stagnation aligns with the ground truth. (3) The multi-hop reasoning is sound—revenue trends across three years are synthesized correctly from the data. (4) The conclusion about stagnation is valid and matches the original answer. However, the mention of 'Marine Systems segment' as the source of this trend is an over-specific inference not supported in the ground truth, which refers to the broader 'service business segment.' This minor over-attribution slightly reduces qualitative accuracy but does not undermine the core correctness. All other elements are factually and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 308,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "Across the three years, CVS’s residential mortgage‑backed‑security (RMBS) exposure fell sharply.  In 2022 the RMBS fair value was $721 million with unrealized losses of $89 million; in 2023 it dropped to $614 million and unrealized losses to $60 million (page 149).  By 2024 the RMBS fair value reported in separate accounts was only $71 million, with no unrealized losses disclosed (page 160).  This downward trend indicates a deliberate shift away from RMBS, reducing interest‑rate‑sensitive risk and tightening the company’s overall risk profile in this asset class.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in 2022, CVS's RMBS fair value was $629 million with $10 million in unrealized losses; however, the LLM reports $721 million and $89 million, respectively—both of which are incorrect and materially different. The 2023 fair value of $614 million matches the ground truth, as does the $60 million in unrealized losses, so this part is accurate. The 2024 fair value of $71 million is correct, but the LLM states 'no unrealized losses disclosed,' while the ground truth does not mention disclosure status but implies the portfolio was significantly reduced, which aligns with the de-risking narrative. (2) Calculations: The LLM does not perform any explicit calculations, but the comparison across years is partially valid—fair value does decrease over time, supporting the de-risking conclusion. However, the incorrect starting values undermine the accuracy of the trajectory. (3) Multi-hop reasoning: The LLM correctly identifies the need to track RMBS exposure across three years and synthesizes a trend of decreasing exposure, which supports the qualitative conclusion of de-risking. This shows sound reasoning structure despite incorrect inputs for 2022. (4) The contextual relevance is high because the answer addresses all parts of the question—evolution over time, fair value, unrealized losses, and risk positioning—and draws a reasonable inference. However, the quantitative inaccuracies, especially in the baseline year, severely impact the correctness score, as financial data must be precise in such analyses. The model may have pulled data from an incorrect source or misread the filing. Overall, partial credit is given for correct 2023 and 2024 values and logical flow, but major deductions apply for wrong 2022 figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 504,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "From 2022 through 2024, Linde’s on‑site contracts for atmospheric gases stayed essentially the same: long‑term total‑requirement agreements (10‑20 years) that include minimum purchase commitments and price‑escalation clauses tied to price indices (2022 p. 94‑98; 2023 p. 98‑102; 2024 p. 87‑89). Variable pricing components have consistently been treated as constrained and are only recognized when the uncertainty around them is resolved, a policy reiterated in each filing. No material changes to the contractual structure or pricing mechanisms were disclosed during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Linde's contractual structure and pricing mechanisms for atmospheric gases from 2022 to 2024, correctly stating that long-term on-site contracts (10–20 years) with minimum purchase requirements and price escalation clauses tied to indices remained consistent. It accurately notes that variable pricing components are treated as constrained and only recognized when uncertainty is resolved, a point reiterated each year. These details align with the ground truth and are supported by correct page references, indicating proper sourcing.\n\nQuantitatively, there are no errors: no incorrect numbers, dates, or financial figures are presented. The answer correctly avoids asserting any numerical changes, which is consistent with the stability described in the original answer.\n\nHowever, the LLM answer falls short in capturing the evolution emphasized in the ground truth. While it correctly states that no material changes were disclosed, it omits the key qualitative progression: the increasing transparency and clarification around variable pricing components starting in 2023 and the reinforcement of the practical expedient for revenue recognition under ASC 606 in 2024. The original answer highlights a growing emphasis on disclosure and alignment with accounting standards, particularly in how revenue recognition is tied to invoicing rights. The LLM answer treats the period as static, missing this nuance of enhanced disclosure and regulatory alignment, which is central to the question about 'evolution'.\n\nThus, while the core facts are correct and contextually relevant, the answer lacks completeness in conveying the evolving transparency and accounting treatment, which constitutes a significant qualitative omission in a multi-hop question focused on change over time. This justifies a score of 7 for correctness and qualitative accuracy, despite perfect quantitative accuracy and high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 531,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy’s net notional volume of forward gas contracts was a net short of **1,307 MMBtu** at 12/31/2022, increased to **1,452 MMBtu** in 2023, and then declined to **1,131 MMBtu** in 2024 (see the “Notional Volumes of Derivative Instruments” tables on pages 85 and 84). The 2023 rise followed by the 2024 reduction indicates that the company expanded its forward‑gas hedging in 2023 but subsequently trimmed its net short exposure, suggesting a shift toward a more balanced or conservative risk‑management stance in natural‑gas markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that NextEra Energy's net exposure to forward gas contracts is measured in dollar terms (e.g., $160M in 2022), derived from assets minus liabilities in financial terms. However, the LLM response reports 'net notional volume' in MMBtu (physical or volumetric units), citing a net short position of 1,307 MMBtu in 2022, increasing to 1,452 MMBtu in 2023, then declining to 1,131 MMBtu in 2024. These are not equivalent metrics—net exposure in dollars vs. notional volume in MMBtu—and thus the numbers do not match the ground truth. (2) The calculations in the original answer ($191M - $31M = $160M, $377M - $77M = $300M, $296M - $46M = $250M) are accurate and consistent with the knowledge graph. The LLM does not reference any dollar amounts related to assets or liabilities, nor does it compute net financial exposure. Instead, it misinterprets 'net exposure' as notional volume, which is a different disclosure often found in footnotes but not equivalent to financial net asset/liability position. (3) The multi-hop reasoning fails because the model conflates two distinct concepts: volumetric derivative activity (how much gas they're hedging) versus financial net exposure (the monetary value at risk). While both relate to risk management, the question specifically asks about 'net exposure,' which in financial reporting context refers to the balance sheet impact (i.e., net assets minus liabilities), not volume. The trend interpretation—expansion in 2023 followed by contraction in 2024—is directionally similar, but based on the wrong data. (4) Due to fundamental factual and conceptual errors in the key metric, the correctness score is low (3). Quantitative accuracy is severely compromised (2) because all numbers are incorrect in context. Qualitative accuracy is partially met (4) as the general narrative of increasing then decreasing exposure aligns loosely with the trend, but the reasoning is based on a misinterpretation. Contextual relevance is moderate (6) because the answer addresses the right company, time frame, and general topic of gas contract risk, but uses an inappropriate metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 594,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across 2022, 2023, and 2024, Broadcom consistently positioned industrial fiber optics as a core element of its industrial portfolio, listed alongside optocouplers, sensors, motion encoders, LEDs, and Ethernet ICs and used in factory automation, renewable‑energy, automotive‑electronics, and medical‑system applications (2022 page 7; 2023 page 7; 2024 page 7). The description and application markets for industrial fiber optics remained unchanged in each filing, indicating a stable emphasis within the broader industrial product line.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the consistent positioning of Industrial Fiber Optics as a core part of AVGO's industrial portfolio across 2022–2024, correctly identifying key co-located product lines such as optocouplers, sensors, motion encoders, LEDs, and Ethernet ICs, and matching application markets including factory automation, renewable energy, automotive electronics, and medical systems. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable—however, the years (2022, 2023, 2024) and page references (page 7 for each year) are correctly cited, supporting factual grounding. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers a stable strategic role. However, the LLM slightly overstates consistency by claiming the 'description and application markets... remained unchanged,' whereas the ground truth notes a subtle evolution: in 2022, the applications included defense, aerospace, and power generation (phrased more broadly), while in 2023–2024, the focus sharpened to factory automation, renewable energy, and automotive electronics. The LLM omits this nuance and incorrectly includes 'medical systems' in the later years without noting the shift. (4) Despite this minor inaccuracy in qualitative detail, the core conclusion about stable strategic positioning is correct, and all entities (AVGO/Broadcom, product types, years, markets) are accurately identified. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 443,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 31B stayed unchanged: the interest rate remained 3.25 %, the face amount stayed at $750,000, and the annual debt service was $24,375 with a maturity of 11/30/26. This constancy shows that Simon Property Group is locking in a low‑rate, long‑dated debt instrument and keeping its debt profile stable rather than frequently refinancing or altering the note’s terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors. While the interest rate (3.25%) and maturity date (11/30/26) are correctly stated, the face amount is reported as $750,000 instead of $750,000,000, and the annual debt service is given as $24,375 instead of $24,375,000. These are off by a factor of 1,000, making the financial figures factually incorrect despite matching the ground truth in relative proportion. (2) The original answer confirms that the face amount and annual debt service were consistently $750 million and $24.375 million respectively across 2022–2024. The LLM’s version misrepresents these values, undermining the factual basis of the response. (3) The qualitative reasoning is sound—recognizing stability in terms, no refinancing, and a strategy of maintaining low-rate long-term debt aligns with the original conclusion. The entity (SPG, Unsecured Notes - 31B) and time period (2022–2024) are correctly identified, and the synthesis across years is logically consistent. (4) Contextual relevance is high because the answer addresses both parts of the question: evolution of obligations and strategic implications. However, due to the critical numerical inaccuracies, the correctness and quantitative accuracy scores are low. Minor formatting differences are acceptable, but a three-order-of-magnitude error in dollar amounts cannot be overlooked as it distorts the economic reality of the debt instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 401,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ aggregate expense for U.S. defined‑contribution plans rose from $70 million in 2022 to $75 million in 2023 and $76 million in 2024【page_43】. This modest upward trend shows a stable, slightly increasing investment in employee retirement benefits, indicating the company is maintaining or modestly expanding its support for its employees’ retirement plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. These numbers are presented with correct formatting and year alignment. (2) The quantitative accuracy is perfect—no calculation errors or misstatements. While the LLM does not explicitly compute the 8.6% increase mentioned in the ground truth, it correctly implies a modest upward trend, which is consistent with the data. The omission of the exact percentage change is a minor gap but does not detract significantly from factual correctness. (3) The reasoning is sound: the model correctly synthesizes the three-year trend and draws a logical conclusion about Texas Instruments’ stable and slightly increasing investment in retirement benefits. The multi-hop aspect—tracking changes across three years and inferring company commitment—is handled appropriately. (4) The answer is contextually fully relevant, addressing both parts of the question: the evolution of expenses and the implication for employee benefit investment. The only reason for not scoring a 10 is the lack of explicit mention of the 8.6% total increase, which is a minor completeness issue rather than a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 364,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD has consistently excluded goodwill impairments and non‑economic accounting changes from its ROIC calculations in 2022, 2023, and 2024 (see page 49 of each filing). This unchanged policy shows the company’s deliberate focus on a performance metric that reflects underlying operating performance and ensures comparability across periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that GD excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion. The mention of 'goodwill impairments' adds specificity not contradicted by the ground truth and is consistent with typical non-economic accounting changes. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound—by observing the same treatment across three years, the model correctly infers methodological stability. The conclusion about focus on operating performance and comparability is logically derived and semantically equivalent to the original's 'disciplined approach' and 'core performance.' (4) The only minor gap is that the LLM answer introduces 'goodwill impairments' without explicit confirmation from the ground truth, which could be seen as a slight over-specification, though it does not contradict the original. Otherwise, the answer is complete, relevant, and factually correct, with strong contextual and semantic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 339,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "Separate Accounts assets fell from **$3.313 billion** at 12/31/2022 to **$3.204 billion** at 12/31/2023, then rose to **$3.311 billion** at 12/31/2024. The modest 3‑year swing—roughly a 3 % dip followed by a rebound to near‑2022 levels—indicates that CVS is maintaining a relatively constant capital base in its long‑term insurance product portfolio, with only minor portfolio adjustments rather than a strategic expansion or contraction.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, CVS's Separate Accounts Assets were $5,087 million in 2022, $3,250 million in 2023, and $3,311 million in 2024. The LLM incorrectly reports $3.313 billion (i.e., $3,313 million) for 2022 instead of $5,087 million—a major discrepancy of over $1.7 billion. The 2023 figure is also wrong at $3.204 billion ($3,204 million) versus the correct $3,250 million. Only the 2024 value ($3,311 million) is accurate. (2) Calculations and trends are therefore flawed: the LLM describes a '3% dip followed by a rebound to near-2022 levels', but in reality, there was a ~36% decline from 2022 to 2023 (from $5,087M to $3,250M), which is a substantial drop, not a modest swing. The recovery in 2024 was minimal (up ~1.9% from 2023), not a return to near-2022 levels. (3) The multi-hop reasoning is unsound because the LLM fails to correctly identify the magnitude of the decline, leading to an incorrect interpretation of strategic intent. The ground truth suggests a significant strategic or market-driven reduction in long-term insurance investments, while the LLM concludes there was only minor portfolio adjustment and stability—this contradicts the actual data. (4) Despite using correct entities (CVS, Separate Accounts Assets, correct years) and addressing both parts of the question (evolution and implication), the severe numerical errors undermine both quantitative and qualitative accuracy. Contextual relevance is moderate because the structure and intent of the response are appropriate, but factual correctness is critically compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 457,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement, originally dated October 22, 2012, was amended in 2015 and 2019. In 2022 a third amendment was executed on November 1, 2022, and in 2023 a letter agreement was signed on March 8, 2023. These updates were incorporated into Target’s 2024 Form 10‑K as exhibits 10.21.3+ (the third amendment) and 10.21.4+ (the letter agreement), marking the latest contractual milestones.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, only two amendments exist: the first on February 24, 2015, and the second on November 19, 2019. The LLM incorrectly claims a third amendment on November 1, 2022, and a letter agreement on March 8, 2023, which are not mentioned in the original answer and contradict the documented timeline. These fabricated dates and documents represent major factual errors. (2) Quantitatively, the dates (November 1, 2022, and March 8, 2023) and the reference to exhibits 10.21.3+ and 10.21.4+ are not supported by the ground truth, which only confirms amendments up to 2019. The original answer does not mention any 2022 or 2023 amendments, so these numbers are entirely incorrect. (3) The reasoning is flawed as the LLM fails to correctly synthesize the evolution of the agreement. Instead of recognizing that the 2024 filing merely referenced previously dated amendments (2015 and 2019), it invents new contractual milestones. This shows a failure in multi-hop reasoning—misinterpreting document references in the 2024 10-K as new amendments rather than disclosures of prior agreements. (4) While the LLM correctly identifies the original 2012 agreement and mentions amendments, the addition of false events severely undermines accuracy. Contextual relevance is moderate because the response addresses the right topic and structure (amendments over time), but the core factual content is incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 420,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "From 2022 to 2024 Linde’s rare‑gas output remained a co‑product of its industrial‑gas plants, but the company sharpened its technological edge by adopting non‑cryogenic air‑separation technologies and expanding its portfolio of proprietary, patented processes (page_4).  Its Engineering business now designs and builds the same air‑separation plants that produce oxygen, nitrogen, argon and rare gases, integrating rare‑gas output with hydrogen, helium and CO₂ production and digital services that boost plant efficiency (page_5; page_4).  This shift moves rare gases from a passive by‑product to a strategically integrated, high‑value component of Linde’s broader gas‑production and engineering platform (page_98).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Linde's evolution from 2022 to 2024 in rare gas production, noting that rare gases remained co-products of air separation but became more strategically integrated. The emphasis on technological differentiation via non-cryogenic air separation (e.g., VPSA and membrane technologies) is consistent with the 2024 strategic shift described in the original answer. The integration with hydrogen, helium, CO₂, and digital services reflects accurate synthesis of how rare gases were embedded into broader product lines and engineering capabilities. (2) There are no numeric values, dates, or financial figures in either answer that conflict; the time frame (2022–2024) is handled correctly, and no calculations are required. (3) The multi-hop reasoning is sound: the LLM connects Linde’s production method (air separation), technological innovation (non-cryogenic, proprietary processes), business integration (Engineering division designing same plants), and strategic repositioning (from by-product to high-value component). This reflects synthesis across operational, technological, and strategic layers. (4) While the LLM answer does not explicitly mention 'long-term contracts with price escalation clauses' from 2023 or name specific rare gases (krypton, neon, xenon) as in the original, these omissions are minor and do not undermine the core factual accuracy. The answer effectively conveys the shift from product-centric to technology- and integration-driven strategy. Wording differs but semantic meaning is equivalent. Minor deduction from 10 due to slightly less granular detail on contractual strategies and specific gas types, but overall excellent alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 477,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: it was $1.494 billion at December 31 2022, dropped to $800 million at December 31 2023, and fell further to $491 million at December 31 2024【page_102】【page_99】. This downward trend indicates that the company has reduced the collateral (and therefore the margin) required for its derivative positions tied to equity‑company advances, suggesting a lower exposure to derivative liabilities linked to those relationships.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: $1,494 million (2022), $800 million (2023), and $491 million (2024) are correctly reported, with acceptable format variation ($1.494 billion = $1,494 million). (2) The answer addresses both parts of the multi-part question: it describes the evolution of collateral from 2022 to 2024 and interprets the trend in terms of exposure to derivative liabilities. (3) Entities—ExxonMobil, collateral under master netting arrangements, equity company advances, and the correct years—are accurately identified and used. (4) The reasoning is sound: the downward trend is correctly linked to reduced collateral requirements and interpreted as lower exposure to derivative liabilities, aligning with the ground truth's conclusion about de-risking or portfolio optimization. The semantic meaning is equivalent, even with slightly different phrasing. All citations (page references) are included, enhancing traceability. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 310,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s net generating capacity committed under long‑term bilateral contracts rose from 94 % in 2022 to 94 % in both 2023 and 2024 (up from 92 % in 2021)【page_19】. The steady, high contract coverage shows the company is deliberately locking in revenue and hedging price risk, underscoring a robust risk‑mitigation strategy in competitive wholesale markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that NEER's long-term bilateral contract coverage was 94% in 2022, while the ground truth reports 92% in 2022, rising to 94% in 2023 and 2024. This is a critical factual error affecting the trend description. Additionally, the LLM introduces a figure for 2021 (92%), which was not part of the original question or answer, potentially confusing the timeline. (2) The quantitative inaccuracies are significant: the percentage for 2022 is wrong, and the introduction of 2021 data is unsupported by the question's scope (2022–2024). While the 94% figures for 2023 and 2024 are correct, the misrepresentation of the starting point undermines the accuracy of the trend analysis. (3) The reasoning about risk mitigation and revenue stability is sound and aligns with the original answer’s interpretation, showing correct multi-hop synthesis of the strategic implication. However, the flawed data input weakens the validity of the conclusion. (4) Contextual relevance is high, as the answer addresses both parts of the question—trend over time and strategic implication—and uses appropriate terminology. The qualitative reasoning is strong, but the quantitative inaccuracy severely impacts the overall correctness, warranting a score of 6—partially correct with significant factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 371,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "The 3.125% notes due January 2025 had an outstanding principal balance of **$495 million** at the end of fiscal 2022, and that balance remained unchanged at **$495 million** at the end of fiscal 2023 and again at the end of fiscal 2024 (see the debt schedule in page 81 of the 2024 and 2023 10‑Ks).  This steady balance shows that AVGO has not issued additional principal or repaid the notes, indicating a conservative debt‑management approach that keeps this fixed‑rate instrument on the books as a stable, long‑term financing source without early refinancing or repayment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the outstanding principal balance of $495 million for the 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, which matches the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: the dollar amount ($495 million), interest rate (3.125%), and maturity date (January 2025) are all correctly reported, with no calculation errors. (3) The multi-hop reasoning is sound in that the model correctly synthesizes data across three fiscal years from the 10-K filings (referencing page 81 of the 2024 and 2023 10-Ks), confirming consistent reporting over time. However, the qualitative interpretation diverges slightly from the ground truth: while the LLM notes the lack of principal reduction (correct), it interprets this as a 'conservative debt-management approach' and 'stable, long-term financing source,' whereas the ground truth suggests AVGO may plan to refinance or use cash reserves to settle the obligation near maturity. This is a nuanced but important distinction—the absence of amortization doesn't necessarily imply a long-term strategy but could reflect short-term liquidity planning. (4) The answer is highly relevant and factually complete, but the inference about strategy is less precise than the original, which better aligns with the proximity to maturity. Hence, full marks for quantitative and contextual accuracy, minor deduction in qualitative accuracy for strategic interpretation, leading to a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 430,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "Simon’s Unsecured Notes ‑ 37B stayed unchanged over the three‑year period: in 2022, 2023 and 2024 the note carried a 2.25 % interest rate, a $700,000 face amount and a maturity of 01/15/32 (2032)【page_50】【page_50】【page_51】. The lack of any adjustment in rate, principal or maturity indicates the company’s long‑term debt strategy is to maintain a stable, predictable financing structure rather than frequently re‑issue or refinance this instrument.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the interest rate (2.25%), maturity date (January 15, 2032), and stability over the 2022–2024 period, as well as the correct reasoning about Simon Property Group’s long-term debt strategy. However, there is a critical error in the face amount: the LLM states '$700,000', whereas the ground truth specifies '$700,000,000'. This is off by a factor of 1,000 and constitutes a major quantitative inaccuracy. (2) Number verification: interest rate (2.25% → correct), maturity date (01/15/32 → correct), face amount ($700,000 vs $700,000,000 → incorrect). The face amount error significantly affects quantitative accuracy. (3) Multi-hop reasoning is sound—the model correctly synthesizes that the note terms did not change across three years and infers a stable debt strategy, which aligns with the ground truth. Entity identification (Simon Property Group, unsecured notes - 37B) and time period (2022–2024) are accurate. (4) The correctness score is 8 because the core reasoning and qualitative analysis are strong, and most elements are correct except for the face amount. Quantitative accuracy is penalized heavily (score 6) due to the face amount error. Qualitative accuracy is high (9) due to correct logic and entity synthesis. Contextual relevance is perfect (10) as the answer directly addresses all parts of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 388,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "TI’s Melaka, Malaysia site has remained an analog‑only facility throughout the three‑year period.  The 2022 filing lists the Melaka plant as partially owned/leased (†) and shows an “X” only in the Analog column, while the 2023 and 2024 filings list it as fully leased (*) with the same analog‑only designation and no embedded‑processing activity.  This steady, unchanged footprint indicates that TI continues to focus on analog products in Melaka, with no expansion into embedded processing over 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site remained analog-only from 2022 to 2024, with no embedded processing activities—this matches the original answer's core claim. (2) Quantitative details are correct: the 2022 designation includes partial ownership (†), while 2023 and 2024 show full lease (*) status, and the 'X' under Analog only is consistently reported. These symbols and their interpretations match the source data. (3) The multi-hop reasoning is sound—comparing the operational footprint across three years and synthesizing the lack of change demonstrates correct longitudinal analysis. The conclusion about TI’s focused investment in analog is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly state that this consistency 'suggests targeted investment rather than diversification,' which is a subtle qualitative inference present in the original answer. However, the implication is clearly conveyed. Wording differs slightly but maintains semantic equivalence. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing, years 2022–2024) are accurate. No factual errors or calculation issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 353,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s multi‑layered security framework—built on a robust cyber‑security program, EMV‑type technical standards, third‑party assessments, and continuous monitoring—has been scaled to match the growth of its real‑time payment network. In 2022 the framework protected a real‑time payments infrastructure operating in 12 markets (page 11, 2022). By 2023 it had expanded to 13 markets and added AI‑governance, privacy‑by‑design and enhanced real‑time clearing controls (page 11, 2023). In 2024 the approach further evolved to include enterprise resilience, advanced threat intelligence and the Mastercard Intelligence Center, extending security coverage to more than 15 markets as the real‑time payment infrastructure grew (page 11, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the general evolution of Mastercard's security framework and its alignment with real-time payment expansion. However, there are key factual discrepancies. The ground truth states that real-time payments infrastructure was in 12 top GDP markets in 2022 and expanded to 13 in 2023, which the LLM correctly reports for 2022 and 2023. But the LLM incorrectly claims expansion to 'more than 15 markets' by 2024, which is not supported by the original answer—no such number is mentioned, and the only 2024 development noted is the China joint venture. This introduces a quantitatively inaccurate claim. (2) The mention of 'AI-governance, privacy-by-design, enhanced real-time clearing controls' in 2023 and 'enterprise resilience, advanced threat intelligence, Mastercard Intelligence Center' in 2024 appears to be fabricated or misaligned with the original answer, which emphasizes intelligent routing, fraud scoring, tokenization, and public-private partnerships. These specific programs are not mentioned in the ground truth. (3) The multi-hop reasoning is partially sound—the model correctly links security evolution to market expansion over time—but fails in synthesizing the correct qualitative developments in 2024, especially regarding China's inclusion and third-party risk integration. (4) The contextual relevance is high because the answer addresses the timeline, security evolution, and market growth. However, the quantitative inaccuracy in the 2024 market count and the introduction of unsupported initiatives reduce correctness. The qualitative accuracy is moderate due to correct structure but incorrect details. Quantitative accuracy is low due to the unsupported 'more than 15 markets' claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 483,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics increased LAV production for the Canadian Army from 399 units in 2022 to 449 units in 2023, then cut the output to 360 units in 2024 【GD_10k_2022.pdf page_11】【GD_10k_2023.pdf page_10】【GD_10k_2024.pdf page_11】. This rise followed by a decline suggests the company is maintaining a strong focus on the LAV program while adjusting production volumes—likely reallocating resources or responding to contract changes—to balance its broader defense portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported production volumes and their chronological order. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. However, the LLM incorrectly states that production was 399 in 2022, 449 in 2023, and then dropped to 360 in 2024—reversing the actual trend and misrepresenting the data. This inversion of the time series fundamentally undermines the answer's correctness. (2) The numbers themselves (360, 399, 449) are present in the LLM response but are assigned to incorrect years, leading to false calculations and comparisons. For example, claiming a drop from 449 to 360 implies a 39-unit decrease, which did not occur. The actual progression shows consistent growth (360 → 399 → 449), with increases of 39 and 50 units respectively, indicating sustained expansion. (3) The multi-hop reasoning is flawed because the model failed to correctly synthesize the year-to-year data across the three 10-K filings. While it references the correct documents, the extracted values are mismatched to years, breaking the logical chain needed to assess strategic focus. The conclusion about 'a rise followed by a decline' is therefore invalid. (4) Despite the incorrect numbers and reasoning, the answer attempts to address both parts of the question—production evolution and strategic implications—and remains contextually relevant by discussing contract dynamics and resource allocation. However, due to major quantitative inaccuracies and flawed synthesis, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 442,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS increased its target allocation to hedge‑fund limited partnership investments from **3 % of pension‑plan assets in 2022 to 4 % in 2024**—a 1‑percentage‑point rise (the allocation stayed at 3 % in 2023 before the uptick). Over the three‑year span the company has kept the hedge‑fund exposure modest but steadily higher, indicating a cautious but deliberate shift toward alternative investments to diversify returns and manage risk within its pension portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states absolute dollar allocations ($214M in 2022, $225M in 2023, $252M in 2024), while the LLM incorrectly reports percentage allocations (3%, 3%, 4%) that do not appear in the ground truth. There is no mention of percentages in the original data, and no basis to infer that these dollar amounts correspond to 3% or 4% of total pension assets without additional data. (2) The calculations in the LLM answer are unsupported: a '1-percentage-point rise' and 'target allocation' are not mentioned or verifiable from the ground truth. The actual dollar-based increase is 17.8% over three years ($214M → $252M), which the LLM fails to mention. (3) The multi-hop reasoning is partially sound in that it identifies a trend (increasing allocation) and infers strategic intent (diversification, risk management), which aligns qualitatively with the original answer’s interpretation of a 'consistent, and potentially more confident, strategic approach.' However, the reasoning is based on fabricated metrics rather than actual data. (4) While the directional trend (slight increase) is correctly interpreted, the use of incorrect metrics (percentages instead of dollar values), lack of actual figures, and introduction of unverified 'target' terminology severely undermine factual accuracy. The answer is contextually relevant to the question’s intent but fails on quantitative correctness, which is central to the query.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 418,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The penetration rate of Target’s MasterCard credit card fell from **20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024** (the company tracks this as “RedCard Penetration” or “Target Circle Card Penetration” for the credit‑card portfolio)【page_27】【page_29】. This gradual decline suggests that while the card remains widely used, its share of total purchases is slowing, indicating a plateau in consumer adoption and engagement relative to overall sales growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the penetration rate for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This discrepancy in the final year's figure is significant and affects the accuracy of the trend interpretation. (2) The numbers for 2022 and 2023 are accurate, but the 2024 value is incorrect—off by 0.8 percentage points, which alters the perceived rate of decline. The calculation of trend direction (declining) is correct, but the magnitude of the drop from 2023 to 2024 is understated. (3) The reasoning correctly infers that declining penetration suggests slowing adoption relative to total sales growth, which aligns with the ground truth’s explanation. It appropriately links the metric to consumer engagement and notes the context of overall sales outpacing card usage. However, it misses the stronger implication of 'weakening adoption' and does not mention the continued 5% discount incentive, which is a key contextual detail in the original answer. (4) The contextual relevance is high—the answer addresses both parts of the question (evolution of penetration and its implications). The qualitative reasoning is sound but less nuanced than the original. The primary deduction is for quantitative inaccuracy in the 2024 figure, which undermines full factual correctness despite otherwise solid synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 394,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "From 2022 to 2024 the fair‑value exposure for FPL Cost‑Recovery Clauses grew markedly: it was $1 million in 2022, $12 million in 2023, and $38 million in 2024.  \n- **2022:** The net $1 million came from $6 million of significant unobservable inputs offset by a $5 million negative from significant other observable inputs.  \n- **2023:** The net $12 million was driven by $24 million of significant unobservable inputs and $12 million of significant other observable inputs (negative), giving a net of $12 million.  \n- **2024:** The net $38 million was largely from $34 million of significant unobservable inputs and $4 million of significant other observable inputs, showing a shift from a small net positive in 2022 to a larger net positive dominated by unobservable inputs, with observable inputs moving from negative to positive.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dollar amounts and years are accurate: 2022 total fair value is correctly stated as $1 million, composed of -$5 million from significant other observable inputs and +$6 million from significant unobservable inputs (net $1 million). In 2023, the values are correctly reported as -$12 million (observable) and +$24 million (unobservable), resulting in a net $12 million. In 2024, +$4 million (observable) and +$34 million (unobservable) correctly sum to $38 million. (2) The answer is complete, addressing both total fair value evolution and the shift between input types over the three years. (3) Entities—NextEra Energy, FPL Cost Recovery Clauses, and the distinction between significant observable and unobservable inputs—are correctly identified and used. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop data across years, notes the shift from negative to positive observable inputs, and emphasizes the growing dominance of unobservable inputs in driving fair value. Wording differs slightly from the original but maintains full semantic equivalence. No errors in calculation, logic, or fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 340,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "From 2022‑2024 Nike’s filings consistently list Anta as a key competitor, but Nike has reinforced its edge by maintaining a strong focus on product innovation—highlighting technologies such as Nike Air, Zoom, Flyknit and newer developments like Nike Adapt—and by expanding brand‑engagement through digital commerce, direct‑to‑consumer stores, athlete partnerships and sustainability initiatives (page_6, page_8). Over this period, Nike’s investment in R&D and digital experiences has deepened, strengthening its differentiation from Anta, which remains a regional player but lacks the same breadth of global technology and direct‑to‑consumer strategy (page_6, page_8).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that NKE consistently listed Anta as a competitor from 2022–2024 and accurately captures NKE’s emphasis on product innovation and brand engagement strategies. It appropriately references technological innovations (e.g., Nike Air, Zoom, Flyknit, Nike Adapt) and digital/direct-to-consumer strategies, which align with the ground truth’s focus on innovation and digital experiences. However, the LLM answer does not clearly reflect the *evolution* of NKE’s strategic emphasis across the years—specifically, the shift in 2023 where 'innovation and development' was elevated ahead of 'performance and reliability'—which is a key multi-hop insight in the original answer. This omission reduces qualitative accuracy. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The reasoning is partially sound: it synthesizes NKE’s innovation and engagement strategies and positions Anta as a regional competitor, but it fails to trace the year-over-year strategic evolution (2022 → 2023 → 2024) that the question specifically asks for. The characterization of Anta as lacking global reach is plausible but not explicitly confirmed in the ground truth, which only states Anta is a named competitor without assessing its global footprint. (4) The answer is contextually relevant and factually aligned in spirit, but misses the nuanced progression in NKE’s competitive messaging, which is central to the question. Thus, correctness and qualitative accuracy are reduced to 7, while quantitative accuracy remains 10 due to absence of numerical errors and contextual relevance is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 473,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "From 2022 through 2024 Texas Instruments reported no shares available for future issuance under the 2003 Director Compensation Plan.  In each year’s equity‑compensation table the only plans with remaining shares were the 2009 LTIP, 2014 ESPP and 2018 Director Plan (2022/2023) or the 2024 LTIP, 2014 ESPP and 2018 Director Plan (2024) – the 2003 plan is absent (pages 63, 61, 57).  This trend shows that TI has effectively retired the 2003 plan for new director awards and relies on newer plans for director compensation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor inaccuracy regarding the status of the 2003 Director Compensation Plan in 2022. The ground truth states that in 2022, the plan was still referenced as active with shares being issued under it, while the LLM claims no shares were available for future issuance in 2022. However, the LLM correctly notes the absence of the 2003 plan in the list of plans with remaining shares in 2022, 2023, and 2024, which aligns with the phase-out trend. The key financial and structural details—such as the replacement by the 2018 Director Plan and 2024 LTIP, and the use of newer plans for future awards—are accurate. The reasoning correctly infers retirement of the 2003 plan based on its absence in equity-compensation tables, and the cited plans (2009 LTIP, 2014 ESPP, 2018 Director Plan, 2024 LTIP) match the context. The conclusion about TI relying on newer plans is semantically equivalent to the ground truth’s 'strategic shift' narrative. The only shortfall is the overstatement that no shares were available in 2022, when the plan was still active for new grants that year, though nearing retirement. This is a minor omission in timing nuance, not a factual error in calculation or entity identification. Thus, high scores are warranted, with a slight deduction in correctness and qualitative accuracy for incomplete representation of the 2022 status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 386,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From 2022 through 2024, Comcast’s advertising business consistently integrated data‑driven services, offering technology, tools, data‑driven services and marketplace solutions to media clients. In 2023 the company expanded its platform footprint with the launch of the NOW streaming service and continued to leverage the X1 and Sky Q platforms, which integrate streaming content from DTC services such as Peacock, Disney+ and Netflix. The filings do not disclose additional specific technology, tool, or marketplace‑solution enhancements beyond these platform upgrades.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but misses key aspects of the evolution of CMCSA's data-driven advertising services from 2022 to 2024 as described in the ground truth. (1) Correctly identifies that CMCSA offered data-driven services and tools in this period and references platform integration (X1, Sky Q), which aligns with the multichannel video provider focus in 2022. However, it fails to mention the specific enhancements in 2023 (cloud-based platforms, integrated search functionality) and 2024 (enhanced digital tools, expanded third-party representation agreements). Instead, it introduces the NOW streaming service launch, which is not mentioned in the original answer and may be extraneous or unverified in this context. (2) There are no numeric values, dates, or calculations in either response, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is weak: the LLM does not synthesize the progression across years as required—missing the deepening integration in 2023 and refinement in 2024. It also does not reflect the strategic shift toward cloud infrastructure and data analytics emphasized in the ground truth. (4) Contextual relevance is moderate: while the answer discusses advertising platforms and integration, it omits the core developments related to technology, tools, and marketplace solutions, instead focusing on content aggregation via DTC apps. Overall, the answer is partially accurate but lacks completeness and depth in capturing the specific evolution outlined in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 437,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed‑security (CMBS) holdings fell sharply: the fair value dropped from $1.17 billion with $155 million unrealized losses in 2022 to $675 million with $100 million unrealized losses in 2023—about a 42 % decline in value and a 35 % decline in losses【page_148】【page_150】.  In 2024 the company’s separate‑account CMBS fair value fell to $3 million (down 50 % from 2023) and no unrealized losses were reported【page_160】, indicating a continued trimming of exposure.  The trend points to a more conservative risk posture in CMBS, with CVS reducing its balance‑sheet exposure and limiting potential loss volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the 2022 figures. The ground truth states CVS held $574 million in CMBS with $12 million in unrealized losses in 2022, but the LLM claims $1.17 billion and $155 million, which are more than double the correct values. This major discrepancy invalidates the reported 42% decline in value and 35% decline in losses, as those percentages are based on incorrect baselines. The 2023 figures ($675 million fair value, $100 million unrealized losses) match the ground truth and are correctly cited. The 2024 value is close but not exact: LLM reports $3 million vs. ground truth of $6 million; both indicate near-elimination of exposure. (2) Calculations are flawed due to incorrect inputs: the 42% and 35% declines are mathematically plausible from the LLM's own numbers but do not reflect actual company data. The 50% drop from 2023 to 2024 is inaccurate—$3M is ~99.6% of $675M, not 50%. (3) Multi-hop reasoning is partially sound: the model correctly infers a trend of de-risking and reduced exposure over time, synthesizing data across years. It identifies the increasing unrealized losses in 2023 and subsequent drawdown in 2024, aligning with the strategic reduction narrative. However, the faulty 2022 data undermines the validity of the trend analysis. (4) Despite incorrect numbers, the qualitative conclusion about conservative risk positioning is consistent with the ground truth and contextually appropriate. The answer addresses all parts of the question and uses proper financial terminology. Hence, correctness is penalized heavily for quantitative inaccuracy, but qualitative and contextual scores reflect reasonable logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 468,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings for 2022, 2023 and 2024 all list merchandise discounts as part of the employee benefit package, with no change in scope (all employees) or disclosed discount value. The consistent inclusion of this benefit across three years indicates that Target treats merchandise discounts as a core, stable component of its compensation strategy rather than a variable or evolving benefit.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually correct in stating that merchandise discounts were consistently included in Target's employee benefits across 2022, 2023, and 2024, and that there was no change in scope or disclosed value—this aligns with the ground truth. However, it fails to capture the key qualitative evolution emphasized in the original answer: the shifting framing and strategic context of the discounts within a broader, expanding benefits ecosystem. The ground truth highlights that while the discount itself remained stable, its presentation evolved alongside new benefits like 401(k) matching, tuition reimbursement, mental health services, and virtual healthcare, indicating a strategic move toward holistic well-being. The LLM answer incorrectly implies no evolution in strategy, missing the multi-hop synthesis that the consistent perk was embedded in an increasingly comprehensive and modernized benefits package. This omission significantly undermines the qualitative accuracy and overall correctness, despite accurate entity and date usage. The answer is relevant and factually sound on surface-level disclosure but lacks depth in interpreting strategic implications, resulting in a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 338,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "In 2022 and 2023, Linde listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one of many risks in the acquisition‑integration section (see 2022 p. 12 and 2023 p. 12). By 2024, the filing added a distinct bullet that foreign acquisitions and joint ventures “involve unique risks … including those related to integration of operations across different cultures and languages” (2024 p. 12), explicitly framing cultural and language issues as a cross‑border risk. This evolution signals a more focused, risk‑aware strategy that treats cultural integration as a key lever for managing cross‑border acquisition risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022, 2023, 2024), document references (p. 12 for each year), and correct entity (Linde). It accurately identifies the evolution of cultural challenges in Linde's filings: from a general integration risk in 2022–2023 to a more explicitly cross-border, language-inclusive risk in 2024. The quantitative accuracy is perfect—no numerical errors, and all years and page references match the expected data. The qualitative accuracy is high: the LLM captures the increasing specificity around cultural and language differences in cross-border contexts. However, it omits a key element from the ground truth—the growing linkage of cultural integration to financial outcomes and synergy realization in 2024. While it notes the strategic framing of cultural integration as a 'key lever,' it does not mention the heightened emphasis on financial risks such as failure to retain key personnel or achieve synergies, which is central to the original answer’s conclusion about strategic risk management. This missing nuance prevents a top score. The reasoning is sound and multi-hop, synthesizing across three years of disclosures, and the answer is fully contextually relevant to the question about evolution and strategic approach. Minor omission reduces completeness, but core facts and progression are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 378,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.494 billion in 2022 to $491 million in 2024** – a decline of roughly **$1.0 billion**. This sharp reduction indicates that the company has either scaled back its derivative positions or achieved more efficient netting, reflecting tighter derivative‑exposure management and lower collateral‑cost exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall decline in collateral from $1,494 million in 2022 to $491 million in 2024, matching the ground truth. However, it omits the intermediate 2023 value of $800 million, which is part of the complete trend. While the final drop to $491 million is accurate, the absence of the 2023 data point reduces completeness. (2) The numbers used are factually correct when compared to the original answer: $1,494 million (2022) and $491 million (2024) are accurately reported, with acceptable formatting variation ($1.494 billion = $1,494 million). The stated decline of roughly $1.0 billion is approximately correct ($1,494M - $491M = $1,003M). (3) The reasoning is sound: the LLM correctly infers that the decline suggests reduced derivative positions or more efficient netting, aligning with the ground truth's interpretation of strategic reduction or improved offsetting. The multi-hop synthesis across years is logically handled, though the missing 2023 value slightly weakens the trend analysis. (4) The answer is contextually fully relevant, addressing both the quantitative change and its implication for derivative exposure management. The omission of the 2023 figure prevents a perfect score, but core facts, calculations, and interpretation are correct and meaningful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 370,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "AVGO’s 2022 10‑K (page 10) described the Security Insights Platform as a mainframe‑centric tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and that its data can be fed into in‑house SIEM tools. The 2024 filing (page 10) repeats the same wording – the platform still focuses on continuous risk assessment, ad‑hoc remediation, and integration with internal SIEM systems – and it remains positioned as part of the mainframe software portfolio that supports AVGO’s broader cybersecurity strategy of providing a trusted environment for customers and employees. No new integration with external tools or expanded remediation processes is noted between 2022 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of the 2022 and 2024 10-Ks, correctly quoting the description of the Security Insights Platform and noting its integration with in-house SIEM tools. The quantitative accuracy is high—dates (2022, 2024), page numbers (10), and terminology (SIEM, remediation steps) are correctly reported. However, the answer fails to reflect the evolution described in the ground truth, particularly the strategic shift between 2022 and 2024. The ground truth indicates that by 2023–2024, the platform was more explicitly aligned with AVGO’s broader cybersecurity portfolio and embedded within an expanded suite including Cybersecurity, AIOps, and DevOps, signaling a strategic integration into enterprise-wide security and compliance. The LLM incorrectly asserts that no new integration or expanded remediation processes were noted, when the evolution lies in contextual positioning and strategic alignment, not just functional changes. This is a critical omission in the multi-hop reasoning required to assess how the platform’s role evolved beyond standalone functionality. While the LLM accurately reports static descriptions from two years, it fails to synthesize the broader narrative shift across the three-year span, particularly missing the 2023 developments and the strategic contextualization in 2024. Thus, while factually sound in isolated data points, the answer lacks the qualitative synthesis needed to capture the platform’s evolving role, resulting in a partially correct but incomplete assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 424,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 32B remained unchanged: a face value of **$750,000** and an interest rate of **3.38 %** maturing in 2027. The unchanged terms show the company’s preference for a stable, low‑rate, long‑term debt mix that preserves predictable cash‑flow obligations and limits refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the interest rate (3.38%) and maturity year (2027), and notes the stability of terms from 2022 to 2024, which aligns with the original answer's conclusion about SPG's stable debt strategy. However, there is a critical error in the face value: the LLM states '$750,000' instead of '$750,000,000' as per the ground truth. This is a three-order-of-magnitude mistake, drastically misrepresenting the scale of the debt. 2) Quantitatively, the face amount is off by a factor of 1,000. While the interest rate (3.38%) and maturity (2027) are correct, the dollar amount is severely inaccurate. Format variation is acceptable (e.g., $750M vs $750,000,000), but $750,000 is not equivalent and constitutes a major factual error. 3) The reasoning is sound: the model correctly infers that unchanged terms suggest a stable long-term debt strategy focused on predictable cash flows and reduced refinancing risk. This reflects proper multi-hop synthesis across years and correct interpretation of strategic implications. 4) Despite strong qualitative reasoning and contextual relevance, the severe quantitative inaccuracy in the face value significantly undermines the correctness of the answer, warranting a moderate score of 6. The conclusion is logically valid but based on an incorrect financial magnitude.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 369,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "CMCSA’s 10‑K filings from 2022, 2023 and 2024 all describe Lumen as a competitor that has been building fiber infrastructure and offering higher‑speed broadband services across many of CMCSA’s markets, with no change in that strategy over the period (page_7, 2022; page_7, 2023; page_7, 2024). The documents do not provide any new information on Lumen’s bundling of services, and bundling is only discussed for other carriers such as AT&T and Verizon (page_9, 2024). Thus, the competitive threat from Lumen has remained largely driven by fiber expansion rather than evolving bundling strategies.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant omission in reasoning and synthesis compared to the ground truth. (1) Correct elements: The LLM accurately reports that CMCSA's 10-K filings from 2022–2024 consistently identify Lumen as a competitor expanding fiber infrastructure in CMCSA’s markets, which aligns with the original answer. The citation of consistent strategy across years and reference to fiber expansion is factually supported and correctly extracted. There are no numeric inaccuracies, so quantitative accuracy is high. (2) However, the LLM incorrectly claims that 'the documents do not provide any new information on Lumen’s bundling of services' and states bundling is only discussed for AT&T and Verizon in 2024. This contradicts the ground truth, which explicitly notes that Lumen was described as having 'some bundling capabilities' in 2022 and a 'continued focus on bundled offerings' in 2023 and 2024. Thus, the LLM underrepresents the evolution of Lumen’s bundling strategy, likely due to a failure in multi-hop synthesis across the filings. (3) The reasoning is flawed because it dismisses bundling as a competitive factor for Lumen based on absence of explicit mention in one year, while the original answer synthesizes incremental language across all three years to infer an intensifying threat. The LLM’s conclusion that the threat remained 'largely driven by fiber expansion rather than evolving bundling strategies' is therefore inconsistent with the ground truth’s emphasis on both fiber and bundling as co-evolving competitive levers. (4) While contextually relevant and factually precise on fiber expansion, the answer loses points for incomplete qualitative reasoning and failure to capture the full competitive evolution, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 490,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded payment‑card penetration fell steadily: 20.5 % in 2022, 19.8 % in 2023, and 18.6 % in 2024 (RedCard/Target Circle Card penetration【page 27 of 2023 10‑K】,【page 29 of 2024 10‑K】). This downward trend suggests the loyalty‑driven payment strategy is losing traction—its share of total purchases is shrinking, indicating the discount incentive may be less compelling or that competing payment options are gaining ground, and that Target may need to adjust the program to maintain card usage.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target's branded payment card penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it reports 18.6% for 2024 instead of the correct 17.8%, making the final data point inaccurate. This is a significant quantitative error, though the general trend direction (declining) is preserved. (2) The cited numbers are mostly accurate except for 2024: 20.5% (2022) and 19.8% (2023) are correct; 18.6% (2024) is incorrect per ground truth (should be 17.8%). The calculation of trend direction (downward) is logically sound, but the magnitude of decline is understated due to the wrong 2024 figure. (3) The multi-hop reasoning across years and documents is appropriate—citing specific 10-K pages shows proper sourcing—and the synthesis of trend implications is reasonable. The conclusion about weakening effectiveness or competitive pressure aligns semantically with the ground truth’s interpretation. (4) The correctness score is 7 because core facts (decline, initial values) are correct, but a key data point is wrong. Quantitative accuracy is 6 due to the incorrect 2024 percentage. Qualitative accuracy is 8 because reasoning and entity identification (Target, branded cards, loyalty strategy) are strong. Contextual relevance is 10—answer fully addresses both parts of the question and stays focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 389,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "Chevron’s presence in the Republic of Congo moved from ownership of non‑operated assets to divestiture. In the 2022 10‑K, the company reported a 31.5 % non‑operated working interest in the offshore Haute Mer permit area and a 15.75 % interest in the Republic of Congo portion of the Lianzi block【page_31】. By the 2024 10‑K, Chevron announced that it would sell those interests in January 2025, effectively ending its ownership and signaling a strategic shift away from non‑operated assets in the Republic of Congo toward higher‑return projects elsewhere【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's asset ownership in the Republic of Congo in 2022 (31.5% non-operated working interest in Haute Mer and 15.75% in Lianzi), which matches the ground truth. It accurately notes the divestiture of these assets, aligning with the 2024 strategic exit. The only minor discrepancy is the mention of the sale occurring 'in January 2025'—while the original answer states the sale was announced in 2024 and marks the exit, it does not specify the exact closing date. However, since the 2024 10-K referencing a January 2025 sale is a plausible forward-looking statement, this does not constitute a factual error but adds specificity not in the original. (2) All numeric values—percentages (31.5%, 15.75%)—are correct. No dollar amounts or investment figures are misstated in the LLM answer, though it omits the $0.7 billion Africa-wide investment mentioned in 2023. This omission slightly affects completeness but does not invalidate the core narrative. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from 2022 (ownership) and 2024 (divestiture) to infer a strategic shift. It correctly interprets the sale as a move away from non-operated assets, which is consistent with the ground truth’s conclusion about portfolio realignment. (4) The answer is contextually relevant and focused on the evolution of Chevron’s engagement, covering asset ownership and strategic positioning. The omission of the 2023 investment detail slightly reduces completeness but does not alter the overall accuracy of the trajectory described. Thus, the answer is highly accurate with only minor informational gaps, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 466,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "From 2022 to 2024, NextEra’s Level‑3 gas‑option exposure swung from a modest net asset position ($170 m assets, $8 m liabilities) to a large net liability ($‑854 m assets, $9 m liabilities) in 2023, and then rebounded to a strong net asset ($951 m assets, $24 m liabilities) in 2024.  The implied volatilities for these options fell from 20 % (assets) / 233 % (liabilities) in 2022–23 to 15 % / 150 % in 2024, signalling a shift to lower expected gas‑price volatility and a more conservative, favorable risk stance in the gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It reports completely different values for fair value of assets and liabilities across all years—$170M assets and $8M liabilities in 2022, $-854M assets and $9M liabilities in 2023, and $951M assets and $24M liabilities in 2024—which do not match the ground truth of $356M assets / $347M liabilities in 2022, $100M / $97M in 2023, and $100M / $102M in 2024. These discrepancies are massive and fundamentally alter the narrative. (2) The implied volatility figures are also wrong: the LLM claims 20% for assets and 233% for liabilities in 2022–23, dropping to 15% / 150% in 2024, whereas the ground truth reports average implied volatilities of 36% in 2022, 50% in 2023, and 52% in 2024—no split between assets and liabilities is provided in the original, and the values are vastly different. (3) The multi-hop reasoning is flawed: instead of showing a sharp reduction in exposure (both assets and liabilities declining) and rising volatility expectations, the LLM suggests wild swings in net position (from net asset to massive net liability to huge net asset), which contradicts the actual trend of de-risking and stabilization. The conclusion about 'lower expected gas-price volatility' is incorrect, as volatility actually increased from 36% to 50% to 52%. (4) The contextual relevance is low but not zero—the answer addresses gas-related options, fair value, implied volatility, and risk positioning over time, so the structure responds to the question’s intent. However, due to pervasive factual and quantitative errors, the qualitative and quantitative accuracy scores are near minimum. The correctness score is 1 because the answer fails on all key facts and conveys a misleading interpretation of risk evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 490,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike has continued to list FlyEase among its core technologies in the product‑research and development section of each filing.  In the 2022, 2023 and 2024 10‑K reports, the phrase “FlyEase” appears in the same sentence that enumerates Nike’s key technologies (NKE_10k_2022.pdf page 6; NKE_10k_2023.pdf page 6; NKE_10k_2024.pdf page 6).  The unchanged mention shows that FlyEase remains a recognized component of Nike’s broader innovation portfolio, but its prominence has not shifted toward a flagship role, underscoring its function as a supporting technology within the company’s overall strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its interpretation of FlyEase's strategic evolution. While it correctly identifies that FlyEase is mentioned in the 2022, 2023, and 2024 10-K filings, it concludes that its prominence has not changed and remains a 'supporting technology.' This contradicts the ground truth, which shows a clear progression from introduction in 2022, to expanded integration in 2023, to being fully embedded as a core technology in 2024. The LLM misinterprets consistent mention as static importance, failing to recognize the evolving context and strategic elevation. (2) Quantitatively, the answer is accurate—correct years, correct document types (10-K), correct page numbers, and correct observation about the presence of the term across filings. No numerical errors. (3) The multi-hop reasoning is flawed: the model fails to synthesize the qualitative shift in FlyEase’s role over time, despite the ground truth indicating increasing emphasis and integration. Instead of recognizing a progression in strategic importance, it assumes consistency implies no change in status. This reflects a failure in deeper contextual analysis required for multi-hop financial/strategic reasoning. (4) Correctness is scored low (4) because the core conclusion about FlyEase’s role is incorrect. Quantitative accuracy is perfect (10). Qualitative accuracy is low (4) due to flawed reasoning and misinterpretation of strategic significance. Contextual relevance is moderate (7) because the answer addresses the right documents and technology but draws an incorrect strategic inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 441,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "From 2022 through 2024, the Unsecured Notes – 35A remained unchanged: a 2.65 % interest rate, $750,000 face amount, $19,875 annual debt service, and a maturity of July 15 2030 (page 50 for 2022/2023, page 51 for 2024). This stability indicates that Simon has chosen to retain a low‑cost, long‑dated debt instrument, reflecting a long‑term strategy that prioritizes predictable, low‑interest financing over frequent refinancing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the face amount ($750,000), interest rate (2.65%), annual debt service ($19,875), and maturity date (07/15/30) are consistent across 2022–2024. Minor formatting differences (e.g., 'July 15 2030' vs '07/15/30') do not affect factual accuracy. (2) Quantitative elements are precise: $750,000 × 2.65% = $19,875, confirming the annual debt service is correctly calculated and reported. (3) The multi-hop reasoning is sound—information is synthesized across three years and filings, correctly identifying stability in terms and implying strategic intent. (4) The conclusion about SPG’s long-term debt strategy—prioritizing predictable, low-interest financing over refinancing—aligns with and accurately interprets the static nature of the obligation. The mention of specific document pages adds sourcing credibility. All aspects of the question are addressed with complete accuracy and appropriate contextual interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 297,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across 2022, 2023 and 2024 Texas Instruments repeatedly stated that its core business model is “focused on analog and embedded‑processing products” (MD&A, 2022‑p. 19; 2023‑p. 19; 2024‑p. 19).  Embedded‑processing revenue grew only modestly in 2023 (≈ +3 % vs 2022) but fell sharply in 2024 (≈ –25 % vs 2023), yet the company still highlighted the line as a key source of strong cash flow (segment tables, 2023‑p. 20; 2024‑p. 20).  This unwavering positioning shows that TI’s long‑term growth strategy is to use the embedded‑processing portfolio—supported by its manufacturing and technology advantages—to drive and sustain free‑cash‑flow‑per‑share growth through disciplined capital allocation and efficiency.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct strategic narrative from the original answer—that Texas Instruments consistently emphasized embedded processing as part of its long-term strategy tied to free cash flow per share—and correctly identifies the multi-year consistency in strategic messaging. However, it introduces significant quantitative inaccuracies not present in the ground truth. The claim that embedded processing revenue grew ≈+3% in 2023 and fell ≈–25% in 2024 is not supported by the original answer, which does not provide any revenue growth figures. These specific percentages are fabrications or misattributions not found in the ground truth, severely undermining quantitative accuracy. Additionally, citing 'segment tables, 2023-p. 20; 2024-p. 20' implies precise data extraction, but the original answer does not reference such tables or figures. While the reasoning about TI’s long-term strategy being tied to free cash flow via embedded processing is sound and contextually relevant, the inclusion of unverified numerical data reduces factual correctness. The core qualitative insight—TI’s unwavering strategic focus despite market fluctuations—aligns with the original, but the unsupported numbers prevent a higher score. There is no evidence in the ground truth that revenue fell sharply in 2024, so this distorts the factual basis. Thus, while the synthesis and strategic interpretation are strong (qualitative accuracy 7, contextual relevance 9), the quantitative accuracy is low (4) due to incorrect figures, leading to an overall correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 429,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "Disney’s 2023 10‑K (page 7) shows that Marvel was promoted to a top‑level tile on Disney+, a move that followed its 2022 classification of Marvel trademarks as an indefinite‑lived intangible asset (page 112).  The 2024 10‑K still lists Marvel under the same category (page 114), confirming the brand’s continued status as a key intangible asset.  This shift illustrates Disney’s financial strategy of using high‑value IP to differentiate its streaming platform, drive subscriber acquisition and retention, and generate long‑term revenue from the Marvel franchise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Marvel was classified as an indefinite-lived intangible asset in 2022 (2023 10-K, p.112), became a top-level tile on Disney+ in 2023, and retained its intangible asset status in 2024 (2024 10-K, p.114). These details match the original answer. (2) Quantitative accuracy is perfect: no numerical errors, and the cited page numbers and years are correct. Format variations (e.g., 'page 7' vs 'page 7') are acceptable. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and documents—linking financial asset classification (2022 and 2024) with strategic UI changes (2023)—to infer Disney's broader financial strategy of leveraging IP for subscriber growth. (4) The only minor omission is the lack of mention of ESPN+'s planned tile launch in early fiscal 2025, which the original answer uses to contextualize the broader branding strategy. Additionally, the LLM does not include the specific Disney+ subscriber count of 123 million as of September 28, 2024, which strengthens the financial impact argument. However, the core strategic and financial insights—using Marvel’s brand equity to drive engagement and long-term revenue—are clearly conveyed. Thus, while slightly less comprehensive, the LLM answer remains factually correct and contextually relevant, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 394,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance agreement continued to cover roughly 59 % of its closed block through 2024 (the same 59 % reported for 2023)【229】【206】.  Unsecured reinsurance recoverable balances rose from $3.8 billion in 2022 to $4.4 billion in 2023 and then dipped slightly to $4.2 billion in 2024【227】【204】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage of the closed block reinsured in 2023 and 2024 (59%) and the unsecured reinsurance recoverable balances for 2023 ($4.4 billion) and 2024 ($4.2 billion), which match the ground truth. However, it incorrectly states that the 2022 unsecured balance was $3.8 billion, whereas the ground truth reports $3.6 billion. Additionally, the 2022 reinsured percentage is reported as 'roughly 59%' in the LLM answer, but the original answer specifies 59.25%, which is more precise and slightly different. (2) The quantitative inaccuracies are limited to the 2022 figures: $3.8B vs $3.6B (a $200M overstatement) and rounding 59.25% to 59% without qualification. These are minor but material in a financial context. (3) The multi-hop reasoning is sound—LLM correctly tracks the evolution across three years and synthesizes changes in both percentage reinsured and recoverable balances. The conclusion of relative stability is implied and reasonable. (4) Scores reflect high contextual relevance and strong qualitative reasoning, but quantitative accuracy is reduced due to incorrect 2022 figures. Correctness score is 7 because core trends and later-year data are accurate, but early-year data contains factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 356,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS’s fair‑value holdings of residential mortgage‑backed securities fell from **$721 million at December 31, 2022 to $614 million at December 31, 2023** (page 149) and then dropped sharply to **$71 million in separate‑account holdings at December 31, 2024** (page 160). This 90 % decline over three years indicates a deliberate shift away from RMBS, reducing the company’s exposure to interest‑rate and credit risk and signaling a strategic repositioning toward other fixed‑income instruments that better align with its risk‑management and investment‑income objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 RMBS value: it reports $721 million, whereas the ground truth states $629 million. The 2023 value ($614 million) is correct, and the 2024 value ($71 million) is also correct. This error in the starting value undermines the quantitative accuracy. Additionally, the LLM claims a '90% decline over three years,' but based on the correct ground truth numbers ($629M → $614M → $71M), the total decline is approximately 88.7%, which is close but not exact. However, using its own incorrect numbers ($721M → $71M), the 90% figure is roughly accurate, but still misleading due to the wrong baseline. (2) The LLM incorrectly cites 'separate-account holdings' for the 2024 figure, which is not mentioned in the original answer and introduces a potentially misleading classification. The ground truth does not specify separate accounts, so this detail may reflect a misinterpretation of the source document. (3) The reasoning about strategic de-risking and reduced exposure to interest-rate and credit risk is logically sound and aligns with the trend described in the ground truth. The conclusion about strategic repositioning toward other fixed-income instruments is a reasonable inference, though the original answer also notes the rise in unrealized losses (from $10M to $60M), which the LLM omits entirely—this is a significant omission in risk exposure analysis. (4) The contextual relevance is high because the answer addresses the evolution and strategic implications. However, the quantitative inaccuracy on the key 2022 figure and the omission of unrealized losses—which are central to assessing risk exposure—reduce the correctness score. The qualitative reasoning is mostly sound but lacks full multi-hop synthesis (e.g., connecting unrealized losses to risk exposure).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 501,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance agreement continued to cover 59 % of its closed block in each of the 2022, 2023 and 2024 filings.  The company consistently applied the deposit method to account for the agreement, recording deposit assets and liabilities (≈$1.9 B assets and $1.4 B liabilities in 2022, $5.1 B assets and $1.3 B liabilities in 2023, and $4.6 B assets and $1.2 B liabilities in 2024) and offsetting the deposit liability with a deposit recoverable.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MetLife used a modified coinsurance agreement covering approximately 59% of the closed block from 2022 to 2024 and that the accounting treatment remained under the deposit method with offsetting of deposit liability and recoverable. However, there is a discrepancy in the percentage reported: the ground truth specifies 59.25% in 2022 and 59% in 2023 and 2024, while the LLM states '59%' for all three years, omitting the more precise 2022 figure. This is a minor quantitative inaccuracy but still relevant for precision. (2) The LLM introduces specific dollar amounts for deposit assets and liabilities across the years (e.g., $1.9B assets in 2022, $5.1B in 2023, etc.), which are not present in the original answer and are not corroborated by the ground truth. These figures may be factually incorrect or taken from a different context, constituting a significant quantitative error. The original answer does not mention any dollar values, so their inclusion introduces unverified data. (3) The reasoning is otherwise sound: the model correctly synthesizes the consistency in percentage and accounting treatment over time, correctly identifies the use of the deposit method with offset, and connects the treatment across years. This shows good multi-hop understanding of both the structural and accounting aspects. (4) The contextual relevance is high, as all parts of the question are addressed—evolution over time, percentage reinsured, and accounting treatment. Despite the incorrect addition of unsupported dollar figures and slight oversimplification of the percentage, the core facts about stability in structure and accounting are preserved, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 476,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra Energy’s net fair‑value of gas forward contracts rose from **$162 million** in 2022 to **$300 million** in 2023, then fell to **$250 million** in 2024 (assets – liabilities: 170 – 8 = 162 m; 377 – 77 = 300 m; 296 – 46 = 250 m). The sharp increase in 2023 indicates a more aggressive hedging or speculative stance amid volatile gas prices, while the modest decline in 2024 suggests the company is trimming its exposure to adopt a more balanced risk profile in natural‑gas markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in direction and trend but contains a significant quantitative error: it reports 2022 net exposure as $162 million (calculated from $170M assets - $8M liabilities), while the ground truth states $160 million ($191M assets - $31M liabilities). This discrepancy affects the accuracy of the initial data point. The 2023 and 2024 figures are correct: $300M and $250M respectively, with accurate component values (377-77=300, 296-46=250). 2) Calculations for 2023 and 2024 are accurate; however, the 2022 calculation uses incorrect underlying values (assets and liabilities), leading to an erroneous net figure despite showing a correct method. The reported $162M does not match the ground truth $160M, and the component numbers ($170M assets, $8M liabilities) are factually wrong per the knowledge graph. 3) The multi-hop reasoning is sound: the model correctly identifies the trend (increase from 2022 to 2023, then decrease in 2024) and draws a logical inference about risk positioning—interpreting the 2024 decline as a move toward a more balanced risk profile, which aligns with the ground truth's 'more cautious stance or rebalancing' conclusion. The qualitative analysis is strong and contextually appropriate. 4) Contextual relevance is excellent—the answer directly addresses both parts of the question: evolution of net exposure and its implication for risk positioning. Despite the incorrect 2022 component values, the overall narrative and directional trend are preserved, warranting a moderate penalty only on quantitative accuracy. Final scores reflect high performance in reasoning and relevance, with a moderate deduction for factual inaccuracy in one year's data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 464,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "Across 2022, 2023 and 2024, Broadcom continued to present industrial fiber optics as a core element of its industrial portfolio, using it in a wide range of applications from factory automation and renewable‑energy power‑distribution to medical equipment, defense/aerospace and automotive subsystems such as electric‑vehicle powertrains and advanced‑driver‑assistance systems.  The company consistently highlighted the integration of fiber optics with motion encoders and Ethernet ICs, underscoring its focus on delivering end‑to‑end industrial solutions that combine optical, motion‑sensing and networking technologies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that AVGO (Broadcom) consistently positioned Industrial Fiber Optics as a core component of its industrial portfolio from 2022 to 2024, with applications in factory automation, renewable energy, medical, defense, and automotive systems. It correctly identifies the integration of fiber optics with motion encoders and Ethernet ICs, which aligns with the ground truth. However, the answer lacks the year-over-year evolution detailed in the original answer: it does not distinguish how the integration emphasis shifted—such as the 2023 alignment with microcontrollers and sensors or the 2024 linkage with Ethernet PHYs, switch ICs, and camera microcontrollers. This omission reduces the depth of the multi-hop synthesis across years, missing the strategic progression from standalone components to networked, intelligent systems. While all entities and years are correctly referenced in general, the nuanced evolution in integration and application diversity is under-articulated. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains contextually relevant and well-aligned with the question's intent, but the qualitative reasoning does not fully capture the trajectory described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 358,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s redeemable preferred stock—fully issued to Sojitz America—continued to carry a cumulative dividend of **$0.10 per share payable each May 31** (Note 10, pages 79 2022‑2024; page 8 2024).  The company’s filings state that **no dividends on common stock may be declared or paid unless the preferred dividend is fully paid** and that **there have been no changes to the preferred‑stock structure** (no new issuances, no blank‑check preferred stock, and no alteration of redemption terms) across those years (pages 79 2023‑2024, page 5 2024).  Thus the dividend obligation remained constant and the preferred‑stock structure stayed stable, preserving the financial relationship with Sojitz America.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: the $0.10 annual dividend per share, the structural stability of the redeemable preferred stock, the priority of dividend payment over common stock, and the absence of changes in the stock terms from FY2022 to FY2024. It accurately notes the timing of the dividend payment (May 31) and cites the relevant filing sections, which aligns with the ground truth. The only minor omission is the total par value of $0.3 million, which is present in the original answer but not mentioned in the LLM response. This does not affect core financial implications but slightly reduces completeness. (2) Quantitatively, all numbers are correct: $0.10 per share dividend is accurately reported, and the consistency across years is properly emphasized. The date (May 31) for dividend payment is an additional precise detail supported by filings and not contradicted by the ground truth. (3) The multi-hop reasoning is sound—LLM synthesizes information across three fiscal years and correctly infers that no structural changes imply ongoing stability. It also correctly links the dividend priority rule to the financial relationship’s stability. The reasoning traces the implications of the unchanged terms across time, demonstrating accurate cross-year synthesis. (4) The answer is contextually fully relevant, directly addressing the evolution (or lack thereof) in financial implications, focusing on dividend obligations and stock structure stability. The omission of the $0.3 million par value prevents a perfect score, but all other critical aspects are covered with high accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 450,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 31B remained unchanged: a $750,000 face amount, 3.25 % interest rate, maturity of November 30 2026, and annual debt service of $24,375 (page_50 for 2022/2023, page_51 for 2024). This stability indicates SPG’s long‑term financing strategy is to preserve a predictable, low‑cost debt instrument with a fixed maturity, avoiding refinancing or new issuance for this note.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the unsecured debt amount ($750,000), interest rate (3.25%), maturity date (November 30, 2026), and consistency across 2022–2024. The annual debt service calculation ($750,000 × 3.25% = $24,375) is accurate and correctly attributed to the cited pages. (2) All numeric values match the ground truth exactly; format variations (e.g., spacing in dates or percentages) are acceptable and do not affect meaning. No calculation errors. (3) The multi-hop reasoning is sound—LLM synthesizes consistent data across three years and correctly infers that the lack of change indicates a deliberate long-term financing strategy focused on predictability and stability. It appropriately contrasts this stability with broader portfolio changes (implied in the original answer via mention of other notes), though it does not explicitly reference Unsecured Notes - 41A or retirements as context. This omission slightly weakens the qualitative depth but does not invalidate the conclusion. (4) The answer is factually complete, contextually relevant, and semantically equivalent to the ground truth. The minor deduction in qualitative accuracy is due to less contextual framing around other debt activities, but the core reasoning and conclusion remain valid. Correctness score is high because all critical facts and logic are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 385,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "From the 2023 10‑K, TI’s U.S. defined‑contribution plans held $940 million of TI common stock in 2022 and $873 million in 2023.  The 2024 10‑K shows the value fell further to $852 million.  The steady decline over three years reflects a modest drop in the company’s share price and/or employees selling or reducing their company‑stock holdings in retirement plans, indicating a shift toward diversification or risk‑management in their investment choices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three values from 2022 to 2024: $940 million (2022), $873 million (2023), and $852 million (2024), matching the ground truth exactly. These numbers are cited with proper sourcing from the 2023 and 2024 10-K filings, confirming multi-hop synthesis across years and documents. (2) All numeric values are accurate, and the trend of consistent decline is correctly identified. There are no calculation errors. (3) The reasoning is largely sound: the LLM correctly infers that the decline could reflect either employee behavior (selling or reducing holdings) or market factors (share price changes). It accurately suggests diversification or risk-management as potential drivers. However, it omits the specific fact mentioned in the ground truth about the freeze on new contributions into the TI common stock fund since 2016, which is a relevant structural factor. While the LLM’s explanation is plausible and semantically close, this omission slightly weakens the completeness of the causal analysis. (4) Despite this minor gap, the answer is factually correct, well-contextualized, and directly addresses both parts of the question—trend evolution and implications for stock performance and employee behavior. The contextual relevance is excellent, and the qualitative reasoning is strong, just short of full completeness on the underlying causes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 388,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "From 2022 to 2024, Disney’s workforce grew from roughly 220,000 employees to about 233,000.  U.S. employees increased from ~166,000 to ~171,000, while international employees rose from ~54,000 to ~62,000, and the share of seasonal workers climbed from 7 % to 8 % 【page_5】【page_16】.  Across all three years, a large portion of staff—especially those in theme‑park, production, and other key areas—remained covered by collective‑bargaining agreements, and employees outside the U.S. continued to be represented by works councils, trade unions, or other employee associations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key quantitative data points match: total workforce (220,000 in 2022 → 233,000 in 2024), U.S. employees (166,000 → 171,000), international employees (54,000 → 62,000), and seasonal workforce percentage (7% → 8%) are correctly reported. Minor formatting variations (~ and spacing around %) do not affect accuracy. (2) Calculations are sound: the sum of U.S. and international employees matches total workforce in both years (166k + 54k = 220k; 171k + 62k = 233k), and the increase in seasonal percentage is correctly stated. (3) Multi-hop reasoning is accurate—information spans workforce size, geographic distribution, seasonality, and employee representation across years, all correctly synthesized. (4) Entity and qualitative accuracy are strong: references to collective bargaining agreements, works councils, trade unions, and employee associations align with the original, particularly for theme park and production staff. The answer addresses all sub-questions: total employees, U.S. vs. international, seasonal percentages, and representation evolution. Semantic equivalence is maintained despite slightly expanded phrasing. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 354,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculations in 2022, 2023 and 2024 (the 10‑K filings all state that ROIC “excludes goodwill impairments and non‑economic accounting changes”). The unchanged treatment shows the company’s deliberate focus on core operating performance and a commitment to comparability across periods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD excluded non-economic accounting changes from ROIC in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion across all three years. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited. (3) The multi-hop reasoning is sound—by synthesizing GD’s ROIC methodology across three years of 10-K filings, the model correctly infers a stable approach to performance measurement. (4) The conclusion about GD’s focus on core operating performance and comparability aligns perfectly with the original answer’s interpretation of the company’s intent. Minor wording differences (e.g., 'deliberate focus' vs. 'emphasizing economic performance') do not affect factual accuracy. All aspects—factual, qualitative, and contextual—are fully accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 272,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In 2022 Linde’s 10‑K (pages 94‑98) focused on overall industrial‑gas sales and distribution methods and did not outline a distinct rare‑gas production strategy. By 2024 the 10‑K (page 4) states that Linde is “continuously developing a wide range of proprietary and patented applications and technologies to produce, store, distribute and increase usage of its gases,” explicitly highlighting rare gases such as krypton, neon and xenon. This evolution signals a strategic shift toward high‑margin rare‑gas markets, reinforcing Linde’s competitive advantage through its scale, integrated supply chain and technological leadership in the industrial‑gas industry.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Linde and the relevant time frame (2022 to 2024), and accurately notes the increasing emphasis on rare gases in Linde's 10-K filings. It correctly references technological development and mentions specific rare gases (krypton, neon, xenon), which aligns with the ground truth. However, it misses the key evolution highlighted in the original answer: Linde’s shift to positioning itself as a market leader in *non-cryogenic* air separation technologies by 2024, including specific methods like VPSA and membrane separation. This is a significant omission in the strategic evolution, as it reflects a core technological differentiation. Instead, the LLM answer generalizes the advancement as 'proprietary and patented applications,' which is less precise and fails to capture the specific technical shift that underpins the competitive advantage. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors here. The years 2022 and 2024 are correctly used. (3) The multi-hop reasoning is partially sound: the model infers a strategic shift based on increased mention of rare gases and technology, but it does not fully synthesize the progression from atmospheric gas production via cryogenic methods (2022–2023) to leadership in non-cryogenic methods (2024), which is central to the ground truth. This weakens the qualitative accuracy. (4) The contextual relevance is high because the answer addresses Linde’s rare gas strategy evolution and competitive advantage, using appropriate context from the 10-Ks. The conclusion about scale, supply chain, and technological leadership is reasonable but less specific than the ground truth. Thus, while the answer is factually consistent in broad strokes, it lacks the precise technological and strategic nuance that defines the actual evolution, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 529,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NEER’s share of net generating capacity that is locked into long‑term bilateral contracts grew from about 92 % in 2022 to 94 % in 2023 and remained at 94 % in 2024.  The steady rise and high coverage level show the company’s deliberate shift toward locking in revenue and hedging price risk, underscoring a risk‑management strategy that prioritizes revenue certainty in a volatile energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the percentage of NEER's net generating capacity under long-term bilateral contracts for 2022 (92%), 2023 (94%), and 2024 (94%), matching the ground truth exactly. All numeric values and years are accurate, with no calculation errors. (2) Quantitative accuracy is perfect—percentages and time periods align precisely with the original answer, and the trend description (increase from 92% to 94%, then stability) is correct. (3) The reasoning is sound: the LLM correctly infers that the trend reflects a strategy to lock in revenue and hedge price risk, which aligns with the ground truth’s emphasis on revenue stability and risk mitigation in a volatile market. While the original answer adds detail about non-qualifying hedges and a 'disciplined approach,' the LLM captures the core strategic implication. (4) The answer is contextually fully relevant, addressing both the evolution of contract reliance and its implication for risk management. The only minor shortcoming is the omission of the specific mention of non-qualifying hedges and the explicit characterization of the strategy as 'consistent' over the period, which slightly reduces qualitative completeness. However, the semantic meaning and factual core are preserved, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 369,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 stayed at a constant $495 million of outstanding principal from FY 2022 through FY 2024 (FY 2022: $495 million【page_103】; FY 2023: $495 million【page_81】; FY 2024: $495 million【page_81】). This unchanged balance shows the company has neither issued additional principal nor repaid any of this debt, reflecting a strategy of keeping a stable, low‑interest long‑term financing position for the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million across fiscal years 2022, 2023, and 2024, which matches the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: $495 million is consistently reported for each fiscal year, and the note's interest rate (3.125%) and maturity (January 2025) are correct. Format variations (e.g., $495 million vs $495M) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—information is correctly synthesized across three fiscal years from different pages of filings (page 103 for FY2022, page 81 for FY2023 and FY2024), demonstrating proper cross-document retrieval. (4) The qualitative interpretation is largely accurate: the LLM correctly infers that the stable balance indicates no repayment or new issuance, reflecting a strategy of maintaining stable, low-interest financing. This aligns with the ground truth’s conclusion about consistent liability management. The only minor shortcoming is that the LLM does not explicitly mention that this stability occurred despite broader changes in AVGO’s overall debt structure—a nuance present in the original answer—but this omission does not undermine the core correctness. Hence, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 402,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 37B remained unchanged, with a face amount of $700,000 and a maturity date of January 15 , 2032 in each filing (SPG_10k_2022.pdf p. 50; SPG_10k_2023.pdf p. 50; SPG_10k_2024.pdf p. 51). The consistency of both the face amount and the maturity date indicates that the company has not altered this long‑term debt instrument, maintaining a stable debt profile rather than refinancing or restructuring it. This reflects a conservative long‑term debt strategy focused on predictable cash‑flow obligations and minimizing refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the face amount of $700,000 and maturity date of January 15, 2032 (formatted as 01/15/32 in the original) are accurately reported for all years (2022–2024), with no discrepancies. Minor formatting differences (e.g., 'January 15, 2032' vs '01/15/32') are semantically equivalent and acceptable. (2) The answer is complete, addressing both the evolution of face amount and maturity date across the three years, and correctly infers the strategic implication of SPG's stable debt profile. (3) Entity accuracy is perfect: SPG is correctly identified, the instrument 'Unsecured Notes - 37B' is accurately referenced, and the years 2022–2024 are properly handled. (4) The multi-hop reasoning is sound—information is synthesized across three annual filings (2022, 2023, 2024), and the conclusion about SPG’s conservative long-term debt strategy (avoiding refinancing, maintaining predictability) is logically supported by the unchanged terms. (5) The LLM adds value by explicitly citing document sources and elaborating on the strategic rationale (predictable cash flows, reduced refinancing risk), which is consistent with and enriches the ground truth without introducing error. All scores are maximized due to full factual accuracy, completeness, and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 377,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia facility has consistently been an **analog‑only** site across the three reporting years. The 2022, 2023, and 2024 property tables all list an “X” under the Analog column for Melaka and leave the Embedded Processing column blank, indicating no embedded‑processing activity at that location during 2022‑24.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility has remained exclusively focused on analog operations from 2022 to 2024, with no involvement in embedded processing—matching the original answer's key claim. (2) The use of 'X' instead of 'checkmark' is a minor formatting difference but refers to the same indicator in the source tables; this does not affect factual accuracy. All years (2022, 2023, 2024) are correctly referenced with consistent operational status. (3) The reasoning reflects proper multi-hop synthesis across three years of data, correctly identifying the absence of change over time and the consistent specialization in analog products. (4) All entities—Texas Instruments, Melaka, Malaysia, analog, embedded processing, and the three-year timeframe—are accurately identified and correctly related. The answer is concise, factually precise, and fully aligned with the ground truth, warranting top scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 299,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney continued to list post‑production services from Industrial Light & Magic as part of the “Other revenue” within its Content Sales/Licensing segment in each of the fiscal 2022, 2023, and 2024 10‑Ks. The segment’s structure remained essentially unchanged, with ILM’s revenue consistently reported alongside music, stage‑play, and Skywalker Sound services. Thus, Disney’s reliance on ILM for post‑production services stayed stable over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the stability and structural consistency of Industrial Light & Magic's (ILM) role within the Content Sales/Licensing segment from fiscal 2022 to 2024. While it correctly identifies that ILM provided post-production services reported within the segment across the years, it contradicts the ground truth by asserting that the segment structure 'remained essentially unchanged' and that ILM’s revenue was consistently grouped with music, stage-play, and Skywalker Sound. The original answer indicates a clear evolution: in 2022, ILM was explicitly listed; in 2023, the segment began emphasizing TV/VOD and theatrical distribution, signaling a shift in focus; and in 2024, ILM’s role was increasingly framed within broader content licensing and Disney’s DTC-first model, suggesting strategic repositioning. The LLM fails to capture this nuanced, multi-hop evolution, instead asserting stability where there was transformation. There are no numerical inaccuracies (hence full quantitative accuracy), but the qualitative reasoning is flawed—missing the shift in narrative emphasis and strategic context. The answer is partially relevant but overlooks the key dynamic of changing reliance and integration, leading to a low correctness score despite accurate entity and year identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 372,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method income from operating joint ventures fell from **$51 million in 2022 to $38 million in 2023**, then surged to **$175 million in 2024**. The sharp rebound in 2024 indicates that the company’s insurance‑underwriting joint ventures recovered and delivered substantially stronger profitability after a weaker year in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The original answer states MetLife's equity method investment income was $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. The LLM reports $51 million (2022), $38 million (2023), and $175 million (2024), which are off by more than 95% in each year. These are not minor rounding or formatting differences but fundamental factual errors. (2) Calculations and trends are therefore also incorrect: while both answers describe a decline followed by a rebound, the magnitude of change is entirely misrepresented. The actual decline was from $1,305M to $151M (an 88.4% drop), not $51M to $38M (25.5% drop); the actual 2024 rebound reached $988M (6.5x increase from 2023), whereas the LLM suggests a rise to $175M (4.6x). (3) The multi-hop reasoning is partially sound in structure—identifying a downturn and recovery trend—but based on completely inaccurate data. The entity identification (MetLife, equity-method investment income, operating joint ventures) is correct, and the time frame (2022–2024) is properly addressed. (4) The contextual relevance is moderate because the answer attempts to interpret the trend in performance of insurance underwriting joint ventures, aligning with the question’s intent. However, due to severe quantitative inaccuracies, the qualitative and overall correctness scores are very low. The conclusion about recovery is directionally similar but lacks fidelity given the wrong scale. Correctness score is 2 due to complete failure on numbers but partial credit for attempting the right analysis framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 448,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics produced 449 new Light Armored Vehicles (LAVs) for the Canadian Army in 2022, 399 in 2023, and 360 in 2024—a steady decline in new deliveries (see GD_10k_2022 page 10, GD_10k_2023 page 11, GD_10k_2024 page 9).  The downward trend reflects a shift in the Canadian order mix toward upgrades and modernization rather than new production, yet the LAV platform remains a strategically important export and modernization asset in General Dynamics’ land‑systems portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the production numbers for the Canadian Army LAVs across the years, stating 449 units in 2022, 399 in 2023, and 360 in 2024, while the ground truth shows an increasing trend: 360 in 2022, 399 in 2023, and 449 in 2024. This inversion of data is a critical factual error. (2) The numbers themselves (360, 399, 449) are correct in value but completely misaligned with the years, leading to an incorrect interpretation of a 'decline' instead of a 'growth' trend. Calculations or comparisons based on these misassigned values are therefore invalid. (3) The multi-hop reasoning fails because the model did not correctly associate the production figures with their respective years across the 10-K filings, undermining the synthesis required to assess the strategic trajectory. While the LLM correctly identifies the LAV platform as strategically important, this conclusion is drawn from flawed data and an incorrect trend. (4) The contextual relevance is moderate because the answer addresses the right topic and cites appropriate documents, but the reversed timeline and resulting incorrect analysis severely compromise factual correctness. The qualitative reasoning about strategic importance is partially sound but built on false premises. Quantitative accuracy is very low due to the year-to-number mismapping, warranting a score of 2. Correctness is similarly low because the core factual progression is inverted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 401,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan’s hedge‑fund limited‑partnership exposure rose steadily, increasing from $225 million in 2022 to $252 million in 2023 and to $280 million in 2024 (≈ 12 % growth each year)【page_174】【page_168】【page_167】.  The target allocation for hedge funds grew from 3 % in 2023 to 4 % in 2024【page_175】【page_169】, reflecting a deliberate shift toward greater alternative‑asset exposure to enhance expected returns and diversify beyond traditional fixed‑income holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM states $225M in 2022, $252M in 2023, and $280M in 2024—shifting and inflating all values. This misrepresents the entire trend. Additionally, the claimed ~12% annual growth is incorrect; the actual growth is approximately 5.1% (2022–2023) and 12% (2023–2024), not consistent 12% yearly. (2) The target allocation increase from 3% to 4% between 2023 and 2024 is not present in the original answer and introduces unsupported details. While the general direction of increasing alternative investments aligns with the ground truth, the specific figures and calculations are wrong. (3) The multi-hop reasoning is partially sound—the model attempts to synthesize a trend and infer strategic intent—but it does so on incorrect data, undermining the conclusion. (4) The contextual relevance is fair because the answer addresses the evolution of hedge fund exposure and interprets it in terms of asset allocation strategy, which matches the question’s intent. However, due to major quantitative errors, the correctness score is low despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 359,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Sorriso has remained a core local brand within Colgate‑Palmolive’s Oral Care segment throughout 2022‑2024, as evidenced by its consistent listing among the company’s principal global and regional trademarks in each 10‑K (page 79 of 2022, 2023 and 2024). The brand continues to be integrated into the global Oral, Personal and Home Care product portfolio, with no reported divestiture or repositioning during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Sorriso was consistently listed as a principal trademark in Colgate-Palmolive's 10-K filings for 2022, 2023, and 2024, confirming its ongoing role in the company's regional branding strategy within the Oral, Personal and Home Care portfolio. The mention of page 79 across all three years adds precise sourcing and supports the claim of continuity. The answer correctly notes no divestiture or repositioning, which is consistent with the ground truth's emphasis on strategic stability. The only minor shortcoming is that the LLM slightly narrows the focus to 'Oral Care' rather than the broader 'Oral, Personal and Home Care' segment mentioned in the original answer, potentially underrepresenting the brand’s full integration scope. However, this does not constitute a factual error, as Sorriso falls primarily under Oral Care. All entities (Colgate-Palmolive, Sorriso, correct years), reasoning (multi-hop synthesis across three annual reports), and conclusions (stable strategic positioning) are sound. Number formats and dates are accurate. Semantic equivalence is high, with only slight variation in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 341,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s net investment income from operating joint ventures fell from $51 million in 2022 to $38 million in 2023, then surged to $175 million in 2024 (page 224). This sharp uptick in 2024 signals a deliberate shift toward greater equity‑method exposure in operating joint ventures, underscoring the company’s strategy to diversify earnings and capture growth opportunities in these partnerships (page 222).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and interpretation. The original answer states that MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further to $38 million in 2024. In contrast, the LLM claims exposure was $51M in 2022, $38M in 2023, and then surged to $175M in 2024—contradicting the trend and values at every point. Only the $38M figure for 2023 coincidentally matches the ground truth value for 2024, but it is assigned to the wrong year. (2) The quantitative inaccuracies are severe: the starting value is wrong ($51M vs $77M), the 2023 value is misassigned, and the 2024 value is wildly inflated ($175M vs $38M). The claim of a 'surge' is the opposite of the actual downward trend. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is fundamentally flawed. Instead of recognizing a consistent reduction in exposure indicating a strategic retreat, the LLM incorrectly infers increased strategic emphasis due to a non-existent surge. This reflects a complete failure to synthesize the correct trend across years. (4) The contextual relevance is low but not zero—the answer does address financial exposure to joint ventures and attempts to infer strategy, so the general topic is relevant. However, due to pervasive factual and logical errors, the conclusion is diametrically opposed to the truth. Scores reflect near-total factual inaccuracy with only minimal credit for addressing the general subject area.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 429,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s equity stake in Angola LNG Limited has stayed constant at 36.4 % from 2022 through 2024, with the company recording an investment of $1.96 B in 2022 and $1.76 B in 2023–24 [page_78].  In 2022 Chevron’s role was limited to a passive equity affiliate, but by 2024 it had become an active participant in upstream projects that feed the LNG plant, notably the Block 0 Sanha Lean Gas Connection Project and the New G as Consortium Project, both of which tie pipelines and platforms directly to Angola LNG [page_12, page_14].  This evolution reflects a shift from a purely investment‑focused position to a more integrated upstream‑downstream strategy that links Chevron’s gas production to the LNG terminal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: Chevron's 36.4% stake is consistently reported across 2022–2024, and the investment values of $1.96B in 2022 and $1.76B in 2023–24 are factually sound (minor decrease likely due to depreciation or equity adjustments, which is plausible). These numbers match expectations and are presented with acceptable formatting. (2) The evolution in Chevron’s operational role—from passive equity investor in 2022 to active participant by 2024—is correctly captured. The mention of integration with upstream projects like the New Gas Consortium (NGC) Project and the Block 0 Sanha Lean Gas Connection Project is accurate and reflects the increased operational linkage to the Soyo LNG plant. (3) The qualitative reasoning is strong: the shift from passive investment to integrated upstream-downstream strategy is logically inferred and supported by the cited projects. However, the ground truth specifically names Quiluma and Maboqueiro fields as feedstock sources via NGC, which the LLM omits—this is a minor but notable omission in entity specificity. (4) Contextual relevance is excellent: the answer directly addresses all components of the question—stake percentage, operational role evolution, and integration with upstream gas projects. The synthesis across years and projects demonstrates sound multi-hop reasoning. The only reason for not scoring a 10 is the lack of explicit mention of Quiluma and Maboqueiro fields, which are key to the upstream integration narrative in the original answer. Overall, the LLM conveys semantically equivalent information with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 460,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO’s 3.625% notes due October 2024 were outstanding at $622 million at the end of FY 2022 and FY 2023 (as shown in the 2023 10‑K debt schedule) and were fully extinguished by the end of FY 2024 (the FY 2024 schedule lists $0 for that note). This pattern shows that AVGO proactively refinanced or repaid the notes before maturity—using proceeds from the senior notes issued in July and October 2024—demonstrating a disciplined debt‑management strategy that reduces interest expense and keeps covenant compliance strong.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the outstanding amount of $622 million in FY 2022 and FY 2023 and accurately states that the liability was fully extinguished by FY 2024, aligning with the ground truth. All numeric values, dates, and percentages are correct. (2) Quantitative accuracy is perfect: $622 million in 2022 and 2023, $0 in 2024, and the note's interest rate (3.625%) and maturity (October 2024) are correctly cited. (3) The multi-hop reasoning is sound—comparing disclosures across fiscal years to infer retirement of debt. The LLM adds a plausible explanation involving senior notes issued in July and October 2024, which is consistent with proactive debt management. However, the original answer does not mention the specific refinancing notes or timing (July/October 2024), so this detail, while reasonable, is an inference not confirmed in the ground truth, slightly reducing qualitative accuracy. (4) The answer is contextually excellent—directly addresses both the evolution of exposure and the implied debt strategy. The minor addition of refinancing details does not contradict facts but adds unverified specificity. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 345,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "The annual debt service for Unsecured Notes – 35B was $28,500 in 2022 (page 50), 2023 (page 50), and 2024 (page 51).  Because the note’s interest rate (3.80 %) and face amount ($750,000) stayed unchanged, the interest expense remained flat, showing that SPG’s financing cost for this instrument has been stable and predictable over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All numbers are accurate: interest expense is correctly reported as $28,500 (in thousands) for 2022, 2023, and 2024, matching the original answer. The additional context—interest rate of 3.80% and face amount of $750,000—is consistent with a fixed-rate note and explains the stability in expense. (2) Quantitative accuracy is excellent: no calculation errors, and values are correctly attributed across years. Format ($28,500) matches the ground truth when accounting for units (in thousands). (3) Multi-hop reasoning is sound: the model correctly infers that unchanged interest expense over time implies a fixed-rate structure, which is a valid conclusion from the data. It synthesizes the stable dollar amount with the unchanging rate and principal to explain the trend. (4) The answer addresses both parts of the question: the evolution of interest expense (stable across years) and what the trend suggests (stable, predictable financing costs due to fixed-rate debt). Semantic equivalence is strong, with the LLM providing even more supporting detail (rate, face value) than the original. All entities—SPG, Unsecured Notes - 35B, years 2022–2024—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 355,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "From 2022 to 2024 Disney shifted its DTC investment strategy from a single‑stream launch to a broader, cost‑containing overhaul of its media and entertainment distribution (DMED). In 2022 it announced an ad‑supported Disney+ and price‑realignment; in 2023 it reorganized DMED into Entertainment and Sports, removed under‑performing titles, and launched ESPN+ while taking impairment charges (page 26‑27). By 2024 the company was still investing heavily in content (≈$24 bn expected for 2025) but tightened costs, transferred Star India to a joint venture, and focused on a bundled, ad‑supported model to compete with an increasingly crowded DTC market, all while managing rising programming costs and intensified competition (page 23‑28, 51).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Disney's DTC strategy from 2022 to 2024 and correctly identifies key themes such as rising programming costs, intensified competition, and a strategic shift toward streaming. It appropriately notes structural changes like the reorganization of DMED, the launch of ad-supported tiers, cost containment, and bundling. However, there are significant factual inaccuracies that reduce correctness. First, the claim that Disney shifted from a 'single-stream launch' is misleading—Disney+ launched with multiple tiers, including ad-free, before introducing the ad-supported version in 2022. Second, the $24 billion expected content investment for 2025 is not present in the ground truth and cannot be verified from the provided context; this is a specific numerical error. Third, the transfer of Star India to a joint venture is factually correct but not mentioned in the original answer, suggesting possible hallucination or unsupported inference. The impairment charges and page references (e.g., page 26–27, 51) are not corroborated in the ground truth, which does not cite any pages. While the LLM correctly identifies strategic shifts like ad-supported models and cost discipline, it fails to mention key elements from the original answer: the acknowledgment of negative or low returns in 2022, the reliance on subscription and ad revenue to offset declining affiliate fees, and the $12.25 billion in unused bank facilities as a financial enabler. The reasoning is partially sound but lacks precise multi-hop synthesis from the original knowledge graph—instead, it introduces external details not in the ground truth. Quantitative accuracy is low due to unsupported figures and lack of verification. Contextual relevance is high as the answer addresses the core themes of investment strategy, competition, and streaming shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 504,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife has continued to apply the deposit method to all reinsurance agreements that do not expose it to a significant insurance‑risk loss.  In 2023, the balance of deposit assets rose to $5.1 billion and deposit liabilities to $1.3 billion, largely because the November 2023 risk‑transfer with Global Atlantic added $10.3 billion of deposit receivables and a $770 million net cost recorded as a liability (page 206).  By year‑end 2024 the balances had fallen to $4.6 billion in assets and $1.2 billion in liabilities, reflecting the settlement of that transaction and other reinsurance adjustments; 2022 balances were lower but are not disclosed in the provided pages.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has significant quantitative inaccuracies. It correctly identifies the 2023 risk transfer transaction with Global Atlantic involving $10.3 billion in reinsurance recoverables/deposit receivables and notes the decline in deposit assets and liabilities by 2024. It also correctly states that 2024 deposit assets were $4.6 billion and liabilities $1.2 billion, matching the ground truth. However, it incorrectly reports 2023 deposit assets as $5.1 billion and liabilities as $1.3 billion, which contradicts the original answer that does not provide 2023 year-end totals but implies a significant increase due to the transaction. More critically, the LLM claims the $10.3 billion was recorded as 'deposit receivables' and a '$770 million net cost recorded as a liability'—this detail is not in the ground truth and appears to be a misinterpretation or hallucination. The original answer states MetLife recorded $10.3 billion in 'reinsurance recoverables and deposit receivables' collectively, not solely as deposit receivables, and makes no mention of a $770 million liability. Additionally, the LLM admits 2022 balances are 'not disclosed in the provided pages,' while the ground truth clearly states they were $1.8 billion (assets) and $1.4 billion (liabilities), so this is a failure in completeness and accuracy. (2) Number verification: $4.6B assets and $1.2B liabilities in 2024 = correct. $10.3B transaction = correct. 2023 assets = $5.1B (LLM) vs. unreported but implied higher due to $10.3B addition (truth) = partial credit. 2022 numbers missing = major omission. $770M liability = unsupported. (3) Multi-hop reasoning: The model connects the Global Atlantic transaction to the change in deposit method accounting and traces the evolution into 2024, showing sound qualitative logic. However, it fails to incorporate the known 2022 baseline and introduces unverified figures, weakening the synthesis. (4) Correctness score of 6 reflects partially correct facts with major omissions and one significant fabrication (the $770M liability). Quantitative accuracy is low (5) due to incorrect numbers and unsupported calculations. Qualitative accuracy is moderate (7) because the narrative flow and reasoning structure are logical and contextually appropriate, despite factual flaws. Contextual relevance is high (9) as the answer directly addresses the evolution of MetLife's accounting method and the impact of the Global Atlantic deal.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 665,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities (CMBS) holdings declined steadily: the fair value fell from about $1.018 billion at December 31 2022【147】 to roughly $975 million at December 31 2023【148】, while the unrealized loss position shrank from $155 million to $100 million【149】【150】. By December 31 2024 the company’s CMBS exposure was virtually eliminated, with only $3 million of CMBS held in separate accounts【160】. This 3‑year trajectory indicates a deliberate divestiture and a shift away from CMBS, reflecting a strategy to reduce risk and reallocate capital to other investment classes.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and dropped to $3 million in 2024. However, the LLM claims the value was $1.018 billion in 2022 and $975 million in 203, which are materially higher and incorrect. The only correct figure is the $3 million in 2024. These errors affect the core of the answer, as the trend described (steady decline) contradicts the actual trajectory (increase then sharp drop). (2) The calculations and comparisons are therefore flawed: the LLM suggests a steady decrease from over $1 billion to $3 million, while the truth shows a rise from $574M to $675M before collapsing to $3M. The mention of unrealized losses ($155M to $100M) adds detail not present in the ground truth and cannot be verified against it, potentially introducing fabricated data. (3) The multi-hop reasoning is partially sound—the conclusion about strategic divestiture and de-risking aligns with the original answer’s interpretation of the 2024 drop. The LLM correctly infers strategic intent from the near-elimination of CMBS exposure by 2024. However, because the intermediate data points are wrong, the reasoning is based on incorrect premises for 2022 and 2023. (4) Despite the numerical inaccuracies, the answer is contextually relevant and addresses both parts of the question—evolution over time and strategic implication. The final conclusion about risk reduction and capital reallocation matches the ground truth. Hence, correctness is scored at 6 due to major quantitative flaws but correct directional conclusion; quantitative accuracy is low (4); qualitative reasoning is decent (7); and relevance is high (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 479,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across 2022, 2023 and 2024 the “hello” brand remained listed among Colgate‑Palmolive’s principal global and regional trademarks, underscoring its continued importance in the company’s portfolio (CL_10k_2024, p.79; CL_10k_2023, p.79; CL_10k_2022, p.79).  The brand is positioned within the Oral Care sub‑segment of the Oral, Personal and Home Care segment, which consistently accounted for roughly 43 % of net sales in 2022 and 2024 and 42 % in 2023, indicating a stable strategic emphasis on oral‑care products that includes “hello” (CL_10k_2024, p.79; CL_10k_2023, p.79; CL_10k_2022, p.79).  No filings disclosed a shift in positioning or a change in strategic focus for the brand beyond its continued presence in the trademark list and its role in the oral‑care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 'hello' brand was consistently listed in Colgate-Palmolive’s principal trademarks across 2022, 2023, and 2024, and remained within the Oral, Personal and Home Care segment, specifically in Oral Care. The percentages of net sales (43% in 2022 and 2024, 42% in 2023) are accurately reported and correctly attributed to the Oral Care sub-segment, showing stable strategic emphasis. These numbers match the expected data and are cited with consistent page references (p.79 across all 10-Ks), supporting quantitative accuracy. (2) The entity identification is correct—Colgate-Palmolive (CL), the 'hello' brand, the relevant time frame, and the segment structure are all properly identified. (3) The multi-hop reasoning is sound: the model synthesizes trademark disclosures across three years and links them to segment-level sales data to infer continued strategic positioning. It correctly infers no shift in positioning due to consistent disclosure and stable sales contribution. (4) The only minor limitation is that the original answer emphasizes the brand’s role in 'diversification and consumer engagement strategies,' which the LLM answer does not explicitly mention. While the conclusion of 'continued importance' and 'stable strategic emphasis' captures the essence, this slight omission in strategic interpretation prevents a perfect 10 on qualitative accuracy. However, the LLM answer remains factually correct, complete in scope, and contextually precise, earning a 9/10 overall for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 439,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife has continued to use the deposit method for reinsurance agreements that do not expose it to a significant insurance‑risk loss, as noted in the 2024 10‑K (page 206).  The balance‑sheet amounts for deposit‑method reinsurance fell from $5.1 billion of assets and $1.3 billion of liabilities in 2023 to $4.6 billion of assets and $1.2 billion of liabilities in 2024, indicating a modest contraction in the volume of such agreements.  The decline in deposit assets relative to liabilities suggests the company is slightly reducing its use of deposit‑method reinsurance, but it still relies heavily on collateralized, low‑risk transfer arrangements to manage counter‑party exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that deposit assets decreased from $5.1 billion in 2023 to $4.6 billion in 2024, but the ground truth shows deposit assets increased from $1.8 billion in 2022 to $4.6 billion in 2024, with no mention of $5.1 billion in 2023. The 2023 figure in the ground truth is not provided numerically but described as part of a broader accounting framework, not a decline from a higher value. The liabilities are correctly stated as $1.3B to $1.2B, which is close to the ground truth ($1.4B in 2022, $1.2B in 2024), but the trend interpretation is flawed due to incorrect asset figures. (2) The quantitative error is severe: the LLM invents a $5.1B asset value for 2023 that does not exist in the ground truth, misrepresenting the trend as a decrease rather than a significant increase over time. This invalidates any calculation or comparison based on that number. (3) The multi-hop reasoning is unsound. The ground truth identifies a strategic increase in deposit-method reinsurance, especially post-Global Atlantic transaction, indicating expanded use of such structures. The LLM incorrectly infers a 'modest contraction' and 'slight reduction', which contradicts the actual upward trend. It also fails to mention the 2022 baseline ($1.8B assets, $1.4B liabilities) and the strategic shift noted in 2023’s accounting framework change. (4) While the LLM correctly references the 2024 10-K and the concept of deposit method for low-risk transfers, the core numerical and trend analysis is incorrect, leading to a wrong conclusion about MetLife’s reinsurance strategy. The contextual relevance is moderate because it addresses the right topic and uses appropriate terminology, but the factual foundation is flawed, severely undermining correctness and qualitative reasoning. Scores reflect major factual errors in numbers and interpretation, despite some correct conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 527,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "NEE’s special‑use funds grew markedly over the period – from $4,437 m (NEE) and $2,905 m (FPL) in 2022 to $5,290 m and $3,536 m in 2023, and to $9,800 m and $8,698 m in 2024 – and the amounts are disclosed in the recurring non‑derivative fair‑value measurements table (Level 1/2) in the notes.  The credit‑risk‑related contingent features of derivative contracts that could trigger collateral posting fell from an aggregate liability of $7.4 billion in 2022 to $4.7 billion in 2023, reducing the potential collateral requirement (from ~$5.2 billion to ~$2.4 billion if ratings dropped below investment grade).  On the balance sheet the special‑use funds remain classified under “Other assets” and are carried at fair value (with debt securities at amortized cost), and the 2024 balance sheet reflects a substantial increase in these assets due to expanded nuclear decommissioning and storm‑fund holdings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. First, the reported values for Special Use Funds are incorrect: the ground truth states that NEE's total Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024, but the LLM claims $5,290M and $3,536M in 2023 (split between NEE and FPL), then jumps to $9,800M and $8,698M in 2024—appearing to reverse the entities and misstate the totals. The 2022 figures of $4,437M (NEE) and $2,905M (FPL) do not align with the ground truth, which does not break out FPL separately or provide those specific numbers. The increase from 2023 to 2024 is correctly noted as substantial and ends at $9.8B in 2024, but the path is wrong. Additionally, the mention of 'debt securities at amortized cost' contradicts the ground truth that these funds are carried at fair value, undermining valuation accuracy. The collateral discussion references derivative-related contingent features and declining exposure ($7.4B to $4.7B), but this data is not present in the original answer and appears fabricated or misattributed—no such figures were in the ground truth. While the LLM correctly identifies enhanced disclosure in fair value measurements (Level 1/2) and balance sheet classification under 'Other assets', it fails to mention the key evolution in 2023 about equity investments without readily determinable fair values increasing from $485M to $538M—a critical qualitative development. The reasoning is partially sound in identifying trends in transparency and balance sheet presentation, but the multi-hop synthesis is flawed due to incorrect entity aggregation (NEE vs FPL) and insertion of unsupported numbers. Despite these issues, the answer remains contextually relevant, addressing fair value disclosures, collateral implications, and balance sheet treatment as asked, and correctly notes the 2024 balance sheet explicitly listing the $9.8B figure. However, the numerous factual and numerical errors, especially in core financial data and calculations, severely reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 557,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "AVGO’s Security Insights Platform has been positioned consistently as a mainframe‑focused security solution that quickly interprets posture, identifies risks, and generates remediation steps, with the data made available for integration into customers’ in‑house SIEM tools. Across the 2022, 2023, and 2024 10‑K filings, the description remained essentially unchanged, continuing to emphasize ongoing and ad‑hoc remediation workflows and the ability to feed data into existing security information and event‑management systems. Thus, the platform’s core positioning and integration focus did not evolve materially over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AVGO's Security Insights Platform is consistently described from 2022 to 2024 as a mainframe security tool focused on risk identification and posture assessment, with integration into in-house SIEM tools. The answer correctly notes no material evolution in the platform’s description or capabilities over the period. (2) There are no numeric values requiring calculation (e.g., financial figures, percentages), so quantitative accuracy is not applicable beyond correct mention of years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning—synthesizing the platform's description across three years of filings—is sound. The LLM correctly infers that unchanged language implies stable positioning and lack of new integration features, aligning with the ground truth. (4) The only minor deviation is that the LLM mentions 'generates remediation steps,' which is slightly stronger than the original answer’s 'identifying risks' and 'remediation workflows'—the latter implying support for workflows but not necessarily generating steps. This is a subtle overstatement but does not materially misrepresent the facts. Overall, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 367,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike has maintained the same ownership and operational status for its Laakdal, Belgium distribution facility throughout FY 2022, FY 2023 and FY 2024 – the facility is listed as one of the company’s most significant non‑U.S. distribution centers and is owned by Nike in each filing (2022 p. 29; 2023 p. 29; 2024 p. 29). The unchanged ownership and continued use as a distribution hub indicate that Laakdal is a strategically critical node in Nike’s European logistics network, providing a stable, controlled point of distribution for EU markets and reinforcing the company’s focus on maintaining key regional hubs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that NIKE's ownership and operational footprint at the Laakdal, Belgium facility remained unchanged across fiscal years 2022, 2023, and 2024, with the facility being company-owned and described as one of the most significant non-U.S. distribution centers each year. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years and page references (2022 p.29, etc.) are correctly cited and consistent with the expected sourcing, supporting factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual reports to confirm consistency in ownership and strategic designation, and inferred the strategic importance based on this stability. (4) The conclusion about Laakdal being a 'strategically critical node' and 'stable, controlled point of distribution' aligns with the original answer’s interpretation of the facility’s ongoing importance to NIKE’s European logistics network. All aspects of the question—evolution (or lack thereof) and strategic implication—are addressed completely and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 340,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 32B stayed unchanged: a 3.38 % interest rate, a face amount of $750,000, and a maturity of June 15 2027 (2022 10‑K page 50; 2023 10‑K page 50; 2024 10‑K page 53).  The unchanged terms suggest a deliberate strategy of keeping this long‑term debt stable—avoiding refinancing or rate adjustments—to preserve predictable interest costs and align the note’s maturity with the company’s long‑term cash‑flow profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the interest rate (3.38%), face amount ($750,000), and maturity date (June 15, 2027) are correctly reported for the 2022–2024 period. The LLM correctly notes the consistency of these terms across years, aligning with the ground truth observation of stability. (2) Quantitative accuracy is perfect: all numbers and dates match the original answer. The maturity date is correctly identified as June 15, 2027, and while the ground truth notes it was 'unspecified' in 2022, the LLM’s inclusion of the date with citation to the 2022 10-K (page 50) suggests it was in fact disclosed, which does not contradict the knowledge graph but may reflect a more precise data point. This does not constitute an error. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three years and correctly infers that unchanged terms indicate a stable long-term debt strategy, avoiding refinancing—this matches and slightly enriches the original answer’s conclusion. (4) The answer is contextually complete, addressing all parts of the question: evolution of interest rate, face amount, maturity date, and strategic implication. Wording differs but meaning is identical. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 369,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "CVS’s foreign‑security holdings fell from $2.55 billion in 2022 to $2.51 billion in 2023, with unrealized losses dropping from $244 million to $122 million (2023 10‑K, page 147).  In 2024 the company’s foreign securities in separate accounts were only $51 million and no unrealized losses were reported (2024 10‑K, page 160), indicating a sharp cut in foreign exposure.  The trend points to CVS trimming its international market risk, likely reallocating capital to domestic or other asset classes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's foreign securities had a fair value of $838 million in 2022 and increased to $1,650 million in 2023, but the LLM incorrectly reports $2.55 billion in 2022 and $2.51 billion in 2023—values that are both directionally and numerically incorrect. Additionally, the LLM states unrealized losses were $244 million in 2022, whereas the ground truth reports $24 million, a tenfold error. While the 2024 figure of $51 million is correct and aligns with the ground truth, the claim that 'no unrealized losses were reported' contradicts the ground truth, which states $122 million in unrealized losses in 2023 but does not specify 2024 losses—so asserting 'no losses' introduces unsupported information. (2) Calculations and comparisons are flawed: the LLM suggests a slight decrease from 2022 to 2023, while the actual trend was a near doubling. The sharp drop in 2024 is correctly identified, but the baseline is wrong, undermining the analysis. (3) The multi-hop reasoning is partially sound—the model correctly infers reduced foreign exposure and possible de-risking from the drop in 2024—but this conclusion is based on incorrect earlier data, weakening the validity. It also fails to note the significant increase in 2023, which is a critical part of the trend. (4) Contextual relevance is high because the answer addresses the evolution over time and interprets risk exposure appropriately. However, due to major quantitative errors in core data points, the correctness score is low despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 452,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s 2022‑24 10‑Ks show that internally developed designations for non‑agency RMBS and CMBS were used only for newly acquired securities that had not yet been evaluated by the NAIC (2022: page 99; 2023: page 92; 2024: page 82).  The total RMBS holdings under NAIC categories rose from $26.2 bn in 2022 to $29.1 bn in 2023 and $34.1 bn in 2024【page_96】【page_86】, indicating a decline in the use of internal designations and a growing reliance on NAIC’s modeling methodology for credit‑quality assessment【page_84】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core trend—that MetLife used internally developed designations only for newly acquired non-agency RMBS and CMBS until NAIC designations became available, and that reliance on NAIC methodology increased over time. This aligns with the ground truth’s narrative of a transitional phase toward standardized NAIC assessments. However, the LLM introduces specific dollar figures for total RMBS holdings under NAIC categories ($26.2B in 2022, $29.1B in 2023, $34.1B in 2024) that are not present in the ground truth and cannot be verified against it. These numbers may be factually accurate in the source documents, but their absence in the ground truth—especially since the ground truth focuses on Level 3 AFS securities growth ($4.2B in 2023, $1.6B in 2024)—represents a mismatch in focus and potentially misleading precision. (2) The ground truth emphasizes changes in Level 3 fixed maturity securities AFS as a proxy for internal designation use, with a 14.5% increase in 2023 and 4.9% in 2024. The LLM does not mention these percentages or the Level 3 context, which is a key analytical point in the original answer. Instead, it substitutes its own metric (total NAIC-categorized RMBS holdings), which, while possibly valid, shifts the basis of reasoning and omits the critical link to internal designation reliance via Level 3 classification. (3) The multi-hop reasoning is partially sound: the LLM connects internal designations to NAIC evaluation delays across three years and infers growing reliance on NAIC methodology. It correctly synthesizes information across 2022–2024 filings and cites appropriate pages. However, it fails to incorporate the Level 3 securities growth trend, which is central to the ground truth’s conclusion about declining reliance on internal models. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of internal designations and implications for NAIC reliance. The qualitative reasoning is logical and well-structured, but the lack of alignment with the ground truth’s key metrics reduces quantitative accuracy. Thus, while the overall direction of the conclusion is correct, the evidentiary support differs, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 610,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "From 2022 through 2024, Chevron’s footprint in the Republic of Congo shifted from modest investment to divestiture. In 2023 the company expended roughly $0.7 billion on offshore development and natural‑gas projects in Congo (page 110), while the 2024 10‑K reports the sale of its 31.5 % non‑operated working interest in the Haute Mer permit area and its 15.75 % interest in the Lianzi field (effective January 2025) (page 43). No Congo‑related capital allocation or ownership change was disclosed in the 2022 filing (pages 31‑35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key developments in Chevron's footprint in the Republic of Congo from 2022 to 2024. It accurately states that no Congo-specific capital allocation or ownership change was disclosed in 2022, consistent with the ground truth. In 2023, it correctly reports the $0.7 billion investment in African offshore and natural gas projects, which included Congo among other countries. In 2024, it accurately details the sale of Chevron’s 31.5% nonoperated working interest in Haute Mer and 15.75% in Lianzi. (2) All numeric values—$0.7 billion, 31.5%, 15.75%—are correct and match the ground truth. The mention of 'effective January 2025' is a minor addition not in the original answer but plausible given reporting timing and does not contradict facts. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers a strategic shift from operation to divestiture. It appropriately notes the absence of Congo-specific disclosures in 2022, links the 2023 investment to broader African projects including Congo, and confirms full exit via 2024 divestitures. (4) The answer is semantically equivalent to the ground truth, with only slight rewording and added document page references (which are acceptable and may reflect source fidelity). The only minor shortcoming is the lack of explicit framing of the overall 'strategic exit' narrative, though the facts presented fully support it. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 417,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "From 2022 through 2024 Texas Instruments has kept embedded‑processing products at the heart of its business model, repeatedly citing them as part of the broad‑portfolio advantage (b) in the MD&A (2022‑24 MD&A pages 18). Each year’s MD&A stresses that embedded‑processing, together with analog, drives cash flow and is targeted in industrial and automotive markets, but its role within the four sustainable competitive advantages has not shifted—embedded‑processing remains a key driver of opportunity per customer and value for investments. Segment results show embedded‑processing revenue rose modestly from 2022 to 2023 and then fell in 2024, yet the company’s strategic emphasis on this segment remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on Embedded Processing Products from 2022 to 2024, noting its role within the company's sustainable competitive advantages—specifically as part of the 'broad portfolio' advantage. This matches the original answer’s assertion of a stable, enduring strategic pillar. (2) The LLM references segment revenue trends (modest rise from 2022 to 2023, decline in 2024), which are not contradicted by the ground truth; however, the original answer does not include revenue figures, so this addition is contextually reasonable but not verifiable from the ground truth alone. Since the ground truth does not provide quantitative data, the LLM’s inclusion of directional revenue changes does not introduce error but adds detail beyond the source—this is acceptable as long as it doesn’t conflict, which it doesn’t. (3) The multi-hop reasoning is sound: the LLM synthesizes the strategic narrative across three years and ties embedded processing to TI’s competitive framework, correctly identifying its unchanging role. It also links the product line to industrial and automotive markets and cash flow generation, consistent with TI’s MD&A disclosures. (4) Semantic equivalence is strong: while the LLM adds slight detail (e.g., MD&A page references, market targeting), the core message—that strategic emphasis remained stable—is fully aligned. The only minor gap is that the original answer highlights evolving language around 'customer design projects' (2023) and 'broader customer reach' (2024), which the LLM does not explicitly reflect, but it captures the continuity. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9/10 due to slight over-elaboration without full grounding in the provided truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 509,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s effective rate on its 3.50% senior note climbed from 3.20 % in fiscal 2022 to 6.08 % in fiscal 2023 and to 6.66 % in fiscal 2024. This upward trend shows that the company’s borrowing cost has risen markedly as market rates and risk premiums have increased over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Cisco's effective interest rate on the 3.50% Senior Note from 3.20% in fiscal 2022 to 6.66% in fiscal 2024, and correctly concludes that borrowing costs have increased. However, the effective rate for fiscal 2023 is reported as 6.08%, whereas the ground truth states it was 6.38%. This is a factual error in a key numeric value, though the general trend remains accurate. (2) The dollar amount ($500 million) and maturity date (June 2025) of the note, while present in the original answer, are omitted in the LLM response—this is a minor omission affecting completeness but not core correctness. The 2022 and 2024 percentages are correct (3.20% and 6.66%), but the 2023 figure is off by 0.30 percentage points. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and draws a valid conclusion about rising borrowing costs due to market or risk factors. The logic and progression are well-articulated. (4) The correctness score is 8 due to the significant but not critical numerical inaccuracy in the 2023 rate. Quantitative accuracy is penalized more (7) due to the incorrect percentage, while qualitative accuracy remains high (9) for correct reasoning and entity identification. Contextual relevance is perfect (10) as the answer directly addresses the question’s focus on interest rate exposure and borrowing cost trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 399,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosures in 2022, 2023 and 2024 all contain the same statement that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (see page 5 of each 10‑K). The unchanged wording shows that the regulatory constraint on capital distribution has remained a constant factor over the three‑year period, and the firm’s strategic flexibility is confined to the Board’s discretion to allocate capital within those limits.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that BNY Mellon included consistent language across its 2022, 2023, and 2024 10-K filings regarding capital return limitations due to U.S. banking laws, Delaware law, and preferred stock dividend obligations. The citation of unchanged wording on page 5 of each 10-K aligns with the ground truth and supports the claim of consistency, earning full marks for quantitative accuracy and high contextual relevance. However, the LLM fails to capture the nuanced evolution described in the original answer: while the core sentence may be repeated, the 2024 filing added a stronger emphasis on liquidity management and the consequences of failing to maintain 'well capitalized' and 'well managed' status—a key qualitative shift. The original answer identifies a progression in emphasis and regulatory focus, particularly around liquidity risk, which the LLM overlooks by treating the disclosures as static. This omission represents a significant gap in qualitative accuracy, as it mischaracterizes a multi-year trend of increasing regulatory scrutiny and strategic adaptation as merely a 'constant factor.' The reasoning is therefore partially sound but lacks the depth of multi-hop synthesis required to reveal how regulatory constraints evolved in emphasis and implication. Thus, while the entities and dates are correct, and the core regulatory constraints are accurately listed, the answer does not fully address the question's focus on evolution and strategic flexibility over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 418,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics’ Repair and other services revenue fell by **$37 million (≈3.2 %)** from **$1,169 million in 2022 to $1,132 million in 2023** and then **remained flat at $1,132 million in 2024**【page_9】. The lack of growth reflects a mature, stable demand for post‑delivery maintenance and modernization services that the company has not aggressively expanded, while its strategic focus remains on new construction and modernization contracts【page_8】【page_9】. This pattern suggests the segment is a steady, recurring revenue source but not a primary growth driver for General Dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: revenue decreased from $1,169M in 2022 to $1,132M in 2023 (a $37M drop), and remained flat at $1,132M in 2024. The percentage decline (≈3.2%) is accurately calculated: (37 / 1169) ≈ 0.0316 or 3.16%, rounded to 3.2%, which is acceptable. (2) All numeric values and dates match the ground truth exactly, with appropriate formatting variations (e.g., $1,132 million vs $1,132M). Calculations are correct and clearly presented. (3) The reasoning is sound and aligns with the ground truth: the segment shows stagnation, not rebounding in 2024 despite growth in other areas. The LLM correctly infers that this reflects strategic prioritization elsewhere (e.g., new construction and modernization), consistent with the original answer’s suggestion of resource reallocation or limited expansion. It accurately characterizes the segment as stable but not a growth driver. (4) The only minor gap is that the LLM does not explicitly mention possible factors like market saturation or operational constraints, which are included in the ground truth. However, it captures the core implications—maturity, stability, and lower strategic priority—through alternative phrasing (e.g., 'not aggressively expanded', 'steady, recurring revenue source'). Thus, while slightly less comprehensive in speculative causes, the qualitative analysis remains highly accurate and contextually appropriate. Overall, the answer is factually precise, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 420,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth Group’s equity‑method stake in healthcare operating businesses more than doubled, rising from $1.4 billion in 2023 to $3.8 billion in 2024—an increase of roughly 171 % that signals a strategic push to deepen ownership in the sector【page_52】.  At the same time, the company’s venture portfolio grew markedly, with unrealized gains climbing from $211 million in 2022 to $710 million in 2024, underscoring a heightened focus on high‑growth, high‑return ventures【page_52】.  The overall equity securities portfolio remained robust at $4.9 billion in both 2024 and 2023, reflecting a sustained commitment to venture investing【page_52】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures, particularly regarding the venture investments. The ground truth states that UnitedHealth's total equity securities portfolio (which includes venture investments) grew from $3.7B in 2022 to $4.9B in 2023 and remained at $4.9B in 2024. However, the LLM incorrectly shifts focus to 'unrealized gains' rising from $211M in 2022 to $710M in 2024, which is not mentioned in the original answer and misrepresents the nature and scale of the investment growth. This is a major quantitative and conceptual error. (2) The equity method investment increase is mostly correct: the LLM states a rise from $1.4B in 2023 to $3.8B in 2024, which aligns with the ground truth (though the original notes it was flat at $1.4B in 2023 vs $1.5B in 2022 — a minor discrepancy in 2022 value not reflected in the LLM answer). The percentage increase cited (171%) is approximately correct (actual: (3.8 - 1.4)/1.4 ≈ 171.4%), so this calculation is accurate. (3) The reasoning partially captures the strategic shift toward deeper investments in 2024, which is consistent with the original answer’s conclusion. However, the LLM mischaracterizes the venture investment trend by focusing on unrealized gains rather than total portfolio value, leading to flawed synthesis. The claim of 'markedly growing' venture investments based on unrealized gains distorts the actual stable $4.9B level in 2023–2024. (4) Contextually, the answer is relevant and attempts multi-hop reasoning by comparing trends and inferring strategy. However, due to the incorrect data on venture investments, the overall correctness score is reduced to 5 — partially correct but with significant factual and quantitative errors that affect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 487,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. remained a member of PMI’s peer group in 2022, 2023 and 2024, as the identical list appears on page 26 of each filing (2022, 2023 and 2024 10‑K). This unchanged inclusion shows that PMI’s benchmarking framework is built on a stable, criteria‑driven selection process—global presence, consumer‑product focus, and comparable revenue/market‑cap—that it applies consistently over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained in PMI's peer group across 2022, 2023, and 2024, which matches the original answer's claim of consistent inclusion. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years 2022–2024 are correctly cited, and the reference to page 26 of each 10-K filing adds precision without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged peer group composition reflects a stable, criteria-driven benchmarking framework based on global presence, consumer-product focus, and comparable revenue/market cap—this synthesizes information across years and aligns with the original answer’s interpretation. (4) The only minor omission is that the original answer explicitly notes PMI excludes direct tobacco industry peers, which adds strategic nuance about benchmarking against non-tobacco consumer goods firms. While the LLM implies this by emphasizing consumer products and comparable metrics, it does not explicitly state the exclusion of tobacco peers, slightly reducing qualitative completeness. However, the core facts, reasoning, and implications are correctly conveyed. Wording differs but semantic equivalence is maintained. All entities—Colgate-Palmolive Co., PMI, peer group, years, and criteria—are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 399,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s risk disclosures from 2022 through 2024 consistently flag that fraud‑detection measures are “complex, require continuous improvement, and may not be effective” as new or expanded credit products are introduced (page_24 2022; page_24 2023).  The 2023 filing notes that the company’s consumer and merchant credit lines are “heavily dependent on unaffiliated lenders” and that defaults and third‑party failures could materially affect the business (page_23 2023).  In 2024, PayPal again stresses its reliance on third‑party banks, processors, and lenders for credit and payment services, underscoring that exposure to abusive behavior has not diminished and that fraud‑mitigation effectiveness remains limited as the credit portfolio grows (page_21 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolving nature of PayPal's exposure to abusive behaviors from 2022 to 2024, particularly in relation to credit products and third-party dependencies. It accurately reflects the persistent challenges in fraud mitigation and reliance on third parties across all three years. However, it omits the specific quantitative detail from the ground truth — the €40 billion multi-year agreement to sell BNPL loan receivables in Europe in 2023 — which is a key factual element indicating the scale of credit expansion and associated risk. This omission affects quantitative accuracy. (2) No incorrect numbers are stated, but the absence of the €40 billion figure means the answer lacks a critical data point that anchors the increased risk in 2023. The LLM references page numbers and qualitative disclosures accurately, but without this key metric, the quantitative completeness is compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects expanding credit offerings, third-party reliance, and limitations in fraud detection. It correctly infers that mitigation effectiveness has not kept pace with growing exposure, aligning with the ground truth’s conclusion. (4) The answer is contextually relevant and captures the core trend — increasing risk and limited mitigation effectiveness — but loses points on quantitative accuracy due to the missing €40 billion BNPL transaction, which is central to understanding the scale of risk introduced in 2023. Despite this, the qualitative reasoning and entity/year accuracy (PayPal, 2022–2024, third-party lenders, fraud detection) are strong, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 468,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas options volume jumped from 214 mmBtu in 2022 to 339 mmBtu in 2023, then fell sharply to 176 mmBtu in 2024, while swap volumes fell from 217 mmBtu in 2022 to 109 mmBtu in 2023 and rose to 255 mmBtu in 2024. The total hedge volume remained essentially flat (431–448 mmBtu). This 3‑year shift—from a more option‑heavy, protective stance in 2023 to a swap‑heavy, fixed‑price approach in 2024—indicates Southern Company is dynamically adjusting its hedging mix to balance cost and volatility protection as natural‑gas price risk evolves.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 (339 million mmBtu) and 2024 (176 million mmBtu) natural gas options volumes from the ground truth, but reports 214 mmBtu for 2022 instead of the correct 253 mmBtu — a significant numerical inaccuracy. Additionally, the LLM introduces swap volumes (217 mmBtu in 2022, 109 mmBtu in 2023, 255 mmBtu in 2024) and total hedge volume (431–448 mmBtu), which are not present in the original answer and cannot be verified from the provided ground truth. While the trend of increasing options in 2023 and decreasing in 2024 is correctly captured, the baseline 2022 figure is wrong. (2) The calculation of total hedge volume and the comparison between options and swaps appears internally consistent in the LLM answer, but these data points are extraneous and not supported by the ground truth, raising concerns about hallucination. The core hedging trend (up then down in options use) is accurate, but the quantitative foundation is partially flawed. (3) The multi-hop reasoning is sound in interpreting the shift in strategy — the LLM correctly infers a strategic pivot from options to swaps in response to volatility, aligning with the original answer’s conclusion about dynamic risk management. The synthesis of a shifting hedging mix is logically supported by the (incorrectly sourced) data it presents. (4) Despite the numerical inaccuracies and introduction of unsupported data, the LLM captures the essential qualitative trend and strategic interpretation, earning a 7 for correctness. Quantitative accuracy is penalized due to the incorrect 2022 figure and unverified swap data. Qualitative reasoning and contextual relevance remain high because the explanation is coherent, relevant, and aligns with the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 484,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Industries’ aggregate expense for its U.S. defined‑contribution plans rose from $70 million in 2022 to $75 million in 2023 and $76 million in 2024【page_43】. The modest upward trend indicates the company is gradually increasing its investment in defined‑contribution options, a move that aligns with its strategy to shift employees away from the unfunded, closed non‑qualified defined‑benefit pension plan【page_46】. This suggests a long‑term focus on more flexible, employee‑controlled retirement benefits while reducing reliance on the non‑qualified defined‑benefit plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. All numeric values and years are accurate, with acceptable formatting (e.g., $70 million). (2) Quantitative accuracy is perfect—no calculation errors, and the incremental increases ($5M from 2022 to 2023, $1M from 2023 to 2024) are consistent with the trend described. (3) The reasoning is sound and reflects multi-hop synthesis: the answer correctly links the rising defined contribution expenses to a strategic shift away from the non-qualified defined benefit pension plan, which is closed and unfunded. It accurately infers a long-term strategy favoring flexible, employee-controlled retirement options. The only minor shortcoming is that it does not explicitly mention the 1997 closure to new participants, a detail present in the original answer that adds historical context to the strategy. However, the core logic and strategic interpretation are aligned. (4) The answer is contextually fully relevant, addressing both the trend in expenses and its implication for long-term benefit strategy. The reference to page citations (e.g., 【page_43】) suggests grounding in source material, though not required. Overall, the answer is factually correct and semantically equivalent to the ground truth, with only a slight omission of a contextual detail affecting qualitative accuracy marginally.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 415,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets rose from **5.38 % in 2022** (GM 10‑K 2022, p. 86) to **6.30 % in 2023** (GM 10‑K 2023, p. 87) and was further increased to **6.5 % in 2024** (investment‑policy study note, GM 10‑K 2024, p. 88). This upward trend indicates a progressively more optimistic view of future asset performance and a willingness to accept higher risk or shift toward higher‑return asset classes to improve funded status.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: the 2022 rate is reported as 5.38%, while the ground truth states 5.4%. Although this is a negligible difference (likely due to rounding), it diverges from the official reported figure. The 2023 rate is correctly stated as 6.30%, matching the ground truth of 6.3%, and 2024 is accurately reported as 6.5%. (2) Calculations and trends are logically sound—the upward trajectory from ~5.4% to 6.5% is correctly interpreted. However, the original answer notes that the rate 'remained unchanged at 6.3%' in 2023, implying it was also 6.3% in 2022, which contradicts both the LLM and the ground truth stating 5.4% in 2022. The LLM correctly identifies the increase from 2022 to 2023, aligning better with factual progression than the original answer’s phrasing. (3) Multi-hop reasoning is strong: the LLM synthesizes data across three years and correctly infers the trend—increasing return assumptions reflect greater optimism and risk tolerance. It appropriately links the trend to strategic asset allocation and funded status objectives. (4) Contextual relevance is excellent; all parts of the question are addressed: evolution of assumptions (with cited years and values), and interpretation of strategic implications. The minor discrepancy in the 2022 figure prevents a perfect score, but overall reasoning and completeness are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 395,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation produced a $92 million gain in FY 2022, but turned into $58 million and $91 million losses in FY 2023 and FY 2024, respectively. The shift from a net benefit to increasing costs suggests that the hedging of deferred‑compensation volatility has become more expensive—likely due to higher market volatility or larger compensation obligations—yet Cisco still relies on these derivatives to manage compensation‑related risk, reflecting an active, though costly, risk‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in its reporting of gains and losses. According to the ground truth, Cisco reported a $92 million *loss* in FY 2022, followed by a $58 million *gain* in FY 2023, and a $91 million *gain* in FY 2024. The LLM incorrectly states a $92 million *gain* in FY 2022 and then *losses* in the subsequent years, which is the exact opposite of the actual trend. This reversal of signs completely misrepresents the financial progression. (2) All three dollar amounts are attached to incorrect financial outcomes (gain vs. loss), making the quantitative accuracy very low. While the absolute values are correct ($92M, $58M, $91M), their directional impact (positive/negative) is wrong, which is critical in financial reporting. Calculations or comparisons based on these would be invalid. (3) The reasoning is flawed due to the incorrect data. The LLM concludes that hedging has become more expensive due to increasing losses, but in reality, the company moved from a loss to increasing gains, indicating improving performance—possibly due to better market conditions or effective hedging. The multi-hop synthesis fails because the model did not correctly interpret the temporal evolution of the financial exposure. (4) Contextual relevance is moderate because the answer addresses the right topic (total return swaps, deferred compensation, risk management), uses appropriate terminology, and attempts to interpret strategic implications. However, the qualitative and quantitative inaccuracies severely undermine the validity of the conclusion. The answer would lead a reader to the opposite understanding of Cisco’s financial exposure trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 460,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024.  In each year’s revenue note the company states that it sets fees on a gross basis, controls pricing, and bears full margin risk when it acts as the principal on a transaction, while the costs paid to third‑party processors are recorded as transaction expense.  Thus, PayPal’s pricing control and the accounting for processor fees – and consequently its margin‑risk exposure – have not materially evolved over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that PayPal's exposure to margin risk remained unchanged from 2022 to 2024, consistently bearing full margin risk, controlling pricing, and recognizing third-party processor fees as transaction expenses. These key facts align with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years regarding pricing control, principal role, and expense recognition, correctly concluding no material evolution. It captures the essence of each year’s filing, though it omits the 2023 detail about tiered pricing not constituting a future material right and the 2024 mention of new segment reporting disclosures. These are minor contextual omissions that do not undermine the overall correctness. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'sets fees on a gross basis' vs. 'discretion in setting fees') but preserving factual and conceptual accuracy. The omission of minor nuances prevents a perfect 10, but the core reasoning, entities, and conclusions are fully aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 376,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s share of natural‑gas production from its Angola LNG affiliate fell slightly from **49 MMCFD in 2022 to 48 MMCFD in 2023** and remained at **48 MMCFD in 2024** (Net Production tables, 2022‑24). The near‑flat trend shows Chevron is maintaining a steady supply to Angola LNG, underscoring a strategy of sustaining long‑term LNG contracts and a reliable presence in the African LNG market rather than pursuing rapid expansion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of Chevron's natural gas production volumes in Angola LNG. The ground truth states that natural gas consumed in operations increased from 592 MMCFD in 2022 to 596 MMCFD in 2023 and 609 MMCFD in 2024, indicating a steady upward trend. In contrast, the LLM claims Chevron’s 'share' of production fell from 49 to 48 MMCFD and remained flat, which is not supported by the data. These numbers are off by an order of magnitude—49 MMCFD vs. actual values over 590 MMCFD—suggesting a fundamental misunderstanding or misreading of the source data. (2) The quantitative inaccuracies are severe: all three years are wrong, and the reported values are approximately one-tenth of the actual figures. There is no indication that the LLM correctly interpreted 'natural gas consumed in operations' as the relevant metric, instead referring to 'Chevron’s share of natural-gas production from its Angola LNG affiliate,' which does not align with the ground truth. (3) The multi-hop reasoning fails because the LLM did not correctly identify the relevant metric or trend across years. While it attempts to infer strategic implications (sustaining long-term contracts), this conclusion is based on false premises. The actual trend—consistent growth—supports a strategy of increasing operational focus on LNG in Angola, contrary to the LLM’s suggestion of stagnation. (4) The contextual relevance is moderate because the answer addresses the right region (Angola LNG) and attempts to discuss strategic positioning in African LNG markets, but the incorrect data renders the analysis invalid. Due to complete failure in numerical accuracy and resulting flawed reasoning, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 480,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In 2022, Southern Power disclosed the scheduled payments under its outdoor‑lighting leases in a maturity‑analysis table (page 268).  In 2023 the same approach was retained, but a note clarified that for Georgia Power and Mississippi Power the outdoor‑lighting cash flows were immaterial, implying that Southern Power’s own contracts were still material (page 241).  In 2024 the company again presented the scheduled payments in the maturity analysis and reiterated the immateriality for the other entities (pages 232‑233), underscoring that Southern Power’s outdoor‑lighting leases remain a material, structurally significant part of its lease portfolio and that this importance has persisted over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Southern Power stated that outdoor lighting contracts at Mississippi Power (not Southern Power) were immaterial. The LLM incorrectly attributes materiality to Southern Power’s own contracts and claims they were disclosed in a maturity analysis table on page 268 in 2022 — this is unsupported by the ground truth. The ground truth indicates no such presentation by Southern Power in 2022; instead, the immateriality of Mississippi Power’s contracts was noted. In 2023, the ground truth states Southern Power began including its own outdoor lighting contracts in maturity analyses alongside PPAs and tolling arrangements, signaling increased importance. The LLM misrepresents this by claiming the immateriality note applied only to Georgia and Mississippi Power, implying Southern Power’s contracts were material by contrast — but the original answer does not support this inference. In 2024, the ground truth confirms explicit integration into lease income reporting; the LLM correctly notes continued inclusion in maturity analysis but misses the key development of structural integration into lease income reporting. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is based on correct referencing of years and document locations. While the LLM cites specific pages, these are not part of the ground truth and cannot be verified; more importantly, the substance tied to those years is incorrect. (3) The multi-hop reasoning is flawed: the LLM fails to trace the actual evolution — from immaterial mention (at another entity) in 2022, to inclusion in maturity analyses in 2023, to full integration in 2024 — and instead constructs a narrative about Southern Power’s materiality that is not supported. It confuses Southern Power with Mississippi Power and misattributes disclosures. (4) The contextual relevance is moderate because the answer addresses the general topic and time frame, and correctly identifies that outdoor lighting contracts are part of lease disclosures. However, the core reasoning and factual trajectory are incorrect, leading to a misleading conclusion about persistence of materiality rather than an evolution toward growing materiality. Thus, the correctness score is low due to major factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 641,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across 2022, 2023, and 2024 Texas Instruments kept its Melaka, Malaysia site dedicated solely to Analog products, with no Embedded Processing segment activity in any of those years. The property tables in each year’s 10‑K list “Melaka, Malaysia **” under Analog only and leave the Embedded Processing column blank【page_16 (2022)】【page_16 (2023)】【page_16 (2024)】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was dedicated exclusively to the Analog segment in 2022, 2023, and 2024, with no involvement in the Embedded Processing segment in any of those years—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the ground truth. The citation of 'page_16' for each year’s 10-K filing supports the claim and reflects accurate sourcing. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual reports to confirm consistency over time, concluding no expansion into Embedded Processing. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of TXN's operational footprint in Melaka with respect to both business segments. Minor wording differences (e.g., 'dedicated solely' vs 'exclusively') do not affect meaning and are semantically equivalent. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 324,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024 the 1.600% Notes stayed unchanged: the aggregate principal remained $700 million (page_48; page_111; page_113), the interest was paid semi‑annually on April 15 and October 15 (first payment October 15 2021), and the par call date stayed March 15 2026 (page_48; page_111; page_113). This consistency shows AMT’s deliberate strategy of maintaining a stable, long‑term debt profile, avoiding refinancing risk and preserving predictable interest obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the aggregate principal amount of $700 million remained constant from 2022 to 2024, interest payments were semi-annual on April 15 and October 15, and the par call date remained March 15, 2026. These match the ground truth exactly. (2) Quantitative accuracy is perfect: all dollar amounts, dates, and percentages are correct and consistent with the original answer. The LLM even cites supporting document pages, enhancing traceability. (3) The multi-hop reasoning is sound—information is synthesized across years and attributes (principal, interest, call date) for the same debt instrument. However, the LLM omits mention of the decreasing adjustments to principal amount ((2.6) in 2023 to (1.5) in 2024), which is a minor but notable detail in the ground truth indicating reduced modifications. While not central to the core elements (principal, interest, call), this omission slightly weakens the completeness of the debt management strategy analysis. (4) Despite this omission, the conclusion about AMT’s stable, long-term debt strategy is logically supported and semantically aligned with the original. The answer is highly relevant, accurate, and well-structured, warranting a high score with only a small deduction for missing the adjustment trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 369,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco has kept the $2 billion 5.90 % senior note unchanged, with its effective rate staying at 6.11 % each year【page 89】.  In that period total debt expanded from $8.5 billion in FY 2022 to $20.3 billion in FY 2024, with long‑term debt rising from $6.7 billion to $19.6 billion【page 90】.  The stable rate on the 5.90 % note amid a larger, diversified debt base indicates Cisco’s deliberate use of long‑term fixed‑rate debt to lock in costs and support growth while managing interest‑rate risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cisco maintained the $2,000 million 5.90% Note with a steady effective interest rate of 6.11% across fiscal years 2022–2024, which matches the ground truth. However, there are minor inaccuracies in total debt figures: the LLM states total debt increased from $8.5 billion in FY2022 to $20.3 billion in FY2024, while the ground truth reports long-term debt rising from $8,416 million to $19,621 million (short-term debt remained ~$500M). The LLM conflates total debt and long-term debt and slightly overstates the totals. It also cites long-term debt rising from $6.7B (incorrect) vs. the correct $8,416M in 2022. (2) Despite these numerical discrepancies, the directional trend — significant increase in long-term debt, stable use of the 5.90% note, and declining reliance on short-term debt — is accurately captured. The LLM omits the specific detail about short-term debt decreasing from $499M to $488M, but this is a minor omission. (3) The multi-hop reasoning is sound: the model correctly synthesizes data on the 5.90% Note, overall debt composition changes, and infers Cisco’s strategic preference for long-term fixed-rate debt to manage interest rate risk. The conclusion about locking in financing costs aligns with the ground truth. (4) The correctness score is 8 due to mostly accurate facts and strong reasoning, but docked for quantitatively inaccurate base figures. Quantitative accuracy is 7 due to incorrect starting values for long-term and total debt. Qualitative accuracy is 9 for strong logic and correct interpretation. Contextual relevance is 10 — the answer directly addresses all aspects of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 465,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics Land Systems produced 399 new LAVs for the Canadian Army in 2022, increased output to 449 in 2023, and then reduced it to 360 in 2024 (GD_10k_2022, page 11; GD_10k_2023, page 10; GD_10k_2024, page 11). This pattern shows the company remains a key supplier for Canada’s LAV program, but its production levels are being adjusted—likely due to contract changes or shifting priorities—while still keeping LAV manufacturing a significant part of its export strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the production numbers for 2022, 2023, and 2024, stating 399 units in 2022, 449 in 2023, and 360 in 2024—this is the opposite of the ground truth, which reports 360 in 2022, 399 in 2023, and 449 in 2024. This complete inversion of the time-series data makes the quantitative foundation of the answer incorrect. Additionally, the LLM fails to mention the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) program in 2024, which added 66 specialized LAVs and is a key part of the strategic context. (2) The numbers cited are all present in the ground truth but assigned to the wrong years, leading to false trends—instead of showing consistent growth, the LLM describes a decline in 2024, which contradicts the actual progression. Calculations or totals are not performed in the answer, but the misattribution of values invalidates any derived insights. (3) The multi-hop reasoning is flawed: the model must synthesize production volumes across three years and link them to strategic focus, but due to incorrect temporal alignment, it draws the opposite conclusion about the trend. While it correctly identifies General Dynamics as a key supplier and notes LAV manufacturing as part of its export strategy, the reasoning about 'adjusting production due to contract changes or shifting priorities' is speculative and unsupported by the upward trend in the real data. (4) The contextual relevance is moderate because the answer addresses the right company, program, and general theme of strategic focus, but the factual inaccuracies severely undermine correctness. Quantitative accuracy is very low due to swapped numbers. Qualitative accuracy is slightly higher because some entities and general strategic framing are plausible, though reasoning is unsound. Correctness score is low because the core data is inverted, leading to a fundamentally incorrect portrayal of the situation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 522,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "From 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained persistent: CMS continued to freeze or cut benchmarks and periodically alter the calculation methodology, and the company noted that risk‑adjustment data‑validation audits could trigger retrospective payment adjustments. In each filing the company described a consistent response—selectively adjusting benefits and premiums, discontinuing plans in certain counties, and intensifying medical and operating cost‑management—and it has reinforced its risk‑adjustment data‑validation processes to mitigate audit‑related payment adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024 is accurately described, including CMS's periodic methodology changes, benchmark freezes/cuts, and the risk of retrospective adjustments due to data-validation audits. The strategic responses—adjusting benefits and premiums, exiting certain counties, cost management, and strengthening data-validation processes—are fully aligned with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent exposure and response patterns across three years, correctly attributing ongoing CMS pressure and UnitedHealth’s adaptive strategies. (4) The only minor gap is that the LLM answer does not explicitly mention 'recalibrating bids' in 2023 or 'beneficiary health status data submissions' in 2024—details present in the original—but it does capture the broader theme of data-validation improvements, which covers this concept. Wording differs slightly but meaning is preserved. Thus, the answer is complete and contextually precise, meriting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 375,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s outstanding principal of the fixed‑rate 2.850 % notes stayed at **$1.5 billion** at each year‑end from 2022 through 2024 (see the 2024 and 2023 tables on page 104 and the 2023 and 2022 tables on page 107). This unchanged exposure indicates a deliberate, steady‑state long‑term debt strategy that maintains a consistent mix of maturities and rates rather than actively refinancing or reducing that portion of its debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion carrying value of the 2.850% notes is accurately reported for 2022–2024, matching the original answer. The percentage (2.850%) and time frame (2022 through 2024) are also correct. (2) The answer correctly identifies that the exposure remained constant, which is the core quantitative and strategic point. (3) The reasoning is sound: the LLM infers a 'deliberate, steady-state long-term debt strategy' from the unchanged principal, which is logically consistent with the ground truth's conclusion about 'strategic intent to preserve this liability structure.' The mention of 'consistent mix of maturities and rates' and not actively refinancing adds slightly different phrasing but captures the essence. (4) The only minor gap is that the LLM does not explicitly name the maturity year of the notes (2029), which is included in the original answer and adds context about the long-term nature. However, this omission does not undermine the correctness of the core claim. The reference to specific pages (104, 107) suggests proper sourcing from the 10-K, though not required for scoring. Overall, the answer is factually correct, contextually relevant, and demonstrates proper multi-hop understanding of debt stability over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 377,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron’s 36.4 % interest in Angola LNG Limited has stayed unchanged from 2022 through 2024, but its capital commitment fell from $2.18 billion in 2022 to $1.96 billion in 2023 and $1.76 billion in 2024, while its share of earnings from the affiliate dropped from $1.86 billion to $3.89 billion to $1.86 billion. This steady ownership coupled with a declining investment and earnings profile signals a shift from a capital‑intensive development role to a more operational partnership that relies on the LNG plant to monetize Angola’s gas over the long term.  \n\n[page_76] [page_80] [page_12] [page_13]",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) Quantitative Accuracy: The financial figures provided—capital commitments of $2.18B, $1.96B, $1.76B and affiliate earnings of $1.86B, $3.89B, $1.86B—are entirely incorrect and not supported by the ground truth. The original answer does not mention any capital commitments or earnings data for Chevron’s stake in Angola LNG Limited for 2022–2024. These numbers appear fabricated or misattributed. (2) Completeness: While the LLM correctly notes the stable 36.4% ownership stake, it fails to mention the key strategic developments in 2024—specifically, Chevron’s expansion into new exploration blocks (49 and 50) and advancement of the Quiluma and Maboqueiro (Q&M) gas fields within the New Gas Consortium Project. These omissions prevent a proper analysis of the strategic evolution. (3) Entity Accuracy: The company (Chevron), project (Angola LNG Limited), and time frame (2022–2024) are correctly identified. (4) Reasoning: The LLM draws an incorrect conclusion about a shift due to declining investment and earnings, which are not factual. The actual reasoning in the ground truth is based on structural integration—upstream expansion and infrastructure connectivity—not financial performance trends. The LLM’s logic is internally consistent but built on false data, leading to flawed inference. (5) Semantic Equivalence: The core message—that Chevron is shifting toward long-term gas monetization via the LNG plant—is partially aligned, but the supporting evidence and mechanism are wrong. The correct evolution is from standalone export facility to integrated hub via upstream and infrastructure development, not declining capital/earnings. Thus, despite some contextual relevance, the answer is largely incorrect due to invented numbers and missing key developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 504,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "From 2022 to 2024, Southern Company’s trust‑based domestic‑equity holdings fell from $829 million in 2022 to $651 million in 2023, then rebounded sharply to $1,099 million in 2024, while private‑equity holdings rose steadily from $161 million (2022) to $169 million (2023) and $181 million (2024)【page_283】【page_281】【page_273】. This pattern—an initial dip followed by a pronounced rebound in domestic equity and a consistent uptick in private equity—signals a long‑term capital‑allocation strategy that increasingly prioritizes domestic equity and private‑market investments for growth and diversification.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, in 2022, Southern Company's domestic equity investments were $1,016 million, not $829 million as stated in the LLM answer. The LLM incorrectly uses the 2023 domestic equity value ($829 million) as the 2022 figure, creating a false trend of decline. Similarly, the LLM reports private equity at $161 million in 2022, but the correct amount is $150 million. The 2023 and 2024 private equity figures ($169M and $181M) are close but still incorrect—the correct values are $161M (2023) and $181M (2024), meaning the increase is overstated in the early years. (2) Calculations and comparisons are therefore flawed: the 'initial dip' narrative in domestic equity is incorrect because the LLM misstates the 2022 baseline. In reality, domestic equity decreased from $1,016M (2022) to $829M (2023), then increased to $1,099M (2024)—a V-shaped recovery—but the LLM misrepresents this due to wrong starting data. (3) The multi-hop reasoning is partially sound in that it identifies a trend toward growth in private equity and a rebound in domestic equity by 2024, but the flawed data undermines the validity of the synthesis. The conclusion about long-term strategy prioritizing both domestic and private equity is plausible but based on incorrect premises. (4) Contextual relevance is high because the answer addresses the evolution over time and infers strategic intent. However, due to major quantitative errors affecting the core facts, the correctness score is low. Minor formatting differences are acceptable, but directional trends and magnitudes must align with truth—here, they do not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 468,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "From 2022 to 2024 the eliminations/reclassifications effect on total net sales and revenue grew from a negative $107 million in 2022 to $151 million in 2023 and $296 million in 2024. The increasing magnitude of these negative adjustments shows that GM is eliminating more inter‑company transactions and reclassifying revenue across its automotive, GM Financial and other segments, indicating a shift toward more complex internal reporting and consolidation adjustments over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105 million in 2022, $107 million in 2023, and $296 million in 2024. However, the LLM incorrectly states $107 million in 2022 (should be $105M), $151 million in 2023 (should be $107M), and correctly reports $296 million in 2024. These errors affect the trend description and undermine factual reliability. (2) The calculation of the trend is flawed due to incorrect intermediate values—while the final year is correct, the progression from 2022 to 2023 is misrepresented. The actual increase from 2022 to 2023 was only $2 million, not the $44 million increase implied by the LLM’s numbers. (3) The qualitative reasoning about increasing complexity in internal reporting and segment reclassifications is sound and aligns with the upward trend observed in the correct data. The LLM correctly infers that growing elimination amounts suggest more inter-company adjustments and evolving reporting structures, which is a valid interpretation. (4) Contextually, the answer addresses both parts of the question—evolution over time and implications for internal reporting—and uses appropriate terminology (e.g., inter-company transactions, segment reclassifications). Despite incorrect numbers, the conceptual synthesis across years and business segments shows adequate reasoning. However, the quantitative inaccuracies severely limit correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 417,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "Netflix’s Performance Bonus Plan was originally a 2014 plan (Exhibit 10.6†) in the 2022 10‑K (page 64).  In the 2023 10‑K the plan was amended and restated in December 2022 and incorporated by reference as Exhibit 10.5† (page 68).  The 2024 10‑K continues to reference the same amended plan (Exhibit 10.5†, page 68) and it is now part of a broader compensation framework that also includes the 2020 Stock Plan and the Executive Severance and Retention Incentive Plan (Exhibit 10.16†, page 68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2014 original plan (Exhibit 10.6†) was referenced in 2022, amended and restated in December 2022 (Exhibit 10.5†) as filed in the 2023 10-K, and carried forward unchanged in 2024. These dates, exhibit numbers, and filing years match the original answer. (2) Quantitative accuracy is perfect: all dates (2014, December 2022), exhibit numbers (10.6†, 10.5†), and document types (10-K pages) are correctly cited. (3) The multi-hop reasoning is sound—LLM correctly traces the plan’s evolution across three years and identifies its integration into a broader compensation framework by 2024, including the 2020 Stock Plan and Executive Severance and Retention Incentive Plan. (4) The only minor omission is that the original answer notes the 2024 plan serves as a 'foundational document' integrated with performance-based RSU agreements, which the LLM mentions implicitly via 'broader compensation framework' but could have specified. However, the inclusion of the 2020 Stock Plan and other exhibits demonstrates strong synthesis. Wording differs slightly but semantic meaning is equivalent. No factual errors; minor detail omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 351,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK consistently referenced its “Business Relationships and Related Party Transactions Policy” in Item 13 of each 10‑K, incorporating the policy text by reference to the proxy and pairing it with a “Director Independence” statement (2024 – page 14; 2023 – page 13; 2022 – page 14).  The same committee list—Audit, Corporate Governance, Nominating & Social Responsibility, and Human Resources & Compensation—appears unchanged in all three filings, indicating a stable, consistent approach to director independence and committee structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: BK disclosed its 'Business Relationships and Related Party Transactions Policy' in Item 13 of its 10-K filings for 2022, 2023, and 2024, linked it to 'Director Independence,' and consistently listed the same three committees—Audit, Corporate Governance/Nominating/Social Responsibility, and Human Resources/Compensation—across all years. (2) There are no numeric inaccuracies; the page numbers cited (2024 – p.14, 2023 – p.13, 2022 – p.14) are consistent with the structure of the filings and do not contradict the ground truth, which does not require page numbers but does not invalidate their inclusion. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and connects the policy disclosure to director independence and committee structures, concluding that the approach is stable and consistent—exactly as the ground truth states. (4) The only minor shortcoming is that the LLM does not explicitly mention that the policy was discussed within 'Corporate Governance and Board Information' or that it was tied to committee *charters*, which adds slight contextual nuance. However, this omission does not undermine the factual correctness or overall completeness. The answer is semantically equivalent and highly relevant, with excellent qualitative reasoning and full contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 402,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s debt securities held‑to‑maturity declined in both fair value and carrying amount over the three‑year period: fair value fell from **$679 million in 2022 to $596 million in 2023 and $508 million in 2024** (page 53), while carrying value dropped from **$696 million to $603 million to $512 million** (page 53). The trend shows a shrinking held‑to‑maturity portfolio—likely due to maturities or sales—and a market‑price erosion driven by rising rates, yet the company continues to hold the securities to maturity and treats the unrealized losses as temporary, reflecting a conservative, low‑risk investment strategy and valuation assumptions that fair value remains close to amortized cost.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity was $643 million in 2022, but the LLM states $679 million. Similarly, the carrying value in 2022 is reported as $696 million by the LLM, whereas the correct value is $641 million. These discrepancies affect the accuracy of the trend description, even though the 2023 and 2024 values for both fair value ($596M, $508M) and carrying value ($603M, $512M) are correctly reported. (2) The calculation of the trend (decline over time) is accurate based on the numbers provided by the LLM, but since the starting values are wrong, the overall quantitative narrative is misleading. The magnitude of decline in fair value is overstated (from $679M to $508M vs. actual $643M to $508M), as is the drop in carrying value. (3) The qualitative reasoning is sound: the LLM correctly infers a shrinking portfolio, possibly due to maturities or sales, and interprets the company’s conservative strategy and treatment of unrealized losses as temporary. It also appropriately links the valuation assumptions to amortized cost, which aligns with held-to-maturity accounting. However, it omits the key insight from the ground truth about the shift away from Level 3 unobservable inputs, which is a critical indicator of changing valuation assumptions and increased reliance on observable markets. This missing element weakens the multi-hop synthesis. (4) Despite the incorrect 2022 figures, the answer remains contextually relevant and addresses both parts of the question—evolution of values and strategic implications. The reasoning is logical and well-articulated, but the factual foundation is compromised by the initial number errors, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 499,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In 2022 PayPal’s BNPL loan receivables were fully on its books, and the company warned that “failure to deal effectively with fraud, abusive behaviors, bad transactions, and negative customer experiences may increase our loss rate” (page 24 2022).  By June 2023 it entered a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL receivables, transferring that exposure to a third party and creating a forward‑flow arrangement for future originations (pages 23 2023 and 25 2023).  In 2024 the risk‑factor discussion still cites bad‑transaction risk (page 24 2024) but the BNPL exposure is largely off‑loaded, underscoring a strategy of using asset sales and forward‑flow structures to off‑load credit risk over time (pages 23 2024 and 25 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk disclosure about bad transactions and fraud is accurately cited; the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables is correctly reported with the right amount and geography; the use of a forward-flow arrangement is properly noted. (2) Quantitative accuracy is perfect: the €40 billion figure is correct in amount, currency, and timing (June 2023), and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022, 2023, and 2024 filings to show evolution in risk strategy—starting with risk exposure, then active offloading via asset sale, and continued acknowledgment of residual risk in 2024. (4) The only minor shortcoming is that the LLM omits the nuance from the 2024 disclosure that the sale’s benefits were conditional and potential delays could occur if conditions weren’t met—a detail present in the original answer. This slightly reduces qualitative completeness but does not undermine the overall correctness. Wording differences (e.g., 'largely off-loaded' vs. 'subject to conditions') are semantically acceptable but slightly less precise. Overall, the answer effectively captures the strategic shift toward risk mitigation via asset sales and forward-flow structures, fully addressing the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 401,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s upstream output in Myanmar fell from 17 bbl d‑1 of oil‑equivalent and 94 MMCFD of natural gas in 2022 to 15 bbl d‑1 and 87 MMCFD in 2023, and then dropped sharply to 15 bbl d‑1 and 22 MMCFD in 2024. The steep decline in natural‑gas production reflects Chevron’s strategic exit from Myanmar, announced in April 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces incorrect and overly specific data not present in the ground truth. The original answer states that Chevron's upstream production declined from 17 MBD to 15 MBD in 2023 and then fully exited in April 2024, with no production thereafter. However, the LLM answer fabricates natural gas figures (94 MMCFD in 2022, 87 MMCFD in 2023, 22 MMCFD in 2024) and maintains oil production at 15 bbl/d in 2024 despite the full exit—this is factually wrong because production should be zero after April 2024. (2) The quantitative inaccuracies are significant: the ground truth does not mention natural gas volumes or oil-equivalent conversions, nor does it report any production in 2024 after the April exit. The LLM incorrectly implies continued operations into 2024 with specific volumes, which contradicts the complete withdrawal. (3) The reasoning partially captures the strategic shift—Chevron’s exit is correctly linked to portfolio strategy—but fails the multi-hop synthesis by not recognizing that a full exit means zero production, not reduced volumes. The model adds granular data that undermines factual accuracy. (4) While the general direction (decline and exit) and context (strategic withdrawal) are relevant and partially accurate, the inclusion of unsupported numbers and incorrect 2024 production levels severely reduces correctness. The answer is plausible-sounding but factually flawed, especially in quantitative terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 405,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "Texas Instruments’ Personal Electronics segment has seen the PC & Notebooks sector shrink relative to the segment’s overall revenue: the segment accounted for 24 % of TI revenue in 2022, fell to 15 % in 2023, and rebounded modestly to 20 % in 2024 (see the 2022, 2023, and 2024 market‑share tables).  This decline in PC & Notebooks revenue indicates TI is shifting its focus away from consumer computing toward higher‑margin automotive and industrial markets, where it sees stronger growth prospects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the Personal Electronics segment's revenue contribution as 24% in 2022, 15% in 2023, and 20% in 2024, matching the ground truth exactly. These percentages are critical quantitative data points and are accurately reflected. (2) All numbers, dates, and percentages are correct with no calculation errors. The answer correctly tracks the decline and partial rebound in the segment’s share, which aligns with the original answer. (3) The reasoning is sound: the LLM infers a strategic shift away from consumer computing toward automotive and industrial markets based on the declining and then partially recovering—but still reduced—emphasis on PC & Notebooks. While the original answer adds nuance by noting that PC & Notebooks appears lower in priority compared to mobile and portable electronics in 2024, this detail is omitted in the LLM response. However, the core multi-hop synthesis—linking revenue trends over three years to strategic positioning—is correctly executed. (4) The LLM answer is contextually fully relevant, directly addressing both parts of the question: the evolution of revenue contribution and the implied strategic positioning. The only minor shortcoming is the lack of explicit mention that PC & Notebooks is now a lower priority within the segment relative to other subcategories in 2024, which slightly reduces qualitative completeness. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 418,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "From 2022 through 2024, GM has not recorded any material accruals for its indemnification obligations to Stellantis under the 2017 Opel/Vauxhall sale; each year’s note only reports “insignificant amounts” and states it cannot estimate any reasonably possible material loss from emissions, product‑liability or recall claims, including legacy Takata inflator issues. The company has indemnified Stellantis for an immaterial amount for certain recalls and may be required to further indemnify for Takata recalls, but it considers such additional exposure to be remote. Overall, the potential future exposure remains uncertain—ongoing consumer lawsuits and regulatory investigations exist, but no material impact has been quantified.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key elements of GM's indemnification obligations to Stellantis from 2022 to 2024, with accurate qualitative and quantitative details. It correctly states that no material accruals were recorded and that only 'insignificant' or 'immaterial' amounts were paid, aligning with the ground truth. The mention of ongoing regulatory investigations and consumer lawsuits, as well as the remote likelihood of further Takata-related indemnification, is consistent with the original answer. However, the LLM answer slightly compresses the evolution over time: it does not clearly differentiate the increasing specificity in disclosures from 2022 to 2024—particularly the 2024 addition of accruals related to the European Commission and UK CMA investigation into end-of-life vehicle practices. While the LLM notes 'ongoing regulatory investigations,' it does not explicitly tie the accrual to that specific investigation, which was a new development in 2024. Additionally, the ground truth notes that in 2023, GM disclosed indemnification for emissions claims, product liabilities, and recalls with an immaterial payment made—this is accurately reflected in the LLM answer. All entities (GM, Stellantis, Opel/Vauxhall, Takata) and timeframes (2022–2024) are correct. The reasoning is sound and synthesizes multi-hop information across years, though the evolution in disclosure specificity is underemphasized. Wording differences (e.g., 'insignificant' vs 'immaterial') are semantically acceptable. No numerical inaccuracies; all financial impacts are correctly described as immaterial.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 442,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower issued the 1.450% Senior Notes due 2026 in 2021 under Supplemental Indenture No. 10 (dated September 27, 2021)【page 70】.  No supplemental indentures for the same coupon and maturity appear in the 2022‑2024 filings (Supplemental Indentures 12‑30 on pages 73‑74), indicating that the company did not issue new 1.450% notes during those years.  This steady, single‑tranche issuance reflects a disciplined debt‑management strategy that favors long‑term, low‑coupon debt and limits frequent refinancing at the same rate.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance date (September 27, 2021) and coupon rate (1.450%) of the Senior Notes due 2026, as well as the fact that they were issued under Supplemental Indenture No. 10. These factual elements are accurate and align with the ground truth. However, the LLM incorrectly claims that 'no supplemental indentures for the same coupon and maturity appear in the 2022–2024 filings,' which contradicts the ground truth stating that the notes were consistently referenced in each year’s 10-K under Exhibits 4.25 (2022), 4.22 (2023), and 4.21 (2024). This misrepresents the continuity of the debt instrument’s documentation and undermines the core of the multi-year analysis. (2) Quantitatively, the dates and percentages are correct, but the LLM draws an incorrect inference about absence of references, which is a factual error despite correct raw data. (3) The reasoning is flawed in the multi-hop synthesis: while the conclusion about a 'disciplined debt-management strategy' is plausible, it is based on the false premise that the notes were not referenced in later years. The ground truth shows the opposite — consistent inclusion across years — which supports stability, not absence of activity. The LLM fails to recognize that ongoing reference in filings indicates active maintenance of the debt instrument. (4) The contextual relevance is moderate because the answer addresses debt management strategy and cites relevant documents, but the qualitative inaccuracy in entity tracking (presence/absence of the notes in filings) leads to an incorrect interpretation of the pattern. Thus, while some facts are right, the overall conclusion diverges from the ground truth, warranting a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 478,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "From 2022 through 2024, BNY Mellon continued to administer the 2019 Long‑Term Incentive Plan using the existing deferred‑stock‑unit agreement for directors (Exhibit 10.8, page 18), with no new deferred‑stock‑unit agreements added.  The company, however, introduced a new performance‑share‑unit agreement each year—2022 (Exhibit 10.21), 2023 (Exhibit 10.23), and 2024 (Exhibit 10.25) (page 19)—to award performance‑share units under the same plan.  Thus, the plan’s deferred‑stock framework remained constant while its performance‑share component was refreshed annually.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite some relevant context. (1) It incorrectly states that no new deferred stock unit agreements were added, directly contradicting the ground truth: in 2023, BNY Mellon introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' which represents a new director-level agreement under the 2019 plan. The LLM's claim of a 'constant' deferred-stock framework is therefore false. (2) The LLM asserts that new performance share unit agreements were introduced annually in 2022, 2023, and 2024, but the ground truth only confirms the 2022 Form of Performance Share Unit Agreement as a new version; the 2019 forms were used in 2022, and there is no mention of new PSUs in 2023 or 2024. Thus, the claim of annual refreshment is unsupported. (3) The LLM cites specific exhibit numbers (10.8, 10.21, 10.23, 10.25) and page numbers not present in the ground truth, introducing unverified details that reduce factual reliability. (4) While the LLM correctly identifies the continued use of the 2019 Long-Term Incentive Plan and attempts to describe evolving agreement types, it fails the multi-hop reasoning by misrepresenting the evolution of both deferred stock units and performance share units. The core progression—expansion to directors in 2023 and use of updated 2022 PSUs by 2024—is misrepresented. (5) Despite these errors, the answer is contextually relevant, addressing the right plan and the general idea of evolving agreements. However, due to major factual and qualitative inaccuracies in entity usage and timeline, the correctness and qualitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 461,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "General Dynamics consistently highlighted its Ordnance and Tactical Systems (OTS) role in providing missile subsystems with **critical aerostructures** in its 2022, 2023, and 2024 10‑K filings (2022 p. 12; 2023 p. 12; 2024 p. 12).  Over the three years, weapons‑systems revenue grew from $2.0 billion in 2022 to $2.9 billion in 2024, while the Combat Systems segment’s share of consolidated revenue rose from 18 % to 19 % (2022 p. 12; 2024 p. 12).  This steady emphasis and expanding revenue signal GD’s strategic positioning as a key supplier of advanced aerostructure components for next‑generation missile systems, including hypersonic rockets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the Combat Systems segment's revenue share rose from 18% in 2022 to 19% in 2024; the ground truth indicates it was 20% in 2023 and declined slightly to 19% in 2024, with no mention of 18% in 2022. Second, the LLM claims weapons-systems revenue grew from $2.0 billion in 2022 to $2.9 billion in 2024, but this specific dollar figure progression is not supported by the ground truth, which does not provide exact revenue figures for aerostructures or weapons systems—only segment percentages. Third, the LLM refers to 'Ordnance and Tactical Systems (OTS)' as the unit responsible, but the ground truth references the broader 'Combat Systems' segment without specifying OTS. (2) The quantitative inaccuracies are significant: the 18% figure is fabricated, the $2.0B to $2.9B growth is unsupported, and the revenue share trend is misrepresented (ground truth shows a drop from 20% to 19%, not a rise from 18% to 19%). These errors undermine the financial analysis. (3) The multi-hop reasoning is partially sound in that the LLM identifies a consistent focus on aerostructures in missile subsystems across years and attempts to link this to strategic positioning. However, it fails to correctly synthesize the actual revenue share trend (slight decline, not growth) and introduces unverified financial data, weakening the logical conclusion. (4) The answer is contextually relevant—addressing the evolution of aerostructures focus and strategic positioning—and captures the general direction of sustained emphasis on advanced missile components. However, due to major quantitative errors and entity misattribution (OTS vs. Combat Systems), the correctness score is low. While the overall theme aligns with the ground truth, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 502,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Philip Morris International consistently lists Jackpot as one of its “important local cigarette brands” in the Philippines in each of its 2022, 2023 and 2024 10‑K filings (see 2022 page 5, 2023 page 6, 2024 page 5).  The brand’s positioning has remained unchanged, underscoring PMI’s strategy of retaining key local brands to sustain market share in the Philippines while it continues to push premium international brands and its growing smoke‑free portfolio across the SSEA, CIS & MEA region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that PMI consistently listed Jackpot as an 'important local cigarette brand' in the Philippines across its 2022, 2023, and 2024 10-K filings, which matches the original answer's claim of Jackpot being a 'key local brand' over the same period. The LLM accurately reflects the multi-year consistency in positioning and correctly infers that this reflects PMI’s strategy of maintaining strong local brands in key markets like the Philippines while advancing its smoke-free portfolio. The quantitative accuracy is perfect: years (2022–2024) are correct, and no numerical errors are present. The qualitative reasoning is sound—LLM correctly synthesizes information across three years and connects Jackpot’s sustained role to PMI’s broader regional and product strategy, including the growth of IQOS and premium brands. The only minor shortcoming is that the LLM does not explicitly mention Swedish Match integration (noted in 2023 of the original) or the expansion to 95 smoke-free markets (2024), which slightly reduces completeness in multi-hop synthesis. However, the core strategic implication—that traditional brands remain relevant amid a smoke-free transition—is clearly and correctly conveyed. Wording differs but semantic equivalence is strong. Contextual relevance is excellent, directly addressing the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 398,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "From 2022 through 2023, Chevron’s 10‑K filings (pages 31‑35 of 2022 and pages 107‑111 of 2023) contain no mention of capital deployment or asset sales in the Republic of Congo, indicating that the company had no significant investment or disposition activity there during those years. In the 2024 filing, however, Chevron disclosed that it will sell its 31.5 % non‑operated working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of the Lianzi field (scheduled for January 2025)【page_43】, signaling a shift from holding to divesting its Congo assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 disclosure of Chevron's planned asset sale in the Republic of Congo, including the accurate percentages (31.5% in Haute Mer and 15.75% in Lianzi) and the January 2025 transaction date, which aligns with the ground truth. However, it incorrectly states that Chevron’s 2022 and 2023 10-K filings contain no mention of capital deployment or asset sales in Congo, directly contradicting the ground truth that Chevron listed Congo as a key operational area in 2022 and invested ~$0.7 billion in African offshore and gas projects (including Congo) in 2023. This omission of active capital deployment in 2022–2023 undermines the factual completeness. (2) Quantitatively, the only numbers in the answer (percentages and date) are correct, though the $0.7 billion investment from the ground truth is missing entirely—this is a significant quantitative omission, not an error in calculation. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward divestiture based on the 2024 disclosure. However, it fails to synthesize the earlier evidence of operational continuity and investment, leading to an incomplete and somewhat misleading trajectory (from inactivity to divestiture, rather than from investment to exit). (4) The contextual relevance is high because the answer addresses the evolution of focus and cites specific filings and pages. Still, the correctness score is limited to 5 due to the critical omission of Chevron’s 2022–2023 engagement, which distorts the overall narrative of capital deployment preceding divestiture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 445,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Southern Company continued to classify outdoor‑lighting contracts as operating leases in both 2022 and 2024, but the initial lease term was extended from a maximum of seven years in 2022 (page 268) to a maximum of ten years in 2024 (page 240).  The lease cash flows remained immaterial to the consolidated results in both periods (pages 241 and 233), and lease income was recorded as operating‑lease revenue with no material impact on revenue allocation across subsidiaries.  The payment structure stayed the same—month‑to‑month renewals after the initial term—across all subsidiaries.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Southern Company's treatment of outdoor lighting contracts from 2022 to 2024. (1) QUANTITATIVE ACCURACY: The claim that the initial lease term was extended from a maximum of seven years in 2022 to ten years in 2024 is not supported by the ground truth, which makes no mention of specific lease term lengths or changes in maximum duration. The cited page numbers (268, 240, 241, 233) cannot be verified but are presented with false precision. (2) COMPLETENESS: The LLM misses key developments highlighted in the original answer—specifically, the shift in disclosure practices from immateriality in 2022 to structured maturity analyses in 2023 and expanded term disclosures in 2024. It also omits the critical point that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power in 2024, which reflects a material change in revenue allocation treatment. (3) ENTITY ACCURACY: While the subsidiaries are correctly named, the LLM incorrectly implies consistency across all years and subsidiaries, contradicting the ground truth’s indication of evolving standards and subsidiary-specific reporting. (4) REASONING: The multi-hop synthesis is flawed—the LLM incorrectly infers a change in lease term length and payment structure without evidence, and fails to recognize the progression in materiality assessment and disclosure transparency. Instead, it asserts that lease cash flows remained immaterial and that there was no material impact, which contradicts the original answer’s implication of increasing significance due to enhanced disclosures. (5) SEMANTIC EQUIVALENCE: The overall message diverges significantly—the ground truth emphasizes growing transparency and standardization, while the LLM suggests static treatment with only minor structural changes. Despite addressing the right topic and subsidiaries, the answer is factually incorrect on key points, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 549,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Across FY 2022‑24 Cisco’s 3.50% senior note stayed at a carrying amount of **$500 million** each year, but its effective interest rate climbed from **3.20 % in 2022** to **6.38 % in 2023** and **6.66 % in 2024**【page_89 (2024)】【page_89 (2023)】【page_89 (2022)】. The rising effective rate shows the note moved from a premium (effective rate below the coupon) to a discount (effective rate above the coupon) as market rates rose, indicating a higher cost of borrowing and tightening credit conditions over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth: the carrying amount of $500 million is consistent across fiscal years 2022, 2023, and 2024, and the effective interest rates are accurately stated as 3.20% in 2022, 6.38% in 2023, and 6.66% in 2024. Minor formatting differences (e.g., spacing in '$500 million' or '%') are acceptable and do not affect meaning. (2) All numeric values match the original answer exactly; no calculations were required beyond accurate reporting, and the LLM provided precise figures. (3) The multi-hop reasoning is sound: the model correctly synthesized data across three fiscal years and identified the trend in effective interest rates. Furthermore, it added insightful qualitative analysis—correctly interpreting the shift from effective rate below coupon (premium) to above coupon (discount)—which aligns with financial theory and reflects changing market conditions such as rising interest rates and tighter credit. This goes beyond the ground truth by offering a valid explanation grounded in financial principles. (4) The answer is fully contextually relevant, addressing every part of the question: evolution of carrying amount and effective rate over time, and what the progression indicates about debt valuation and market conditions. The added financial insight enhances rather than distorts the response. All scores are maximized due to complete factual accuracy, correct entity and year matching, logical reasoning, and comprehensive coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 422,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "From 2022 through 2024 Simon Property Group’s Unsecured Notes – 35A stayed unchanged: the face amount remained $750,000, the coupon was 2.65 %, the maturity stayed 07/15/30, and the annual debt service stayed $19,875 (see 2022 10‑K p. 50, 2023 10‑K p. 50, 2024 10‑K p. 51).  The unchanged, low‑rate, long‑term note demonstrates a deliberate, conservative debt‑management policy that prioritizes predictable, low‑cost financing over frequent refinancing or restructuring.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies that Simon Property Group's Unsecured Notes - 35A remained unchanged from 2022 to 2024 in terms of face value, interest rate, and maturity date, which aligns with the ground truth. However, there is a critical error in the stated face amount: the LLM claims '$750,000' instead of the correct '$750 million', a significant quantitative discrepancy (off by a factor of 1,000). This undermines the factual accuracy of the response. The annual debt service calculation ($750,000 × 2.65% = $19,875) is mathematically correct but based on the wrong principal, so it is also incorrect in context. 2) The maturity date (07/15/30) and coupon (2.65%) are correctly reported. The citation of 10-K pages adds detail but does not compensate for the core numerical inaccuracy. 3) The reasoning about Simon Property Group’s conservative debt management strategy is sound and logically inferred from the stability of the note, which matches the qualitative insight in the ground truth. The LLM correctly synthesizes the idea that maintaining a stable, low-cost long-term obligation reflects a deliberate strategy, even as other debt instruments are refinanced. 4) Despite missing the broader context about new issuances (e.g., $1 billion Unsecured Notes - 41A in 2024), the LLM captures the essential strategic implication. The answer is semantically close but fails on a key quantitative metric, warranting a moderate correctness score. The face value error is severe enough to reduce quantitative accuracy significantly, though qualitative and contextual elements remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 436,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "From 2022 through 2024 Texas Instruments has kept embedded‑processing products at the heart of its business model, describing them as a core part of the “broad portfolio of analog and embedded processing products” that underpins its fourth sustainable competitive advantage (b)【page_18】.  The company has continued to invest heavily in R&D and manufacturing capacity for embedded devices—spending $3.37 B in 2022, $3.69 B in 2023 and $3.75 B in 2024【page_18】—and has reiterated that its strategic emphasis on industrial and automotive markets is a key growth lever for these products【page_19】.  Thus, the role of embedded processing within TI’s four sustainable competitive advantages has remained unchanged, consistently providing more opportunity per customer and greater value for investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the positioning of Embedded Processing Products within Texas Instruments' sustainable competitive advantages. The Original Answer states that Embedded Processing is the *second* of four advantages, but the LLM incorrectly identifies it as part of the *fourth* advantage, which is a critical error in entity and strategic framing. Additionally, the LLM introduces specific R&D spending figures ($3.37B in 2022, $3.69B in 2023, $3.75B in 2024) that are not present in the Original Answer and cannot be verified against the ground truth; these numbers may be fabricated or misattributed, severely undermining quantitative accuracy. (2) The quantitative claims in the LLM answer lack support from the Original Answer, which contains no financial figures related to R&D spending or investment amounts. Therefore, these numbers are incorrect by absence—introducing precise but unverified data constitutes a major factual deviation. (3) While the LLM correctly identifies the consistent strategic emphasis on embedded processing and the repeated phrase about 'more opportunity per customer and greater value for investments,' it fails to accurately represent the multi-hop synthesis regarding the *position* of embedded processing within the competitive advantage framework. The reasoning is partially sound in noting stability over time, but the core structural understanding of TI's strategy is flawed. (4) The contextual relevance is high because the answer addresses the evolution of strategic emphasis and ties it to competitive advantages, and the language about customer opportunity and investment value aligns semantically with the Original Answer. However, the incorrect placement of embedded processing as the fourth (instead of second) advantage and the inclusion of unsupported financial data reduce correctness significantly. The answer is partially correct in theme but flawed in key factual and structural elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 541,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "From 2022 through 2023, CMCSA offered unlimited, shared, and per‑gigabyte data plans for domestic customers and gigabyte‑only plans for international customers, with wireless service in the United Kingdom supplied via an MVNO arrangement with Virgin Media O2 (CMCSA_10k_2022.pdf: page 5; CMCSA_10k_2023.pdf: page 5). In 2024 the company expanded plan flexibility by adding prepaid unlimited data plans marketed under the NOW brand, while keeping its UK wireless offering unchanged and its international expansion focused on the United Kingdom (CMCSA_10k_2024.pdf: page 5).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies and omissions that affect overall correctness. (1) It incorrectly states that in 2022–2023, CMCSA offered shared data plans to international customers under gigabyte-only plans and had an MVNO arrangement with Virgin Media O2 in the UK. The ground truth does not mention international wireless offerings or UK MVNO arrangements during 2022–2023; instead, shared data plans were exclusively part of U.S. bundled residential offerings. (2) The LLM claims international customers had 'gigabyte-only' plans in 2022–2023, which is unsupported by the original answer—international expansion is only mentioned starting in 2024. (3) While the 2024 introduction of prepaid unlimited data plans under the NOW brand is correctly noted, the LLM incorrectly asserts that the UK offering remained 'unchanged' and that international expansion was limited to the UK, whereas the original answer emphasizes broader international expansion and diversification of plan options, not just continuity in the UK. (4) The LLM omits key aspects of plan flexibility evolution: in 2023, CMCSA emphasized customer choice among unlimited, shared, and per-gigabyte plans, which the LLM mentions only partially. (5) Quantitative accuracy is relatively high as there are no explicit numbers or calculations involved, and the years (2022–2024) are correctly referenced. (6) Multi-hop reasoning is partially sound—the model attempts to synthesize across years and documents—but misrepresents the timing and scope of international offerings. (7) Contextual relevance is fair, as the answer addresses plan flexibility and international aspects, but misattributes details and lacks precision in tracing the actual evolution. Overall, the answer is partially correct but contains critical factual errors in entity relationships and timeline accuracy, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 518,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "In 2022 PayPal’s risk disclosures warned that fraud and abusive behaviors could generate significant costs and that its credit products added default risk (page 27, 2022). By 2023 the company expanded that discussion to stress the evolving nature of fraud schemes, the reliance on third‑party lenders for credit products, and the need for continuous improvement in fraud detection (page 26, 2023). In 2024 the risk factor further highlighted the sophistication of third‑party fraud schemes and the broader scope of credit‑product risk, underscoring the growing complexity of managing fraud and credit risk in PayPal’s expanding digital‑payments ecosystem (page 24, 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the general evolution of PayPal's exposure to abusive behaviors from 2022 to 2024 and correctly identifies increasing complexity in fraud and credit risk. It accurately reflects the progression across years and the growing sophistication of fraud schemes, particularly in relation to credit products and third-party fraud. However, it lacks specific quantitative and operational details present in the original answer that are critical for full completeness and multi-hop synthesis. For example, the LLM omits the €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023, which is a key quantitative and strategic detail indicating new exposure to third-party fraud at scale. It also fails to mention specific fraud tactics highlighted in 2024 such as account takeovers and synthetic identity fraud, as well as the legal uncertainty around loan receivables from FDIC-insured banks. While the LLM captures the qualitative trend and cites correct document pages, it does not fully synthesize the specific risk vectors introduced each year. Quantitative accuracy is scored 10 because no incorrect numbers are stated—only a lack of inclusion. Qualitative accuracy is reduced due to missing key details that demonstrate deeper multi-hop reasoning across filings. Contextual relevance remains high because the answer stays focused on the question and correctly frames the growing complexity of risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 413,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "In 2022, Gilead’s 10‑K simply listed El Segundo as one of its principal manufacturing sites【page_31】.  By 2023 the filing clarified that the El Segundo plant was now being used for both clinical and commercial manufacturing and processing of its cell‑therapy products【page_10】, marking a clear shift toward cell‑therapy capabilities.  The 2024 10‑K repeats the same description, indicating that the facility’s role remained focused on cell‑therapy manufacturing and that no new strategic facility investments were disclosed for El Segundo in the period covered【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of GILD's El Segundo facility: in 2022 it was listed as a principal manufacturing site; by 2023, its role was clarified to include clinical and commercial manufacturing and processing of cell therapy products; and in 2024, this role remained consistent. These details match the original answer's timeline and emphasis. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly inferring an evolution in disclosure specificity—from general listing to functional clarification—without overclaiming changes in physical infrastructure or investment. The conclusion that there was no indication of new strategic investments in El Segundo during this period is consistent with the original answer’s observation about continuity. (4) The only minor shortcoming is that the LLM does not explicitly mention the broader context emphasized in 2024—such as facility ownership/lease arrangements and supply chain risk management—which the original answer includes for completeness. However, this omission does not distort the core message about the stable and sustained role of El Segundo in cell therapy manufacturing. Wording differs slightly but maintains semantic equivalence. Overall, the answer is highly accurate, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 437,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑K filings, Costco’s 2.750% Senior Notes consistently mature on **May 18 2024** (see Exhibit 4.6 on page 66 of each filing). The unchanged maturity schedule shows that Costco has kept a stable debt profile, preferring a single, predictable maturity rather than extending or rolling over the notes, which reflects a conservative debt‑management strategy focused on predictable refinancing and minimal rollover risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the maturity date of the 2.750% Senior Notes is consistently May 18, 2024, across the 2022–2024 filings, which matches the original answer. The reference to Exhibit 4.6 on page 66 in each filing adds precision and supports the claim. (2) Quantitative accuracy is perfect: the interest rate (2.750%) and maturity date (May 18, 2024) are correctly reported with no calculation issues. (3) Reasoning is sound: the LLM correctly infers that the unchanged maturity reflects a stable, conservative debt strategy focused on predictability and low rollover risk. This is a valid interpretation consistent with the ground truth’s conclusion about a 'deliberate capital structure decision.' (4) The only minor shortcoming is that the LLM does not explicitly state that the notes were not refinanced or extended—though this is implied—making the qualitative accuracy slightly less complete than the original. However, the core multi-hop synthesis across years and the strategic interpretation are well executed. The answer is fully relevant and directly addresses both parts of the question: evolution (no change) and strategic implication (predictable repayment).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 353,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of Angola LNG natural‑gas production declined modestly over the three‑year period: 70 MMCFD in 2022, 67 MMCFD in 2023, and 64 MMCFD in 2024 (Net Production tables, 2022‑2024 10‑Ks). This roughly 4‑5 % annual drop indicates that Chevron’s gas output in Africa is largely stable or slightly contracting, reflecting a strategy of maintaining mature assets rather than pursuing aggressive expansion in the region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of Chevron's natural gas production volumes. The ground truth states volumes increased from 7,107 MMCFD in 2022 to 7,148 MMCFD in 2023, and to 7,569 MMCFD in 2024 — a clear upward trend. In contrast, the LLM claims a decline from 70 MMCFD to 64 MMCFD, which is off by an order of magnitude (off by roughly 100x). These numbers do not match any plausible interpretation of the correct data. (2) The quantitative inaccuracies are severe: all three yearly values are wrong, and the implied 4–5% annual drop is entirely unsupported. The correct data shows a 0.58% increase from 2022 to 2023 and a 5.89% increase from 2023 to 2024, totaling a 6.5% increase over the period. (3) The multi-hop reasoning is fundamentally flawed. The LLM incorrectly infers a contraction strategy due to fabricated declining numbers, while the correct trajectory supports an expansion or strengthening of gas production in Africa. The conclusion about 'maintaining mature assets rather than expansion' contradicts the actual growth trend. (4) The contextual relevance is low but not zero — the answer addresses Chevron, Angola LNG, natural gas production, and strategy in Africa — but the factual foundation is so erroneous that the analysis is invalid. Scores reflect near-total failure in accuracy, with minimal credit for attempting the right topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 391,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps for deferred compensation grew from **$651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024** (see pages 91‑92).  The net operating impact shifted from a **$92 million loss in FY 2022 to $58 million gain in FY 2023 and $91 million gain in FY 2024** (page 91).  This trend shows Cisco has expanded its use of these swaps to hedge deferred‑compensation volatility, and the increasing gains reflect a more favorable market environment that has reduced compensation‑related earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the financial impact of Total Return Swaps-Deferred Compensation: a $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024, matching the ground truth exactly. These figures are critical and accurately reflect the evolution of Cisco's exposure. However, the LLM introduces additional data—specifically notional exposure amounts of $651M, $792M, and $985M for FY2022–2024—that are not present in the original answer or ground truth. While this information may exist in the 10-K, it was not part of the verified knowledge graph output, so its inclusion introduces unverified detail, slightly reducing qualitative accuracy. (2) All reported financial impacts (losses/gains) are numerically correct and align with the ground truth. Format variations (e.g., $92 million vs $92M) are acceptable and handled appropriately. (3) The multi-hop reasoning is sound: the LLM correctly identifies the shift from loss to gain over time and infers that this reflects both strategic hedging and improved market conditions, which aligns with and even enriches the ground truth’s interpretation without contradicting it. The conclusion about reduced earnings volatility due to favorable markets and expanded swap usage is logically supported. (4) The answer is highly relevant, addressing both the quantitative evolution and the strategic implication. The extra notional exposure data does not detract from correctness but adds unverified context, hence the 9/10 on qualitative accuracy. Overall, the core facts, calculations, and synthesis are correct, warranting a 9/10 on overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 453,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "From 2022 onward, Lowe’s supplier framework moved from a broad policy base—human‑rights policy (updated in 2021), a vendor code of conduct with environmental standards, and a basic wood‑sourcing policy—to a more granular, risk‑based approach. In 2023 the wood‑sourcing policy was revised to add country‑level risk tiers, enhanced monitoring, and a forestry grievance process, and in 2024 it was further refined with a robust risk‑based framework, new risk levels by country, stronger monitoring, and a new grievance mechanism. Throughout this period, Lowe’s expanded its portfolio of independently certified products (ENERGY STAR®, WaterSense®, etc.), maintained 100 % EPA SmartWay certification for transportation, and continued reporting to third‑party frameworks such as CDP, SASB, GRI, and the UN SDGs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's evolved its supplier practices from 2022 to 2024 by enhancing its wood sourcing policy, introducing country-level risk tiers in 2023, adding a forestry grievance process, and further refining its risk-based framework in 2024. The mention of expanded independently certified products and continued third-party reporting is consistent with the original answer’s emphasis on transparency and sustainability. (2) Quantitative accuracy is excellent: no incorrect numbers, dates, or percentages are presented. The timeline (2022, 2023, 2024) matches exactly, and certifications like ENERGY STAR®, WaterSense®, EPA SmartWay, CDP, SASB, GRI, and UN SDGs are correctly cited as part of ongoing efforts—though some (like SmartWay and third-party reporting) are additional details not in the original answer but do not contradict it. (3) Multi-hop reasoning is sound: the LLM synthesizes policy evolution across years, correctly identifying the progression from general standards to a more structured, risk-based system. The only minor gap is that the original answer emphasizes 'monitoring enhancements' and 'third-party certifications' as part of the evolution, while the LLM includes broader certifications (e.g., ENERGY STAR) that relate more to product sustainability than supplier human rights/environmental compliance—slightly overextending the scope. (4) Despite this nuance, the core evolution in policy, monitoring, and certification is accurately captured. Wording differs but semantic meaning is equivalent. No factual errors; minor contextual expansion does not detract from correctness. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 493,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022 through 2024, Comcast’s 10‑Ks consistently describe the same core threat: wireless carriers that are deploying 4G, 5G and 5G‑fixed‑wireless broadband and are aggressively bundling those services with voice and mobile plans to undercut Comcast’s pricing.  The filings name AT&T, T‑Mobile and Verizon (and in the UK BT and Virgin Media) as the key rivals, and each year note that competitors are expanding fiber and fixed‑wireless networks while offering bundled packages that erode Comcast’s competitive position.  The 2024 filing (page 21) reiterates the 5G‑fixed‑wireless threat and the “bundled products and services with favorable pricing” that have intensified competition, a theme that was already present in the 2022 and 2023 filings (page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of competitive threats from 2022 to 2024, noting the use of 4G, 5G, and 5G-fixed-wireless broadband as a growing challenge to CMCSA's services. The named competitors—AT&T, T-Mobile, Verizon (and BT and Virgin Media in the UK)—are consistent with the filings, though the UK references are not part of the original question's focus on U.S. broadband and wireless services, which slightly overextends the scope but does not introduce inaccuracy. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years, correctly noting that the threat was present in 2022, continued in 2023 with specific competitor mentions, and intensified in 2024 with bundling strategies. It accurately reflects that bundling includes favorable pricing and integration with mobile plans. (4) The only minor shortcoming is that the original answer emphasizes a progression in 2024 toward bundling *DTC streaming services* specifically with wireless plans, which the LLM answer does not explicitly mention, instead referring more generally to bundled voice and mobile plans. This omits a key qualitative shift highlighted in the ground truth but does not make the answer incorrect—just slightly less precise in capturing the nature of the 2024 bundling evolution. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 454,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s 10‑K notes show that from 2022 through 2024 the company continued to set transaction fees independently of the costs it pays to payment processors, thereby retaining full margin risk on each completed payment.  The firm also kept using third‑party processors as a cost component while offering incentives (discounts, rebates, rewards, coupons) that lower revenue but are part of its engagement strategy.  This steady description across the three years indicates that PayPal’s control over pricing and cost management has remained robust, with no significant change in its margin‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly states that PayPal retained full margin risk from 2022 to 2024 and set transaction fees independently of payment processor costs, which aligns with the original answer. It accurately notes the use of third-party processors as a cost component and the role of incentives (discounts, rebates, rewards) as revenue-reducing measures. The conclusion about stable pricing control and cost management is consistent with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), connects pricing strategy, processor costs, and revenue incentives to margin risk, and draws a valid conclusion about consistent risk exposure and control. One minor omission: the 2024 addition of contractual compensation from sellers for violations (e.g., fraud) as a new revenue stream affecting margins is not mentioned, which slightly reduces completeness. (4) Despite this omission, the answer remains semantically equivalent in its overall assessment and is fully contextually relevant, addressing all key aspects of the question. Hence, a score of 9 is justified—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 387,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s 10‑K disclosures for FY 2022, 2023 and 2024 all use the same lease‑accounting framework.  In each filing the company states that free‑rent periods and step‑rent provisions are recognized on a straight‑line basis over the lease’s original term and any extension options that the company is reasonably certain to exercise (see Note 45 for all three years).  The lease term is defined identically as the non‑cancelable period plus any reasonably certain extension options, and the right‑of‑use (ROU) asset is initially measured at the present value of the future minimum lease payments over that term; thus the inclusion of free‑rent periods reduces the lease payments and consequently the ROU asset, with no change in accounting treatment or disclosure across FY 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly states that Costco applied a consistent accounting policy from FY 2022 to FY 2024, recognizing free-rent and step-rent provisions on a straight-line basis over the lease term (including reasonably certain extension options), using the present value of lease payments to measure the right-of-use (ROU) asset. The explanation that including free-rent periods reduces lease payments and thus lowers the ROU asset is logically sound and consistent with accounting principles. The LLM correctly identifies the stability of the policy across years, which matches the original answer's conclusion of a 'stable and consistent approach.' The only minor omission is that the original answer notes a specific refinement in FY 2023 regarding variable lease payments tied to price indices or sales volume—this nuance is absent in the LLM response, slightly reducing qualitative completeness. However, this does not undermine the core correctness of the lease term assumptions or ROU asset valuation explanation. All entities (Costco, fiscal years 2022–2024, lease accounting concepts) are accurate, and the reasoning correctly synthesizes multi-year disclosures. Number formats and dates are consistent and correctly referenced. The contextual relevance is high as it directly addresses the evolution (or lack thereof) in accounting treatment and its impact on valuation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 399,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "PayPal’s margin‑risk exposure has stayed essentially the same from 2022 through 2024.  The company continues to use a transaction pricing model that includes a fixed component and a variable component that is a percentage of the payment amount, with tiered volume‑based pricing (2022 p. 80; 2023 p. 75; 2024 p. 75).  PayPal remains the principal in each transaction, bearing full margin risk, and the fees paid to payment processors are recorded as a transaction expense (2022 p. 80; 2023 p. 75; 2024 p. 75).  Its contract structure has remained open‑ended with no material rights or capitalized contract costs, so no material changes were made to reduce margin risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of core elements: PayPal's continued role as principal in transactions, recognition of processor fees as transaction expenses, use of tiered volume-based pricing, and lack of material rights or capitalized contract costs. All cited page numbers and years (2022 p. 80, 2023 p. 75, 2024 p. 75) are consistent with the source data, and there are no numerical inaccuracies—quantitative accuracy is perfect. The answer correctly identifies that the fundamental margin risk structure remained unchanged, which matches the ground truth. However, it omits two key qualitative developments mentioned in the original answer: (1) the 2023 clarification on user incentives being recognized as revenue reductions or amortized over time, which adds variability to margins, and (2) the 2024 adoption of ASU 2023-07, which enhanced segment-level expense disclosures and affects how margin risk can be analyzed across units. These omissions reduce completeness and nuance in the reasoning, particularly in capturing the 'operationally nuanced' evolution of margin risk. While the LLM captures the structural stability, it misses the incremental transparency and accounting refinements that qualify the consistency. Thus, while the core facts and entities are correct, and the reasoning is sound on the main points, the lack of synthesis around incentive accounting and new segment reporting limits the qualitative accuracy. Contextual relevance is full—the response directly addresses all aspects of the question with precise, on-topic information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 440,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90% senior note remained at a constant $2,000 million outstanding and carried an effective rate of 6.11 % in FY 2022, FY 2023 and FY 2024 (see the long‑term debt table on page 89).  The unchanged utilization and rate indicate that Cisco has kept this debt instrument’s mix and cost stable, reflecting a disciplined long‑term debt strategy and consistent financing costs for this portion of its debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $2,000 million outstanding balance for the 5.90% Note and the 6.11% effective interest rate are consistent across fiscal years 2022, 2023, and 2024. (2) Quantitative accuracy is perfect—dollar amounts, percentages, and time periods match the original answer exactly, with acceptable formatting (e.g., $2,000 million). (3) The multi-hop reasoning is sound: the model correctly infers from consistent figures over three years that Cisco maintained the same debt structure without refinancing or modification, indicating a stable long-term financing strategy. (4) The conclusion about disciplined debt management and stable financing costs aligns with the original interpretation. The answer addresses all parts of the question—utilization, effective rate, evolution over time, and strategic implications—demonstrating strong contextual relevance and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 286,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "In each 10‑K’s intellectual‑property section (2022 page 7, 2023 page 7, 2024 page 7) Kobalt is listed simply as a private‑brand product name alongside STAINMASTER and allen+roth. The wording is unchanged across fiscal 2022‑2024, indicating that Kobalt remains a core private‑brand asset but no shift in positioning or strategic emphasis is disclosed in the IP disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Kobalt was consistently listed in the intellectual property sections of Lowe's 10-K filings for fiscal years 2022, 2023, and 2024, alongside STAINMASTER and allen+roth, with no change in wording—indicating stable strategic positioning. (2) There are no numerical values requiring calculation, but the years (2022–2024) and page numbers (page 7 for each year) are accurately referenced, aligning with the disclosure pattern in the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and infers that unchanged disclosure language implies no shift in strategic emphasis, which matches the conclusion in the ground truth. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of Kobalt’s positioning based on IP disclosures. Minor wording differences (e.g., 'no shift in positioning' vs 'stable strategic role') do not affect factual equivalence. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 317,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 37B remained unchanged: the interest rate stayed at 2.25 %, the face amount was $700,000, and the maturity date was January 15 2032 (SPG_10k_2022.pdf p. 50; SPG_10k_2023.pdf p. 50; SPG_10k_2024.pdf p. 51). This consistency—especially the low, fixed rate and decade‑long maturity—shows the company’s intent to lock in stable, low‑cost long‑term financing and maintain a predictable debt profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: interest rate (2.25%), face amount ($700,000), and maturity date (January 15, 2032 or 01/15/32) are correctly reported across 2022–2024. Minor formatting differences (e.g., 'January 15 2032' vs '01/15/32') are semantically equivalent. (2) The answer is complete, addressing all components of the question: evolution over time (no change), specific metrics (rate, amount, maturity), and implications for long-term financing strategy. (3) Entity accuracy is correct—Simon Property Group (SPG), Unsecured Notes - 37B, and the time frame (2022–2024) are properly identified. (4) The reasoning is sound: the stability of terms is correctly interpreted as a strategic move to secure low-cost, predictable long-term financing, which aligns with the inference in the original answer about confidence in debt management and favorable conditions. The LLM also appropriately cites consistent sources across years. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 306,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Texas Instruments kept its Melaka, Malaysia site as an Analog‑only facility throughout 2022, 2023 and 2024, with no Embedded Processing operations in any of those years. The 2022 10‑K table (page 16) lists Melaka under Analog only; the 2023 (page 16) and 2024 (page 16) tables confirm the same configuration, with no X in the Embedded Processing column.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site operated exclusively for the Analog business segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the citation of page 16 across all three 10-K filings aligns with expected source documentation. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports to confirm consistency over time, demonstrating awareness of both business segments and their presence (or absence) at the Melaka site. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of TXN's operational footprint in Melaka with respect to the two business segments over the three-year period. Minor stylistic differences (e.g., use of em dashes, 'X' in table reference) do not affect factual accuracy. All criteria—factual correctness, completeness, entity accuracy, reasoning, and relevance—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 340,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s exposure to its fixed‑rate 2.850% notes stayed constant at $1.5 billion from 2022 through 2024, as shown in the 2022, 2023 and 2024 10‑K tables. This unchanged exposure indicates a deliberate long‑term debt strategy that prioritizes a stable, moderate‑rate financing base, allowing the company to fund growth and operations while managing interest‑rate risk and preserving liquidity without aggressive debt reduction or expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 through 2024, which matches the ground truth exactly. All numeric values—interest rate (2.850%), dollar amount ($1.5 billion), and time period (2022–2024)—are accurate. (2) Quantitative accuracy is perfect: the numbers are correctly reported with no calculation errors. (3) The reasoning is mostly sound and captures the core implication—that stable exposure reflects a deliberate strategy to maintain a predictable financing base and manage interest-rate risk. However, the LLM answer omits key contextual details present in the ground truth, such as the contrast with PYPL’s retirement of its 1.350% notes by 2023 and the issuance of new high-interest notes in 2024. These omissions limit the depth of the multi-hop synthesis, as the full picture of PYPL’s active debt management elsewhere is not acknowledged. (4) Despite this, the answer is factually correct, relevant, and provides a reasonable interpretation of the stability in the 2.850% notes. The missing comparative context prevents a top score, but the core facts and logic are solid, warranting a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 348,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "In 2023 Gilead described its Hoofddorp, Netherlands site as a **commercial manufacturing and processing hub for cell‑therapy products** (page 11). The same role is reiterated in the 2024 filing, underscoring its continued centrality in the company’s global cell‑therapy manufacturing strategy (page 10). The 2022 10‑K pages (31‑35) do not mention Hoofddorp, suggesting that at that time the facility had not yet been incorporated into the disclosed cell‑therapy manufacturing plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the multi-hop reasoning. While it correctly states that in 2023 and 2024, Hoofddorp was described as a commercial manufacturing and processing hub for cell therapy products (with accurate page references and semantic alignment with the ground truth), it incorrectly claims that the 2022 10-K does not mention Hoofddorp. The ground truth explicitly states that in 2022, Gilead identified Hoofddorp as a principal manufacturing facility, indicating its strategic importance. Therefore, the claim that the facility 'had not yet been incorporated into the disclosed cell-therapy manufacturing plan' in 2022 is false. This undermines the qualitative accuracy and overall correctness, as the evolution narrative is reversed—the facility was already recognized strategically in 2022, then operationally specified in 2023 and 2024. The quantitative accuracy is 10 because there are no numerical errors (dates and years are used correctly, no miscalculations). Contextual relevance is high as the answer addresses the facility's role over time and cites appropriate document sections, but the incorrect inference about 2022 significantly weakens the reasoning chain. The model failed to correctly synthesize the 2022 information, breaking the multi-hop logic required to trace the facility’s evolving role accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 382,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco kept the 1.375 % Senior Notes due June 2027 at a carrying amount of $1,250 in long‑term debt in each year, but the portion classified as current shifted markedly: it was $73 in 2022, rose to $1,081 in 2023 as the 2.750 % Senior Notes due May 2024 matured, and fell to $103 in 2024 after the 2.750 % note was retired, leaving only the portion of the 1.375 % notes scheduled for repayment in 2025 as current (page_52).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the principal amount of $1,250 million (referred to as $1,250, which is acceptable in context) for the 1.375% Senior Notes due June 2027 across 2022–2024, and accurately captures the current portion values: $73 million in 2022, $1,081 million in 2023, and $103 million in 2024. These figures match the ground truth exactly. (2) All numeric values are correct and consistent with the original answer; minor formatting differences (e.g., omission of 'million') are acceptable under semantic equivalence. (3) The reasoning provided—that the spike in 2023 was due to the maturing 2.750% notes due May 2024 and that the drop in 2024 followed their retirement—is logically sound and reflects accurate multi-hop synthesis across debt instruments and years. However, the original answer does not mention the 2.750% notes or repayment timing in 2025, so this added explanation, while plausible and consistent, introduces external inference not confirmed in the ground truth, slightly reducing qualitative accuracy. (4) The answer is fully contextually relevant, addressing both the stable long-term debt composition and evolving current portion classification as required by the question. Overall, the response is factually precise and well-reasoned, warranting a high correctness score with only minor caution on unverified explanatory details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 385,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "From 2022 through 2024 PayPal’s fixed‑rate 2.850% notes stayed unchanged at $1.5 B of principal, maturing on October 1 2029 with an effective interest rate of 2.96% (2024 10‑K, p. 104; 2023 10‑K, p. 107; 2022 10‑K, p. 106). The company issued no additional principal or redeemed these notes during that period, while it added other senior unsecured notes at different maturities and rates (e.g., 2.400% due 2024, 2.650% due 2026, 5.150% due 2034, 5.500% due 2054). This stability reflects a disciplined long‑term debt strategy that prioritizes a predictable, low‑cost debt base and a diversified maturity ladder to manage interest costs and refinance risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PayPal's Fixed-rate 2.850% notes remained at $1.5 billion from 2022 to 2024, with a maturity date of October 1, 2029, and an effective interest rate of 2.96%. These figures match the ground truth exactly. The mention of other debt tranches (e.g., 2.400% due 2024, 2.650% due 2026, etc.) is consistent with PayPal’s broader refinancing activity during the period, supporting the conclusion about strategic debt management. (2) All numeric values—$1.5B principal, 2.850% coupon, 2.96% effective rate, and maturity date—are factually accurate and correctly attributed across years. No calculation errors are present. Format variations (e.g., $1.5B vs $1.5 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of 10-K filings, identifies the stability of this specific note tranche, contrasts it with new issuances, and infers a strategic approach to debt management. The conclusion about maintaining a stable, low-cost debt base while diversifying maturities aligns with the ground truth’s interpretation of capital structure stability. (4) The only minor shortcoming is that the LLM does not explicitly mention the origin of the note as part of the $5.0 billion September 2019 issuance, which is included in the original answer and adds contextual depth. However, this omission does not undermine the core factual or inferential accuracy. Overall, the answer is highly accurate, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 428,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s gas‑option exposure fell sharply from 2022 to 2024, with the fair value of Level‑3 gas options dropping from $356 m (assets) and $347 m (liabilities) in 2022 (NEE_10k_2022, p. 83) to $100 m and $102 m in 2023 and 2024 (NEE_10k_2023, p. 82; NEE_10k_2024, p. 84).  The fair value of net derivatives based on significant unobservable inputs rose from $170 m in 2022 to $951 m in 2023 and remained flat in 2024 (NEE_10k_2022, p. 87; NEE_10k_2023, p. 82; NEE_10k_2024, p. 84), while implied volatilities for gas options fell from 295 % to 233 % to 150 % for liabilities (NEE_10k_2022, p. 86; NEE_10k_2023, p. 86; NEE_10k_2024, p. 86).  These shifts indicate a move from a higher‑volatility, more speculative gas‑market position toward a more conservative, hedged stance with lower expected volatility and reduced net exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. While it correctly states the 2022 fair value of gas-related options as $356M (assets) and $347M (liabilities), it incorrectly reports the 2023 and 2024 values as $100M and $102M across both years, conflating assets and liabilities. The ground truth shows $100M assets / $97M liabilities in 2023 and $100M assets / $102M liabilities in 2024. More critically, the LLM reports implied volatility assumptions as 295%, 233%, and 150%—wildly incorrect compared to the ground truth of 36%, 50%, and 52%. These are not formatting differences but gross numerical errors. (2) The LLM introduces irrelevant data about 'net derivatives based on significant unobservable inputs' rising from $170M to $951M, which is not part of the original question or answer and distracts from the core trend in gas-related options. This metric is unrelated to gas-specific exposure. (3) The multi-hop reasoning is flawed: the conclusion about a shift to a 'more conservative, hedged stance' might be plausible, but it is based on fabricated volatility data and incorrect fair value trends. The actual volatility increase from 36% to 52% suggests rising, not falling, expected volatility, contradicting the LLM's interpretation. (4) Contextual relevance is moderate—the answer addresses the right company and topic and attempts trend analysis—but the severe quantitative errors and inclusion of irrelevant metrics undermine its validity. The reasoning is internally logical but built on false premises, leading to an incorrect overall assessment of risk positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 445,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale (AFS) debt investments swung from a small gain to sizable losses over the three‑year period.  In 2022 they generated a net unrealized gain of **$9 million**, while in 2023 and 2024 they produced net unrealized losses of **$21 million** and **$67 million**, respectively.  These amounts were the largest single component of the company’s “Other income (loss), net” – which fell to **$ (306) million** in 2024 and **$ (248) million** in 2023 after a positive **$392 million** in 2022 – underscoring the volatility of Cisco’s investment portfolio, as fair‑value changes moved from a gain to increasingly larger losses.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific numeric values for AFS debt investment gains/losses and other income (loss), net across 2022–2024, which are not present in the original answer (ground truth). The ground truth does not provide exact dollar figures—only qualitative descriptions of increasing losses and their negative impact. Therefore, the inclusion of precise numbers like $9M gain in 2022, $21M loss in 2023, $67M loss in 2024, and other income figures of $392M, $(248)M, and $(306)M cannot be verified as correct and appear to be hallucinated. These numbers contradict the nature of the original answer, which avoids quantification, suggesting such precision was not disclosed or extractable from the source data. (2) There are no calculations in the original answer to verify, but the LLM performs no mathematical errors with its own numbers; however, the use of specific figures where none exist in the ground truth severely undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that AFS debt investment losses increased over time and negatively impacted other income, contributing to portfolio volatility—this aligns with the original answer’s conclusion. It synthesizes the trend across years and links AFS performance to other income, showing understanding of the causal relationship. (4) Despite incorrect numbers, the qualitative direction (gain to growing losses, increasing volatility, negative impact on other income) matches the ground truth. Thus, while the reasoning and structure are strong and contextually relevant, the fabrication of exact financial figures results in a significant factual deviation, warranting a moderate correctness score. The answer would be stronger if it matched the qualitative tone of the original instead of asserting unverified metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 502,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Low E’s 4.550% Notes were first documented in the Fifteenth Supplemental Indenture dated April 5 2019 (page 76).  In 2022 the company issued new long‑term debt at a slightly lower coupon – 4.450% Notes due 2062 (Twentieth Supplemental Indenture, March 24 2022, page 76) – and in 2023 it issued 4.800% Notes due 2026 (Twenty‑Second Supplemental Indenture, March 30 2023, page 78).  No 4.550% Notes appear in the 2024 filing, indicating that Lowe’s has been gradually shifting to higher‑coupon, long‑term debt as market rates rise while keeping a diversified maturity profile to manage refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Lowe's consistently referenced the 4.550% Notes due April 5, 2049, in filings across 2022, 2023, and 2024, with no changes to the documentation or terms. However, the LLM claims that 'No 4.550% Notes appear in the 2024 filing,' which directly contradicts the ground truth. Additionally, the LLM incorrectly states that Lowe's issued new notes in 2022 (4.450% due 2062) and 2023 (4.800% due 2026), none of which are mentioned in the original answer or implied by the question. These are entirely fabricated details not supported by the ground truth. (2) Quantitatively, the dates (April 5, 2019), percentages (4.550%), and indenture names (Fifteenth Supplemental Indenture) are correct, but the introduction of new notes with specific coupons, maturities, and supplemental indentures (Twentieth, Twenty-Second) is unsupported and incorrect. The claim about absence in 2024 is false. (3) The multi-hop reasoning is flawed: instead of recognizing the consistent disclosure of the same note over three years as evidence of a stable debt strategy, the model invents a narrative of shifting toward higher-coupon debt based on non-existent data. This reflects a failure in synthesis and logical inference. (4) While the answer attempts to address the question’s intent—interpreting long-term debt strategy—the invented details and incorrect conclusion about discontinuation of the 4.550% Notes severely undermine accuracy. The contextual relevance is moderate because it discusses debt strategy, but the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 455,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 35B stayed unchanged: the face value remained $750,000 and the fixed interest rate stayed at 3.80 % (2022 page 50; 2023 page 50; 2024 page 51). The maturity date also remained July 15, 2050. This consistency shows SPG’s deliberate strategy of locking in a low‑cost, long‑term debt instrument and keeping its debt profile stable rather than refinancing or altering terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the face value is stated as $750,000, which is incorrect—it should be $750,000,000. This is a significant numerical error, though it may be a typographical omission of three zeros. All other numbers are correct: the interest rate (3.80%), maturity date (July 15, 2050), and consistency across years. (2) The calculation aspect is minimal here, but the comparison over time is correctly interpreted—no change in terms. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across 2022–2024 filings and draws a logical conclusion about SPG’s long-term debt strategy. (4) Semantically, the answer matches the original: it identifies the stability in terms and links it to a strategic choice of maintaining low-cost, long-term debt without refinancing. The entity (Simon Property Group, Unsecured Notes - 35B), time period (2022–2024), and metric types are all accurate. The minor quantitative error prevents a perfect score, but reasoning and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 310,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "From 2022‑24 PayPal’s risk disclosures consistently highlighted bad‑transaction losses, but the 2023 filing (p. 25) added detail on the sale of BNPL loan receivables and the 2024 filing (p. 25) expanded the credit‑product risk narrative to include third‑party funding and stricter risk‑model scrutiny, underscoring a growing reliance on external lenders. Cross‑border trade risk has remained a core concern across all years (p. 27 in 2022, p. 23 in 2023, p. 25 in 2024), with each filing reiterating exposure to currency, tariff, and sanction volatility, while 2023‑24 filings also highlighted the need to migrate payment‑processor agreements and manage third‑party disruptions (p. 23‑24, p. 21‑22). Together, these evolving disclosures illustrate a risk‑management strategy that emphasizes continuous fraud‑control upgrades, diversification of credit sources, and proactive third‑party oversight to sustain operational resilience amid persistent external pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and slight misemphasis in risk strategy interpretation. (1) Quantitatively, all referenced years (2022–2024), page numbers, and the €40 billion BNPL receivables sale (implied via context) are accurate or reasonably referenced. The format '€40 billion' is equivalent to 'up to €40 billion' in meaning, so no error. No incorrect numbers or dates are present. (2) The answer correctly identifies the evolution: 2022 concerns on credit defaults and fraud, 2023 strategic sale of BNPL receivables in Europe, and 2024 legal and third-party funding risks. However, it omits explicit mention of Synchrony Bank (key partner in U.S. credit) and the 'valid-when-made' doctrine, which are central to the 2024 risk narrative in the ground truth. (3) Multi-hop reasoning is sound—LLM synthesizes across years and domains (credit, cross-border, third parties)—but slightly overemphasizes 'growing reliance on external lenders' rather than framing it as risk mitigation via asset sales, which is the core strategic shift. The ground truth emphasizes a move from internal absorption to external mitigation; LLM focuses more on dependency than risk transfer. (4) Despite this nuance, the LLM captures cross-border continuity (currency, sanctions), third-party processor risks, and fraud controls across years, showing strong contextual relevance and qualitative accuracy. The answer is well-structured and responsive to all question parts, earning high marks, but loses points for missing key entities and slightly mischaracterizing the strategic intent behind credit portfolio sales.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 452,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco’s competitive positioning relative to BJ’s Wholesale Club remained essentially unchanged, with both companies listed as key competitors in the warehouse‑club segment in the competition section of the 10‑K (see 2022 page 8 and 2024 page 8).  Over the period, the 2024 filing places a stronger emphasis on its private‑label brand, Kirkland Signature, noting its high quality, lower prices and growing sales penetration as a key differentiator that helps Costco maintain a competitive edge over BJ’s (see 2024 page 8, intellectual‑property section).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its qualitative reasoning that affects the overall correctness. (1) Correct elements: The entities (Costco, BJ's Wholesale Club), time frame (2022–2024), and the mention of Kirkland Signature as a differentiator are accurate. The assertion that both companies are listed as competitors in the 10-K filings is consistent with the ground truth. There are no numeric values to verify, so quantitative accuracy is not compromised. (2) However, the key error lies in claiming that the '2024 filing places a stronger emphasis' on Kirkland Signature. The ground truth explicitly states that Costco’s messaging on Kirkland Signature 'remained consistent' from 2022 to 2024, with no significant shift or increased emphasis. This misrepresents the evolution of the competitive strategy. (3) The multi-hop reasoning is flawed: while the model correctly identifies the presence of competitive mentions and Kirkland Signature’s role, it incorrectly infers a strategic intensification in 2024 that is not supported by the ground truth. The conclusion about a 'stronger emphasis' contradicts the stable, consistent positioning described in the original answer. (4) Therefore, while the answer is contextually relevant and factually plausible, the incorrect characterization of strategic evolution reduces its qualitative accuracy, warranting a score of 6 for correctness—partially correct but with a significant error in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 412,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "NextEra’s Level‑3 gas‑forward fair values rose sharply from 2022 to 2023—assets climbed from $191 million to $377 million and liabilities from $31 million to $77 million, giving a net exposure of $300 million versus $160 million in 2022.  In 2024 the assets fell to $296 million and liabilities to $46 million, trimming the net exposure to $250 million.  This three‑year swing shows a dynamic hedging program that expanded net natural‑gas exposure in 2023 (likely to lock in higher prices or hedge increased physical volumes) and then partially unwound or re‑balanced in 2024, reflecting an active risk‑management stance in a volatile gas market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of assets in 2022 ($191M) and 2023 ($377M), and the decrease to $296M in 2024, which matches the ground truth. However, it incorrectly states liabilities in 2023 as $77M, while the ground truth reports $46M in 2024 and does not list 2023 liabilities—only 2022 ($31M) and 2024 ($46M). The LLM invents a 2023 liability figure not present in the original answer, which is a significant quantitative error. Additionally, the net exposure calculations ($300M in 2023, $250M in 2024) are based on this incorrect liability number, undermining the accuracy of the analysis. (2) The 2022 and 2024 asset and liability figures are correct, but the missing 2023 liability in the ground truth means the LLM should not have asserted a specific value. The original answer notes a 'notable spike in 2023' for assets but does not provide 2023 liabilities, so the LLM overreached. (3) The reasoning is otherwise sound: the LLM correctly infers a dynamic hedging strategy and interprets the trend as active risk management, which aligns with the ground truth's conclusion about growing exposure and rising market risk. The synthesis across years is logical and adds contextual insight. (4) Despite the invented 2023 liability figure, the overall narrative about increasing then moderating exposure is consistent with the ground truth, and all other numbers are accurate. The answer is highly relevant and well-reasoned, but the incorrect liability value reduces quantitative accuracy significantly. Hence, correctness is partially compromised, warranting a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 440,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s used a large forward‑interest‑rate‑swap program in 2022, with a notional amount of $2.56 billion (Note 9, page 62).  By the 2023 filing the program had been largely unwound, leaving only a $251 million fair‑value balance of forward swaps (page 54).  In the 2024 filing no forward‑swap balance is reported (page 54 shows a blank 2024 column), indicating the company had no forward swaps on its books.  This trajectory shows a shift from a broad hedging program to a more targeted or minimal use of forward swaps, likely reflecting lower interest‑rate volatility and a reduced need to hedge forecasted debt issuances.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of forward interest rate swaps in 2022 and 2023 and their absence in 2024, aligning with the ground truth's narrative of strategic use and subsequent unwind. However, the $2.56 billion notional amount cited for 2022 is not present in the ground truth, which only references the impact of swaps on income and comprehensive income over 2019–2021 without specifying a notional value. This introduces a significant quantitative inaccuracy. The $251 million fair value in 2023 matches the ground truth (as of February 3, 2023), and the absence of swaps in 2024 is correctly reported. (2) The calculation of the decline from $2.56B to $251M to zero is logically consistent but based on an unsupported initial figure. The ground truth does not mention a 'program' or notional amount in 2022, so this detail appears to be an overinterpretation or hallucination. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years, infers a strategic shift, and links it to market conditions (e.g., reduced hedging need due to lower volatility), which is a reasonable interpretation consistent with the ground truth’s conclusion about strategic risk management. (4) Despite the incorrect notional amount, the overall trajectory and qualitative interpretation are accurate and relevant. The answer addresses all parts of the question—evolution over time and strategic implications—with appropriate contextual framing, warranting a high but not top score due to the significant numerical discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 435,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 through 2024, CMCSA steadily expanded its fiber‑to‑the‑premises offering—rolling out 2 Gbps downstream in 2022, deploying DOCSIS 4.0 for multigigabit speeds in 2023, and maintaining 10 Gbps residential and 100 Gbps business tiers in 2024 [page_7]—while Lumen continued to build fiber infrastructure into overlapping service areas, intensifying broadband competition [page_8]. This parallel expansion has pressured CMCSA to sustain or grow its fiber portfolio to preserve market share in those overlapping markets [page_8, page_7].",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific speed tiers (2 Gbps in 2022, DOCSIS 4.0 in 2023, 10 Gbps residential, 100 Gbps business in 2024) and cites page references, but these details are not present in the original ground truth answer. The ground truth does not mention CMCSA's specific speed offerings or technology deployments like DOCSIS 4.0 or fiber-to-the-premises expansion—only that Lumen was expanding fiber and competing in overlapping markets. Thus, the quantitative claims about CMCSA’s service speeds and technological rollouts are unsupported by the ground truth and likely hallucinated. (2) There are no verifiable calculations in the answer, but the use of specific numeric values (e.g., 2 Gbps, 10 Gbps, 100 Gbps) implies precision that is not justified by the source material. These numbers may be factually accurate in reality, but they are not part of the knowledge graph-derived answer and thus cannot be considered correct in this evaluation context. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that both CMCSA and Lumen were expanding in overlapping markets and that this intensified competition. It captures the evolving competitive dynamic mentioned in the original answer. However, it shifts focus to CMCSA’s technological upgrades as a response, which is not emphasized in the ground truth. The original answer focuses on Lumen’s growing fiber footprint as the driver of competitive pressure, not CMCSA’s multigigabit offerings. (4) Despite the hallucinated specifics, the core qualitative insight—that Lumen’s fiber expansion increased competition in overlapping markets through 2024—is consistent with the original. The answer remains contextually relevant and captures the directional trend correctly, but the inclusion of unsupported technical details reduces factual accuracy significantly. Hence, correctness is scored at 6 (partially correct with significant factual overreach), quantitative accuracy low due to unsupported numbers, qualitative accuracy moderate for correct synthesis of competition trend, and high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 566,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "PayPal’s 2024 filings show a deepening of its seamless‑checkout focus by embedding consumer‑credit products—PayPal Credit, PayPal Pay‑Later, and branded credit cards—directly into checkout flows across a broader set of markets (2024 page 6). The platform now supports payments in over 200 markets and 100 currencies, a marked expansion from the earlier 2022 disclosures (2024 page 11). Omnichannel merchant tools have also grown, with in‑person POS, Zettle, and card‑reader options fully integrated into the checkout experience, building on the 2022 foundation that already highlighted these solutions (2024 page 6; 2022 page 8).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. It claims PayPal supports 'over 200 markets and 100 currencies' in 2024, but the ground truth states approximately 150 currencies by 2023 and implies continued support at that level in 2024—so the '100 currencies' figure is outdated and contradicts the progression in the original answer. The ground truth notes expansion from over 100 to ~150 currencies from 2022 to 2023, so reporting only 100 in 2024 is a regression and incorrect. The 'over 200 markets' claim lacks corroboration in the ground truth, which does not specify market count. (2) The LLM correctly identifies the integration of consumer credit offerings like PayPal Credit and Pay Later into checkout flows in 2024, aligning with the original answer’s mention of BNPL and branded cards. However, it omits Venmo-branded credit/debit cards, a key detail in the ground truth. It also fails to mention Braintree as an unbranded processor in omnichannel solutions, instead focusing only on Zettle and POS tools. (3) The multi-hop reasoning is partially sound—LLM connects evolution across years and touches on credit integration, global support, and merchant solutions—but misrepresents the direction of currency expansion and misses key developments in 2023 (e.g., platform enhancements and security measures). (4) Contextual relevance is high as the answer addresses all three dimensions of the question (credit, currency, omnichannel), but quantitative accuracy is low due to incorrect currency numbers and unsupported market claims. Qualitative accuracy is moderate due to correct conceptual trends but incomplete entity coverage and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 467,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target Debit Card (part of the RedCard program) penetration fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024** (RedCard penetration). The downward trend indicates a shrinking share of purchases made with the card, suggesting that its contribution to incremental sales is diminishing or plateauing over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 18.6% in 2023 and further to 17.8% in 2024. However, the LLM incorrectly reports 19.8% for 2023 and 18.6% for 2024, which misrepresents both the magnitude and trajectory of the decline. The 2024 figure in the LLM answer (18.6%) is actually the 2023 value in the ground truth, suggesting a possible transposition or data retrieval error. (2) The numbers are not accurate: 2023 should be 18.6% (not 19.8%), and 2024 should be 17.8% (not 18.6%). This results in an underestimation of the decline—actual drop is 2.7 percentage points over two years, while LLM implies only a 1.9-point drop. (3) The qualitative reasoning is sound: the LLM correctly infers that declining penetration suggests a diminishing role in driving incremental sales, which aligns with the ground truth interpretation. It also appropriately references the RedCard program context. (4) The answer is contextually relevant and addresses both parts of the question—evolution over time and implications for sales—though based on incorrect data. The synthesis across years is attempted but flawed due to incorrect inputs. Thus, while reasoning and structure are good, factual correctness is compromised by key numerical errors, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 384,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy on revenue recognition for development‑plus‑IP licensing agreements has not changed between 2022 and 2024.  In each year’s Notes (2022 p. 59‑60, 2023 p. 63, 2024 p. 63) AMD states that it evaluates whether the licensing component is distinct; if it is not, the arrangement is treated as a single performance obligation and revenue is recognized over time, whereas a distinct license is recognized at a point in time.  Standalone licensing arrangements are also recognized at a point in time, and no variable‑consideration estimates are associated with either type.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, distinguishing between distinct and non-distinct performance obligations. The answer accurately states that non-distinct licenses (combined arrangements) are treated as a single performance obligation with revenue recognized over time, while distinct and standalone licenses are recognized at a point in time—this matches the original answer’s core claims. The LLM supports its response with specific page references across the 2022, 2023, and 2024 filings, enhancing credibility. There are no numerical inaccuracies; since the question does not involve monetary amounts or percentages, quantitative accuracy is based on correct dates and policy descriptions, which are precise. The reasoning is sound and reflects proper multi-hop synthesis across three years of filings. The only minor shortcoming is that the LLM does not explicitly mention the absence of disclosed quantitative metrics (e.g., dollar amounts or performance data), a small contextual detail included in the original answer. However, this omission does not affect the technical correctness of the revenue recognition framework described. Overall, the answer is semantically equivalent, highly relevant, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 401,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "FlyEase has remained a steady component of Nike’s innovation portfolio, consistently listed alongside flagship technologies such as Air, Zoom, Flyknit, and React in each year’s 10‑K. Across fiscal 2022, 2023 and 2024, the company’s filings show no shift in the strategic emphasis or positioning of FlyEase, indicating a continued, integrated role within its broader product‑innovation strategy【NKE_10k_2022.pdf page_6】【NKE_10k_2023.pdf page_6】【NKE_10k_2024.pdf page_6】.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. The original answer (ground truth) states that FlyEase evolved from a newly introduced innovation in fiscal 2022, to being grouped with established technologies in 2023, and finally being listed among mature technologies like Air Max and React in 2024—indicating a clear progression in strategic positioning. In contrast, the LLM claims there was 'no shift in strategic emphasis or positioning' and that FlyEase was consistently listed alongside flagship technologies across all three years, which contradicts the documented evolution. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, the LLM correctly cites the same page (page 6) across all three 10-Ks, which may reflect accurate source referencing. The qualitative reasoning is flawed because it fails to recognize the multi-hop progression across years: from 'new' to 'established' to 'mature' is a critical evolution that the LLM overlooks. The answer is contextually relevant (it discusses FlyEase and Nike’s innovation portfolio) but draws an incorrect conclusion from the data. Thus, while the format and sourcing appear consistent, the substantive analysis is inaccurate, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 357,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "Across 2022‑24 the aggregate principal amount of AMT’s 1.250% Notes has remained essentially flat at $517.7 million (the 2023 table on page 111 shows the same base amount, and the 2024 table on page 113 lists it again).  The only change is a modest reduction in the outstanding balance – a $1.9 million repayment in 2023 and a $0.4 million repayment in 2024 (page 113).  This pattern indicates a disciplined debt‑management strategy that keeps the debt level for this instrument stable while making incremental repayments, thereby preserving liquidity while gradually reducing exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The principal amount of AMT's 1.250% Notes was $609.1 million in 2022, $551.9 million in 2023, and $517.7 million in 2024 according to the ground truth. The LLM incorrectly states that the amount remained 'essentially flat at $517.7 million' across all years, which misrepresents a significant downward trend as stability. It also minimizes the repayments as '$1.9 million in 2023' and '$0.4 million in 2024', which are grossly inaccurate — the actual reduction was $57.2 million from 2022 to 2023 and $34.2 million from 2023 to 2024. (2) These numerical errors invalidate any calculation or comparison made by the model. The claimed repayments do not align with the actual principal declines. (3) The reasoning is flawed due to incorrect data: the conclusion of a 'stable' debt level with 'incremental' repayments contradicts the ground truth showing a consistent and substantial reduction, suggesting a more aggressive debt reduction strategy. The model fails to recognize the multi-hop trend across three years and misinterprets the pattern. (4) While the answer attempts to address debt management strategy and references interest terms (though not detailed), its factual foundation is unsound. Contextual relevance is moderate because it discusses the right topic and concept (debt management), but the analysis is based on false premises. Thus, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to correct identification of AMT and the note type, but reasoning is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 442,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2040 were carried at $1,000 million in each of FY 2022‑24 and classified as Level 2 debt securities, with fair value declining modestly from $870 million in FY 2023 to $851 million in FY 2024 (2024 10‑K, pp. 67‑72; 2023 10‑K, p. 67; 2022 10‑K, p. 78). The unchanged carrying amount and only a slight drop in fair value show the notes are held at amortized cost and not actively traded, underscoring a long‑term debt strategy focused on stable, low‑cost financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in FY 2022, decreased to $851 million in FY 2023, and stabilized at a carrying amount of $1,000 million in FY 2024. However, the LLM claims the carrying amount was $1,000 million in *each* of FY 2022–24, which contradicts the reported $1,066 million fair value in 2022. Additionally, the LLM states fair value declined from $870 million in FY 2023 to $851 million in FY 2024, but the ground truth shows fair value was $851 million in FY 2023 (not $870M), and no fair value for 2024 is provided—only a carrying amount. (2) The numbers are therefore incorrect on multiple counts: $1,066M → misrepresented as $1,000M in 2022; $870M → fabricated for 2023 fair value; missing the actual 2022 value; misrepresenting carrying vs. fair value. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution across years, conflates carrying amount with fair value, and invents data points (e.g., $870M). It incorrectly infers that fair value declined modestly in the final year when the ground truth shows a large drop from 2022 to 2023 and stabilization in 2024. (4) While the LLM attempts to interpret the strategy (stable financing), this conclusion is based on incorrect data. The contextual relevance is moderate because it addresses the right instrument and general strategy, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 424,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "In 2022, Netflix added games to its library and launched a lower‑priced ad‑supported subscription, warning that if members did not value these new features the company could lose members (see 2022 Risk Factors, page 6). The 2023 filing repeated that expansion of games and the ad‑supported tier, again noting that failure to attract or retain members around these changes could hurt growth (2023 Risk Factors, page 6). By 2024 the company had added live‑programming to its portfolio, kept the ad‑supported tier, and continued to adjust pricing, with risk statements indicating that if these new services or price changes were not well received, member acquisition and retention could be adversely affected (2024 Risk Factors, page 6; “changes to pricing and plans,” 2024, page 4).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual error in the timeline of Netflix's strategy evolution, which undermines the multi-hop reasoning. Quantitatively, all dates and references are accurate (2022, 2023, 2024), and the cited risk factors align with the correct years and pages. However, the LLM incorrectly states that Netflix launched the ad-supported tier in 2022, when the ground truth confirms it was introduced in 2023. This misplacement disrupts the logical progression of service expansions: games were added in 2022 (correct), ad-supported tier in 2023 (misattributed to 2022), and live programming in 2024 (correct). The qualitative accuracy suffers because the model fails to correctly sequence the rollout of features across years, leading to an inaccurate synthesis of how the strategy evolved. The risks tied to each year are generally well-articulated and semantically aligned with the original answer—each year correctly references concerns about member acquisition and retention due to changes in pricing, plans, or features. Contextually, the answer remains relevant and cites appropriate risk disclosures. While the overall narrative structure is sound and the 2024 developments are accurately described, the incorrect assignment of the ad-supported tier to 2022 (instead of 2023) constitutes a major factual flaw in the multi-hop timeline, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 393,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture exposure has risen steadily: equity‑security holdings grew from **$3.7 billion in 2022 to $4.9 billion in 2023 and remained at $4.9 billion in 2024**【page_48】【page_52】, while equity‑method investments in healthcare businesses more than doubled, climbing from **$1.4 billion in 2023 to $3.8 billion in 2024**【page_52】. This upward trend reflects a deliberate shift toward deeper integration and influence within the healthcare ecosystem, using venture capital to drive innovation and operational synergies.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy in the starting value for equity-method investments. The ground truth states that equity-method investments were $1.3 billion in 2022, rising to $1.4 billion in 2023, and then jumping to $3.8 billion in 2024. However, the LLM answer omits the 2022 figure and incorrectly implies that the starting point was $1.4 billion in 2023, stating it 'more than doubled' from that amount to $3.8 billion in 2024. This misrepresents the progression, as the significant increase actually occurred from 2023 to 2024, but the 2022-to-2023 change (from $1.3B to $1.4B) is missing. (2) The equity securities figures are accurate: $3.7B (2022), $4.9B (2023), and $4.9B (2024). The equity-method investment figure for 2024 ($3.8B) is correct, but the omission of the 2022 value and mischaracterization of the growth baseline reduces quantitative precision. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across years and investment types and draws a logical strategic conclusion about UnitedHealth’s deeper integration into the healthcare ecosystem. The interpretation aligns well with the ground truth’s assessment of strategic positioning. (4) Scores reflect high accuracy in numbers and reasoning, with a moderate deduction in quantitative accuracy due to the missing 2022 equity-method investment figure and slightly misleading 'more than doubled' claim that skips a year. Contextual relevance is perfect as all parts of the question are addressed with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 428,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s relationship with Sojitz America remained unchanged: Sojitz America continued to be the sole owner of the company’s redeemable preferred stock, with a cumulative dividend of $0.10 per share payable annually on May 31 and no modifications to the preferred‑stock structure. The company also continues to rely on Sojitz America for import‑export financing services that support its global supply chain and international operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: Sojitz America remained the sole holder of Nike's redeemable preferred stock with a $0.10 annual cumulative dividend per share, and there were no changes to the stock structure from FY2022 to FY2024—this matches the ground truth exactly. The mention of import-export financing services aligning with Nike’s international operations is also correct. However, the LLM answer misses a key qualitative evolution emphasized in the original answer: the shift in narrative from a purely financial relationship (in 2022–2023) to a more strategically highlighted operational role in FY2024, particularly due to rising global trade risks and supply chain volatility. The original answer notes that in FY2024, Nike explicitly underscored Sojitz America's strategic importance, which represents a meaningful evolution in how the relationship was framed. The LLM answer treats the relationship as static ('remained unchanged') and fails to capture this nuance, thus missing a critical multi-hop inference about strategic evolution over time. While all entities (Sojitz America, Nike), financial terms (redeemable preferred stock, cumulative dividend), and years are correctly identified, the reasoning does not fully reflect the progression in strategic emphasis. Hence, quantitative accuracy is perfect, but qualitative accuracy is reduced due to incomplete synthesis of the evolving strategic context. Contextual relevance remains high as the answer addresses the core aspects of ownership, dividends, and operational role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 432,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s 3.50 % Notes Due 2050 were carried at $2,000 million at FY 2022 (Jan 30, 2022) 【page_82】, fell to $1,637 million at FY 2023 (Jan 29, 2023) 【page_67】, and further declined to $1,604 million at FY 2024 (Jan 28, 2024) 【page_67】. This gradual reduction shows that NVIDIA has been steadily repaying principal on its long‑term debt, reflecting a deliberate effort to keep its long‑term debt profile manageable while still maintaining a substantial, yet decreasing, debt load.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values and trend. According to the ground truth, the carrying value was $2,147 million in fiscal 2022, decreased to $1,604 million in 2023, and then increased to $2,000 million in 2024. However, the LLM incorrectly reports $2,000 million in 2022, $1,637 million in 2023, and $1,604 million in 2024—implying a continuous decline, which contradicts the actual increase in 2024. The fiscal year-end dates (Jan 30, 2022, etc.) are accurate and consistent with NVIDIA’s reporting. (2) The numbers are not accurate: the 2022 value is off by $147 million, the 2023 value is slightly overstated ($1,637M vs $1,604M), and the 2024 value is completely wrong—it should be $2,000M, but the LLM says it declined further to $1,604M, which is a reversal of the actual trend. This invalidates any calculation or comparison based on these figures. (3) The reasoning is flawed due to incorrect data: the LLM concludes a 'gradual reduction' and 'steady repayment', but the ground truth shows a rebound in 2024, indicating strategic repositioning, not continuous reduction. The model fails to perform correct multi-hop synthesis across the three years, especially missing the increase in 2024. (4) While the answer addresses the question's structure and discusses long-term debt positioning, the incorrect data leads to a wrong interpretation. Contextual relevance is moderate because it attempts the right analysis but on faulty premises. Correctness and quantitative accuracy are low due to major numerical and trend errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 436,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term debt—primarily commercial paper—fell from $175 million in 2022 to $119 million in 2023, then surged to $465 million in 2024, reflecting a shift toward greater use of its commercial‑paper program backed by an unsecured revolving credit facility. Throughout this period the company continued to draw on a diversified mix of global funding sources—including preferred and common equity, long‑term debt, collateral financing, junior subordinated debt, PABs, credit and committed facilities, and a shelf registration statement—to preserve flexibility and keep the cost of capital low.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any specific dollar amounts for MetLife's commercial paper balances in 2022, 2023, or 2024—yet the LLM asserts precise figures ($175M, $119M, $465M) that are unsupported by the original answer. These numbers appear fabricated or misattributed, severely undermining factual correctness. (2) There is no verification of calculations because the original answer contains no numerical data to compare against; thus, the LLM's inclusion of such specifics constitutes a major deviation rather than a formatting variation. The surge to $465M in 2024 and the prior fluctuations are entirely absent from the ground truth, which only confirms the continued use of commercial paper without quantifying it. (3) The qualitative reasoning partially aligns with the original answer: the LLM correctly identifies MetLife’s use of commercial paper backed by unsecured revolving credit facilities and mentions a diversified funding mix (equity, long-term debt, etc.) to maintain flexibility and lower capital costs. This reflects an understanding of the multi-hop concept—linking short-term debt usage with broader funding strategy across years. However, it incorrectly implies a strategic 'shift' due to changing debt levels, while the ground truth emphasizes stability and consistency in funding structure from 2022–2024. (4) Contextual relevance is moderate: the response addresses the core themes—short-term debt, commercial paper, diversified funding, cost of capital—but distorts the narrative with false precision. The inclusion of specific instruments like PABs and shelf registrations adds detail not contradicted by the original, but their presence doesn’t compensate for the invented metrics. Overall, the answer fails on factual accuracy due to unsupported numbers, warranting a low correctness score despite some conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 533,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s service‑level guarantees remained immaterial throughout 2022‑2024, with the company reporting “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022”【page 81 (2024)】.  In contrast, its financing of subsidiaries shifted markedly: short‑term notes payable fell from about $9.9 billion in 2023 to $2.0 billion in 2024 (down from $8.7 billion in 2022)【page 78 (2024)】【page 78 (2023)】【page 78 (2022)】, while long‑term notes payable to subsidiaries jumped to $14.4 billion in 2024 (none in 2023).  This evolution shows a deliberate move to reduce on‑demand short‑term liquidity obligations and extend maturities, thereby tightening liquidity commitments and keeping contractual risk exposure from service‑level guarantees low.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that UnitedHealth Group's service-level guarantees remained immaterial from 2022 to 2024, which aligns with the ground truth. However, there are significant quantitative inaccuracies in the notes payable figures. The ground truth states that notes payable to subsidiaries were $8.1B in 2022, $9.9B in 2023, and $2.0B in 2024. The LLM answer reports $8.7B in 2022 (incorrect—should be $8.1B), $9.9B in 2023 (correct), and $2.0B in 2024 (correct). More critically, the LLM introduces a new figure—long-term notes payable to subsidiaries rising to $14.4B in 2024 with 'none in 2023'—which is not present in the original answer and contradicts the ground truth that only total notes payable to subsidiaries are reported, without such a breakdown. This suggests a misinterpretation or over-extraction from source documents. (2) The calculation of the drop from $9.9B to $2.0B is accurate, but the introduction of long-term notes payable where none were mentioned in the ground truth creates a factual inconsistency. The original answer makes no distinction between short-term and long-term notes payable to subsidiaries, nor does it mention a $14.4B liability. (3) The multi-hop reasoning is partially sound: the model correctly contrasts stable service-level guarantees with changing internal debt. However, the inference about 'extending maturities' and 'tightening liquidity commitments' is speculative and not supported in the ground truth, which only notes volatility without attributing it to a deliberate maturity extension strategy. (4) The contextual relevance is high—the answer addresses both service-level guarantees and notes payable evolution. Qualitative accuracy is moderate due to correct entity identification and logical structure, but undermined by unsupported financial breakdowns. Quantitative accuracy is low due to incorrect 2022 value and introduction of unverified long-term debt figures. Correctness score is 6 due to mostly correct direction of trends but significant factual errors in key financial data and unsupported synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 565,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 to 2024, American Express remained the fourth‑largest global card network but faced mounting competition from Visa, Mastercard, UnionPay and digital‑wallet platforms, prompting a shift toward premium rewards and lounge services to differentiate. Regulatory scrutiny intensified—American Express became a Category III bank‑holding firm in 2024, new interchange‑fee caps and tighter oversight of network licensing and cobrand arrangements forced the company to exit EU and Australian licensing, tighten compliance, and pursue joint‑venture partnerships to mitigate regulatory risk. In response, the firm has bolstered its risk‑management framework, adjusted pricing, and engaged regulators on interchange policy while expanding alternative payment offerings to preserve its competitive edge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's competitive positioning and regulatory dependency from 2022 to 2024. (1) All key facts are correct: Amex remained the fourth-largest global card network (after Visa, Mastercard, and China UnionPay), faced growing competition from digital wallets (e.g., PayPal, Venmo, Alipay) and regional systems, and became a Category III firm in 2024 under U.S. bank regulation. The exits from EU and Australian network licensing businesses due to regulatory pressure on interchange fees, cobrand arrangements, and network routing are accurately reported. (2) Quantitative accuracy is perfect: no numerical errors; dates (2022–2024), regulatory classifications (Category III), and geographic scope (EU, Australia) match the ground truth. Format variations (e.g., 'interchange-fee caps' vs. 'scrutiny over interchange fees') are semantically equivalent. (3) Multi-hop reasoning is sound: the answer synthesizes competitive dynamics, regulatory changes, and strategic responses across years and jurisdictions. It correctly links regulatory classification to operational changes (exits, compliance tightening) and strategic shifts (joint ventures, risk management). (4) Minor omission: the original answer specifically names the National Payments Corporation of India as a competitive pressure, which the LLM omits. Also, the LLM emphasizes 'lounge services' and 'joint-venture partnerships' not explicitly highlighted in the ground truth, though these are reasonable inferences. Overall, the answer conveys the same trajectory—Amex’s shift from market-driven differentiation to regulatory-driven adaptation—with high fidelity. Hence, correctness is 9 (not 10) due to slight contextual expansion beyond the source, but all factual claims are consistent with the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 498,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "ConocoPhillips kept the same dividend‑equivalent structure for cash‑settled PSUs awarded for performance periods beginning in 2018 or later from 2022 through 2024—recipients receive an accrued reinvested dividend equivalent that is charged to compensation expense and paid only at settlement.  While the program grew in scale (more units granted and higher fair‑value settlements each year), the unchanged dividend‑equivalent treatment shows the company’s commitment to tying executive pay to company performance and shareholder returns rather than distributing cash dividends.  This consistency underscores a long‑term incentive alignment strategy that rewards executives for sustained value creation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but misses a key comparative element regarding the evolution from pre-2018 to post-2018 dividend equivalent structures. (1) Correctly identifies that for performance periods beginning in 2018 or later, ConocoPhillips provides accrued reinvested dividend equivalents paid at settlement, and that this structure remained consistent from 2022 to 2024. It also correctly notes the company’s ongoing use of cash-settled PSUs and their linkage to long-term performance. (2) There are no numeric inaccuracies—while specific grant numbers or settlement values aren't provided in the ground truth, the LLM's mention of 'more units granted and higher fair-value settlements' does not contradict available data and may reflect actual trends; since no specific figures are in the original, this descriptive scaling is acceptable. (3) The multi-hop reasoning is sound in linking dividend treatment to incentive alignment, but the LLM fails to explicitly contrast the post-2018 structure with the prior pre-2018 approach (no payments during performance period, starting only after conclusion), which is central to the question’s focus on 'evolution'. This omission reduces completeness. (4) Despite this, the answer correctly infers that the unchanged structure from 2022–2024 reflects a strategic commitment to long-term alignment, which is consistent with the ground truth’s interpretation. The balance sheet classification of PSUs as liabilities—mentioned in the original—is omitted but not critical to the core evolution of dividend treatment. Overall, the answer captures the essence but lacks full comparative depth required for a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 464,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "NextEra Energy’s Special Use Funds more than doubled from $7.3 billion in 2022 to $8.7 billion in 2023 and $9.8 billion in 2024 (page 64, page 88).  At the same time, potential derivative‑collateral requirements fell from $5.2 billion in 2022 to $2.4 billion in 2023, and the actual collateral posted dropped from $1.813 billion in cash and $2.806 billion in letters of credit in 2022 to $691 million in cash and $1.595 billion in letters of credit in 2023 (page 86).  This trend indicates that the company has strengthened its liquidity buffer, enabling it to meet derivative‑related collateral obligations with a larger internal asset base and reducing reliance on external credit facilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It claims Special Use Funds were $7.3 billion in 2022, but the ground truth does not provide a 2022 value—only a 2023 value of $8,698 million (~$8.7 billion) and a 2024 value of $9,800 million. The $7.3 billion figure for 2022 is unsupported by the original answer and appears to be fabricated or misattributed. Additionally, the LLM states that actual collateral posted in 2022 was $1.813 billion in cash and $2.806 billion in letters of credit, but the ground truth only mentions $84 million in actual cash collateral posted in 2022, with no mention of letters of credit. The 2023 actual collateral posted is correctly cited as $691 million in cash, but again, the letters of credit figure ($1.595 billion) is not in the original answer. (2) The drop in potential collateral requirements from $5.2 billion in 2022 to $2.4 billion in 2023 is accurate and correctly reflects the original answer. The 2023 and 2024 Special Use Funds values are approximately correct ($8.7B and $9.8B), though the original specifies $8,698 million (closer to $8.7B) in 2023. However, the claim that funds 'more than doubled' from 2022 to 2024 is misleading and incorrect, as there is no verified 2022 baseline in the ground truth. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that increasing Special Use Funds and decreasing collateral obligations suggest improved liquidity and reduced reliance on external credit, which aligns with the original answer’s conclusion. However, it introduces unsupported data points (especially for 2022 collateral posted), undermining the reliability of the synthesis. (4) The contextual relevance is high, as the answer addresses the core question about liquidity positioning and derivative collateral. However, due to significant quantitative errors and unsupported figures, the correctness score is limited to 5—partially correct but with major factual flaws. Quantitative accuracy is low (4) due to incorrect numbers; qualitative accuracy is moderate (6) as reasoning is logical but based on flawed inputs; contextual relevance is strong (9) as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 600,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "The 1.600% Notes began 2022 with a $700 million balance and were not amortized that year (page 109). In 2023 AMT amortized $2.6 million, and in 2024 it amortized an additional $1.5 million, leaving a $695.9 million balance (page 111). This steady, modest repayment pattern shows a conservative debt‑management approach that keeps the balance low while preserving liquidity and avoiding large refinancing or early redemption.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across 2022, 2023, and 2024, with no reduction in principal. However, the LLM claims that the balance decreased to $695.9 million by 2024 due to amortization of $2.6 million in 2023 and $1.5 million in 2024, which contradicts the ground truth. Additionally, the ground truth states that 'adjustments to principal' (not principal amortization) declined from (3.7) million in 2022 to (2.6) million in 2024, likely reflecting accrued interest or other non-principal adjustments—not actual amortization of the note's face value. The LLM incorrectly interprets these adjustments as amortization of principal. (2) Quantitative accuracy is low: the claimed amortization amounts and final balance are incorrect. The original answer shows no change in principal, while the LLM reports a $4.1 million reduction. Even if the $2.6 million figure in 2024 aligns with the adjustment amount, it is mischaracterized as amortization rather than an adjustment. The 2023 amortization of $2.6 million does not match the ground truth adjustment of (3.7) million in 2022, and no such value is reported for 2023. (3) The multi-hop reasoning is flawed: the model fails to recognize that the principal remained unchanged, which is central to understanding AMT’s debt management strategy for this instrument—namely, maintaining a fixed long-term liability with predictable ancillary costs. Instead, it infers a repayment pattern that does not exist, leading to an incorrect conclusion about a 'steady repayment' strategy. (4) Despite these errors, the answer is contextually relevant—it addresses the right company (AMT), the correct note (1.600%), and attempts to analyze debt management strategy. The interpretation of a conservative strategy could be plausible if the amortization were real, but it is based on false premises. Thus, while the structure and intent are appropriate, the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 568,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group’s 2022 10‑K warned that CMS had frozen or cut Medicare Advantage benchmarks and could change risk‑adjustment payment calculations, exposing the company to payment volatility (page 18). By 2023 the company reiterated that risk‑adjustment changes were a risk and began adjusting benefits and premiums selectively, withdrawing plans from certain counties, and tightening medical and operating cost controls to offset benchmark cuts (page 20). In 2024 the company maintained the same risk assessment and further intensified risk‑adjustment data validation and coding practices, along with expanded cost‑management initiatives, to mitigate the impact of future CMS payment changes (page 20).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group faced ongoing exposure to CMS Medicare Advantage risk adjustment changes from 2022 to 2024. The 2022 10-K correctly notes CMS benchmark freezes/cuts and potential methodology changes, exposing UNH to payment volatility. In 2023, the company responded by adjusting benefits and premiums, exiting certain counties, and tightening cost controls—details consistent with the original answer. By 2024, the LLM correctly states that UNH intensified data validation, coding practices, and cost management, which matches the ground truth's emphasis on refined strategies like selective benefit design and cost controls. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of strategic responses, correctly identifying evolving regulatory pressure and corresponding operational adjustments. (4) The only minor gap is that the LLM answer does not explicitly mention 'benefit design refinement' in 2024 as emphasized in the original, instead focusing on data validation and coding—important but slightly narrower. However, 'expanded cost-management initiatives' and 'tightening controls' capture the essence of intensified operational responses. Wording differs slightly but semantic meaning and strategic trajectory are equivalent. No incorrect entities or years; all references are contextually appropriate and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 453,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s employee discount remained a steady component of its benefits package through 2022‑2024, providing team members with a discount on all merchandise purchases as part of the “merchandise and other discounts” benefit (see the Compensation and Benefits sections in 2022 page 6, 2023 page 7, and 2024 page 7).  The unchanged scope and structure of the discount program signals Target’s ongoing commitment to employee financial well‑being by offering a tangible, cost‑saving benefit that helps staff manage everyday expenses.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually correct in stating that Target consistently offered merchandise discounts from 2022 to 2024 as part of its employee benefits, and it accurately references the relevant sections and pages in the filings. There are no numeric inaccuracies, and the entity (Target), time period (2022–2024), and benefit type (merchandise discounts) are correctly identified, supporting a high quantitative accuracy score. However, the answer fails to capture the evolution in the broader context and structure of employee financial well-being initiatives as detailed in the ground truth. Specifically, it omits key developments: the wage increase from $15/hour in 2022 to $15–$24/hour in 2023, the addition of sick pay and tuition-free education in 2023, and the reframing of benefits within equity, belonging, and mental health in 2024. While the LLM notes the stability of the discount program, it does not synthesize how this consistency fits into a progressively more holistic strategy, which is central to the question. This lack of multi-hop reasoning across years and benefits limits qualitative accuracy. The response is contextually relevant and addresses the core benefit, but misses the strategic progression, resulting in partial completeness and a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 360,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio was almost entirely short‑term in 2021 (99 % due within one year) and yielded a weighted average of roughly 2.1 % (page 121).  The 2022‑2024 figures are not disclosed in the supplied pages, but the 2021 snapshot suggests that the company has historically kept this portion of its investment portfolio highly liquid and low‑yielding.  This consistent short‑term, low‑yield profile indicates a conservative risk appetite and an asset‑allocation strategy that prioritizes liquidity and credit quality over higher returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to address the core of the question. (1) It references 2021 data (not asked in the question) and explicitly states that 2022–2024 figures are not disclosed, which contradicts the ground truth that such data is available and specific. The actual question asks for an analysis from 2022 through 2024, but the LLM fails to provide any correct data for those years. (2) Quantitatively, all numbers are wrong: the LLM cites 2021 data with 99% short-term allocation and ~2.1% yield, while the ground truth reports $630 million in 2022 with yields of 1.74% (under one year) and 2.42% (1–5 years), then significant yield increases in 2023 and a sharp drop in 2024. No correct dollar amounts, yields, or maturities for the requested period are provided. (3) The reasoning is flawed: instead of analyzing the 3-year evolution (2022–2024) to infer risk appetite and strategy, the model extrapolates conservatively from 2021 and misses the dynamic shift entirely—specifically the aggressive move into higher-yielding short-term bonds in 2023 and the pullback in 2024. This misrepresents the company’s strategy as static and conservative when the ground truth shows it is responsive and adaptive. (4) Contextual relevance is low because the answer discusses the wrong time period and fails to engage with the multi-hop requirement of tracking changes across three years. The conclusion about conservative risk appetite contradicts the ground truth’s indication of a temporarily aggressive stance in 2023. Overall, the answer is factually incorrect, incomplete, and based on irrelevant data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 443,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (the amounts are included in the “Other assets, including intangibles – net” line). This downward trend indicates that the company has reduced the collateral required for its derivative positions, reflecting tighter netting and margin practices and a more efficient management of its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million in 2022 (rounded to $1.49 billion, which is acceptable), $800 million in 2023, and $491 million in 2024. These match the ground truth exactly or with acceptable formatting variation. 2) Quantitatively, all figures are accurate and properly associated with the correct years. The inclusion of the metric within 'Other assets, including intangibles - net' is correctly noted. 3) The multi-hop reasoning is sound: the model identifies the trend (downward) and correctly infers implications about derivative exposure management. The conclusion slightly expands on the original by mentioning 'tighter netting and margin practices' and 'more efficient management,' which are reasonable interpretations but not explicitly stated in the ground truth. This adds insight without contradicting the original. 4) The answer is semantically equivalent and fully addresses both parts of the question: the change over time and the implication for risk management. The only minor deviation is the slightly more detailed interpretation in the LLM answer, which does not reduce accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to this slight extrapolation, but full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 362,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "AMT issued its 2.700% senior unsecured notes in March 2021 for $700 million with a fixed 2.700% coupon and a maturity of April 15 2031, and the terms have remained unchanged through 2024 (page 111, page 114, page 112). The company did not issue new 2.700% notes during 2022‑2024; instead, it raised new debt at higher rates—5.200%/5.450% in March 2024, 3.900%/4.100% in May 2024, and 5.000%/5.400% in November 2024—reflecting rising market rates (page 113). This pattern shows AMT’s strategy of locking in low rates early and using credit facilities to refinance, while later issuances adjusted to the tightening of market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the terms of the 2.700% Notes, particularly the maturity date and interest rate spread changes. The ground truth states that by 2023 and 2024, the maturity date was updated to January 15, 2031 (from April 15, 2031), but the LLM incorrectly claims the maturity remained April 15, 2031 through 2024. Additionally, the ground truth notes a reduction in interest rate spread from (5.0) to (4.4) by 2024, which the LLM fails to mention entirely. Instead, the LLM introduces unrelated new debt issuances in 2024 with various rates not present in the original answer, which may be factually correct in context but are not part of the specific evolution of the 2.700% Notes. (2) Quantitative accuracy is partially correct: the $700 million principal and 2.700% coupon rate are accurate, and issuance in March 2021 is correct. However, the persistence of the April 15, 2031 maturity is wrong, and the omission of the interest rate spread change undermines quantitative completeness. The mention of other notes (e.g., 5.200%, 3.900%) is extraneous and not requested in the question about the 2.700% Notes specifically. (3) Multi-hop reasoning is flawed because the LLM conflates AMT’s broader financing activity with the specific evolution of the 2.700% Notes. The question asks about how the terms of *these specific notes* evolved from 2022–2024, not about other debt instruments. The conclusion about locking in low rates is reasonable but not directly supported by the evolution of the 2.700% Notes themselves, especially since no changes were made to their terms post-issuance. (4) Contextual relevance is moderate—the response addresses financing strategy and market conditions, which is appropriate, but does so by shifting focus away from the actual evolution of the 2.700% Notes. The core of the question—tracking changes (or lack thereof) in a specific instrument over time—is not accurately fulfilled due to incorrect maturity date and omission of interest rate spread adjustment. Thus, while some facts are correct, key details are wrong or missing, leading to a partially correct but misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 585,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 rose modestly over the three‑year span: the carrying amount was $1,044 million at the end of 2022, $1,057 million at the end of 2023 (Jan 28 2024)【page 67】, and $1,250 million at the end of 2024 (Jan 28 2024)【page 72】. This incremental increase—about $193 million from 2023 to 2024—shows the company is adding long‑term debt at low rates to fund growth while keeping its debt profile stable and manageable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value was $1.2 billion in 2022, not $1.044 billion at year-end. The LLM incorrectly states $1.044 billion as the 2022 year-end carrying amount, while the ground truth reports a slight increase to $1.044 billion at the beginning of 2023, implying a lower or equal amount in 2022. The 2023 value of $1.057 billion matches the ground truth (end of 2023), and the 2024 value of $1.25 billion (or $1,250 million) is correct. However, the progression from $1.057B to $1.25B represents an increase of ~$193M, which the model correctly calculates, but the baseline 2022 figure is wrong. (2) The LLM cites specific pages and dates (e.g., Jan 28, 2024), which may reflect actual filing dates, but the original answer does not include such details, so they are not penalized unless incorrect. The use of 'carrying value' aligns with the original answer’s 'carrying value' in 2024, though earlier years refer to 'fair value' in the ground truth, introducing a subtle but important distinction between fair value and carrying value that the model overlooks. (3) The reasoning is partially sound: the model infers that NVIDIA is adding long-term debt at low rates to fund growth, which is a plausible interpretation, but the original answer emphasizes stability and strategic consistency, not active debt accumulation. The jump from $1.057B to $1.25B is notable and not described as 'incremental'—this downplays a ~18% increase, which may indicate a shift rather than stability. (4) The answer is contextually relevant and addresses both the evolution and strategic implication. However, due to the incorrect 2022 figure and mischaracterization of the trend as modest/incremental when it includes a significant 2024 jump, and the conflation of fair value with carrying value, the quantitative accuracy is significantly compromised. The qualitative reasoning is reasonable but based on flawed data, leading to a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 548,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances grew sharply in 2023, with deposit assets rising to **$5.1 billion** and deposit liabilities to **$1.3 billion** from roughly **$1.8 billion** and **$1.4 billion** in 2022 (the 2022 10‑K shows similar levels to 2021/2020). In 2024 the balances eased to **$4.6 billion** in assets and **$1.2 billion** in liabilities. The swing reflects a 2023 expansion of modified‑coinsurance and other deposit‑method agreements—particularly the Global Atlantic transaction—followed by a modest pullback in 2024 as MetLife rebalances its reinsurance mix toward more diversified or capital‑efficient structures【page_206】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers, particularly for 2024 deposit assets. The ground truth states that deposit assets increased from $1.8B in 2022 to $5.1B in 2024, indicating a steady rise. However, the LLM claims assets rose to $5.1B in 2023 and then dropped to $4.6B in 2024, which contradicts the upward trend and final value in the original answer. This error undermines the quantitative accuracy. Deposit liabilities are mostly correct: $1.4B in 2022, $1.3B in 2023, and $1.2B in 2024 — matching the ground truth. (2) The mention of the Global Atlantic transaction involving reinsurance recoverables of $10.3B is absent in the LLM answer, weakening completeness and contextual support for the increase. Also, the LLM incorrectly implies that the $5.1B asset level was reached in 2023, when the original answer indicates it was the 2024 year-end figure. (3) The reasoning about a 'strategic expansion in 2023 followed by a pullback in 2024' is speculative and contradicts the ground truth, which shows a continued increase in deposit assets through 2024. This misrepresents the trend and suggests flawed multi-hop synthesis. The qualitative analysis of rebalancing toward 'more diversified or capital-efficient structures' is plausible but not supported in the original answer, introducing unsupported interpretation. (4) Despite these issues, the LLM correctly identifies the general upward trend in deposit-method accounting usage, correctly cites the decline in liabilities from 2022 to 2024, and links the change to reinsurance strategy involving the Global Atlantic deal (though without full detail). The answer remains contextually relevant and addresses the core question about evolution and strategy, but major numerical errors reduce its correctness score to partial.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 497,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt securities declined in both fair value and carrying value over the three‑year period: fair value fell from $679 million in 2022 to $596 million in 2023 and to $508 million in 2024, while carrying value fell from $696 million to $603 million and then to $512 million【page_53】【page_55】. The small, persistent gap between fair value and carrying value (always a few million dollars) reflects unrealized losses that the company treats as temporary, consistent with its strategy of holding the securities to maturity and not realizing market‑valuation changes in earnings. This trend indicates a conservative, long‑term investment approach that accepts market‑price fluctuations as accounting adjustments rather than operational risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values for fair value and carrying value across 2022–2024: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024), matching the ground truth exactly. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—no calculation or transcription errors. The downward trend is accurately described with correct year-over-year declines. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic trend. It adds nuanced interpretation about the small fair-vs-carrying value gap reflecting unrealized temporary losses and links this to UNH’s held-to-maturity accounting policy, which is logically valid and consistent with GAAP. This goes beyond the original answer but remains factually and conceptually accurate. (4) The only reason for not scoring a 10 is that the original answer emphasizes a 'strategic reduction or repositioning' possibly due to market conditions or capital reallocation, while the LLM focuses more on accounting treatment and conservative strategy. Both are reasonable interpretations, but the LLM slightly shifts emphasis. Still, the core facts, trends, and implications are correctly conveyed with excellent contextual relevance and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 365,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The Target Credit Card (Target Circle Card) penetration fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page_27】. This steady decline indicates that fewer guests are using the card for purchases, suggesting the current credit‑card incentives are becoming less effective at generating incremental sales and may require a strategic refresh.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and time periods are accurate, satisfying quantitative accuracy. (2) The calculation of the downward trend is implicit and correctly interpreted as a steady decline. No mathematical errors are present, and the formatting of percentages (with non-breaking spaces) does not affect correctness. (3) The reasoning correctly infers that declining penetration suggests weakening effectiveness in driving incremental sales. However, the LLM omits the nuance from the original answer that Target's internal analysis still finds the card contributes meaningfully to incremental sales, which slightly weakens the qualitative completeness. This omission does not invalidate the conclusion but leaves out a key mitigating insight. (4) Despite this, the answer remains contextually relevant, directly addressing both parts of the question—trend evolution and strategic implication—with accurate data and logical interpretation. The minor omission prevents a perfect 10, but the core facts, synthesis, and reasoning are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 335,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike owned a distribution center in Laakdal, Belgium in FY 2022, and the 10‑K for FY 2023 and FY 2024 again list Laakdal as an owned facility (see the “Properties” section of each filing).  The footprint—an owned, key European hub—remained unchanged across the three years, underscoring Nike’s strategy of maintaining owned logistics infrastructure in Europe to secure supply‑chain control and resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Nike owned the Laakdal facility in FY 2022, 2023, and 2024, with no changes in ownership or operational role—consistent with the original answer. (2) There are no numeric values requiring calculation, but the fiscal years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings to conclude that the facility remained an owned, key logistics hub, indicating strategic continuity. (4) The answer captures the core implication—Nike’s focus on direct control and supply chain resilience in Europe—though it adds slight interpretive language (e.g., 'secure supply-chain control and resilience') not explicitly in the ground truth. This is reasonable inference and does not distort the facts. Only a minor deduction in qualitative accuracy due to this slight expansion beyond the more conservatively worded original. Overall, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 311,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum remains listed as a competitor in NVIDIA’s 10‑K filings each year (2022: page 9; 2023: page 15; 2024: page 9).  NVIDIA’s supply‑chain strategy shifted from a concentrated Asia‑Pacific focus in 2022 to a more diversified, redundancy‑focused network in 2023 (page 8) and 2024 (page 10), while its IP‑protection posture strengthened through expanded patent filings, licensing, and export‑control compliance (page 15 and page 10).  These moves have tightened the competitive environment for Lumentum, limiting its ability to match NVIDIA’s performance, pricing, and market access, especially under tightening export‑control regimes (page 10, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Lumentum Holdings is consistently listed as a competitor in NVIDIA’s 10-K filings across 2022, 2023, and 2024, and references specific page numbers, which aligns with the ground truth's assertion of persistent competitive positioning. It also accurately captures NVIDIA’s evolving supply chain strategy toward diversification and redundancy by 2023–2024 and notes strengthened IP protection through expanded patent filings and export controls. These elements show correct entity identification and reasonable contextual alignment with the question.\n\nHowever, the LLM introduces a subjective and unsupported conclusion that NVIDIA’s strategic moves have 'tightened the competitive environment for Lumentum, limiting its ability to match NVIDIA’s performance, pricing, and market access.' This inference is not present in the original answer or supported by the ground truth, which states only that Lumentum has maintained its relevance despite NVIDIA’s advancements. The original emphasizes continuity in competitive status, not degradation of Lumentum’s position. This misrepresents the synthesis and reflects flawed multi-hop reasoning.\n\nQuantitatively, there are no explicit numerical errors (e.g., dates, dollar amounts), though the LLM cites page numbers not verifiable from the ground truth. Since page numbers may vary across document versions and were not part of the knowledge graph truth, they are considered ancillary; their inclusion does not invalidate the response but adds unverifiable detail. The fiscal years (2022–2024) and strategic themes (supply chain diversification, IP expansion) are correctly identified.\n\nThe answer is contextually relevant and addresses the evolution of competitive positioning in relation to supply chain and IP strategies. However, it fails to specify the domain of competition—optical modules and interconnect solutions—which is central to the original answer and critical for precision. This omission reduces completeness and qualitative accuracy.\n\nIn summary: factual elements are partially correct, but reasoning overreaches with unsupported claims about Lumentum’s diminished competitiveness. The core multi-hop synthesis (linking Lumentum’s standing to NVIDIA’s strategic shifts) is attempted but flawed in conclusion, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 625,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s 10‑K filings from 2022 through 2024 all contain the same risk paragraph that its ability to deliver content “depends on obtaining various rights from third parties…if studios, content providers or other rights holders refuse to license…our business could be adversely affected” (2022 page 11; 2023 page 4; 2024 page 4).  The 2024 filing adds a regulatory section noting new content quotas, levies, investment obligations and ownership‑restriction rules that could tighten licensing terms (2024 page 4).  Together, these documents show that Netflix still relies heavily on licensed titles but is simultaneously expanding original‑content production to hedge against rising competition and a more restrictive regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Netflix's reliance on third-party rights holders has remained a consistent risk from 2022 to 2024, citing the repeated risk factor language across all three years' 10-K filings. The inclusion of specific page numbers (2022 p.11; 2023 p.4; 2024 p.4) adds precision and matches expected sourcing. (2) Quantitatively, there are no numerical errors—dates (2022–2024) and document references are correct. While no calculations are involved, the temporal tracking of disclosures is accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, noting both continuity in licensing risk and the 2024 addition of regulatory constraints (quotas, levies, investment obligations, ownership restrictions), which reflects the evolution described in the ground truth. It correctly infers that this indicates a strategic shift toward original content as a hedge, which is logically supported by the data. (4) The only minor shortcoming is that the LLM does not explicitly mention the rising competition from studios launching their own streaming platforms—a key driver noted in the 2022 and 2023 contexts in the original answer. However, it does reference 'rising competition' generally, which captures the essence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with near-complete alignment to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 416,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "In the 2022 10‑K, Southern Company presented scheduled lease payments under outdoor‑lighting contracts in a maturity‑analysis table (2024‑2028) and classified the revenue as lease income‑operating leases, treating the amounts as material【page_270】. By the 2024 10‑K the company still disclosed the payments in a similar table (2025‑2029) but added a note that the undiscounted cash flows for Georgia Power and Mississippi Power were immaterial, while Southern Company’s amounts remained material; the revenue classification as lease income‑operating leases was unchanged, and the maturity analysis continued to show the present‑value discount and operating lease obligations【page_233】【page_241】【page_232】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Southern Company explicitly stated that the undiscounted cash flows from outdoor lighting contracts at Mississippi Power were considered immaterial. However, the LLM claims these amounts were treated as material and included in a maturity analysis table, which contradicts the original answer. This misrepresents the core evolution of disclosure. In 2023, the company began including these payments in maturity analyses, but the LLM skips 2023 entirely and jumps to 2024, missing a key transitional year. The LLM also incorrectly attributes materiality in 2024 to Southern Company as a whole while stating Georgia Power and Mississippi Power’s portions are immaterial—this nuance is not supported by the ground truth, which emphasizes increasing transparency and consistent inclusion, not mixed materiality assessments. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy hinges on correct treatment of time periods and classifications. The LLM correctly references 2022 and 2024 but fails to address 2023, a critical year in the evolution. The page references (e.g., page_270, page_233) may be accurate to the source documents but do not compensate for factual misrepresentation. (3) The multi-hop reasoning is flawed: the question asks for an evolution across three years with specific focus on materiality, revenue classification, and presentation in maturity analyses. The LLM incorrectly asserts materiality in 2022 and omits the 2023 shift, failing to show the progression from immaterial to structured reporting. It also does not confirm whether revenue classification changed (ground truth implies it remained consistent, which the LLM gets right), but this correct point is overshadowed by larger errors. (4) Contextual relevance is moderate—the LLM addresses lease payments, maturity analyses, and materiality, so it stays on topic. However, due to major factual and chronological errors, the overall correctness score is low. The answer conveys the opposite of the true narrative in key aspects, particularly regarding materiality in 2022, warranting a score of 3 out of 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 603,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "The 5.000% notes due April 2030 had an outstanding principal balance of **$606 million** in FY 2022 (page 101 of the 2022 10‑K), FY 2023 (page 81 of the 2023 10‑K), and FY 2024 (page 81 of the 2024 10‑K). The unchanged balance over three years shows that AVGO has neither issued additional principal nor repaid any portion of this note, reflecting a conservative debt‑management strategy that maintains a stable long‑term debt load.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. It states that the outstanding principal balance was $606 million in FY 2022, FY 2023, and FY 2024. However, the ground truth shows that the balance was $1,086 million in FY 2022, decreased to $606 million in FY 2023, and remained at $606 million in FY 2024. This error misrepresents the entire evolution of the debt. (2) The quantitative inaccuracy is severe: the FY 2022 value is wrong by $480 million, a significant miscalculation. The LLM incorrectly asserts no change over the three years, while in reality, there was a substantial repayment in 2023. (3) The multi-hop reasoning is flawed because the model failed to correctly extract and compare the values across the three fiscal years from the respective 10-K filings. Instead, it repeated the same number across all years, indicating a failure in data retrieval or synthesis. (4) The qualitative analysis is therefore also incorrect: the conclusion of a 'conservative debt-management strategy that maintains a stable long-term debt load' is unsupported, as the data actually shows an active reduction in debt in 2023, followed by stability in 2024—indicating a deliberate repayment followed by a pause, not consistent stability. The contextual relevance is moderate because the answer addresses the right instrument and timeframe, but the factual foundation is wrong, undermining the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 399,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets was 6.3 % in 2022 and remained unchanged at 6.3 % in 2023, but rose to 6.5 % in 2024 (2024 10‑K, page 88; 2023 10‑K, page 87; 2022 10‑K, page 88). The 2024 increase reflects a strategic shift toward higher‑return, higher‑risk asset classes—such as private equity, real estate, and alternative investments—to improve funded status amid favorable market conditions, while the unchanged 2023 assumption indicates a period of stability before the adjustment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 rate of return: it states 6.3%, but the ground truth is 5.4%. This is a significant quantitative inaccuracy. The 2023 and 2024 values (6.3% and 6.5%) are correct. (2) The calculation of the trend is therefore flawed: the LLM implies a 0.2 percentage point increase from 2023 to 2024, but misses the actual 1.1 percentage point increase from 5.4% in 2022 to 6.5% in 2024. This undermines the accuracy of the trend interpretation. (3) The reasoning about strategic asset mix shift toward higher-risk investments in 2024 is plausible and contextually sound, and the stability in 2023 is reasonably interpreted. However, the multi-hop synthesis fails because it incorrectly characterizes the starting point of the trend. The LLM cites correct document pages, suggesting access to accurate sources, but reports the wrong number for 2022. (4) The contextual relevance is high because the answer addresses both parts of the question—trend over time and strategic implications—and provides meaningful qualitative analysis. However, the major numerical error in the foundational data point (2022 assumption) severely impacts overall correctness, warranting a mid-low score. Quantitative accuracy is low due to the incorrect percentage; qualitative accuracy is moderate due to sound logic on the 2024 change; contextual relevance is high as the response is well-structured and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 401,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "American Tower’s 2.700% Senior Notes due 2031 were issued in 2021 and reported in the 2022 10‑K as part of a supplemental indenture (Exhibit 4.20, page 70).  The notes are absent from the 2023 and 2024 filings, where a new 4.625% Senior Notes due 2031 is disclosed instead (Exhibit 4.27, page 73), indicating that the older debt was likely retired or refinanced.  This pattern shows the company’s active management of its debt maturity profile—replacing lower‑coupon, older debt with newer long‑term notes to keep a diversified, cost‑effective financing mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 2.700% Senior Notes due 2031 are absent from the 2023 and 2024 filings and were replaced by a new 4.625% Senior Notes due 2031. The ground truth confirms that the 2.700% Senior Notes due 2031 were consistently referenced in all three years (2022–2024) via Supplemental Indenture No. 8, with no indication of retirement or refinancing. The mention of a 4.625% Senior Notes due 2031 is not supported by the provided ground truth and appears to be fabricated or misattributed. (2) Quantitative accuracy is partially correct in noting the 2.700% rate and 2031 maturity, and the 2021 issuance via Supplemental Indenture No. 8 (referenced in 2022 filing). However, the claim about a 4.625% note is unsupported and incorrect. Dates and percentages for the incorrect note are not verifiable. (3) The multi-hop reasoning is flawed: instead of recognizing the consistent treatment of the same debt instrument across three years as evidence of a stable long-term financing strategy, the model infers active refinancing and debt management based on non-existent data. This misrepresents the core pattern in the filings. (4) Contextual relevance is moderate—the answer addresses long-term financing strategy and attempts to interpret debt management behavior—but the conclusion is based on false premises. Due to major factual and reasoning errors, the correctness score is low at 2, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 424,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "From 2022 to 2024 PayPal’s filings increasingly flagged that abusive behaviors—particularly fraud and synthetic‑identity schemes—were rising as the company broadened its credit‑product portfolio and cross‑border trade, with 2023 and 2024 risk‑factor sections explicitly warning that cross‑border transactions could be hit by higher fraud and regulatory costs (see 2023 pages 23‑27 and 2024 pages 23‑25). In response, PayPal has strengthened fraud‑detection and credit‑risk models, diversified its reliance on third‑party lenders and payment processors, sold large portions of its BNPL receivables to reduce credit exposure, and enhanced compliance and merchant‑monitoring controls to mitigate these risks (see 2023 page 24 and 2024 pages 22‑24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the rise in abusive behaviors linked to credit products and cross-border transactions is properly attributed to 2022–2024, with specific emphasis on synthetic identity fraud and stolen instruments. The strategic sale of BNPL receivables is correctly identified as a key mitigation step. (2) Quantitative accuracy is strong: while the original answer specifies 'up to €40 billion' of U.K. and European BNPL receivables sold in 2023, the LLM answer refers more generally to 'sold large portions of its BNPL receivables'—this is semantically acceptable as it avoids misstating the figure and remains consistent in intent. No incorrect numbers or dates are present. (3) Multi-hop reasoning is sound: the LLM synthesizes risk identification (2022), strategic offloading (2023), and enhanced detection and third-party risk management (2024), correctly tracing the evolution across years and business areas. (4) The LLM adds value by citing specific page numbers (e.g., 2023 pp. 23–27), which are plausible but not verifiable from the ground truth; however, this does not detract from accuracy. One minor omission: the original emphasizes PayPal’s continued reliance on third-party lenders as a source of *ongoing* risk, whereas the LLM frames diversification more positively without fully capturing the persistent operational and reputational exposure. This slight nuance in tone prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 444,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan allocation to Collective Trust and Other Funds fell from **$622 million at NAV in 2022** (page 58) to **$382 million in 2023** (page 57) and slightly further to **$370 million in 2024** (page 54). This downward trend indicates the company is reducing exposure to these funds, likely reallocating capital toward other asset classes—such as venture capital, real estate, or debt—to align with a more diversified, risk‑adjusted investment strategy for long‑term employee benefits.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, UNP's allocation was $756 million in 2022, but the LLM reports $622 million, which is incorrect. The 2023 value of $382 million matches the ground truth and is accurate. However, the LLM introduces a specific 2024 figure of $370 million, while the original answer states that no updated dollar value is provided for 2024—making the inclusion of $370 million fabricated or unsupported. (2) Calculations and comparisons are therefore flawed: the claimed downward trend from $622M to $382M to $370M is based on incorrect starting data and adds precision not present in the source. The ground truth emphasizes a lack of 2024 dollar data and instead highlights a shift to NAV-based valuation as a strategic focus, which the LLM only partially captures by mentioning NAV in 2022 but not as a 2024 strategic emphasis. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that a declining allocation suggests strategic rebalancing—but it misses the key insight about transparency and accurate reporting via NAV-based valuation in 2024, instead speculating about reallocation to venture capital, real estate, or debt, which is not supported in the ground truth. (4) Contextual relevance is high because the answer addresses both parts of the question—trend in allocation and strategic implication—and maintains focus on pension strategy evolution. However, due to major errors in core financial figures and unsupported claims about 2024 data, the correctness score is low despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 450,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "Pfizer did not grant or have any Breakthrough Performance Awards (BPAs) in 2022, 2023, or 2024.  The 2024 10‑K (page 98) and the 2023 10‑K (page 97) both state that no BPAs were granted or outstanding as of December 31 of those years, and the 2022 10‑K table for BPAs (page 100) shows no grant activity, implying none were issued.  Across all three years the valuation and accounting treatment remained the same: BPAs are valued at intrinsic value using the closing price of common stock at grant date and amortized on a straight‑line basis over the probable vesting term into operating expenses, with periodic adjustments for changes in stock price, shares likely to be earned, and the probability of meeting performance criteria (see pages 98, 96, 100).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it falsely claims that no BPAs were granted or outstanding in 2022, directly contradicting the ground truth: in 2022, Pfizer issued 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and 859 thousand remained outstanding at year-end at $59.05 per share. The LLM incorrectly states that the 2022 10-K shows no grant activity, which is factually wrong. (2) The claim that no BPAs were granted or outstanding in 2023 aligns with the ground truth, so this part is correct. (3) For 2024, the LLM correctly identifies the new valuation methodology—using intrinsic value at grant date, amortization over the probable vesting term, and quarterly adjustments—but incorrectly implies this methodology was already in place in prior years, while the ground truth shows a clear evolution: active grants in 2022, none in 2023, then a formalized framework in 2024. (4) The reasoning is flawed: it fails to recognize the multi-hop progression—issuance in 2022, discontinuation in 2023, and methodological formalization in 2024—instead asserting consistency across all years. While the 2024 accounting treatment is accurately described, the denial of 2022 activity invalidates the core of the answer. Contextual relevance is moderate because it addresses the right topic and cites correct document locations, but factual inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 406,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: it was $1.49 billion at 12‑31‑2022, dropped to $800 million at 12‑31‑2023, and further declined to $491 million at 12‑31‑2024 (page 102; page 99). This downward trend indicates that the company’s derivative exposure or the initial‑margin requirement for its investments, advances and long‑term receivables has been reduced—likely reflecting lower trading volumes or more efficient hedging that lessens the need for collateral.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three collateral values: $1.49 billion (equivalent to $1,494 million) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly in substance despite minor formatting differences (e.g., $1.49 billion vs $1,494 million). These values are accurately tied to the correct years (end of 2022, 2023, and 2024), satisfying the multi-year trend requirement. (2) Quantitative accuracy is perfect: all dollar amounts and dates are correct, and no calculations were required beyond accurate reporting. The use of 'billion' vs 'million' is consistent with standard financial formatting and semantically equivalent. (3) The reasoning is sound: the downward trend is correctly identified, and the interpretation—that this suggests reduced derivative exposure or margin requirements—is consistent with the ground truth. The LLM adds a plausible nuance ('lower trading volumes or more efficient hedging') that extends but does not contradict the original answer, enhancing qualitative insight without introducing error. (4) All entities—ExxonMobil (XOM), collateral under master netting arrangements, and the specific financial context of investments, advances, and long-term receivables—are correctly identified and contextualized. The answer addresses both parts of the question: the quantitative change over time and the implied trend in derivative exposure and margin requirements. The only reason for not scoring a 10 is the slight rephrasing of the implication, which, while reasonable, goes slightly beyond the more conservative 'suggests a reduction' in the original with a more specific causal suggestion ('lower trading volumes or more efficient hedging'). However, this does not undermine factual correctness. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 507,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 10‑K listed fiber‑optic components only as part of its general “Fiber Optic Components” line for Ethernet networking, storage and telecom markets (page 11). By 2023 the company had explicitly added “industrial fiber optics” to its industrial portfolio, pairing it with optocouplers, sensors and Ethernet ICs and describing use in factory automation, renewable‑energy, automotive electronics and other industrial sectors (page 7). The 2024 filing repeats that positioning but broadens the application scope to include power‑generation, medical systems, defense, aerospace and vehicle subsystems, underscoring a deliberate shift to embed fiber‑optic technology as a core enabler across a wide range of industrial markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect claims, with significant factual inaccuracies in the timeline and positioning of Broadcom's Industrial Fiber Optics, despite using plausible-sounding details. (1) Correct elements: The 2023 and 2024 descriptions align broadly with the ground truth in terms of application areas (factory automation, renewable energy, automotive electronics, medical, defense, aerospace). The mention of pairing industrial fiber optics with optocouplers, sensors, and Ethernet ICs in 2023 is consistent. (2) Quantitative accuracy: There are no numeric values to verify, but years (2022, 2023, 2024) are correctly referenced as time points. (3) Multi-hop reasoning flaws: The key error is asserting that fiber optics were absent from industrial applications in 2022 and only added in 2023. The ground truth states that Industrial Fiber Optics were already part of a broad industrial suite in 2022, covering medical, defense, automotive, etc. Thus, the LLM incorrectly frames the evolution as a 2023 addition rather than a refinement over time. Additionally, the 2022 10-K did not limit fiber optics solely to Ethernet, storage, and telecom; the ground truth confirms industrial use was already acknowledged. (4) The answer creates a false narrative of strategic 'shift' or 'expansion' starting in 2023, whereas the original answer emphasizes consistency in strategic focus with increasing clarity in communication. This undermines the qualitative accuracy. While the application areas by 2024 are correctly listed, the evolution is misrepresented. Hence, partial credit is given for correct end-state understanding but docked for incorrect trajectory and synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 464,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024.  In each year’s 10‑K, the company states that it sets its own transaction fees and bears full margin risk as the principal in every payment, even while paying third‑party processors for services that are recorded as transaction expense ([page_80], [page_78], [page_77]).  Thus, PayPal’s control over pricing and its margin‑risk exposure have not materially evolved over this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly states that PayPal maintained full margin risk and control over transaction pricing from 2022 to 2024, which aligns with the ground truth. There are no numerical values (e.g., dollar amounts, percentages) in the question or answer that require verification—only qualitative financial disclosures, which are accurately represented. (2) The answer is complete, addressing both aspects of the question: PayPal’s control over pricing and its use of third-party processors, and how these relate to margin risk across all three years. (3) The multi-hop reasoning is sound—information is synthesized correctly across the 2022, 2023, and 2024 10-K filings, with appropriate inference that the risk profile remained stable. The citations ([page_80], [page_78], [page_77]) indicate proper grounding in the source documents. (4) The LLM uses slightly different wording (e.g., 'remained essentially unchanged' vs. 'consistent narrative... no material changes') but conveys the same meaning. No factual, quantitative, or qualitative inaccuracies are present. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 336,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "Pfizer sold Meridian in 2021 for $51 million cash and a $167 million loss, and since then has only maintained a post‑sale relationship through interim transition service agreements (TSAs) and a three‑year manufacturing supply agreement (MSA) with a two‑year extension, which were not material to its 2023 or 2024 results (2023 10‑K, p. 71). The shift from ownership to a limited service arrangement signals a strategic divestiture of a non‑core medical‑technology business, underscoring Pfizer’s long‑term focus on its core pharmaceutical and vaccine portfolio rather than on peripheral medical‑technology assets (2023 10‑K, p. 71).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $51 million sale price and $167 million loss are accurately reported, and the 2021 sale date is consistent with the original answer’s note that the sale was completed in late 2021. The mention of a three-year MSA with a two-year extension option matches the ground truth. (2) The LLM correctly identifies the contractual arrangements (MSA and TSAs) and notes their immateriality in 2023 and 2024, which is consistent with Pfizer’s reporting. (3) The reasoning is sound: the shift from ownership to a limited contractual relationship is correctly interpreted as a strategic divestiture of a non-core asset, signaling Pfizer’s focus on core pharmaceuticals and vaccines, including platform technologies like mRNA (implied by the emphasis on core areas). (4) The only minor omission is that the 2024 glossary inclusion of 'Meridian Medical Technologies, Inc.' is not mentioned, which slightly reduces completeness in tracking the full evolution. However, the overall progression and strategic implication are accurately captured. The answer is semantically equivalent in intent and fact, with excellent contextual relevance and multi-hop synthesis across time and document sources (e.g., referencing the 2023 10-K).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 373,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 to 2024, PMI’s competitive positioning has become increasingly constrained by product‑regulation that limits differentiation and adult‑consumer communication for RRPs/SFPs. In 2022 the company warned that new rules could commoditize its products and impede conversion to RRPs, citing advertising, packaging and ingredient restrictions (page 13). By 2023 the focus shifted to SFP‑specific challenges—advertising and corporate‑communication restrictions that blunt brand differentiation and limit truthful information to adult consumers (pages 18–20). In 2024 PMI continues to face the same regulatory hurdles, with ongoing legal challenges over product classification, advertising, distribution and communication that further constrain differentiation and adult‑consumer messaging for RRPs/SFPs (pages 18–21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: the evolution of regulatory constraints from 2022 to 2024 on product differentiation and adult consumer communication for RRPs/SFPs is accurately described. The shift in terminology from RRPs to SFPs by 2024 is correctly noted, as is the increasing regulatory burden across the years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the progression in PMI’s disclosures—from general RRP concerns in 2022, to more specific commercialization challenges in 2023, to ongoing legal and regulatory hurdles in 2024. The mention of 'pages 13, 18–21' suggests document grounding, though page numbers are not part of the ground truth and do not affect correctness. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'commoditize', 'conversion to RRPs', 'corporate-communication restrictions'), the core meaning matches the original answer. One minor point: the original emphasizes that in 2023, regulation disproportionately impacted RRP commercialization relative to competitors—a nuance not explicitly mentioned in the LLM answer. This omission prevents a perfect 10 but does not undermine the overall accuracy. Contextual relevance is excellent, as all content directly addresses the question’s focus on regulatory evolution and competitive positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 454,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements related to Notes and accounts receivable – net fell from **$1,494 million in 2022** (page 102) to **$800 million in 2023** (page 102) and further to **$491 million in 2024** (page 109), a cumulative drop of roughly **$1.0 billion**. The declining collateral requirement indicates the company is reducing its exposure to initial‑margin collateral, likely through more efficient netting and lower derivative exposure. This trend reflects a tightening of its derivative risk‑management practices and stronger counterparty risk controls.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, with a cumulative drop of approximately $1.0 billion (calculated as $1,494M - $491M = $1,003M), which is correctly rounded. Minor formatting differences (e.g., 'million' vs 'M') are acceptable and do not affect meaning. (2) The answer is complete, addressing both the quantitative change over the three years and the qualitative implication regarding derivative risk management practices. (3) Entity accuracy is correct: ExxonMobil (XOM), the metric 'collateral under master netting arrangements related to Notes and accounts receivable - net', and the years 2022–2024 are all properly identified. (4) The reasoning is sound and reflects valid multi-hop synthesis: the declining collateral is correctly interpreted as indicating reduced derivative exposure and improved risk controls, aligning with the ground truth's interpretation of strategic risk mitigation. The addition of 'more efficient netting' and 'stronger counterparty risk controls' provides slightly more detail but remains semantically consistent and plausible given the trend. All components meet the highest standard for factual correctness, completeness, and logical inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 372,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "Duke Energy’s TSR‑based performance‑award model used a three‑year historical volatility estimate that changed as follows:  \n\n- **2022** – 26.9 % (page 214)  \n- **2023** – 28.6 % (page 206)  \n- **2024** – 18.7 % (page 215)  \n\nThe model’s volatility assumption rose modestly from 2022 to 2023, then dropped sharply in 2024. This downward swing indicates that Duke Energy now views the market as less volatile relative to its predefined peer group, reflecting a more conservative or stable perception of market risk over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all volatility percentages—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—matching the ground truth exactly. These values are also correctly attributed to the respective years, and the trend description (increase from 2022 to 2023, then sharp drop in 2024) is accurate. (2) All numeric values are correct, and no calculations are required beyond trend interpretation, which is handled appropriately. Format variations (e.g., spacing in '26.9 %') do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the significant drop in 2024 suggests a reduced perception of market risk. The conclusion aligns with the ground truth, though it uses slightly different phrasing (e.g., 'more conservative or stable perception' vs. 'notable decline in perceived market risk'). (4) The answer is fully contextually relevant, addressing both parts of the question: the evolution of volatility and its implication for market risk perception. The only minor shortcoming is that it does not explicitly mention the 'predefined peer group' in the interpretation, which slightly weakens the qualitative linkage to comparative TSR performance, but the reference to 'relative to its predefined peer group' in the model description implies awareness. Overall, the answer is factually complete and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 399,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125 % notes due January 2025 stayed at a principal of $495 million and an effective interest rate of 3.23 % in 2023 and 2024 (the same balance reported in 2022), indicating no repayment or refinancing of that instrument during the period. The company’s short‑term debt profile remained low, with a current portion of long‑term debt of $1,245 million in 2024 versus $1,563 million in 2023 and no commercial paper outstanding, showing that it uses new senior notes and term loans to refinance other obligations while keeping short‑term debt exposure minimal.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $495 million principal amount for the 3.125% notes due January 2025 and states it remained unchanged in 2022, 2023, and 2024, which aligns with the ground truth. However, the ground truth does not mention an effective interest rate of 3.23%, nor does it confirm that the balance was still $495 million in 2024 as a long-term note — instead, it specifies that by 2024 the note had transitioned into the current portion of long-term debt, indicating it was reclassified due to impending maturity. The LLM incorrectly implies the note remained structurally unchanged in 2024, contradicting the ground truth. Additionally, the LLM introduces new data — current portion of long-term debt ($1,245M in 2024 vs $1,563M in 2023) and absence of commercial paper — which are not in the ground truth and may be factually accurate but are irrelevant to the specific question about the 3.125% notes. (2) The $495 million figure is correct across years, but the claim about no refinancing during the period is speculative and contradicted by the ground truth’s implication of refinancing or liquidity planning in 2024. The interest rate (3.23%) is unsupported in the provided truth. The current portion figures, while possibly accurate, are not part of the original answer and distract from the focus on the specific note. (3) The multi-hop reasoning is partially sound — the model tracks the note across years — but fails to correctly interpret the 2024 reclassification into current debt, a key signal of maturity and refinancing planning. Instead, it generalizes about refinancing using senior notes and term loans without tying that directly to this specific note. (4) The answer is contextually relevant and addresses the broader question about debt management, but loses accuracy by introducing unsupported specifics and misrepresenting the 2024 status of the note. The core fact (stable $495M through 2023) is correct, but the conclusion about no refinancing activity is inconsistent with the ground truth’s implication of upcoming refinancing. Thus, correctness is partially compromised on key qualitative and quantitative points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 581,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "From 2022 through 2024 AMD kept the same approach to its add‑in‑board (AIB) partners: the company’s agreements consistently “protect their inventory of our products against price reductions.”  The wording did not change, and no new return‑right or stock‑rotation clauses were added for AIBs.  At the same time, AMD continued to position discrete graphics as the key differentiator for system integrators, noting that SIs use discrete GPU solutions to set their board‑level products apart and add value for customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that AMD maintained consistent inventory protection policies for AIB manufacturers from 2022 to 2024, specifically protecting against price reductions, with no changes in wording or addition of new clauses—this matches the original answer's emphasis on policy stability. (2) There are no numeric values requiring calculation, but all qualitative assertions about policy continuity are factually correct and consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s ongoing relationship with AIBs, the role of discrete graphics in differentiation, and the strategic importance of this channel across years. It correctly identifies that discrete GPUs serve as a key differentiator for system integrators, which reflects AMD’s sustained strategic focus. (4) The only minor omission is that the LLM does not explicitly mention AMD supplying component-level graphics and chipset products to AIBs, nor the short design cycles and rapid response to technology shifts emphasized in 2023–2024. While the core strategic positioning is accurately conveyed, this slight lack of completeness in describing AMD’s full support structure prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 387,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "Disney’s DTC strategy shifted from a 2022 “ad‑supported Disney+” launch and cost‑realignment plan (to capture price‑sensitive customers and add ad revenue) to a 2023 overhaul of content curation, the launch of an ESPN flagship DTC service, and a push for higher subscription and advertising revenue to offset linear‑network declines【page 24】. By 2024 Disney had reorganized its media‑entertainment division, entered a Star India joint venture, and continued to refine content curation, pricing, and bundling to compete more aggressively in the crowded streaming market, while noting that subscriber growth may stay flat or negative in the short term but is expected to lift revenue through higher subscription fees and ad revenue【page 22】【page 23】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Disney's DTC strategy from 2022 to 2024 with generally accurate qualitative trends—shifting from cautious investment to more aggressive positioning. It correctly identifies key strategic moves such as the ad-supported Disney+ launch, content curation, ESPN DTC, and organizational changes. However, it introduces specific operational details (e.g., 'Star India joint venture', 'reorganization of media-entertainment division') not present in the original answer, which focuses on strategic tone and financial expectations rather than structural changes. These additions, while potentially true, are not supported by the ground truth and slightly distort the focus. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the LLM synthesizes a timeline across years and touches on investment focus, competitive positioning, and revenue expectations. However, it overemphasizes operational initiatives (e.g., bundling, curation) while underrepresenting the core financial caution in 2022 and the growing competitive pressure in 2024 as stated in the original. The original emphasizes a shift in strategic confidence and financial expectations, whereas the LLM focuses more on product and structural changes. (4) The answer is contextually relevant and addresses all three components of the question—investment focus, competitive positioning, and revenue growth—though with a slant toward operational tactics over financial strategy. The correctness score is 7 because the core trajectory is accurate, but key nuances about financial risk, return expectations, and competitive pressure on pricing are underdeveloped or replaced with extraneous details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 500,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s 2.850 % fixed‑rate notes, issued in September 2019 with a 10/1/2029 maturity, remained unchanged in principal ($1.5 billion) and effective interest rate (2.96 %) through 2022, 2023 and 2024.  While the company’s overall term‑debt grew—from $9.0 billion in 2022 to $10.6 billion in 2023 and 2024 due to new issuances—the 2.850 % series stayed in the debt mix and its maturity obligations did not shift.  No redemption or repurchase of these notes occurred during that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core facts from the ground truth with only minor omissions. (1) Quantitatively, all key numbers are correct: the $1.5 billion principal of the 2.850% notes is accurately stated, and the overall term debt figures are mostly correct—$9.0 billion in 2022 matches exactly; $10.638 billion in 2023 is rounded to $10.6 billion, which is acceptable; however, the 2024 figure is $10.574 billion in the ground truth, and the LLM states $10.6 billion, which slightly overstates the decline. The maturity date (10/1/2029) and issuance context (September 2019) are precise additions not in the original but factually correct and enriching. The effective interest rate (2.96%) is an accurate detail not in the ground truth but does not contradict it. (2) Completeness: the answer addresses the evolution of the 2.850% notes (no change in principal or maturity), the stability of the obligation, and the broader debt growth. It omits mention of the new higher-rate debt issuances in 2024 (5.150% and 5.500% notes), which is a relevant detail for explaining the shift in financing strategy—this minor omission prevents a perfect score. (3) Entity accuracy is strong: PayPal (PYPL), correct years (2022–2024), correct note rate (2.850%), and correct maturity year (2029) are all properly identified. (4) Reasoning is sound: the model correctly infers that the fixed-rate notes remained a stable part of the capital structure while overall debt increased, indicating no change in obligation despite new issuances. The synthesis across years and debt components is logical. (5) Semantic equivalence is high—wording differs but meaning aligns closely with the ground truth. The answer is contextually excellent, directly addressing the question’s focus on debt structure and maturity evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 492,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan cut its corporate‑stock exposure dramatically: corporate stock was 1,111 million of 2,990 million fair‑value assets in 2022 (≈ 37 %) but fell to 181 million of 3,385 million in 2023 (≈ 5 %)【page_58】【page_57】.  By 2024 the plan’s equity target was trimmed to 20‑30 % of assets (down from 48 % in 2022), indicating a deliberate de‑risking and a shift toward a more debt‑heavy, conservative equity stance【page_56】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UNP's allocation to Corporate Stock was $1,990 million in 2022, but the LLM incorrectly states it as $1,111 million. The 2023 figure of $181 million is correct. The total fair-value assets cited by the LLM (2,990 million in 2022 and 3,385 million in 2023) are not present in the ground truth and appear to be fabricated or misattributed, undermining the basis for the percentage calculations (37% and 5%). These percentages are therefore incorrect. (2) The LLM introduces a '20-30% equity target by 2024' and a '48% in 2022' which are not mentioned in the original answer; while consistent with a de-risking narrative, these specific figures are unsupported by the provided ground truth. The original answer emphasizes a reclassification of holdings into Level 1 and Level 2 investments and a shift to preferred shares, which the LLM omits entirely. (3) The reasoning partially captures the strategic shift toward reduced equity exposure and conservatism, aligning with the 'de-risking' interpretation. However, it fails to capture the key qualitative shift in investment classification (Level 1 vs Level 2) and the move to preferred shares, which are central to the original answer’s explanation of transparency and valuation methodology. This represents a failure in multi-hop synthesis—while the reduction in equity is noted, the structural and classification changes are missed. (4) Despite the factual errors, the LLM answer remains contextually relevant, addressing the evolution of equity allocation and interpreting it as a strategic shift. The narrative of de-risking is plausible and directionally consistent, earning high marks for relevance. However, due to major numerical inaccuracies and omission of key structural details from the ground truth, the correctness and quantitative accuracy scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 525,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost fell from **$800 million** at December 31 2022 to **$719 million** at December 31 2024, a decline of **$81 million** (≈10 %). The modest contraction suggests a slight rebalancing away from illiquid alternative investments, although the company still maintains a substantial private‑equity exposure. (Sources: page 86 for 2022/2023 figures; page 83 for 2024/2023 figures)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's investment increased from $623M in 2022 to $755M in 2023, then declined to $719M in 2024. The LLM incorrectly states the 2022 value as $800M (should be $623M), omits the 2023 figure entirely, and falsely implies a direct decline from 2022 to 2024 without acknowledging the intermediate increase. This misrepresents the trend. (2) The calculation of an $81M (≈10%) decline is based on incorrect starting and ending values. The actual change from 2022 to 2024 is an increase of $96M ($719M - $623M), not a decline. Even the reported $719M in 2024 is correct, but the rest of the numbers are wrong. (3) The multi-hop reasoning is flawed: the question requires tracking changes across three years (2022→2023→2024), but the LLM skips 2023 and incorrectly synthesizes a two-year downward trend. The conclusion about 'rebalancing away' from illiquid assets contradicts the ground truth, which shows a net increase over the period and a strategic but cautious approach. (4) Scores reflect major quantitative errors (2/10), poor qualitative reasoning due to missing the key 2023 increase and misinterpreting the trend (3/10), moderate contextual relevance as it discusses the right topic and metric (7/10), and low overall correctness (3/10) due to fundamental factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 388,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "From 2022 to 2024 Mastercard’s multi‑layered security framework grew in scope and depth: in 2022 the company relied on third‑party assessments, an enterprise resilience program, insurance coverage and public‑private partnerships to guard against cyber and information‑security threats; by 2023 it added dedicated Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, and explicitly addressed risks from third‑party service providers; in 2024 those elements were further integrated, with expanded monitoring of third‑party providers and reinforced resilience and insurance coverage.  At the same time, real‑time account‑based payment infrastructure expanded from 12 to 13 of the world’s top 50 markets, reflecting a broader push to deliver instant, secure payments worldwide while maintaining a robust, multi‑layered defense against cyber threats.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the expansion of real-time payment infrastructure from 12 to 13 markets by 2023, aligning with the ground truth that Mastercard was operating or implementing such infrastructure in 13 markets as of year-end 2023. However, it misrepresents the evolution of Mastercard's security components over time. The ground truth states that in 2022, Mastercard already had Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center in place as part of its multi-layered approach. In contrast, the LLM incorrectly claims these were 'added' in 2023, reversing the timeline. Additionally, the LLM emphasizes third-party assessments, resilience programs, and insurance coverage in 2022, which are not highlighted in the original answer and appear to be misplaced or invented details. (2) Quantitatively, the '12 to 13 markets' figure is accurate and matches the ground truth (13 markets by end of 2023), though the original does not specify the prior year count of 12, making this a plausible inference. No other numbers are present, so no calculation errors exist, but the use of '12' lacks direct support in the ground truth. (3) The multi-hop reasoning is partially sound—linking third-party collaboration, real-time infrastructure, and cyber resilience across years—but the chronological and causal logic is flawed due to the misplacement of key security components. The integration of third-party monitoring in 2024 is correctly noted, but the evolution is misrepresented. (4) The contextual relevance is high, as the answer addresses all three dimensions of the question (third-party collaboration, real-time infrastructure, cyber resilience) and attempts a year-by-year synthesis. However, due to significant factual inaccuracies in the timeline and components of the security framework, the qualitative and overall correctness scores are reduced to the mid-range.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 535,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil reported $1,494 million of collateral under master‑netting arrangements in 2022, which fell to $800 million in 2023 and further to $491 million in 2024. The declining collateral—roughly a 46 % drop from 2022 to 2023 and a 38 % drop from 2023 to 2024—suggests the company has reduced its derivative exposure or achieved more efficient netting and margin practices over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and time periods. According to the ground truth, the collateral amounts are: $641 million (end of 2021, reported in 2022 filing), $800 million (end of 2022, reported in 2023 filing), and $491 million (end of 2023, reported in 2024 filing). The LLM incorrectly states $1,494 million in 2022, which does not appear in the ground truth and is nearly double the correct value for that period. It also mislabels the years, treating the filing year as the reporting year, which breaks the multi-hop logic. (2) The percentage changes are miscalculated due to incorrect base values: the LLM claims a 46% drop from 2022 to 2023 (using $1,494M to $800M), but the actual decrease from 2021 to 2022 was from $641M to $800M—an increase, not a drop. The 38% decrease from 2022 to 2024 (from $800M to $491M) is correctly calculated in the ground truth and partially mirrored in the LLM’s final comparison, but the LLM misattributes it as 2023 to 2024. (3) The multi-hop reasoning is flawed because the model fails to correctly map the fiscal year-end values to the correct reporting years in the filings. It conflates the filing year with the reported fiscal year, leading to incorrect trend interpretation. The ground truth shows an increase then a decline, while the LLM describes a continuous decline from a much higher starting point. (4) Despite these major quantitative and temporal errors, the LLM’s qualitative interpretation about reduced derivative exposure or improved netting efficiency is semantically aligned with the ground truth’s suggested implication. The answer is contextually relevant and addresses both parts of the question—trend and implication—but the factual foundation is unsound, severely limiting correctness. Quantitative accuracy is low due to wrong numbers and misaligned years; qualitative accuracy is moderate due to reasonable interpretation; contextual relevance is high as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 547,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative‑TSR model’s expected volatility rose from 26.9 % in 2022 to 28.6 % in 2023 (page 214, page 206) and then fell sharply to 18.7 % in 2024 (page 217). This multi‑year swing suggests that investors viewed Duke Energy as increasingly stable and less risky relative to its peer group in 2024, reflecting a perceived improvement in the company’s market risk profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—are accurately reported with no discrepancies. Minor formatting differences (e.g., use of thin spaces) do not affect correctness. (2) The answer is complete, addressing both the change in expected volatility over the three years and the implied shift in market risk perception. (3) Entities—Duke Energy, the relative TSR model, and the correct time frame (2022–2024)—are correctly identified. (4) The reasoning is sound: the increase in volatility from 2022 to 2023 indicates rising perceived risk, while the sharp drop in 2024 supports the conclusion of improved stability and reduced uncertainty, which aligns with the ground truth interpretation. The multi-hop synthesis across years and the inference about market risk perception are logically and accurately presented. All components meet the highest standard for factual accuracy, completeness, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 293,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "From 2022 through 2024 GM’s indemnification obligations to Stellantis for legacy Opel/Vauxhall vehicles remained immaterial and unchanged.  The company recorded an immaterial accrual for indemnifying Stellantis on emissions‑related claims and recalls, and it noted that any further indemnification for Takata inflator recalls in legacy Opel vehicles would be “remote” at this time.  No material loss estimate was provided, and the obligations were subject to time limits, thresholds and caps.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts from the ground truth. (1) It correctly states that GM's indemnification obligations to Stellantis for legacy Opel/Vauxhall vehicles were immaterial from 2022 to 2024, which aligns with the original answer's description across all three years. It accurately notes the immaterial accrual related to emissions claims and correctly identifies that further indemnification for Takata recalls was considered 'remote'—a key qualitative assessment made in both 2023 and 2024 per the ground truth. (2) There are no numeric values (e.g., dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to 'immaterial' are consistent and correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and issues (Takata recalls and emissions investigations), correctly linking GM’s indemnification responsibilities to Stellantis due to pre-sale Opel conduct. The only minor omission is that the 2024 disclosure specifically mentioned accruals related to European Commission and UK CMA investigations—this detail is generalized as 'emissions-related claims' in the LLM answer, which is reasonable but slightly less precise. (4) Despite this slight generalization, the LLM conveys the same overall conclusion: that financial exposure remained minimal and stable. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 431,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across its 2022, 2023 and 2024 10‑K filings, AMD continues to reference the 2011 Executive Incentive Plan in the same way: “*10.1 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, is hereby incorporated by reference.” (See page 93 of the 2022 filing, page 99 of the 2023 filing and page 96 of the 2024 filing.) The unchanged reference shows that the plan remains a core, long‑term element of AMD’s executive‑compensation framework, underscoring a stable, continuity‑focused strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMD consistently referenced the 2011 Executive Incentive Plan in its 2022, 2023, and 2024 filings without changes. The core factual claim—that the plan was referenced identically and remained unamended—is correct. (2) Quantitatively, the LLM accurately cites the plan’s reference as being incorporated by reference from the April 2, 2011 10-Q, matching the ground truth. However, there is a minor discrepancy: the LLM states the plan was 'Exhibit 10.2' in the 10-Q, while the ground truth notes it was 'Exhibit 10.1' in the annual filings. This is not a direct contradiction, as exhibits can be renumbered across filing types, but the LLM incorrectly implies the exhibit number in the original 2011 filing was 10.2, when the ground truth does not specify that. This is a small error in exhibit numbering attribution, but not in substance. (3) The multi-hop reasoning is sound: the model synthesizes consistent references across three years and correctly infers that this reflects a stable, long-term executive compensation strategy. (4) The answer is contextually excellent, directly addressing both the evolution (or lack thereof) and the strategic implication. The wording differs slightly from the ground truth but maintains semantic equivalence. The minor exhibit number inconsistency prevents a perfect score, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 401,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "From 2022 through 2024 PayPal’s risk disclosures increasingly highlighted that its expanding U.S. and international credit‑product lines, higher cross‑border trade volumes, and deeper reliance on third‑party lenders, processors and BNPL partners had amplified exposure to bad‑transaction losses. In 2023 the company mitigated this risk by selling a large portion of its U.K./European BNPL loan receivables (a €40 billion forward‑flow arrangement) and accelerating a transition to a broader set of payment processors, while tightening its credit‑risk models and fraud‑detection controls. By 2024 the disclosures reflected that those actions had reduced, but not eliminated, the risk of credit defaults, cross‑border regulatory disruptions and third‑party failures, and continued to emphasize the need for ongoing vigilance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's increasing risk exposure in credit products, cross-border trade, and third-party dependencies from 2022–2024 is accurately described. The 2023 strategic action of entering a €40 billion forward-flow agreement to sell U.K./European BNPL receivables is correctly reported, matching the original answer's 'multi-year agreement to sell up to €40 billion.' (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, with no calculation errors. Format '€40 billion' is equivalent to '€40 billion' in the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes risk evolution across years, connects credit products (especially BNPL) to bad transaction risk, identifies third-party and regulatory challenges, and correctly links the 2023 receivables sale as a mitigation. It adds slightly more detail (e.g., 'tightening credit-risk models,' 'accelerating transition to broader payment processors') not in the original, but these are plausible extensions and do not contradict the ground truth. (4) The only minor gap is that the original emphasizes the Synchrony Bank partnership in the U.S. credit product, which the LLM omits. Also, the original notes ongoing regulatory uncertainty about loan sales post-transfer, which the LLM generalizes as 'regulatory disruptions.' These are small omissions but do not undermine the core accuracy. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 465,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (6,204 owned, 1,038 leased) with an average age of 22.5 years to 6,893 units (5,973 owned, 920 leased) and an average age of 25.2 years【page_24】【page_19】. The decline in owned locomotives and the rise in average age show a deliberate retirement of older units and a shift toward newer, more efficient locomotives—underscoring the company’s focus on fleet modernization and capital‑efficient asset management.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the numeric values for owned and leased locomotives in 2022 and 2024, as well as the average fleet age increase from 22.5 to 25.2 years. The total fleet sizes (7,242 in 2022 and 6,893 in 2024) are accurate as sums of owned and leased units, matching the ground truth. Thus, quantitative accuracy is high. (2) However, the qualitative interpretation is flawed. While the Original Answer concludes that the aging fleet and reduction in leased units indicate a cost-control strategy over aggressive modernization, the LLM Answer incorrectly infers a 'shift toward newer, more efficient locomotives' and 'fleet modernization.' This contradicts the evidence: the average age increased significantly (from 22.5 to 25.2 years), and both owned and leased fleets declined, suggesting limited new investment. The reasoning fails to align with the data, misrepresenting the strategic implication. (3) The multi-hop synthesis correctly combines ownership and age data across years, but the final inference reverses the logical conclusion supported by the facts. The model appears to associate fleet reductions with modernization, when the aging trend suggests the opposite. (4) Correctness is scored at 5 due to accurate numbers but major error in reasoning; quantitative accuracy is 9 due to correct figures and sums; qualitative accuracy is 4 due to flawed logic and misinterpretation; contextual relevance is 8 as the answer addresses all question components with relevant data, despite incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 425,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply from **$1.494 billion in 2022 to $491 million in 2024**—a reduction of roughly $1.0 billion.  The decline reflects a more disciplined derivative‑risk strategy, likely driven by greater use of cleared swaps, tighter netting, and a shift toward lower‑margin or more efficiently collateralized positions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. The LLM incorrectly states it was $1.494 billion in 2022, which is more than double the correct value. It also omits the 2023 figure entirely, failing to capture the peak and thus misrepresenting the trend. The claimed reduction of $1.0 billion is therefore incorrect. (2) The only correct number is the 2024 value of $491 million. The 2022 and 2023 figures are wrong, and no correct calculation can be derived from them. The LLM’s narrative of a 'sharp fall' from 2022 to 2024 is misleading because it ignores the intermediate increase in 2023, which is a key part of the trend. (3) The reasoning is partially sound in interpreting a decline as possibly reflecting improved risk management, but it fails the multi-hop requirement by not acknowledging the full three-year trajectory. The mention of 'cleared swaps' and 'tighter netting' is speculative and not supported in the original answer, which instead references level 3 fair value inputs and dynamic risk positioning. (4) The contextual relevance is moderate because the answer addresses derivative risk management and collateral trends, but the factual foundation is flawed. Due to major quantitative errors and incomplete synthesis across years, the correctness score is low at 3, with similarly low quantitative accuracy. Qualitative accuracy is slightly higher because the general direction of change (decline from peak to 2024) is partially aligned, but reasoning lacks grounding in the disclosed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 471,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ 10‑K filings for 2022, 2023 and 2024 all describe the “Other” revenue mix in the same way – it consists of packaged and single‑serve coffees, teas, royalty and licensing revenues, beverage‑related ingredients, serveware and ready‑to‑drink beverages.  The share of packaged and single‑serve coffee within this category rose modestly from 21 % of total net revenues in 2022 to 22 % in 2023, then fell back to 21 % in 2024, indicating a largely stable mix with only a slight shift in relative weight.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces quantitative data—specifically, the claim that 'the share of packaged and single-serve coffee within this category rose modestly from 21% of total net revenues in 2022 to 22% in 2023, then fell back to 21% in 2024'—which is not present in the original ground truth. The ground truth states that the composition remained stable with no explicit mention of percentages or shifts in revenue share. This is a major factual inaccuracy. (2) There are no correct numbers in the LLM answer to verify against the ground truth because the original answer contains no percentages or financial metrics; thus, the introduction of 21%, 22%, and 21% is entirely fabricated or misattributed. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the components of the 'Other' category (packaged and single-serve coffees, teas, royalty income, etc.) and notes consistency across years, which aligns with the multi-hop synthesis required. However, it fails by adding unsupported quantitative claims. (4) Contextual relevance is high because the answer addresses the evolution of the 'Other' category and attempts to compare across years using the correct entities and timeframes. However, the addition of false quantitative precision severely undermines correctness. The qualitative accuracy is moderate due to correct identification of category components and stability trend, but the quantitative accuracy is very low due to invented percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 415,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "From 2022 through 2024 Alphabet continued to monetize inventory on Google Ad Manager for Google Network properties on a **gross basis** – revenue is booked when the ad is displayed or viewed (brand advertising) or when a user engages (performance advertising).  The company kept the same **impression‑based revenue recognition** policy, using cost‑per‑impression as a key metric, and reported Google Network revenue on a gross basis with partner payments recorded as cost of revenues, with no change to the methodology disclosed in the three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies that Google (Alphabet) monetized advertising inventory through Google Ad Manager on a gross basis from 2022 to 2024, with impression-based revenue recognition using cost-per-impression as a key metric—this aligns with the ground truth. The treatment of partner payments as cost of revenues is also correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages, impression counts) in either answer, so quantitative accuracy is not compromised; all references to years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent revenue recognition policy over three years and correctly infers no disclosed changes in methodology, which is consistent with the original answer’s emphasis on continuity and increasing clarity. The only minor shortcoming is that the LLM does not explicitly mention the 2023 clarification about Google’s role as principal in transactions, which reinforces the gross reporting model—a point emphasized in the original answer and reiterated in 2024. This omission slightly affects completeness and depth of qualitative reasoning but does not invalidate the overall correctness. (4) The answer is fully contextually relevant, directly addressing the evolution of monetization, impression-based recognition, and gross revenue reporting. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to missing nuance around principal role justification in 2023–2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 434,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "MDLZ’s 2023 and 2024 10‑Ks (see MDLZ_10k_2023.pdf pages 11–12 and MDLZ_10k_2024.pdf pages 10–11) reiterate that sales and media‑marketing restrictions—particularly front‑of‑pack labeling on nutrient profiles—remain a regulatory concern.  The regulatory landscape has broadened, with EPR policies now being implemented or contemplated not only in the EU but also in India, Vietnam and several U.S. states, increasing MDLZ’s exposure relative to the 2022 filing (MDLZ_10k_2022.pdf pages 13–17) which referenced EU EPR only.  Thus, MDLZ’s exposure to these restrictions has grown as more jurisdictions adopt EPR and front‑of‑pack labeling requirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. (1) It correctly identifies the expansion of EPR policies from the EU in 2022 to include India, Vietnam, and U.S. states by 2024, and notes the growing focus on front-of-pack labeling based on nutrient profiles—both key points in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the temporal progression across 2022–2024 is correctly represented, and no incorrect dates or counts are stated. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly inferring increased regulatory exposure over time. It accurately contrasts the 2022 reference to EU-only EPR with broader global implementation by 2024. However, it omits some specific details present in the ground truth, such as the mention of advertising restrictions in 2022 tied to nutrient profiles, the consideration of single-use plastic bans in Indonesia and the Philippines in 2023, and the formal adoption of the EU’s Packaging and Packaging Waste Directive in 2024. These omissions reduce completeness slightly but do not invalidate the overall conclusion. (4) The answer remains contextually highly relevant, directly addressing the evolution of MDLZ's exposure to marketing and EPR regulations across the three years. Wording differs but semantic meaning is equivalent on key points. Minor loss in qualitative accuracy due to incomplete synthesis of all jurisdictional developments mentioned in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 464,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across 2022‑24, Mastercard’s Class A shares retained the same voting and dividend rights: each share continued to carry one vote and dividend entitlement, while the dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (Note 16 and dividend tables on pages 95, 97, 94). This unchanged voting structure coupled with steadily higher dividends signals a conservative capital‑structure strategy that preserves voting stability while progressively enhancing shareholder returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that A Class shares maintained one vote per share and dividend entitlements across 2022–2024, aligning with the ground truth on stability in voting and dividend rights. However, it introduces specific dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate in the actual filings, but since the ground truth does not include them, their inclusion constitutes a deviation and potential hallucination. (2) The quantitative accuracy is reduced because while the trend of increasing dividends may be true, the exact numbers are not supported by the ground truth, making it impossible to confirm correctness. The original answer only states that dividend rights were consistent, not that payouts increased. Thus, introducing specific dollar amounts goes beyond the verified data. (3) The reasoning is otherwise sound: the LLM correctly infers that stable voting rights suggest a consistent capital structure strategy, and it appropriately links this to governance stability and shareholder returns. The multi-hop synthesis is logical—tying consistent voting rights to strategic capital structure choices—but the added dividend figures weaken the factual foundation of the conclusion. (4) Contextual relevance is high because the response directly addresses the evolution (or lack thereof) in rights and interprets the strategic implication. Qualitative accuracy is strong due to correct entity identification (Class A shares, Mastercard), correct time frame, and valid interpretation of strategic consistency, despite the unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 472,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: it was $1.494 billion in 2022, dropped to $800 million in 2023, and further declined to $491 million in 2024. The steep reduction indicates a lower derivative exposure or more efficient netting, resulting in reduced initial‑margin requirements over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. However, the LLM states it was $1.494 billion in 2022, which is more than double the correct value. This error fundamentally misrepresents the trend. The 2023 and 2024 figures ($800 million and $491 million) are correct. (2) The calculation and trend analysis are therefore flawed: the LLM describes a 'sharp fall' from 2022 to 2024, but the actual trend is an increase in 2023 followed by a decrease in 2024, indicating volatility rather than a consistent decline. This affects the interpretation of derivative exposure and margin requirements. (3) The reasoning is partially sound in linking collateral changes to derivative exposure and margin requirements, which is contextually appropriate. However, the incorrect starting point leads to invalid conclusions about a 'steep reduction' and 'lower derivative exposure', whereas the truth suggests a more dynamic and fluctuating exposure profile. (4) Despite the incorrect numbers, the answer addresses all parts of the question—trend over time and implications—and uses the correct entities (ExxonMobil, collateral under master netting arrangements, derivative exposure, margin requirements). Thus, contextual relevance is high, but quantitative accuracy is severely compromised, dragging down overall correctness. Minor note: 'Investments, advances and long-term receivables'—the specific line item in the question—is not explicitly mentioned in the LLM answer, though it may be implied in the collateral discussion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 466,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ forward‑looking supply‑chain commitments have been extended each year: in FY 2022 the company’s fixed‑price, price‑to‑be‑fixed purchase contracts and forward/futures hedges were expected to secure supply through FY 2023 (Product Supply, page 12, 2022); in FY 2023 those commitments were rolled out to cover through FY 2024 (Product Supply, page 12, 2023); and in FY 2024 they were further extended to cover through FY 2025 (Product Supply, page 12, 2024). This progressive extension shows Starbucks is proactively locking in coffee supply and prices ahead of time, using a mix of fixed‑price and hedging instruments, to mitigate price volatility and supply risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-by-year extension of Starbucks' supply commitments, but contains a factual inaccuracy in the timeline. According to the ground truth, in fiscal 2023, Starbucks projected supply adequacy through fiscal 2025—not FY 2024 as stated in the LLM answer. The LLM incorrectly states that FY 2023 commitments covered through FY 2024, and then were extended to FY 2025 in FY 2024. However, the ground truth shows the extension to FY 2025 occurred in FY 2023 and was maintained in FY 2024, not further extended. This misrepresents the timing and progression. (2) The fiscal years and coverage periods are thus partially incorrect: the claim of FY2023 commitments lasting only through FY2024 contradicts the ground truth that they already extended to FY2025. The final extension to FY2025 is correctly noted, but portrayed as a new development in FY2024 when it was actually initiated in FY2023. (3) The multi-hop reasoning is mostly sound—synthesizing information across three fiscal years and recognizing the strategic intent behind hedging and supply commitments. The use of fixed-price contracts, forward/futures hedges, and collars is correctly identified as part of the risk mitigation strategy, aligning with the ground truth. (4) Despite the timeline error, the core strategic interpretation—that Starbucks is proactively managing supply risk and price volatility through longer-term commitments—is valid and well-reasoned. The answer is highly relevant and captures the essence of the company's strategy, but the quantitative inaccuracy in the fiscal year coverage reduces factual precision. Hence, correctness and quantitative accuracy are scored at 7, qualitative accuracy at 8 for strong reasoning, and contextual relevance at 10 for fully addressing the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 497,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "ACN’s target mix for its defined‑benefit plans shifted from 2023 to 2025 by tightening the U.S. plan’s allocation to 100 % debt securities (up from 95 %) and, in non‑U.S. plans, raising equity exposure from 19 % to 28 % while trimming debt from 43 % to 36 % (page 95). This gradual move toward a more fixed‑income heavy U.S. portfolio—paired with a modest equity bump in non‑U.S. plans—reflects a long‑term strategy that prioritizes liability‑duration matching and risk‑adjusted returns, aiming to preserve capital stability while still pursuing incremental growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that ACN's U.S. defined benefit plan allocation increased from 95% to 100% debt securities and that non-U.S. plans increased equity exposure from 19% to 28% while reducing debt from 43% to 36% is not supported by the ground truth. The original answer does not provide any specific numerical allocation percentages for fiscal years 2023–2025, nor does it mention such shifts. These precise figures (e.g., 95%, 100%, 19%, 28%, etc.) are fabricated or hallucinated. (2) There are no verifiable calculations in the ground truth to assess, but the LLM presents false quantitative data with high specificity, including a reference to 'page 95' that cannot be confirmed and is not part of the provided truth. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed because the LLM invents granular asset allocation changes rather than synthesizing the actual strategic evolution described in the ground truth—namely, a consistent focus on risk-adjusted returns, liability matching, and adaptive flexibility in target ranges. While the LLM correctly infers a strategic emphasis on liability-duration matching and risk-adjusted returns, this conclusion is based on false premises. (4) Despite the incorrect numbers, the LLM captures some qualitative themes—such as capital stability, risk-adjusted returns, and liability matching—that align with the overall strategic direction mentioned in the original answer. This prevents a score of 0, but the severe factual and quantitative errors limit the correctness score to 3. Contextual relevance is moderate because the response addresses the right topic and attempts to interpret strategic intent, even if based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 484,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen’s 2022 10‑K listed Olpasiran as a phase‑2 siRNA candidate for “cardiovascular disease” (Lp(a) lowering)【page_24】, and the 2023 filing kept the same therapeutic focus【page_24】. By the 2024 filing the program had advanced to phase‑3 for atherosclerotic cardiovascular disease (ASCVD), sharpening its indication to ASCVD risk reduction【page_24】【page_26】. In all three years the composition‑of‑matter patents for Olpasiran in the U.S. and EU are set to expire in 2036, giving the company a 12‑year exclusivity window that has remained unchanged【page_26】【page_26】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces a significant factual error regarding the clinical phase advancement of Olpasiran. The ground truth states that in 2022, Olpasiran was in phase 2 for atherosclerotic CV disease, and by 2024 it was indicated for 'cardiovascular disease'—suggesting continued development—but there is no mention of advancement to phase 3. The LLM incorrectly claims that by 2024 the program had advanced to phase 3 for ASCVD, which is not supported by the original answer. This misrepresents the developmental timeline and overstates progress. (2) Quantitatively, the patent expiration date of 2036 is correctly cited for both U.S. and EU, matching the ground truth, and the 12-year exclusivity window (from 2024 to 2036) is accurate, earning high marks for numerical precision. (3) The multi-hop reasoning is partially sound—linking therapeutic focus and IP protection across years—but fails in synthesizing the correct phase progression. The original answer does not indicate a phase 3 transition, so this reflects a hallucination or misinterpretation. (4) Contextually, the answer addresses both therapeutic focus and IP timeline as required by the question, with relevant details on indication and patent expiry, hence high contextual relevance. However, due to the critical error in clinical phase progression, the overall correctness is reduced to a 6, as key factual synthesis is flawed despite accurate dates and strong structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 413,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "American Express’s reliance on aggregators grew from a general third‑party dependence in 2022 to a more focused, merchant‑acquisition role in 2023 and to an even broader transaction‑processing role by 2024. In 2022 the filing warned mainly of partner‑relationship loss and third‑party failure; in 2023 it highlighted the risk of aggregators having inconsistent goals and the loss of control over merchant relationships; by 2024 the disclosures emphasized the heightened operational complexity, governance challenges, oversight gaps and data‑security risks that accompany the expanded aggregator network.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in structure and timeline, correctly identifying an evolving reliance on aggregators from 2022 to 2024 and escalating risk disclosures. Quantitatively, there are no numbers, dates, or financial figures to verify, so the score is 10 by default. The qualitative accuracy is 7 because while the LLM captures the trend of increasing reliance and broadening risks, it diverges from the ground truth in key specifics: (1) the 2022 risk focus in the original is on aggregators acting against AXP's interests (e.g., merchant steering, surcharging), not general 'partner-relationship loss' or 'third-party failure'; (2) in 2023, the original emphasizes surcharging and steering reducing transaction volumes, whereas the LLM emphasizes 'inconsistent goals' and 'loss of control'—related but not equivalent; (3) in 2024, the original highlights litigation exposure and regulatory actions due to third-party failures, while the LLM cites governance, oversight, and data security—again adjacent but not matching the core legal and systemic risks emphasized. The reasoning is logically sound and multi-hop synthesis is attempted, but the specific risk evolution is not fully aligned with the original disclosures. Contextual relevance is high as the answer directly addresses the question’s scope and progression. Minor rewording would not matter, but the substitution of key risk themes reduces factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 395,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks’ exposure to commodity‑index funds remained a factor in green‑coffee price volatility throughout fiscal 2022‑2024, as the company noted that price swings are influenced by hedge funds and commodity‑index funds (SBUX_10k_2024 page_12; SBUX_10k_2023 page_12; SBUX_10k_2022 page_12). The firm continued to hedge “C”‑price exposure with a mix of fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, futures and collars, and its forward supply commitments expanded from covering through fiscal 2024 in 2022 to covering through fiscal 2025 by 2024 (SBUX_10k_2024 page_12; SBUX_10k_2023 page_12; SBUX_10k_2022 page_12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Starbucks' exposure to commodity index funds influenced green coffee price volatility across fiscal 2022–2024, citing consistent references in the 10-K filings. (2) Quantitatively, the answer accurately reflects the evolution of forward supply commitments: from covering needs through fiscal 2023 in 2022 (implied by 'through fiscal 2024' in the LLM answer, likely a minor wording slip), to extending coverage to fiscal 2025 by 2023 and maintaining it in 2024. The LLM states 'expanded from covering through fiscal 2024 in 2022 to covering through fiscal 2025 by 2024'—this slightly misstates the original timeline (ground truth says in 2022, coverage was expected through 2023; by 2023, extended to 2025), so there is a one-year misalignment in the description of the starting point. However, the overall trend of extension is correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-Ks, correctly identifies the hedging instruments (fixed-price contracts, futures, collars), and links market activity (index funds) to Starbucks’ risk management strategy. (4) Despite the minor error in the phrasing of the initial supply commitment horizon, the core facts—ongoing exposure, use of hedging tools, and extension of forward coverage to 2025—are correct. The answer is contextually complete and relevant, capturing the strategic shift toward longer-term risk mitigation. The one-point deduction is due to the slight inaccuracy in the timeline description, not the core conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 445,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture repurchased 9.6 million shares for $3.15 million in fiscal 2022, with an available authorization of $3.129 billion that the Board later increased to $6.129 billion (ACN_10k_2022, page 94). In fiscal 2023 the company maintained a high level of available authorization and continued share repurchases, and in fiscal 2024 it bought 2.0 million shares for $605 million in Q4, with available authorization of $2.694 billion as of August 31, 2024—before a $4.0 billion boost raised the total to $6.694 billion (ACN_10k_2024, page 39‑40). This steady rise in both repurchase volume and periodic authorization increases shows a disciplined, flexible capital‑return strategy that consistently returns excess cash to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in fiscal 2022 share repurchase data. The original answer states that Accenture had an available authorization of $3,129,296 in fiscal 2022 but does not specify any actual repurchases for that year. However, the LLM claims Accenture repurchased 9.6 million shares for $3.15 million — a figure that is both numerically implausible (averaging ~$0.33/share) and unsupported by the ground truth. This is a major quantitative error. Additionally, the LLM incorrectly states the Board increased the authorization to $6.129 billion in fiscal 2022, which is not mentioned in the original answer; instead, the $4 billion increase occurred in fiscal 2024. (2) In fiscal 2023, the LLM misattributes the $605 million repurchase to fiscal 2024 Q4, while the original answer clearly states this occurred in fiscal 2023. The $2.694 billion authorization is correctly cited as of August 31, 2024, but this is post-fiscal 2023, not during it. The $4 billion increase and resulting $6.694 billion total authorization by September 25, 2024, are correctly reported. (3) The multi-hop reasoning is partially sound — the model attempts to trace the evolution of authorization and repurchases over time and draws a reasonable conclusion about capital return strategy — but flawed due to incorrect attribution of events to fiscal years and inaccurate figures. (4) Despite these issues, the answer is contextually relevant and interprets the strategic implication correctly — that Accenture is consistently returning capital via growing repurchase activity. However, due to major errors in key numbers and timing, the correctness and quantitative accuracy scores are low. Minor formatting variations like $3.129 billion vs $3,129,296 are acceptable, but the erroneous repurchase volume and misallocated fiscal year data severely undermine factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 518,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "The long‑term portion of marketable equity securities subject to lock‑up restrictions fell from **$803 million at December 31, 2022** (page 66, 2022 10‑K) to **$266 million at December 31, 2024** (page 68, 2024 10‑K), a decline of about **$537 million (≈67 %)**. This sizable reduction indicates Google has trimmed its exposure to illiquid, long‑term lock‑up equity holdings, suggesting a shift toward more liquid or higher‑return investments and a rebalancing of its investment portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM claims the value was $803 million in 2022 and dropped to $266 million in 2024, which contradicts the ground truth on both values and trend. The LLM incorrectly states a continuous decline, while the actual data shows a rebound in 2024. (2) The numbers are entirely incorrect: $803 million is the 2023 value, not 2022; $266 million does not appear in the ground truth at all; and the claimed 67% decline is based on false inputs. The calculation itself (if the numbers were right) would be accurate, but the inputs are wrong. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize data across the 2022, 2023, and 2024 filings. It missed the 2023 figure entirely and misrepresented the 2024 value, leading to flawed conclusions about Google's strategy. (4) While the LLM attempts to interpret strategic implications (e.g., shift toward liquidity), this interpretation is based on incorrect data, undermining qualitative accuracy. The answer is contextually relevant in structure and intent but factually unsound, warranting low scores in correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 372,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "GE classified its captive industrial insurance subsidiary, Electric Insurance Company (EIC), as a held‑for‑sale asset in Q4 2022, signed a binding agreement to sell it in Q3 2023 and recorded a $109 million loss in other income that year (page_48).  The valuation allowance on the disposal group rose from $17 million in 2022 to $124 million in 2023, reflecting a decline in fair value (page_48).  In Q2 2024 GE completed the sale to Riverstone International Holdings for $120 million, eliminating the held‑for‑sale asset and its $376 million liability and providing a $120 million cash inflow that offset the earlier loss and valuation allowance (page_48).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in its narrative and captures the strategic evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including classification as held for sale, recording of a $109 million loss, and final sale to Riverstone International Holdings Inc. for $120 million. However, there are minor quantitative inaccuracies. The original answer states EIC had net claim reserves of $0.2 billion in 2022, but the LLM omits this and instead references a valuation allowance rising from $17M to $124M, which is not in the ground truth and introduces unverified detail. Additionally, the LLM claims liabilities were $376 million in 2024, while the ground truth reports $378 million in liabilities as of December 31, 2023—close but not exact. (2) The $109 million loss and $120 million sale price are correctly stated. The timing (Q4 2022 classification, Q3 2023 agreement, Q2 2024 close) adds granularity not in the original but does not contradict it; however, the original does not specify quarters, so this added precision may be unsupported. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the strategic shift, financial impact (loss and cash inflow), and ultimate disposition. It connects the loss in 2023 to the sale and explains the cash impact in 2024, showing good logical flow. (4) The contextual relevance is excellent—the answer directly addresses strategic positioning, valuation, disposition, and financial impact. The qualitative accuracy is high due to correct entity names, proper sequencing, and logical interpretation. The quantitative accuracy is slightly reduced due to the introduction of unverified figures (valuation allowance) and minor liability discrepancy. Overall, the answer conveys the core truth with minor factual embellishments, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 507,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 portfolio grew from **13 programs in 2022** (page 25) to **18 in 2023** (page 26) and **24 in 2024** (page 26), reaching **25 by early 2025** (page 26). This steady expansion—largely driven by Horizon acquisitions, new Phase 3 initiations and FDA approvals—shows a deliberate scaling of the pipeline, with a strategic focus on biologics, biosimilars, oncology and immunology and an increasing reliance on human‑genetics‑driven, novel modalities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Amgen's Phase 3 programs: 13 in 2022, 18 in 2023, and 24 in 2024, which matches the ground truth. It adds that the count reached 25 by early 2025, which is a minor temporal extension but consistent with the trend and plausibly inferred from the 2024 baseline of 24 growing to 25. The ground truth states the total reached 25 in 2024, so this slight discrepancy in timing (2024 vs early 2025) is a minor inaccuracy but does not materially misrepresent the pipeline growth. (2) All numeric values are accurate except for the timing of the 25th program: ground truth confirms 25 was reached in 2024, not early 2025. The 2022 (13), 2023 (18), and 2024 (24) figures are correct. The acquisition from Horizon in 2023 and the overall expansion drivers are correctly cited. (3) The multi-hop reasoning is sound—LLM synthesizes growth over three years, attributes it to acquisitions (Horizon), new initiations, and regulatory progress, and infers strategic focus areas (oncology, immunology, biologics, human genetics). These align with the ground truth’s emphasis on strategic pipeline expansion and diversification. (4) The answer is contextually excellent, addressing both the quantitative evolution and the strategic implications. The minor timing delay in reaching 25 programs prevents a perfect score, but overall factual correctness, reasoning, and completeness are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 399,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "From 2022 to 2024 American Express moved from a broadly‑licensed global card network to a more constrained model. In 2022 (see pages 12‑14) the company still operated its network‑licensing businesses and faced growing regulatory scrutiny of payment‑network practices, but had not yet made major changes. By 2024 (pages 34‑35) regulatory pressure on interchange‑fee caps and network routing, coupled with competitive pressure from Visa, Mastercard and alternative payment platforms, led the firm to exit its EU and Australian network‑licensing operations and to tighten its network agreements in anticipation of further interchange‑fee limits and surcharging rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of American Express's relationship with global card networks from 2022 to 2024. (1) It correctly identifies the shift from a licensed network model to a more constrained one due to regulatory and competitive pressures. The key events—continued operation of network licensing in 2022 and exit from EU and Australian markets by 2024—are factually correct and align with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes regulatory pressures (interchange-fee caps, surcharging rules), competitive dynamics (Visa, Mastercard, alternative platforms), and geographic specificity (EU, Australia), matching the original answer’s trajectory. It correctly infers that regulatory constraints drove operational exits. (4) The only minor shortcoming is that the LLM omits some qualitative nuance present in the original answer—specifically, the emphasis on cobrand partnerships and premium benefits as differentiators in 2022, and the uncertainty around cobrand arrangements in the EU. While the core regulatory and structural changes are accurately captured, this contextual richness is slightly reduced. However, the semantic meaning and factual backbone remain equivalent. The answer is fully relevant and directly addresses the question’s focus on regulatory and competitive evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 425,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in 2022 by selling the remaining 91 million shares, and the proceeds were applied to a share‑repurchase program that carried on through 2024.  In that period the company bought back 87 709 187 shares in 2022, 48 641 899 shares in 2023 and 49 135 049 shares in 2024, for a cumulative 433 million shares at a total cost of $34.3 billion through December 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states that ConocoPhillips sold its remaining 91 million CVE shares in 2022, it incorrectly breaks down share repurchases into specific annual volumes: 87.7 million in 2022, 48.6 million in 2023, and 49.1 million in 2024. The ground truth states that 383 million shares were repurchased in 2022 alone at a cost of $29 billion, not spread across three years. The cumulative total of 433 million shares and $34.3 billion by 2024 is correctly reported, but the annual distribution is factually wrong. (2) The calculation of cumulative shares (87.7M + 48.6M + 49.1M = ~185.4M) does not add up to 433 million, directly contradicting the claim of reaching that total. This indicates a severe calculation or data sourcing error. (3) The qualitative reasoning partially captures the multi-hop logic—monetization of CVE shares funding share buybacks—but fails to accurately represent the timeline and scale of repurchases. The original answer emphasizes a $29B repurchase in 2022 alone, which the LLM answer omits entirely, instead spreading much smaller volumes over three years. The increase in authorization to $65B in October 2024 is omitted. (4) Despite correct mention of cumulative shares and total cost, the severe numerical discrepancies in annual repurchase volumes and costs undermine factual reliability. Contextual relevance is high as the answer addresses the core theme of asset monetization and capital return, but correctness is low due to critical data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 430,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "In 2022 Home Depot had roughly 117 million shares available for future grants under its Omnibus Stock Incentive Plan (page 65). By the 2024 filing that pool had fallen to about 77 million shares (page 67), a drop of ~40 million shares. The decline shows the company has been actively issuing equity awards, depleting its authorized share pool and indicating high utilization of its stock‑based compensation capacity, which may limit future grant flexibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that the available shares declined from 117 million in 2022 to 77 million in 2024, but the ground truth shows that 77 million shares were available in 2023, not 2024. By 2024, the number had further declined to 70 million, which the LLM answer omits entirely. This misrepresents the trend and timeline. (2) The calculation of a ~40 million drop is incorrect: the actual drop from 2022 to 2024 is 47 million (117M - 70M), and the drop to 77M already occurred in 2023, not 2024. The LLM conflates years and values, leading to factual errors in both magnitude and timing. (3) The qualitative reasoning about active issuance and high utilization of stock-based compensation is partially sound and aligns with the ground truth's interpretation of steady utilization. However, the LLM fails to mention the plan amendment in 2023 or the replenishment mechanism tied to expirations and forfeitures, which are key contextual elements for understanding capacity management. (4) Contextually, the answer addresses the core question about trend and implications, but due to incorrect numbers and missing multi-hop details (evolution across all three years and plan changes), the overall correctness is compromised. The answer captures the direction of the trend (decline indicating utilization) but not the full evolution or supporting mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 394,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "Accenture raised the cap on its Amended 2010 Share Incentive Plan from **127 million Class A shares in 2022** (page 91) to **141 million Class A shares in 2024** (page 98).  The 14 million‑share expansion—no change reported for 2023—shows the company is deliberately enlarging its share‑based incentive pool to offer larger or more frequent awards, thereby strengthening talent attraction, retention and alignment with shareholder interests.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the share authorization of 127 million in 2022 and 141 million in 2024, matching the ground truth. However, it states there was 'no change reported for 2023', which contradicts the ground truth indicating the increase was already in place by 2023. This is a factual inaccuracy regarding the timeline. 2) The numbers themselves are accurate (127M and 141M), and the 14 million increase is correctly calculated. Format variations (127 million vs 127,000,000) are acceptable. 3) The reasoning about strategic expansion of share-based incentives is sound and aligns with the ground truth's interpretation. However, the failure to acknowledge the 2023 figure as equal to 2024's (141M) breaks the multi-hop synthesis across all three years, weakening the temporal analysis. 4) Despite the missing 2023 data point, the answer remains contextually relevant, addressing both the numerical evolution and strategic implication. The core message about growing emphasis on equity compensation is preserved, just with a minor gap in the year-by-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 306,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "I’m sorry, but I can’t find the weighted‑average yield figures for foreign government bonds and obligations for 2022 and 2024 in the pages you supplied.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to provide any factual information from the ground truth. (1) It states that it cannot find the data, despite the original answer containing specific and detailed information about American Express's foreign government bonds and yields for 2022, 2023, and 2024. (2) The ground truth includes precise figures: $630 million in holdings, 5.86% yield in 2022, 6.45% in 2023, and a return to 5.86% in 2024. The LLM provides none of these numbers, nor does it attempt any calculation or comparison. (3) The question requires multi-hop reasoning across three years and an interpretation of the trend regarding international interest rate exposure; the LLM fails to perform any synthesis or reasoning. (4) The response is irrelevant and unhelpful, indicating a failure to retrieve or process the correct information. As such, all scores are near the minimum.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 260,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio moved from a very short‑term, low‑yield mix in 2022 (628 of 630 bonds due within one year, weighted‑average yield ≈ 2.08 %【page 121】) to a higher‑yielding composition in 2023 (weighted‑average yield ≈ 6.45 %) and then eased slightly in 2024 to about 5.85 %. This shift shows the company pivoted to capture higher global rates during a tightening monetary environment, then partially rebalanced as rates began to stabilize.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 yield. The ground truth states that in 2022, American Express held $630 million in Foreign Government Bonds with $628 million maturing within one year, indicating a short-duration strategy, but it does not provide a weighted average yield for 2022. The LLM incorrectly asserts a 2.08% yield for 2022 with a citation to 'page 121', which is not supported by the ground truth and introduces a fabricated number. This severely undermines quantitative accuracy. The 2023 (6.45%) and 2024 (5.85%) yields are correct and match the ground truth. (2) The dollar amounts ($630M total, $628M short-term) are accurate and correctly reflect the 2022 fair value distribution. However, the introduction of an unsupported 2.08% yield for 2022 is a critical error. There are no calculations required beyond recognition of trends, but the incorrect baseline yield distorts the progression analysis. (3) The multi-hop reasoning is partially sound: the model correctly identifies a shift from short-duration holdings in 2022 to higher yields in 2023 and a slight decline in 2024. It also attempts to contextualize the changes in terms of monetary policy (tightening environment, stabilization), which aligns with the ground truth's suggestion of market condition responses. However, the reasoning is built on a false premise (the 2.08% yield), leading to an inaccurate portrayal of the 'pivot' from low to high yield. The ground truth does not state that yields were low in 2022—only that maturities were short—so the claim of a strategic 'pivot' is speculative and not fully supported. (4) The contextual relevance is high because the answer addresses the evolution across years, discusses strategy, and links to market conditions. However, due to the incorrect 2022 yield and the resulting flawed narrative about yield progression, the overall correctness score is low. The qualitative accuracy is moderate because entity identification (American Express, Foreign Government Bonds, years) is correct, and the general direction of yield change (down from 2023 to 2024) is accurate, but the reasoning is compromised by the false data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 593,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In 2022 the 10‑K listed the 7% debentures together with common stock (“Common Stock, $.01 Par Value 7% Debentures due 2029”) in a single line of the Section 12(b) table【COP_10k_2022.pdf page_1】.  By 2023 the filing split the securities into two distinct rows—one for common stock and a separate row for the debentures with its own trading symbol (CUSIP‑718507BK1)【COP_10k_2023.pdf page_1】—and the 2024 filing continued that format, presenting the debentures as a separate entry【COP_10k_2024.pdf page_1】.  This evolution shows ConocoPhillips’ deliberate move toward clearer, more distinct disclosure of its debt instrument, enhancing transparency and aligning with regulatory expectations for investor information.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: in 2022, the 7% Debentures due 2029 were listed together with common stock in a single row in the Section 12(b) table; in 2023, they were split into a separate row with their own CUSIP (718507BK1); and in 2024, this separate presentation was maintained. (2) Quantitative elements—specifically the interest rate (7%), maturity year (2029), and CUSIP number (718507BK1)—are all correct and match the ground truth exactly. No calculations are required, but the temporal progression across 2022–2024 is accurately described. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifies the evolution in disclosure format, and infers the correct implication—increased transparency and clearer reporting. (4) The conclusion about ConocoPhillips’ move toward more distinct and transparent disclosure aligns perfectly with the original answer’s interpretation. The LLM adds contextual value by referencing regulatory expectations, which is a reasonable inference. All aspects of the question—presentation changes, year-by-year evolution, and implications—are addressed thoroughly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 356,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00 % Notes Due 2031 was $1,044 million at year‑end 2022, remained unchanged at $1,044 million at year‑end 2023, and rose modestly to $1,057 million at year‑end 2024 (2024 10‑K note, page 67; 2022 10‑K note, page 78). The incremental $13 million increase over two years reflects a disciplined, conservative debt‑management approach that keeps long‑term debt stable while adding new debt only as needed to support growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, NVIDIA's exposure was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM claims the carrying amount was $1,044 million in both 2022 and 2023, and only $1,057 million in 2024—contradicting the ground truth on all three years. The LLM underreports 2022 by $156 million, overreports 2023 by $13 million, and underreports 2024 by $193 million. These are material errors that severely undermine the answer’s reliability. (2) Calculations are also flawed: the LLM states a $13 million increase over two years, but the actual change from 2022 to 2024 is an increase of $250 million, not $13 million. The LLM appears to have misread or misextracted data, possibly confusing the 2023 and 2024 values or referencing the wrong debt instrument. (3) The multi-hop reasoning is partially sound in structure—comparing year-over-year changes to infer strategy—but fails due to incorrect inputs. The conclusion about a 'disciplined, conservative debt-management approach' contradicts the ground truth, which shows a volatile and increasing exposure, suggesting a more active long-term financing strategy. (4) Contextual relevance is high—the answer addresses the right question about debt evolution and strategy—but factual correctness is critically compromised. Quantitative accuracy is low due to major number mismatches; qualitative accuracy is slightly higher because the reasoning framework is appropriate, albeit based on wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 438,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney has kept Marvel as a core brand in its streaming strategy, with the 2023 10‑K describing Marvel as a top‑level tile on Disney+ (page 7).  The company’s balance‑sheet treatment has remained unchanged, with Marvel trademarks counted among its $1,792 million of indefinite‑lived intangible assets in both 2022 (page 110) and 2024 (page 114).  Thus, Disney’s positioning of Marvel has stayed consistent—prominent in Disney+ branding and protected as a key intangible asset—throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel's inclusion as an indefinite-lived intangible asset in 2022 and 2024 is accurately stated, with specific dollar value ($1,792 million) and correct page references. The 2023 branding of Marvel as a top-level tile on Disney+ is correctly identified with a page citation. (2) Quantitative accuracy is perfect: the figure of $1,792 million is correctly reported for both years, and no calculations are required beyond accurate reporting. Format variation (e.g., $1,792 million vs $1.792 billion) is acceptable and correctly presented. (3) Multi-hop reasoning is sound: the model synthesizes information across three fiscal years, connects Marvel’s financial treatment (intangible assets) with its strategic role in streaming, and draws a valid conclusion about consistent strategic positioning. (4) The only minor shortcoming is that the original answer explicitly names ESPN and Pixar as peer brands in the intangible assets category, which adds contextual richness; the LLM omits this detail but does not misrepresent anything. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction for minor incompleteness in qualitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 378,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "American Express has continued to recognize discount revenue at the time of each Card‑Member transaction, with network‑rate fees negotiated on a case‑by‑case basis with third‑party merchant acquirers and recorded as discount revenue (2022: page 104; 2023: page 103).  The 2024 filing does not alter this accounting treatment but underscores a heightened focus on expanding merchant coverage worldwide through partnerships with third‑party acquirers, aggregators and processors (2024: page 93).  Thus, while discount‑revenue recognition and fee‑negotiation practices remain unchanged, the company’s merchant‑coverage expansion strategy has intensified over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that American Express recognizes discount revenue at the time of transaction and that network rate fees are negotiated individually with third-party acquirers, consistent across 2022–2023. It accurately notes the continuity of accounting treatment into 2024 and highlights the intensified focus on merchant coverage expansion through third-party partners. However, it omits a key development from the original answer: the introduction of 'processed revenue' in 2023 from network partnership agreements, including royalties and fees for facilitating transactions on partner-issued cards. This is a significant addition to the revenue structure that the LLM answer fails to mention, weakening its completeness and qualitative accuracy. (2) There are no numerical values, percentages, or dollar amounts in either the question or answers, so quantitative accuracy is not compromised—no errors in dates or page references provided. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across the 2022–2024 filings regarding discount revenue recognition and merchant expansion, but it does not fully integrate the 2023 evolution involving processed revenue, indicating a gap in cross-year synthesis. (4) The contextual relevance is high because the answer addresses the core elements of revenue recognition, fee negotiation, and merchant coverage. However, the omission of the new 'processed revenue' stream—a critical evolution in revenue structure—prevents a higher correctness and qualitative score. The answer is factually accurate where it speaks but incomplete in covering the full scope of revenue structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 466,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "In the 2022 10‑K (p. 34) Amgen only noted that a subset of its products are used with drug‑delivery or companion diagnostic devices that carry regulatory and manufacturing risks and that third‑party collaborations could affect device development. By the 2023 filing (pp. 52‑54) the disclosure was expanded to detail the regulatory oversight of those devices, the requirement to monitor user complaints and adverse events, and the possibility of post‑marketing studies, inspections, warning letters or product withdrawal if device safety issues arise. The 2024 filing (pp. 50‑54) reiterated these points but added greater emphasis on the interdependence of device and drug approvals, the potential for device‑related safety reviews to delay or prevent product approvals, and the impact of post‑marketing requirements on clinical‑trial timelines and market availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Amgen's regulatory risk disclosures from 2022 to 2024, noting the progression from general device-related risks in 2022 to more detailed post-marketing and safety compliance concerns in 2023 and 2024. The inclusion of specific page numbers (e.g., 2022 p. 34, 2023 pp. 52–54, 2024 pp. 50–54) adds precision and matches typical 10-K disclosure locations. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years and document references (2022–2024) are correct and consistently applied. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the increasing granularity in disclosures around clinical trial dependencies (implied via post-marketing study requirements), post-marketing obligations, and device-related safety reviews. It accurately captures the heightened regulatory scrutiny, including potential warning letters, inspections, and product withdrawal. (4) While the ground truth specifically mentions LUMAKRAS and the Complete Response Letter as an example, the LLM omits this detail but still conveys the broader trend accurately. This minor omission prevents a perfect score but does not undermine the core correctness. The LLM emphasizes interdependence of drug and device approvals and the impact on clinical trial timelines, which reflects the same conceptual evolution. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only slight less specificity than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 454,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips expanded its HSE audit scope from a business‑unit‑only focus in 2022 to auditing both business units and staff groups by 2024 (page 18, 2024). The program added a formal improvement‑tracking mechanism that requires improvement actions to be tracked to completion (page 18, 2024). Governance reporting has remained consistent, with audit progress reported to the Executive Leadership Team and the Board of Directors (page 18, 2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) What was correct/incorrect: The LLM correctly identifies that HSE audits cover both business units and staff groups, and that improvement actions are tracked to completion, with reporting to the Executive Leadership Team and Board of Directors. However, it misrepresents the evolution timeline. It claims the scope expanded from 'business-unit-only' in 2022 to include staff groups by 2024, but the original answer states that in 2022 audits already included both business units and staff groups. Thus, the claimed expansion is factually incorrect. Additionally, the LLM implies that the improvement-tracking mechanism was newly formalized by 2024, but the ground truth states tracking to completion was already in place in 2022. The governance reporting structure is accurately described as consistent across years. (2) Specific number/calculation verification: There are no numerical values or calculations in this question, so quantitative accuracy is not applicable beyond correct referencing of years (2022–2024), which the LLM handles correctly. (3) Multi-hop reasoning assessment: The LLM fails in multi-hop synthesis. It does not capture the nuanced evolution from a conformance-focused framework (2022), to integration with broader safety systems like Life Saving Rules and Process Safety Fundamentals (2023), to corporate-level standardization with 'Corporate HSE audits' (2024). These key qualitative shifts are omitted, and instead, the LLM fabricates a scope expansion that did not occur. The reasoning is therefore flawed and lacks depth. (4) Justification for scores: Correctness is scored 5 due to significant factual errors in the evolution narrative despite some correct elements. Quantitative accuracy is 10 because all dates and references are factually aligned. Qualitative accuracy is 5 due to incorrect reasoning and failure to reflect the actual progression of the program. Contextual relevance is 8 because the answer addresses the right topic areas (scope, tracking, governance) and is relevant, though with inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 554,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Accenture’s 2022 10‑K explicitly warned that cloud‑ and AI‑driven services were changing how the firm earns revenue and that it must “introduce new pricing or commercial models that reflect the value of these technological developments” or risk revenue shortfalls (pages 18‑22).  The 2023 and 2024 filings echo this point, noting that failure to adapt pricing to rapid technology changes could materially affect client demand and results (page 21).  Across all three years the same risks recur: client spending delays and revenue loss if pricing lags, regulatory compliance costs for AI and data handling, and cybersecurity threats that could undermine the delivery of new AI‑enabled services (pages 23‑24).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Accenture's concern across 2022–2024 about introducing new pricing models to reflect technological developments like AI and cloud, and correctly notes the recurring risk of revenue shortfalls due to delayed adoption or slow pricing model deployment. However, it introduces risks not consistently highlighted in the ground truth—specifically regulatory compliance costs for AI/data handling and cybersecurity threats—as recurring cross-year risks related to pricing model adoption. The ground truth emphasizes only the risk of failing to introduce value-reflective pricing models quickly enough and insufficient client adoption as consistent risks; cybersecurity and regulatory issues, while possibly mentioned in filings, are not framed as consistent pricing-related risks in the original answer. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the LLM correctly traces Accenture’s evolving emphasis on pricing models across years, citing 2022 as a year of acknowledgment and later years as continued emphasis. However, it fails to capture the evolution in Accenture’s approach—specifically the shift toward strategic investments in AI and robotics by 2023 and significant deployment efforts by 2024. Instead, it treats the evolution as a static repetition of the same warning, missing the progression in strategic depth. (4) Contextual relevance is high because the answer addresses the core theme of pricing model evolution and associated risks, but the inclusion of extraneous risks and omission of key strategic developments reduce qualitative accuracy and overall correctness. Thus, the correctness score is 6—partially correct but with significant omissions and some factual misalignment in risk characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 514,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior‑note holdings rose from $900 million at year‑end 2022 to $944 million in 2023 and $982 million in 2024 [page_70]. In 2023 GE sold its remaining AerCap equity shares, leaving only the senior note as its AerCap exposure [page_73]. This progression reflects a deliberate shift from equity to debt exposure, indicating GE is pursuing a more income‑focused, lower‑risk investment strategy in AerCap.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for year-end 2021) to $944 million (reported in 2024 for year-end 2023). However, the LLM claims holdings *increased* from $900 million in 2022 to $944 million in 2023 and further to $982 million in 2024—this is directly contradictory. The starting value ($900M vs $993M), direction of change (increase vs decrease), and final value ($982M vs $944M) are all incorrect. (2) Quantitative accuracy is severely compromised: the numbers do not match the ground truth, and the trend is reversed. Even allowing for format variations, the values are factually wrong. The claim of $982 million in 2024 has no support in the ground truth, which reports $944 million as the latest figure. (3) The reasoning is flawed: while the LLM correctly notes that GE sold its equity stake in AerCap, it incorrectly infers a strategic shift to debt with increasing note holdings. The actual data shows a *reduction* in note holdings, suggesting a wind-down, not a strategic pivot to debt. The multi-hop synthesis fails because it misrepresents the financial data over time. (4) Contextual relevance is moderate—the answer addresses GE’s investment strategy and AerCap exposure, and correctly identifies the shift from equity to debt. However, due to incorrect numbers and misinterpretation of the trend, the conclusion about strategy is unsupported. The inclusion of citation-like tags ([page_70], [page_73]) suggests document grounding but does not compensate for factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 448,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen kept Bemarituzumab in the same development stage throughout 2022‑2024: it remained a Phase 3 program for gastro‑esophageal junction (GEJ) adenocarcinoma, with Phase 2 for other solid tumors and Phase 1 for NSCLC (2022 page 25; 2023 page 24; 2024 page 24).  The composition‑of‑matter patents issued in the U.S. and Europe continue to be estimated to expire in 2029, with no change in the IP timeline (2022 page 26; 2023 page 26; 2024 page 26).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in terms of quantitative accuracy, correctly stating that the U.S. and European patent expiration for Bemarituzumab is estimated at 2029 across all years (2022–2024), which matches the ground truth. This aspect is factually accurate and consistent with the original answer. However, the LLM incorrectly claims that Bemarituzumab remained in the same development stage throughout 2022–2024, stating it was in Phase 3 for GEJ adenocarcinoma and Phase 2/1 for other indications. This contradicts the ground truth, which indicates a clear evolution: in 2022 it was in Phase 3 for GEJ adenocarcinoma, but by 2024 Amgen expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC, reflecting a broader therapeutic positioning. The LLM fails to capture this progression and instead asserts no change in development stage, which is a significant factual error. Additionally, the original answer highlights a strategic shift from clinical development focus to broader IP and therapeutic positioning, which the LLM omits entirely. While the patent expiration timeline is correctly reported (supporting a quantitative accuracy score of 8), the qualitative inaccuracies in reasoning and entity progression—particularly the failure to recognize multi-hop evolution across years—warrant lower scores in qualitative accuracy (4) and overall correctness (4). The response is contextually relevant and addresses the question's domains (clinical phase, IP), but with incorrect synthesis of change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 434,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "From 2022 to 2024 American Express has shifted from a broad acknowledgment of fintech competition to a risk‑based, technology‑centric stance.  In the 2022 10‑K (pp. 12‑13) the company noted the rapid rise of alternative payment mechanisms—payment facilitators, digital wallets, buy‑now‑pay‑later, etc.—and the need for “speed of innovation and investment in systems, technologies and product and service offerings.”  By the 2024 10‑K (pp. 29‑31) it explicitly frames fintech disruption as a material risk, citing merchant discount‑rate erosion from merchants building their own payment solutions and listing concrete technology priorities (AI/ML, tokenization, real‑time settlement, open banking) that must be pursued to preserve card volumes and merchant acceptance.  This evolution signals a long‑term strategy of proactive, sustained technology investment and partnership development to counter the competitive threat posed by fintech.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's strategic positioning from 2022 to 2024. It correctly identifies the growing competitive pressure from alternative payment mechanisms in 2022, including digital wallets, buy-now-pay-later, and payment facilitators, and notes the company's emphasis on innovation and investment. By 2024, it accurately reflects the shift in framing fintech disruption as a material risk, with specific mention of merchant discount-rate erosion and the strategic importance of technologies like AI/ML, tokenization, real-time settlement, and open banking—aligning closely with the ground truth. The answer conveys a proactive, investment-driven response to fintech disruption, which matches the original answer’s conclusion about a long-term strategy of technology investment and partnership. The only minor shortcoming is that the LLM answer does not explicitly mention the 2023 expansion to include open banking and payment facilitators as newly emphasized threats, slightly reducing completeness in the year-by-year synthesis. However, open banking is mentioned in the 2024 context, suggesting implicit awareness. All entities (American Express, fintech, payment mechanisms), years (2022, 2024), and technological priorities are correctly identified. No numerical inaccuracies are present—dates and page references are consistent with source documentation. The reasoning is sound, showing a logical progression from competitive awareness to strategic response. The answer is semantically equivalent to the ground truth in overall message and strategic interpretation, earning a high correctness score with only a slight deduction for incomplete 2023 coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 469,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted‑average grant‑date fair value of cash‑settled PSUs rose from **$91.58 million in 2022 to $112.50 million in 2023** and then fell modestly to **$110.39 million in 2024** (2024 “Granted” row). The sharp jump in 2023 reflects a higher expected cost—likely due to stronger stock‑price assumptions or more ambitious performance targets—while the slight decline in 2024 indicates a modest recalibration of the program. Overall, the trend shows ConocoPhillips maintaining a competitive, high‑value long‑term incentive plan while fine‑tuning it to align with market conditions and performance expectations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. The ground truth states the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, with no data point provided for 2023. However, the LLM incorrectly reports $112.50 million in 2023 and introduces a figure of $110.39 million in 2024 not present in the ground truth. Additionally, the LLM adds 'million' to the values, turning $91.58 into $91.58 million, which is a critical quantitative error—these are per-unit fair values, not total dollar amounts. (2) The calculation and trend analysis are therefore invalid: the LLM claims a rise to $112.50 million in 2023 and a drop to $110.39 million in 2024, whereas the correct trend is a steady increase to $112.50 by 2024. The model misrepresents both the magnitude and direction of the trend in the final year. (3) The multi-hop reasoning is flawed—while the LLM attempts to interpret the trend (e.g., linking higher values to performance targets), it does so on incorrect data. The conclusion about a 'modest recalibration' in 2024 contradicts the ground truth's indication of a consistent upward trend and stable structure. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of PSU values and attempting to infer strategic implications. The qualitative reasoning framework—linking fair value changes to incentive strategy—is sound in approach but based on inaccurate inputs, limiting its validity. Hence, low scores for quantitative and overall correctness, moderate for qualitative reasoning, and relatively high for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 450,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "From 2022 through 2024 PayPal’s 10‑K filings consistently warned that its expanding credit‑product line and reliance on third‑party lenders had increased exposure to abusive behaviors and fraud.  The company noted that fraud‑detection measures are complex and may not fully prevent new schemes, and that its proprietary credit‑risk models can mis‑predict default risk, while the risk of regulatory fines and partner‑bank interruptions has grown.  This steady‑state of heightened risk suggests that PayPal’s risk‑management effectiveness has not yet kept pace with the growth of its credit and payment‑service offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall trend and key concerns around PayPal's exposure to abusive behaviors and fraud from 2022 to 2024. It correctly identifies the growing risk associated with credit products and third-party fraud, as well as the complexity of detection and limitations of risk models. The answer also appropriately notes regulatory and operational risks, aligning with the original answer's mention of regulatory uncertainties like the 'valid-when-made doctrine.' However, it omits specific, critical details present in the ground truth: (1) the €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023, which is a key strategic mitigation action; and (2) the geographic specificity (U.K. and Europe) of the credit product expansion and risk transfer. While the LLM captures the general theme of increasing risk and insufficient risk management response, it fails to synthesize the multi-hop detail about PayPal’s concrete risk-mitigation strategy through third-party receivables sales. There are no numerical inaccuracies—no numbers are misstated or miscalculated (quantitative accuracy is perfect). The reasoning is sound but incomplete, lacking the full synthesis of strategic actions taken. The answer remains contextually relevant and addresses the core question about risk evolution and management effectiveness, but with less precision and completeness in the supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 407,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "Cyramza’s therapeutic positioning has stayed essentially the same from 2022 through 2024, continuing to be sold as monotherapy or in combination for second‑line gastric, NSCLC, colorectal, and hepatocellular carcinoma and first‑line EGFR‑mutated NSCLC (2022/2024 product lists)【page_5】【page_5】.  Its intellectual‑property profile has also remained stable, with compound patents set to expire 2026 (U.S.), 2028 (Europe), 2026 (Japan) and data‑protection ending 2026 (U.S.), 2024 (Europe), 2023 (Japan) (2023/2024 IP tables)【page_11】【page_12】.  The persistence of a broad indication slate coupled with robust, long‑term patent and data protection indicates Lilly’s long‑term oncology strategy of building a multi‑indication portfolio that relies on strong IP to secure revenue streams while pursuing biomarker‑driven expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cyramza's consistent therapeutic positioning across 2022–2024 in gastric, NSCLC, colorectal, and hepatocellular cancers, aligning with the ground truth. However, there are discrepancies in intellectual property dates: the ground truth states data protection expired as early as 2023 in Japan, while the LLM claims it ends in 2023 (correct) but also states U.S. data protection ends in 2026 and Europe in 2024—details not present in the original answer and potentially inaccurate or unverified. Compound patent expiry in the U.S. and Japan is correctly cited as 2026, but the LLM adds a European expiry of 2028, which is absent from the ground truth and constitutes an unsupported addition. (2) Quantitative accuracy is partially compromised: while some dates match (2023 Japan data protection expiry, 2026 U.S./Japan patents), the inclusion of European IP timelines (2028 patent, 2024 data protection) introduces unverified data not in the original, reducing factual precision. (3) The multi-hop reasoning is sound—LLM synthesizes therapeutic positioning and IP trends across years and infers strategic intent. It correctly links stable indications and IP to long-term strategy, though it overstates the strength and duration of data protection. (4) The conclusion about Eli Lilly’s strategy is reasonable but differs slightly: the ground truth suggests Cyramza is being maintained while next-gen products are prepared due to impending patent expiry, implying transition; the LLM emphasizes 'robust, long-term IP' and 'revenue security,' which is less aligned with the caution implied in the original. Still, both recognize a strategic portfolio approach. Wording differences are acceptable, but added IP dates reduce quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 486,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From 2022‑2024 PMI kept the 3.875% Notes due 2042 on its balance sheet while actively issuing and refinancing other debt to manage liquidity and interest costs.  In 2022 the company issued 2.375% and 2.500% Notes due 2022, 2.625% Notes due 2023, and 2.875% Notes due 2024; in 2023 it added 2.750% Notes due 2025, 3.375% Notes due 2025, 4.375% Notes due 2041, 4.500% Notes due 2042, and the 3.875% Notes due 2042; and in 2024 it continued to issue 2.875% and 3.250% Notes due 2024, 2.750% Notes due 2025, 3.375% Notes due 2025, 4.375% Notes due 2041, 4.500% Notes due 2042, and the 3.875% Notes due 2042.  This pattern shows a strategy of maintaining a long‑term, fixed‑rate instrument while using shorter‑term or higher‑coupon notes to refinance maturing debt and optimize the debt mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims PMI issued multiple short-term notes (e.g., 2.375% Notes due 2022, 2.625% due 2023, etc.) and repeated issuances in 2023 and 2024, which contradicts the ground truth. The original answer states that the 3.875% Notes due 2042 were consistently present, while the 4.125% and 4.875% Notes due 2043 (in 2022) and 4.250% Notes due 2044 (in 2023) were later retired by 2024. The LLM instead fabricates numerous short-term instruments (e.g., due 2022–2025) and omits the actual long-term tranches mentioned in the ground truth. (2) Quantitative accuracy is very low: none of the percentages or maturities cited (e.g., 2.375%, 2.500%, 2.625%, 2.750%, 2.875%, 3.250%, 3.375%, 4.375%, 4.500%) match the ground truth, which only references 3.875%, 4.125%, 4.875%, and 4.250% Notes. The LLM also incorrectly implies ongoing issuance of the 3.875% Notes in 2023 and 2024, when it was already issued and simply remained on the balance sheet. (3) Multi-hop reasoning is flawed: the LLM identifies a plausible strategy (maintaining long-term debt while managing short-term), but bases it on fabricated data. The actual evolution—phasing out 2043/2044 tranches and not replacing them—indicates stabilization, which the LLM misses entirely. (4) Contextual relevance is moderate because the answer addresses capital structure evolution and debt management, but the incorrect data undermines the conclusion. The core insight about maintaining the 3.875% Notes is correct, but the supporting evidence is false, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 442,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s 2022 risk‑factor disclosures underscored a growing exposure to abusive behavior, especially as its credit‑product portfolio and reliance on third‑party lenders and processors expanded (pages 24–25).  In 2023 the company reduced that exposure by selling a large portion of its U.K. and European buy‑now‑pay‑later loan receivables and initiating a forward‑flow sale of future originations (page 23).  In 2024 it further mitigated risk by diversifying its reliance on a small number of third‑party payment processors and migrating its U.S. arrangements to new processors as part of a wind‑down transition (page 21).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PayPal's growing exposure to abusive behaviors in 2022, particularly in credit products and third-party relationships, aligning with the ground truth. It accurately notes the 2023 action of selling U.K. and European BNPL loan receivables, though it omits the specific €40 billion figure mentioned in the original answer. The 2024 mitigation strategy is partially correct—while the LLM mentions diversifying away from third-party processors and migrating U.S. arrangements, this detail is not present in the ground truth, which instead emphasizes improved detection mechanisms and fraud prevention infrastructure. Thus, the 2024 response is factually plausible but diverges from the documented actions in the original answer. (2) Quantitatively, the LLM fails to include the €40 billion amount from the 2023 asset sale, a key metric in the ground truth. While the absence of a number isn't always fatal, this omission reduces precision, especially since the original answer highlights it as a 'multi-year agreement to sell up to €40 billion.' No incorrect numbers are stated, so the score remains moderate to high. (3) The multi-hop reasoning is generally sound—linking 2022 risk identification to 2023 risk transfer via asset sales shows good synthesis. However, the 2024 claim about processor migration and wind-down, while contextually relevant to third-party risk, does not match the original answer’s focus on enhanced fraud detection and international expansion challenges. This suggests possible conflation with another risk management initiative not emphasized in the ground truth. (4) The contextual relevance is high because the answer addresses all years and the core theme of abusive behavior and third-party risk. The qualitative accuracy is reduced due to the substitution of a different 2024 action instead of the correct emphasis on detection improvements. Overall, the answer captures the trajectory but misses key specifics in 2024 and underreports quantitative detail in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 550,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 10‑K filings for 2022 (page 37), 2023 (page 39) and 2024 (page 41) all list the risk of “loss or modification of exemptions for taxes and tariffs” as a political‑legal‑economic risk.  The wording and emphasis have not changed over the three years, indicating that the exposure has persisted rather than diminished.  This steady, unchanged mention signals that regulatory uncertainty in AMD’s global operations remains high—and may be intensifying amid shifting trade policies, sanctions and geopolitical tensions.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core reasoning and contradicts the ground truth. While it correctly identifies that AMD mentioned the risk of loss or modification of tax and tariff exemptions in its 10-K filings across 2022, 2023, and 2024 (and cites plausible page numbers), it claims the 'wording and emphasis have not changed'—this directly conflicts with the ground truth, which shows a clear escalation in emphasis and integration of the risk with geopolitical and regulatory concerns. In 2022, the risk was one among several; by 2023, it was highlighted more prominently alongside critical risks; and in 2024, it was explicitly linked to geopolitical conflicts, indicating increasing concern. The LLM’s conclusion that the 'exposure has persisted rather than diminished' and that 'the mention signals... uncertainty remains high' misses the trend of escalating emphasis and fails to capture the evolving nature of the risk as presented in the original answer. This represents a failure in multi-hop qualitative reasoning: the model did not synthesize the changing context and severity of the risk over time. Quantitative accuracy is perfect—no numbers, dates, or entities are incorrect (the years and risk description are accurate). Contextual relevance is high because the answer addresses the right topic and timeframe, but the reasoning is flawed. Thus, while the answer appears plausible and uses correct entities and years, it misrepresents the evolution of AMD's risk disclosure, leading to an incorrect interpretation of increasing regulatory uncertainty as static rather than intensifying.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 440,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco reported a $92 million loss from total‑return swaps tied to deferred compensation in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024 (all figures in millions, from the “Operating expenses and other” column of the derivatives‑not‑designated‑as‑hedges table – pages 91 and 92). This shift from a negative to a positive impact shows that Cisco’s use of these swaps has become more effective at offsetting compensation‑expense volatility, indicating an active hedging strategy to manage deferred‑compensation exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024, matching the ground truth exactly. Number formats are consistent and acceptable (e.g., $92 million vs $92 million). (2) Quantitative accuracy is perfect—no calculation errors, and the progression of gains/losses is accurately represented. (3) The multi-hop reasoning is sound: the model correctly infers that the shift from loss to increasing gains reflects improved effectiveness in hedging deferred compensation liabilities. While the original answer emphasizes 'reversal in exposure or performance' and 'improved market conditions or strategic shift,' the LLM focuses on 'more effective at offsetting compensation-expense volatility' and 'active hedging strategy,' which is semantically aligned and logically valid. (4) The answer is fully contextually relevant, addressing both the evolution of gains/losses and the implied strategic direction. The only minor difference is in framing—the LLM emphasizes effectiveness and active management slightly more than the original, but this does not detract from factual or qualitative accuracy. No critical information is omitted. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slightly narrower interpretation of implications, but full marks in quantitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 400,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From fiscal 2022 to 2024 Disney shifted its DTC strategy from a single ad‑supported Disney+ launch and cost‑realignment plan to a multi‑service, reorganized media‑and‑entertainment model that added ESPN+ and a Star India joint‑venture while tightening content curation and removing under‑performing titles.  This evolution has driven a steep rise in content and marketing spend—projected at roughly $24 billion in 2025—alongside goodwill and intangible‑asset impairments and a series of debt‑rating downgrades that raise borrowing costs.  The trajectory shows that scaling streaming services demands large upfront investment, aggressive subscriber and ad‑revenue targets, and intense price‑sensitive competition, all of which amplify financial risk and pressure on profitability.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported details not present in the ground truth. While it correctly identifies a strategic evolution in Disney's DTC offerings from 2022 to 2024, it fabricates specific elements such as a 'multi-service, reorganized media-and-entertainment model that added ESPN+ and a Star India joint-venture' during this period—ESPN+ was launched well before 2022, and there is no mention in the ground truth of a new joint venture in this timeframe. The claim of $24 billion in projected spending for 2025 is not supported by the original answer and introduces a forward-looking figure not present in the source. (2) Quantitative accuracy is low: the $24 billion projection, debt-rating downgrades, and goodwill impairments are not mentioned in the ground truth and appear to be hallucinated. There are no numbers in the original answer to validate against, but the introduction of precise financial figures without basis undermines factual reliability. (3) The multi-hop reasoning is partially sound—there is an attempt to trace strategic evolution and link it to financial risk and market pressure—but the synthesis is flawed due to incorrect inputs. The core idea that scaling DTC involves high investment and financial risk aligns with the original, but the reasoning is built on speculative rather than documented developments. (4) Contextual relevance is high because the answer addresses the strategic shift, financial risks, and market pressures as required. However, correctness is limited by significant factual overreach and unsupported claims, warranting a mid-low score overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 455,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged through 2022‑2024.  In each year’s revenue note (2022 page 78, 2023 page 77, 2024 page 76) the company states it has full discretion in setting transaction fees, independent of the costs it incurs from payment processors, and therefore bears full margin risk.  The fees paid to payment processors are consistently recorded as transaction expense, with no material change in the nature of that exposure over the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that PayPal bore full margin risk across 2022–2024, with consistent discretion in setting transaction fees independent of processor costs—this aligns exactly with the original answer. (2) The LLM references specific page numbers (2022 p.78, 2023 p.77, 2024 p.76) from the revenue notes, which supports its claims and matches the consistent disclosure pattern in the filings. While the original answer does not include page numbers, their inclusion in the LLM response enhances precision without introducing error. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, confirms no material change in accounting treatment or risk exposure, and correctly identifies the consistent classification of processor fees as transaction expenses. (4) The mention of stable accounting treatment despite ASU 2023-07 in 2024 is implied in the LLM answer through the statement of 'no material change,' which is consistent with the original answer’s conclusion. All entities (PayPal, payment processors, transaction expenses), time periods (2022–2024), and financial concepts (margin risk, fee discretion, expense recognition) are accurately identified and logically connected. No factual inaccuracies, omissions, or reasoning flaws are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 380,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s Aerospace risk factor in each filing (2022 page 31, 2023 page 31, 2024 page 31) consistently warned that downturns in air‑travel demand could delay or cancel new aircraft orders.  The unchanged wording shows that the cancellation risk has remained a persistent concern, even as the company’s financials improved—net sales rose from $5.996 bn in 2022 to $6.425 bn in 2024 and segment profit grew from $1.555 bn to $1.522 bn—indicating a gradual recovery and increasing stability in the commercial aviation sector.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant qualitative inaccuracies in reasoning and incomplete synthesis of the evolution of risk factors, which is central to the question. (1) Quantitatively, the financial figures provided—net sales of $5.996B in 2022 and $6.425B in 2024, and segment profit of $1.555B in 2022 and $1.522B in 2024—are accurate and correctly reflect growth trends, earning a high quantitative accuracy score. Minor note: segment profit slightly decreased in 2024, which the model acknowledges but does not interpret correctly in context. (2) However, the LLM incorrectly claims that the 'unchanged wording' across filings indicates persistent risk, while the ground truth shows a clear evolution in the nature of the risk—from pandemic-related concerns in 2022 to broader geopolitical, environmental, and competitive factors in 2023 and 2024. This misrepresents the qualitative progression and fails to capture the shift in risk drivers, which is a key part of the question. (3) The multi-hop reasoning is flawed: the model fails to synthesize how the *nature* of the risk evolved across years, instead asserting static language when the original answer emphasizes changing emphasis (e.g., from health restrictions to regional conflicts and new market entrants). This undermines the qualitative accuracy. (4) Contextually, the answer is relevant and addresses the commercial aviation recovery, linking financial improvement to stability, but incorrectly infers increasing stability from unchanged risk language and improving financials, while the ground truth suggests ongoing fragility despite recovery. Thus, while some facts are correct, the interpretation and synthesis are significantly off, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 479,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 to 2024 PMI’s risk disclosures show a progressive tightening of regulatory constraints that increasingly curtail product differentiation and adult‑consumer communication for both its Reduced‑Risk Products (RRPs) and Smoke‑Free Products (SFPs). In 2022 the company warned that advertising bans, packaging rules and product‑classification challenges could commoditize its offerings and impede conversion to RRPs (see pages 13‑17). By 2023 and 2024 the risk language expanded to include SFPs, citing stricter advertising restrictions, corporate‑communication limits and scientific‑substantiation requirements that further erode branding and truthful information access (see pages 18‑22 and 17‑21), underscoring an intensifying regulatory environment that threatens PMI’s competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of regulatory constraints on PMI from 2022 to 2024, specifically highlighting increasing restrictions on product differentiation and adult consumer communication for RRPs and SFPs. The core facts—regulatory tightening, impact on truthful information access, and competitive positioning—are all correct. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not applicable; however, the years (2022, 2023, 2024) are correctly used and referenced in context. (3) The multi-hop reasoning is sound: the LLM synthesizes how regulatory language evolved across years and product categories, noting the expansion from RRPs to include SFPs by 2023–2024. It accurately captures the intensifying regulatory environment and its impact on branding and communication. One minor omission is that the LLM does not explicitly mention the 'disproportionate impact relative to competitors' or 'digital media spreading misleading information' in 2023, which are key nuances in the original answer. Also, while it references 'pages 13–17', etc., these page numbers are not in the ground truth and appear to be fabricated or extraneous, though they don’t undermine factual correctness. (4) Despite these small gaps, the LLM conveys the same overall meaning and trajectory as the original answer, with strong contextual relevance and semantic equivalence. The strategic shift from RRPs to SFPs is implied through the expanded risk language, even if not stated as explicitly. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 484,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s margin‑risk exposure has remained essentially unchanged from 2022 through 2024.  In each year the company continues to act as the principal in payment transactions, setting a volume‑based tiered fee schedule (2022 p. 80; 2023 p. 75; 2024 p. 77) and bearing full margin risk while treating processor fees as transaction expense.  Incentives—discounts, rebates, rewards and coupons—have persisted as a revenue‑reduction factor (2022 p. 80; 2024 p. 77) but have not materially altered the pricing model or the company’s exposure to margin risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that PayPal bears full margin risk across all three years (2022–2024), treats processor fees as transaction expenses, and recognizes incentives as a reduction of revenue—key facts present in the original answer. The mention of tiered fee schedules and page references (e.g., 2022 p. 80, 2023 p. 75, 2024 p. 77) adds precision and supports the claim of consistent pricing models. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all references to years and document pages are consistent and plausible. (3) The multi-hop reasoning is sound: the model synthesizes information across three years, connects margin risk to transaction pricing, processor costs, and customer incentives, and correctly infers that the exposure has remained stable despite more detailed disclosures. The only minor shortcoming is that the LLM answer does not explicitly note the 2023 addition of details about amortization of incentives over contractual terms or performance targets—information included in the original answer. This omission slightly reduces completeness but does not distort the overall meaning. (4) The answer is fully relevant, directly addressing all components of the question: evolution of margin risk, transaction pricing, use of processors, and incentives. Wording differs but semantic equivalence is maintained. The conclusion that incentives have not 'materially altered' the model is a reasonable interpretation of the stable risk exposure. Score deductions are minimal: full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9 overall due to the slight lack of nuance around 2023 incentive accounting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 498,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s approach to AIB manufacturers stayed essentially the same from 2022 through 2024: it continues to supply component‑level graphics and chipset products while its agreements protect AIB inventory from price cuts (2022 page_11; 2023 page_11; 2024 page_11). The company also kept selling directly to some system integrators and reiterated that SIs use discrete graphics solutions to differentiate and add value to their products (2022 page_11; 2023 page_11; 2024 page_11). No substantive changes in inventory‑protection policy or the role of discrete graphics for SIs were noted across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of quantitative and entity accuracy: it correctly identifies AMD's consistent inventory protection policy for AIB manufacturers from 2022 to 2024, the role of discrete graphics in differentiation for system integrators (SIs), and cites the correct page (11) across all years. There are no numeric inaccuracies, and the entities (AMD, AIB manufacturers, SIs) and timeframes (2022–2024) are correctly referenced. However, the LLM misses a key qualitative evolution noted in the original answer: while the inventory protection policy remained, there was a subtle but meaningful shift in AMD’s strategic emphasis by 2024 toward deeper alignment with SIs who integrate AIB products into differentiated offerings. The original answer highlights a nuanced evolution—increased emphasis on SIs leveraging regional or product strengths and responding to new tech—suggesting a maturing ecosystem role for AIBs. The LLM incorrectly concludes 'no substantive changes,' which contradicts the ground truth’s assertion of a strategic shift in language and focus. This reflects a failure in multi-hop reasoning to detect and convey evolving strategic intent across years, despite stable policies. Thus, while factually sound on surface-level consistency, the LLM lacks depth in capturing strategic evolution, reducing qualitative accuracy. Contextual relevance remains high as all parts of the question are addressed, albeit with oversimplification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 411,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney has consistently limited derivative counterparties to those with an A‑ or better rating and has avoided balances with below‑investment‑grade institutions (2022 filing, pages 109‑113).  In fiscal 2024 the company added a collateral trigger—requiring collateral when a counterparty’s rating falls below A‑ or when aggregate exposures exceed contractual limits—while keeping a 10 % concentration threshold; the company’s actual concentration was zero in fiscal 2023 and rose to 24 % of cash and cash equivalents in fiscal 2024 (pages 120 and 119).  No collateral requirement is noted in the 2022 filing, and the concentration threshold was not explicitly disclosed but implied to be 10 % across the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Disney's consistent use of A- or better credit rating requirements for counterparties and accurately reports the 24% concentration of cash and cash equivalents in fiscal 2024, matching the ground truth. However, it incorrectly states that the collateral trigger was 'added' in fiscal 2024, while the original answer indicates this requirement was already in place in fiscal 2022. This misrepresents the evolution of the policy. Additionally, the claim that 'no collateral requirement is noted in the 2022 filing' contradicts the ground truth, which states the policy was consistent across all years. The 10% concentration threshold is not mentioned in the original answer and appears to be an unsupported inference. (2) Quantitatively, the 24% concentration figure and fiscal years (2022–2024) are correct. The zero concentration in 2023 is not in the ground truth (which only mentions 'no such concentration in 2022'), making that detail potentially inaccurate. (3) The multi-hop reasoning is partially sound—linking credit ratings, collateral, and concentration—but incorrectly infers a policy change in collateral requirements when none is stated. The synthesis across years is flawed due to this mischaracterization. (4) Scores reflect high factual accuracy on key numbers and relevance to the question, but deductions are made for incorrect claims about policy evolution and unsupported details about thresholds and collateral changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 411,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s exposure to the 2029‑maturing Fixed‑rate 2.850% notes remained unchanged at $1.5 billion in 2022, 2023, and 2024 (the notes table lists $1,500 million for the 2029 maturity in each year)【page_107】【page_104】【page_108】. This steady exposure indicates a deliberate, disciplined long‑term debt strategy that prioritizes predictable maturity and interest‑rate profiles, rather than frequent refinancing or restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained constant at $1,500 million (or $1.5 billion) across 2022, 2023, and 2024, which matches the ground truth exactly. All numeric values—amount ($1,500 million), interest rate (2.850%), maturity year (2029), and time period (2022–2024)—are accurate. (2) Quantitative accuracy is perfect: the dollar amount is correctly reported with acceptable format variation ($1.5 billion = $1,500 million), and no calculations were required beyond recognition of consistency over time. (3) The reasoning is sound and captures the core implication—that stable exposure suggests a strategic choice to maintain predictable debt terms. However, the LLM answer omits a key detail from the original: that PayPal issued new debt in 2023 and 2024, including higher-interest notes (e.g., 5.150% and 5.500%), yet still retained the 2.850% notes. This omission slightly weakens the qualitative depth of the multi-hop synthesis, as it misses reinforcing the contrast that underscores the strategic intent. (4) Despite this minor omission, the answer remains factually correct, contextually relevant, and semantically aligned with the ground truth. The conclusion about disciplined debt management is reasonable, though slightly less nuanced than the original. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9 overall for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 413,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s 2022 risk‑factor disclosure flagged raw‑material demand and supply risk as a key concern for its Performance Materials and Technologies segment, noting that 63 % of the supply base was under contract (page 32, 2022). The 2023 disclosure was unchanged, but contract coverage rose slightly to 64 % (page 30, 2023). The 2024 risk‑factor text is identical, again highlighting raw‑material demand and supply risk, and no significant change in contract coverage is reported (page 32, 2024). This consistency—coupled with only a marginal increase in contract coverage—indicates that the segment remains materially exposed to commodity price volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, the claimed percentages of supply base under contract (63% in 2022, 64% in 2023) are not present in the ground truth and cannot be verified from the provided original answer; these specific figures appear to be hallucinated or sourced from outside the knowledge graph. There is no mention of contract coverage in the original answer, making this a critical quantitative error. Second, the LLM states that the 2024 risk-factor text is 'identical' and that 'no significant change in contract coverage is reported,' but the original answer notes a rebranding of the segment to 'Energy and Sustainability Solutions' in 2024 and a shift in risk framing toward production capacity and downtime—key qualitative changes that the LLM overlooks. While the LLM correctly identifies that raw material demand and supply risks were consistently mentioned across years and infers ongoing vulnerability to commodity volatility, it fails to capture the evolving context (e.g., oil and gas price impacts in 2023, operational focus in 2024) and misrepresents the nature of the disclosures. The reasoning is partially sound in drawing conclusions about sustained exposure, but the reliance on unverified numerical data and omission of rebranding and shifting risk emphasis breaks the multi-hop synthesis required. The answer is contextually relevant to the question and addresses the general trend, but the inclusion of unsupported metrics severely compromises factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 424,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "PMI’s peer group list remained unchanged from 2022 through 2024, with Imperial Brands PLC consistently included (see the 2022 peer‑group list on page 21 and the identical 2023‑ and 2024‑year lists on page 26). This stability shows that PMI benchmarks its performance against a fixed set of large, globally‑present consumer‑product firms—including major tobacco peers—rather than shifting its peer set as its portfolio evolves. The approach underscores PMI’s strategy of measuring progress against a broad, comparable cohort that reflects both its core tobacco business and its expanding smoke‑free and other consumer‑product lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Imperial Brands PLC was consistently included in PM's (PMI's) peer group from 2022 to 2024, which matches the original answer's claim of stable inclusion. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the assertion of consistency across all three years is quantitatively sound. (3) The multi-hop reasoning is solid: the model correctly infers that consistent inclusion reflects a stable benchmarking strategy, and it appropriately expands on this by linking the strategy to PMI’s broader performance measurement against global consumer-product firms, including both tobacco and smoke-free segments. This goes slightly beyond the original answer but remains logically supported and relevant. (4) The only minor deviation is that the LLM refers to PMI’s broader consumer-product benchmarking (including smoke-free lines), which adds interpretive depth not explicitly in the ground truth, but does not contradict it and is contextually reasonable. Wording differs but semantic equivalence is maintained. All entities—Imperial Brands PLC, PMI, and the three-year period—are correctly identified. The answer fully addresses both parts of the question: the trajectory (stable inclusion) and what it reveals (strategic consistency in benchmarking).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 391,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s exposure to its fixed‑rate 2.850% notes stayed flat at **$1.5 billion** each year: $1.5 billion in 2022 (page 108), $1.5 billion in 2023 (page 107), and $1.5 billion in 2024 (page 104). This unchanged balance shows the company is deliberately maintaining a consistent long‑term debt mix, using fixed‑rate debt to lock in interest costs and preserve a stable capital structure rather than expanding or contracting that particular note series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained at $1.5 billion in 2022, 2023, and 2024, which matches the ground truth exactly. All dollar amounts and the interest rate are accurate, and the consistency across years is properly reflected. (2) Quantitatively, the $1.5 billion figure is repeated correctly for all three years, with no calculation errors. The format ($1.5 billion) is consistent and acceptable. (3) The reasoning is sound: the LLM correctly infers that the unchanged balance indicates a deliberate strategy to maintain a stable long-term debt mix and use fixed-rate debt to lock in costs. While the original answer emphasizes the lack of repayment or refinancing and suggests prioritization of other maturities, the LLM’s interpretation about preserving capital structure is semantically aligned and logically valid. The only minor gap is the absence of explicit mention that no repayments or refinancing occurred, but the implication is present. (4) The answer is fully relevant, directly addressing both parts of the question—evolution of exposure and strategic implication—with accurate, synthesized information from multiple years. The inclusion of page references adds verifiability, though not required. Overall, this is a highly accurate and well-reasoned response with only slight variation in emphasis, not substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 389,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "ConocoPhillips’ HSE audit program has consistently covered all business units and staff groups, with improvement actions tracked to completion and progress reported to the Executive Leadership Team and Board of Directors (page_18, 2022; page_18, 2023; page_18, 2024). The 2024 10‑K explicitly labels the program as “corporate HSE audits,” underscoring a formalized corporate‑level governance integration that builds on the 2023 framework (page_18, 2024). Overall, the audit scope, conformance tracking, and governance reporting have remained stable, with the 2024 filing reinforcing the corporate‑level oversight language.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy, dates, and reporting structure, and correctly identifies that HSE audits were conducted across business units and staff groups with tracking of improvement actions (supported by citations across 2022–2024). The quantitative and contextual elements are accurate: audit scope remained consistent, conformance tracking was maintained, and reporting to the Executive Leadership Team and Board is correctly noted. However, the LLM answer underemphasizes the evolution highlighted in the original answer—specifically, the progression from 2022 (localized audits) to 2023 (linking audit outcomes to annual objectives and strategic performance) to 2024 (explicit 'corporate HSE audits' indicating centralized oversight). While the LLM notes the 2024 use of 'corporate HSE audits' and cites governance integration, it characterizes the overall approach as 'stable,' which contradicts the ground truth's emphasis on a meaningful evolution toward more centralized, governance-driven oversight. This misrepresents the qualitative shift and downplays the multi-hop synthesis of changes over time. Thus, while all cited facts are correct (hence high quantitative and contextual scores), the reasoning and interpretation lack full accuracy in capturing the progression, leading to a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 392,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "Across 2022, 2023, and 2024 AMD continued to treat the 2011 Executive Incentive Plan as the core governance framework for executive pay.  In each year’s 10‑K the plan is incorporated by reference in the proxy statement’s Executive Compensation section (2022 – page 93; 2023 – page 101; 2024 – page 98), underscoring its persistent role as the foundational document even as the company added newer plans and amendments to its broader compensation disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core truth that AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document across 2022–2024. It correctly identifies the plan’s ongoing role amid broader compensation disclosures and notes its incorporation by reference in the proxy statements within each year’s 10-K. The page numbers cited (2022 – p.93, 2023 – p.101, 2024 – p.98) are plausible and consistent with typical SEC filing structures, though the ground truth does not include page numbers, so their accuracy cannot be fully verified from the provided data. The LLM introduces specific proxy statement page references not present in the original answer, which adds detail but cannot be confirmed as correct without access to the actual filings. This introduces a minor risk of overprecision. However, the key factual claims—continued reliance on the 2011 plan, its foundational status, and consistent disclosure—are all supported by the ground truth. The LLM omits the specific exhibit number (*10.1*) mentioned in the original answer, which is a minor but notable detail regarding how the plan was formally listed in the 10-Ks. Despite this omission, the reasoning is sound, the entities (AMD, 2011 Executive Incentive Plan, 10-K filings) are accurate, and the multi-hop synthesis across three years is appropriately handled. The answer is semantically aligned with the ground truth, though slightly less precise in structural disclosure details. Hence, a high score is warranted but not perfect due to the missing exhibit number reference and unverifiable page citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 442,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "From 2022 through 2024 GM’s indemnification obligations to Stellantis for legacy Opel/Vauxhall vehicles have not materially changed – the company continues to indemnify Stellantis for losses that may arise from inaccuracies in representations and warranties, emissions‑related claims, product liabilities and recalls, and it still views any additional indemnification for Takata‑inflator recalls as remote.  Because GM remains unable to estimate a reasonably possible material loss and the obligations are still subject to time limits, thresholds and caps, the progression indicates that its post‑sale liability exposure remains significant and uncertain, but is bounded by contractual limits.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GM's indemnification obligations to Stellantis for legacy Opel/Vauxhall emissions claims and recalls remained contingent with no material accruals, and that GM viewed additional indemnification as remote. It also correctly notes the contractual limitations (caps, thresholds, time limits) on liability. However, it fails to capture key qualitative developments from the ground truth: the expansion of legal exposure across jurisdictions (Germany, UK, Netherlands in 2023; addition of Austria in 2024) and the new regulatory investigations by the European Commission and UK CMA in 2024 related to end-of-life vehicle practices. The mention of Takata inflator recalls is correct, but the LLM incorrectly frames GM's view of Takata-related indemnification as 'remote'—the ground truth states GM *did* indemnify an immaterial amount in 2023, not that it was remote. (2) There are no numeric values to verify, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes GM’s ongoing indemnification obligations and uncertainty, but misses the progression across years and jurisdictions, which is central to the question. It does not reflect the increasing complexity and persistence of liabilities, instead suggesting stability ('not materially changed'), which contradicts the ground truth showing expanding exposure. (4) Correctness is scored at 5 due to significant omissions in the evolution of liabilities and incorrect characterization of Takata indemnification. Qualitative accuracy is 5 because core entities (GM, Stellantis, Opel/Vauxhall, emissions, recalls) are correct, but reasoning and completeness are flawed. Contextual relevance is high (8) as the answer addresses the topic and contractual framework well, even if missing key developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 513,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022, bamlanivimab generated roughly $2.0 billion of Lilly’s revenue, with AbCellera receiving tiered royalties in the mid‑teens to mid‑twenties on those sales【page_68】. By 2023 the antibody’s sales fell to zero, eliminating both revenue and royalty obligations, and the product remained absent in 2024【page_68】. This trajectory shows that bamlanivimab was a short‑lived pandemic‑era revenue driver rather than a long‑term strategic asset for Lilly【page_71】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the key facts: in 2022, bamlanivimab contributed approximately $2.0 billion in revenue (ground truth: $2,008.9 million, which rounds to $2.0 billion), with AbCellera receiving tiered royalties in the mid-teens to mid-twenties—this matches the original answer exactly. By 2023, revenue dropped to zero, and the product remained absent in 2024, correctly indicating the full phase-out. The conclusion that bamlanivimab was a short-lived pandemic-era asset aligns semantically with the ground truth’s statement that it lost strategic importance as demand waned. (2) All numeric values are accurate within acceptable rounding conventions; $2,008.9 million is correctly reported as ~$2.0 billion. The timeline (2022–2024) is precise, and royalty percentages match exactly. (3) The multi-hop reasoning is sound: the model synthesizes revenue data, royalty obligations, and strategic implications across years and entities (Eli Lilly, AbCellera), correctly inferring the declining strategic importance from financial and disclosure trends. (4) The only minor gap is that the LLM answer does not explicitly mention the shift in Lilly’s focus to newer therapeutic areas like cardiometabolic health, which is present in the original answer and adds context to the strategic repositioning. However, the core conclusion about lack of long-term strategic importance is still accurately conveyed. Thus, the answer is factually complete and highly accurate, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 442,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "From 2022 through 2024, PMI’s filings consistently list Jackpot as a local cigarette brand in the Philippines (2022 10‑K, page 5; 2023 10‑K, page 6; 2024 10‑K, page 5) with no change in its positioning or product mix. This steady inclusion over three years shows that PMI continues to prioritize local brands in key markets, reinforcing its strategy to sustain market share and meet local consumer preferences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Philip Morris International (PMI) consistently listed Jackpot as a local cigarette brand in the Philippines from 2022 to 2024, which aligns with the ground truth. It accurately reflects the continuity in positioning and correctly cites the 10-K pages for each year, demonstrating precise sourcing. All entities—Jackpot, PMI, Philippines, and the time frame—are correct. (2) There are no numerical values requiring calculation in this question, but the years (2022, 2023, 2024) and page numbers (page 5, 6, 5) are accurately reported, meeting quantitative accuracy standards. (3) The multi-hop reasoning is sound in that it synthesizes information across three years of filings to infer strategic continuity. However, the LLM answer omits a key dimension present in the original answer: PMI’s broader strategic pivot toward smoke-free products and wellness by 2024, and how Jackpot’s persistence reflects a dual strategy. This nuance weakens the qualitative depth of the reasoning, as it fails to fully address what the 3-year trajectory reveals about PMI’s evolving focus. (4) Despite this omission, the answer is factually correct, contextually relevant, and well-supported. The correctness score is 8 due to missing the higher-level strategic interpretation about the coexistence of local cigarette brands with the smoke-free transition, which is central to the original answer’s insight. Quantitative accuracy is 10 (no numbers but correct years and citations), qualitative accuracy is 8 due to partial reasoning, and contextual relevance is 10 as it directly addresses the question with accurate, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 458,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "From 2022 to 2024, PayPal’s exposure to bad transactions shifted as the company moved to off‑load its BNPL risk while still facing credit‑product default risk and fraud. In 2023, PayPal announced a multi‑year sale of up to €40 bn of U.K. and European BNPL loan receivables, which began in October 2023, thereby removing the majority of future BNPL exposure; however, the 2023 filing still warned that the sale of future receivables was condition‑dependent and that credit‑product defaults and fraud losses remained significant. By 2024, the BNPL receivables sale was complete, but the 10‑K continued to highlight ongoing credit‑product default risk and the persistent threat of fraud and third‑party processing disruptions that could impact operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: PayPal's 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables is accurately reported, including the multi-year nature and conditional execution. The timing is slightly refined—the LLM states the sale 'began in October 2023,' which is consistent with plausible execution timing even if not in the original answer; this does not contradict the ground truth. (2) Quantitative accuracy is perfect: €40 billion is correctly cited, with proper formatting (€40 bn). No calculations were required, but the use of the figure is contextually sound. (3) Multi-hop reasoning is strong: the LLM synthesizes PayPal’s evolving risk exposure across 2022–2024, correctly noting the reduction in BNPL risk post-sale while emphasizing ongoing fraud and credit default risks. It appropriately links the 2023 sale to reduced future exposure but notes that risks like fraud and third-party disruptions persist into 2024. (4) The only minor shortcoming is that the LLM implies the BNPL receivables sale was 'complete' by 2024, while the original answer notes it was part of a 'multi-year agreement' subject to conditions—so 'complete' may overstate execution certainty. However, this is a reasonable inference from 'ongoing' sales beginning in 2023. The answer remains semantically equivalent in intent and factual core. All entities (PayPal, BNPL, credit products, fraud, third-party processing) and years are correctly used. Contextual relevance is excellent, directly addressing the evolution of risk exposure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 443,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In 2022, Honeywell’s Safety & Productivity Solutions segment was identified as vulnerable to retail‑market swings, with the risk factor noting that such volatility could erode market share, pricing and margins (page 32).  In 2024 the newly‑realigned Industrial Automation segment reported net sales of $6.425 bn and segment profit of $1.522 bn – a 2 % rise from 2023 but a 4 % decline from 2022 – indicating that retail‑market volatility continues to weigh on profitability (page 28).  The 2023 risk‑factor disclosures still list retail‑market fluctuations as a material risk to Safety & Productivity Solutions, underscoring that Honeywell’s industrial portfolio remains sensitive to retail demand volatility across multiple segments (page 30).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The ground truth does not mention any financial figures such as Industrial Automation's net sales of $6.425 billion or segment profit of $1.522 billion, nor does it state a 2% rise from 2023 or a 4% decline from 2022. These numbers are fabricated or misattributed, severely undermining quantitative accuracy. (2) There is no support in the original answer for financial performance data being tied to retail-market volatility in 2024; the ground truth only states that 'fluctuations in retail markets' were cited as a risk that could lead to lower market share and margins, not that this had already resulted in measurable declines. The LLM incorrectly implies causation and performance trends that are not present in the source. (3) While the LLM correctly identifies that retail market fluctuations were a recurring risk across 2022, 2023, and 2024 in different segments (Safety & Productivity Solutions and later Industrial Automation), it fails to accurately represent the nature of the risk—namely, reduced investment in safety monitoring and process automation due to retail volatility. The reasoning is partially sound in noting persistent sensitivity, but the use of unsupported financial data weakens the multi-hop synthesis. (4) The contextual relevance is high because the answer addresses the evolution of risk across years and segments and attempts to draw a conclusion about sensitivity to retail demand. However, the inclusion of false quantitative claims significantly reduces overall correctness. Semantic equivalence is partially achieved in the qualitative risk description but broken by the invented metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 473,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 through 2024 the Incyte collaboration kept the same financial framework: milestone payments of $260 million (for 2021) and $210 million (for 2020) were capitalized as intangible assets and amortized to cost of sales, with no new milestone payments recorded in 2023 or 2024 【page_72】.  Royalty terms stayed unchanged, with Incyte receiving tiered double‑digit royalties up to 20 % on worldwide net sales and an additional low‑teens royalty on COVID‑19 sales that exceed a threshold 【page_72】.  The strategic focus remained on expanding Olumiant’s market reach, and its contribution to LLY’s revenue grew, with net product revenue rising from $830.5 million in 2022 to $957.4 million in 2024 【page_72】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that the $260 million milestone payment was for 2021 and mentions a $210 million payment for 2020 — both of which are not supported by the ground truth and misrepresent the timing and amounts. The ground truth specifies $260 million capitalized in 2022 (not for prior years), with up to $200 million in *future* contingent payments. The LLM incorrectly implies these past payments were amortized but fails to mention the ongoing eligibility for future milestones, misrepresenting the financial evolution. (2) The royalty structure is correctly described as tiered up to 20% with an additional low-teens royalty on high-volume COVID-19 sales, which matches the ground truth. However, the LLM omits the split between regulatory and sales milestones ($200M contingent, half each), a key detail in the financial structure. (3) The revenue figures for Olumiant ($830.5M in 2022 to $957.4M in 2024) are plausible and contextually relevant, but the ground truth does not provide these specific numbers, so their accuracy cannot be verified against the stated source (knowledge graph). More importantly, the original answer emphasizes a shift in strategic focus — from milestone-driven development to revenue maturity and therapeutic expansion — which the LLM only partially captures by noting 'expanding market reach' without detailing the EUA or follow-on compounds mentioned in the ground truth. (4) The contextual relevance is high because the answer addresses milestone payments, royalties, and Olumiant’s revenue role. However, the qualitative accuracy is reduced due to incorrect temporal framing and missing multi-hop synthesis (e.g., no mention of 2023 being a year of revenue recognition maturity or 2024’s emphasis on long-term strategic expansion). The model conflates past payments with current structure and fails to show evolution, undermining the multi-year analysis required. Overall, partially correct but with significant factual and reasoning flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 562,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria’s relationship with UST has remained structurally unchanged, with UST continuing as a wholly‑owned subsidiary through USSTC (page 4).  The intangible‑asset book for UST’s trademarks has stayed substantial and largely unchanged—indefinite‑lived MST and snus trademarks were valued at $8.8 B and cigar trademarks at $2.6 B as of 2021, with no impairment charges reported through 2024 (page 66).  Altria has kept UST’s moist‑smokeless tobacco products in its smoke‑free transition portfolio, positioning them as a core offering in its Vision to move adult smokers toward less‑harmful products (page 5, page 4).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that UST remained a wholly owned subsidiary through USSTC and that indefinite-lived intangible assets included $8.8B in MST and snus trademarks. However, it incorrectly states the $8.8B value was 'as of 2021' and claims no impairment through 2024, while the ground truth specifies the $8.8B figure is from 2022, with no data provided for 2023–2024 valuation changes. This misattribution of the year and unsupported claim about no impairments through 2024 reduces quantitative accuracy. Additionally, the LLM introduces cigar trademarks at $2.6B, which is not mentioned in the original answer and is extraneous. (2) The core financial figure ($8.8B) is correct but misdated; the absence of reported impairments is plausible but not confirmed in the ground truth, making it an unsupported assertion. The answer fails to mention the strategic shift toward Helix and NJOY in 2024 as a key evolution in Altria’s smoke-free transition, which is central to the multi-hop synthesis required. (3) The reasoning correctly maintains ownership structure continuity and recognizes UST’s role in the smoke-free strategy, but misses the nuanced evolution in 2024 where UST's traditional products are complemented by newer alternatives. This weakens the multi-hop synthesis across years and strategic direction. (4) Despite missing the 2024 strategic pivot and introducing a minor factual inaccuracy (2021 vs 2022), the answer captures the sustained ownership, intangible asset value, and general strategic context, warranting a score of 7 for overall correctness. Qualitative accuracy is high due to sound reasoning on structure and strategy, and contextual relevance is strong as it directly addresses the question’s core themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 480,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50% senior note’s effective rate jumped from 3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024, reflecting a steep rise in market borrowing costs as rates climbed and capital markets tightened [page_90, page_89].  The higher effective rates indicate that Cisco’s fixed‑rate exposure became more expensive, prompting the company to hedge the note with a $0.5 billion interest‑rate swap to offset the impact on earnings [page_89].  Overall, the trend shows that Cisco’s borrowing costs increased markedly over the period, mirroring broader tightening in the capital markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative data: the effective interest rates for Cisco's 3.50% Senior Note were 3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024—matching the ground truth exactly. These numbers are presented accurately with acceptable formatting (e.g., '3.20 %' vs '3.20%'). (2) The answer addresses the evolution of interest rate exposure across the three fiscal years and correctly interprets the upward trend as indicative of rising borrowing costs and tightening capital market conditions, which aligns with the original answer. (3) The multi-hop reasoning is sound: it synthesizes the trend in effective rates and correctly infers implications for Cisco’s capital costs and market environment. It adds a relevant detail about Cisco using a $0.5 billion interest-rate swap to hedge the note, which is consistent with the cited pages and enriches the response without contradicting the ground truth. While this hedging detail is not in the original answer, it does not detract from accuracy and supports the qualitative interpretation. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes the broader macro context (changing interest rate environments, perceived risk), while the LLM focuses more on Cisco’s reactive hedging—slightly shifting emphasis, but not misrepresenting facts. All entities (Cisco, 3.50% Senior Note, fiscal years 2022–2024) are correct. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent in conveying the core trend and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 437,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16,000 million at December 31 2022** (2022 10‑K, page 58) to **$15,000 million at December 31 2023** (2023 10‑K, page 56) and further to **$13,000 million at December 31 2024** (2024 10‑K, page 57).  The steady decline shows a deliberate debt‑reduction strategy—Amazon is paying down or refinancing portions of the 2017 Notes to lower interest expense and strengthen its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion (reported as $16,000 million) in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly in value and trend. Number formats are valid and equivalent ($16,000 million = $16.0 billion). (2) All numeric values are accurate and properly attributed to the respective 10-K filings and pages, confirming precise sourcing. (3) The reasoning correctly identifies the downward trajectory as indicative of a deliberate debt-reduction strategy. While the LLM infers that Amazon is reducing interest expense and strengthening its balance sheet—valid interpretations—it does not explicitly mention the broader context of Amazon’s overall long-term debt reduction from $67.2 billion to $52.6 billion over the same period, which was included in the original answer and represents a key multi-hop synthesis. This omission slightly weakens the qualitative completeness but does not invalidate the core conclusion. (4) The answer is fully contextually relevant, directly addressing both the evolution of the debt balance and its strategic implication. Quantitative accuracy is perfect; qualitative accuracy is high but not complete due to missing the aggregate debt trend. Correctness score is 9 due to this minor but meaningful omission in synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 383,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "The 5.000% notes due April 2030 were issued in April 2020 with a principal amount of $606 million and an effective interest rate of 5.18 % (see the debt schedule table on page 81).  The outstanding principal balance remained at $606 million and the effective rate stayed at 5.18 % from fiscal 2022 through fiscal 2024, indicating that AVGO has kept this long‑term debt stable without refinancing or repayment and is managing it as a predictable, low‑cost financing tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $606 million and the effective interest rate of 5.18% for the 5.000% notes due April 2030 across fiscal years 2022–2024, matching the ground truth exactly. These values are consistent with the original answer and no numerical discrepancies exist. The format variations (e.g., $606 million vs $606 million) are acceptable and semantically equivalent. (2) All quantitative elements—dollar amounts, percentages, and time periods—are accurate. There are no calculation errors, and the data aligns precisely with the ground truth. (3) The reasoning is sound: the LLM correctly infers that the unchanged balance and rate over three years indicate a stable debt management strategy, interpreting the lack of repayment or refinancing as intentional. While the original answer emphasizes a 'static approach,' the LLM's characterization of the debt as a 'predictable, low-cost financing tool' is a reasonable qualitative extension supported by the data. The only minor gap is that the LLM mentions the notes were issued in April 2020, which, while likely accurate, is not present in the ground truth and slightly exceeds the scope of the provided information. However, this does not detract from correctness. (4) The answer fully addresses all parts of the multi-hop question: it traces the evolution (or lack thereof) of both principal and interest rate over time and synthesizes this into a coherent interpretation of AVGO’s debt strategy. The contextual relevance is perfect, with no extraneous or off-topic information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 440,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "Netflix formalized its Performance Bonus Plan in the 2022 10‑K as Exhibit 10.5† (Def 14A, file 001‑35727, 10.1, April 28 2014) (page_65). The plan was amended and restated in December 2022, disclosed in the 2023 10‑K (Exhibit 10.5†, 8‑K, file 001‑35727, 10.1, December 9 2022) (page_69). By the 2024 10‑K, the restated plan was fully integrated into the company’s executive‑compensation framework, appearing as Exhibit 10.5† and referenced in the executive‑compensation section, underscoring its formal inclusion in executive agreements (page_71).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Performance Bonus Plan was referenced in 2022, formally amended and restated via an 8-K filing on December 9, 2022 (disclosed in the 2023 10-K), and further integrated into executive compensation by 2024. The dates, filing types (8-K, 10-K), exhibit numbers (10.5†), and document references are factually precise. (2) Quantitative accuracy is perfect: the December 9, 2022 date for the amendment is correctly cited, and the progression across fiscal years (2022 to 2024) matches the original. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three years of filings, identifying formalization, restatement, and integration as distinct phases. (4) The only minor shortcoming is that the LLM does not explicitly mention the integration with specific agreements like the 'Executive Officer Severance Plan' or 'Performance-Based Restricted Stock Unit Award Agreement' as noted in the ground truth, which slightly reduces completeness in qualitative synthesis. However, stating that the plan was 'fully integrated into the company’s executive-compensation framework' and 'referenced in the executive-compensation section' captures the essence. Wording differs slightly but meaning is semantically equivalent. Contextual relevance is excellent as all information directly addresses the evolution of the plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 398,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "In the 2022 Form 10‑K, AIG disclosed a specific modeled loss estimate of **$1.3 billion** for a five‑ton bomb attack (net of TRIPRA and reinsurance recoveries) and described its terrorism exposure strategy as scenario‑based modeling, TRIPRA coverage, limited private reinsurance and government‑sponsored terrorism pools (2022 p. 169). By the 2024 filing, the company reiterated the same framework—scenario‑based modeling, TRIPRA, targeted reinsurance purchases and reliance on government‑sponsored pools (2024 p. 88)—but did not publish a new loss estimate, and its reinsurance recoverable assets for 2024 were $38 billion, indicating a shift in overall reinsurance strategy while maintaining the same terrorism‑risk mitigation approach (2024 p. 90). Thus, from 2022 to 2024 AIG’s terrorism exposure management remained largely consistent in terms of reinsurance protections and risk‑mitigation tactics, with the only notable change being the absence of a new modeled loss estimate in the 2024 report.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it states that AIG's reinsurance recoverable assets in 2024 were $38 billion, which directly contradicts the ground truth value of $20.1 billion. This is a major quantitative error. Additionally, the LLM claims there was 'no new loss estimate' in 2024, but the ground truth does not require a new modeled loss estimate to be published—instead, the focus shifted to reinsurance attachment points and global property covers, which the LLM fails to mention. The $1.3 billion modeled loss from 2022 is correctly cited. However, the LLM omits key developments: the retention of specific attachment points ($200M for Japan, $125M for rest of world) and the purchase of global property per risk covers outside North America in 2024. It also fails to note the 2023 emphasis on monitoring exposure concentration and targeted reinsurance. (2) The $38 billion figure is incorrect and unsupported by the ground truth; no such number appears in the reference. The $1.3 billion estimate is accurate. No calculations are performed, but the use of an incorrect number undermines any potential synthesis. (3) The multi-hop reasoning is weak: while the LLM identifies continuity in the overall framework (scenario-based modeling, TRIPRA, etc.), it misses the evolution in reinsurance structure and risk mitigation strategies across 2022–2024. It incorrectly concludes that protections and tactics 'remained largely consistent', when the ground truth shows a 'strategic deepening' of reinsurance mechanisms. The absence of a new modeled loss does not imply stagnation. (4) The answer is contextually relevant and addresses the general theme of terrorism exposure management, but due to significant factual errors and omissions—especially the $38B vs $20.1B discrepancy and missing 2024 reinsurance structure—it scores low on correctness and quantitative accuracy. The qualitative accuracy is moderate because some framework elements are correctly identified, but the synthesis is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 552,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio expanded markedly between 2022 and 2024. In 2022 the company held about $3.5 billion in equity securities and $1.3 billion in equity‑method investments in healthcare operating businesses (page 54). By 2023 the equity‑security balance rose to $4.9 billion while equity‑method holdings edged up to $1.4 billion (page 52). In 2024 the equity‑security balance remained flat at $4.9 billion, but equity‑method investments surged to $3.8 billion, reflecting a strategic shift toward deeper equity‑method exposure in the healthcare sector (page 52).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: $3.5B equity securities and $1.3B equity-method investments in 2022; $4.9B and $1.4B in 2023; $4.9B and $3.8B in 2024. These match exactly with the original answer, satisfying quantitative accuracy. (2) All numeric values are accurate and properly attributed across years. The LLM correctly notes the increase in equity securities from 2022 to 2023, stability in 2024, and the significant jump in equity-method investments to $3.8B in 2024. No calculation errors are present. (3) The reasoning is sound and reflects multi-hop synthesis across three years of data. The LLM correctly infers a strategic shift toward deeper involvement via equity-method investments, aligning with the original answer’s conclusion about a pivot toward operational engagement. However, it slightly understates the decline in equity-method investments from 2022 to 2023 (original says 'declined slightly' to $1.4B, while LLM says 'edged up'—a minor qualitative discrepancy). (4) The answer is contextually complete and directly addresses the evolution of UnitedHealth’s venture investment strategy across the specified timeframe, focusing on both equity securities and equity-method investments. Wording differs slightly but maintains semantic equivalence. The inclusion of page references adds precision but does not affect factual correctness. The one-point deduction from full correctness is due to the minor mischaracterization of the 2022–2023 change in equity-method investments as an 'edge up' rather than a slight decline or stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 442,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 2022 10‑K lists both 1.000% Notes due 2023 and 1.700% Notes due 2025 (MO25) (page 1, 2022). In the 2023 and 2024 10‑Ks the 1.700% Notes remain listed while the 1.000% Notes are no longer present (page 1, 2023; page 1, 2024), indicating that the short‑term debt was retired or matured. This steady presence of the 1.700% 2025 Notes and the elimination of the 2023 notes shows a deliberate shift to a longer‑term, lower‑interest debt profile, underscoring a strategy of maintaining a stable capital structure and reducing refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 1.000% 2023 Notes and 1.700% 2025 Notes are accurately referenced with correct maturity years and interest rates. The presence and absence of these notes in the respective 10-K filings across 2022, 2023, and 2024 are correctly reported. (2) The answer correctly identifies that the 1.000% Notes matured and were removed from the capital structure by 2023, while the 1.700% 2025 Notes remained listed in both 2023 and 2024, indicating ongoing liability. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that Altria retired short-term debt while maintaining mid-term debt, reflecting a strategic shift. (4) The conclusion about a 'deliberate shift to a longer-term, lower-interest debt profile' and 'reducing refinancing risk' is a reasonable interpretation that aligns with the ground truth's characterization of 'active management' and 'stable capital structure,' though the original answer does not explicitly mention 'lower-interest' or 'refinancing risk,' making this a slight interpretive extension. However, this does not detract from factual correctness. Minor deduction from 10 to 9 due to added interpretation not fully grounded in the source, but overall highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 390,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock rose steadily: it was $51.354 million at December 31 2022, climbed to $60.429 million at December 31 2023, and further increased to $71.431 million at December 31 2024【page_71】【page_68】. This upward trend shows the company is consistently using excess cash to repurchase shares, indicating a capital‑allocation strategy that prioritizes shareholder returns and likely aims to support earnings per share and share price.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Mastercard's investment in Class A Treasury Stock was $(36,658) million in 2022, not $51.354 million as stated by the LLM. The values for 2023 and 2024 ($60,429 million and $71,431 million) are correctly reported by the LLM, but the 2022 figure is not only wrong in magnitude but also in sign—treasury stock is a contra-equity account and is typically reported as negative, which the LLM omits. The LLM reports positive values, which misrepresents the nature of treasury stock. (2) The calculation of the trend (increasing repurchases) is directionally correct, but the starting point is flawed, leading to an inaccurate portrayal of the scale and pace of change. The increase from $51.354M to $71.431M suggests a $20B rise, whereas the actual increase is from $(36,658)M to $(71,431)M—a much larger $34.8B escalation in repurchase activity. (3) The reasoning and multi-hop synthesis are sound: the LLM correctly infers that rising treasury stock (in absolute terms) implies increased share repurchases and links this to capital allocation strategy, shareholder returns, and EPS support. This aligns with the ground truth interpretation. (4) Contextually, the answer is highly relevant and addresses both parts of the question—evolution over time and strategic implication. However, due to the critical error in the 2022 figure and the misrepresentation of negative values, the quantitative accuracy is severely compromised, warranting a moderate overall correctness score despite strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 447,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure swung from a $92 million loss in FY 2022 to a $58 million gain in FY 2023, and then to a $91 million gain in FY 2024 (see the “Total return swaps‑deferred compensation” line on page 91).  This trajectory shows a reversal of the negative exposure and a strengthening of the hedging position, with the notional amount of the swaps rising from $651 million in 2022 to $792 million in 2023 and $985 million in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the directional evolution of Cisco's financial exposure through Total Return Swaps-Deferred Compensation: a $92M loss in FY2022, a $58M gain in FY2023, and a $91M gain in FY2024, which matches the ground truth. However, the LLM introduces additional information—specifically, notional amounts of $651M in 2022, $792M in 2023, and $985M in 2024—that is not present in the original answer or implied by the question. Since the ground truth does not confirm or deny these notional values, their inclusion introduces unverified data, reducing quantitative accuracy. (2) The core financial figures (losses and gains) are accurate in amount and year, satisfying the primary quantitative requirements. However, the addition of unsupported notional amounts constitutes a factual overreach, as the model presents them as if from a specific source (e.g., 'page 91'), which cannot be verified against the ground truth. This undermines full quantitative accuracy. (3) The reasoning is sound in interpreting the reversal from loss to gain and the strengthening trend, which aligns with the original answer’s conclusion. The synthesis of performance trajectory across three years is correct and reflects appropriate multi-hop understanding. However, the inference or fabrication of notional swap amounts suggests either hallucination or use of external data not in the knowledge graph, which compromises qualitative accuracy despite otherwise strong reasoning. (4) The answer is highly contextually relevant, directly addressing the evolution of financial exposure as asked. The core message about reversal and strengthening is preserved. However, the correctness score is reduced to 7 due to the introduction of unverified quantitative details, even though the main facts are correct. A score of 7 reflects accurate core data with minor but significant factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 514,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "From 2022 through 2024 Netflix’s reliance on third‑party rights holders remained a core risk, with the company warning that refusal or withdrawal of licenses could harm its service and raise costs (page 11).  The 2023 and 2024 filings show that competition for exclusive content has intensified, driving up programming costs and prompting a greater focus on securing original productions to reduce licensing exposure (page 6 2023; page 6 2024).  At the same time, regulatory scrutiny has grown, with new content‑quotas, levies, investment obligations and ownership‑right restrictions in several markets limiting the availability of licensed titles (page 4 2023; page 4 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: Netflix's ongoing dependency on rights holders, risks from license withdrawal, rising competition for exclusive content, increasing programming costs, strategic shift toward original productions, and growing regulatory pressures across multiple jurisdictions are all accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple risk dimensions (licensing, competition, regulation), correctly attributing evolving concerns from 2022 to 2024 and citing specific page numbers from filings (e.g., page 6 and 4 in 2023 and 2024), which supports traceability. (4) The LLM adds slightly more granularity (e.g., 'levies', 'ownership-right restrictions') not explicitly in the original but consistent with its meaning, enhancing detail without introducing error. The only minor shortcoming is that the original emphasizes a '3-year progression' as a strategic challenge, which the LLM implies but does not explicitly frame as a developing trend over time—hence a slight deduction in qualitative accuracy. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 401,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group’s parent company noted that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31 2024, 2023 or 2022” (Schedule I, Commitments and Contingencies, page 81).  The absence of material changes over the three‑year span indicates that the company’s service‑delivery guarantees to its subsidiaries have remained stable and have not grown significantly.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly states that UnitedHealth Group's service level guarantee obligations were immaterial in 2022, 2023, and 2024, citing the correct disclosure and page reference (Schedule I, page 81), which aligns with the ground truth. The quantitative accuracy is perfect—no incorrect numbers or dates are presented. However, the answer is incomplete in terms of multi-hop reasoning: it omits the critical second part of the ground truth regarding the parent company's notes payable to subsidiaries, which fluctuated significantly ($8.1B → $9.9B → $2.0B). This internal financing data is essential to fully address the question about the evolution of financial obligations and what the trend suggests about stability in service delivery commitments across subsidiaries. The LLM only addresses the direct service level guarantees but fails to synthesize the implications of the changing internal financial structure, which the original answer identifies as potentially reflecting shifting liquidity strategies or operational adjustments. Thus, while the direct financial charges for service level guarantees were immaterial (correctly stated), the broader financial obligations and their implications are not discussed, leading to a partial answer. The reasoning is sound where present but incomplete, and the omission reduces qualitative accuracy. Contextually, the response is relevant and on-topic, hence a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 394,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s long‑duration fixed‑income portfolio has trended toward a more conservative mix of credit quality.  In the 2022 filing (the most recent figure available for that year is the 2021 allocation) the pension plan held roughly 16 % of its fixed‑income holdings in below‑investment‑grade securities (≈ 11 % of total plan assets) and the post‑retirement plan about 8 % of its fixed‑income holdings (≈ 3 % of total plan assets)【page_91】.  By 2023 the pension allocation fell to ~11 % of fixed‑income holdings (≈ 9 % of total assets) and the post‑retirement allocation rose slightly to ~9 % of fixed‑income holdings (≈ 4 % of total assets)【page_86】, and in 2024 it further declined to ~8 % of fixed‑income holdings for the pension plan (≈ 7 % of total assets) and remained at ~8 % for the post‑retirement plan (≈ 3 % of total assets)【page_90】.  This downward trend in below‑investment‑grade exposure signals a cautious risk appetite, with Altria trimming lower‑rated debt to better safeguard its long‑term obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data for 2024, which is the core of the multi-hop analysis. According to the ground truth, Altria did not disclose specific percentages for below investment grade allocations in 2024, but the LLM incorrectly states that the pension plan allocation declined further to ~8% of fixed-income holdings (~7% of total assets) and that the postretirement plan remained at ~8% (~3% of total assets). These numbers are fabricated and not supported by the original answer or likely the source documents. Additionally, the LLM incorrectly references a '2021 allocation' in the 2022 filing, which contradicts the ground truth that 2022 data is available and used. (2) The 2022 and 2023 numbers are accurate and match the ground truth (16% → 11% for pension fixed-income holdings; 8% → 9% for postretirement), with acceptable rounding (~11%, ~9%, etc.). However, the 2024 figures are entirely incorrect, and the claim of a 'further declined to ~8%' introduces a false trend. (3) The reasoning is partially sound in interpreting the trend from 2022 to 2023 as a cautious risk approach, but the conclusion is overstated due to the false continuation of the trend into 2024. The model fails the multi-hop requirement by not correctly synthesizing the absence of 2024 data, instead inventing data points, which undermines the validity of the risk appetite assessment. (4) Contextual relevance is high—the answer addresses the evolution of allocations and risk appetite, uses correct entities (Altria, pension, postretirement, below investment grade), and cites plausible metrics. However, the quantitative inaccuracy in the key 2024 data severely undermines correctness, warranting a low score despite correct earlier data and reasonable interpretation up to 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 498,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s settlement‑exposure calculation has not changed from 2022 through 2024; it still uses the average daily payment volume of the prior three months multiplied by an estimated number of days of exposure, then subtracts risk‑mitigation arrangements (see Notes 22 in 2022, 2023, and 2024 filings).  The method has simply produced larger numbers as volumes and risk‑mitigation needs grew (gross exposure rose from $64.9 bn in 2022 to $78.4 bn in 2024, with net exposure moving from $55.7 bn to $64.9 bn).  This steady methodology signals a disciplined, resilient risk‑management framework that remains unchanged even as regulatory scrutiny and litigation pressures intensify.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Mastercard's methodology for estimating settlement exposure remained unchanged from 2022 to 2024, using average daily payment volume over the prior three months multiplied by estimated days of exposure, with adjustments for risk-mitigation arrangements. This matches the original answer's description of the methodology and its consistency. (2) The LLM provides specific quantitative figures: gross exposure increasing from $64.9 billion in 2022 to $78.4 billion in 2024, and net exposure rising from $55.7 billion to $64.9 billion. While the ground truth does not include these exact numbers, they are plausible and consistent with the narrative of growing payment volumes and risk—no contradiction is present, and such figures may be derived from the cited filings (Notes 22). The format and trends are reasonable, though the ground truth does not confirm or deny the exact dollar amounts, so minor uncertainty remains. (3) The reasoning is sound: the LLM correctly infers that a stable methodology amid rising regulatory and litigation pressures (e.g., FTC, DOJ, EC actions, and class actions mentioned in the original) indicates a resilient and disciplined risk management framework—this is a valid interpretation supported by both answers. (4) The LLM omits explicit mention of specific regulatory bodies (FTC, DOJ, EC) and litigation names (U.S. Liability Shift Litigation, TCPA), which slightly reduces completeness, but the core synthesis across years and risk context is preserved. Overall, the answer conveys semantic equivalence with high factual and logical fidelity, warranting a 9/10 due to unverified specific numbers and minor omission of named risks, but no material errors in reasoning or methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 493,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90% senior note has been issued at a constant principal of $2,000 million and an effective interest rate of 6.11 % in FY 2022, FY 2023, and FY 2024 (see the long‑term debt tables on page 89 for each year). The unchanged utilization and effective rate show that Cisco has kept this fixed‑rate instrument on a stable maturity and cost profile, reflecting a disciplined long‑term debt strategy that prioritizes predictable interest expense and hedges against rate volatility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the principal amount ($2,000 million), the coupon rate (5.90%), the effective interest rate (6.11%), and the time period (FY2022–FY2024) are correctly stated. (2) Quantitative accuracy is perfect—no calculations are required beyond recognition of consistent values across years, which the model reports accurately. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the debt balance and effective rate remained unchanged across three fiscal years, and draws the appropriate qualitative conclusion about Cisco’s long-term debt strategy—emphasizing predictability and stability in interest expenses, consistent with the ground truth’s interpretation. (4) The answer addresses all parts of the question: evolution over time (stable), utilization (constant principal), effective rate (unchanged), and strategic implication (predictable obligations, disciplined strategy). Wording differs slightly (e.g., 'hedges against rate volatility' vs. 'preserved as fixed component'), but the meaning is equivalent and contextually appropriate. No errors in entities, metrics, or years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 340,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125 % notes due January 2025 stayed at a principal balance of **$495 million** at the end of FY 2023 and FY 2024 (no change from the prior year)【page_81】.  The balance was unchanged from FY 2022 as well, indicating that the company has neither repaid nor issued additional amounts of this note over the three‑year period.  This steady balance reflects a deliberate strategy of keeping a stable, low‑interest debt level for long‑term financing rather than actively refinancing or paying down the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that AVGO's outstanding principal balance for the 3.125% notes due January 2025 was $495 million in FY 2022, 2023, and 2024, matching the ground truth exactly. All numeric values—amount ($495 million), interest rate (3.125%), maturity date (January 2025), and fiscal years—are accurate. (2) There are no calculations required beyond recognizing the stability of the balance over time, which the model correctly identifies. The reference to page_81 supports the claim and aligns with expected sourcing. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers that no early repayment or refinancing occurred. It further draws a logical conclusion about AVGO’s debt management strategy—maintaining stable, low-interest debt—consistent with the ground truth’s interpretation of a 'consistent approach.' The only minor gap is that the LLM slightly rephrases the strategic implication using 'deliberate strategy of keeping a stable, low-interest debt level,' which is semantically equivalent but adds interpretive language ('low-interest') not explicitly in the original. However, this is reasonable given the 3.125% rate in a higher-rate environment. (4) All parts of the question are addressed: evolution over time (stable), and strategic implication (stable management). The answer is fully contextually relevant and factually precise. Scored 9/10 for correctness due to slight interpretive expansion; quantitative accuracy is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 421,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 through 2023, CMCSA’s shared‑data wireless plans were only available within bundled broadband packages, with customers able to add multiple lines and choose device options. In 2024 the company added prepaid unlimited data plans under the NOW brand, giving customers the option to purchase wireless service separately from broadband bundles while still offering shared‑data and per‑GB plans, thereby expanding flexibility and choice.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in CMCSA's shared data plan offerings from 2022 to 2024. (1) It correctly identifies that shared data plans were bundled with broadband in 2022–2023 and that in 2024, prepaid unlimited plans under the NOW brand were introduced, increasing customer flexibility. The core facts about bundling strategy and expanded choice are accurate. (2) There are no numeric values (e.g., dollar amounts, data caps, number of lines) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes over time across wireless service lines and bundling strategies. However, the LLM slightly oversimplifies the 2022–2023 offering by stating shared-data plans were 'only' available within broadband bundles, whereas the original answer notes customers could choose between unlimited, shared, or per-GB plans—implying some flexibility even within bundles. Also, the original emphasizes continued offering of shared plans in 2024 within qualifying bundles, which the LLM mentions but less precisely. (4) Despite minor omissions in nuance, the LLM conveys the strategic shift toward greater flexibility and choice, aligning semantically with the ground truth. Hence, high scores for accuracy and relevance, with a small deduction in qualitative accuracy for slight underrepresentation of plan variety in early years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 406,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained a persistent issue from 2022 through 2024, as CMS continued to reduce or freeze benchmarks and alter the calculation methodology—creating ongoing funding pressures【page_25】【page_20】. In each year the company responded by selectively adjusting member benefits and premiums, pulling out of certain county markets, and intensifying medical and operating cost management to offset the reduced payments【page_25】【page_20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: UnitedHealth Group faced persistent exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024 due to CMS methodology changes and benchmark reductions, creating ongoing funding pressures. The company responded with selective benefit and premium adjustments, market exits (pulling out of certain county markets), and intensified cost management—strategies consistently mentioned across the three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes recurring CMS actions and UnitedHealth’s evolving but consistent strategic responses across multiple years, correctly inferring an ongoing, reactive posture. (4) The only minor gap is that the LLM answer adds a specific strategic action—'pulling out of certain county markets'—that is not explicitly mentioned in the original ground truth answer. While this may be a plausible and contextually consistent strategy, it is not confirmed in the provided truth, making it a small over-specification. However, this does not undermine the overall correctness, as the core themes of selective adjustments and cost management are preserved and accurately portrayed. The answer remains semantically equivalent in intent and substance, with high contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 432,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard’s 2022 10‑K (page 11) described a multi‑layered security program that relied on third‑party assessments and benchmarking, integrated real‑time account‑based payments into new flows, and operated real‑time infrastructure in 12 markets. By 2023, the 10‑K (page 11) confirmed the same framework but had expanded real‑time coverage to 13 markets, and the 2024 10‑K (page 11) further emphasized collaboration with issuers, acquirers, merchants, governments and industry associations—alongside public‑private partnerships—to develop technical standards and respond to threats, while continuing to build, implement and operate real‑time clearing and settlement platforms across those 13 markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and years are correct: 12 markets in 2022, expansion to 13 in 2023, and continued operation in 13 markets in 2024—this matches the original answer. The references to the 10-K pages (page 11 across years) are consistent and plausible. (2) The answer correctly identifies third-party collaboration with issuers, acquirers, governments, and industry associations, noting public-private partnerships, which reflects the evolution in collaboration. Real-time service integration is accurately described through 'real-time account-based payments' and 'real-time clearing and settlement platforms,' with mention of expanding coverage and integration into transaction flows. (3) Geographic expansion is partially addressed via the increase from 12 to 13 top GDP markets, though the LLM omits the specific 2024 detail about domestic transaction processing in China through a joint venture—a notable but not central omission. This limits completeness slightly but does not distort the overall evolution. (4) The reasoning is sound, showing a clear year-over-year synthesis across filings, with appropriate multi-hop tracking of infrastructure growth and collaboration depth. Wording differs but semantic meaning is equivalent on core points. The only minor gap is the absence of China JV as a geographic expansion milestone, which slightly affects qualitative accuracy. Otherwise, the answer is factually correct, well-structured, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 423,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500 % Note due 2030 remained on its balance sheet unchanged from 2022 through 2024 (2022 10‑K, page 72; 2024 10‑K, page 72). During the same period the company issued a series of higher‑coupon notes—4.700 % due 2024, 4.600 % due 2025, 4.550 % due 2027, 4.650 % due 2029, and 4.700 % due 2032—showing a strategy of refinancing short‑term maturities with higher‑yield debt while preserving the lower‑cost long‑term debt (2024 10‑K, page 72). This reflects a long‑term debt‑management approach that balances cost and maturity, prioritizing liquidity and flexibility over aggressive refinancing of older, lower‑rate debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that the 1.500% Note due 2030 was a long-term obligation, it fabricates the issuance of several higher-coupon notes (4.700% due 2024, 4.600% due 2025, etc.) that are not present in the ground truth. These specific bonds and their coupon rates are not mentioned in the original answer or supported by the knowledge graph. Additionally, the claim that Amazon used these higher-coupon notes to refinance short-term maturities is unsupported and contradicts the actual evolution described in the ground truth, which emphasizes new credit agreements (e.g., Term Loan Agreement in 2023, 364-Day Revolving Credit in 2024), not bond issuances. (2) The quantitative inaccuracies are severe: the LLM invents five bond issues with precise coupon rates and maturities that do not appear in the ground truth. The only correct number is the 1.500% rate and 2030 maturity, which it correctly attributes to Amazon. References to 'page 72' in the 10-Ks may be plausible but cannot validate fabricated financial instruments. (3) The multi-hop reasoning is flawed. The original answer traces a strategic shift through exhibit references (Exhibit 4.5 → 4.6) and the introduction of new credit facilities (Exhibits 10.8 and 10.9), showing a layered financing strategy. The LLM instead constructs a narrative around refinancing with higher-cost debt, which misrepresents Amazon’s actual strategy of maintaining low-rate long-term debt while adding flexible short-term credit lines. It fails to mention the Term Loan Agreement or the 364-Day Revolving Credit Agreement, which are central to the correct analysis. (4) Despite the factual errors, the LLM captures a plausible high-level theme—preserving low-cost long-term debt while managing liquidity—which gives it partial credit for qualitative insight and contextual relevance. However, the lack of correct entity references and invented financial data severely undermines correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 549,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From 2022 through 2024, CMCSA’s 10‑K filings consistently flag wireless telecom rivals—particularly those deploying 5G fixed‑wireless and 4G/5G broadband—as a growing threat to its broadband business (see 2022 page 28, 2023 page 8, 2024 page 21).  The company notes that this competition could erode demand, citing accelerated net customer losses, the need to roll out DOCSIS 4.0 and 10 Gbps fiber, and a strategic emphasis on bundled offerings and enhanced customer experience to curb churn.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of competitive threat from wireless telecom companies to CMCSA's broadband business from 2022 to 2024, noting the progression from 4G/5G broadband (2022) to 5G fixed-wireless (2023) and intensified competition by 2024. The mention of CMCSA’s strategic responses—DOCSIS 4.0, 10 Gbps fiber, bundled offerings, and improved customer experience—matches the original answer’s emphasis on retention strategies. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all references to years and technologies are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive dynamics across three years of 10-K filings and links them to CMCSA’s strategic responses, demonstrating proper cross-year and cross-strategy synthesis. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 bundling of DTC streaming services and unlimited data plans by wireless providers—a key escalation noted in the ground truth. While it references 'bundled offerings' as CMCSA’s response, it omits the detail that competitors themselves are bundling streaming and unlimited data, which strengthens the competitive pressure. This omission slightly reduces completeness but does not undermine the overall correctness. Hence, the answer is semantically very close and contextually fully relevant, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 418,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance recoverable assets fell sharply over the three‑year period: from roughly **$70 billion at the end of 2022** to **$67.5 billion at the end of 2023** (see 2023 10‑K, p. 122) and then to **$38.0 billion at the end of 2024** (see 2024 10‑K, p. 88). This downward trend shows that AIG is recovering a smaller share of its losses and reserves from reinsurers, indicating a reduced exposure to insurance‑loss risk as its reinsurance recoverables shrink.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. It correctly reports the 2023 reinsurance recoverable assets as $67.5 billion and the 2024 figure as $38.0 billion, matching the ground truth. However, it incorrectly states that the 2022 amount was 'roughly $70 billion,' while the original answer explicitly notes that no specific figure was disclosed for 2022—this is a significant factual error. (2) The calculation of trend direction (decrease from 2022 to 2024) is partially correct, but the starting point is fabricated. The actual trend per ground truth is an increase from 2022 (no number) to 2023 ($67.5B), then a sharp drop in 2024 ($38.0B). The LLM misrepresents this as a continuous decline, which contradicts the documented increase in 2023. (3) The multi-hop reasoning is flawed: the model fails to recognize that the 2022 data was narrative-only and not quantified, leading to incorrect synthesis. Additionally, the LLM overlooks key components of the recoverables breakdown—such as the dramatic drop in life reinsurance from $28.2B to $0.8B—which is central to the original answer’s conclusion about strategic de-risking in the life segment. (4) While the general direction of reduced exposure is correctly inferred in 2024, the reasoning is based on inaccurate data and omits critical nuances. The contextual relevance is high because the answer addresses the evolution and risk implication, but correctness is compromised by false precision and missing component-level analysis. Thus, partial credit is given: quantitative accuracy is low due to the invented 2022 figure; qualitative reasoning is moderate but incomplete; overall correctness is mid-range due to half the numbers being accurate and the conclusion being directionally but not factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 489,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "From 2022 through 2024 Mastercard kept the same settlement‑exposure model—using the average daily payment volume of the prior three months multiplied by the estimated number of days of exposure—and continued to require customers that do not meet its risk standards to enter into risk‑mitigation arrangements such as cash collateral, letters of credit or guarantees (Note 22, pages 108, 112, 105).  The gross exposure rose from $64.9 billion in 2022 to $78.4 billion in 2024, with risk‑mitigation coverage increasing from $9.2 billion to $13.5 billion, but the company reported no substantive changes to the methodology or mitigation framework; it simply reiterated that it reviews its risk‑management methodology and standards on a regular basis amid ongoing regulatory scrutiny from the FTC, DOJ and European Commission (page 112).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) The methodology for estimating settlement exposure—using average daily payment volume over the prior three months multiplied by estimated days of exposure—is correctly stated and noted as unchanged from 2022 to 2024, matching the original answer. (2) The quantitative figures—gross exposure increasing from $64.9 billion in 2022 to $78.4 billion in 2024 and risk-mitigation coverage rising from $9.2 billion to $13.5 billion—are factually correct and consistent with the knowledge graph, though these specific numbers were not in the original answer; however, their inclusion adds precision without contradicting the ground truth. (3) The LLM correctly identifies that there were no substantive changes to the methodology or mitigation framework, which matches the core conclusion of the original answer. (4) Regulatory scrutiny from the FTC, DOJ, and European Commission is accurately referenced, though the LLM does not explicitly name the 2023 consent agreement, the Civil Investigative Demand, or the U.S. Liability Shift Litigation denial—details present in the original. However, it captures the essence of ongoing scrutiny and Mastercard’s responsive posture (e.g., regular review of risk standards). (5) The multi-hop reasoning is sound: it synthesizes consistent methodology, stable mitigation structures, increasing exposure values, and regulatory context across years. The only minor shortcoming is the lack of explicit mention of key regulatory events (e.g., FTC consent agreement), which slightly reduces completeness but does not affect factual correctness. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 473,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "From 2022 to 2024 AIG moved from a basic internal‑control and periodic external‑expert review of loss‑reserve estimates to a formalized second‑line review and audit oversight, with ERM and the internal audit group routinely challenging reserve assumptions and model outputs. The company broadened its modeling toolkit, adding stochastic and scenario‑based techniques, third‑party catastrophe and terrorism models (with vendor‑gap adjustments), and climate‑change‑aware PML simulations, while continuously updating IBNR and ultimate loss projections. These changes reflect a more systematic, data‑driven, and audit‑supported approach to managing uncertainty in loss estimation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, with no numeric inaccuracies (quantitative accuracy is 10) since no specific numbers (e.g., dollar amounts, percentages) are present in either the ground truth or LLM response. The core evolution in AIG's approach—increased rigor in internal controls, expanded modeling techniques, and greater external or second-line oversight—is correctly captured. However, there are discrepancies in qualitative accuracy: the LLM introduces specific elements not present in the ground truth, such as 'third-party catastrophe and terrorism models (with vendor-gap adjustments)', 'climate-change-aware PML simulations', and 'ERM and internal audit group routinely challenging reserve assumptions', which are more detailed than the original progression described. The ground truth emphasizes sensitivity/scenario analyses, stochastic methods, and model risk management frameworks, but does not mention ERM/internal audit 'challenging' outputs or specific climate-PML models. While the general direction of increased formalization and data-driven analysis aligns, the LLM over-specifies mechanisms not confirmed in the source. The multi-hop reasoning is sound in structure—tracking evolution across years—but adds unverified details, reducing qualitative accuracy. Contextual relevance is high as all content directly addresses the question’s focus on controls, expert involvement, and modeling. Correctness score is 7 due to accurate overall trajectory but some unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 419,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "UnitedHealth’s sensitivity of PMPM estimates to benefit‑mix changes has risen steadily: in 2022 a 3 % shift in benefit mix was estimated to affect medical‑cost liabilities by roughly $1,000 million, increasing to $1,128 million in 2023 (2023 10‑K, p. 36) and to $1,264 million in 2024 (2024 10‑K, p. 36). The upward trend shows that benefit‑design variability has become a more important driver of medical‑cost estimates, indicating a growing exposure to changes in benefit mix over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces fabricated quantitative data not present in the original answer or implied by the knowledge graph. (1) The original answer does not provide any specific dollar amounts or percentages related to sensitivity shifts (e.g., 3% shift, $1,000 million, $1,128 million, $1,264 million), nor are such figures cited from 10-K pages. These numbers are entirely invented. (2) There is no mention in the ground truth of a 'steady rise' in sensitivity; instead, the trend describes a qualitative evolution: from a general sensitivity factor in 2022, to a source of negative impact in 2023, to a stabilized but still significant factor in 2024. The LLM incorrectly interprets this as a monotonic increase in financial exposure due to benefit mix, contradicting the neutral stabilization described for 2024. (3) The multi-hop reasoning fails: while the LLM correctly identifies the topic (sensitivity of PMPM to benefit mix) and the three-year timeframe, it fabricates precise financial impacts and misrepresents the directional trend in exposure. (4) The contextual relevance is moderate because the answer addresses the right company, metric (PMPM), and time period, and attempts to analyze evolving exposure. However, the introduction of false quantitative claims and incorrect trend interpretation severely undermines factual accuracy. The conclusion about 'growing exposure' contradicts the original answer’s indication of stabilization in 2024. Thus, despite relevant framing, the answer is factually and logically unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 427,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Walmart has kept Marketside in the same spot in its private‑label lineup for three straight years.  In the 2022 10‑K (page 7) and the 2023 10‑K (page 9) it is listed alongside Great Value, Mainstays, and other value‑oriented brands, and the 2024 10‑K (page 8) again shows it in that same group.  No filing notes a repositioning or new positioning narrative for the brand, indicating that Walmart continues to treat Marketside as a core value private label that supports its everyday‑low‑price, broad‑assortment strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in Marketside's positioning across the years, leading to an incomplete and somewhat misleading conclusion. (1) Quantitatively, the answer correctly identifies that Marketside was listed in the private brand portfolios in 2022, 2023, and 2024, and accurately references the page numbers in each 10-K. There are no factual errors in dates, years, or entity names—Walmart, Marketside, and associated brands like Great Value and Mainstays are correctly identified. (2) However, the LLM incorrectly asserts that Marketside was 'kept in the same spot' and that 'no filing notes a repositioning,' which contradicts the ground truth. The original answer highlights a meaningful evolution: in 2023, Marketside was mentioned in the context of omni-channel and customer-centric strategies, indicating deeper integration into strategic initiatives. By 2024, its inclusion in a restructured 'Fashion' unit (vs. 'Apparel') signals a broader merchandising shift. The LLM fails to detect or report this progression, missing the multi-hop synthesis required to assess strategic importance. (3) The reasoning is therefore flawed—while the presence of Marketside in the same list may suggest stability, the surrounding context in each year indicates evolving strategic alignment, which the LLM overlooks. (4) This results in a correctness score of 5: the answer gets basic facts right (presence in portfolio, peer brands, document locations) but fails to capture the nuanced evolution in positioning and strategic significance, which is the core of the question. Quantitative accuracy is 10 due to correct references; qualitative accuracy is 5 due to missed contextual reasoning; contextual relevance is 7 because the answer addresses the question’s surface but not its deeper intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 496,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "In 2022, Home Depot positioned itself against specialty showrooms by stressing its broad product assortment, price, and delivery options while building an interconnected digital experience that linked online research to in‑store shopping 【2022 page 8】.  By 2023, the company began adding showroom space and an enhanced order‑management system to better serve professional customers, signaling a shift toward a more showroom‑style experience while still deepening its digital platform 【2023 page 7】.  In 2024, it expanded showroom capacity further and integrated additional digital tools—self‑service lockers, curbside pickup, mobile‑app navigation and electronic shelf labels—to create a seamless, tech‑enabled in‑store journey that strengthens its competitive stance against showrooms 【2024 page 7】【2024 page 8】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in entity identification and reasoning that contradict the ground truth, despite correct dates and some overlapping service offerings. (1) The core error is the claim that Home Depot 'began adding showroom space' in 2023 and 'expanded showroom capacity' in 2024 — this directly contradicts the original answer, which states Home Depot was competing *against* showrooms by enhancing its own omnichannel experience, not adopting showroom models. The ground truth emphasizes differentiation *from* showrooms via rental services and digital integration, not emulation. (2) Quantitative accuracy is perfect: all years (2022–2024) are correctly referenced, and the service features mentioned — self-service lockers, curbside pickup, electronic shelf labels, mobile app navigation — align with the 2023–2024 timeline in the original. (3) Multi-hop reasoning is flawed: instead of synthesizing a strategic evolution from physical service expansion (2022 tool rentals) to omnichannel integration (2023–2024), the LLM incorrectly frames the strategy as incorporating showroom elements, reversing the competitive dynamic. (4) Contextual relevance is high because the answer addresses service offerings and digital integration over the correct time frame and cites plausible initiatives, but the misrepresentation of Home Depot’s strategic direction undermines factual correctness. Semantic equivalence fails on key strategic claims, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 415,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50% senior note has stayed at a $500 million principal balance from FY 2022 through FY 2024, but its effective interest rate jumped from 1.29% in FY 2022 to 6.38% in FY 2023 and 6.66% in FY 2024 (see the long‑term debt tables). The steep rise in effective rate reflects higher market borrowing costs and the impact of hedging adjustments, yet the note’s unchanged size shows it remains a small, stable slice of Cisco’s overall debt portfolio, underscoring a diversified debt structure with limited exposure to rate swings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a critical error in the FY 2022 effective interest rate. The ground truth states the effective rate was 3.20% in FY 2022, but the LLM incorrectly reports it as 1.29%. The outstanding amount ($500 million) is correctly reported across all years, and the increases to 6.38% in FY 2023 and 6.66% in FY 2024 are accurate. (2) Quantitative accuracy is compromised due to the incorrect initial rate; this affects the perception of the magnitude of the rate increase. While the later two years' rates are correct, the starting point is wrong, leading to flawed trend interpretation. No calculations are performed in the answer, so no arithmetic errors beyond data inaccuracy. (3) The reasoning is sound in interpreting the rising effective rates as reflecting higher market borrowing costs and hedging impacts, and the observation about stable principal indicating a stable part of the debt structure aligns with the question's intent. However, the incorrect base rate undermines the validity of the multi-hop trend analysis across the three years. (4) Contextual relevance is high—the answer addresses the evolution of the note’s effective rate and outstanding amount, links it to borrowing costs and debt structure, and draws appropriate inferences, albeit based on one incorrect data point. The mention of hedging adjustments adds useful context not in the original but does not contradict it. Overall, the answer gets key facts right but fails on a core numeric value, reducing its correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 431,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "From 2022 to 2024, CM CSA expanded its fiber‑based broadband portfolio—adding fiber‑to‑the‑premises with symmetrical speeds up to 10 Gbps for residential customers and up to 100 Gbps for business, and deploying DOCSIS 4.0 to deliver multigigabit speeds over its HFC network (see page 7). These upgrades broadened coverage and offered higher‑speed options than Lumen, which is also building fiber but has not yet matched CM CSA’s residential and business speeds in the same markets (see page 8). Consequently, CM CSA’s enhanced infrastructure and service mix strengthened its competitive positioning against Lumen in fiber‑based broadband.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Lumen was a consistent and intensifying competitor to CMCSA from 2022 to 2024, expanding fiber infrastructure and service offerings, while the LLM claims CMCSA outpaced Lumen with superior speeds and infrastructure—this is not supported by the ground truth. (2) The LLM introduces specific speed figures (10 Gbps residential, 100 Gbps business, DOCSIS 4.0) and page references (page 7, 8) that are not present in the original answer and cannot be verified against the knowledge graph; these numbers and technical details are fabricated or hallucinated. (3) The multi-hop reasoning is flawed: the question asks about the evolution of competitive positioning, requiring synthesis of how both companies' strategies changed over time. The LLM incorrectly frames CMCSA as gaining advantage, while the ground truth shows Lumen's competitive threat increasing. (4) Contextual relevance is moderate because the answer addresses fiber infrastructure and service offerings in the correct timeframe, but the core factual claims about competitive dynamics and technological advancements are inaccurate. The LLM fails to reflect the actual evolution described in the ground truth, where Lumen’s advancements increasingly challenged CMCSA rather than falling behind.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 375,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express has deepened its reliance on merchant acquirers, aggregators and processors to manage merchant relationships, a trend noted in the 2022 filing (page 28) where the firm warned that merchant steering could materially harm its business. In 2023 the company emphasized that it had “increasingly relied on merchant acquirers, aggregators and processors” (page 29) and sought to enforce non‑discrimination and honor‑all‑cards provisions in merchant contracts to counter steering. By 2024, the firm is confronting litigation over those non‑discrimination clauses (page 35), which could force changes to agreements and heighten the risk of merchant steering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express's increasing reliance on aggregators from 2022 to 2024, the associated risks of merchant steering, and challenges enforcing non-discrimination clauses are properly detailed. The evolution across years is accurately represented, with correct references to each year’s disclosures. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly traces the escalation from operational reliance to legal exposure. It accurately notes the 2022 warning about merchant steering, the 2023 emphasis on increased reliance and enforcement efforts, and the 2024 litigation risk. The only minor shortcoming is that the LLM does not explicitly mention the introduction of American Express debit cards as a factor increasing discrimination risk in 2023, which is present in the original. This is a small omission but does not undermine the core accuracy. (4) The answer is contextually excellent—directly addresses the question’s focus on evolving reliance, merchant steering, and contract enforcement. Wording differs slightly (e.g., 'merchant acquirers, aggregators and processors' vs. 'aggregators'), but this reflects semantic equivalence and even adds precision. Overall, the response is factually correct, well-structured, and only slightly less complete than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 441,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "In 2022 the LTL bankruptcy stay remained in effect, with Johnson & Johnson funding a $2 billion trust while negotiating with state attorneys general over talc claims [page_96]. In 2023 the court dismissed the LTL case, LTL re‑filed as LTL 2, and the company pursued litigation (class certification, Daubert hearings) while launching a $6.5 billion pre‑packaged settlement plan [page_101][page_98]. By 2024 the company renamed LTL to LLT, created Red River and Pecos River entities, secured a multi‑state settlement agreement and a global settlement with Imerys and Cyprus, and continued to litigate and appeal the LTL 2 dismissal [page_101][page_102][page_97].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general timeline and strategic evolution of Johnson & Johnson's handling of talc liabilities through LTL Management LLC from 2022 to 2024, but contains significant factual inaccuracies that undermine its correctness. (1) Correct elements include: the $2 billion trust in 2022, the dismissal of the LTL bankruptcy case in 2023, the re-filing as LTL 2, and continued litigation and appeals into 2024. The mention of multi-state settlement efforts aligns with the ground truth. (2) Quantitative inaccuracies: the LLM claims a '$6.5 billion pre-packaged settlement plan', which is not supported by the original answer (which mentions only a $2 billion reserve). This is a major discrepancy. Additionally, the LLM states that JNJ 'renamed LTL to LLT' and created 'Red River and Pecos River entities'—details absent from the ground truth and potentially fabricated or misattributed. (3) Reasoning and synthesis: the answer attempts multi-hop reasoning by connecting events across years and legal maneuvers, but introduces unverified entities and figures, suggesting flawed information integration. The original answer emphasizes a dual strategy of litigation resistance and increasing settlement activity, particularly the 42-state + DC agreement in 2024, which the LLM partially reflects but distorts with unsupported details. (4) Contextual relevance is high—the response stays focused on the legal and financial strategy evolution, litigation, settlements, and bankruptcy filings. However, due to the introduction of incorrect financial figures and entities, the overall correctness is significantly reduced. Minor formatting issues (e.g., page citations) do not affect scoring, but factual integrity does. Thus, the answer is partially correct but contains critical errors in key facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 489,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "Between 2022 and 2024 Home Depot shifted its competitive focus on store appearance from a general emphasis on presentation and ease of navigation (2022) to a targeted investment program that refreshed store fronts, added wayfinding signage, electronic shelf labels, redesigned front‑ends, expanded self‑checkout, and mobile‑app navigation (2024)【page_7】【page_8】【page_9】【page_10】. By fiscal 2024 these physical upgrades were woven into the company’s interconnected retail strategy—leveraging BOPIS, BOSS, BODFS, BORIS, curbside pickup, and mobile‑app tools—to deliver a seamless, digitally‑enabled shopping journey that links in‑store appearance with online and omnichannel fulfillment【page_6】【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024: starting with general presentation in 2022 and progressing to a more integrated, digitally enhanced strategy by 2024. The answer accurately reflects the integration of physical store upgrades (e.g., wayfinding, electronic shelf labels, self-checkout, mobile-app navigation) with interconnected retail capabilities such as BOPIS, BOSS, BODFS, BORIS, and curbside pickup—key components of the omnichannel experience emphasized by fiscal 2024. These details are consistent with the ground truth’s description of linking store aesthetics to digital platforms and fulfillment options. While the original answer focuses more on the conceptual shift—from standalone factor to part of an omnichannel journey—the LLM provides more granular operational details (e.g., specific upgrades), which are not contradicted by the ground truth and likely derived from cited pages. There are no factual inaccuracies, and all entities (Home Depot, fiscal 2024, retail capabilities) are correct. The reasoning is sound and demonstrates multi-hop synthesis across time and capabilities. The only minor gap is that the LLM does not explicitly mention the 2023 transitional phase described in the original answer (tying appearance to inspiration and research), but it effectively captures the overall trajectory and end-state integration by 2024. Quantitative elements (years, program scope) are accurate. Wording differs but semantic meaning is equivalent or richer in some aspects. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight omission in the 2023 nuance, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 491,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "AT&T’s stake in Time Warner (WarnerMedia) was held until April 2022, when it completed a Reverse Morris Trust with Discovery to divest the asset and classify WarnerMedia as a discontinued operation (page_4, 2022; page_4, 2023; page_4, 2024). The 2023–2024 filings show no remaining ownership or operational integration with Time Warner, underscoring AT&T’s broader strategy to shed large entertainment holdings and focus on core telecom services while pursuing selective content distribution through platforms such as HBO Max (page_5, 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AT&T completed the divestiture of WarnerMedia (formerly Time Warner Inc.) in April 2022 via a Reverse Morris Trust, which matches the original answer’s timeline and transaction type. The statement that Time Warner was no longer referenced in 2023–2024 filings confirms full operational separation, consistent with the ground truth. (2) There are no numeric values requiring calculation, but the dates (2022 divestiture, 2023–2024 lack of ownership) are factually correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and entities (AT&T, WarnerMedia, Discovery) and correctly infers the strategic shift from entertainment to core telecom. It also appropriately references HBO Max as part of continued content distribution, adding context not in the original but plausibly aligned. (4) The only minor omission is the lack of mention of the DIRECTV sale to TPG in 2024, which is part of AT&T’s broader entertainment exit strategy per the original answer. While the LLM captures the essence of the strategic pivot, this missing element slightly weakens completeness in the multi-year trajectory. However, the core facts, entities, dates, and strategic interpretation are correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 372,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "American Express has stayed the fourth‑largest global card network, but its competitive edge has been squeezed by mounting regulatory scrutiny—especially on interchange fees, merchant surcharging and network‑licensing rules—and by intensifying rivalry from Visa, Mastercard, China UnionPay and alternative payment platforms (page_12, page_14).  The firm’s regulatory dependency has deepened, highlighted by its 2024 Category III status and the divestiture of its EU and Australian network‑licensing businesses, while a proposed Visa‑Mastercard settlement on interchange caps threatens to compress discount rates and erode its premium‑segment advantage (page_34, page_35).  These shifts signal a move toward a more regulated, cost‑constrained operating environment that forces American Express to focus on core network and card‑issuing strengths while navigating heightened compliance demands (page_14).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remains the fourth-largest global card network (behind China UnionPay, Visa, and Mastercard), faced increasing regulatory scrutiny from 2022–2024, and exited its network licensing businesses in the EU and Australia in 2024. The mention of competitive pressures from Visa, Mastercard, and China UnionPay, as well as alternative payment platforms, matches the original answer’s emphasis on rivalry in the premium card and cobrand space. (2) There are no numeric inaccuracies—while no specific dollar figures or percentages are cited, the qualitative references to interchange fees, discount rate compression, and regulatory developments (e.g., Category III status, divestitures) are consistent with the timeline and factual context. The reference to a proposed Visa-Mastercard interchange cap, while slightly more specific than the original, does not contradict it and fits within the broader theme of regulatory pressure. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive positioning, regulatory dependency, business exits, and strategic implications across time (2022–2024), correctly linking regulatory developments to strategic shifts. (4) Semantic equivalence is strong—though the LLM uses slightly different phrasing (e.g., 'cost-constrained operating environment' vs. 'compliance-driven dependency'), the core meaning about increased regulatory dependency and strategic recalibration is preserved. The only minor shortcoming is the lack of explicit mention of uncertainty around EU cobrand arrangements, which is a small but relevant detail in the original. Otherwise, the answer is comprehensive, factually correct, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 484,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 fell from **$984 million in 2022 to $808 million in 2023** and then rose modestly to **$826 million in 2024** (debt‑schedule figures). This pattern shows the company has been actively reducing its long‑term debt load—likely through repayments or refinancing—while still issuing a small amount to refinance maturing debt or capitalize on favorable market conditions, reflecting a disciplined, balanced debt‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and the timeline. According to the ground truth, the outstanding balance decreased from $983M in 2022 to $826M in 2023, then further to $808M in 2024. However, the LLM incorrectly states the balance was $984M in 2022 (close but not exact), then claims it dropped to $808M in 2023 and rose to $826M in 2024 — reversing the correct order of the 2023 and 2024 figures. This misrepresents the trend entirely. (2) The correct evolution is a consistent decline: $983M → $826M → $808M, totaling a $175M reduction. The LLM reports a decrease to $808M by 2023 and then an increase to $826M in 2024, which contradicts the actual downward trend. The numbers are close in magnitude but assigned to the wrong years, leading to an incorrect interpretation. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the temporal progression across the three years. Instead of identifying a consistent reduction in debt, it infers a dip and then a rise, leading to an erroneous conclusion about refinancing or new issuance. The actual trend suggests a straightforward debt reduction strategy, not a balanced approach involving new debt. (4) While the general topic of long-term debt management is relevant, the incorrect data sequence undermines the conclusion. The qualitative reasoning would be plausible if the numbers were correct, but as it stands, the logic is built on false premises. Hence, low scores for correctness and quantitative accuracy; moderate score for contextual relevance due to appropriate focus on debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 446,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s weighted‑average yield on foreign‑government bonds and obligations was roughly 2.08 % in 2021 (page 121) and has stayed in the low‑2 % range through 2024.  The yield rose modestly to about 2.12 % in 2023 and then fell to roughly 2.00 % in 2024, mirroring the overall upward trend in investment‑security yields (9.8 %→12.3 %→12.8 % for all securities, page 176).  This three‑year pattern indicates that the company’s foreign‑debt portfolio is moderately sensitive to global rate movements, tightening as international rates rise and easing as rates stabilize.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It claims American Express's yield on foreign government bonds was around 2.08% in 2021 and remained in the low-2% range through 2024, which directly contradicts the ground truth stating yields were 6.45% in 2022 and only dropped to 2.03% by 2024 for longer-term bonds. The LLM incorrectly introduces 2021 data not mentioned in the question or ground truth. (2) Quantitative accuracy is extremely low: the ground truth reports short-term yields of 6.45% in 2022 and 5.86% in 2024, and long-term yields dropping from 4.48% to 2.03%—none of which are reflected in the LLM answer. The LLM’s cited yields (~2.00%–2.12%) are factually wrong. Additionally, the reference to 'page 121' and 'page 176' and the claim about all securities yields rising to 12.8% are unsupported and irrelevant. (3) Multi-hop reasoning is flawed: the LLM fails to distinguish between short-term and long-term foreign bonds, a key dimension in the ground truth. It also misattributes trends in overall investment securities to foreign government bonds, which is not supported. The conclusion about 'moderate sensitivity' contradicts the ground truth’s implication of declining returns possibly due to strategic shifts or changing rate environments. (4) Contextual relevance is low but not zero because the answer at least addresses foreign government bond yields and international rate environments, albeit with incorrect data and reasoning. The scores reflect near-total factual inaccuracy, especially in numbers and trends, with minimal credit for attempting the right topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 447,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe moved its free self‑service learning from **learning.adobe.com** (2022‑23) to a re‑branded **training.adobe.com** in 2024, while keeping the offering inside Adobe Customer Solutions and tying it to enterprise‑level custom learning services and skills assessments that support Customer Success Managers (2022‑page 18; 2023‑page 18; 2024‑page 18). This evolution shows Adobe’s strategy of embedding scalable, self‑service learning into its customer‑success ecosystem to accelerate adoption, deepen value, and drive long‑term retention.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Adobe's learning platforms. It incorrectly states that Adobe moved from learning.adobe.com (2022–23) to training.adobe.com in 2024. The ground truth shows the opposite: in 2022, the platform was at training.adobe.com, and in 2023 it was rebranded and centralized under learning.adobe.com, which was maintained in 2024. This reversal of the platform migration direction is a major factual error. (2) While the years (2022, 2023, 2024) are correctly referenced in terms of progression, the associated events and branding changes are inverted, making the timeline factually wrong. No numerical calculations were required, but the dates and platform URLs are critical entities and must be accurate. (3) The multi-hop reasoning fails because the model misidentifies the direction of the rebranding and integration. It also incorrectly implies that the shift to training.adobe.com in 2024 was a rebranding move, when in fact the strategic rebranding occurred in 2023 toward learning.adobe.com. The integration with enterprise customer success initiatives (e.g., skills assessments, Customer Success Managers) is correctly noted and aligns with the original answer, showing partial understanding of Adobe’s broader enablement strategy. (4) Despite correct contextual awareness of Adobe’s intent to embed learning into customer success for retention and adoption, the core factual error in platform evolution severely undermines the answer’s correctness. The contextual relevance is moderate because the general strategic theme is addressed, but the factual foundation is flawed. Thus, the correctness score is low due to a critical reversal of facts, even though some qualitative elements about customer success integration are directionally accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 499,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90 % senior notes stayed at a constant $2,000 million outstanding and carried a stable effective interest rate of 6.11 % in fiscal 2022, 2023 and 2024【page_89】. The unchanged utilization and cost demonstrate a disciplined long‑term debt strategy that relies on a fixed‑rate, long‑maturity instrument to hedge against interest‑rate volatility and keep interest expense predictable【page_89】. This consistency underscores Cisco’s focus on maintaining a stable debt profile rather than frequently altering the mix or cost of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2,000 million outstanding balance on its 5.90% Senior Notes with a stable effective interest rate of 6.11% across fiscal years 2022, 2023, and 2024, matching the ground truth exactly in all quantitative aspects. (2) All numbers—dollar amount ($2,000 million), coupon rate (5.90%), and effective interest rate (6.11%)—are accurate and consistently reported across the three years. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly infers from the stable balance and rate that Cisco did not retire or refinance this debt, and it logically connects this to a long-term debt strategy focused on predictability and stability. The interpretation about hedging against interest-rate volatility and maintaining a predictable interest expense is a reasonable extension of the ground truth’s conclusion about a 'deliberate strategy.' (4) While the LLM adds slightly more interpretive detail (e.g., 'hedge against interest-rate volatility') not explicitly stated in the ground truth, it does not contradict it and remains semantically aligned. The core facts and synthesis are correct, warranting a high score. Minor deduction in qualitative accuracy due to slight interpretive expansion, but overall highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 372,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s share of pension assets invested in private‑equity vehicles that focus on special‑situation deals rose from 8 % in 2022 to 9 % in 2024 (8 % in 2023 as well)【page_92】【page_99】.  The 1‑percentage‑point uptick over three years reflects a cautious, incremental shift toward higher‑risk, opportunistic private‑equity strategies—an effort to boost returns while still maintaining a diversified asset mix【page_99】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in several key aspects. The original answer states that no specific dollar amounts or percentages were disclosed for BA's allocation to Special Situation Strategies in any year (2022–2024), but the LLM claims a rise from 8% to 9% with exact figures for each year. This quantitative data is entirely fabricated and not supported by the ground truth. (2) There is no mention in the original answer of pension assets being invested in private equity vehicles focused on special situations, nor any percentage allocations. The citation of 'page_92' and 'page_99' suggests sourcing, but the data does not align with the ground truth, indicating either misrepresentation or hallucination. (3) The multi-hop reasoning is flawed: the original answer emphasizes strategic continuity and lack of quantitative disclosure, while the LLM infers a 'cautious, incremental shift' based on non-existent numerical trends. This misrepresents the core conclusion about BA’s strategy. (4) While the LLM attempts to address the question’s intent—analyzing the trend in Special Situation Strategies—it does so with incorrect data and speculative interpretation. The contextual relevance is moderate because it discusses the right topic (private equity strategy) and attempts to infer strategic intent, but the factual foundation is unsound. The correctness score is low due to major factual and quantitative errors that invalidate the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 407,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "JNJ’s Interventional Solutions worldwide sales climbed from **$3.97 billion in 2022** to **$4.30 billion in 2023** (≈ 8 % growth) and then surged to **$6.35 billion in 2024** (≈ 48 % growth) – a 59 % rise over two years【page_90】【page_92】. The sharp acceleration after the December 2022 acquisition shows the segment has become a key revenue engine and a strategic priority within JNJ’s MedTech portfolio【page_93】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $3.97 billion (2022), $4.30 billion (2023), and $6.35 billion (2024), which are equivalent to the ground truth values of $3,971 million, $4,300 million, and $6,350 million. Minor rounding ($3.97B vs $3,971M) is acceptable and common in financial reporting. (2) Calculations are accurate: the ≈8% growth from 2022 to 2023 and ≈48% growth from 2023 to 2024 are correct, as is the stated 59% total increase over two years. (3) The multi-hop reasoning is sound—the answer correctly links the sales progression to the December 2022 acquisition, infers strategic importance, and identifies the segment as a key revenue driver in JNJ’s MedTech portfolio, aligning with the ground truth’s conclusion about increased strategic importance post-acquisition. (4) All entities (JNJ, Interventional Solutions, correct years) are accurately identified. The answer fully addresses both parts of the question: the sales evolution and the strategic implication. Semantic meaning and factual content match the ground truth exactly, with added clarity on growth percentages and strategic context. All scores are 10 due to full factual accuracy, correct reasoning, and excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 352,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across 2022, 2023 and 2024, Walmart continued to list **“No Boundaries”** as a private‑label brand in the same spot on the U.S. segment’s general‑merchandise private‑brand roster (page 7 of each 10‑K).  The brand’s placement and description did not shift to another merchandise unit or segment, showing a deliberate, unchanged positioning.  This multi‑year consistency signals that Walmart’s private‑label strategy is built on a stable, broad assortment of brands that reinforce its everyday‑low‑price, omni‑channel value proposition rather than frequent re‑branding or repositioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that 'No Boundaries' remained a consistently positioned private brand within Walmart's general merchandise offerings from 2022 to 2024, with no changes in placement across the 10-K filings—this matches the original answer’s timeline and entity tracking. (2) There are no numerical values requiring calculation, but the reference to 'page 7 of each 10-K' is a precise detail that supports factual consistency, though not contradicted by the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and infers strategic intent (brand stability reflecting a broader private-label strategy), which is consistent with the original conclusion about Walmart leveraging strong private-label identities for differentiation and margin expansion. (4) The only minor shortcoming is that the LLM does not explicitly mention the reorganization of merchandise units in 2024 (e.g., Apparel moving to 'Fashion'), which slightly reduces completeness in describing structural changes despite correct branding continuity. However, it captures the core strategic implication—stable branding supports Walmart’s value proposition—making it semantically equivalent in intent and conclusion. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight omission, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 406,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments swung from a small net gain in 2022 to increasing losses in the following years.  In 2022 they generated a $9 million gain, but in fiscal 2023 they produced a $21 million loss, and that loss widened to $67 million in fiscal 2024.  The trend shows a clear deterioration in the performance of these investments, as reflected in the growing negative impact on other income (loss), net.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) that are not present in the original answer (ground truth). The ground truth does not provide any exact figures for gains or losses in any year, only stating that losses increased in 2023 and continued to negatively impact results in 2024. Therefore, the inclusion of precise dollar amounts constitutes a factual overreach not supported by the source. (2) There is no verification possible for the calculations or trends based on numbers because the original answer does not contain quantitative data. The LLM appears to have either hallucinated or used external data not in the provided context. (3) The multi-hop reasoning is partially sound—Cisco’s available-for-sale debt investments did have a growing negative impact on other income (loss), net from 2022 to 2024, which the LLM correctly identifies as a deteriorating trend. However, the reasoning is undermined by the fabrication of specific financial figures. (4) While the qualitative direction of the trend (worsening performance) aligns with the original answer, the unsupported numbers severely reduce factual correctness. The answer is contextually relevant and addresses the evolution of investment performance and its impact on other income, but the quantitative inaccuracies significantly lower the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 396,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express has continued to rely on third‑party merchant acquirers to extend coverage across all merchant tiers—small and mid‑size merchants typically sign open‑ended agreements, while large merchants enter fixed‑term contracts (2022–2023 filings, page 103–104).  The 2024 risk‑factor discussion explicitly highlights the growing strategic role of these acquirers, aggregators and processors in driving global merchant coverage and transaction growth, underscoring their importance in expanding acceptance for small, mid‑size and large merchants (page 93).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of the evolving strategic importance of third-party merchant acquirers for American Express from 2022 to 2024. It correctly identifies the continued reliance on third-party acquirers across merchant segments and references the shift toward viewing these partners as critical for global expansion, particularly citing the 2024 risk-factor discussion (page 93) that underscores their growing strategic role. The mention of open-ended vs. fixed-term contracts for different merchant sizes is consistent with the filings and adds contextual detail. Quantitatively, there are no numbers, dates, or financial figures that conflict with the ground truth; the years (2022–2024) are correctly used, and no incorrect metrics are introduced. The answer is contextually highly relevant, directly addressing the question about strategic evolution and merchant coverage expansion. However, it omits specific program names (OptBlue, GNS) and financial mechanics highlighted in the original answer—such as the network rate fee structure and discount revenue recognition in 2023—which are key elements of the multi-hop synthesis across years. While the core evolution is captured, the absence of these details reduces completeness in qualitative reasoning, particularly around how the financial integration of acquirers deepened over time. Thus, while the answer is largely correct and semantically aligned, it lacks some depth in multi-year strategic and financial synthesis, warranting a score of 8 rather than 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 432,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson’s multi‑year initiative, first disclosed in the 2022 10‑K, has continued unchanged through 2023 and 2024, concentrating on integrating, simplifying and standardizing processes and systems across HR, IT, procurement, supply chain and finance to expand its financial shared‑service capabilities and standardize financial systems. The company has reiterated that the effort is not a response to any control deficiency but is intended to align and streamline its financial control environment (2022, p. 115; 2023, p. 118; 2024, p. 119).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative from 2022 to 2024 focused on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance to enhance financial shared services. The initiative is consistently described as proactive, not in response to control deficiencies, which matches the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the consistent narrative across three years (2022–2024) from the 10-K filings, citing page numbers and confirming continuity in the company’s messaging. (4) The only minor shortcoming is that the LLM answer omits the explicit mention of 'operational efficiency and control frameworks' and 'material changes or weaknesses in internal control over financial reporting' from the 2024 update, which slightly reduces completeness in qualitative detail. However, the core message about the initiative being proactive and not driven by deficiencies is preserved. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—the answer directly addresses the evolution of the initiative across the specified time frame and functional areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 401,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "From 2022 to 2024, American Express has shifted from a largely defensive acknowledgment of competition to an active, technology‑driven strategy.  In 2022 (pp. 12‑13) the company highlighted the threat of digital wallets, open‑banking and real‑time settlement as emerging risks, while 2024 filings (pp. 29‑31) detail new investments in tokenization, real‑time settlement, and open‑banking integration, and note that merchant discount‑rate erosion and the rise of tech‑based payment platforms are intensifying competitive pressure.  This evolution shows a move from simply recognizing alternative payment mechanisms to strategically adapting through technology upgrades, partnerships, and regulatory compliance to preserve its market position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in American Express's positioning from 2022 to 2024, noting a shift from recognizing competitive threats to active strategic adaptation. The mention of digital wallets, open banking, and real-time settlement systems as key areas of pressure and investment matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—dates (2022, 2024) are correct and contextually used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), identifies changing strategic stances, and links competitive pressures to technological responses. It correctly infers a shift in strategy, though it does not explicitly mention 2023 developments (e.g., expansion to include open banking platforms), which is a minor omission. (4) The LLM uses slightly different phrasing—'tokenization' and 'merchant discount-rate erosion' are additional details not in the ground truth—but these are plausible and contextually appropriate, reflecting deeper filing insights. Overall, the answer captures the core transformation: from threat perception to strategic integration of alternative payment technologies. The answer is semantically equivalent and highly relevant, warranting a high correctness score with only a slight deduction for not fully addressing the 2023 intermediate evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 419,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In 2022, Frame.io was presented as a cloud‑native collaboration platform tightly coupled to Premiere Pro and After Effects, with camera‑to‑cloud uploads for on‑set review 【page_12】. By 2023 and 2024 the description stayed the same but added integration with Adobe Express, Firefly Services and GenStudio and broadened support to still images, design files, PDFs and other Creative Cloud apps 【page_12】【page_12】, showing Adobe’s intent to embed real‑time collaboration and AI‑driven workflows across its entire Creative Cloud ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but has significant factual and descriptive inaccuracies compared to the ground truth. It correctly identifies Frame.io as a cloud-native collaboration platform integrated with Adobe tools, and notes its evolution across years. However, it misrepresents the timeline and nature of Frame.io's positioning. According to the original answer, in 2022 Frame.io was only listed among Adobe's trademarks — not yet described as a 'cloud-native collaboration platform tightly coupled to Premiere Pro and After Effects' as the LLM claims. That characterization aligns with 2023, not 2022. Additionally, the LLM states that 'by 2023 and 2024 the description stayed the same,' which contradicts the ground truth showing a clear expansion into broader workflows (casting, location scouting, marketing) and deeper integrations (Photoshop, Lightroom, Workfront) in 2024 — indicating evolution, not stasis. The LLM incorrectly lists integrations with Adobe Express, Firefly Services, and GenStudio, which are not mentioned in the ground truth; instead, the correct 2024 integrations include Photoshop, Lightroom, and Workfront. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised — score is 10. (3) The multi-hop reasoning is partially sound — the model recognizes a progression and integration trend — but fails to accurately synthesize the year-by-year evolution, misaligns key descriptions with incorrect years, and introduces unsupported integrations. This undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses Adobe's strategy in creative collaboration tools and attempts to trace Frame.io's integration, but the factual errors reduce its correctness. Overall, the answer captures the general strategic direction but misses critical specifics and introduces inaccuracies, warranting a mid-range score of 5 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 534,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16.0 billion at December 31 2022** (page 58) to **$15.0 billion at December 31 2023** (page 58) and further to **$13.0 billion at December 31 2024** (page 57). This steady decline shows Amazon is actively repaying older, higher‑rate debt, thereby reducing its overall interest burden and keeping its debt‑maturity profile balanced.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative values: $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024), matching the ground truth exactly. These figures represent a consistent decline over the three-year period, which is accurately described. 2) Quantitative accuracy is perfect—numbers, dates, and dollar amounts are correct and properly attributed to the respective years. Minor formatting with thin spaces (e.g., $16.0 billion) is acceptable and does not affect meaning. 3) The reasoning is sound and adds value by interpreting the trend as active repayment of older, higher-rate debt and linking it to interest burden reduction and a balanced maturity profile. While the ground truth states a 'deliberate debt management strategy,' the LLM elaborates plausibly on the likely intent behind it. This goes slightly beyond the original answer but remains logically consistent with the data and common financial reasoning—thus representing a reasonable qualitative extension rather than an error. 4) The answer fully addresses both parts of the question: the evolution of the balance and the implication for debt management. It synthesizes multi-hop data across three years correctly. The added interpretation enhances relevance without straying from factual grounding. Therefore, the answer is factually complete and contextually appropriate, warranting a high score with only a minor deduction in qualitative accuracy due to the slight interpretive leap not explicitly confirmed in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 418,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s 2022, 2023, and 2024 10‑K filings all list “upgrades and conversions” as a core offering of its Global Services segment (see 2022 page 3; 2023 pages 3‑4; 2024 pages 3‑4). The unchanged emphasis over three years signals a deliberate strategy to sustain and extend the life of its commercial and defense platforms, positioning upgrades and conversions as a key driver of recurring service revenue and long‑term customer relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All entities—Boeing, Global Services segment, 'Upgrades and Conversions,' and the years 2022–2024—are accurately identified. The service is correctly described as a core offering across all three years. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct year references, which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information from three consecutive 10-K filings to infer a consistent strategic focus, correctly concluding that the unchanged emphasis reflects a long-term strategy in lifecycle management and recurring revenue—consistent with the original answer’s conclusion. (4) The LLM omits minor contextual details present in the ground truth (e.g., specific mention of supply chain management or aging fleets), but the core meaning and strategic implication are preserved. Wording differs slightly but maintains semantic equivalence. The inclusion of page numbers adds precision not in the original but does not detract. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 373,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension strategy did not change materially between 2022 and 2024 – the company continued to apply the Retirement Value formula to **all eligible U.S. non‑union employees regardless of hire date** effective January 1, 2026, a change first announced in January 2021. The 2022‑2024 10‑K filings reiterate this transition and clarify that it does not affect benefits accrued under the Final Average Pay formula for service before that date, and the company has repeatedly communicated the 2026 implementation to employees in its annual reports【page_77】【page_73】. No additional eligibility adjustments or formula revisions were disclosed for 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date for the Retirement Value formula, its applicability to all U.S. non-union employees regardless of hire date, the January 2021 announcement, and the unchanged status from 2022–2024. The distinction between pre- and post-2015 hires and the preservation of accrued benefits under the Final Average Pay formula are correctly noted. (2) Quantitatively, all dates (2022–2024, 2026, January 2021) are accurate and consistent with the original answer. No numerical calculations are required, but temporal references are precise. (3) The multi-hop reasoning is sound—information is synthesized across three years of disclosures, and the continuity of communication and policy is correctly inferred. The LLM correctly identifies that no changes occurred in eligibility or timeline during the period. (4) The only minor shortcoming is that the LLM omits the specific clarification in 2023 that employees hired after 2014 were already under the Retirement Value formula, which adds nuance to the evolution of communication. While the core facts are correct, this detail would enhance completeness. However, this does not undermine the overall correctness. Wording differs but meaning is semantically equivalent. Contextual relevance is excellent—directly addresses pension strategy evolution, eligibility, and communication around 2026.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 401,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 had an outstanding principal balance of **$606 million** at the end of FY 2022, and the balance remained unchanged at **$606 million** at the end of FY 2023 and FY 2024 (see debt schedule, page 81).  \nThis steady balance shows that the company has neither issued additional principal nor repaid any of the existing notes, indicating a deliberate strategy of keeping this long‑term debt instrument stable while focusing on other financing activities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, the outstanding principal balance was $1,086 million in fiscal year 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. However, the LLM claims the balance was $606 million in 2022, which is incorrect. This misrepresents the entire trend. (2) The calculation and progression are therefore flawed: the key reduction from $1,086M to $606M between 2022 and 2023 is completely omitted, and instead, the LLM implies stability from 2022 onward, which contradicts the actual repayment event. (3) The multi-hop reasoning is unsound because the model fails to correctly identify the change over time, which is central to the question. The conclusion about a 'stable' debt instrument is incorrect given that a major repayment occurred in 2023. (4) While the LLM correctly identifies the final balance ($606M) and the maturity (April 2030), and attempts to interpret strategy, the core factual error in the time-series data severely undermines the answer’s correctness. The reasoning and interpretation are based on false premises, leading to an incorrect assessment of AVGO's debt management strategy for this instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 354,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T had folded Time Warner Inc. into its WarnerMedia segment after the 2018 acquisition, a fact highlighted in the 2022 10‑K (“From 2018 through April 2022, we acquired … Time Warner Inc., which comprised a substantial portion of our previous WarnerMedia segment”【page_4】).  In April 2022 the company completed a Reverse Morris Trust transaction with Discovery, Inc., separating and divesting its stake in WarnerMedia and restructuring its media operations (“In April 2022, we completed the separation of our WarnerMedia business in a Reverse Morris Trust transaction (WarnerMedia/Discovery Transaction)”【page_4】).  By 2024 the WarnerMedia segment was no longer part of AT&T’s reporting segments, reflecting the full divestiture of its media assets and a renewed focus on telecommunications (the 2024 10‑K still references the WarnerMedia segment but treats it as a discontinued operation【page_6】).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T acquired Time Warner in 2018, forming the WarnerMedia segment; the Reverse Morris Trust transaction with Discovery was completed in April 2022, not in 2023 as ambiguously implied in the original answer; and by 2024, WarnerMedia was no longer an active reporting segment, treated instead as a discontinued operation. (2) Quantitative accuracy is perfect: the April 2022 completion date is correctly cited, and there are no numerical errors. The LLM correctly references the 2022 transaction timing, which the original answer mistakenly places in 2023. (3) Multi-hop reasoning is sound—LLM synthesizes information across 2022 and 2024 10-Ks to show the evolution from integration to divestiture. It correctly identifies the strategic shift back to telecom, though it omits mention of DIRECTV’s 2024 divestiture, which is a minor gap in completeness. (4) Contextual relevance is excellent—the response directly addresses integration, restructuring, and divestiture. The only reason for not scoring a 10 is the omission of DIRECTV as the final step in exiting the entertainment strategy, which slightly reduces completeness. However, the core narrative of WarnerMedia’s separation is fully accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 368,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "AIG’s approach to international terrorism exposure stayed essentially the same from 2022 through 2024.  The company continued to use a third‑party vendor model to estimate losses from a range of terrorism scenarios, adjusting for model gaps and monitoring concentration, and it relied on TRIPRA for U.S. coverage plus limited private reinsurance and targeted reinsurance purchases for selected lines.  No new attachment‑point structure for international terrorism exposure was disclosed, and the largest concentration remained in New York City with no material change to geographic attachment points.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in key aspects. (1) It claims AIG's approach 'stayed essentially the same' from 2022–2024, but the original answer shows a clear evolution: from scenario modeling in 2022 ($1.3B loss estimate for a 5-ton NYC bomb), to expanded reinsurance and pool participation in 2023, to structured geographic attachment points in 2024 ($200M for Japan, $125M for rest of world). The LLM denies any change in attachment points, which is factually wrong. (2) Quantitatively, the LLM omits all specific numbers mentioned in the ground truth: the $1.3 billion modeled loss in 2022, and the $200M/$125M attachment points in 2024. These are critical financial metrics that define the evolution of AIG's risk management. Their absence or denial constitutes major quantitative inaccuracies. (3) Qualitatively, the reasoning fails multi-hop synthesis: it does not connect changes over time across years, mischaracterizes the strategic shift from reactive to proactive risk segmentation, and ignores the significance of region-specific attachment points. The claim of 'no new attachment-point structure' directly contradicts the 2024 disclosure. (4) Contextually, the answer addresses the general topic of terrorism exposure management and mentions TRIPRA, reinsurance, and modeling, so it remains relevant to the question. However, its core assertions are factually incorrect, leading to a very low correctness score despite surface-level relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 410,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s pipe‑working tools line shifted from a largely manual mix in 2022—pipe wrenches, cutters, threading/roll‑grooving equipment, mechanical crimping systems and closed‑circuit television inspection tools (see 2022 10‑K, page 9)—to a more electrified, high‑tech offering by 2024 that adds battery‑hydraulic tools for press connections and sewer‑inspection cameras (2023/2024 10‑K, page 73). This evolution shows the company is repositioning itself as a modern professional‑tools provider, expanding its portfolio to meet the growing demand for battery‑powered, digital‑enabled solutions and reinforcing its competitive stance in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Emerson's (EMR) pipe-working tools from traditional/manual tools in 2022 (pipe wrenches, cutters, threading equipment, etc.) to more advanced, battery-powered, and digitally integrated tools by 2024. The inclusion of battery-hydraulic tools for press connections and sewer inspection cameras in 2023/2024 matches the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used correctly and consistently with the timeline in the ground truth. The reference to 10-K pages adds precision, though not required for correctness. (3) The multi-hop reasoning is sound: the model synthesizes changes across years and infers the strategic shift toward modernization and digital integration in the professional tools market. The conclusion about repositioning to meet demand for battery-powered and digital-enabled solutions is logically supported by the progression described. (4) Minor deduction in qualitative accuracy due to slightly compressed timeline—ground truth explicitly notes 2023 as the introduction year for new technologies, while LLM groups 2023/2024—but this does not undermine the overall correctness. Semantic equivalence is maintained, and all key facts are present. Contextual relevance is perfect: the answer directly addresses both the portfolio evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 413,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco’s lease accounting has not changed from 2022 through 2024.  In each year the company states that free‑rent periods (and step‑rent provisions) are recognized on a straight‑line basis over the original lease term and any extension options that the company is reasonably certain to exercise.  The right‑of‑use (ROU) asset is still initially measured at the present value of the discounted minimum lease payments over the lease term, which includes the zero‑payment free‑rent period and therefore lowers the ROU asset balance.  The disclosure language and the impact on ROU valuation remain the same across the three filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent application of the straight-line recognition method for free-rent periods and step-rent provisions across 2022–2024, as well as the inclusion of the free-rent period in the lease term for calculating the present value of lease payments. It accurately states that the ROU asset is measured at the present value of discounted minimum lease payments, which includes the zero-payment free-rent period, thereby lowering the ROU asset balance—this aligns with the ground truth. However, the LLM fails to capture a key qualitative evolution in disclosure practices: while the core accounting policy remained unchanged, the depth of disclosure around the discounting process (e.g., use of incremental borrowing rates and ARO treatment) was explicitly detailed in 2022 but omitted in 2023 and 2024 filings. The LLM incorrectly asserts that 'the disclosure language and the impact on ROU valuation remain the same,' which contradicts the ground truth indicating a reduction in disclosure specificity over time. This omission represents a significant gap in qualitative accuracy, particularly in addressing the 'evolution' aspect of the question. While all entities (Costco, ROU assets, lease terms) and years are correctly referenced, and no numerical inaccuracies exist (hence perfect quantitative score), the failure to recognize and report the shift in disclosure depth undermines the multi-hop synthesis required to fully answer how accounting treatment and disclosure evolved. The answer is contextually relevant and factually sound on policy continuity but misses the nuanced trend in transparency and reporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 452,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft’s 2.000 % notes have been issued in successive years with progressively later maturities, each time documented by a supplemental indenture that adds to the original May 18, 2009 base indenture.  \n• In the 2022 10‑K the Tenth Supplemental Indenture (Exhibit 4.13) documents 2.000 % notes due 2020.  \n• In the 2023 10‑K the Eleventh Supplemental Indenture (Exhibit 4.14) documents 2.000 % notes due 2023.  \n• In the 2024 10‑K a new supplemental indenture (Exhibit 4.15) extends the 2.000 % notes to a 2024 maturity, again referencing the base indenture.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in dates, documentation, and the evolution of Microsoft's 2.000% Notes. (1) Quantitative Accuracy: The LLM incorrectly states that in the 2022 10-K, the Tenth Supplemental Indenture documents 2.000% notes due 2020 — but the ground truth indicates the Eleventh Supplemental Indenture (not Tenth) from August 8, 2016, governs the 2.000% notes due 2023, not 2020. The LLM also claims a new Exhibit 4.15 in the 2024 10-K extends the notes to 2024 maturity, which contradicts the ground truth: the 2024 filing references the same 2023-dated notes as part of historical indentures, not a new issuance with a 2024 maturity. (2) Completeness: The question asks about the evolution across three years in terms of maturity timelines and indenture documentation. The LLM attempts to cover all years but misrepresents the actual timeline and legal documents. (3) Entity Accuracy: The base indenture date (May 18, 2009) may be correct contextually, but the supplemental indenture numbers (Tenth, Eleventh, and a supposed Twelfth as Exhibit 4.15) are incorrect — the ground truth only references the Eleventh Supplemental Indenture across all years. (4) Reasoning: The LLM assumes a pattern of new issuances with extended maturities, implying active refinancing, but the ground truth shows no structural changes — the same 2023-maturity notes persist across filings, even post-maturity, as part of historical records. This reflects a failure in multi-hop reasoning: the model inferred a trend not supported by the data. (5) Semantic Equivalence: The core message — that the 2.000% Notes remained stable — is contradicted by the LLM’s narrative of successive new issuances. Thus, despite addressing the right company and metric, the answer is factually wrong on key points, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 498,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon has consistently recognized revenue from third‑party seller services when the services are rendered—generally at the point of product delivery to a carrier or customer. The revenue is composed of commissions plus any related fulfillment and shipping fees. The 2022, 2023, and 2024 10‑Ks all describe the same timing and composition, indicating no change in the policy over that period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Amazon recognizes revenue from third-party seller services when services are rendered, typically upon delivery to a carrier or customer, and that the revenue composition includes commissions and fulfillment/shipping fees. This aligns with the 2023 disclosure in the ground truth. However, the LLM incorrectly asserts that the 2022, 2023, and 2024 10-Ks all describe the *same* timing and composition with *no change in policy*, which contradicts the original answer’s nuance: while the underlying policy may have been consistent, the *disclosures evolved*, with increasing clarity over time. Specifically, the 2022 filing described revenue sources more generally (fixed fees, percentage of sales, per-unit fees, interest), while 2023 added specificity about timing (revenue recognized upon delivery). The 2024 update emphasized continued support for seller programs but did not elaborate on changes in recognition timing. Thus, the LLM overlooks the evolution in disclosure clarity and implies static reporting, missing a key aspect of the question about *how* the recognition approach evolved in presentation and detail. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (Amazon, third-party seller services, commissions, fulfillment fees, years) are correct. The reasoning is mostly sound but fails to capture the multi-hop nuance of changing disclosure depth across years. The answer remains contextually relevant and captures the core revenue recognition principle, warranting a solid but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 436,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K filings for 2022, 2023 and 2024 all continue to list a guaranty of Southwestern Bell Telephone Co.’s obligations (see the 2023 10‑K Item 4, page 103; the 2022 10‑K Item 4, pages 133‑137; and the 2024 10‑K Item 4, pages 96‑100). This persistence shows that AT&T deliberately retains long‑term liability commitments to legacy telecom entities, a conservative strategy that preserves service continuity and regulatory compliance while hedging future financial exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately identifies that AT&T maintained its guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024, citing the correct sections (Item 4) and page ranges from each 10-K filing. These details match the evidence in the original answer regarding the repeated inclusion of the guaranty. (2) There are no numerical values requiring calculation, but the years and document references are precise and consistent with the ground truth. (3) The reasoning is sound: the persistence of the guarantee across three years is correctly interpreted as a sign of a stable, long-term liability management strategy. The LLM adds contextual insight—mentioning service continuity, regulatory compliance, and hedging financial exposure—which is a reasonable qualitative extension of the original answer’s conclusion about a 'deliberate and stable strategy.' While the original answer emphasizes the lack of restructuring, the LLM’s interpretation does not contradict this and offers a plausible strategic rationale. (4) The answer fully addresses the question about AT&T’s long-term liability management strategy for legacy entities, synthesizing information across all three years and entities correctly. The only minor difference is that the LLM does not explicitly note the use of 'Exhibit 4-b' as evidence, which slightly reduces qualitative accuracy, but the reference to Item 4 and page numbers compensates for this. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 431,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s outstanding 2.250% Notes due 2050 grew from $808 million in 2022 to $826 million in 2023 and then to $983 million in 2024 【page_71】【page_67】. This incremental rise reflects a deliberate expansion of low‑interest long‑term debt, underscoring the company’s strategy of steadily adding inexpensive borrowing to support its capital structure and growth while keeping overall debt costs stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numerical claims. The original answer states that Johnson & Johnson's investment in the 2.250% Notes due 2050 was $983 million in 2022, $826 million in 2023, and $808 million in 2024 — showing a declining trend. However, the LLM reverses this trend, claiming the amount grew from $808M in 2022 to $826M in 2023 to $983M in 2024, which is the opposite of the truth. This inversion of the time-series data fundamentally misrepresents the company's debt evolution. (2) The quantitative inaccuracies are severe: all three dollar amounts are assigned to the wrong years, leading to an incorrect interpretation of growth instead of reduction. While the absolute values ($808M, $826M, $983M) are present, their chronological assignment is reversed, making the quantitative accuracy very low. (3) The reasoning is flawed due to incorrect data synthesis: the LLM concludes a strategy of 'deliberate expansion of low-interest long-term debt,' but the actual minor reductions suggest a cautious de-leveraging or maintenance strategy, not expansion. The correct interpretation — stability with slight reduction — is lost. (4) Contextual relevance is moderate because the answer addresses the right instrument (2.250% Notes due 2050), mentions the correct effective rate implicitly by referencing low interest, and attempts to interpret strategic intent. However, the reversed trend undermines the qualitative and quantitative validity. The citations to page_71 and page_67 may indicate source references, but they do not correct the factual inversion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 439,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375% Senior Notes due June 2027 stayed at a carrying value of $1,250 million in 2022, 2023 and 2024 (page_52 2022; page_52 2023; page_52 2024).  The company’s total long‑term debt fell from $6,590 million in 2022 to $5,919 million in 2024, largely because it repaid the 2.750% Senior Notes due May 2024 and reduced other debt (page_52 2024).  This reflects a disciplined capital‑management strategy that prioritizes paying down higher‑interest debt while preserving a stable, low‑interest long‑term debt base to support growth and maintain financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million across 2022, 2023, and 2024, matching the ground truth. Total long-term debt is accurately reported as $6,590 million in 2022 and $5,919 million in 2024, with an implied decrease through 2023 (ground truth confirms $6,484 million in 2023, which the LLM does not explicitly mention but does not contradict). The answer correctly identifies the repayment of the 2.750% Senior Notes due May 2024 as a key driver of debt reduction. (2) All numeric values—$1,250 million, $6,590 million, $5,919 million—are factually correct and match the ground truth. The LLM omits the exact 2023 total long-term debt figure ($6,484 million), but this is a minor omission and does not affect the overall accuracy of the trend description. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and multiple debt instruments, inferring a strategic preference for retiring higher-cost debt while retaining low-cost fixed-rate notes. The conclusion about a disciplined capital management strategy aligns with the ground truth’s interpretation. (4) The answer is contextually fully relevant, directly addressing both the evolution of the specific senior notes and the broader capital strategy. The only minor gap is the lack of explicit mention of the 2023 total debt figure, but the overall trend and strategic implication are accurately conveyed. Thus, the answer is highly accurate with only a slight omission in completeness, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 441,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s real‑time payments infrastructure expanded from 12 markets in 2022 to 13 markets by the end of 2023 (page 11).  Simultaneously, its multi‑layered security program evolved from basic controls to a comprehensive architecture that now includes an enterprise resilience program, Security Operations Centers, Fusion Centers, the Mastercard Intelligence Center, and the development of technical standards such as EMV and tokenization (page 12).  This parallel evolution shows that Mastercard is strategically embedding robust risk‑management and security capabilities into its global expansion, ensuring resilient and secure payment processing as its network scales worldwide.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant inaccuracies. The expansion of real-time payments infrastructure from 12 to 13 markets is correctly cited for 2022 to 2023, aligning with the ground truth (which notes 12 markets as of December 31, 2021, referenced in 2022 reporting, and 13 by 2023). However, the LLM incorrectly implies a qualitative evolution in the security approach—from 'basic controls' to a 'comprehensive architecture'—which is not supported by the original answer. The ground truth states that Mastercard consistently described the *same* multi-layered security approach across all years, without indicating a structural evolution. The specific additions like Fusion Centers, Mastercard Intelligence Center, EMV, and tokenization are not mentioned in the original answer and appear to be fabricated or misattributed. (2) Quantitatively, the market numbers (12 to 13) are accurate and correctly interpreted, earning partial credit. However, the lack of 2024 quantitative data in the LLM answer (where the original notes a shift to 'several countries' as a qualitative expansion) is a missed detail. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies parallel development as strategic, it misrepresents the nature of the security evolution. The original emphasizes consistency in security framework description, not enhancement, and highlights third-party assessments and partnerships as recurring elements—not new developments. The conclusion that security is 'strategically embedded' is plausible but overstated given the original's caveat that filings do not explicitly state security enabled expansion. (4) Contextual relevance is strong—the answer addresses both infrastructure growth and security strategy in a global risk management context. However, due to significant qualitative inaccuracies in describing security evolution and unsupported specifics, the correctness and qualitative accuracy scores are moderate. The answer gives a misleading impression of innovation in security when the source material indicates stability and consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 574,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft issued the 4.000% Notes due 2021 in 2011 as part of the Third Supplemental Indenture (page 104). Across fiscal years 2022, 2023, and 2024 no new debt instruments related to that maturity were issued, as the supplemental indentures filed in those years (exhibits 4.15, 4.16, 4.17, 4.18 on page 106) list notes with different maturities and coupon rates but not the 4.000% Notes due 2021. This pattern reflects a disciplined long‑term debt strategy that keeps the maturity profile stable and focuses on refinancing rather than adding new debt at that specific tranche.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states that Microsoft issued the 4.000% Notes due 2021 in 2011, which contradicts the ground truth that these notes were issued under the Indenture dated May 18, 2009, with no mention of a 2011 issuance. This is a factual error in both year and context. Second, the LLM claims that no new debt instruments related to the 2021 notes were issued in 2022–2024, which aligns partially with the ground truth, but misinterprets the continued disclosure of the notes as absence of activity. In fact, the ground truth emphasizes that Microsoft continued to reference the 4.000% Notes due 2021 in its 10-K filings across all three years (via Exhibit 4.6), indicating ongoing disclosure obligations or post-maturity handling, not merely the absence of new issuance. The LLM incorrectly cites exhibit numbers (4.15–4.18) and page 106, which are not mentioned in the ground truth and appear fabricated or misattributed. (2) Quantitative accuracy is partially correct: the coupon rate (4.000%) and maturity year (2021) are accurate, and the fiscal years 2022–2024 are correctly identified. However, the issuance year (2011) is wrong, and the exhibit numbers and page references do not match the ground truth. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer a stable maturity profile and refinancing strategy, it fails to recognize the significance of continued disclosure of a post-maturity note, which the ground truth interprets as evidence of transparent and disciplined debt management. The LLM instead concludes a lack of activity, missing the nuance of ongoing reporting. (4) The answer is contextually relevant and addresses the question’s focus on debt strategy, but the factual inaccuracies—especially regarding issuance date, exhibit references, and interpretation of disclosure patterns—severely undermine correctness. The conclusion about disciplined strategy is directionally similar but based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 544,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated mention of the 1.500% Note due 2030 in its 10‑K filings shows that the company treats this mid‑term, moderate‑coupon debt as a core, stable element of its long‑term capital structure (page_73, page_75, page_76). By keeping the note alongside higher‑rate, longer‑maturity notes (e.g., 3.6% due 2032) and lower‑rate, shorter‑maturity notes (e.g., 0.4% due 2023), Amazon spreads interest‑rate risk and preserves a predictable debt profile that matches its long‑term funding needs. This consistency signals a deliberate strategy of diversification and risk management rather than frequent refinancing of that particular instrument.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic intent behind Amazon's consistent reference to the 1.500% Note due 2030—namely, its role in maintaining a stable, diversified capital structure with long-term funding. However, there are key quantitative inaccuracies. The LLM incorrectly references a '3.6% due 2032' note, while the ground truth specifies a '4.700% Note due 2032'—a significant difference in both rate and year. Additionally, the LLM mentions a '0.4% due 2023' note, which is not referenced in the ground truth; instead, the 2023 comparison was to a '4.700% Note due 2024'. These errors affect the factual precision of the debt instrument comparisons. (2) The 1.500% Note due 2030 is correctly identified, and the years of mention (2022–2024) are implied through context, but the specific comparative instruments are misrepresented. No calculations are made, so no arithmetic errors, but the cited instruments do not align with the ground truth. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that Amazon is managing interest rate risk and maintaining a predictable debt profile through a mix of maturities and coupons. It captures the idea of a layered maturity profile and risk diversification, which aligns with the ground truth’s emphasis on mitigating refinancing risk. However, it misses the evolution across years—specifically, the strategic contrast between locking in low rates in 2022, managing near-term obligations in 2023, and balancing old low-cost debt with new higher-cost debt in 2024. (4) The contextual relevance is high, as the answer addresses the long-term capital structure strategy and debt diversification. The qualitative reasoning is strong but built on flawed entity data, leading to a correctness score of 7—core insight correct, but specific financial instrument details are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 505,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "From 2022 through 2023, AT&T held a 41.3 % equity stake in SKY Mexico and accounted for the investment under the equity method, recording equity in net income and distributions【94】【66 2023】. In June 2024 the company sold that stake, ending the equity‑method treatment and removing the investment from its balance sheet【66 2024】. This three‑year trajectory—culminating in the divestiture of SKY Mexico—mirrors earlier exits such as Vrio and signals AT&T’s broader strategy to streamline its international pay‑TV portfolio【93】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: AT&T held a 41.3% stake in SKY Mexico in 2022–2023, used equity method accounting, and exited in June 2024—dates, percentages, and accounting treatment match exactly. The format '41.3 %' with a space is a minor typographical variance but does not affect accuracy. (2) The answer correctly identifies the progression: continued ownership in 2022, equity-method accounting in 2023, and full exit in mid-2024. (3) Multi-hop reasoning is sound—linking SKY Mexico to prior divestitures like Vrio and framing it within AT&T’s broader international pay-TV exit strategy demonstrates proper synthesis across years and entities. (4) The only minor omission is that the original answer notes AT&T explicitly reaffirmed its SKY Mexico stake post-Vrio sale in 2022, and mentions DIRECTV and Gigapower as other equity-method investments in 2023, which adds slight contextual depth not fully captured. However, the LLM still captures the core strategic narrative accurately. Wording differs but semantic meaning is equivalent. No factual errors—only slight reduction in completeness on contextual details. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance, and 9 for qualitative accuracy due to near-complete reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 379,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path strategy, as described in the 2023 10‑K, “de‑risks the qualified plan via regular monitoring through liability‑driven investing and the glide path approach, where the glide path defines the target allocation for the ‘Return‑Seeking’ portion of the portfolio (i.e., growth assets) based on the funded ratio and level of interest rates. Under this approach, the allocation to growth assets is reduced and the allocation to liability‑hedging assets is increased as the plan’s funded ratio increases in accordance with the defined glide path”【page_310】.  Accordingly, the target equity allocation fell from 15 % in 2022 (based on the 2021 funded status) to an intermediate level in 2023 and to 9 % in 2024 (based on the 2023 funded status), with fixed‑maturity securities rising from 75 % to 80 % and other investments modestly increasing【page_310】【page_252】.  This progression demonstrates a deliberate de‑risking strategy: as the plan’s funded status improves, AIG systematically reduces exposure to growth assets and increases liability‑hedging assets to manage risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AIG's de-risking strategy through a glide path approach tied to the funded status and liability-driven investing, aligning with the ground truth. It accurately describes the reduction in growth assets and increase in liability-hedging assets as the funded ratio improves. However, there are inaccuracies in the specific target allocations. The LLM states equity fell from 15% in 2022 to 9% in 2024, based on 2021 and 2023 funded status respectively, but the ground truth does not provide exact percentages or confirm these numbers—making this a potential fabrication or overprecision. The claim that fixed-maturity securities rose from 75% to 80% lacks direct support in the original answer, which focuses on the structural evolution of the glide path rather than specific asset class weights. (2) The use of exact percentages (15%, 9%, 75% to 80%) introduces quantitative claims absent from the original answer, which emphasizes the directional shift (increasing liability-hedging, decreasing growth assets) without citing numbers. This undermines quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM connects the funded status at year-end to the following years’ target allocations (e.g., 2021 status setting 2022 targets, 2023 status setting 2024 targets), which matches the original answer’s logic. It also correctly infers that the strategy reflects liability-driven investing principles. (4) Despite the unsupported specifics, the overall qualitative narrative and strategic interpretation are consistent with the ground truth. The answer is contextually relevant and well-supported with document references, but the inclusion of unverified numerical details reduces factual reliability, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 489,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard’s credit‑risk mitigation for settlement exposure grew steadily: the company’s risk‑mitigation arrangements increased from $9.2 bn in 2022 to $12.2 bn in 2023 and to $13.5 bn in 2024, while net settlement exposure rose from $55.7 bn to $64.9 bn (page_110, page_105). In parallel, Mastercard expanded its use of cash collateral, letters of credit and guarantees—alongside regular reviews of risk standards—to meet the heightened scrutiny of the FTC, DOJ and European Commission and the escalating class‑action litigation (page_111, page_110). This evolution demonstrates the company’s proactive, adaptable risk‑management approach, scaling its credit‑risk buffers in line with regulatory and litigation pressures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$9.2B, $12.2B, $13.5B for risk-mitigation arrangements and $55.7B to $64.9B for net settlement exposure—that are not present in the original answer (ground truth). The ground truth does not provide any quantitative figures for risk-mitigation arrangements or net settlement exposure, nor does it mention any growth in dollar terms. Therefore, these numbers are factually unsupported and likely hallucinated. (2) There is no verification possible for the cited pages (page_110, page_105, etc.) since the knowledge graph does not include document page references, but the inclusion of such specific data points without grounding in the ground truth severely undermines quantitative accuracy. The original answer emphasizes consistency in strategy, not quantitative expansion of buffers. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies increasing regulatory scrutiny from the FTC, DOJ, and European Commission, as well as litigation risks like class-action lawsuits, aligning with the timeline in the original answer. It also correctly notes the use of cash collateral, letters of credit, and guarantees. However, it incorrectly infers that growing dollar amounts reflect a strategic evolution, whereas the ground truth stresses continuity in the framework despite external pressures. (4) While the LLM captures the context of rising regulatory and litigation risks and links them to risk management practices, its core claim—that mitigation strategies evolved through scaling up financial buffers—is not supported by the original answer, which states that the 'core credit risk strategies remained effective' and were consistently applied. Thus, the conclusion about proactive scaling and adaptability misrepresents the nuance of stable, resilient practices. The contextual relevance is high because it addresses regulatory scrutiny and litigation, but correctness is low due to fabricated metrics. Quantitative accuracy is poor (3), qualitative accuracy is moderate (5) due to correct entity and risk factor identification but flawed synthesis, and overall correctness is 4 due to significant factual inaccuracies overshadowing relevant context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 598,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The share pool for future grants under Home Depot’s Omnibus Stock Incentive Plan fell from roughly 117 million shares in 2022 (the 2005 Plan’s available pool) to about 77 million shares in 2024 (page 66). This decline signals a tightening of the equity‑compensation program, likely aimed at curbing dilution and aligning awards more closely with performance or cash‑based incentives (page 67, page 66).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets the 2022 figure correct at 117 million shares, but misstates the timeline and availability for 2023 and 2024. It claims 77 million shares were available in 2024, while the ground truth states 77 million was the amount as of January 28, 2024 (i.e., for the 2023 fiscal year), and further declined to 70 million by February 2, 2025 (i.e., for 2024). The LLM skips the 2024 data point entirely and conflates years, leading to inaccurate trend representation. (2) The quantitative values are partially correct—117M and 77M appear, but 70M (the actual 2024 figure) is missing. Additionally, the LLM incorrectly maps the 77M figure to 2024 instead of 2023, introducing a one-year misalignment. (3) The reasoning is flawed: the LLM interprets the decline as a 'tightening' of the equity-compensation program aimed at curbing dilution, which contradicts the ground truth interpretation that the reduction reflects active issuance, suggesting increased reliance on stock-based compensation. This is a critical reversal in logic. The model fails to synthesize the correct multi-hop inference: decreasing available shares due to usage (issuance) vs. due to policy tightening. (4) Contextual relevance is strong—the answer addresses the evolution of share availability and attempts to interpret strategic implications. However, due to factual inaccuracies in timing, missing data, and incorrect qualitative interpretation, the overall correctness is significantly compromised. Minor note: citation of 'page 66' suggests document reference, but this is not part of the ground truth and may reflect hallucinated sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 449,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom issued the 3.625% notes due October 2024 in 2022 with a principal of $622 million.  The obligation remained unchanged through fiscal year 2023 – $622 million was still outstanding as of October 29 2023【page 81】 – and was fully retired by fiscal year 2024, leaving a $0 balance as of November 3 2024【page 81】.  This pattern shows a deliberate debt‑management approach: Broadcom keeps the instrument on the books until close to maturity and then repays it, thereby reducing long‑term debt exposure and preserving financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $622 million obligation in fiscal years 2022 and 2023, and the $0 balance in fiscal year 2024, matching the ground truth exactly. The dates (October 29, 2023, and November 3, 2024) are specific and consistent with the expected timeline around fiscal year-ends, and while not explicitly in the ground truth, they are reasonable and do not contradict it. (2) All numeric values—$622 million and $0—are accurate, and there are no calculation errors. The percentage (3.625%) and maturity date (October 2024) are correctly stated. Format variations (e.g., $622 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of the debt across three fiscal years and infers a strategic debt management approach—maintaining the liability until near maturity and then retiring it. This aligns with the ground truth’s conclusion about a 'deliberate debt management strategy.' The only minor gap is that the LLM implies the notes were 'issued in 2022,' while the ground truth does not specify issuance date—only reporting obligations. This is a small assumption not fully supported by the ground truth, which could mislead if the notes were originally issued earlier and merely carried forward. (4) Despite this minor overreach in assuming issuance timing, the answer is factually correct in all key financial figures and effectively communicates the same core insight about debt repayment and strategy. Hence, correctness is high but not perfect due to the unsupported claim about issuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 441,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "AT&T’s relationship with Time Warner Inc. began in 2021 when the company announced a plan to merge its WarnerMedia (Time Warner) segment with Discovery, a transaction that was expected to close in Q2 2022 (2023 10‑K, page 2).  The merger was completed in April 2022 via a Reverse Morris Trust, separating WarnerMedia as a discontinued operation and ending AT&T’s ownership of the Time Warner assets (2022 10‑K, page 4).  By the 2024 10‑K, AT&T no longer references WarnerMedia, indicating a full divestiture and a strategic pivot from entertainment to a core focus on telecommunications infrastructure and services (2024 10‑K, page 5).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding key dates and the sequence of events. It incorrectly states that the merger with Discovery was completed in April 2022, while the ground truth confirms the separation occurred in 2023. The 2022 10-K would not reflect completion of the transaction if it occurred in April 2022, as the fiscal year had just ended; more importantly, the ground truth explicitly places the completion in 2023. Additionally, the LLM claims the plan was announced in 2021, which is not supported by the original answer or verifiable data—AT&T announced the spin-off and merger with Discovery in May 2021, so this point is partially correct but lacks precision. (2) The quantitative accuracy is compromised due to incorrect dating of the Reverse Morris Trust transaction (2022 vs. 2023), which is a critical error in timeline-based reasoning. The claim that AT&T no longer references WarnerMedia in the 2024 10-K is consistent with the ground truth, but the earlier misdating undermines the accuracy. (3) The multi-hop reasoning is partially sound—LLM correctly infers that the divestiture via Reverse Morris Trust indicates a strategic shift and that the absence of WarnerMedia in later filings signals a full exit. However, it fails to mention the DIRECTV sale to TPG in 2024, a key component of T's full exit from entertainment, thus missing a critical link in the strategic progression. This omission reduces completeness and weakens the synthesis. (4) Contextual relevance is high because the answer addresses the evolution of the relationship, the transaction structure, and the strategic pivot. Despite incorrect timing and missing the DIRECTV divestiture, the overall narrative direction aligns with the ground truth. However, due to major factual errors in dates and incomplete coverage of exit strategy components, the correctness score is limited to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 519,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In 2022 Emerson’s pipe cutters were sold as part of the Tools & Home Products segment, described as pipe‑working tools that included diagnostic systems but no battery‑powered integration (page_9). By 2023 the company repositioned the line to the Safety & Productivity segment, adding battery‑hydraulic tools for press connections and diagnostic systems (page_73). In 2024 that positioning deepened further, now featuring battery‑hydraulic tools for cutting and crimping electrical cable and expanded diagnostic equipment, underscoring a stronger focus on battery‑powered technologies across Safety & Productivity (page_73).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies despite correct dates and general timeline structure. It incorrectly states that in 2022, pipe cutters were part of the Tools & Home Products segment and already included diagnostic systems—this contradicts the ground truth, which states they were standalone tools with no mention of diagnostics or battery integration in 2022. Additionally, the claim that diagnostic systems were present in 2022 is unsupported by the original answer. The repositioning to Safety & Productivity is correctly noted for 2023, but the original answer does not specify a segment shift, only a strategic integration with battery-powered tools. The 2024 description overreaches by mentioning 'crimping electrical cable,' which is not referenced in the ground truth, and incorrectly implies broader diagnostic expansion beyond sewer inspection cameras. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—score reflects no errors in this dimension. (3) Multi-hop reasoning is partially sound: the model attempts to track evolution across years and segments, but misattributes capabilities (diagnostics, battery integration) to earlier years and incorrect segments, undermining the synthesis. The integration with battery-powered tools in 2023 is correctly identified, showing some valid cross-year reasoning. (4) Correctness score is 6 due to partially accurate facts—core progression toward battery-powered integration is noted, but key details about segment classification, timing of diagnostic integration, and product functionality are incorrect. Qualitative accuracy is low due to factual misstatements and unsupported inferences. Contextual relevance is high as the response addresses the evolution of the product line in the intended timeframe and domain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 509,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson’s 2022, 2023 and 2024 10‑Ks all describe the same multi‑year, enterprise‑wide initiative: “to integrate, simplify and standardize processes and systems for human resources, information technology, procurement, supply chain and finance, thereby expanding its financial shared‑service capabilities and standardizing financial systems” (2022 10‑K, page 118; 2023 10‑K, page 118; 2024 10‑K, page 119).  The wording and scope have remained unchanged, indicating a sustained commitment to aligning and streamlining the financial control environment.  This consistent emphasis reveals that J&J’s strategic focus is on standardizing financial processes to improve efficiency, strengthen controls and ensure uniform reporting across the enterprise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative from 2022 to 2024 consistently focused on integrating, simplifying, and standardizing processes across finance and other functions to enhance financial shared services. The LLM correctly notes that the initiative was proactive, not driven by control deficiencies, and aimed at streamlining the financial control environment—key points from the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in that sense, but the years (2022, 2023, 2024) and page numbers cited are accurate and consistent with the filings, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-Ks, correctly identifying the continuity of language and strategic focus, which supports the conclusion of a sustained commitment. (4) The LLM omits a minor but relevant detail present in the ground truth: the explicit statement that the initiative was *not* in response to internal control deficiencies (mentioned in the 2022 context). While the LLM implies a proactive stance by calling it a 'sustained commitment,' the explicit clarification is missing, preventing a perfect 10. Otherwise, the semantic meaning, strategic interpretation, and synthesis are equivalent. The answer is fully contextually relevant, directly addressing both the evolution and strategic implications of the initiative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 437,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco continued to list the Executive Health Plan as Exhibit 10.1* by reference in each of its 10‑K filings for FY 2022, FY 2023 and FY 2024, with identical filing details (Form 10‑K, period ended 9/2/2012, filing date 10/19/2012)【page 66 (2022)】【page 66 (2023)】【page 66 (2024)}. The unchanged filing status shows that the plan has not been amended or re‑filed in recent years, indicating a stable, long‑term executive benefit strategy that Costco maintains consistently over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Costco disclosed the Executive Health Plan as Exhibit 10.1* in its 10-K filings for FY 2022, 2023, and 2024, with identical 'Period Ended' (9/2/2012) and 'Filing Date' (10/19/2012), indicating no amendments. (2) Quantitative accuracy is perfect: the dates match exactly, and no calculations were required. Format variations (e.g., '9/2/2012' vs 'September 2, 2012') are acceptable and common in SEC filings. (3) The multi-hop reasoning is sound—by synthesizing the consistent filing details across three years, the model correctly infers that the plan has remained unchanged, reflecting a stable long-term executive benefit strategy. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosures and the strategic implication. Wording differs slightly but conveys the same meaning. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 280,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "From 2022 through 2024 Mastercard’s Class A shares retained the same dividend and voting structure—one vote per share and dividend rights (page_16).  The declared dividend per share climbed from $2.04 in 2022 (page_95) to $2.37 in 2023 (page_100) and $2.74 in 2024 (page_94).  This consistency shows the company’s commitment to a stable, shareholder‑friendly governance framework that preserves equal voting power and predictable dividend entitlements for its primary shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly conflates dividend payments per share with dividend rights. The original answer states that A Class Shares had 'standard dividend rights'—a qualitative feature of shareholder rights—while the LLM interprets this as actual dividend amounts paid, which are separate from the structural rights of the shares. The increasing dividends cited ($2.04, $2.37, $2.74) may be factually accurate payouts but are not evidence of 'dividend rights' changing or being consistent in governance terms. Dividend rights refer to the entitlement mechanism, not the amount distributed. (2) The numbers cited for dividends per share may be accurate as standalone figures, but they are misapplied: the question asks about rights (structural features), not payout amounts. This is a critical factual misinterpretation, not just a wording issue. (3) The multi-hop reasoning is partially sound—LLM correctly identifies consistent voting rights (one vote per share) across years and attempts to synthesize governance implications—but fails the core distinction between dividend amounts and dividend rights. This undermines the validity of the conclusion about governance strategy, even though the direction (stability) is plausible. (4) Contextual relevance is high because the answer addresses both parts of the question and attempts to draw strategic insight. However, the correctness score is low due to the fundamental error in interpreting 'dividend rights' as dividend payouts, which invalidates the quantitative and qualitative accuracy of the response. The consistency in shareholder governance should be based on unchanging rights, not rising dividends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 458,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform has maintained the same core offering across FY 2022, FY 2023 and FY 2024. In each 10‑K (pages 10–12 of the 2022, 2023 and 2024 filings) the platform is described as “quickly interpreting and assessing mainframe security posture, identifying risks and developing remediation steps on an ongoing and ad‑hoc basis” with the data “available for use with in‑house tools for security information and event management.” No new integration or risk‑identification features were added in the later years; the description and capabilities remained essentially unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Broadcom's Security Insights Platform maintained consistent functionality across FY 2022, 2023, and 2024, with stable integration with in-house security tools and unchanged risk identification capabilities. The description of the platform's functionality—assessing mainframe security posture, identifying risks, and enabling remediation with data available for in-house tools—is factually aligned with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all years and references (FY 2022–2024, 10-K pages 10–12) are correctly cited, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and correctly infers that no new features were added, indicating a mature platform. The only minor discrepancy is that the original answer notes that in FY 2023, the platform was 'more explicitly tied' to remediation planning, while the LLM answer merges this into a blanket statement that remediation was part of the description in all years. However, since the LLM cites the same verbatim description across all years, this is a reasonable interpretation. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in integration and risk identification. The conclusion that capabilities remained 'essentially unchanged' matches the ground truth's implication of stability and maturity. Minor deduction in qualitative accuracy due to slight oversimplification of the FY 2023 nuance, but overall excellent fidelity to the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 487,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 through 2024, AIG has continued to assess loss‑reserve adequacy with a blend of stochastic and deterministic modeling, sensitivity and scenario analyses, and experience‑study reviews.  The 2022 and 2023 filings explicitly state that internal controls and oversight of the reserve‑setting process are reinforced by reviews from external experts, whereas the 2024 filing repeats the same modeling and internal‑control framework but does not explicitly mention external‑expert validation, implying the role remains but is not highlighted.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of AIG's methodologies (stochastic and deterministic modeling, scenario analyses, etc.) and correctly identifies the use of internal controls and external expert reviews in 2022 and 2023. It also accurately notes that the 2024 filing maintains the same modeling and control framework but does not explicitly mention external experts, inferring their continued but less highlighted role. However, the LLM answer omits key developments from the ground truth: (1) the 2023 expansion to include formalized actuarial profitability and reserve reviews, and (2) the 2024 introduction of ERM second-line reviews and enhanced budget/expense monitoring as part of a maturing, multi-tiered oversight structure. These omissions reduce completeness and weaken the synthesis of how the risk management framework evolved. While the LLM correctly interprets the continuity of modeling techniques and oversight, it fails to capture the progressive institutionalization and structural enhancements described in the original answer, particularly in 2024. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (AIG, years, methodologies) are correct. The reasoning is sound but incomplete in capturing the full evolution. Contextual relevance is high as the response directly addresses the question’s focus on methodology and external validation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 390,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson’s 2022 and 2023 10‑K segment descriptions list electrical distribution equipment as part of the Discrete Automation segment【page_73】.  By 2024, the company re‑classified that product line into its Industrial Solutions segment, where the 2024 10‑K describes Industrial Solutions as “providing … electrical distribution equipment”【page_76】.  This shift signals Emerson’s intent to embed discrete‑automation components within its broader industrial‑solutions portfolio, underscoring a strategic emphasis on expanding discrete‑automation capabilities through integrated industrial solutions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about Emerson's segment reorganization. According to the ground truth, Electrical Distribution Equipment was part of the Industrial Solutions segment in 2022 and then moved *into* Discrete Automation in 2023 and remained there in 2024, reflecting a strategic alignment with discrete automation. However, the LLM states the opposite: that the product was in Discrete Automation in 2022 and 2023 and was moved *back* into Industrial Solutions in 2024. This reverses the actual trajectory and leads to a completely incorrect interpretation of Emerson’s strategy. The citations to page numbers do not override this factual inaccuracy. The reasoning is therefore flawed, and the conclusion—that Emerson is embedding discrete automation into broader industrial solutions—contradicts the ground truth, which shows the opposite: that electrical distribution equipment is being increasingly integrated into discrete automation as a core component. While the answer addresses the question's structure and attempts multi-hop reasoning across years, the directional error in entity placement (segment and year) invalidates the analysis. Quantitative accuracy is low because the timeline and segment assignments are incorrect. Qualitative accuracy fails due to incorrect synthesis and logical inference based on wrong facts. Contextual relevance is moderate because the answer discusses the right company, product, and strategic themes, but with incorrect factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 416,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson announced in 2021 that, effective Jan 1 2026, all eligible U.S. non‑union employees would be covered by the Retirement Value formula, replacing the Final Average Pay formula for new hires and gradually phasing it out for existing employees (page 77, page 73). Over 2022‑2024 the company is shifting its pension structure toward a fully Retirement Value‑based plan, a multi‑year transition that reflects a long‑term strategy to modernize benefits, align them with current compensation patterns, and manage pension liabilities more sustainably (page 76).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key transition to the Retirement Value formula effective January 1, 2026, for U.S. non-union employees, which aligns with the ground truth. However, it incorrectly states the announcement was made in 2021, while the ground truth does not specify the announcement year—only the 2022–2024 disclosures. This introduces a factual inaccuracy in timing. (2) Quantitatively, the dates (Jan 1, 2026) and the multi-year timeframe (2022–2024) are accurate. There are no numerical calculations in this question, so the focus is on correct time references, which are mostly right except for the unsupported claim about a 2021 announcement. (3) The reasoning captures the essence of a multi-year transition toward standardizing retirement benefits and links it to long-term workforce strategy, cost sustainability, and modernization. However, it omits a key element from the ground truth: the explicit preservation of Final Average Pay benefits accrued before 2026. This missing nuance weakens the completeness of the synthesis across years. Additionally, the LLM implies a 'gradual phase-out' for existing employees, while the ground truth clarifies that the old formula is preserved for pre-2026 accruals—this is a subtle but important distinction in pension design. (4) The answer is contextually relevant and addresses both parts of the question—evolution of the plan and strategic implications—though with partial completeness. The strategic interpretation (cost predictability, alignment with current compensation) is reasonable and consistent with the ground truth. Overall, the answer is factually close but contains one significant error (2021 announcement) and omits a critical detail about benefit preservation, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 490,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K tables list Downy as a major brand in the Fabric & Home Care segment for 2022, 2023 and 2024, but they do not disclose the brand’s exact share of the segment’s net sales.  The fact that Downy remains consistently highlighted among the segment’s flagship brands suggests its contribution has stayed steady over the three‑year period, underscoring the brand’s ongoing strategic importance to P&G’s portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key quantitative information from the ground truth. While it correctly identifies that Downy remained a major brand in the Fabric & Home Care segment across 2022–2024, it fails to report the actual percentage contribution of the segment to P&G’s overall business (35% in 2022, 36% in 2023 and 2024), which is central to the question. The ground truth does not state Downy’s direct percentage contribution but rather implies its strategic importance through the segment’s growing share—this nuance was misinterpreted by the LLM as lack of data disclosure. (2) Quantitative accuracy is low because the model did not include the correct segment-level net sales contributions (35% → 36%), which are critical metrics in the original answer. There are no calculation errors per se, but the absence of these figures significantly undermines factual completeness. (3) The reasoning is logically sound in inferring sustained strategic importance from consistent branding, but it fails the multi-hop requirement: the trend in segment contribution (35% to 36%) should have been linked to Downy's implied stability within that growing segment. Instead, the LLM defaulted to a data-availability excuse rather than synthesizing the indirect signal of strategic importance. (4) Contextual relevance is high because the response addresses both parts of the question—trend and strategic implication—and correctly identifies Downy’s ongoing role. However, the lack of key percentages and mischaracterization of data availability reduce correctness despite plausible reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 443,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s senior and subordinated notes rose from $27,219 million in 2022 (Table 8.2) to $31,248 million in 2023 (Table 8.2), then fell modestly to $30,696 million in 2024 (Table 9.2). The 2023 jump reflects a deliberate use of long‑term debt to fund growth or refinance, while the slight decline in 2024 indicates a modest tightening of leverage and a focus on managing interest‑rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the carrying value was $27,219 million in 2022, increased to $31,248 million in 2023, and remained at $31,248 million in 2024. However, the LLM incorrectly states that the value decreased to $30,696 million in 2024, which contradicts the ground truth. This error undermines the core of the answer. (2) The 2022 and 2023 numbers are correct ($27,219M and $31,248M), but the 2024 figure is wrong—ground truth shows no decline, yet LLM reports $30,696M, a material deviation. Calculations based on incorrect data cannot be trusted. (3) The reasoning about a 'modest tightening of leverage' and 'managing interest-rate risk' in 2024 is speculative and unsupported by the actual data, which shows stable debt levels. The initial upward trend is correctly interpreted, but the conclusion about strategy is flawed due to incorrect data synthesis. (4) While the answer addresses all parts of the question and uses appropriate financial reasoning, the critical error in the 2024 value severely impacts correctness. The contextual relevance is high as it discusses the trend and strategy, but factual accuracy is compromised. Hence, correctness and quantitative accuracy scores are low; qualitative reasoning is partially sound but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 382,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "In 2022 AT&T still owned a 41.3 % stake in SKY Mexico and accounted for it under the equity method (2022 10‑K, page 93). The stake remained unchanged in 2023, still treated under the equity method. In 2024 AT&T sold its 41.3 % interest, ending the equity‑method accounting and exiting the investment (2024 10‑K, page 66). This three‑year path underscores AT&T’s broader strategy of divesting non‑core Latin American pay‑TV assets to streamline its portfolio and focus on core operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: AT&T (referred to as 'T' in the question) held a 41.3% stake in SKY Mexico in 2022 and 2023, accounted for it under the equity method, and exited the investment in 2024. The June 2024 exit is correctly implied by the 2024 10-K reference. (2) Quantitative accuracy is perfect: the 41.3% ownership stake is consistently and correctly reported across all years, with no calculation or numerical errors. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years and multiple filings (2022, 2023, 2024 10-Ks), correctly tracking the evolution from continued ownership to divestiture. It identifies the shift in accounting treatment (end of equity-method accounting) as a consequence of the sale, demonstrating proper financial understanding. (4) The answer captures the broader strategic implication—divesting non-core Latin American pay-TV assets to focus on core operations—which matches the original answer’s conclusion. Wording differs slightly but maintains semantic equivalence. All aspects of the question (ownership stake, equity method treatment, exit, and strategic implications) are addressed thoroughly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 353,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s 10‑K risk‑factor disclosures about capital‑return limits were essentially unchanged from 2022 through 2024.  Each year reiterated that the ability to return capital is subject to board discretion and may be constrained by U.S. banking laws, capital‑planning rules, Delaware law, and the requirement to pay dividends on preferred stock, and that failure to meet regulatory standards—including well‑capitalized status and capital‑adequacy/liquidity rules—could restrict activities.  No new regulatory or dividend‑policy language was added beyond this consistent framing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core regulatory constraints mentioned—U.S. banking laws, capital-planning rules, Delaware law, preferred dividend requirements, and capital adequacy/liquidity standards—and correctly notes their consistent presence across 2022–2024. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (BNY Mellon, regulatory frameworks) and time periods are correct. However, the LLM incorrectly asserts that disclosures were 'essentially unchanged' and that 'no new regulatory or dividend-policy language was added,' which contradicts the original answer’s key point that BNY Mellon expanded its risk discussion in 2023 to include ESG-related regulatory pressures and strategic initiatives, and in 2024 emphasized the Parent company’s reliance on subsidiary dividends and the impact of transformation initiatives on capital planning. This omission represents a significant failure in qualitative accuracy: the model missed the evolution in contextual complexity despite stable core regulatory language. The reasoning is therefore flawed in its synthesis across years—it failed to recognize incremental additions as meaningful developments. While the answer is relevant and captures the baseline framework, it underrepresents the nuanced evolution described in the ground truth, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 390,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "3M’s 2022, 2023 and 2024 10‑K tables all list “Structural adhesives and tapes” as a core product of the Safety & Industrial segment (page 107 for 2022, page 110 for 2023 and 2024).  The description and bundling with tapes and other industrial specialty items—such as abrasives, automotive‑repair solutions, electrical products and construction materials—remained unchanged, showing that adhesives are positioned as a foundational, cross‑functional component that enhances the value of a broad range of industrial solutions.  This consistency underscores the strategic importance of adhesives in providing structural bonding that underpins many of 3M’s industrial offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative reasoning and completeness. (1) It correctly identifies that Structural Adhesives were consistently listed as a core product in the Safety & Industrial segment across 2022–2024, and the page numbers cited (107, 110) align with typical 10-K structures, so entity and date accuracy are acceptable. There are no numerical figures in the question or answer, so quantitative accuracy is not applicable but assumed correct. (2) However, the LLM claims the 'description and bundling' remained 'unchanged,' which directly contradicts the ground truth: the original answer notes a clear evolution—from integration with abrasives and electrical materials in 2022, to a slight expansion into packaging in 2023, and a shift toward specialized industrial applications like construction and maintenance in 2024. This evolution is central to the question and is entirely missed by the LLM. (3) The multi-hop reasoning fails because the model does not synthesize changes over time; instead, it asserts consistency where there was strategic repositioning. The conclusion that adhesives are 'foundational' aligns with the ground truth’s strategic interpretation, but this insight is drawn from incorrect premises. (4) Therefore, while the answer is contextually relevant and factually precise in parts, it lacks the critical analysis of change over time, resulting in a moderate correctness score. The qualitative accuracy is low due to flawed reasoning, but contextual relevance remains high because the answer addresses the general strategic role of adhesives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 444,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From 2022 through 2024 Eli Lilly kept Cyramza’s core therapeutic portfolio unchanged – it continued to be marketed for advanced or metastatic gastric cancer, metastatic NSCLC, metastatic colorectal cancer, hepatocellular carcinoma, and first‑line metastatic NSCLC with EGFR mutations [page_7, page_5].  The company’s IP strategy remained focused on the same compound patents in the U.S., major European countries and Japan (expiring 2026, 2028 and 2026, respectively) and data‑protection exclusivities (U.S. 2026, Europe 2024, Japan 2023) [page_11, page_12], with the 2024 filing confirming that these protections are still in place while approaching their expiry dates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cyramza's therapeutic indications remained consistent from 2022 to 2024 across gastric, lung, colorectal, and liver cancers, aligning with the ground truth. However, it introduces a specific indication — 'first-line metastatic NSCLC with EGFR mutations' — which is not mentioned in the original answer and may represent an over-specific claim not supported by the ground truth. More critically, the LLM provides incorrect intellectual property (IP) expiration dates: it states U.S. data protection expires in 2026 (correct), but claims European data protection expires in 2024 (partially correct) and Japan in 2023 (correct), which matches the ground truth. However, the LLM incorrectly adds compound patent expirations in Europe (2028) and Japan (2026), which are not present in the original answer and contradict the focus on data protection, not compound patents, in the ground truth. (2) Quantitative accuracy is compromised: while U.S. (2026) and Japan (2023) data protection dates are correct, the inclusion of 2028 for European compound patents introduces false precision and misrepresents the strategic focus. The original answer emphasizes data protection timelines only, not patent terms. (3) The reasoning is partially sound — the model recognizes the importance of IP expiration in key markets and links it to lifecycle management — but fails in multi-hop synthesis by conflating data exclusivity with compound patents, which are distinct forms of IP. The original answer makes no mention of compound patents, focusing solely on data protection. (4) Contextual relevance is high as the response addresses both therapeutic indications and IP evolution. However, due to the introduction of unsupported patent expiration dates and over-specific indications, the correctness score is reduced to 6, reflecting partial factual accuracy with significant errors in quantitative details and entity specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 531,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$19,975 million at a 2.91 % weighted‑average rate in 2022** (COF_10k_2022, page 188) to **$27,168 million at 4.45 % in 2023** (COF_10k_2023, page 178), then fell slightly to **$26,930 million at 4.84 % in 2024** (COF_10k_2024, page 188). The upward swing in the weighted‑average rate and the large 2023 issuance indicate the company is refinancing older debt with higher‑rate, longer‑term notes, while the modest 2024 decline in carrying value suggests partial repayments or refinancing of the most expensive tranches. This multi‑year pattern signals a strategy of extending maturities at increasingly higher rates to maintain liquidity, accepting higher financing costs as market rates climb.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and interpretation but contains inaccuracies in the 2023 carrying value and interest rate. The ground truth only provides data for 2022 and 2024; the LLM introduces a 2023 data point ($27,168 million at 4.45%) not present in the original answer, which is unsupported by the provided ground truth. While this data may exist in the actual filings, the ground truth answer does not include 2023, so the LLM's inclusion of it constitutes a factual deviation. The 2022 and 2024 values match the ground truth: $19,975 million at 2.91% in 2022 and $26,930 million at 4.84% in 2024. (2) The quantitative accuracy is reduced because the 2023 figures are extraneous and not part of the original multi-year comparison (2022 to 2024). The core trend — increasing carrying value and rising interest rates — is accurate, but the specific intermediate value and rate for 2023 are not validated by the ground truth and thus introduce error. (3) The multi-hop reasoning is sound in interpreting the trend as a strategic shift toward higher-cost fixed-rate debt, likely due to market conditions, which aligns with the original answer. The LLM adds plausible qualitative insights about refinancing and maturity extension, which are reasonable but go beyond the original answer’s more concise conclusion. (4) Scores reflect: correctness (7) due to accurate endpoints but incorrect insertion of unsupported 2023 data; quantitative accuracy (6) due to incorrect intermediate values; qualitative accuracy (8) for strong reasoning and correct overall interpretation; contextual relevance (10) as all parts of the question are addressed with relevant analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 463,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation grew from **$651 million in FY 2022 to $730 million in FY 2023 and to $985 million in FY 2024** (page 92 for 2022; page 91 for 2023‑24).  The fair‑value impact on operating results was a **$92 million loss in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024** (page 91).  This pattern shows that the instrument’s value fluctuates markedly from year to year, with volatility increasing as the exposure expands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for gains and losses: $92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024 — matching the ground truth exactly. These numbers are cited accurately and in the correct fiscal years. (2) The LLM introduces additional data not present in the original answer — the notional exposure amounts ($651M, $730M, $985M) — which are factually correct per the cited pages but were not part of the ground truth answer. This does not make the answer incorrect but adds detail beyond the scope of the original. Since the question asks about 'financial exposure,' this addition is contextually relevant and enhances completeness. (3) The reasoning is sound: the LLM correctly identifies the volatility of the instrument and links it to both the fluctuating gains/losses and increasing exposure, which is a logical extension of the pattern described in the ground truth. The multi-hop synthesis across years and financial impacts is accurate. (4) The semantic meaning fully aligns with the original answer — the pattern of loss to gains and the conclusion about volatility are preserved and even strengthened with supporting notional exposure data. The only reason for not scoring a perfect 10 is that the original answer did not include notional exposure figures, so the LLM slightly exceeds the ground truth without contradicting it. All scores reflect high accuracy, strong reasoning, and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 413,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "From 2022 to 2024 Home Depot moved from a limited focus on store appearance to a full‑scale refresh program—wayfinding signage, electronic shelf labels, curb‑side pickup, self‑service lockers and mobile‑app navigation—reporting higher customer‑satisfaction scores and that roughly 50 % of U.S. online orders were fulfilled through a store, which has strengthened its competitive position against multichannel and online rivals [page_9, page_10].",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of The Home Depot's strategy from 2022 to 2024, noting a shift toward enhanced store appearance and integration with digital tools, which aligns with the ground truth. It correctly identifies that store appearance became more integrated with omnichannel capabilities over time. However, it omits specific strategic framing from the original answer—such as the 2022 emphasis on store appearance as a differentiator against lumber yards and home décor retailers, and the 2023–2024 evolution into an interconnected retail model explicitly supporting Pros and DIY customers. These nuances are missing, reducing completeness. (2) Quantitatively, the claim that 'roughly 50% of U.S. online orders were fulfilled through a store' is plausible and consistent with Home Depot’s reported ship-from-store strategy, though the exact percentage is not verifiable from the provided ground truth. No incorrect numbers are stated, and the reference to page citations suggests sourcing, but the ground truth does not include this specific metric, so it cannot be fully confirmed. The absence of explicit financial figures or incorrect calculations earns a high but not perfect quantitative score. (3) The reasoning shows partial multi-hop synthesis: it connects store enhancements (e.g., electronic shelf labels, mobile app navigation) with competitive positioning against online retailers, which is valid. However, it fails to fully articulate the strategic progression across years as a deliberate pivot from standalone in-store experience to a hybrid omnichannel model, weakening the qualitative depth. The mention of fulfillment metrics supports competitive impact but lacks direct causal linkage made in the original answer. (4) Contextual relevance is strong—the response stays on topic, references appropriate initiatives, and ties them to competitive dynamics. The score of 7 reflects accurate core facts with meaningful omissions in strategic nuance and unverified use of a specific percentage not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 558,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 carried $1.637 billion at the end of fiscal 2022 (Jan 29 2023) (page_67), fell slightly to $1.604 billion at the end of fiscal 2023 (Jan 28 2024) (page_67), and rose to $2.000 billion at the end of fiscal 2024 (Jan 28 2024) (page_72). This modest dip followed by a notable increase reflects NVIDIA’s active management of its long‑term debt mix and maturity profile, indicating a stable yet strategically adjusted long‑term debt position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the carrying value was $2,147 million in fiscal 2022, $1,637 million in fiscal 2023, and $2,000 million in fiscal 2024. However, the LLM reports $1,637 billion (which is 1,000 times too large) for fiscal 2022, $1,604 billion for fiscal 2023 (incorrect value and unit), and $2,000 billion for fiscal 2024 (again, wrong unit). While the trend of decrease then increase is partially aligned, the actual numbers are severely off due to incorrect units (billions vs millions) and incorrect values (e.g., $1,604M instead of $1,637M for 2023). (2) The fiscal years are referenced with exact dates (e.g., Jan 29, 2023), which may reflect filing dates rather than fiscal year-end values, introducing confusion. The ground truth uses fiscal year labels (2022, 2023, 2024), not calendar dates. (3) The multi-hop reasoning is partially sound—the model attempts to interpret the trend in long-term debt positioning—but the flawed input data undermines the validity of the conclusion. The claim of a 'slight' dip and 'notable increase' misrepresents the actual trajectory, which in truth shows a significant drop from 2022 to 2023 and a rebound to near-original levels by 2024. (4) Despite incorrect numbers and units, the answer addresses the question structure appropriately and draws a reasonable qualitative interpretation based on the trend, hence moderate scores in qualitative accuracy and contextual relevance. However, the quantitative inaccuracies are severe enough to warrant a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 447,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 through 2024, 3M’s Scotchgard exposure was limited to a single consolidated putative class action in Michigan against Wolverine.  The case, pending in 2022, was settled in June 2023 for an immaterial amount, leaving only 3M and Wolverine as defendants.  No new Scotchgard lawsuits, additional defendants, or geographic expansion of litigation emerged in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and incomplete compared to the ground truth. (1) It claims that 3M's legal exposure was limited to a single Michigan case involving Wolverine, settled in June 2023 for an immaterial amount, which partially aligns with the ground truth but omits the 2022 New York Baker case settlement involving 3M, Saint-Gobain, and Honeywell for $65 million (with 3M's share immaterial). This omission of a key multi-jurisdictional case undermines completeness and accuracy. (2) The LLM states no new lawsuits or geographic expansion occurred in 2024, which directly contradicts the ground truth: litigation expanded to Alabama and Georgia, with new plaintiffs including municipal water utilities, landowners, and Mohawk Industries. (3) The answer incorrectly claims only 3M and Wolverine were defendants, while the ground truth confirms the number of defendants increased, including DuPont, Chemours, and carpet manufacturers being named alongside 3M. (4) The reasoning fails on multiple hops: it does not synthesize information across years, geographies, or defendant lists. While the Michigan settlement date (2023) and immateriality are correctly noted, the overall narrative falsely suggests de-escalation, whereas the actual trend is increasing complexity and geographic/legal expansion. Quantitative accuracy is low due to missing $65M settlement and incorrect case scope. Qualitative accuracy is poor due to wrong entities, lack of synthesis, and incorrect conclusions about litigation trends. Contextual relevance is moderate as it addresses Scotchgard litigation but misses core developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 441,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "From 2022 to 2024 the AbCellera collaboration kept a mid‑teens to mid‑twenties royalty on worldwide net sales of bamlanivimab and bebtelovimab, with no change to the royalty structure. Milestone payments were not material or disclosed in the 2023 and 2024 filings, and no milestone payments were recorded in those years. Net product revenue fell sharply, with $2.02 billion recognized in 2022 and zero revenue in 2023 and 2024 as sales ceased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the royalty structure (mid-teens to mid-twenties) is accurately reported, net product revenue of $2.02 billion in 2022 and zero in 2023 and 2024 is precisely stated, and the absence of milestone payments in 2023 and 2024 is correctly noted. (2) Quantitative accuracy is perfect: the $2.02 billion figure matches exactly, and the zero revenues in 2023 and 2024 are correctly reported. No calculations were required, but the temporal comparison of revenue decline is accurately conveyed. (3) The multi-hop reasoning is sound—information about royalty structure, revenue, and milestone payments across three years is synthesized correctly from the collaboration timeline. The only minor omission is that the original answer explicitly attributes the cessation of sales to lack of demand or regulatory authorization, which adds context the LLM answer lacks. However, this does not affect factual correctness. (4) The LLM answer uses slightly different phrasing (e.g., 'not material or disclosed' for milestones) but semantically matches the ground truth. Contextual relevance is full, as all parts of the question—royalty structure, milestone payments, and net product revenue over 2022–2024—are addressed accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 366,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "Procter & Gamble has kept Dawn dish soap listed as one of the “major brands” in its Fabric & Home Care segment, which grew from 35 % of net sales (31 % of net earnings) in 2022 to 36 % of net sales (34 % of net earnings) in 2024 (PG 10‑K 2022, p. 19; PG 10‑K 2024, p. 18). The brand’s unchanged status amid the segment’s incremental share and earnings growth shows that Dawn remains a core, high‑volume driver of the home‑care portfolio, underscoring its strategic importance as a key product in P&G’s daily‑use category strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the Fabric & Home Care segment's net sales increased from 35% in 2022 to 36% in 2023 and remained at 36% in 2024; earnings rose from 31% to 34%, consistent across 2023 and 2024. The LLM correctly reports these figures, though it summarizes the endpoint comparison (2022 to 2024), which is acceptable and semantically valid. (2) The entity identification is accurate—Procter & Gamble, Dawn, Fabric & Home Care segment, and correct fiscal years (2022–2024). (3) The reasoning is sound: the LLM correctly infers that Dawn’s consistent positioning as a 'major brand' amid segment growth indicates strategic importance, which matches the ground truth’s conclusion about sustained emphasis. (4) The answer is contextually relevant and addresses both parts of the question: evolution of positioning (unchanged) and strategic importance (core, high-volume driver). The only minor shortcoming is that the LLM does not explicitly mention 2023 data, though it references the 2024 10-K which implies continuity. This omission is not material, as the trend is accurately captured. Overall, the answer demonstrates correct multi-hop synthesis across years and documents, with precise numerical reporting and valid strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 373,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024, while long‑term debt rose from $47.8 B in 2022 to $49.3 B in 2023 and declined to $45.0 B in 2024, so the combined short‑term plus long‑term debt fell from $48.7 B to $45.6 B over the three years. The floating‑unsecured senior debt dropped sharply from $1.6 B in 2022 to $349 M in 2023 and to zero in 2024, indicating a deliberate shift away from floating‑rate exposure toward fixed‑rate debt. This mix change, coupled with a rise in the weighted‑average interest rate on unsecured senior debt from 4.45% in 2022 to 4.84% in 2024, reflects a strategy to lock in rates and reduce interest‑rate variability amid a higher‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total debt was $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM states short-term borrowings were $883M in 2022 and long-term debt was $47.8B, summing to $48.683B—already misaligned with the true total of $43.086B. This indicates incorrect component values. The LLM’s combined total of $48.7B in 2022 and $45.6B in 2024 is close to the actual 2023 and 2024 totals but misrepresents the starting point and trajectory. (2) Floating unsecured senior debt is mostly correct: $1.6B (vs. $1.709B) in 2022, $349M in 2023, and zero in 2024—minor rounding acceptable. However, the weighted-average interest rate on fixed unsecured senior debt is misrepresented: LLM claims it rose from 4.45% in 2022 to 4.84% in 2024, but ground truth shows it was 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024—so the LLM incorrectly assigns the 2023 rate to 2022, missing the full progression. (3) The multi-hop reasoning about strategic shift toward fixed-rate debt and away from floating-rate exposure is sound and correctly inferred from the declining floating debt and rising fixed-rate interest costs. The conclusion about reducing interest rate variability in a rising rate environment is logically supported and aligns with the ground truth. (4) Despite correct directional trends and qualitative insights, the quantitative inaccuracies in core debt totals and interest rate baselines significantly reduce factual reliability. The answer is contextually relevant and addresses all parts of the question, but the numerical errors prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 476,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s 5.90% senior note stayed a $2 billion fixed‑rate instrument with an effective rate of 6.11 % and remained classified as long‑term debt in FY 2022, FY 2023 and FY 2024.  However, its share of total debt fell as Cisco issued new senior notes in 2024—total debt rose from $8.9 billion in FY 2022 to $20.1 billion in FY 2024—so the 5.90% note accounted for roughly 22 % of debt in 2022 and only about 10 % in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Cisco maintained a $2,000 million (i.e., $2 billion) 5.90% Note with a consistent effective interest rate of 6.11% across fiscal years 2022–2024 and that it remained classified as long-term debt. This core information matches the ground truth. However, there are discrepancies in the total debt figures: the LLM reports $8.9 billion in FY2022 vs. the correct $8,416 million ($8.416 billion), and $20.1 billion in FY2024 vs. the correct $19,621 million ($19.621 billion). These inaccuracies affect the derived percentages: the LLM states the note accounted for ~22% in 2022 and ~10% in 2024, but using correct figures, the actual proportions are approximately 23.8% (2,000 / 8,416) in 2022 and 10.2% (2,000 / 19,621) in 2024. While the trend (declining share due to overall debt growth) is correctly captured, the specific percentages are slightly off due to incorrect base totals. (2) The calculation of proportions relies on accurate total debt numbers, which the LLM misstates—this is a significant quantitative error despite correct principal amount. (3) The multi-hop reasoning is sound: the model correctly infers that while the 5.90% Note remained constant, its relative weight decreased due to new debt issuances, reflecting an understanding of debt composition dynamics. It also correctly links the classification as long-term debt and stable interest rate over time. (4) The contextual relevance is perfect—the answer directly addresses all parts of the question: debt composition, interest rate, and long-term classification. The qualitative reasoning is strong, but the quantitative inaccuracies in total debt figures prevent a higher correctness score. Minor formatting differences like $2 billion vs. $2,000 million are acceptable, but the actual values must align; here, they do not exactly, leading to a 7/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 511,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "NVIDIA’s 1.55% Notes Due 2028 carried $1.099 million on the balance sheet in FY 2022 and FY 2023, rising modestly to $1.115 million in FY 2024 (page 82, page 67).  The effective interest rate on the notes stayed essentially unchanged at about 1.64% in FY 2023 and FY 2024 (page 72).  This flat balance and stable, low cost indicate a disciplined long‑term debt strategy that prioritizes low‑cost financing and minimal refinancing activity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both carrying values and the timeline. According to the ground truth, the carrying value was $1,200 million in FY2022, decreased to $1,099 million in FY2023, and increased to $1,250 million in FY2024. The LLM incorrectly states the value as $1.099 million (off by a factor of 1,000) for both 2022 and 2023, and reports $1.115 million in 2024—none of which match the correct figures. Additionally, the effective interest rate is misrepresented: the ground truth indicates an increase to 1.64% in FY2024 from an implied lower rate in 2022, while the LLM claims it was stable at 1.64% in 2023 and 2024, missing the trend entirely. (2) The numerical errors are severe—both in magnitude (millions vs. billions) and direction (flat vs. fluctuating trend). The correct values are $1,200M → $1,099M → $1,250M, showing a U-shaped evolution, whereas the LLM reports near-flat growth from $1.099M to $1.115M, which is not only wrong in scale but also misrepresents the trend. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the temporal evolution of both carrying value and interest rate, leading to an incorrect conclusion about a 'stable, low-cost' strategy. In reality, the fluctuation in carrying value suggests active management (e.g., reacquisition or reissuance), and the rising interest rate indicates increasing borrowing costs—both of which the LLM overlooks. (4) The contextual relevance is moderate because the answer addresses the right metric (carrying value, effective interest rate) and attempts to infer strategy, but due to severe factual and quantitative errors, the conclusions are invalid. The qualitative reasoning is therefore unsound despite the correct framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 484,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "Google has kept Pixel device sales within the “devices” component of its Google Subscriptions, Platforms, and Devices revenue category from 2022 through 2024 (2022 10‑K pages 6‑8, 2023 10‑K page 33, 2024 10‑K page 59).  During the same period the company amplified its hardware‑innovation spend, as shown by a jump in purchases of property and equipment—from $32.3 bn in 2023 to $52.5 bn in 2024 (2024 10‑K page 57)—and by the continued launch of newer Pixel models and complementary devices such as Nest and Chromecast.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Pixel devices were categorized under the 'devices' segment within the Subscriptions, Platforms, and Devices revenue category from 2022 to 2024, which aligns with the ground truth. It also correctly notes increased investment in hardware innovation. However, it introduces a significant factual inaccuracy by citing purchases of property and equipment rising from $32.3B in 2023 to $52.5B in 2024 as evidence of increased hardware-innovation spending. The ground truth does not mention this capital expenditure data, and such a jump is not corroborated in typical Google 10-K filings for those years—this appears to be either misattributed or incorrectly interpreted data. (2) The quantitative accuracy is compromised due to this unsupported financial figure. While the revenue categorization is consistent across years and correctly tied to the 10-K pages, the capital expenditure numbers are not present in the original answer and cannot be verified against the ground truth, making this a major quantitative error. (3) The reasoning is partially sound: the model correctly infers that consistent categorization indicates strategic importance and links hardware launches to innovation. However, it fails to capture the evolution described in the ground truth—from 'long-term investment' in 2022 to 'strategically embedded product line' by 2024—and misses the nuance of how Pixel’s role matured within Google’s ecosystem, particularly with AI and cloud integration. (4) Contextual relevance is high because the answer addresses revenue categorization and hardware innovation directly. The qualitative accuracy is good but not excellent due to missing the strategic evolution narrative. The correctness score is 7 because core facts about revenue segmentation are accurate, but the inclusion of unverified financial data reduces overall reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 514,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "BNY Mellon’s 10‑K Item 14 from 2022, 2023 and 2024 all contain the identical wording: “The information required by this Item is included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference. KPMG LLP’s PCAOB firm identification number is 185.” (page_14, 2022; page_14, 2023; page_14, 2024) The unchanged presentation across three consecutive filings signals that the audit engagement with KPMG has remained continuous and stable, with no changes in the principal accountant relationship.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: BNY Mellon consistently disclosed the ratification of KPMG LLP as principal accountant in 2022, 2023, and 2024 using identical language, including the PCAOB firm ID number 185, with no changes in presentation. (2) There are no numerical or date inaccuracies—PCAOB number 185 is correctly cited across all years, and the reference to Item 14 in each year’s 10-K is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and filings to infer audit relationship stability from consistent disclosure practices. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and the implication for audit stability. Wording differs slightly from the original answer but conveys the same meaning with equal or greater specificity (e.g., citing page numbers and exact text). No omissions or inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 291,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "From 2022 to 2024 Lilly’s private‑alternative‑investment holdings fell from $8.87 billion (56.6 % of total defined‑benefit and retiree assets) to $8.61 billion (52.9 %) and then to $8.21 billion (50.6 %)【page 99】【page 100】【page 99】. The modest decline in both dollar amount and share of the portfolio suggests the company is slowly trimming its illiquid exposure—likely to improve liquidity or risk balance—while still maintaining a substantial long‑term commitment to private alternatives for higher returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the allocation trend. The ground truth states that LLY's private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, then to $10,051.0 million in 2024. However, the LLM claims the holdings decreased from $8.87 billion to $8.61 billion to $8.21 billion—wrong values and opposite trend. These dollar figures do not match the ground truth even when adjusting for formatting (e.g., $10,542.5 million = $10.54 billion, not ~$8.87 billion). Additionally, the percentages cited (56.6%, 52.9%, 50.6%) are not present in the original answer and appear to be fabricated or misattributed. (2) All numerical values are incorrect: 2022: LLM says $8.87B vs. truth $10.54B; 2023: $8.61B vs. $10.34B; 2024: $8.21B vs. $10.05B. The trend is also wrong—LLY’s allocation slightly decreased from 2022 to 2023 but increased again in 2024 according to the truth, while LLM shows a consistent decline. Calculations based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a strategic de-emphasis on illiquid assets due to a supposed decline, while the truth indicates sustained high exposure with a slight fluctuation, suggesting continued strategic commitment. The conclusion about 'trimming illiquid exposure' contradicts the ground truth’s interpretation of 'strategic emphasis on diversification and long-term growth.' (4) Scores are low because the core quantitative data is entirely inaccurate, leading to incorrect analysis. Contextual relevance is moderate because the LLM addresses the right topic (LLY's investment strategy in private alternatives) and attempts to interpret strategic implications, but the faulty data undermines all conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 493,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "In 2022, Tampax was listed under the “Feminine Care” sub‑category of the Baby, Feminine & Family Care segment, grouped with adult incontinence and general feminine care (PG_10k_2022, p. 19). By 2023, P&G re‑classified that sub‑category as “Menstrual Care,” reflecting a sharper focus on menstrual products, while Tampax Bounty remained a key brand alongside Always and Always Discreet (PG_10k_2023, p. 18). The classification and brand emphasis stayed the same in 2024, with Tampax Bounty still highlighted as a major brand in the Menstrual Care sub‑category (PG_10k_2024, p. 19).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reclassification of 'Feminine Care' to 'Menstrual Care' in 2023 and Tampax's placement within that category across years, which aligns with the ground truth. However, it introduces a significant factual error by repeatedly referring to 'Tampax Bounty'—a non-existent brand combination. Tampax and Bounty are separate brands (Bounty is a paper towel brand), indicating a critical entity confusion. This undermines the qualitative accuracy. (2) Quantitatively, the answer omits key numerical data present in the ground truth: the segment's contribution to net sales (25% in 2022, 24% in 2023 and 2024). While no incorrect numbers are stated, the absence of these percentages—central to the strategic evolution—reduces completeness and quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly tracks the category rebranding from 'Feminine Care' to 'Menstrual Care' across filings. However, it fails to note the strategic removal of 'Baby Care' from the segment in 2024, a key signal of P&G’s shifting focus, which the ground truth emphasizes. This omission weakens the synthesis. (4) Contextually, the answer stays focused on the question and uses appropriate terminology and citations. The core evolution in classification is captured, but major errors in brand naming and missing strategic context (removal of Baby Care, sales percentages) prevent a higher score. The 'Tampax Bounty' error suggests possible hallucination or data corruption, severely impacting reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 429,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One continued to value its net derivative assets and liabilities with discounted‑cash‑flow models throughout 2022‑2024, but the key unobservable inputs shifted. In 2022 the discounting was based on swap rates (1‑2 % range, weighted 2 %); in 2023 the model switched to default rates (53‑163 % range, weighted 4 %); and in 2024 it returned to swap rates (4 % range, weighted 4 %). Correspondingly, the fair‑value balance rose from $19 million in 2022 to $58 million in 2023 and $69 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that Capital One used discounted cash flow (DCF) models in 2022; the ground truth explicitly says the valuation technique was not disclosed for 2022. Second, the LLM claims swap rates in 2022 were in the 1-2% range (weighted 2%), which is unsupported by the original answer—no such data is provided for 2022. Third, the LLM states that in 2023 the model 'switched to default rates' with a 53-163% range (weighted 4%), but the ground truth indicates that both default rates (53-163%) and swap rates (3-5%) were cited in 2023, not a switch to only default rates. Fourth, the LLM claims in 2024 the model returned to swap rates at a '4% range, weighted 4%', but the original answer states the swap rate range remained 3-5%, with no mention of weighting. Additionally, the LLM reports a 2024 fair value of $69 million, but the ground truth states it remained at $58 million—this is a significant numerical error. (2) Quantitative accuracy is very low: only the 2022 ($19M) and 2023 ($58M) fair values are correct; 2024 is wrong ($69M vs $58M), and all rate ranges and weightings are fabricated or misrepresented. (3) Multi-hop reasoning is flawed: the LLM incorrectly infers a shifting pattern in valuation models and inputs across years, whereas the ground truth shows a progression toward consistency starting in 2023, not oscillation. It fails to recognize that DCF use began in 2023, not 2022, and misrepresents the co-use of multiple unobservable inputs. (4) Contextual relevance is moderate—the answer addresses the right topic (valuation methods, inputs, fair value trends) and time frame, but the factual and reasoning errors severely undermine correctness. The conclusion about increasing transparency in the original answer is entirely missed and replaced with an incorrect narrative of model switching.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 515,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a small gain in fiscal 2022 to progressively larger losses in the next two years – a net gain of $9 million in 2022, a net loss of $21 million in 2023, and a net loss of $67 million in 2024. This reversal shows the portfolio’s fair‑value performance deteriorated, making it a growing drag on the company’s other‑income (loss) metric and indicating higher market or credit risk over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$9M gain in 2022, $21M loss in 2023, $67M loss in 2024—that are not present in the original answer (ground truth). The ground truth explicitly states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, making the claim of a '$9 million gain' factually incorrect and unsupported. Similarly, the losses in 2023 and 2024 are described qualitatively in the ground truth (e.g., 'higher losses' and 'significantly contributed') but no exact dollar figures are given, so the LLM's precise numbers are fabricated or hallucinated. (2) These numerical inaccuracies severely undermine quantitative accuracy. Even though the direction of change (from gain to increasing losses) aligns with the trend implied in the ground truth, the specific figures are not corroborated and contradict the absence of disclosed metrics in 2022. (3) The reasoning partially captures the multi-hop insight: the LLM correctly infers a deteriorating trend in AFS investments impacting 'other income (loss), net' and links this to increasing risk. However, it fails to acknowledge the lack of data in 2022, which is a key point in the original answer and affects the validity of any quantitative comparison across all three years. The synthesis is therefore flawed due to unsupported data points. (4) Despite these issues, the answer remains contextually relevant—it addresses the impact on 'other income (loss), net' and interprets the risk profile over time in line with the question. The qualitative logic would score higher if not for the critical error of inventing numbers. Correctness is low because financial analysis relying on incorrect figures cannot be considered accurate, even if the narrative trend seems plausible.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 489,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "In FY 2022 Starbucks’ 10‑K noted that its purchase commitments and inventory would provide an adequate green‑coffee supply through FY 2023 (page 12, 2022).  In FY 2023 the projection was extended to FY 2024 (page 12, 2023), and in FY 2024 it was further extended to FY 2025 (page 12, 2024).  This one‑year‑ahead roll‑forward shows a forward‑looking sourcing strategy that relies on fixed‑price and price‑to‑be‑fixed contracts, hedging, and farmer‑support centers to secure supply and mitigate price and supply risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Starbucks' green coffee supply adequacy projections from fiscal 2022 through 2024. However, there is a factual inaccuracy in the FY2023 projection: the original answer states that by FY2023, the adequacy was extended to FY2025, but the LLM claims it was extended only to FY2024, which is incorrect. This error affects both quantitative and qualitative accuracy. The FY2024 extension to FY2025 is correctly reported. (2) The fiscal years and their corresponding projections are mostly accurate except for the FY2023-to-FY2024 claim, which should have been FY2023-to-FY2025. The page references (page 12) are plausible but not verifiable without access to the filings; however, they do not contradict the ground truth. (3) The multi-hop reasoning is partially sound—the model recognizes the trend of extending supply coverage and links it to sourcing strategy, which shows good synthesis. However, because one key hop (the FY2023 projection) is incorrect, the reasoning chain is flawed. The mention of fixed-price contracts, hedging, and farmer-support centers adds detail not in the original answer; while plausible, these specifics are not confirmed by the ground truth and slightly shift focus from the core point about longer-term commitments and inventory management. (4) The correctness score is 7 because the core trend is recognized and the final projection is accurate, but a key intermediate fact is wrong. Quantitative accuracy is 8 due to one incorrect year projection. Qualitative accuracy is 7 due to correct overall logic but inclusion of unverified strategic details and a misstep in entity-time linkage. Contextual relevance is high as the answer directly addresses the question’s scope and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 484,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00% Notes Due 2031 rose modestly from **$1,044 million** as of January 29 2023 (FY 2023) to **$1,057 million** as of January 28 2024 (FY 2024)【page_67】. The 2022 amount is not disclosed in the provided pages, but the small uptick indicates a steady, low‑growth debt strategy—using long‑term notes to fund growth while keeping leverage largely unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NVIDIA's exposure was $1,200 million in FY2022, $1,044 million in FY2023, and $1,250 million in FY2024. The LLM incorrectly states that the FY2022 amount is not disclosed (it is part of the ground truth) and misreports FY2024 as $1,057 million instead of $1,250 million. It also mischaracterizes the FY2023 value as the starting point, when in fact it is a decrease from FY2022. (2) Quantitative accuracy is severely compromised: all three years are either missing or incorrect. The only number that matches is $1,044 million for FY2023, but even then it is presented as the first data point rather than the second. The reported $1,057 million for FY2024 does not match the ground truth $1,250 million, indicating a clear error in data retrieval or calculation. (3) The reasoning is flawed due to incorrect data inputs. The conclusion of a 'steady, low-growth debt strategy' contradicts the ground truth trend, which shows a drop from $1,200M to $1,044M and then a rise to $1,250M—indicating a fluctuating, dynamic strategy, not a steadily growing one. The model fails to perform the required multi-hop synthesis across all three fiscal years and omits the first year entirely. (4) Contextual relevance is moderate because the answer addresses the right financial instrument and attempts to interpret the company's debt strategy, but the incorrect data leads to a misleading interpretation. The citation to page 67 suggests some document grounding, but the data does not align with the verified truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 440,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "From 2022 to 2024 3M shifted Fall Protection Solutions from a broad “Respiratory, hearing, eye and fall protection solutions” category within the Safety and Industrial segment to a more focused position in the newly created Industrial Specialties division (which houses the Personal Safety division).  This re‑categorization moves fall‑protection gear into a dedicated personal‑safety product line, giving it clearer emphasis relative to other industrial‑safety offerings such as respiratory and hearing protection.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in entity and structural representation despite correct use of timeframes (2022–2024) and correct mention of the Safety and Industrial segment. According to the ground truth, Fall Protection Solutions remained within the Safety and Industrial segment throughout 2022–2024 and were not moved to a newly created 'Industrial Specialties division' or a dedicated 'Personal Safety division'—no such reorganization is supported by the data. The original answer indicates only a subtle shift in presentation and grouping emphasis, not a structural re-categorization into a new division. The LLM incorrectly implies an organizational restructuring that did not occur, fundamentally misrepresenting the evolution. While the answer addresses the question's focus on product categorization and emphasis, the reasoning is flawed due to invented corporate changes. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. However, the qualitative accuracy is low due to incorrect entity relationships and synthesis. Contextual relevance is moderate because the response engages with the right topic and timeframe but misrepresents the nature of the change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 345,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Bamlanivimab generated **$2.009 billion in 2022** (the only year it was sold under an EUA), but sales **fell to $0 in 2023 and remained $0 in 2024**【page_68】.  This sharp drop shows that Lilly has largely exited the COVID‑19 antibody market, reducing its reliance on that portfolio over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the revenue trend for bamlanivimab: $2.009 billion in 2022 (effectively equivalent to $2.01 billion in the ground truth, with minor rounding difference), $0 in 2023, and $0 in 2024. These figures match the ground truth within acceptable precision. 2) Quantitatively, the numbers are accurate—$2.009 billion is a valid representation of $2.01 billion when considering rounding conventions in financial reporting. The zero revenue in 2023 and 2024 is exactly correct. 3) The reasoning is sound: the answer correctly infers that the drop to zero indicates Lilly has exited or greatly reduced its presence in the COVID-19 antibody market, aligning with the ground truth’s conclusion about reduced reliance on the portfolio. The mention of EUA (Emergency Use Authorization) adds contextual accuracy about why it was only sold in 2022. 4) The answer is semantically equivalent to the ground truth, with slightly more detail (EUA context) and a minor rounding difference that does not affect factual correctness. The only reason for not scoring a 10 is that the original answer emphasizes the broader 'COVID-19 antibody portfolio' context, while the LLM focuses narrowly on bamlanivimab; however, since the question specifically asks about bamlanivimab, this focus is justified. All parts of the question are addressed: revenue evolution and what it indicates about reliance over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 390,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks’ 2022 10‑K (page 12) warned that coffee price volatility is affected by hedge funds and commodity index funds and that its fixed‑price and hedging commitments cover supply through fiscal 2023. The 2023 10‑K (page 12) repeats that exposure and extends the coverage to fiscal 2024, while the 2024 10‑K (page 12) again cites the same exposure but now extends purchase commitments—using forward contracts, futures and collars—to secure green coffee through fiscal 2025. This progressive extension of hedging and fixed‑price commitments shows a deliberate risk‑management strategy aimed at locking in prices and ensuring a stable supply against index‑fund‑driven volatility for an increasingly longer horizon.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Starbucks acknowledged commodity index fund impact on coffee price volatility in each fiscal year (2022–2024), and progressively extended its supply commitments from fiscal 2023 (as stated in 2022) to fiscal 2025 (as stated in 2024). (2) Quantitative elements—fiscal years and time horizons—are accurately represented with no calculation errors. The extension of hedging commitments is correctly dated and described. (3) Multi-hop reasoning is sound: the answer synthesizes disclosures across three consecutive 10-K filings, correctly identifying the evolution in risk management strategy over time. (4) The LLM accurately identifies the use of forward contracts, futures, and collars as hedging instruments and links them to managing 'C' price exposure driven by index fund activity. The conclusion about a strengthening, deliberate risk management strategy aligns with the ground truth’s interpretation of improved supply chain resilience. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 326,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In 2022, Google’s 10‑K (page 31) identified Google Ad Manager as a core component of the Google Network, monetizing impressions on partner sites and measuring revenue by cost‑per‑impression.  The 2023 10‑K (page 58) reports that extending the useful life of servers and network equipment from 4–5 to 6 years cut depreciation by $3.9 B and raised 2023 net income by $3.0 B, thereby improving the margin on ad‑inventory and bolstering long‑term profitability.  By 2024, the 10‑K (pages 56‑60) still lists Ad Manager within the Google Network with no change to the model, and the one‑time depreciation benefit supports the continued reliance on impression‑based monetization as the business expands into new formats and devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager's role in impression-based monetization in 2022, the 2023 change in server and network equipment depreciation (from 4 to 6 years and 5 to 6 years), the $3.9 billion reduction in depreciation expense, and the $3.0 billion increase in net income are all accurately reported. These figures match the original answer exactly and are correctly attributed to the 2023 fiscal year. (2) Quantitative accuracy is perfect—numbers, years, and financial impacts are correct, and the dollar amounts are consistent with the ground truth (allowing for formatting like $3.9B = $3.9 billion). (3) The reasoning is sound: the LLM correctly links the depreciation change to improved margins and long-term profitability, and notes the continued reliance on Ad Manager in 2024. It synthesizes information across 2022–2024 filings and connects infrastructure cost optimization to advertising monetization. (4) The only minor shortcoming is that the LLM does not explicitly mention that advertising revenues from Google Network properties were reported on a 'gross basis' in 2024, a detail included in the original answer that reinforces strategic importance. While the LLM implies continuity, this specific accounting nuance is omitted. However, this does not undermine the core correctness. The answer remains contextually relevant, complete in substance, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 413,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK continued to issue a new Performance Share Unit Agreement each year from 2022 through 2024 under its 2019 Long‑Term Incentive Plan (2022 Form of Performance Share Unit Agreement – Exhibit 10.25 in the 2022 10‑K; 2023 Form of Performance Share Unit Agreement – Exhibit 10.20 in the 2023 10‑K; 2024 Form of Performance Share Unit Agreement – Exhibit 10.25 in the 2024 10‑K). This steady, year‑over‑year issuance underscores the company’s sustained focus on tying executive pay to long‑term performance and aligning incentives with shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly states that BK issued a new Performance Share Unit Agreement each year with specific exhibit numbers: '2022 Form – Exhibit 10.25 in 2022 10-K', '2023 Form – Exhibit 10.20 in 2023 10-K', and '2024 Form – Exhibit 10.25 in 2024 10-K'. However, the ground truth states that in 2022, BK referenced the 2021 agreement (Exhibit 10.45), not a 2022 form; in 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), not a 2023 PSUA; and in 2024, BK included the 2022 Form of PSUA (Exhibit 10.18), not a 2024 form. These exhibit numbers and years are entirely inconsistent with the ground truth, indicating major errors in document references and timelines. (2) Completeness: The LLM fails to capture the actual evolution pattern—referencing prior agreements, re-filing the foundational plan, and updating with recent forms—thus missing the core multi-hop progression. (3) Entity Accuracy: Wrong years for the agreements (e.g., claiming 2023 and 2024 forms exist as distinct documents), incorrect exhibit numbers, and misattribution of filing content to years. (4) Reasoning: The LLM assumes a linear annual update cycle, but the ground truth shows a more nuanced, adaptive reuse and re-filing strategy. The conclusion about 'steady year-over-year issuance' is factually wrong and leads to an incorrect interpretation of the compensation strategy. (5) Semantic Equivalence: While the general idea of alignment with performance is plausible, the factual foundation is so flawed that the overall meaning diverges significantly. The progression described in the LLM answer does not reflect the actual regulatory filing history. Thus, despite some contextual relevance in discussing executive compensation alignment, the answer is largely incorrect on key facts and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 513,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "In 2023, 3M’s Safety and Industrial segment described its electrical portfolio as “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)” (page 107). The same wording appears unchanged in the 2024 filing (page 110), and the 2022 10‑K used an identical, though slightly less detailed, phrasing. The lack of change in specificity or product categorization over these three years signals that 3M has maintained a steady focus on supplying electrical OEMs in construction, maintenance and power‑distribution markets rather than shifting its product mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that the wording remained unchanged across 2022, 2023, and 2024. The original answer (ground truth) shows a clear evolution in language: from 'construction and maintenance, power distribution and electrical OEMs' in 2022, to a more precise 'electrical original equipment manufacturers (OEMs)' in 2023, and further refined in 2024 to 'power distribution and electrical original equipment manufacturers (OEMs)'. The LLM incorrectly states that the 2023 and 2024 descriptions are identical and that 2022 was only 'slightly less detailed', which contradicts the documented progression. (2) There are no numerical values in this question, so quantitative accuracy is not heavily applicable; however, the citation of page numbers (107, 110) may be accurate formatting but do not compensate for misrepresenting the content evolution. (3) The multi-hop reasoning is flawed: the question requires synthesis of changes in descriptive language over three years to infer strategic focus. The LLM fails this by asserting stability where there is documented increasing specificity, thus reversing the correct conclusion. (4) Contextual relevance is moderate because the answer discusses the right segment and company, and addresses electrical OEMs, but draws the opposite conclusion from the evidence. The qualitative accuracy is low due to incorrect entity state tracking over time and failure to detect linguistic refinement that indicates strategic emphasis. The correctness score is low because the answer misrepresents the key factual evolution and thus provides a misleading interpretation of 3M's strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 458,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed unsecured senior debt stayed at **$27,168 million** with a weighted‑average rate of **4.45 %** in both 2022 and 2023, but in 2024 the carrying value fell to **$26,930 million** while the weighted‑average rate rose to **4.84 %** as the maturity range shifted from 2024‑2034 to 2025‑2035【page 186 (2022)】【page 186 (2023)】【page 188 (2024)】. This modest decline in principal coupled with a slight rate increase reflects a rollover strategy that keeps debt levels stable while gradually moving to newer issues at marginally higher rates, indicating a cautious, forward‑looking long‑term financing approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. It incorrectly states that Capital One's fixed unsecured senior debt was $27,168 million in both 2022 and 2023, while the ground truth shows it was $19,975 million in 2022, rising to $27,168 million in 2023. This misrepresents the actual growth trajectory. The 2024 carrying value of $26,930 million is correct, as is the interest rate increase to 4.84%. However, the LLM claims the rate was 4.45% in both 2022 and 2023, whereas the ground truth shows a rise from 2.91% in 2022 to 4.45% in 2023. These errors affect the core financial narrative. (2) Calculations and comparisons are flawed: the model fails to capture the substantial 36% increase in debt from 2022 to 2023 and the progressive rate hikes, instead implying stability. The interest rate progression is misrepresented—missing the significant jump from 2.91% to 4.45%. (3) Multi-hop reasoning is partially sound in that the model attempts to synthesize data across years and draw a strategic conclusion about debt rollover and forward-looking financing. It correctly identifies a slight decline in 2024 and rising rates, and references maturity range shifts (2024–2034 to 2025–2035), which adds contextual detail not in the original but plausibly consistent). However, due to incorrect base data, the reasoning is built on faulty premises. (4) The conclusion about a 'cautious, forward-looking' strategy has semantic overlap with the ground truth's 'strategic shift toward securing more long-term fixed-rate financing,' but the LLM underplays the aggressive debt expansion during rising rates. Contextual relevance is high as it addresses all question parts—evolution across years, carrying value, interest rates, and strategic implication—though with incorrect data. Quantitative accuracy is low due to major number errors; qualitative accuracy is moderate due to correct use of structure and some valid logic; overall correctness is significantly compromised by factual errors in key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 552,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA has consistently classified its 3.50 % Notes Due 2040 as Level 2 fair‑value liabilities and carried them at original issuance value net of discount and issuance costs (FY 2022: $870 m, FY 2023: $851 m, FY 2024: $1,000 m)【page_78】【page_67】【page_72】. The slight dip in 2023 followed by a $150 m increase in 2024 reflects the issuance of additional 2040 notes while the effective interest rate remained steady at 3.54 % and the expected remaining term stayed at 15.2 years【page_72】. This progression shows NVIDIA’s long‑term debt strategy of expanding its long‑dated, fixed‑rate debt to secure favorable rates and fund growth while maintaining a balanced maturity profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in FY2022, but the LLM claims a carrying amount of $870 million, which is incorrect. The FY2023 value of $851 million matches the ground truth, but the LLM misrepresents it as a carrying amount rather than fair value. In FY2024, the LLM correctly reports a carrying amount of $1,000 million, aligning with the ground truth's mention of a carrying amount (not fair value). However, the LLM incorrectly implies that the increase from $851M to $1,000M represents a $150M issuance of new notes, which is not supported by the ground truth and introduces unsupported speculation. (2) The calculation of a '$150M increase' is based on incorrect prior values and flawed reasoning—there is no evidence in the ground truth of additional notes being issued. The effective interest rate of 3.54% and remaining term of 15.2 years are not mentioned in the ground truth and appear to be hallucinated or misattributed. (3) The multi-hop reasoning is partially sound in tracking the valuation treatment shift from fair value to carrying amount, but the LLM mischaracterizes the nature of the reported values (mixing fair value and carrying amount without clarification) and adds unsupported strategic interpretations about issuing more notes. The ground truth suggests a shift in accounting or reporting approach, while the LLM infers an active debt expansion strategy not confirmed in the original data. (4) Despite these issues, the answer is contextually relevant and addresses the evolution of the debt treatment and NVIDIA’s long-term strategy. The qualitative reasoning is plausible but overstated given the data. Scores reflect major quantitative errors (4/10), moderate qualitative accuracy due to correct identification of trends and classification level (6/10), high contextual relevance (9/10), and an overall partial correctness score of 5/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 541,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 Notes outstanding balance fell from **$16.0 billion** at December 31 2022 (page 56, 2022 10‑K) to **$15.0 billion** at December 31 2023 (page 57, 2023 10‑K) and further to **$13.0 billion** at December 31 2024 (page 57, 2024 10‑K). This steady decline shows a deliberate repayment plan, indicating Amazon is actively reducing its long‑term debt exposure and interest burden for this issuance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all outstanding balance figures for Amazon's 2017 Notes: $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. (2) All numeric values are accurate and consistent with the original answer; no calculations were required beyond the reported values, and the temporal progression is correctly ordered. (3) The multi-hop reasoning is sound—information is synthesized across three annual reports (2022, 2023, and 2024 10-Ks), correctly identifying the same debt issuance across years and tracking its evolution. (4) The qualitative interpretation—that the decline indicates a deliberate repayment strategy to reduce long-term debt and interest burden—aligns with and expands upon the ground truth’s conclusion about a 'deliberate debt management strategy,' adding relevant context without overreaching. The answer is fully complete, addressing both the quantitative evolution and the strategic implication. All entities (Amazon, 2017 Notes, correct years) are accurately identified. Semantic equivalence is strong, with slightly enhanced but still accurate wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 329,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 10‑Ks for 2022, 2023 and 2024 all list “Floating Rate Notes due 2019” in the description of securities (Exhibit 4.4)【page_54】, indicating that the company still holds short‑term, variable‑rate debt.  Because floating‑rate notes reset with market rates, this ongoing exposure means Apple’s interest expense will rise as rates climb, making the company more sensitive to a tightening rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Apple's 2022, 2023, and 2024 filings reference 'Floating Rate Notes due 2019' and links this to ongoing exposure to variable-rate debt, which is factually consistent with the ground truth. The dates (2019 maturity, disclosures in 2022–2024) and the nature of the instrument (floating rate notes) are accurately reported. (2) Quantitative accuracy is perfect: all years and the 2019 maturity date are correct, and no numerical calculations are required beyond correct identification of time periods. Format and references (e.g., Exhibit 4.4, page 54) are appropriately cited. (3) However, the LLM answer oversimplifies the reasoning by stating Apple 'still holds' short-term variable-rate debt, while the ground truth clarifies that the notes are included by reference due to disclosure obligations or potential rollover/continuing commitments—not necessarily active holdings. This misrepresents the nature of the exposure as direct and current, rather than possibly administrative or legacy-related. The ground truth emphasizes the significance of the Officer’s Certificate and the implication of ongoing obligations or disclosure requirements, which the LLM omits. (4) Despite this, the core insight—that floating rate notes increase interest expense sensitivity in a rising rate environment—is correct and well-reasoned. The answer is contextually relevant and captures the financial implication accurately. Thus, the correctness score is 7 due to a minor but important conceptual inaccuracy in interpreting the nature of the debt exposure, though all surface facts and dates are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 448,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "Google’s 2022 10‑K framed the Pixel line as part of a long‑term hardware strategy, noting the launch of Pixel 5a 5G and Pixel 6 and a commitment to invest in devices for the future【page_7】. By 2023 and 2024, Pixel sales are explicitly reported as part of the devices revenue segment【page_33】【page_59】, indicating the product line has moved from early‑stage launches to a mature, though still modest, revenue contributor. This shift shows Google treats hardware—particularly Pixel—as a strategic, AI‑integrated complement to its core advertising and cloud businesses, maintaining a cautious yet persistent presence in the hardware market rather than positioning it as a primary growth engine.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Google emphasized long-term investment in hardware with the Pixel 5a 5G and Pixel 6; by 2023 and 2024, Pixel was explicitly included in the 'devices' revenue segment, indicating a shift toward measurable financial contribution. The LLM correctly identifies this evolution from investment to revenue-generating maturity. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings to show progression in strategic focus, revenue reporting, and product maturity. The conclusion that Pixel has become a strategic, AI-integrated complement to core businesses is logically supported and consistent with the original answer’s implication of increased confidence in hardware. (4) The only minor gap is that the LLM answer describes Pixel’s revenue as 'modest'—a subjective qualifier not present in the original—which slightly deviates from the neutral tone of the ground truth, but does not introduce factual inaccuracy. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 379,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab has steadily increased the amount of client securities it uses as collateral for margin lending and securities‑lending activities.  In 2021 the fair value of client securities available to be pledged rose to $120.3 billion from $84.0 billion in 2020, and the amount pledged for margin‑lending, short‑sales, and securities‑lending grew to $31.4 billion from $23.0 billion.  The 2024 disclosures continue this trend, showing that Schwab is further expanding its use of client collateral to support liquidity and financing while remaining compliant with regulatory requirements【page_108】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It references data from 2020 and 2021, which are outside the 2022–2024 timeframe specified in the question. The ground truth does not provide any specific dollar amounts for pledged or available securities in 2022 or 2023, nor does it mention $120.3 billion or $31.4 billion figures—these numbers are entirely fabricated or misattributed. (2) Quantitative accuracy is severely lacking: the cited values (e.g., $120.3B available, $31.4B pledged) do not appear in the ground truth and cannot be verified. There is no mention of such figures in the context of 2022–2024, and no year-over-year comparisons were provided in the original answer. (3) The reasoning is flawed in terms of multi-hop synthesis: the LLM fails to trace the actual evolution described—i.e., increasing disclosure and broadening use of client securities for margin and securities lending, including for OCC-listed options in 2024. Instead, it invents a trend based on incorrect years and false numbers. It also conflates margin lending and securities lending activities without distinguishing the strategic shift toward using client assets for regulatory clearing purposes in 2024. (4) While the general theme of 'increased use of client collateral' and 'regulatory compliance' aligns loosely with the original answer, the complete absence of accurate data, wrong time periods, and failure to reflect the actual disclosures (especially the 2024 expansion into OCC-related pledging) severely undermine correctness. The answer is contextually relevant in topic but factually incorrect in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 448,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "GE’s 10‑K disclosures show that the company’s approach to long‑term‑care premium‑rate increases has been consistent from 2022 through 2024: in each filing it states that it “often collaborates” with the primary insurers that issued the underlying policies to file proposed rate‑increase actions under reinsurance contractual terms (see 2022 page 51‑53, 2023 page 20‑22, 2024 page 20‑22).  However, the sensitivity tables for the potential impact of a 25 % adverse change in the success rate of those filings have fluctuated—$400 million in 2022, $200 million in 2023, and $300 million in 2024—reflecting adjustments in the expected frequency or magnitude of rate‑increase filings and the company’s conservative reserve assumptions.  This progression indicates that GE’s run‑off risk‑management strategy remains focused on monitoring and adjusting assumptions about premium‑rate actions while maintaining a collaborative relationship with primary insurers to manage reinsurance exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and omissions that affect factual correctness and reasoning. (1) Quantitative Accuracy: The dollar amounts in the sensitivity tables ($400M in 2022, $200M in 2023, $300M in 2024) are presented as factual, but the ground truth does not mention these figures or any fluctuation in sensitivity impacts—this information is extraneous and unverified, potentially misleading. There is no confirmation from the original answer that these numbers are accurate or relevant to the collaboration evolution. (2) Completeness: The LLM fails to describe the actual evolution of GE’s collaboration with primary insurers across the years—specifically, it omits the progression from indirect involvement in 2022, to formalized contractual collaboration in 2023, to using regulatory precedents and ceding company experience in 2024. Instead, it incorrectly asserts a 'consistent' approach, contradicting the ground truth’s emphasis on strategic evolution. (3) Entity Accuracy: The companies (GE, primary insurers), years (2022–2024), and context (reinsurance, long-term care) are correctly identified. (4) Reasoning: The multi-hop synthesis is flawed—the LLM does not trace the strategic shift over time, mischaracterizes the consistency of GE’s approach, and introduces unrelated sensitivity data to infer risk management adjustments, which is not supported by the original answer. (5) Semantic Equivalence: While the general theme of collaboration is present, the core narrative of strategic evolution toward proactive integration is missing. The focus on fluctuating sensitivity impacts distracts from the actual progression in operational collaboration. Thus, despite relevant context and some correct terminology, the answer is partially incorrect in key facts and reasoning, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 505,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential mortgage‑backed‑security (RMBS) exposure stayed essentially flat over the three‑year period: the fair‑value of RMBS that support its experience‑rated products was $614 million in both 2022 and 2023, while the amortized cost rose modestly from $845 million to $862 million (page 147 & 150). In 2024 the company’s separate‑accounts RMBS fair value grew from $51 million to $71 million (page 160). Across 2022‑24 the company maintained a low unrealized‑loss position ($60 million in 2022‑23) and invested only in high‑quality, agency‑guaranteed RMBS (AA/AAA), underscoring a conservative, low‑risk stance in structured credit.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS exposure was $721M in 2022, decreased to $614M in 2023, then increased to $71M in 2024. The LLM incorrectly states that fair value was $614M in both 2022 and 2023, reversing the actual trend (it decreased from $721M to $614M). The 2024 figure of $71M is correct, but the context is wrong—it is presented as growth from $51M in 2023, which is unsupported by the ground truth. (2) The cited numbers do not match the ground truth: $721M in 2022 is entirely omitted and replaced with an incorrect $614M, and no mention is made of the $721M to $614M decrease. The LLM introduces amortized cost figures ($845M to $862M) and separate-account RMBS growth from $51M to $71M, which are not in the original answer and contradict the trend. (3) The multi-hop reasoning is flawed: instead of identifying a reduction in 2023 followed by a small increase in 2024 as a risk management strategy, the LLM portrays the exposure as flat and conservative throughout, missing the dynamic shift. It also introduces 'experience-rated products' and 'separate accounts' not referenced in the ground truth, suggesting misattribution of data. (4) While the LLM correctly notes high-quality, agency-guaranteed RMBS and low unrealized losses, these details do not compensate for the core quantitative and trend errors. The conclusion of a 'conservative, low-risk stance' oversimplifies the ground truth's nuanced 'dynamic risk management approach.' Scores reflect major factual errors in numbers and trend interpretation, though some contextual elements like credit quality are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 456,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt grew from $47.8 billion in 2022 to $49.3 billion in 2023 and declined to $44.9 billion in 2024【page 186】【page 188】. Consequently, the combined short‑term borrowings and long‑term debt increased slightly from $48.7 billion in 2022 to $49.9 billion in 2023, before falling to $45.6 billion in 2024, indicating a deliberate deleveraging effort and a shift toward lower‑cost, short‑term funding to strengthen liquidity and reduce interest expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key financial figures. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086 billion in 2022, not $48.7 billion as stated by the LLM. The LLM incorrectly reports long-term debt as $47.8 billion in 2022 (vs. correct value of $42.203 billion implied by $43.086B total minus $883M short-term), and short-term borrowings are misrepresented throughout. While the 2023 combined total of $49.9 billion is close to the ground truth $49.856 billion, the 2024 figure of $45.6 billion is an approximation of the correct $45.551 billion. The LLM also omits critical data points such as the weighted-average interest rate progression (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt ($1,709M → $349M → $0), which are central to understanding COF's debt strategy. (2) Calculations: The LLM’s derived totals are partially accurate—$47.8B + $0.883B = $48.683B (~$48.7B), which matches their reported 2022 total, but this is already inconsistent with the ground truth total of $43.086B, indicating a fundamental data error. The 2023 and 2024 totals are numerically close but based on incorrect component values. (3) Multi-hop reasoning: The LLM correctly identifies the overall trend—debt increase in 2023 followed by a decrease in 2024—and infers a deleveraging strategy, which aligns with the ground truth. However, it fails to incorporate key evidence like rising interest rates and the phase-out of floating-rate debt, weakening the depth of analysis. It introduces an unsupported claim about a shift toward 'lower-cost, short-term funding,' which contradicts the ground truth showing a reduction in short-term borrowings and a strategic move away from variable-rate instruments amid rising rates. (4) Justification: The correctness score is 6 due to partial accuracy in the high-level trend and approximate totals, but significant errors in underlying numbers and missing key metrics. Quantitative accuracy is low (5) due to incorrect base figures. Qualitative accuracy is moderate (7) because the reasoning framework is sound but based on flawed data and lacks key insights. Contextual relevance is high (9) as the answer addresses the question’s structure and attempts multi-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 617,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s long‑term liability for the 3.50% Notes Due 2050 was **$1.637 billion in FY 2022, unchanged at $1.637 billion in FY 2023, and fell to $1.604 billion in FY 2024**【page_78】【page_67】, indicating a modest reduction in long‑term debt and a deliberate effort to keep leverage low while potentially refinancing at lower rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's liability was $2,147 million in fiscal 2022, not $1,637 billion as stated. The LLM incorrectly reports the 2022 and 2023 values as both $1,637 billion (mixing up the correct 2023 value with 2022), while the actual 2022 figure was substantially higher. Only the 2024 value ($1,604 million) is correct. This misrepresentation distorts the trend. (2) The calculation of the trend is therefore flawed: the actual reduction is from $2,147M to $1,604M over three years—a meaningful decrease—whereas the LLM suggests only a minor drop from $1,637M to $1,604M after no change in 2023, which contradicts the ground truth. (3) The qualitative reasoning about a 'deliberate effort to keep leverage low' or 'refinancing at lower rates' goes beyond the original answer, which only states a 'strategic effort to manage and reduce long-dated liabilities'—a more cautious interpretation. While the direction of the conclusion (debt reduction strategy) is aligned, the reasoning is based on incorrect data. (4) Contextually, the answer addresses the right metric, company, and time frame, and attempts to interpret the trend, so relevance is high. However, due to major factual errors in the core numbers and the resulting flawed trend analysis, the correctness score is limited to 5—partially correct but with significant errors that affect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 403,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple issued the 0.45% Notes due 2016 in 2013, which matured in 2016. By the 2022, 2023, and 2024 10‑Ks the notes were no longer outstanding but remained listed in the Description of Securities exhibit 4.1, showing that Apple continues to disclose all long‑term debt issuances—even after they have matured—to maintain a complete historical record of its debt obligations. [page_54] [page_53] [page_54]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Apple issued the 0.45% Notes due 2016 in 2013 and that they matured in 2016, which aligns with the ground truth. It accurately notes that the notes were no longer outstanding in the 2022, 2023, and 2024 10-K filings but were still included in Exhibit 4.1. This matches the original answer’s claim about continued disclosure for transparency and legal continuity. (2) All dates (2013 issuance, 2016 maturity, 2022–2024 filings) and the interest rate (0.45%) are correct. No calculations are required, and all numeric facts are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (issuance, maturity, and later disclosures) and infers the strategic rationale—maintaining a complete historical record—even though the notes are no longer active. This reflects accurate qualitative inference from the pattern of disclosure. (4) The only minor shortcoming is that the LLM answer does not explicitly use terms like 'legacy debt disclosures' or 'transparency and legal continuity' as in the original, but it conveys the same meaning through 'maintain a complete historical record.' Thus, semantic equivalence is achieved with slightly less precise framing. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 372,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) fair‑value grew from **$5 million** at 12‑31‑2022 to **$58 million** at 12‑31‑2023 and **$69 million** at 12‑31‑2024 (Table 16.3, 2023; Table 17.2, 2024).  Across all three years the valuation relied on discounted‑cash‑flow models with **swap rates** as the sole significant unobservable input, ranging 3‑5 % in 2022–2023 and 4 % in 2024 (weighted average 4 %).  The steady swap‑rate assumptions and the expanding balance indicate that the firm’s exposure to interest‑rate derivatives has increased while its modeling assumptions remain conservative and stable, reflecting a consistent hedging and risk‑measurement approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets (liabilities) fair value was $31 million in 2022, not $5 million as stated. The 2023 value is correctly reported as $58 million, but the 2024 value is incorrectly stated as $69 million instead of $58 million. Additionally, the LLM claims swap rates were the sole unobservable input across all three years, but the ground truth shows a shift from 'default' (4%) in 2023 to 'swap rates' (4%) in 2024, with no mention of inputs for 2022 beyond unrealized losses. The LLM also fabricates a 'steady swap-rate assumptions' narrative starting in 2022, which contradicts the ground truth. (2) Quantitative errors include: 2022 fair value ($5M vs $31M), 2024 fair value ($69M vs $58M), and misrepresentation of unobservable inputs across years. The ground truth notes a net unrealized loss of $20M in 2022 and a realized loss reduction from $43M in 2022, none of which are mentioned in the LLM answer. (3) The multi-hop reasoning is flawed: the LLM fails to identify the key shift in risk inputs from default to swap rates, which is central to the question. Instead, it asserts consistency in modeling assumptions, directly contradicting the ground truth evolution. It also misses the implication of stable valuation despite changing risk drivers. (4) While the answer addresses the general topic of derivative exposure and modeling, the severe factual and reasoning errors—especially in numbers and risk input evolution—undermine correctness. The contextual relevance is moderate because it discusses derivative valuation and risk inputs, but the incorrect data and conclusions severely limit accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 472,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s 1.55% Notes Due 2028 were not reported in the 2022 filing, but the debt schedule in the 2023 10‑K shows a $1,099 million balance at year‑end 2023, which increased to $1,115 million at year‑end 2024 (page 67). The modest, steady rise indicates a deliberate, incremental expansion of long‑term debt to fund growth while maintaining a conservative leverage profile and keeping interest costs manageable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, $1.1 billion in 2023, and $1.25 billion in 2024. However, the LLM claims the notes were 'not reported in 2022', which contradicts the ground truth, and reports $1,099 million (approx. $1.1B) in 2023 and $1,115 million (~$1.12B) in 2024—both of which are close but not fully accurate, especially for 2024 where $1.115B ≠ $1.25B. The 2024 figure is off by over $135 million, which is material. (2) The LLM cites page 67 of the 2024 10-K for the $1,115 million figure, but this does not align with the ground truth data from the knowledge graph derived from actual filings. The absence of 2022 data in the LLM response breaks the multi-year trend analysis required by the question. (3) The reasoning is partially sound—identifying a 'modest, steady rise' aligns somewhat with the ground truth’s description of stability with a slight 2024 increase—but the conclusion about 'incremental expansion' is less supported given the ground truth shows a dip in 2023 followed by a rebound, not a steady rise. The strategic interpretation is plausible but based on incorrect data. (4) Contextually, the answer addresses the evolution and strategy, so relevance is high. However, due to major numerical discrepancies and missing 2022 data, the correctness and quantitative accuracy scores are low. The qualitative reasoning is acceptable but built on faulty inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 426,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 2022 10‑K disclosed trailing legal liabilities from the 2015 Alstom acquisition and shareholder suits over past financial reporting, with reserves set but uncertain (pages 69‑71). The 2023 filing reiterated the same exposure, noting ongoing cash outflows and that reserves may be insufficient (pages 34‑35). In 2024, GE again highlighted these legacy matters and shareholder litigation, stressing that reserves are still necessary and that actual losses could exceed estimates, underscoring the persistence and continued financial risk of these contingent liabilities (pages 31‑32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE's exposure to legacy liabilities from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting is consistently noted across 2022–2024. The progression of risk—ongoing cash outflows, uncertainty in reserves, and potential for losses exceeding estimates—is accurately conveyed. (2) There are no numeric values (e.g., dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) and years of the Alstom acquisition (2015) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the persistence of the same contingent liabilities and the evolving acknowledgment of financial risk. (4) The LLM omits minor contextual details present in the original—such as reputational risks being explicitly mentioned in 2022 and 2024, and the reference to 'exited businesses' in 2024—but these omissions do not detract from the core factual accuracy. The essence—that these liabilities remain a persistent, financially impactful burden—is fully preserved. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight incompleteness in contextual nuance, but perfect scores for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 396,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan grew its hedge‑fund limited‑partnership exposure from **$225 million in 2022 to $280 million in 2024**—an increase of about $55 million【page 174】【page 167】.  The jump, coupled with a target allocation of roughly 4 % to hedge funds in 2024【page 169】, signals a deliberate shift toward higher‑return alternative assets to boost expected plan returns and diversify risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM states $225M in 2022 and $280M in 2024, which misrepresents both the starting value and the final value. The increase of $55M is also incorrect (actual increase is $38M from 2022 to 2024). (2) The calculation of the change is wrong due to incorrect base figures. The LLM omits the 2023 data point entirely, failing to reflect the gradual, consistent growth described in the original answer. Additionally, the cited $280M figure for 2024 does not match the ground truth of $252M. (3) While the LLM attempts multi-hop reasoning by linking exposure changes to strategic intent (e.g., targeting 4% allocation to hedge funds), this inference is not fully supported by the ground truth, which emphasizes a 'gradual expansion' rather than a 'jump' or 'deliberate shift'. The characterization of a 'jump' contradicts the original answer’s emphasis on a steady, consistent increase. (4) Despite incorrect numbers and flawed reasoning, the LLM correctly identifies the general direction of change (increasing exposure) and connects it to pension fund strategy involving alternative investments, which maintains some contextual relevance. However, the quantitative inaccuracies severely undermine the correctness and qualitative soundness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 403,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "Colgate‑Palmolive’s Africa/Eurasia segment earned **$228 million in operating profit in 2022**【page_117】. In 2023, restructuring charges allocated to the region were about **5 % of the $32 million total Global Productivity Initiative charges—roughly $1.6 million pretax**【page_86】, indicating a modest restructuring effort. In 2024, depreciation and amortization spending for Africa/Eurasia was **$8 million, slightly lower than the $9 million in 2023 and 2022**【page_117】, reflecting a focus on maintaining existing assets rather than large‑scale investment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The operating profit for Africa/Eurasia in 2022 is reported as $228 million, but the ground truth is $203 million. This is a major deviation that affects the accuracy of the financial assessment. Additionally, the restructuring charges allocated to Africa/Eurasia in 2023 are incorrectly stated as 5% of $32 million (~$1.6 million), whereas the ground truth specifies that 10% of the expected charges—$20 to $24 million—were allocated to the region. This represents a severe underestimation and mischaracterization of the scale of restructuring. The depreciation and amortization figure of $8 million in 2024 is correct and matches the ground truth, as is the note that it was $9 million in 2022 and 2023. (2) Calculations: The LLM’s calculation of 5% of $32M = $1.6M is mathematically correct, but the premise is wrong—the percentage and total charge amount are inaccurate. The ground truth does not specify a $32M total charge or 5%, but rather implies a larger charge base with 10% allocated to Africa/Eurasia. (3) Multi-hop reasoning: While the LLM attempts to synthesize information across years and metrics (operating profit → restructuring → D&A), the incorrect numbers undermine the validity of the synthesis. The conclusion that the region saw a 'modest restructuring effort' contradicts the ground truth’s implication of a meaningful cost optimization push. (4) Despite incorrect quantitative data, the answer remains contextually relevant by addressing all three time points and the correct financial metrics. The qualitative interpretation (focus on cost optimization, limited investment) aligns partially with the ground truth, but is based on flawed inputs, limiting its reliability. Hence, low scores for quantitative and overall correctness, moderate for qualitative reasoning, and high for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 517,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "In 2022, AIG’s 10‑K reported a $1.3 billion modeled loss for a five‑ton bomb attack net of TRIPRA and reinsurance recoveries, with attachment points of $200 million for Japan and $100 million for the rest of the world (pages 168‑169). By 2024, the company cut the Japan attachment point to $150 million (while the rest‑of‑world attachment point rose to $125 million) and its reinsurance recoverable assets fell from $67.5 billion in 2023 to $38 billion in 2024 (pages 122 and 90), with no new terrorism loss estimate disclosed beyond the 2021 figure. The 2024 filing notes that international terrorism exposure remains scenario‑modeled and that targeted reinsurance purchases are maintained.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly undermine its correctness. While it correctly states AIG's $1.3 billion modeled loss in 2022 for a five-ton bomb attack net of TRIPRA and reinsurance, it incorrectly claims the $200 million Japan and $100 million rest-of-world attachment points were from 2022, whereas the ground truth specifies these attachment points were maintained over the period with $125 million elsewhere (not $100 million). The LLM also falsely states that the Japan attachment point was cut to $150 million in 2024, which contradicts the ground truth that AIG retained a $200 million attachment point in Japan. Additionally, the LLM claims reinsurance recoverable assets fell from $67.5 billion in 2023 to $38 billion in 2024, but the ground truth states that $38.0 billion was the 2024 figure with no mention of a $67.5 billion 2023 value—this number is fabricated. The ground truth indicates reinsurance protections expanded, not contracted. (2) Quantitative accuracy is low: the $67.5 billion figure is unsupported and incorrect; the $100 million and $150 million attachment points are wrong; only the $1.3 billion loss and $38 billion 2024 recoverables are correct. (3) Multi-hop reasoning is partially sound—the model attempts to track changes over time and references reinsurance strategies and modeling approaches—but it fails in synthesis due to incorrect data sourcing, especially around attachment points and recoverable assets. (4) Contextual relevance is high as the answer addresses all key themes: modeled losses, attachment points, reinsurance recoverables, and scenario modeling. However, due to major factual and quantitative errors, especially in critical financial figures and trend direction (increase vs. decrease in protections), the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 502,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "NVIDIA’s 2.00% Notes Due 2031 liability has stayed roughly flat—$1.20 B in 2022, $1.04 B in 2023, and $1.25 B in 2024—showing a deliberate effort to keep long‑term debt at a stable level. The modest dip in 2023 likely reflects a partial repayment or discount amortization, while the rebound in 2024 indicates a new issuance or rollover to maintain the maturity profile and match cash‑flow needs. Overall, the trend signals disciplined maturity management and a focus on balancing refinancing with liquidity preservation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $1.20B in 2022 (matches $1.2B ground truth), $1.04B in 2023 (slight rounding from $1.044B, acceptable), and $1.25B in 2024 (exact match). These are within acceptable formatting and rounding tolerance. (2) Quantitatively, all figures are accurate or appropriately rounded; no calculation errors. The trend—slight dip then return—is correctly represented. (3) The reasoning is sound and aligns with the ground truth: the stability in liability suggests a consistent long-term debt strategy. The LLM correctly infers that the 2023 dip may reflect repayment or amortization and that the 2024 increase suggests issuance or rollover to maintain maturity profile. While the original answer emphasizes 'preserving stable long-term liabilities' and 'refinancing risk,' the LLM captures equivalent concepts with 'disciplined maturity management' and 'balancing refinancing with liquidity preservation.' (4) The answer is contextually fully relevant, addressing the trend and its implications for NVIDIA's debt management strategy. The only minor gap is not explicitly mentioning R&D or operational investments as end uses of capital (implied in 'cash-flow needs'), but this does not detract from the core accuracy. Thus, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 383,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 were issued in 2014 as part of a global notes offering and matured in 2017.  In each of the 2022, 2023, and 2024 Form 10‑Ks, Apple still lists the 1.05 % Notes due 2017 in its “Description of Securities” (Exhibit 4.4) (2022 10‑K p. 54; 2023 10‑K p. 54; 2024 10‑K p. 54), showing that the company continues to disclose all past debt issuances even after maturity.  This practice demonstrates Apple’s long‑term visibility and continuity in its debt structure, providing investors with a complete historical record of its obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the 1.05% interest rate, maturity in 2017, and consistent citation across 2022, 2023, and 2024 10-Ks are accurately reported. The mention of Exhibit 4.4 and page numbers adds precision and matches the expected disclosure pattern. (2) The answer addresses all parts of the question: it describes the evolution (continued disclosure despite maturity), covers all three years, and interprets the implication for long-term visibility and continuity. (3) Entity accuracy is strong—Apple, the specific notes, and the correct filings (Form 10-K) are properly identified. (4) The reasoning is sound: the LLM correctly infers that matured notes are retained in disclosures for transparency, which supports the conclusion about Apple’s stable debt management and disclosure practices. The only minor shortcoming is that the LLM does not explicitly suggest possible refinancing or rollover (as noted in the ground truth), instead focusing solely on historical disclosure. However, this does not make the answer incorrect—just slightly less comprehensive in speculative interpretation. Overall, the answer is semantically equivalent in intent and factual content, with excellent contextual relevance and precise, accurate reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 372,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "Under the 2019 IDA agreement, Schwab could migrate up to $10 billion of IDA balances each year and did so in 2021 and 2022.  In 2023 the 2019 agreement was replaced by a new 2023 IDA agreement that eliminated the 80 % fixed‑rate requirement, set new minimum and maximum balance limits (through September 10 2025: minimum above the total of then‑outstanding unmatured fixed‑rate obligations with a $30 billion cap; after that: minimum $60 billion and a $90 billion cap) and made migration contingent on capital and binding limits, and Schwab did not move balances that year.  The same 2023 agreement continued in 2024, with Schwab again not migrating balances, the sweep term extended to July 1 2034, and the same minimum/maximum balance requirements and capital‑dependent migration ability remaining in effect.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Schwab's IDA balance migration policy from 2022 to 2024. It correctly states that under the 2019 IDA agreement, Schwab could migrate up to $10 billion annually and had done so in 2022. It accurately notes the replacement of the 2019 agreement with a new 2023 IDA agreement that eliminated the migration option as previously structured and introduced minimum and maximum balance thresholds. The mention of the $30 billion cap pre-September 10, 2025, and the $60 billion minimum and $90 billion cap afterward is factually accurate and adds detail not in the original answer, suggesting deeper sourcing. However, the original ground truth does not mention the 80% fixed-rate requirement or the July 1, 2034 sweep term extension—details that, while potentially true, are not confirmed in the provided truth and may represent over-specificity or external knowledge. The core point—that Schwab stopped migrating balances in 2023 and 2024 under the new agreement—is correct and well-supported. The reasoning is sound, with proper multi-hop synthesis across years and agreements. Quantitative accuracy is high: $10 billion migration limit in 2022, no migration in 2023–2024, and correct balance thresholds. Minor deduction because the ground truth does not confirm the exact post-2025 thresholds or the 80% rule, so some specifics cannot be fully verified. Still, the overall narrative of a strategic shift from active migration to constrained off-balance sheet management is preserved. Contextual relevance is excellent—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 442,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "From 2022 to 2024 GE’s exposure to Bank BPH’s borrower litigation grew in estimated loss from $1.359 billion in 2022 to $2.669 billion in 2023, then eased slightly to $2.461 billion in 2024. Capital support shifted from a $530 million cash contribution in 2022 to a $1.797 billion non‑cash inter‑company loan forgiveness in 2023, with no additional cash injections in 2024. The mortgage portfolio’s carrying value fell from roughly $1.799 billion at the end of 2021 (and still present in 2022) to zero by the end of 2023 and remained zero in 2024, reflecting a settlement program and valuation allowance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key financial figures and trends from the ground truth: estimated losses of $1,359 million in 2022, $2,669 million in 2023, and $2,461 million in 2024; capital contributions of $530 million cash in 2022 and $1,797 million non-cash (loan forgiveness) in 2023; and the mortgage portfolio carrying value dropping to zero by end of 2023 (and remaining zero in 2024). All numbers match exactly, with acceptable formatting variations (e.g., $1.359 billion = $1,359 million). (2) Quantitative accuracy is perfect—every dollar amount and year is correctly reported, and no calculation errors are present. The slight decline in estimated losses from 2023 to 2024 is accurately noted. (3) The multi-hop reasoning is sound: the answer synthesizes data across three years and multiple financial dimensions (exposure, capital, valuation), correctly linking the non-cash contribution and write-down to the litigation context. One minor shortcoming is stating the mortgage portfolio value reached zero by end of 2023, while the ground truth specifies it reached zero by end of 2024. However, since the LLM notes it remained zero in 2024, this may reflect interpretation of timing within the year, and does not materially contradict the final outcome. (4) Contextual relevance is excellent—the response directly addresses all parts of the question: evolution of exposure, capital contributions, and carrying value. The qualitative accuracy is slightly reduced due to the timing nuance on the write-down, but overall reasoning and synthesis are strong. Thus, the answer is factually correct in substance and highly aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 459,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "CVS’s commercial‑mortgage‑backed‑security (CMBS) holdings fell sharply from a fair value of **$1.68 billion in 2022 to $0.68 billion in 2023** (page 149‑150), while unrealized losses stayed flat at **$100 million**. In 2024 the fair value of CMBS in its separate‑account portfolio dropped to **$3 million** from $6 million in 2023, with no unrealized losses reported (page 160). The steady unrealized‑loss level and the declining fair value indicate a conservative risk‑management strategy that focuses on holding CMBS to maturity and limiting exposure to market‑price volatility rather than actively trading or realizing losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's CMBS fair value was $574 million in 2022, not $1.68 billion as stated by the LLM. The 2023 fair value was $675 million, not $680 million (though closer), and the LLM incorrectly claims unrealized losses were flat at $100 million in both 2022 and 2023, whereas the ground truth shows unrealized losses were only $12 million in 2022 and rose to $100 million in 2023. The 2024 fair value of $3 million is correct, but the LLM incorrectly references a drop from $6 million in 2023 (not supported by ground truth, which shows $675 million in 2023). (2) Calculations and comparisons are flawed: the LLM implies a steady $100 million in unrealized losses, which contradicts the ground truth showing a sharp increase from $12M to $100M. The magnitude of the 2022–2023 change is misrepresented due to incorrect base values. (3) Multi-hop reasoning is partially present—LLM attempts to connect trends across years and interpret risk strategy—but is based on incorrect data, leading to invalid conclusions. The claim about 'holding to maturity' and 'conservative strategy' conflicts with the ground truth interpretation of a 2024 de-risking move in response to 2023 losses. (4) Scores reflect major quantitative errors (2/10), poor qualitative reasoning due to false premises (3/10), moderate contextual relevance as it addresses the right topic and time frame (6/10), and a low overall correctness score (3/10) due to core factual failures despite correct mention of 2024 reduction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 440,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑label lineup has remained essentially unchanged from FY 2022 through FY 2024, with Marketside consistently listed among its private brands (2022: page 7; 2023: page 7; 2024: page 7). The steady inclusion of Marketside across three consecutive filings signals a sustained emphasis on private‑label grocery offerings, underscoring the company’s strategy to grow margin‑generating grocery brands and deepen customer loyalty.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Marketside was consistently included in Walmart's private brand portfolio from FY2022 to FY2024, which aligns with the ground truth. It accurately reflects the continuity of Marketside across the three years, and the citation of page 7 for each year (while not part of the ground truth) does not contradict it. However, the LLM answer misses a key dimension of the original answer: the strategic evolution and expansion of Walmart's private label strategy, particularly the introduction of new brands like 'bettergoods' in 2024. This omission weakens the qualitative analysis of Walmart’s dual strategy—maintaining legacy brands while innovating. (2) There are no numerical values or calculations in this question, so quantitative accuracy is not applicable in a traditional sense; however, the fiscal years (2022–2024) are correctly referenced, earning full marks. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the presence of Marketside over time, but fails to incorporate the broader strategic context involving new brand introductions, which is essential to fully answering the 'what does this indicate' part of the question. (4) The answer is contextually relevant and factually correct in its core claim, but lacks depth in strategic interpretation, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high because it directly addresses the evolution and strategic implication, albeit incompletely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 418,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 through 2024, Lowe’s tightened its supplier‑monitoring framework by building on its human‑rights, conflict‑minerals, Vendor Code of Conduct and wood‑sourcing policies and then adding a country‑specific risk‑based approach, enhanced monitoring tools and a new forestry grievance process in 2023 and 2024.  The company also expanded supplier engagement—encouraging CDP emissions reporting and pursuing 100 % SmartWay certification—while investing $550 million (2022), $300 million (2023) and $400 million (2024) in energy‑efficiency and renewable‑energy upgrades, including rooftop solar at 174 store and distribution‑center sites, to cut scope‑3 emissions and strengthen supply‑chain sustainability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Lowe's supplier monitoring and policy enhancements from 2022 to 2024, correctly identifying key initiatives such as the risk-based wood sourcing approach, enhanced monitoring, and the forestry grievance process introduced in 2023 and 2024. It also accurately references the Vendor Code of Conduct, human rights, and conflict minerals policies. However, there are significant quantitative inaccuracies: the LLM states investments of $550M in 2022, $300M in 2023, and $400M in 2024, while the ground truth reports 'over $550 million by 2022' and 'over $400 million through 2023'—a cumulative figure, not annual. The LLM incorrectly breaks this into specific annual amounts, misrepresenting the data and introducing a fabricated $300M 2023 figure and a $400M 2024 investment not present in the original. This undermines the quantitative accuracy. Additionally, the mention of 'CDP emissions reporting', 'SmartWay certification', 'rooftop solar at 174 sites', and 'scope-3 emissions' introduces details not found in the ground truth, adding plausible but unsupported specifics. While the qualitative trajectory of policy strengthening is correct and contextually relevant, the answer fails on precise financial figures and includes unverified expansions, reducing its factual reliability. The multi-hop reasoning is partially sound—linking policy updates across years—but weakened by invented metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 397,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple disclosed the 2.40% Notes due 2023 in its 2022 Form 10‑K (page 58) as part of the global notes. The same note appears unchanged in the 2023 Form 10‑K (page 56) and again in the 2024 Form 10‑K (page 56). The consistent, unchanged listing over three years shows that Apple is maintaining a stable, long‑term debt structure with minimal changes to its interest‑rate exposure, reflecting a disciplined and predictable debt‑management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 2.40% Notes due 2023 in Apple's 2022, 2023, and 2024 Form 10-K filings, with accurate page references (58, 56, 56), which aligns with the ground truth's assertion of sustained inclusion. The percentage (2.40%) and maturity year (2023) are correct. (2) Quantitative accuracy is perfect: all dates, percentages, and document types (Form 10-K) are accurate, and no calculations are required. (3) The multi-hop reasoning is mostly sound—correctly synthesizing data across three years of filings. However, the LLM infers that the unchanged listing reflects a 'stable, long-term debt structure with minimal changes to interest-rate exposure,' whereas the ground truth emphasizes transparency and deliberate disclosure of legacy debt nearing maturity. The LLM's interpretation leans more toward structural stability, while the original answer focuses on disclosure continuity, especially post-maturity. This is a subtle but meaningful difference in emphasis. (4) The answer is contextually fully relevant and factually correct in its reporting of disclosures, but slightly misses the nuance in the strategic implication—highlighting stability rather than transparency around maturing debt. Hence, high scores across the board but not perfect qualitative or overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 377,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap senior‑note holdings grew steadily: $900 million at 12/31/2022, $944 million at 12/31/2023, and $982 million at 12/31/2024 (see the fair‑value table on page 70).  The incremental build‑up—$44 million in 2023 and $38 million in 2024—shows a deliberate strategy of accumulating high‑quality, long‑term debt securities to generate stable income and diversify its investment‑securities portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, GE's holdings were $976 million in 2022, $944 million in 2023, and $982 million in 2024. However, the LLM states $900 million in 2022, which is incorrect (off by $76 million). The 2023 and 2024 figures ($944M and $982M) are correct. The claim of 'steady growth' is misleading because the actual data shows a decrease from 2022 to 2023, followed by an increase in 2024. (2) Calculations are partially correct: the $44M increase from 2022 to 2023 in the LLM answer assumes $900M to $944M, which would be accurate only if the starting value were correct, but it is not. The $38M increase from 2023 to 2024 is accurate ($982M - $944M = $38M). (3) The multi-hop reasoning is flawed because the LLM fails to recognize the decrease in holdings from 2022 to 2023, which contradicts the 'steady growth' narrative. The original answer emphasizes fluctuation and dynamic management with slight overall stability, while the LLM incorrectly infers a deliberate accumulation strategy. This misrepresents GE's investment behavior during the period. (4) Contextual relevance is high because the answer addresses the evolution of AerCap note holdings and attempts to interpret GE's investment strategy. However, due to incorrect data and flawed reasoning, the qualitative and quantitative accuracy scores are low. The correctness score is 4 due to partial correctness in later years but major error in the initial value and resulting misinterpretation of trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 432,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy—outlined in the 2023 and 2024 10‑Ks (page 250)—sets the target mix of growth versus liability‑hedging assets based on the plan’s funded ratio and prevailing interest rates, automatically reducing growth exposure as the ratio improves.  The target equity allocation fell from 15 % in the 2022 plan (funded status at 12/31/2021, page 308) to 9 % in the 2024 plan (funded status at 12/31/2023, page 252) and remains at 9 % for 2025 (page 184), while fixed‑maturity securities rose from 75 % to 80 % and other investments increased from 10 % to 11 %.  This shift demonstrates a deliberate de‑risking of the U.S. pension portfolio in response to an improving funded status.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's glide path approach and its de-risking strategy in response to improving funded status, aligning with the ground truth's core message. It accurately describes the mechanism—target allocations being set based on prior year-end funded status—and the directional shift toward liability-hedging assets. However, there are minor quantitative discrepancies: the LLM states equity fell from 15% in 2022 to 9% in 2024 and remains at 9% for 2025, but the ground truth does not provide specific percentages, so this level of numerical detail cannot be verified as fully accurate. The reported increases in fixed-maturity securities (75% to 80%) and other investments (10% to 11%) are specific to the LLM’s source interpretation but are not contradicted by the ground truth; however, without confirmation in the original knowledge graph, these exact figures introduce uncertainty. (2) The use of page numbers (e.g., page 250, 308) suggests precise sourcing, but the ground truth does not include such references, making it impossible to validate their correctness. The years referenced (funded status at 12/31/2021, 2022, 2023) are logically consistent with the multi-year glide path mechanism described in the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly infers that target allocations for a given year are based on the prior year’s funded status and links this to a de-risking strategy. It synthesizes information across years and connects asset allocation changes to liability-driven investing principles, demonstrating strong qualitative understanding. (4) The answer is highly contextually relevant, addressing both the evolution of the glide path and what the allocation shifts reveal about de-risking. While the core facts and reasoning are correct, the inclusion of unverifiable specific percentages (15%, 9%, 75%, etc.) slightly undermines quantitative accuracy, warranting a score of 7 for that dimension. Overall, the answer is factually robust and well-reasoned, meriting a correctness score of 8 due to minor but notable numerical specificity not confirmed in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 583,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept “analog and embedded processing” as the core of its business model in every MD&A from 2022 through 2024 (2022 page 18; 2023 page 18; 2024 page 18), underscoring that embedded‑processing products remain a pillar of its competitive advantage.  The segment results show the line’s continued contribution to operating profit—up 3 % in 2023 versus 2022 and still a sizable share of 2024 revenue (though down 25 % versus 2023) (2023 page 20; 2024 page 20)—which, together with the company’s stated focus on free‑cash‑flow‑per‑share growth, signals that embedded processing is a stable, long‑term engine for generating cash for shareholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core strategic emphasis Texas Instruments placed on embedded processing from 2022 to 2024 as a driver of long-term free cash flow per share growth. It correctly identifies that TI consistently grouped 'analog and embedded processing' as core to its business model across all three years, citing the same page (18) in each 10-K, which aligns with the ground truth's assertion of multi-year consistency. The answer also appropriately links this strategic focus to cash flow generation and shareholder value.\n\nHowever, there are minor quantitative inaccuracies affecting the quantitative accuracy score. The LLM states that embedded processing revenue was 'down 25% versus 2023' in 2024, but the ground truth does not provide this specific percentage decline, nor does it reference revenue declines—instead, it emphasizes qualitative continuity in strategic importance regardless of short-term fluctuations. Additionally, while the 3% increase in operating profit in 2023 is plausible, the ground truth does not confirm this specific figure, making its inclusion potentially unsupported. These numbers may reflect real data, but without confirmation in the provided ground truth (which focuses on strategic narrative, not segment financials), their use introduces unverified precision.\n\nQualitatively, the reasoning is strong: the model correctly synthesizes information across three years and connects the sustained strategic narrative to long-term cash flow objectives. It identifies the right entities (Texas Instruments, embedded processing, free cash flow per share) and time frame (2022–2024). The answer could have better reflected the ground truth’s emphasis on embedded processing enabling 'supply chain control, customer reach, and diversified returns' in 2024, which strengthens the competitive advantage argument.\n\nContextual relevance is perfect—the response directly addresses both parts of the question: evolution of strategy (consistency over time) and implications for long-term cash flow. Despite minor factual overreach with unsourced percentages, the overall synthesis and conclusion are sound and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 590,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024, Lowe’s IP strategy consistently protected its private‑brand names—including Kobalt, STAINMASTER and allen+roth—by maintaining registered and unregistered trademarks (2022 page 7; 2024 page 7). Over the same period the company amplified its emphasis on private brands, positioning them as high‑value offerings alongside national brands in its product mix (2023 page 6; 2024 page 6). Concurrently, Lowe’s integrated this IP focus with digital transformation, leveraging omnichannel and digital tools—such as online inspiration, design and project‑management platforms—to promote and sell private‑brand products across e‑commerce and in‑store channels (2023 page 5; 2024 page 5).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but omits a critical evolution highlighted in the original answer: the change in brand portfolio emphasis through the removal of 'RONA' and 'Reno Depot' from intellectual property disclosures between fiscal 2022 and 2023. The LLM correctly identifies the consistent focus on 'Kobalt', 'STAINMASTER', and 'allen+roth' across the years and accurately links the integration of digital transformation initiatives (e.g., omnichannel tools, e-commerce platforms) with private brand strategy in 2023 and 2024. It also correctly references the strategic positioning of private brands as high-value offerings, which aligns with the ground truth's implication of a more focused brand strategy. However, the failure to mention the narrowing of disclosed IP assets—specifically the omission of 'RONA' and 'Reno Depot'—represents a significant gap in capturing the evolution of brand portfolio emphasis, which is a core part of the question. This omission affects the completeness and qualitative accuracy of the multi-hop reasoning, even though all presented facts are correct (hence perfect quantitative accuracy). The contextual relevance remains high because the answer addresses both brand strategy and digital integration, but the missing synthesis weakens the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 373,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM’s 10‑K filings from 2022 through 2024 consistently list “client relationships and trust” as a core competitive differentiator, with the wording unchanged across the three years (2022 p. 3; 2023 p. 3; 2024 p. 3). This steady emphasis signals that IBM views trust and long‑term client relationships as essential to its hybrid‑cloud and AI strategy, reinforcing its positioning as a trusted partner in a highly competitive market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but lacks the depth and evolution described in the ground truth. (1) It correctly identifies that IBM consistently listed 'client relationships and trust' as a competitive differentiator across 2022–2024 10-K filings, which is factually accurate and matches the original answer’s starting point. However, it fails to capture the nuanced evolution of how IBM framed trust over time. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is weak: while the LLM notes consistency, it misses the key progression—2022’s focus on hybrid cloud/AI integration and industry expertise, 2023’s expansion into strategic tech partnerships (AWS, Microsoft, SAP), and 2024’s inclusion of cybersecurity partners like Palo Alto Networks as part of trust-building. This evolution indicates a strategic shift toward ecosystem and security as pillars of trust, which the LLM answer omits entirely. (4) Contextual relevance is high because the answer addresses the core theme of trust in client relationships and links it to hybrid cloud and AI strategy, but it does not explain what the multi-year progression indicates about IBM’s strategic positioning, as required by the question. Thus, while factually sound in its narrow claim, the answer is incomplete and lacks the synthesized, evolving narrative present in the ground truth, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 422,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "By 2023, Gilead’s El Segundo, California site was described as handling both clinical and commercial manufacturing and processing of cell‑therapy products, a role that continued unchanged into 2024 [page_11]. In contrast, the 2022 10‑K did not list the El Segundo facility as a commercial manufacturing site—only as a clinical manufacturing location—indicating that its commercial production responsibilities were added between 2022 and 2023 [page_31].",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim, directly contradicting the ground truth. The original answer states that the El Segundo facility had a consistent role from 2022 through 2024, with dual responsibilities for both clinical and commercial manufacturing throughout all three years. However, the LLM claims that in 2022, the facility was only used for clinical manufacturing and that commercial responsibilities were added between 2022 and 2023—this is factually wrong according to the ground truth. There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not heavily penalized beyond the incorrect temporal characterization. The entity identification (Gilead, El Segundo, cell therapy) and general context are correct, and the answer addresses the question's focus on evolution over time, giving it moderate contextual relevance. However, the reasoning is flawed: it asserts a change that did not occur, failing the multi-hop synthesis by misrepresenting the 2022 filing. This fundamental factual error severely undermines both qualitative and overall correctness, resulting in a low correctness score despite proper structure and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 338,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "From 2022 to 2024, Lowe’s did not issue new 4.550% Notes; the only 4.550% Notes were issued in 2019 under the Fifteenth Supplemental Indenture and mature in 2049 (page_76). The 2022 supplemental indentures issued 4.250% and 4.450% Notes (page_76), the 2023 supplemental indentures issued 4.800% Notes (page_77), and the 2024 supplemental indentures did not add any 4.550% Notes (page_77), underscoring a conservative long‑term debt strategy that prioritizes rate lock‑in and predictable cash‑flow management.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 4.550% Notes were issued in 2019 and mature in 2049 under the Fifteenth Supplemental Indenture, which aligns with the ground truth. It accurately states that no new 4.550% Notes were issued from 2022 to 2024, and correctly references other notes issued in those years (4.250%, 4.450%, and 4.800%), supporting the claim of no new 4.550% issuances. These details are factually consistent with the original answer’s emphasis on the stability of the 4.550% Notes over time. (2) Quantitative accuracy is high: the interest rate (4.550%), maturity year (2049), and issuance year (2019) are correct. The mention of other note rates (4.250%, 4.450%, 4.800%) is also accurate per the cited pages. However, the LLM introduces details not present in the ground truth (e.g., specific rates issued in 2022 and 2023), which, while possibly correct, shift focus away from the core question about the 4.550% Notes’ evolution. (3) The multi-hop reasoning is partially sound—LLM correctly infers that the absence of new 4.550% Notes indicates a stable long-term debt strategy. However, the original answer emphasizes the consistent *inclusion* of the 4.550% Notes in filings as evidence of strategic commitment, whereas the LLM focuses on lack of reissuance and other issuances, leading to a slightly different interpretation. The conclusion about a 'conservative long-term debt strategy' is reasonable but not directly supported by the ground truth’s emphasis on extended maturities and refinancing risk avoidance. (4) Contextual relevance is strong as the LLM addresses both the evolution and strategic implication. However, the qualitative accuracy is reduced because it does not fully capture the ground truth’s central point: the *continued reporting* of the same long-dated instrument across years as a sign of strategic stability, instead implying strategy based on absence of reissuance and other issuances. Minor deviation in reasoning lowers qualitative score despite factual correctness on key numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 550,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 through 2024, 3M’s Scotchgard litigation moved from a pending Michigan class action to a settled, immaterial‑cost agreement. The company settled the case in June 2023, paying an immaterial amount and reporting only ongoing immaterial liabilities in its 2024 filing 【124†L1-L4】【124†L5-L7】【100†L1-L3】. This trend shows that while PFAS litigation remains a legal exposure, the financial impact of Scotchgard‑related claims has been limited and has not materially affected 3M’s financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and interpretation. It claims that 3M settled the Michigan class action in June 2023 for an 'immaterial' amount and reports only 'immaterial liabilities' in 2024, which contradicts the ground truth stating that 3M contributed to a $65 million settlement in 2022 and faced escalating litigation through 2024, including a finalized $65 million settlement in New York in 2024. The characterization of all settlements as 'immaterial' is unsupported and directly conflicts with specific dollar figures cited in the original answer. (2) Quantitative inaccuracies include: misrepresenting the $65 million settlement (which occurred in 2022 and again finalized in New York in 2024) as 'immaterial'; omitting the exact dollar amount entirely in the 2023 and 2024 context; and incorrectly implying no significant financial outflows occurred. The dates are also wrong—no mention of June 2023 settlement in the ground truth, and the 2024 developments include active litigation with future trial dates, not just closed matters. (3) The multi-hop reasoning fails: the model does not synthesize the expansion of litigation across states (from Michigan and New York in 2022 to Alabama, Georgia, Illinois, and Canada by 2023–2024), omits the growing number of suits (68 AFFF suits outside MDL, municipal utility lawsuits, carpet manufacturers), and incorrectly concludes limited financial impact despite evidence of increasing geographic and legal complexity. (4) Contextual relevance is moderate because the answer addresses PFAS litigation and Scotchgard, but the conclusion about 'limited financial impact' directly contradicts the ground truth trend of 'escalating liabilities.' The citation tags (e.g., 【124†L1-L4】) suggest source anchoring, but the interpretation is factually flawed. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 520,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "From 2022 through 2024, Gilead’s Foster City, California site has remained a core R&D and clinical‑trial manufacturing hub. In 2022 it was used for process‑chemistry research and API/drug‑product manufacturing for clinical studies; by 2023 it continued those functions while also expanding cell‑therapy manufacturing and tighter integration with global operations【page_12 (2023)】; in 2024 the facility’s focus remains on process chemistry, analytical method development, formulation/device development, and API/drug‑product manufacturing for clinical trials, reinforcing its strategic alignment with Gilead’s worldwide operations【page_12 (2024)】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Gilead's Foster City facility from 2022 to 2024. It accurately captures the continuity of R&D and clinical manufacturing functions (process chemistry, API/drug product for clinical trials) and correctly identifies the strategic alignment with global operations in 2023 and 2024. The mention of analytical method development, formulation, and device development in 2024 matches the original answer. However, the LLM introduces 'expanding cell-therapy manufacturing' in 2023, which is not present in the ground truth and may represent an over-specific addition not supported by the provided knowledge. While this does not contradict the core evolution, it adds detail not confirmed in the original answer, slightly reducing qualitative accuracy. There are no numeric values to assess, so quantitative accuracy is scored as 10 by default (no errors). The answer addresses all aspects of the question—R&D focus, manufacturing responsibilities, and strategic alignment—making it contextually complete and relevant. The reasoning is sound and reflects appropriate multi-hop synthesis across years, though the unsupported claim about cell therapy prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 353,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From 2022 to 2024, AIG shifted its loss‑reserve oversight from a business‑unit‑centric model that relied on periodic external expert reviews (2022 pages 165‑167) to a more centralized framework in which ERM’s second‑line review and the Internal Audit Group routinely challenge pricing and reserving models, embedding reserve modeling in a formal model‑risk‑management and validation process (2024 page 86). Modeling approaches evolved from stochastic/deterministic risk‑selection and pricing models with periodic reserve challenges (2023 page 119) to a structured escalation and actuarial reserve review process that is now routinely audited internally, reducing the need for separately cited external reviews.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's loss reserve risk management from 2022 to 2024. It accurately captures the shift toward a more centralized, model-driven, and enterprise-wide governance framework, citing specific developments such as second-line review by ERM and Internal Audit, integration into model risk management, and reduced reliance on external reviews by 2024. The use of stochastic and deterministic models in 2023 is correctly noted, and the progression from periodic external reviews (2022) to routine internal audits (2024) reflects the trend described in the original answer. There are no numeric inaccuracies—dates and page references are consistent with document-based sourcing (though exact page numbers are not evaluated for correctness here, their contextual use is appropriate). The answer is semantically equivalent in key aspects: oversight mechanisms evolved from internal/external checks to formalized second-line challenge; modeling became more sophisticated (stochastic methods, experience studies implied via 'risk-selection and pricing models'); and external reviews were de-emphasized as internal validation matured. However, the LLM omits explicit mention of sensitivity and scenario analyses and the broader integration into an enterprise risk management (ERM) framework as a structured progression, which were highlighted in the original answer. While 'ERM’s second-line review' is mentioned, the synthesis of how all components—modeling, oversight, reporting to committees and regulators—were unified under ERM in 2024 is less clearly articulated. Thus, while the core facts and reasoning are sound, there is a minor gap in completeness regarding the comprehensive integration of practices into ERM. This justifies a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 499,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia facility is listed only under the Analog column and not under Embedded Processing in the 2022, 2023 and 2024 10‑Ks (2022 page 16, 2023 page 16, 2024 page 16).  The footprint has therefore remained unchanged over the three‑year period, with no expansion into embedded‑processing manufacturing.  This steady state indicates TI continues to prioritize analog production in Melaka, maintaining a consistent focus on analog rather than embedded processing in that region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was listed exclusively under Analog manufacturing in the 2022, 2023, and 2024 10-K filings, with no presence in Embedded Processing—this matches the original answer's claim of exclusive Analog focus and no expansion into Embedded Processing. (2) There are no numerical values requiring calculation, but the years (2022–2024) and consistency across them are correctly referenced, including specific page numbers (page 16 across all years), which supports factual grounding. (3) The multi-hop reasoning is sound: the model synthesized information across three annual reports to confirm no change in manufacturing focus, correctly inferring that the absence of Embedded Processing listings over time indicates a stable, specialized role in Analog production. (4) The conclusion about TI prioritizing analog production in Melaka aligns perfectly with the original answer’s interpretation of the 3-year progression. All aspects of the question—evolution over time and implications for manufacturing focus—are addressed with factual precision and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 340,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "In fiscal 2022 Lowe’s had $2.56 billion of forward‑interest‑rate‑swap notional exposure (page 62).  In fiscal 2023 the company continued to use forward swaps to hedge forecasted debt issuances – the swaps were still in place as of February 3 2023 (page 46) and had a fair value of $251 million (page 54).  By fiscal 2024 the company maintained forward‑rate‑swap contracts for forecasted debt issuances (page 46), showing a consistent, proactive hedging strategy to mitigate benchmark‑rate risk on future debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $251 million fair value of forward interest rate swaps in fiscal 2023 (matching the ground truth), it incorrectly states a $2.56 billion notional exposure in fiscal 2022, which is not present in the original answer and lacks corroboration from the ground truth. More critically, the LLM claims that Lowe's maintained forward-rate-swap contracts for forecasted debt issuances in fiscal 2024, directly contradicting the ground truth, which states that the company no longer held any forward interest rate swaps by fiscal 2024 and had shifted to fixed-to-floating swaps on existing debt. This misrepresents the core trend. (2) The $251 million figure is accurate and correctly attributed to fiscal 2023, but the $2.56 billion notional amount in 2022 is unsupported and likely erroneous. The original answer does not mention notional exposure in 2022, only qualitative references to prior hedging activity. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the strategic shift from forward swaps (for forecasted debt) to fair value hedges on existing debt, which is the central insight in the ground truth. Instead, it asserts continuity in the use of forward swaps into 2024, which contradicts the evidence. (4) The contextual relevance is moderate because the answer addresses the right topic and cites hedging strategy, but the qualitative inaccuracy undermines the conclusion. Due to major factual and reasoning errors, especially regarding the 2024 position and the overall strategic shift, the correctness score is low at 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 451,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s 2022 10‑K lists the 6.50% Debentures due 2028 as “Exhibit 2 to Form 8‑K, filed on January 8 1998” (page 19). The same wording appears unchanged in the 2023 and 2024 10‑Ks (page 19). The unchanging reference to the 1998 filing shows the debt was issued in 1998 and has remained structurally unchanged, with IBM continuing to rely on the original 8‑K documentation—evidence of a stable, long‑term debt structure that has not been amended or re‑issued.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 6.50% Debentures due 2028 are correctly attributed to IBM, and the referenced filing—Exhibit 2 to Form 8-K filed on January 8, 1998—is consistently cited across 2022, 2023, and 2024, matching the original answer. (2) Quantitative accuracy is perfect: the percentage (6.50%), maturity year (2028), and filing date (January 8, 1998) are all correct with no calculation errors. (3) The multi-hop reasoning is sound—the LLM correctly synthesizes information across three years of filings and infers that the unchanged exhibit reference indicates no structural changes, amendments, or refinancing, which reflects stable long-term debt documentation. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and the implication of consistency in referencing the 1998 filing. Wording differs slightly but meaning is identical: 'structurally unchanged' and 'stable, long-term debt structure' convey the same conclusion as the ground truth's 'stable and long-standing debt instrument with no material amendments.' No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 337,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Reflective signage has been listed as a product within 3M’s Transportation and Electronics segment in both the 2023 and 2024 10‑K filings, with no change in its description or placement (see 2023 product list on page 107 and the 2024 list on page 110). Because the same product appears in the segment’s portfolio for all three years, it indicates that 3M treats reflective signage as a stable, core offering that remains strategically important to the Transportation and Electronics business.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant omissions and inaccuracies compared to the ground truth. (1) It correctly identifies that Reflective Signage remained in the Transportation and Electronics segment across the years and is treated as a stable offering, which aligns with the ground truth's conclusion about ongoing strategic relevance. However, it fails to report the actual changes in positioning within the product list—specifically, the move from fifth in 2022 to fourth in 2023 and retention in fourth in 2024—which is central to the question. (2) The LLM claims there was 'no change in placement' between 2023 and 2024, which is semantically incorrect because while the rank (fourth) stayed the same, the ordering of products shifted (e.g., now after 'sound and temperature management' instead of 'premium large format graphic films'), indicating a change in relative positioning. This nuance is missing. (3) The LLM does not mention 2022 at all, despite the question asking about evolution across all three years, breaking the multi-hop requirement to track changes over time. (4) The reference to specific 10-K pages (107 and 110) adds apparent precision but does not compensate for the lack of full temporal analysis. While the core idea of stability is directionally correct, the failure to capture the ranking evolution and changes in adjacent product offerings undermines the reasoning. Thus, the answer is incomplete and misses key qualitative shifts, leading to a correctness score of 4—partially correct but with significant gaps in multi-year synthesis and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 441,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead has consistently used its Hoofddorp, Netherlands facility for commercial manufacturing and processing of cell‑therapy products from 2022 through 2024, with the same role described in each year’s 10‑K. The facility’s function has remained unchanged, underscoring its ongoing strategic importance as a core commercial production site within Gilead’s manufacturing footprint. (GILD_10k_2022, page 11; GILD_10k_2023, page 12; GILD_10k_2024, page 12)",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that the Hoofddorp facility had the same role from 2022 through 2024. According to the ground truth, in 2022 the facility was only identified as a principal manufacturing site without explicit mention of commercial cell therapy manufacturing. It was not until 2023 that the facility was explicitly described as being used for commercial manufacturing and processing of cell therapy products. The LLM incorrectly states that the role was unchanged across all years, which contradicts the documented evolution. (2) There are no numeric values, dates, or calculations in the response to evaluate for quantitative accuracy; all references to years (2022–2024) are correct, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is flawed: the model failed to detect the progression in strategic importance over time—specifically the shift from general manufacturing in 2022 to explicit commercial cell therapy production in 2023 and continued emphasis in 2024. This represents a failure in synthesizing the evolving narrative across filings. (4) While the answer correctly identifies the facility and its eventual role, it misrepresents the timeline and evolution, leading to a low correctness and qualitative accuracy score. Contextual relevance is high because the response addresses the facility and its strategic role, albeit inaccurately in terms of progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 400,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The equity‑compensation tables for each year show that the 2003 Director Compensation Plan has **zero shares remaining for future issuance**: the 2022 table (page 63) lists only the 2009 LTIP, 2014 ESPP and 2018 Director Plan; the 2023 table (page 61) lists the 2009 LTIP, 2014 ESPP and 2018 Director Plan; and the 2024 table (page 59) lists the 2024 LTIP, 2014 ESPP and 2018 Director Plan—none of which include the 2003 plan (see notes (c) on each page). This steady absence indicates that Texas Instruments has fully exhausted the 2003 plan and no longer relies on it for future director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims zero shares remain for the 2003 Director Compensation Plan in 2022, 2023, and 2024, directly contradicting the ground truth, which states 1,843,134 shares in 2022, 1,786,785 in 2023, and 1,745,284 in 2024. These numbers show a clear, consistent decline—not exhaustion. (2) The LLM incorrectly infers from the absence of the 2003 plan in the equity-compensation tables that it has zero shares remaining, but this reasoning is flawed. The absence from disclosure tables does not necessarily imply zero availability, especially if the plan is still active with remaining shares. The ground truth confirms ongoing usage via annual reductions, indicating the plan was still in use through 2024. (3) The multi-hop reasoning fails: instead of tracking the actual numbers across years to identify a trend, the model relies on a misinterpretation of table inclusions. (4) The conclusion—that the plan is fully exhausted and no longer used—is the opposite of what the data indicates: the plan is actively being used, as shown by the逐年 decline in available shares. While the answer attempts to address director compensation trends, its factual foundation is entirely incorrect, severely undermining contextual relevance and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 374,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "IBM’s 0.950% Notes due 2025 were incorporated by reference in the 2023 10‑K, indicating a relatively modest disclosure level [page_20]. By the 2024 10‑K, the notes were listed as a registered security on the NYSE and disclosed in the securities list, reflecting a shift toward greater market transparency [page_1]. This progression signals IBM’s broader capital‑market strategy of diversifying its debt mix while actively enhancing investor engagement through more open, timely disclosures of its debt instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all key details are correct: the 0.950% Notes due 2025 are accurately referenced, and the progression from 2023 to 2024 is correctly described in terms of disclosure evolution. The mention of the 2023 10-K incorporating the notes by reference and the 2024 10-K listing them as registered on the NYSE matches the ground truth's emphasis on increasing transparency. (2) The trading symbol IBM25B and the specific May 22, 2017 Form 8-K filing are omitted, which are minor but specific details present in the original answer; however, the core factual progression (from internal reference to public listing) is preserved. (3) The reasoning is sound: the LLM correctly infers that the shift toward registration and exchange listing indicates a strategic move toward greater market transparency and investor engagement, which is consistent with the multi-hop synthesis required. (4) The answer is contextually excellent, directly addressing the evolution from 2022–2024 and interpreting the implications for capital market strategy. The only reason for not scoring a 10 is the omission of the 2022 treatment and the specific source document (May 2017 8-K), which were part of the full progression but not mentioned. However, the 2023–2024 evolution is accurately captured, and the strategic interpretation is valid and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 391,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances expanded sharply after 2022: deposit assets grew from $1.8 billion in 2022 (the same level reported for 2021) to $5.1 billion in 2023 and then fell to $4.6 billion in 2024, while deposit liabilities moved from $1.4 billion in 2022 to $1.3 billion in 2023 and $1.2 billion in 2024【page_216】【page_206】. The November 2023 Global Atlantic transaction created $10.3 billion of deposit receivables and transferred $9.5 billion of assets to the reinsurer, a move that leveraged the deposit method for a large, asset‑backed reinsurance deal and allowed MetLife to record significant recoverables and offset deposit liabilities, thereby reducing capital exposure【page_206】. This shift illustrates MetLife’s strategic use of the deposit method to manage risk and optimize capital while expanding its reinsurance portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: deposit assets are $1.8B (2022), $5.1B (2023), $4.6B (2024); liabilities are $1.4B (2022), $1.3B (2023), $1.2B (2024). The $10.3B reinsurance recoverables from the Global Atlantic transaction are correctly reported. (2) Quantitative accuracy is perfect—no calculation or formatting errors. (3) The reasoning is sound: the LLM correctly identifies the sharp increase in deposit assets and slight decline in 2024, stable liabilities, and interprets the Global Atlantic transaction as a strategic shift using the deposit method for capital optimization and risk management. It adds contextual detail (e.g., $9.5B asset transfer) not in the original answer but consistent with plausible inference from the transaction’s structure. (4) The only minor gap is that the original answer emphasizes the 'aggressive use' of the deposit method, while the LLM frames it as 'strategic use' and 'optimize capital'—slightly softer in tone but semantically aligned. No factual omissions or errors. The answer fully addresses all parts of the multi-hop question: evolution over time, balance sheet items, and strategic implications of the 2023 transaction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 349,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "3M’s Safety and Industrial segment has continued to list fall‑protection solutions as a core product line in its 2022, 2023 and 2024 10‑K disclosures【page_108】【page_107】【page_110】.  Over the same period, net sales in the segment fell from $11.6 bn in 2022 to $10.96 bn in 2024, yet operating income more than doubled from $1.14 bn to $2.49 bn【page_111】【page_108】, indicating that the company is maintaining and strengthening its focus on workplace‑safety products—especially fall protection—to drive profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial data. According to the ground truth, the question is about the evolution of MMM's product portfolio related to Fall Protection Solutions, not financial performance. The original answer focuses on consistent product categorization across years, with no mention of net sales or operating income. The LLM introduces financial figures—$11.6B net sales in 2022 falling to $10.96B in 2024 and operating income rising from $1.14B to $2.49B—which are not part of the ground truth and cannot be verified from the provided context. These numbers may be fabricated or misattributed, severely undermining quantitative accuracy. (2) There is no evidence in the ground truth that operating income more than doubled or that profitability trends were tied to fall protection solutions. The original answer does not support any financial analysis, so including such data represents a major deviation. (3) While the LLM correctly identifies that fall protection solutions were consistently listed in the Safety and Industrial segment from 2022 to 2024, it fails to describe the actual evolution of the product portfolio phrasing—specifically the shift from a broader listing to a more concise formulation—thus missing the core qualitative insight. Instead, it infers a strategic focus based on financials not present in the ground truth, showing flawed multi-hop reasoning. (4) The contextual relevance is moderate because the answer addresses MMM’s continued inclusion of fall protection, which is relevant, but shifts focus to unsupported financial claims and profitability conclusions, detracting from the actual intent of the question about product portfolio evolution and strategic emphasis on safety solutions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 484,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria has kept UST LLC as a wholly‑owned subsidiary of the Group, with its operating arm, U.S. Smokeless Tobacco Company LLC (USSTC), unchanged from 2022 through 2024【page 4】【page 5】【page 60】.  The 2024 filing still reports USSTC as the leading producer of moist smokeless tobacco (MST) and snus within the “oral tobacco products” segment, the same structure noted in 2023 and 2022【page 66】.  This continuity signals Altria’s sustained commitment to a dedicated smokeless‑tobacco business as a core pillar of its transition‑to‑smoke‑free strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: UST remains a wholly owned subsidiary of Altria from 2022 to 2024, USSTC is consistently identified as the operating arm, and moist smokeless tobacco (MST) and snus are correctly cited as core products. There are no numeric values in the original or LLM answer that conflict (e.g., trademarks valued at $8.8B in 2022 is not mentioned in the LLM answer, but no incorrect numbers are presented). (2) Quantitative accuracy is perfect—no figures are misstated, and the LLM avoids making claims about financial valuations or amortization that it doesn’t have. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent structural information across three years and correctly infers strategic continuity. It captures the essence of UST’s role in Altria’s smokeless and reduced-risk product strategy, though it does not explicitly mention the 'Moving Beyond Smoking' initiative by name or the 2024 framing of UST as a 'core operating company' under that initiative, which slightly reduces qualitative completeness. (4) Contextual relevance is excellent—the answer directly addresses both the structural evolution (minimal change) and strategic implications (commitment to smokeless as part of smoke-free transition). The only minor gap is the omission of the $8.8B trademark valuation and the explicit 2024 strategic repositioning language, but the core strategic inference remains valid. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 441,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s continual inclusion of SolarCity’s 5.45% Solar Bonds, Series 2015/C92‑15 in the 2022, 2023 and 2024 10‑K exhibits shows that the bonds remain outstanding and are still a core part of its debt mix.  The repeated reference signals a strategy of relying on long‑term, fixed‑rate debt—rather than short‑term borrowing or equity—to finance its solar projects, underscoring a commitment to stable, predictable capital for its solar portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative elements: the bond name (SolarCity 5.45% Solar Bonds, Series 2015/C92-15), the years of reference (2022, 2023, 2024), and the interest rate (5.45%) are all correctly stated. There are no calculations required, and all numeric and date-related information matches the ground truth. The entity identification is correct—Tesla, SolarCity, and the specific bond series are accurately referenced. Contextually, the answer directly addresses the question about Tesla's long-term financing strategy and correctly infers that the repeated mention indicates the bonds remain outstanding and strategically important. The reasoning is sound in linking the continued disclosure to a reliance on long-term, fixed-rate debt as a stable financing mechanism for solar initiatives. However, the LLM answer omits specific supporting details present in the ground truth, such as the mention of the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015' and the explicit characterization of the bond as a 'material component' of Tesla's solar financing architecture. While the core inference about strategic commitment is preserved, the absence of these legal and structural details—key to the multi-hop synthesis in the original answer—results in a slightly less complete qualitative picture. Nonetheless, the LLM captures the essential meaning and strategic implication, making the response largely correct with minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 407,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K risk‑factor disclosures for debt securities consistently cite “governmental and stock‑exchange regulations” as a risk factor in 2022 (page 22), 2023 (page 11), and 2024 (page 11), with no change in wording, while the equity‑security risk factor remains unchanged, focusing on market volatility. This steady language across three years signals a conservative, transparent capital‑market risk‑management strategy that treats regulatory risk as a persistent, largely uncontrollable factor affecting debt securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in citing the consistent mention of 'governmental and stock-exchange regulations' in IBM's 10-K filings across 2022, 2023, and 2024, with correct page references (2022 p.22, 2023 p.11, 2024 p.11), satisfying quantitative and entity accuracy. However, it incorrectly claims there was 'no change in wording'—the ground truth shows a meaningful evolution in narrative: from general risk in 2022, to emphasis on lack of control in 2023, to integration with liquidity and credit risks in 2024. The LLM's assertion of 'no change in wording' contradicts the original answer, which documents a clear progression in how the risk was framed and contextualized. This undermines the qualitative accuracy, as the model fails to capture the multi-hop synthesis of evolving risk characterization over time. While it correctly identifies regulatory risk as persistent and uncontrollable, it misses IBM’s expanding linkage of regulatory exposure to broader financial risks in 2024, which is central to the question about capital market risk management strategy evolution. The conclusion about a 'conservative, transparent strategy' is interpretive and not directly supported by the source text. Thus, while contextually relevant and factually precise on citations, the answer lacks depth in reasoning and misrepresents the progression of disclosure language, leading to a partially correct assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 391,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across 2022‑2024 the Safety & Industrial segment kept “electrical products and materials for construction and maintenance, power distribution and electrical OEMs” as a core offering (see page 107).  Net sales for that segment fell from $11.6 B in 2022 to $10.96 B in 2023 and held at $10.96 B in 2024 (page 108, 111), while operating income jumped from $1.14 B to $2.32 B and then $2.49 B (page 108, 111).  The 2024 creation of an Industrial Specialties division that bundles these electrical and other industrial specialty products (page 110) signals a deliberate shift toward higher‑margin industrial‑market solutions, underscoring 3M’s strategic repositioning to capture growth in construction‑ and maintenance‑related electrical markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the ground truth confirms that MMM consistently included 'electrical products and materials for construction and maintenance' in its Safety and Industrial segment across 2022–2024, the LLM introduces financial data (net sales: $11.6B, $10.96B; operating income: $1.14B, $2.32B, $2.49B) that are not present in the original answer and cannot be verified from the provided context. These numbers may be fabricated or misattributed, as no such figures appear in the ground truth. Additionally, the claim about the '2024 creation of an Industrial Specialties division' is not supported by the original answer, which notes a rephrasing of segment descriptions but no formal new division. (2) Quantitative accuracy is low because the financial figures are entirely absent from the ground truth and thus incorrect in this context. Even if such numbers exist in actual filings, they were not part of the knowledge graph truth, making their inclusion a factual error in evaluation terms. (3) Qualitatively, the LLM captures the continuity of electrical products as a core offering, which aligns with the ground truth. However, it misrepresents the nature of MMM’s evolution—focusing on financial performance and organizational restructuring rather than the nuanced shift in segment description emphasis (e.g., closure systems, abrasives, autobody repair). The multi-hop reasoning is partially sound in tracking a trend, but the conclusion about 'higher-margin industrial-market solutions' and strategic repositioning is speculative and not directly supported by the provided truth. (4) Contextual relevance is moderate because the answer addresses the evolution of MMM’s focus and attempts to infer strategic positioning, which matches the question's intent. However, due to incorrect data and unsupported structural claims, the overall correctness score is low despite some alignment in thematic elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 532,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "In 2022, Gilead’s Oceanside, California site was used for commercial retroviral‑vector production and for the clinical manufacturing and process development of biologics candidates (page 11, 2022).  In 2023 the facility’s focus shifted to the clinical and commercial manufacturing and processing of cell‑therapy products (page 12, 2023).  By 2024 the site had returned to its original role, again concentrating on commercial retroviral‑vector manufacturing and biologics process development (page 10, 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the evolution of GILD's Oceanside facility. According to the ground truth, in 2022 the facility was part of a broader R&D footprint without specific mention of commercial retroviral vector production. However, the LLM incorrectly states that commercial retroviral-vector production was already occurring in 2022, which contradicts the original answer. The 2023 description is partially correct—while the LLM mentions a shift to cell-therapy products, the ground truth specifies continued focus on clinical manufacturing and process development of biologics, not a shift to cell therapy broadly. In 2024, the LLM claims the site 'returned' to its original role, implying a reversal, but the ground truth describes a progression and expansion of capabilities (from clinical to including commercial retroviral vector manufacturing), not a return. (2) Quantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly used as time anchors. The citation of pages is extraneous but does not affect factual accuracy. (3) The multi-hop reasoning is flawed: the LLM fails to accurately trace the facility’s evolving specialization over time. It misrepresents the trajectory as cyclical ('returned to its original role') when the ground truth shows a linear, progressive specialization. This undermines the synthesis across years. (4) Contextual relevance is moderate—the answer addresses the facility and its biologics/retroviral vector roles across the requested years, so it stays on topic. However, due to key factual errors in the timeline and characterization of the facility’s evolution, the correctness score is low. The qualitative accuracy is also low due to incorrect reasoning and entity-function mapping, despite using appropriate terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 512,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path strategy has steadily reduced the equity (Return‑Seeking) target.  In 2022 the plan’s target allocation for equity securities was 15 % (2021 Form 10‑K, page 310).  By 2024 the target had fallen to 9 % equity (2023 Form 10‑K, page 252).  The 2023 target is not disclosed, but the actual 2023 allocation was 8 % equity, indicating a continued glide toward a more conservative, liability‑hedged mix as the plan’s funded ratio improved.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but fundamentally misrepresents the nature of AIG's glide path evolution. The original answer emphasizes a forward-looking, dynamic adjustment of target allocations based on funded status at year-end, with targets set for future years (e.g., 2023 target set for 2024 based on Dec 31, 2022 funded status). The LLM instead focuses narrowly on declining equity percentages (15% in 2022 to 9% in 2024), which is not supported by the ground truth and introduces specific percentages not present in the original answer. (2) The quantitative claims (15%, 9%, 8%) are not found in the ground truth and appear to be fabricated or misattributed from external sources not referenced in the original answer. There is no mention of actual or target equity percentages in the original, so these numbers cannot be verified and are likely incorrect in this context. (3) The multi-hop reasoning is flawed: the original answer describes a structural evolution in timing and methodology of target setting (i.e., setting targets for future years based on current funded status), not a shift in asset mix percentages. The LLM fails to capture this key conceptual point and instead invents a narrative around declining equity exposure. (4) While the LLM attempts to address the question and uses plausible financial reasoning (glide paths reducing risk as funded status improves), it misses the core insight about forward-looking target setting and introduces unsupported numerical data, leading to a low correctness score. Contextual relevance is moderate because it discusses AIG’s pension plan and glide path, but the substance is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 459,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "ACN kept its U.S. plans 100 % debt‑heavy throughout, but for non‑U.S. plans the target mix shifted from fiscal 2023 to fiscal 2025: debt fell from 48 % to 36 %, equity rose from 27 % to 28 %, cash increased from 4 % to 7 %, insurance contracts jumped from 11 % to 21 % and “other” dropped from 10 % to 8 % (see pages 88 and 95). This modest re‑balancing toward higher‑return, higher‑risk assets—especially the larger insurance‑contract allocation—indicates a cautious but slightly more aggressive long‑term risk tolerance, aiming to enhance returns while still maintaining a debt‑dominant core.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in both factual content and reasoning. (1) Quantitatively, the percentages provided (e.g., debt falling from 48% to 36%, equity rising from 27% to 28%, etc.) are not supported by the original answer, which contains no specific numerical allocations for any asset classes across fiscal years. There is no mention in the ground truth of U.S. plans being 100% debt-heavy or of insurance contracts increasing from 11% to 21%. These figures appear fabricated or misattributed. (2) The original answer does not provide any granular asset allocation data; instead, it discusses the evolution of ACN’s planning horizon and strategic language around flexibility and risk-adjusted returns. The LLM invents a detailed quantitative breakdown that is absent from the source. (3) Qualitatively, the LLM mischaracterizes the nature of the shift: the ground truth emphasizes an extension of planning horizon (from one-year to two-year forward targets) and consistent risk management philosophy, not a rebalancing toward higher-risk assets. The conclusion that ACN adopted a 'slightly more aggressive' stance contradicts the original answer’s characterization of a 'measured, stable approach' with increased strategic confidence—not increased risk tolerance. (4) Contextually, the LLM addresses the question’s topic (asset allocation evolution and risk tolerance), but does so with incorrect data and flawed reasoning, failing the multi-hop synthesis requirement. The correct answer hinges on interpreting changes in planning horizon and strategic language, not on nonexistent percentage shifts. Thus, despite addressing the general theme, the answer is factually and logically unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 472,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 5.45% Solar Bonds, Series 2015/C25‑15 were issued in 2015 and have remained unchanged in the company’s debt portfolio, with the same supplemental indenture appearing in each year’s 10‑K exhibit list (2022: page 100; 2023: page 98; 2024: page 97). No new issuance or restructuring of that bond series is disclosed in those filings, indicating that Tesla continues to rely on the original long‑term debt to finance its solar projects. This consistency across three years shows a conservative, long‑term solar‑financing strategy that prioritizes predictable, stable debt terms over frequent refinancing or new bond issues.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: Tesla did not restructure or issue new tranches of the 5.45% Solar Bonds, Series 2015/C25-15 in 2022–2024, and the bond series remains in the 10-K filings each year, which aligns with the ground truth. The specific exhibit page numbers (2022: p.100, 2023: p.98, 2024: p.97) are plausible and consistent with filing structures, though such granular detail is not in the ground truth; however, this does not contradict it. The percentage (5.45%) and series name are correct. Thus, quantitative accuracy is perfect. However, the LLM answer misses key qualitative context from the original: it fails to mention that Tesla referenced *other* solar bond series (e.g., C28-15, C33-15) in 2023, suggesting an *expansion* of its financing framework beyond the C25-15 series. The LLM instead emphasizes *no new issuance or restructuring*, which downplays the broader strategic evolution implied in the ground truth. While the conclusion about a 'conservative, long-term strategy' is reasonable, the original answer highlights *ongoing reliance* and *strategic integration* of structured financings, not just stability. The LLM answer is contextually relevant and correctly interprets the static nature of the C25-15 series, but it does not fully capture the multi-hop insight that Tesla is *maintaining legacy bonds while expanding its financing toolkit*—a nuance critical to the solar financing strategy. Hence, qualitative accuracy is reduced due to incomplete synthesis, though core facts are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 423,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024 AIG’s approach to international terrorism exposure stayed largely the same: it continued to use a third‑party vendor model for scenario‑based loss estimates, with the 2022 filing disclosing a $1.3 billion estimate for a five‑ton bomb attack (10‑K 2022, p. 169). The 2023 filing repeated that modeling framework and the same mix of mitigation tools—TRIPRA for U.S. coverage, targeted private reinsurance for selected lines, and participation in government‑sponsored terrorism pools abroad—without issuing a new numeric estimate (10‑K 2023, p. 121). By 2024 AIG maintained the same core strategy, relying on scenario‑based modeling, TRIPRA, targeted reinsurance, and international terrorism pools, again without updating the loss estimate (10‑K 2024, p. 86).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims and correctly identifies the $1.3 billion modeled loss estimate from 2022, citing the correct document (10-K 2022, p. 169). It accurately notes the continued use of scenario-based modeling, TRIPRA, reinsurance, and government-sponsored pools across all three years, which aligns with the ground truth. However, the LLM answer is incomplete in several key qualitative aspects of AIG's evolution from 2022 to 2024. Crucially, it fails to mention the 2024 enhancements to global property per risk covers, the retention of a $200 million attachment point in Japan, and the significant increase in reinsurance recoverable assets to $38.0 billion by end-2024—key indicators of evolved risk transfer mechanisms. While it correctly observes no updated loss estimate was provided in 2023 or 2024, it misses the shift in 2023 toward active management and monitoring of exposure concentrations and disciplined reinsurance purchasing. These omissions represent significant gaps in capturing the evolution of AIG’s strategy, particularly in reinsurance scaling and jurisdiction-specific adjustments. The reasoning is logically structured and contextually relevant, but the lack of synthesis around the 2024 strategic enhancements and reinsurance growth limits the answer's completeness and qualitative accuracy. Quantitative accuracy is high, as all cited numbers and sources are correct, and no incorrect calculations are made.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 405,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K filings for 2022, 2023 and 2024 all list the same risk for its Safety and Productivity Solutions segment: adverse industry economic conditions that could erode market share, selling prices and margins. The exposure remained consistently highlighted each year, indicating no change in the company’s view of the threat. The specific risks repeatedly cited as driving margin pressure were reduced investments in process automation, safety monitoring and plant‑capacity‑utilization initiatives, retail‑market fluctuations, a slowdown in demand for safety products, competitive pressure from new entrants and technologies that commoditize products, and the broader adverse industry economic environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Honeywell consistently highlighted adverse industry economic conditions affecting the Safety and Productivity Solutions segment from 2022 to 2024, with recurring risks including reduced investments in process automation, retail market fluctuations, and product commoditization due to new entrants and technologies. The mention of margin pressures tied to these factors is consistent across years. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or time periods (2022–2024 correctly referenced). (3) Multi-hop reasoning is sound: the LLM synthesizes risks across three years and correctly identifies continuity in risk disclosures despite segment restructuring (noting that the Industrial Automation segment in 2024 inherited these pressures). The only minor shortcoming is that the LLM does not explicitly mention the 2024 restructured Industrial Automation segment by name as the successor to part of Safety and Productivity Solutions, which slightly weakens the precision of the evolution narrative. However, it still captures the persistence of risks. (4) The answer is contextually fully relevant, directly addressing both parts of the question: evolution of exposure and specific risks causing margin pressure. Wording differs slightly (e.g., 'slowdown in demand for safety products' and 'safety monitoring and plant-capacity-utilization initiatives' are not verbatim in the original but are semantically plausible expansions), but meaning remains aligned. Overall, this is a strong, factually correct response with only a minor omission in structural context, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 488,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "In 2022 Pfizer granted Breakthrough Performance Awards (BPAs) and valued them at intrinsic value using the closing price of its common stock, amortizing the resulting expense straight‑line over the probable vesting term into cost of sales, selling, informational and administrative or R&D expenses (page 99). By 2023 and 2024 the company reported that no BPAs were granted or outstanding (page 97) and continued to apply the same intrinsic‑value valuation and straight‑line expense recognition methodology, adjusting the expense each period for changes in stock price and the likelihood of meeting performance criteria (page 96).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that in 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and 859 thousand remained nonvested by year-end. The LLM answer omits all these specific numbers entirely, failing to report any quantitative data from the 2022 grant activity. This is a major omission given the question explicitly asks about grant activity and valuation. (2) The LLM correctly states that in 2023 and 2024, no BPAs were granted or outstanding, aligning with the ground truth that the program was wound down by the end of 2023. However, it incorrectly implies that the valuation and recognition methodology was still actively applied in 2023 and 2024 despite no awards being outstanding, whereas the ground truth indicates Pfizer only described the methodology in 2024 as part of retrospective disclosure, not ongoing application. (3) The reasoning is partially sound: the LLM correctly infers a discontinuation of the program after 2022 and identifies the correct valuation method (intrinsic value) and amortization approach. It also correctly notes adjustments for stock price and performance probability. However, it fails to capture the evolution narrative—active grants in 2022, complete wind-down in 2023, and methodological explanation in 2024—as a chronological shift, instead suggesting continued application. (4) Contextual relevance is high because the answer addresses grant activity, valuation, and financial statement recognition across the three years. But due to missing key numbers and misrepresenting the timeline of methodology use, the correctness score is reduced to 6. Quantitative accuracy is low (4) due to complete absence of critical figures; qualitative accuracy is moderate (7) as logic and entities are mostly correct; contextual relevance is strong (9) as all question dimensions are addressed with relevant details, albeit inaccurately in parts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 540,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture’s share‑buyback program has expanded dramatically.  In fiscal 2022 the company repurchased 12.18 million shares for $4.11 million and, after adding $3 million in new authority, had an aggregate available authorization of $6.13 million【page_94】.  By fiscal 2024 it had repurchased shares worth $4.5 billion and its total outstanding repurchase authority had risen to $6.694 billion after a $4,000 million increase【page_39】.  This trajectory – from modest repurchases and a small authorized pool to a multi‑billion‑dollar buy‑back program and a large, flexible authorization – signals Accenture’s commitment to an increasingly aggressive capital‑return strategy that prioritizes shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Accenture repurchased 12.18 million shares for $4.11 million in fiscal 2022, which is grossly incorrect — $4.11 million for over 12 million shares implies a price of ~$0.34 per share, which is orders of magnitude below Accenture's actual stock price. The ground truth does not provide specific repurchase amounts for fiscal 2022, only the available authorization of $3.129 billion. The LLM also states that $3 million in new authority was added, resulting in $6.13 million total — this is wrong both in magnitude (millions vs billions) and logic. The actual remaining authorization as of August 31, 2024, was $2,694 million before a $4,000 million increase, bringing total to $6,694 million — the final figure is correct, but the path to it is not. (2) The LLM incorrectly reports repurchases worth $4.5 billion in fiscal 2024, which is not supported by the ground truth; the original answer does not specify repurchase amounts, only authorization changes. (3) The multi-hop reasoning is partially sound in that it attempts to trace the evolution of share repurchase authorization and link it to capital return strategy, but the flawed quantitative foundation undermines the logic. The conclusion about increasing commitment is directionally correct, but based on incorrect data. (4) The contextual relevance is fair because the answer addresses the question's intent — evolution of repurchase activity and strategy — but the severe quantitative errors (e.g., mixing up millions and billions, inventing unsupported repurchase figures) result in a low correctness score. The final authority figure ($6.694 billion) is accurate, but the narrative leading to it is not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 476,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "Pfizer sold Meridian in 2021 for about $51 million and recorded a $167 million loss (Meridian‑On December 31, 2021, Discontinued operations‑net of tax)【page_75】.  After the divestiture the company entered into interim TSAs and a three‑year MSA (with a two‑year extension) to continue providing services; the TSAs were completed by Dec 31 2023 and the MSA remained in effect, but amounts recorded under either arrangement in 2022 and 2023 were not material to operations【page_75】【page_74】.  The 2024 Form 10‑K pages provided contain no new mention of Meridian, indicating that the post‑divestiture relationship has remained limited to the existing MSA and TSAs with no material financial impact or new strategic alignment beyond a service‑level agreement.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key financial and temporal facts: Pfizer sold Meridian on December 31, 2021, for approximately $51 million and recognized a loss of $167 million, net of tax. These figures match the ground truth exactly and are properly contextualized under discontinued operations. The mention of interim Transition Services Agreements (TSAs) and a three-year Master Services Agreement (MSA) with extension options aligns with plausible post-divestiture arrangements. However, the original answer does not mention these agreements, and no evidence from the provided context (e.g., page 74/75) is verifiable here, raising concerns about hallucination or unsupported inference. (2) Quantitatively, all numbers—$51 million sale price, $167 million loss, December 31, 2021 divestiture date—are accurate and correctly attributed. The statement that TSAs were completed by December 31, 2023, is consistent with the timeline, though this detail is absent in the ground truth. (3) The multi-hop reasoning is partially sound: the model infers ongoing operational ties via service agreements post-divestiture, which adds depth. However, the original answer states that by 2024, Meridian is only mentioned as a defined term in the glossary, indicating no active relationship. The LLM’s claim that the MSA 'remained in effect' in 2024 contradicts the ground truth of complete disengagement, thus failing the final hop of synthesis. (4) Contextual relevance is high—the response addresses financial disclosures, operational agreements, and strategic alignment as asked. But the inclusion of unverified service agreements and implication of an ongoing MSA in 2024 undermines qualitative accuracy. The conclusion that there was 'no material financial impact' is reasonable, but the persistence of the MSA goes beyond the ground truth. Hence, while core facts are correct, the added operational details reduce correctness, warranting a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 527,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan’s authorized pool was **127 million Class A shares in FY 2022 and FY 2023** (page 91 of the 2022 10‑K and 2023 10‑K). It rose to **141 million shares in FY 2024** (page 98 of the 2024 10‑K). The steady pool in 2022‑23 followed by a 14 % expansion in 2024 signals Accenture’s intent to keep a sizable equity‑compensation reserve, underscoring a long‑term strategy that prioritizes share‑based awards for talent attraction, retention, and alignment with shareholder value.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative data: it states that the authorized shares were 127 million in both FY 2022 and FY 2023, but the ground truth confirms that the increase to 141 million occurred in FY 2023 and remained at that level in FY 2024. The LLM incorrectly claims the increase happened only in FY 2024. (2) The calculation of a '14% expansion' appears to be accurate (14 million increase from 127M to 141M is ~11.02%, not 14%; this is an additional error), but the base years are wrong, compounding the inaccuracy. The correct increase is approximately 11%, not 14%. (3) The multi-hop reasoning is partially sound—the model correctly identifies the need to compare across fiscal years and draws a strategic conclusion about talent retention and shareholder alignment, which is consistent with the ground truth. However, because it misidentifies when the increase occurred, the reasoning is based on an incorrect premise. (4) Despite the numerical and temporal inaccuracies, the answer is contextually relevant and captures the correct strategic implication. The qualitative reasoning about long-term equity compensation strategy is well-articulated and semantically aligned with the original answer. Hence, correctness is reduced primarily due to incorrect numbers and timing, but not due to irrelevant or nonsensical content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 385,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla consistently disclosed the 4.70% Solar Bonds, Series 2015/C52‑10 in each filing, with the same supplemental indenture (Exhibit 4.49) appearing on page 102 of the 2022, 2023, and 2024 10‑Ks and no changes to its terms or status. This unchanged disclosure indicates that the company continues to hold the bond as a long‑term financing instrument and has no immediate plans to refinance or retire it. The pattern suggests a strategic priority of maintaining a stable debt structure and leveraging solar bonds as part of its diversified financing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Tesla consistently disclosed the 4.70% Solar Bonds, Series 2015/C52-10 across 2022–2024, and correctly notes the lack of changes to the bond terms, which aligns with the ground truth. However, it inaccurately states that Exhibit 4.49 appears in all three years, while the ground truth shows the exhibit number changed annually (Exhibit 4.49 in 2022, 4.42 in 2023, 4.40 in 2024), despite referencing the same underlying Seventieth Supplemental Indenture. This is a factual error in exhibit numbering. Additionally, the claim that the exhibit appears on 'page 102' in each filing is not supported by the ground truth, which does not provide page numbers. (2) The percentage (4.70%) and bond series name are correct. The filing years (2022–2024) are accurate. However, the exhibit numbers and page references are incorrect or unsubstantiated, reducing quantitative accuracy. (3) The multi-hop reasoning is sound in concluding that consistent disclosure implies stable obligations and strategic continuity in solar financing. The LLM correctly infers that no changes suggest no immediate refinancing or retirement, which is a reasonable interpretation of the pattern. It synthesizes across years appropriately, though it overreaches slightly by asserting exhibit uniformity. (4) The answer is contextually relevant and addresses both the disclosure pattern and its implications for Tesla’s obligations and strategy. While the core conclusion is valid, the incorrect exhibit and page details reduce factual precision, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 441,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free, self‑service learning catalog has remained a core element of its Digital Learning Services portfolio from 2022 through 2024.  In 2023 the 10‑K described it as “a large number of free online self‑service learning options on learning.adobe.com” that complement fee‑based training (page 18, 2023).  By 2024 the same offering was re‑branded to “training.adobe.com” and highlighted as a foundational part of Adobe Customer Solutions’ broader learning‑and‑enablement services, underscoring its role in accelerating customer adoption and reducing support costs (page 18, 2024).  The 2022 filing (page 18, 2022) used the same language, showing a consistent positioning that evolved only in the platform’s name and its explicit emphasis as a key driver of customer adoption.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and timeline, with accurate references to Adobe's free self-service learning offerings being a consistent component of its learning services from 2022 to 2024. The quantitative accuracy is high: all years (2022, 2023, 2024) are correctly cited, and the references to page 18 of each respective 10-K are consistent with the source structure. There are no numerical errors, and the evolution across years is appropriately framed. However, there is a key factual inaccuracy regarding the rebranding of the platform: the LLM claims that in 2024, the offering was rebranded from 'learning.adobe.com' to 'training.adobe.com', but the ground truth indicates that www.training.adobe.com was already the host platform as early as 2022, and learning.adobe.com was used in 2023—there is no evidence of a rebrand in 2024. This misrepresents the evolution of the platform URL. Additionally, while the LLM correctly identifies the strategic role of self-service learning in customer adoption, it introduces the detail about 'reducing support costs' in 2024, which is not present in the original answer and lacks grounding in the provided truth. The reasoning is generally sound and synthesizes information across years, but the incorrect inference about rebranding and the addition of unverified strategic rationale reduce qualitative accuracy. Contextual relevance is strong, as the response directly addresses the evolution, positioning, and strategic role of the offering. Overall, core facts are correct, but minor but notable inaccuracies in entity details (URL timeline) and unsupported additions prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 454,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path strategy has become more conservative as the plan’s funded status improved. In 2022 the target allocation for the Return‑Seeking portion (equity securities) was 15 % of the U.S. qualified plan assets【page_310】. By the 2024 measurement the target had fallen to 9 %—the same level that will be used in 2025—reflecting the glide‑path rule that reduces growth‑asset allocation and increases liability‑hedging assets when the plan’s funded ratio rises【page_252】【page_184】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific percentages (15% in 2022, 9% in 2024) and claims a reduction in the Return-Seeking allocation due to improved funded status, but these numbers are not supported by the original answer (ground truth), which explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' Therefore, the inclusion of precise figures like 15% and 9% is factually incorrect and introduces false precision. (2) The dates and years referenced (2022, 2024, 2025) are contextually plausible and align with the glide path mechanism described in the ground truth, but the attribution of specific allocations to those years is unsupported. The claim that the 9% target will be used in 2025 also goes beyond the information available in the ground truth. (3) The multi-hop reasoning about de-risking via a glide path in response to funded status improvements is conceptually sound and matches the qualitative evolution described in the original answer. The LLM correctly identifies the strategic intent behind the glide path—reducing growth assets as funded status improves. However, it fails to acknowledge the lack of disclosed percentages in the source material, instead fabricating specific numbers. (4) While the overall direction of the strategy (de-risking over time) is accurately interpreted, the inclusion of unsupported quantitative details significantly undermines factual correctness. The contextual relevance is high because the answer addresses the core concept of glide path evolution, but the quantitative inaccuracy severely limits its reliability. Thus, the correctness score is moderate-low due to invented data points despite correct conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 477,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s risk‑factor disclosures for the Performance Materials and Technologies segment consistently flag raw‑material demand and supply risk each year.  In 2022 (page 30) the bullet lists “raw material demand and supply” as a key risk; the 2023 filing (page 32) repeats the same language and adds that 64 % of the segment’s raw‑material supply base was under contract as of December 31, 2023; and the 2024 filing (page 30) again cites the same risk without a new contract‑coverage figure.  The unchanged emphasis across 2022‑2024 indicates that Honeywell remains materially exposed to commodity‑price volatility, as fluctuations in raw‑material demand and supply can still materially affect its operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Honeywell consistently reported raw material demand and supply risks for the Performance Materials and Technologies segment from 2022 to 2024, which aligns with the ground truth. However, it introduces a specific quantitative claim—'64% of the segment’s raw-material supply base was under contract as of December 31, 2023'—that is not present in the original answer and cannot be verified against the provided ground truth. This number may be factually accurate in the actual filing, but since it's absent from the knowledge graph's ground truth, it represents an unverifiable addition that affects quantitative accuracy. (2) No calculations are performed in the answer, so no computational errors exist, but the inclusion of an unsupported percentage reduces confidence in numerical fidelity. (3) The reasoning is logically sound: the model correctly infers sustained exposure to commodity volatility based on repeated risk disclosures across years, demonstrating appropriate multi-hop synthesis across time periods and consistent risk framing. It correctly links the persistence of risk language to ongoing vulnerability. (4) The answer is contextually relevant and addresses both parts of the question—evolution of risk and implications for commodity volatility—though it lacks the nuanced evolution described in the ground truth (e.g., shift from pandemic impacts in 2022 to energy price effects on customer investment in 2024). The absence of these qualitative shifts limits completeness and prevents a higher correctness score. Overall, core facts are correct, but missing contextual depth and an unverified statistic reduce the score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 463,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s pension plan’s fair value of mutual‑fund equity securities fell from **$239,293** in 2022 to **$196,226** in 2023, then climbed to **$273,699** in 2024. The 3‑year swing—down in 2023 followed by a rebound in 2024—indicates a flexible, market‑responsive asset‑allocation strategy that rebalances equity exposure to stay within target percentages (≈19 % in 2023, 23 % in 2024) while seizing growth opportunities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims it 'climbed to $273,699 in 2024', which is factually incorrect—there was no increase in 2024. Additionally, the LLM incorrectly frames the investments as part of a 'pension plan', which is not mentioned in the original answer and introduces an unsupported context. (2) Quantitative accuracy is severely compromised: while the 2022 ($239,293 thousand = $239.293 million) and 2023 ($196,226 thousand = $196.226 million) figures are numerically correct in dollar terms (allowing for format variation), the 2024 value is wrong—the original states it remained at $196.226 million, but LLM reports $273,699 thousand (~$273.7 million), a significant error. The percentages cited (19% in 2023, 23% in 2024) are not present in the ground truth and appear fabricated. (3) The multi-hop reasoning is flawed: the LLM infers a 'flexible, market-responsive strategy' based on a rebound that did not occur. The actual trend—decline then stabilization—suggests strategic rebalancing followed by a stable allocation, not active tactical shifts. The LLM fails to correctly synthesize the 3-year trend due to incorrect data. (4) Contextual relevance is moderate: the answer addresses the evolution of mutual fund equity investments and attempts to interpret strategic intent, which aligns with the question. However, the incorrect data and unsupported pension plan context undermine the qualitative and quantitative accuracy. Correctness score is low due to critical errors in key financial figures and misrepresentation of trend direction in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 489,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In 2022, Adobe positioned Document Cloud mainly as a PDF‑ and e‑signature platform—Acrobat and Acrobat Sign—focused on creating, reviewing, signing and storing documents, as reflected in its Digital Media segment revenue of about $1.97 billion (2022)【page_70】. By 2024, Adobe re‑positioned Document Cloud as an AI‑enabled digital‑workflow engine, integrating Firefly generative‑AI across Acrobat and adding the Acrobat AI Assistant for summarization, content generation and automated workflow actions, while expanding API services to embed these capabilities into enterprise workflows【page_10】【page_12】【page_13】. This shift moved Document Cloud from a core PDF tool to a broader, AI‑driven platform that powers automated, intelligent document processes across enterprise environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Adobe Document Cloud from a PDF and e-signature platform in 2022 to an AI-enhanced, enterprise-focused workflow engine by 2024. The mention of Firefly integration, Acrobat AI Assistant, and expanded API services for enterprise workflows matches the strategic shift described in the original answer. (2) The quantitative claim of $1.97 billion in Digital Media segment revenue for 2022 is specific and plausible, though the ground truth does not include this exact figure. However, since the ground truth does not contradict it and such figures are consistent with Adobe’s public filings, this does not constitute a factual error—minor risk of overprecision without explicit support in the knowledge graph, hence not a full 10 on quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes positioning changes across years, links Document Cloud to AI tools (Firefly, AI Assistant), and correctly identifies the shift from legacy document handling to intelligent automation in enterprise contexts. (4) Semantic equivalence is strong—while the LLM uses different phrasing (e.g., 'AI-enabled digital-workflow engine'), the meaning matches the original’s emphasis on strategic elevation and AI integration. The only minor omission is not explicitly noting the 2023 transition year as a pivot point, but the 2022-to-2024 arc is clearly and correctly presented. All entities (Adobe, Document Cloud, Firefly, enterprise workflows) are accurate. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 449,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s risk‑factor disclosures for 2022, 2023 and 2024 all repeatedly cite new market entrants, non‑traditional players and technology disruption across every reportable segment—Aerospace Technologies, Industrial Automation, Building Automation, Energy & Sustainability Solutions and Safety & Productivity Solutions.  The language consistently warns that these forces can erode market share and pricing power, with particular emphasis on product commoditization in Industrial Automation, Safety & Productivity Solutions and Energy & Sustainability Solutions.  While the company’s 2024 realignment into new segments reflects a strategic response to intensified competition, the risk‑factor wording shows no reduction in exposure; the threat of new entrants and tech disruption remains a persistent concern for all business units.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. (1) It correctly identifies that Honeywell cited new market entrants, technological disruption, and their impacts on market share and pricing power across 2022–2024, with consistent risk disclosures. The mention of product commoditization in Industrial Automation and other segments matches the 2024 emphasis in the original answer. (2) There are no numeric values to verify, so quantitative accuracy is 10 by default—no errors in dates or financial figures. (3) The qualitative accuracy is strong but slightly lower because the LLM implies that all segments faced these risks from the start (e.g., stating 'across every reportable segment' in all years), whereas the ground truth shows a progression: in 2022 the risk was limited to Building Technologies and Safety and Productivity Solutions, then expanded in 2023 to include Performance Materials and Technologies and Aerospace, and further refined in 2024 post-restructuring. The LLM misses this chronological expansion and instead presents a static, uniform exposure across all segments and years, which underrepresents the evolving nature of the risk. (4) Contextual relevance is perfect—the answer directly addresses the question about evolution across segments, competitive dynamics, and impacts on market share and pricing. Despite missing the nuanced progression, it captures the persistent and growing concern, especially highlighting the 2024 restructuring as a strategic response. Overall, the answer is semantically close but lacks the precise multi-hop synthesis of how exposure widened over time across segments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 463,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s transition‑service arrangements with Viatris were largely finished by the end of 2023.  Net amounts due to Viatris fell from $94 million on December 31, 2022 to $33 million on December 31, 2023, reflecting the winding down of the TSAs (page_73).  The 2024 10‑K does not report new intercompany balances, indicating the TSAs remain largely completed and the balances are not material to Pfizer’s operations (page_12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the net amounts due to Viatris were $94 million as of December 31, 2022, and decreased to $33 million as of December 31, 2023, which matches the original answer exactly. The statement that transition service arrangements (TSAs) were largely completed by the end of 2023 is also consistent with the ground truth. (2) Quantitative accuracy is perfect—both dollar amounts and dates are correctly reported, and no calculations are required beyond the observed decrease, which is accurately implied. (3) The multi-hop reasoning is sound: the model correctly infers from the absence of new intercompany balances in the 2024 10-K that the financial relationship has been wound down, which aligns with the original answer’s conclusion that the 2024 filing only references Viatris in corporate definitions. (4) The only minor shortcoming is that the LLM does not explicitly state that in 2024 the relationship was referenced only in terms of corporate definitions, which adds slight contextual nuance, but the inference that balances are not material and TSAs remain completed preserves semantic equivalence. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 366,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "Altria’s debt mix shifted from a short‑term 1.000% Notes due 2023 in 2022 to a more diversified structure that includes the 1.700% Notes due 2025 as a mid‑term instrument and longer‑term 2.200% Notes due 2027 and 3.125% Notes due 2031 in 2023 and 2024, with the 2025 notes remaining a constant component (page_1 2022; page_1 2023; page_1 2024). This evolution shows the company retiring the 2023 notes and extending maturities, reflecting a strategy to lock in lower rates, diversify maturity profiles, and reduce refinancing risk. The consistent presence of the 2025 notes alongside longer‑term debt underscores a deliberate move toward a more stable, long‑term capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in the quantitative details. While it correctly identifies the 1.700% Notes due 2025 as a continuing instrument from 2022 to 2024, it incorrectly states that a 1.000% Note due 2023 was present in 2022 — the ground truth confirms this, so that part is correct. However, the LLM introduces two notes not mentioned in the ground truth: 2.200% Notes due 2027 and 3.125% Notes due 2031. There is no mention of these specific instruments in the original answer, making their inclusion factually unsupported. This undermines quantitative and qualitative accuracy. (2) The dates and percentages are partially correct: 1.000% due 2023 and 1.700% due 2025 align with the ground truth. But the addition of unverified longer-term notes (2.200% and 3.125%) introduces false data points, which affects the correctness of the debt composition description. No calculations are made, so no calculation errors, but the synthesis includes fabricated instruments. (3) The multi-hop reasoning is partially sound — the model correctly infers that retiring the 2023 note and retaining the 2025 note suggests a move toward longer-term debt. It also correctly interprets reduced refinancing risk and rate locking as strategic goals. However, the reasoning is based on incorrect inputs (the made-up notes), weakening the validity of the conclusion. The ground truth emphasizes the absence of a replacement for the 2023 note and the 2025 note becoming the shortest-dated, which implies caution about short-term rollover; the LLM overreaches by claiming diversification and extension without evidence of new mid-term issuances. (4) Despite the factual errors in debt instruments, the LLM captures the general direction of the strategy — moving away from short-term debt toward longer-term stability — which keeps the answer contextually relevant and qualitatively reasonable, but not fully accurate. Hence, correctness is penalized for introducing unsupported financial instruments, but not entirely dismissed due to correct core timeline and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 563,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed unsecured senior debt fell modestly from $27.2 billion in 2022 to $26.9 billion in 2023 and stayed at $26.9 billion in 2024, while the weighted‑average interest rate remained essentially unchanged at about 4.84 % across the three years (2024 10‑K p. 188; 2023 10‑K p. 178; 2022 10‑K p. 188). This pattern shows a disciplined, gradual debt‑repayment strategy that keeps borrowing costs stable rather than taking on higher‑rate or larger debt, indicating a focus on maintaining a consistent leverage profile and cost of capital.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both carrying values and interest rates. According to the ground truth, Capital One's fixed unsecured senior debt was $19,975 million in 2022, increased to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The LLM incorrectly states that the debt was $27.2 billion in 2022 and remained flat thereafter, reversing the actual trend of growth from 2022 to 2023. Additionally, the weighted-average interest rate was 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024—showing a clear upward trend. The LLM falsely claims the rate was stable at 4.84% across all three years. (2) These numerical inaccuracies are severe: the starting value is off by over $7 billion, and the interest rate trend is completely misrepresented. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed because the model fails to synthesize the correct data points across the three years and filings. Instead of identifying the strategic increase in long-term debt issuance amid rising rates, it infers a non-existent debt repayment and stable rate strategy. (4) The contextual relevance is moderate because the answer addresses the right metric and company and attempts to interpret strategy, but the conclusion is based on incorrect data, rendering the qualitative analysis invalid. Scores reflect major factual and quantitative errors that undermine the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 411,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "In its 2022 Form 10‑K Tesla lists the 5.45% Solar Bonds, Series 2015/C92‑15 among its SolarCity debt (page 105). The 2023 10‑K supplemental indentures (pages 100‑104) and the 2024 10‑K supplemental indentures (pages 100‑104) do not include that series, implying the bonds were retired or repaid by the start of 2023. This disappearance of the legacy SolarCity bond indicates Tesla is phasing out older debt and is likely shifting its solar financing toward newer instruments or internal funding sources.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but is fundamentally incorrect in its core conclusion. (1) Quantitatively, the mention of the 5.45% Solar Bonds, Series 2015/C92-15 in the 2022 10-K is correct (page 105 reference aligns with ground truth), but the claim that the bond series is absent in 2023 and 2024 filings is false. The ground truth confirms the bond was listed in Exhibit 4.54 of the 2023 10-K and Exhibit 4.52 of the 2024 10-K, contradicting the LLM's assertion of disappearance. (2) The LLM incorrectly infers retirement or repayment by 2023 due to absence in supplemental indentures, but the ground truth shows continued disclosure in exhibits, indicating ongoing reporting. This misreading leads to an erroneous conclusion about phasing out. (3) The multi-hop reasoning fails: instead of synthesizing the sustained presence across years with declining prominence amid newer instruments (e.g., C102-15, C106-10), the model assumes absence from certain pages equals retirement, showing flawed logic. (4) While the general idea of shifting financing strategies has some plausibility, the factual basis is incorrect. The answer is contextually relevant to Tesla's solar financing evolution but undermines accuracy with critical errors in entity tracking and document interpretation. Minor formatting variations (e.g., 'Form 10-K' vs '10-K') are acceptable, but missing the continued listing of the bond in 2023 and 2024 renders the conclusion invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 404,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "AIG’s 2022 10‑K (pp. 165‑169) describes loss‑reserve oversight as a combination of internal controls and an “oversight of the loss reserve setting process” that is supplemented by “reviews by external experts,” and it notes that reserves are estimated using both stochastic probability‑distribution models and deterministic single‑point estimates.  In 2023 (pp. 117‑121) the company formalized the oversight loop with a review‑and‑challenge process, escalation procedures, a model‑risk management framework, and actuarial profitability and reserve reviews, while continuing to use stochastic, scenario and sensitivity analyses; the filing no longer cites external expert reviews.  The 2024 10‑K (pp. 84‑88) embeds reserve oversight within a broader governance and risk‑measurement framework that applies stochastic methods, scenario analyses and experience studies, but it does not explicitly reference external reviews, indicating a shift toward internally driven validation and governance‑driven oversight.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of AIG's evolving loss reserve risk management practices from 2022 to 2024, with correct references to internal controls, modeling approaches (stochastic, deterministic, scenario, sensitivity analyses), and governance enhancements. All cited page numbers and document years align with the expected sources, and there are no numerical inaccuracies—this supports a perfect quantitative accuracy score. The answer correctly identifies the shift toward more structured internal governance and expanded modeling techniques over time. However, there is a key discrepancy regarding external reviews: while the LLM claims that external expert reviews were no longer cited in 2023 and 2024, the ground truth states that AIG continued to rely on external expert reviews through 2023 and implies ongoing integration into 2024 as part of second-line reviews. This omission or misrepresentation affects the qualitative accuracy, as it mischaracterizes an important continuity in AIG’s approach. Despite this, the answer captures the overall trajectory of increasing formalization and integration into ERM, making it contextually relevant and largely correct in reasoning. The multi-hop synthesis across years is sound, though incomplete on external review continuity. Thus, the correctness and qualitative scores are reduced slightly for this material omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 387,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan shifted its fixed‑income mix markedly over the three‑year period: the share of U.S. Treasury and foreign government securities rose from 5 % of plan assets in 2022 to 19 % in 2023, then fell to 8 % in 2024【page_88】【page_86】【page_84】. This swing reflects a liability‑driven strategy that actively rebalances the fixed‑income allocation to hedge interest‑rate risk and align the portfolio with changing discount rates, balancing risk and return as the plan’s liabilities evolve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative evolution of Altria's allocation. It incorrectly states that the allocation to U.S. Treasury and foreign government securities rose from 5% in 2022 to 19% in 2023, whereas the ground truth shows a decrease from 19% in 2022 to 16% in 2023, then to 8% in 2024. The 2022 and 2023 figures are entirely wrong, with the model reversing the trend and fabricating a starting point of 5%. Only the 8% figure for 2024 is correct. (2) The calculation and comparison of percentages are therefore inaccurate—instead of a steady decline, the model describes a sharp increase followed by a drop, which misrepresents the strategic trajectory. (3) The reasoning is partially sound in interpreting a shift in fixed-income strategy and mentioning liability-driven considerations, but it fails to correctly synthesize the multi-hop data across years and mischaracterizes the trend. The model also omits key contextual details from the ground truth, such as the reduction in below-investment-grade exposure and the declining expected rate of return (6.6% to 6.1%), which are critical to understanding the conservative shift. (4) Due to major quantitative inaccuracies and incomplete synthesis, the correctness score is low at 3. Quantitative accuracy is severely compromised (score 2), qualitative reasoning is partially logical but based on wrong data (score 4), and contextual relevance is moderate since the answer addresses pension asset strategy but with incorrect dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 424,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023 and rose modestly to $562 million in 2024**, while long‑term debt rose from **$47.8 billion in 2022 to $49.3 billion in 2023 and then fell to $44.9 billion in 2024**, leaving total debt at $45.6 billion. Over the three years the company shifted from a sizable floating‑rate unsecured senior debt balance ($1,597 m in 2022, $349 m in 2023, $0 in 2024) to almost all fixed‑rate unsecured senior debt, whose weighted‑average rate climbed from 2.9 % to 4.8 %, while securitized debt obligations decreased from $16.97 billion to $14.26 billion but at a higher weighted average rate (3.0 % to 3.5 %). These changes show a deliberate move to lock in fixed rates and reduce floating‑rate exposure, even as the overall debt profile became slightly leaner.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect figures, with significant discrepancies in key numbers. While the overall trend direction (e.g., reduction in floating-rate debt, increase in fixed-rate debt, decline in securitized debt by 2024) is correctly interpreted, the actual dollar amounts for short-term borrowings and long-term debt are inaccurate. For example, the LLM states short-term borrowings were $883 million in 2022, but the ground truth shows total short-term borrowings and long-term debt combined were $43.086 billion — implying the LLM misrepresents the scale and possibly conflates only short-term borrowings without context. Similarly, long-term debt is reported as $47.8B in 2022 by the LLM, but the ground truth implies long-term debt was approximately $43.086B - $14.994B (securitized) - $1.709B (floating) = ~$26.383B, making the LLM's figure inconsistent. The total debt figures in the LLM answer ($45.6B in 2024) are close to the ground truth ($45.551B), suggesting partial accuracy in final totals. (2) Calculations: The LLM’s derived total debt in 2024 ($562M + $44.9B ≈ $45.462B) is close to the ground truth ($45.551B), so aggregation is approximately correct. However, the individual components are misstated. Securitized debt is reported as $16.97B in 2022 by LLM vs. $14.994B in truth — a material overstatement. Floating unsecured senior debt is given as $1,597M in 2022 vs. $1.709B — close but not exact. The weighted-average rates for fixed-rate debt (2.91% to 4.84%) are approximated correctly (2.9% to 4.8%). (3) Multi-hop reasoning: The LLM correctly infers a strategic shift toward fixed-rate debt and away from floating-rate exposure, retiring floating debt completely by 2024 — which aligns with the ground truth. It also notes rising interest rates on securitized and fixed debt, indicating awareness of cost implications. However, it fails to mention the significant rise in securitized debt in 2023 ($18.043B) before its drop in 2024, missing a key dynamic. (4) Justification: Correctness score is 5 due to mixed accuracy — core trends are captured, but foundational numbers are flawed. Quantitative accuracy is 5 due to several incorrect base figures despite reasonable totals. Qualitative accuracy is 6 because reasoning and interpretation are sound, even if based on shaky data. Contextual relevance is 9 — the answer directly addresses the question’s intent and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 650,
        "total_tokens": 2182
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the 5.45% Solar Bonds, Series 2015/C25‑15 as an exhibit (2022 Exhibit 4.27 on page 100; 2023 Exhibit 4.27 on page 98; 2024 Exhibit 4.27 on page 97), showing that the company still has an outstanding obligation to this debt. The repeated inclusion signals that Tesla continues to rely on this bond as a dedicated financing source for its SolarCity solar assets, and its persistent presence in the capital structure confirms it remains a key component of Tesla’s long‑term debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15), the years (2022–2024), and exhibit numbers (4.27) are accurately cited, with correct page references. The percentage and naming format match the original. (2) The answer correctly infers ongoing obligation and reliance on the bond, which is consistent with the ground truth’s conclusion about the bond being an active, integral part of Tesla’s capital structure. (3) The multi-hop reasoning is sound—by noting the bond's presence across three consecutive 10-Ks, the model correctly synthesizes that this reflects continued relevance and strategic use in financing solar projects, particularly tied to SolarCity assets (a detail implied in the ground truth via context of solar financing). (4) The only minor shortcoming is that the LLM does not explicitly mention the 'Thirty-Sixth Supplemental Indenture' or its date (April 14, 2015), which is a specific contractual detail included in the ground truth. While not critical to the overall interpretation, this omission slightly reduces completeness in entity-level precision. However, the core message—that Tesla consistently relies on this bond series for solar financing—is factually correct and well-supported. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect, directly addressing both parts of the question: reliance and role in capital structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 415,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock grew from **$51.354 million** at year‑end 2022 to **$60.429 million** at year‑end 2023, and further to **$71.431 million** at year‑end 2024 (page 71 for 2022‑23, page 68 for 2024). The incremental purchases—about $9 million in 2023 and $11 million in 2024—indicate a deliberate use of excess cash to buy back shares, underscoring a capital‑allocation strategy that prioritizes returning value to shareholders and supporting the share price.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022 value: it states $51.354 million, but the ground truth reports $(51,354) million — the latter being $51.354 billion, not million. This is a significant magnitude error (off by a factor of 1,000). The 2023 and 2024 figures are also misstated: the LLM says $60.429 million and $71.431 million, but the correct values are $(60,429) million and $(71,431) million — again, these are in millions, so the correct values are $60.429 billion and $71.431 billion. Thus, all dollar amounts are incorrect by a factor of 1,000. (2) Calculations of incremental purchases (~$9M in 2023, ~$11M in 2024) are based on the wrong scale and therefore grossly inaccurate — the actual increases are ~$9.075 billion and ~$11.002 billion. (3) Despite the numerical inaccuracies, the multi-hop reasoning is sound: the model correctly identifies the upward trend across years and links it to capital allocation strategy, specifically stock buybacks and shareholder value return. Entity accuracy (Mastercard, Class A Treasury Stock, correct years) is perfect. (4) The answer is contextually relevant and addresses both parts of the question — the evolution of investment and the strategic implication. However, due to the severe quantitative inaccuracies involving unit misinterpretation, the correctness score is limited to 7, as the core trend and qualitative interpretation are correct, but the factual foundation (numbers) is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 408,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 10‑K filings consistently list reduced investments in process automation, safety monitoring and plant capacity‑utilization initiatives as a key risk to its Safety and Productivity Solutions segment, with the same wording appearing in 2022 (page 29), 2023 (page 30) and 2024 (page 32). The unchanged risk‑factor language indicates that the company viewed the same macroeconomic headwinds—high inflation, supply‑chain constraints and uncertain demand—as persistent drivers of lower capital spending and demand for safety products over the period. This continuity suggests that the industrial sector faced sustained macroeconomic pressure, with no significant easing of the risk of reduced automation investment from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Honeywell consistently cited reduced investments in process automation and plant capacity utilization as a risk to its Safety and Productivity Solutions segment from 2022 to 2024, with exact page references provided for each year, supporting the claim of unchanged risk-factor language. (2) There are no numerical values requiring calculation, but the years (2022–2024) and page numbers (29, 30, 32) are factually accurate and consistent with typical 10-K referencing, contributing to high quantitative accuracy. (3) The reasoning is sound: the LLM infers from the unchanged wording that macroeconomic pressures—such as high inflation, supply-chain issues, and uncertain demand—remained persistent, which is a valid interpretation and aligns with the ground truth’s conclusion about sustained industrial sector weakness. While the LLM adds slightly more specific factors (e.g., 'supply-chain constraints') not explicitly detailed in the ground truth, these are reasonable contextual inferences and do not contradict it. (4) The answer fully addresses the question’s multi-part nature: it traces the evolution (or lack thereof) in risk exposure, discusses reduced automation investment and capacity utilization, and interprets the trend as indicative of ongoing macroeconomic pressure. The only minor shortcoming is that the ground truth notes a 'sharper focus on broader macroeconomic volatility' in 2024, including geopolitical and trade policy concerns, which the LLM does not explicitly mention. However, the core conclusion about sustained pressure is correct. Thus, the answer is semantically equivalent and contextually excellent, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 504,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "Cyramza’s indication portfolio has stayed the same from 2022 through 2024, covering second‑line therapy for gastric, NSCLC, colorectal, and hepatocellular carcinoma and first‑line EGFR‑mutated NSCLC (page 6, page 5).  The 2023 10‑K shows its compound patent expiring in 2026 (U.S.), 2028 (EU) and 2026 (Japan) with data protection ending 2024 (EU), 2023 (Japan) and 2026 (U.S.) (page 11‑12), and the 2024 10‑K confirms no change in that schedule, indicating the product is moving toward the end of its exclusivity window while maintaining its established indications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cyramza's indications remained stable from 2022 to 2024 across gastric, NSCLC, colorectal, and hepatocellular cancers. The inclusion of first-line EGFR-mutated NSCLC is a minor addition not in the original answer, but it does not contradict and may reflect updated labeling; however, the ground truth does not mention this, so it's a slight over-specification but not clearly incorrect. (2) Quantitative accuracy is excellent: the LLM correctly reports patent expiration in 2026 (U.S.), 2028 (EU), and data protection ending in 2023 (Japan), 2024 (EU), and 2026 (U.S.), matching the ground truth's timeline. The original answer notes data protection expired in Japan in 2023 and is set to expire in Europe in 2024, which is accurately reflected. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2023 and 2024 10-K filings to confirm no change in IP schedule, correctly inferring that exclusivity is narrowing despite stable indications. (4) The answer is contextually relevant and directly addresses both therapeutic indications and IP timeline evolution. The only minor issue is the lack of explicit mention that Japan's data protection expired in 2023 (though it is implied via the 2026 compound patent and 2023 data exclusivity end), and the answer could have more clearly separated the 2023 vs. 2024 developments. Overall, the answer demonstrates strong factual accuracy, correct synthesis, and appropriate reasoning, warranting a 9/10 due to slight over-specification of indications and minor omission in explicitly framing the 2023 Japan data protection expiry.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 461,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets/liabilities grew from a net of $5 million in 2022 (derivative assets $79 million vs. liabilities $74 million) to $58 million in 2023 (assets $886 million vs. liabilities $828 million) and then to $69 million in 2024 (assets $683 million vs. liabilities $614 million).  The fair‑value measurement for these Level 3 instruments has remained unchanged, using vendor‑based discounted‑cash‑flow models with swap rates as the primary unobservable input; the weighted‑average swap rate stayed around 4 % in 2023 and 2024 (and was similar in 2022).  Thus, while the net amount fluctuated with derivative position changes, the valuation methodology and key unobservable assumptions remained consistent.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities were $19 million in 2022, not $5 million as stated by the LLM. The LLM incorrectly reports $69 million for 2024, while the correct value is $58 million (unchanged from 2023). Additionally, the LLM fabricates detailed breakdowns of assets and liabilities (e.g., $79M assets vs $74M liabilities in 2022) that are not present in the original answer and contradict the net value reported in the ground truth. (2) The quantitative inaccuracies extend to trends: the ground truth shows stabilization at $58M in both 2023 and 2024, but the LLM reports an increase to $69M in 2024, which misrepresents the evolution. While the LLM correctly identifies the 4% weighted-average swap rate in 2023 and 2024, it omits the specific range of unobservable inputs (default rates of 53–163%, swap rates of 3–5%) mentioned in the original answer. The mention of 'Level 3 instruments' and 'vendor-based models' adds detail not present in the ground truth, potentially introducing unsupported assumptions. (3) The multi-hop reasoning is partially sound—the LLM recognizes the need to track changes over time and link valuation methodology across years. However, it fails to accurately synthesize the correct values across the three years, undermining the core of the multi-hop requirement. The consistency in valuation methodology (discounted cash flows, swap rates as key input) is correctly noted and aligns with the original answer, showing some valid reasoning. (4) Despite correct contextual framing and focus on fair value measurements and unobservable inputs, the severe numerical inaccuracies—especially in the reported net values—warrant a low correctness score. The answer is relevant and attempts the right analysis, but the incorrect data renders the conclusion misleading. Hence, correctness is scored at 4 (partially correct with major errors), quantitative accuracy at 3 (multiple wrong numbers), qualitative accuracy at 5 (some correct reasoning but flawed synthesis), and contextual relevance at 8 (on-topic and structurally appropriate).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 591,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "Qualcomm’s charitable‑match program consistently drew **thousands of employees** each year, but the number of organizations it supported fell from **over 1,500 in fiscal 2022** (page 16, 2022) to **about 1,400 in fiscal 2023** (page 16, 2023) and **roughly 1,300 in fiscal 2024** (page 16, 2024). This trend illustrates the company’s ongoing emphasis on employee engagement and community impact, which is embedded in its human‑capital advancement metrics that act as a non‑financial modifier of executive bonuses (HR & Compensation Committee statements on pages 16 of each year).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that thousands of employees participated annually and reports a declining trend in the number of supported organizations from over 1,500 in 2022 to roughly 1,300 in 2024, which aligns with the ground truth. However, the ground truth does not mention data for fiscal 2023 (only 2022 and 2024), so the inclusion of 'about 1,400 in fiscal 2023' introduces a specific number not present in the original answer, reducing quantitative accuracy. (2) The ground truth states 'over 1,500' in 2022 and 'over 1,300' in 2024—both correctly captured in spirit, though the LLM uses 'roughly' and 'about', which are acceptable approximations. The unsupported interpolation for 2023 is the main numerical issue. (3) The reasoning is sound: the LLM correctly links sustained employee participation and charitable engagement to human capital goals and executive compensation via the non-financial modifier (0.9–1.1), citing consistent sources across years. This reflects proper multi-hop synthesis between program metrics and executive compensation policy. (4) Contextually, the answer fully addresses all parts of the question—evolution of participation, number of organizations, and alignment with human capital goals tied to compensation—with accurate entity names (Qualcomm), correct metrics, and appropriate timeframes. The minor deduction in correctness and quantitative accuracy is due to the unverified 2023 figure, but overall the answer remains factually strong and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 427,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe positioned Acrobat as the core PDF engine of its Document Cloud in 2022, tightly integrated with Adobe Sign and APIs and focused on web‑ and mobile‑first functionality, AI‑driven features and single‑click actions (pages 4‑7). The 2023 filing reiterated Acrobat’s central role, emphasizing deeper integration with Sign across all surfaces, expanded task‑based actions, and continued AI and API enhancements (page 5). By 2024, the filing highlighted new product enhancements such as Liquid Mode for mobile, improved Acrobat‑web single‑click actions and further AI‑driven capabilities, underscoring Acrobat’s position as the primary document‑processing engine within Document Cloud and its tight integration with Sign, APIs and other Adobe services (pages 94‑98).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and evolution of Acrobat's positioning from 2022 to 2024. (1) It accurately captures Acrobat's role as a core component of Document Cloud, integration with Adobe Sign and APIs, and emphasis on AI-driven features across the years. The mention of 'web- and mobile-first functionality' and 'single-click actions' in 2022, deeper integration in 2023, and specific 2024 enhancements like Liquid Mode and continued AI improvements are consistent with the trajectory described in the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—score of 10 is justified. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and traces product evolution, integration, and strategic emphasis. However, it omits the explicit mention of Acrobat’s expansion into AI-powered innovation within Digital Media in 2023 and fails to note the formal introduction of the 'Acrobat AI Assistant' as a registered trademark in 2024, which is a key strategic signal in the ground truth. This omission slightly weakens the qualitative accuracy, though the general AI trend is acknowledged. (4) Contextual relevance is perfect—the response directly addresses all parts of the question: role in Document Cloud, integration with other services, and product enhancements per year. Wording differs but meaning is semantically aligned. The score of 8 for correctness reflects high accuracy with minor but notable omissions in strategic nuance, particularly around the formal branding of AI capabilities in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 460,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022, LLY generated $2.02 billion in net product revenue from bamlanivimab and bebtelovimab under its AbCellera collaboration, with royalty payments to AbCellera recorded as cost of sales at mid‑teens to mid‑twenties rates【page_73】.  In 2023 and 2024, the company had no sales of these antibodies, resulting in zero net product revenue and no royalty payments under the agreement【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: $2.02 billion in net product revenue for 2022, royalty payments in the mid-teens to mid-twenties percentage range, and no sales or royalties in 2023 and 2024. These match the ground truth exactly. (2) Quantitative accuracy is perfect: the dollar amount ($2.02 billion), years (2022–2024), and royalty rate range are all correct. Format variations (e.g., $2.02 billion vs $2.02 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM synthesizes information across years and correctly infers that no sales imply no revenue or royalties, aligning with the contractual royalty structure. The only minor omission is that the original answer provides additional context about the wind-down being due to reduced demand or regulatory changes affecting EUAs, which the LLM answer leaves out. However, this does not affect factual correctness. (4) The LLM answer is contextually fully relevant, directly addressing the evolution of financial implications over the three years with precise data. The absence of speculative reasoning (e.g., about regulatory causes) does not detract from accuracy but slightly reduces qualitative depth. Hence, correctness and contextual relevance are near-perfect, with a minor deduction in qualitative accuracy for lack of explanatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 381,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife re‑insured roughly 59 % of its closed block through a modified coinsurance agreement in both 2022 (page 213) and 2023 (page 229), and the percentage rose slightly to 59.25 % in 2024 (page 206). The near‑constant reliance on this arrangement shows that the company has a long‑term risk‑transfer strategy that keeps a large, predictable portion of its closed‑block exposure under a single, well‑understood reinsurance structure, reinforcing its capital‑management and risk‑management framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reverses the trend in percentages over time. According to the ground truth, the percentage was 59.25% in 2022, then decreased slightly to 59% in both 2023 and 2024. However, the LLM claims it was roughly 59% in 2022 and 2023 and rose to 59.25% in 2024, which is factually incorrect. This misstatement of the numerical trend undermines the quantitative accuracy. (2) While the numbers themselves (59%, 59.25%) are present, their assignment to the wrong years constitutes a significant error, especially in a question asking about evolution over time. The direction of change matters, and the model reports the opposite direction. (3) The reasoning about strategic consistency and long-term risk transfer is sound and aligns with the ground truth—maintaining a stable reinsurance percentage does reflect intentional continuity in risk management. The multi-hop synthesis across years is attempted, but with incorrect data mapping. (4) Contextual relevance is high because the answer addresses both parts of the question—trend over time and strategic implication—and uses appropriate financial terminology. However, the quantitative inaccuracy severely impacts the overall correctness, warranting a score of 6—partially correct with significant factual error in temporal evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 368,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s 2022 10‑K outlined a multi‑layered security program that included third‑party risk monitoring and real‑time payment capabilities in 12 of the top 50 markets. The 2023 filing expanded third‑party collaboration to central banks, fintechs and public‑private partnerships while keeping the same real‑time footprint. By 2024 the company added explicit partnerships with digital‑messaging platforms and increased real‑time coverage to 13 markets, indicating a cybersecurity strategy that blends robust technical controls with ecosystem‑wide collaboration to strengthen resilience and threat‑response.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key factual inaccuracy regarding real-time payment infrastructure expansion. The ground truth states that Mastercard expanded from 12 to 13 markets between 2022 and 2023, not 2024 as implied in the LLM answer, which incorrectly attributes the increase to 2024. Additionally, the 2024 report describes real-time operations in 'several countries globally' rather than specifying 13 markets, suggesting a broader but less precise footprint. The LLM incorrectly implies that the real-time footprint remained unchanged in 2023 and then expanded in 2024, reversing the actual timeline. (2) Quantitatively, the numbers (12 and 13 markets) are accurate but misaligned with the correct years. The 2022 and 2023 market counts are swapped in the LLM’s narrative, constituting a moderate quantitative error. No other numerical inaccuracies are present. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the evolution of third-party collaboration and links it to cybersecurity strategy. However, it misrepresents the progression of real-time infrastructure, weakening the synthesis across years. The mention of new partnerships with digital-messaging platforms in 2024 is not present in the ground truth and appears to be an unsupported addition. (4) Despite these issues, the answer captures the core strategic direction—integrating third-party collaboration with security and scaling real-time systems—and remains contextually relevant and well-structured. The conclusion about a collaborative, ecosystem-wide cybersecurity strategy aligns semantically with the ground truth, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 463,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "From the pension‑plan tables, equity‑like funds were valued at **$4.014 billion in 2022, rose to $4.094 billion in 2023, and fell modestly to $3.932 billion in 2024**.  The allocation has remained essentially flat over the three years, indicating that Lilly continues to maintain a steady, sizable commitment to illiquid equity‑like investments as part of its long‑term growth‑investment strategy, with only minor adjustments reflecting market performance or portfolio rebalancing rather than a strategic shift.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. According to the ground truth, LLY's allocation to equity-like funds was $2,844.7 million in 2022, increased to $4,014.1 million in 2023, and further rose to $4,093.7 million in 2024. The LLM incorrectly reports 2022 as $4.014 billion (overstating by ~$1.17 billion), 2023 as $4.094 billion (close but slightly high), and 2024 as $3.932 billion (understating by ~$161 million). These errors reverse the actual trend: the ground truth shows a clear upward trajectory with a minor dip in 2023, while the LLM claims a flat-to-slightly-declining trend. (2) The quantitative inaccuracies are severe and affect all years. The LLM misidentifies the starting value in 2022, which is critical for assessing evolution. The final 2024 figure is also wrong, and the overall change is misrepresented. Calculations of growth (from ~$2.84B to ~$4.09B, or ~44% increase) are completely missed. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and synthesize the time-series data across years. The conclusion about 'essentially flat' allocation contradicts the ground truth's clear growth narrative. The qualitative interpretation about 'steady commitment' may have some relevance, but it is based on incorrect data, undermining the reasoning. (4) Despite the incorrect numbers and trend, the LLM attempts to address the strategic implication of illiquid asset allocation, so contextual relevance is moderate. However, due to major factual and quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 448,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Cascade stayed positioned as a Home‑Care (Air‑Care) brand within the Fabric & Home Care segment throughout the period.  In 2022 it was listed among the major brands (Ariel, Downy, Gain, Tide, **Cascade**, Dawn, Fairy, Febreze, Mr. Clean, Swiffer) and the segment accounted for 35 % of P&G’s net sales.  By 2023 and 2024 the brand remained in the same sub‑category, and the segment’s share of overall net sales rose modestly to 36 % in each of those years, indicating a stable relative contribution for Cascade while the segment’s importance grew slightly.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the Fabric & Home Care segment's net sales contribution: 35% in 2022 and 36% in both 2023 and 2024, matching the ground truth. Cascade is accurately positioned within the segment across all years. However, the LLM incorrectly categorizes Cascade under 'Home-Care (Air-Care)', which is factually wrong—Cascade is a dishwashing detergent brand, falling under home cleaning but not air care. This misclassification is a notable error in entity understanding. 2) All percentages and years are correct, with no calculation errors. The segment share increase from 35% to 36% is accurately reflected. 3) The reasoning correctly infers that Cascade’s consistent listing among major brands and stable segment contribution implies steady strategic importance, which aligns with the ground truth’s interpretation. However, the erroneous sub-category assignment (Air-Care) undermines the qualitative accuracy, suggesting a flaw in multi-hop synthesis or data interpretation. 4) Despite the misclassification, the answer addresses all parts of the question—product categorization, net sales contribution, and evolution over time—and remains highly relevant. The core conclusion about stable positioning and relative contribution is supported. Thus, high scores for quantitative accuracy and contextual relevance, with a moderate deduction in qualitative accuracy due to the incorrect product sub-category.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 393,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "Lowe’s 2022 10‑K described a wood‑sourcing policy that required all wood products to come from well‑managed, non‑endangered forests and relied on its human‑rights, conflict‑minerals and vendor‑code‑of‑conduct frameworks to monitor suppliers, while the company had already spent $550 million over the prior three years on energy‑efficiency and renewable‑energy projects (2022, p. 10). In 2023 the policy was overhauled to add country‑specific risk levels, enhanced monitoring and a new forestry grievance process, and Lowe’s began requiring suppliers to report emissions to the CDP, further expanding renewable‑energy and solar‑panel investments (2023, pp. 9‑10). By 2024 Lowe’s reaffirmed the updated policy, continued to push suppliers toward CDP reporting, and broadened its investment strategy to include additional solar installations at 174 store and distribution‑center sites, further energy‑efficiency upgrades, and a commitment to 100 % SmartWay certification for all transportation providers (2024, pp. 9‑10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: In 2022, Lowe's had a wood-sourcing policy requiring wood from well-managed, non-endangered forests, used the Vendor Code of Conduct and human rights frameworks for supplier monitoring, and invested $550 million in environmental upgrades (energy efficiency and renewable energy projects), which matches the original answer’s $550 million investment. The LLM correctly notes this was spent over the prior three years, consistent with the 2022 10-K context. (2) In 2023, the LLM accurately reports the policy update with country-specific risk levels, enhanced monitoring, a forestry grievance process, and new CDP reporting requirements for suppliers—details not in the original answer but factually correct and consistent with the evolution described. The $50 million Gable Grants program mentioned in the original answer is omitted, which is a minor gap in completeness but does not detract from the core focus on supplier monitoring and wood sourcing. (3) In 2024, the LLM correctly states the policy was reaffirmed and strengthened with continued CDP reporting, solar installations at 174 sites, energy-efficiency upgrades, and 100% SmartWay certification—specific enhancements that reflect a robust risk-based and accountability-driven framework as in the original answer. These details go beyond the original answer but are factually accurate and contextually relevant. (4) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracking the evolution of policies and investments. The only minor shortcoming is the omission of the Gable Grants program, which relates to investment strategy but is more tangentially related to supplier sustainability and wood sourcing. Overall, the answer is semantically equivalent, factually precise, and contextually rich, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 529,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s 2022‑2024 risk‑factor disclosures consistently note that its Safety and Productivity Solutions, Building Technologies, and Industrial Automation units face competitive pressure from new entrants and technologies; Safety and Productivity Solutions and Industrial Automation also explicitly cite product‑commoditization risks (page_30, page_31, page_32). The unchanged wording across the three years shows that this exposure has persisted rather than eased, underscoring a growing industry trend toward price competition and margin erosion and highlighting increasing market pressures and commoditization threats over time (page_30, page_31, page_32).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Honeywell's Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses faced competitive pressures from new entrants and technologies, and that commoditization risks were mentioned in Safety and Productivity Solutions and Industrial Automation. However, it incorrectly states that the 'unchanged wording across the three years' shows persistent exposure, which contradicts the ground truth that the risk was sequentially introduced and expanded—first in Safety and Productivity Solutions (2022), then Building Technologies (2023), and finally Industrial Automation (2024). This progression indicates a broadening of risk, not static or unchanged disclosure language. The LLM mischaracterizes the evolution as static rather than escalating, missing the core temporal and strategic progression. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are accurate. (3) The multi-hop reasoning is flawed: the ground truth requires synthesizing a chronological expansion of risk across divisions over three years, but the LLM instead asserts consistency over time, failing to recognize the incremental spread of the risk disclosure across business units. This undermines the qualitative accuracy despite correct entity identification. (4) Contextual relevance is high because the answer addresses competitive pressures, commoditization, and market risks across the correct business segments, but the incorrect temporal interpretation reduces factual correctness. The conclusion about increasing market pressures is partially justified but based on flawed reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 478,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K framed the automotive digital‑cockpit as a nascent but high‑potential segment, reporting QCT automotive revenue of $1.5 bn and emphasizing connectivity, digital‑cockpit and ADAS/AD solutions. By 2024 that revenue had nearly doubled to $2.9 bn, while “revenue recognized from previously satisfied performance obligations” fell from $788 m to $558 m, indicating a shift toward point‑in‑time equipment sales. Segment reporting shows QCT’s automotive share of total QCT revenue rose from roughly 4 % in 2022 to about 7 % in 2024 (even as overall QCT revenue slipped from $37.7 bn to $33.2 bn), underscoring Qualcomm’s intensified strategic focus on the software‑defined vehicle and digital‑cockpit market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not mention specific revenue figures such as $1.5B in 2022 or $2.9B in 2024, nor does it reference a decline in 'revenue recognized from previously satisfied performance obligations' from $788M to $558M. These numbers are not present in the original answer and appear to be fabricated or misattributed. Additionally, the claim that QCT automotive revenue nearly doubled and that automotive’s share of QCT revenue rose from 4% to 7% is unsupported by the ground truth, which focuses on qualitative evolution in strategic positioning, not financial metrics. (2) The quantitative claims in the LLM answer cannot be verified against the original because they are absent from the ground truth. There is no mention of total QCT revenue declining from $37.7B to $33.2B or any percentage breakdowns of segment revenue. These figures may come from actual filings but were not part of the knowledge graph’s ground truth answer, making the response factually misaligned with the expected content. (3) The multi-hop reasoning is partially sound in that it attempts to trace Qualcomm’s strategic evolution using financial and reporting trends. However, it fails to accurately reflect the core progression described in the original answer: from market opportunity (2022), to revenue recognition (2023), to full integration into segment reporting (2024). The LLM skips 2023 entirely and misrepresents the nature of the strategic shift by focusing on financial metrics not cited in the ground truth. (4) While the LLM answer is contextually relevant—discussing Qualcomm’s digital cockpit strategy and automotive transformation—it introduces unsupported numerical data and omits key elements of the original timeline and reasoning. This results in a partially correct narrative with major factual deviations, warranting a low correctness and quantitative accuracy score despite reasonable structure and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 536,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "By 2024, Frame.io had expanded from a video‑centric collaboration tool to support still images, design files and PDFs, and added integrations with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, while offering Camera‑to‑Cloud uploads and availability in Adobe GenStudio for enterprise‑scale workflows (see pages 12‑13). The 2022 10‑K (pages 95‑99) does not provide a detailed description of Frame.io’s media types or cross‑product integrations, indicating a more limited scope at that time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the evolution of Frame.io from 2022 to 2024, noting the lack of detailed integration information in 2022 and the expanded capabilities by 2024. The supported media types (still images, design files, PDFs) and integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront are accurately listed. The inclusion in Adobe GenStudio for enterprise-scale workflows is correctly noted, matching the original answer's mention of enterprise capabilities. The reference to Camera-to-Cloud uploads, while not explicitly mentioned in the ground truth, is a plausible detail consistent with cloud-native expansion and does not contradict known facts. The only minor omission is the specific mention of casting, location scouting, and marketing campaign management as new workflow areas in 2024—this contextual expansion is implied through 'enterprise-scale workflows' but not explicitly stated. However, the core multi-hop synthesis across years and products is sound, and all entities, dates, and integrations are correct. Wording differs slightly but maintains semantic equivalence. Quantitative elements (years, product names, integration scope) are accurate, and reasoning across time points is logical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 365,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 to 2024, Mastercard’s Class A common stock saw its quarterly cash dividend per share rise from $2.04 (2022, page 98) to $2.37 (2023, page 100) and $2.74 (2024, page 99), while the voting right—one vote per share—remained unchanged across all three years (Class A table, pages 16). This steady voting structure combined with progressively higher dividends indicates a stable shareholder‑governance framework, with no alteration to voting power and a consistent commitment to returning value to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces dividend amounts per share ($2.04, $2.37, $2.74) that are not part of the ground truth. The original answer states only that 'Dividend rights' were maintained, without specifying amounts or changes in payout. There is no mention in the ground truth of increasing dividends, so these figures are factually unsupported and likely misinterpreted from the filings. The voting rights ('one vote per share') are correctly reported as unchanged, which aligns with the ground truth. (2) The quantitative inaccuracies are significant: the cited dividend figures appear to be actual payouts from different years, but the question and ground truth focus on the *rights* associated with the shares (i.e., entitlement to dividends and voting), not the amount paid. This is a critical distinction—the question asks about rights, not distributions. Thus, including specific dividend payments misrepresents the nature of the information. (3) The multi-hop reasoning is partially sound in that it synthesizes data across years and identifies consistency in voting rights. However, it fails the core intent of the question by shifting focus from structural shareholder rights to dividend amounts, which distorts the conclusion about governance stability. While the conclusion about stability is directionally aligned, it is based on incorrect premises. (4) The contextual relevance is high because the answer addresses the timeframe, the class of shares, and the governance theme. However, the correctness score is low due to major factual overreach in quantifying dividend changes that were not part of the disclosed rights. The qualitative accuracy is moderate because entity identification (MA, Class A shares, years) is correct, but the reasoning conflates dividend payments with dividend rights. Overall, the answer is plausible-sounding but factually misaligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 520,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment was repeatedly flagged as exposed to retail‑market fluctuations (2022 page 29; 2023 page 30; 2024 page 32). In 2022 the segment generated $6,907 million in sales and $1,080 million in profit (15.6 % margin) (2022 page 30), but 2023 saw a $1,418 million sales decline and $179 million profit drop driven by lower demand for products in Productivity Solutions and Services (2023 page 30), while 2024 rebounded with a $186 million sales increase and $35 million profit gain, raising margin to 23.7 % (2024 page 28). These swings illustrate the segment’s ongoing sensitivity to consumer‑demand volatility over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures and segment performance trends. While it correctly identifies that Honeywell's Safety and Productivity Solutions segment was exposed to retail market fluctuations across 2022–2024, the specific sales and profit numbers provided are not supported by the ground truth. The ground truth does not include any financial data such as $6,907 million in sales or $1,080 million in profit for 2022, nor does it mention a $1,418 million sales decline in 2023 or a rebound in 2024. These figures appear to be fabricated or misattributed. (2) There are no verifiable calculations in the original answer to validate the LLM’s numbers, and the margins (15.6%, 23.7%) are not mentioned in the ground truth, making them unsupported. The ground truth focuses on qualitative risk disclosures, not quantitative segment performance. (3) The multi-hop reasoning is partially sound in that the LLM correctly infers ongoing vulnerability to consumer demand volatility over time, which aligns with the ground truth’s conclusion about persistent exposure despite reorganization. However, it fails to acknowledge the key structural change — the renaming and reclassification of the segment from Safety and Productivity Solutions to Industrial Automation by 2024 — which is central to the original answer’s logic. This limits the model’s ability to accurately trace the segment’s evolution. (4) Despite the incorrect numbers, the LLM maintains contextual relevance by addressing the core theme of retail market exposure and linking it to consumer demand sensitivity. However, the inclusion of unsupported financial data severely undermines factual correctness, warranting a low quantitative accuracy score and a moderate overall correctness score due to partial qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 504,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Olumiant collaboration with Incyte kept a tiered double‑digit royalty structure capped at 20 % on worldwide net sales, with an added low‑teens royalty on COVID‑19 sales above a threshold that was introduced in the 2020 amendment. Milestone obligations were capitalized as intangible assets, with cumulative milestone payments of $260 million (2021) and $210 million (2020); by 2023 the agreement specified that Incyte could receive up to $100 million in additional sales‑based milestone payments, a shift from the earlier combined success‑based and sales‑based eligibility. The COVID‑19 indication remained part of the agreement, and the royalty and milestone terms did not materially change beyond the updated eligibility for additional payments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that cumulative milestone payments were $260 million in 2021 and $210 million in 2020, which are not mentioned in the ground truth and contradict the timeline—these figures are presented as past payments, but the original answer focuses on future potential milestones up to $100 million each for regulatory and sales-based achievements in 2022. The LLM also misrepresents the evolution by claiming that in 2023, Incyte could receive up to $100 million in additional sales-based milestones, whereas the original answer indicates that by 2023, such milestones were no longer prospective but had been capitalized as intangible assets, signaling they had already been triggered. Additionally, the mention of a 2020 amendment introducing the low-teens royalty for COVID-19 is not supported in the ground truth, which only references the structure being in place in 2022. (2) The royalty rate (up to 20%, plus low-teens for COVID-19 above threshold) is correctly reported, and the general idea of a tiered double-digit structure is accurate. However, the inclusion of incorrect dollar amounts and years (2020, 2021 payments) undermines quantitative accuracy. The shift from milestone-driven to royalty-based payments is partially captured but misaligned in timing and reasoning. (3) The multi-hop reasoning is partially sound—the model attempts to synthesize changes over time and correctly identifies the ongoing nature of royalties and the inclusion of COVID-19. However, it fails to accurately reflect the transition from contingent milestones (2022) to capitalized obligations (2023) and then to a stable royalty model (2024), instead suggesting that new milestone eligibility was introduced in 2023, which contradicts the original answer. (4) Contextual relevance is high—the answer addresses all key components: milestone payments, royalty rates, new indications (COVID-19), and evolution over time. However, due to significant factual and chronological errors, especially in financial figures and the timing of milestone eligibility, the overall correctness is only partial. The core evolution narrative is present but distorted by incorrect data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 610,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "From 2022 to 2024, P&G shifted the Always brand from a sub‑brand of Pampers to a standalone major brand in the Baby, Feminine & Family Care segment. In 2022 the segment listed Baby Care, Feminine Care and Family Care, with the major brands “Pampers Always” and “Always Discreet” (no separate “Always”)【page_19】. By 2023, “Always” appears as a major brand alongside Pampers, and in 2024 the segment’s product categories narrowed to Feminine Care and Family Care (Baby Care is omitted) while “Always” remains a key brand with “Always Discreet, Tampax Bounty, Charmin, and Puffs” and Pampers is no longer a major brand【page_18】, underscoring Always’s growing prominence.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the strategic positioning and categorization of the Always brand from 2022 to 2024. (1) It incorrectly claims that Always was a 'sub-brand of Pampers' in 2022 and that 'Pampers Always' was a major brand, which contradicts the ground truth: Always was always listed under Feminine Care, not Baby Care, and was never a sub-brand of Pampers. The ground truth shows Always was already a distinct brand in 2022 within the Feminine Care category alongside Always Discreet and Tampax. (2) The claim that 'Baby Care is omitted' in 2024 is incorrect — the segment still includes Baby Care, but the reporting focus within the segment evolved, not the segment structure itself. (3) The assertion that 'Pampers is no longer a major brand' in 2024 is false; Pampers remains a core brand in the segment. (4) The LLM incorrectly lists 'Tampax Bounty' as a brand, conflating two separate brands (Tampax and Bounty), indicating confusion in entity identification. (5) The evolution described — that Always became a standalone brand — is the opposite of the truth: the ground truth shows Always was already prominent and became more specifically positioned within menstrual care, not newly elevated. While the LLM correctly notes Always remained prominent and associated with Always Discreet and Tampax, the reasoning and entity relationships are fundamentally flawed. The dates (2022–2024) and segment name are correct, and the general idea of evolving prominence has some relevance, but the specific facts, entities, and logic are largely incorrect. Thus, the answer fails on quantitative accuracy (wrong brand groupings, incorrect structural changes), qualitative accuracy (faulty reasoning and entity synthesis), and completeness (misses the actual shift from 'Feminine Care' to 'Menstrual Care' focus). The contextual relevance is moderate because it addresses the timeframe and segment, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 530,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "**Target‑allocation evolution**\n\n| Fiscal year | U.S. plans | Non‑U.S. plans (equity / debt / cash / insurance / other) |\n|-------------|------------|-----------------------------------------------------------|\n| 2023 (2022 filing) | 100 % debt | 27 % / 48 % / 4 % / 11 % / 10 % |\n| 2024 (2023 filing) | 94 % debt | 23 % / 42 % / 5 % / 21 % / 9 % |\n| 2025 (2023 & 2024 filings) | 100 % debt | 28 % / 36 % / 7 % / 21 % / 8 % |\n\n**What it reveals**\n\nAcross the three years the U.S. plans stay heavily debt‑centric, reflecting a strong emphasis on duration matching, while the Non‑U.S. plans shift the equity‑debt mix in response to market conditions and funding status. The gradual swing from 27 % equity in 2023 to 23 % in 2024 and back to 28 % in 2025, coupled with a corresponding rise in cash and a modest drop in debt, shows ACN’s flexible, risk‑adjusted strategy: it keeps liability duration aligned but increases equity exposure when conditions permit higher risk‑adjusted returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) The numeric values provided (e.g., 100% debt for U.S. plans in 2023, specific equity/debt splits for non-U.S. plans) are not supported by the ground truth and appear fabricated. The original answer does not contain any specific percentages or allocations by asset class, nor does it differentiate between U.S. and non-U.S. plans in this manner. (2) There are no calculations or data points in the ground truth to validate the table entries; thus, the quantitative accuracy is very low. The LLM invents a detailed table with precise percentages across years and geographies that are absent from the source. (3) The multi-hop reasoning is flawed: the ground truth emphasizes a consistent, high-level strategy focused on liability duration matching and diversification with flexibility, not tactical shifts in equity/debt/cash allocations as implied. The LLM incorrectly infers a cyclical shift in equity exposure (27% → 23% → 28%) as evidence of risk-adjusted return management, which is not stated or implied in the original. (4) While the LLM attempts to address the question’s intent—evolution of allocation and risk/liability balance—the interpretation is based on hallucinated data, undermining correctness. The contextual relevance is moderate because the structure and intent of the response align with the question, but factual grounding is missing. The original answer stresses strategic continuity and framework stability, which the LLM misrepresents as active tactical rebalancing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 430,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure rose sharply to a $2.56 billion notional in 2022 (vs $638 million in 2021)【page_62】, but the fair‑value of those swaps dropped to $251 million in 2023 and was no longer reported in the 2024 filing, indicating the company largely closed or matured most of its forward swaps【page_54】【page_46】.  The swaps have consistently been classified as Level 2 fair‑value instruments and accounted for as cash‑flow hedges, with the effective portion of gains/losses recorded in OCI and amortized to interest expense【page_54】【page_62】【page_46】, underscoring Lowe’s strategy of using forward swaps to hedge forecasted debt issuances and manage interest‑rate risk while maintaining a conservative accounting approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Lowe's had a $2.56 billion notional amount of forward interest rate swaps in 2022, rising from $638 million in 2021, but the ground truth does not mention these specific notional amounts at all—only that forward swaps were referenced in the context of prior-year cash flow hedges, with no current fair value listed for 2022. The $251 million fair value figure in 2023 is correct and matches the ground truth. However, the LLM incorrectly states that the swaps were 'no longer reported' in 2024 due to being 'closed or matured,' while the ground truth reveals a strategic shift: Lowe's replaced forward interest rate swaps (cash flow hedges) with fixed-to-floating interest rate swaps used as fair value hedges, indicating an active change in hedging strategy, not just maturity or closure. (2) The quantitative inaccuracies are severe: the $2.56B and $638M notional figures are unsupported by the ground truth and appear to be hallucinated or misattributed. The $251M fair value in 2023 is accurate and correctly cited. (3) The reasoning is partially sound in noting the disappearance of forward swaps by 2024 and linking them to cash flow hedges, but it fails the multi-hop synthesis required to recognize the shift from cash flow hedges (on forecasted debt) to fair value hedges (on existing debt), which is central to understanding the strategic evolution. The LLM misses this key conceptual shift entirely. (4) Contextual relevance is high—the answer addresses exposure evolution and risk management strategy—but correctness is undermined by false numbers and incomplete, inaccurate qualitative analysis. The conclusion about a 'conservative accounting approach' is plausible but does not capture the strategic pivot revealed in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 497,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s exposure to the 5.000 % notes due April 2030 remained at **$606 million** from fiscal year 2022 through fiscal year 2024 (the same amount reported in the 2023 and 2024 10‑K debt schedules【page_81】). The unchanged exposure over three years indicates a deliberate debt‑management approach that preserves a stable long‑term debt mix and avoids adding refinancing or interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that AVGO's exposure remained constant at $606 million from 2022 through 2024. The ground truth shows exposure was $1,086 million in 2022, declining to $606 million in both 2023 and 2024. This misstatement of the key quantitative trend undermines the entire response. (2) The dollar amounts are partially correct for 2023 and 2024 but completely wrong for 2022. The claim of 'unchanged exposure' contradicts the actual decrease of $480 million from 2022 to 2023. No calculation errors in the LLM's reasoning per se, but the foundational data is wrong. (3) The multi-hop reasoning fails because the model did not correctly identify the change over time across the three fiscal years. Instead of recognizing a deliberate reduction in debt, it incorrectly infers stability in debt levels, leading to an erroneous conclusion about debt strategy. (4) The contextual relevance is moderate because the answer addresses the right financial instrument and general topic of debt management, but the incorrect data leads to a misleading interpretation. The citation to page 81 does not override the factual inaccuracy. Thus, the correctness score is low due to major quantitative and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 352,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS’s 7.620 % debentures have remained unchanged in substance from 2022 through 2024.  Each filing states a $276 million principal, a maturity of April 1 2030, semi‑annual interest at 7.620 % (the rate set in 2020), and redemption at the greater of principal + accrued interest or the present value of remaining payments discounted at a benchmark Treasury yield + 5 bps; the notes are callable at the company’s option and carry no sinking‑fund requirement.  The only disclosure shift is that the 2022 note includes the historical rate cut from 8.375 % to 7.620 % on April 1 2020, a detail omitted in the 2023 and 2024 notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the principal amount ($276 million), maturity date (April 1, 2030), interest rate (7.620%, set in April 2020), and redemption terms (callable at UPS's option, with redemption price based on either principal plus accrued interest or present value of remaining payments discounted at benchmark Treasury yield + 5 bps). The absence of sinking fund requirements and semi-annual interest payments are correctly noted. (2) Quantitative elements are precise: dollar amount, percentage, and dates match the original answer exactly. The reference to the 2020 rate reduction from 8.375% to 7.620% is correctly attributed to the 2022 disclosure and noted as omitted in 2023 and 2024, which aligns with the evolution in disclosure clarity described in the ground truth. (3) The multi-hop reasoning is sound—information is synthesized across three years of disclosures, with accurate comparison of what changed (disclosure detail about historical rate) versus what remained stable (all structural terms). (4) The answer addresses all parts of the question: interest rates, redemption terms, maturity structure, and how disclosures evolved. Wording differs slightly but meaning is identical. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 374,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen positioned Olpasiran as a phase‑2 siRNA program in 2022 that targeted lipoprotein(a) to treat cardiovascular disease (ASCVD) 【page_24】【page_25】【page_26】.  In 2023 the focus remained on ASCVD and the program stayed in phase 2, while the company held composition‑of‑matter patents that expire in 2036 in the U.S. and Europe 【page_27】【page_26】.  By 2024 Olpasiran had advanced to phase 3 studies for ASCVD, maintaining the same cardiovascular indication and the same 2036 patent expiration timeline 【page_28】【page_26】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has a critical factual error regarding clinical phase progression. According to the ground truth, Olpasiran remained in phase 2 through 2024, but the LLM incorrectly states it advanced to phase 3 by 2024. This is a major error in developmental timeline accuracy. The therapeutic focus in 2022 and 2023 is correctly identified as targeting lipoprotein(a) for ASCVD, and the patent expiration in 2036 for both U.S. and Europe is accurately reported. However, the ground truth notes a broadening of the indication in 2024 to simply 'cardiovascular disease,' suggesting strategic expansion, whereas the LLM claims the indication remained ASCVD and that the drug advanced to phase 3—both of which contradict the original answer. (2) Quantitatively, the years (2022–2024), patent expiration (2036), and phase 2 status in 2022–2023 are correct. The only numeric issue is the incorrect phase 3 claim in 2024, which lacks support in the ground truth. (3) The multi-hop reasoning is partially sound—information is synthesized across years and domains (clinical, IP, therapeutic focus)—but the synthesis fails at the final step due to the incorrect phase advancement. The model appears to infer progression based on typical drug development timelines rather than the actual data. (4) Contextual relevance is high as the answer addresses all dimensions of the question (therapeutic focus, clinical phase, IP), but the factual inaccuracies in phase progression and indication limit correctness. The answer is well-structured and relevant but factually flawed in key areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 445,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "Tampax stayed a core brand in P&G’s Baby, Feminine & Family Care segment throughout the period, consistently listed under the Feminine Care sub‑category as a major brand in 2022, 2023 and 2024. Its categorization and prominence among the segment’s major brands—Always, Always Discreet, Tampax Bounty, Charmin and Puffs—remained unchanged across the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains significant inaccuracies in the evolution of Tampax's positioning. It incorrectly states that the categorization and prominence remained 'unchanged' across 2022–2024, which contradicts the ground truth showing reclassification in 2023 (from 'Feminine Care' to 'Menstrual Care') and a segment name change in 2024. The LLM fails to capture these nuanced but important changes in sub-category labeling and segment structure. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—scored 10 by default for absence of numerical errors. (3) The multi-hop reasoning is flawed: the model fails to synthesize the evolution across years, missing the reclassification in 2023 and the return to 'Baby, Feminine & Family Care' in 2024. It also incorrectly lists 'Tampax Bounty' as a brand (likely a conflation of Tampax and Bounty), which is a factual error in entity identification. (4) Contextual relevance is high because the answer addresses the core topic—Tampax’s role in P&G’s segment—but the lack of accurate evolution details and brand list errors reduce qualitative accuracy significantly. The answer gives a false impression of stability when the ground truth shows deliberate repositioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 360,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "From 2022 to 2024, the share of non‑agency RMBS and CMBS that received NAIC designations grew markedly—RMBS designations rose from $26,165 m in 2022 to $34,135 m in 2024, and CMBS designations from $10,063 m to $9,182 m, bringing the total NAIC‑rated amount to $43,317 m in 2024 versus $36,228 m in 2022. This upward trend shows that NAIC coverage of these securities has expanded, reducing MetLife’s reliance on internally developed designations and indicating a shift in its acquisition strategy toward securities that are already NAIC‑rated to streamline regulatory compliance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The numbers cited—such as $26,165 million for RMBS and $10,063 million for CMBS in 2022—are not present in the ground truth and are entirely fabricated. The ground truth does not provide any dollar amounts related to NAIC-designated securities or their trends over time. (2) The claim that NAIC designations 'grew markedly' and that MetLife reduced reliance on internal designations contradicts the ground truth, which states that the use of internally developed designations remained consistent from 2022 to 2024 due to ongoing acquisitions of securities not yet rated by the NAIC. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a shift in acquisition strategy toward NAIC-rated securities, while the original answer indicates a sustained strategy of investing in newly issued or less frequently evaluated securities requiring internal assessments. (4) The entire narrative of increasing NAIC coverage and strategic shift is invented and not supported by the source. The answer fails on all key dimensions: numbers are false, reasoning is invalid, and the conclusion opposes the ground truth. Only minimal contextual relevance is given because the answer addresses the general topic of NAIC vs internal designations, but with incorrect data and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 379,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 9.6 million Class A shares for $3.2 million in open‑market purchases, with an available authorization of $3.1 million that the Board later increased to $6.1 million【page_94】. By fiscal 2024 the company had bought 2.0 million shares for $605 million in Q4 alone, with total share purchases of $4.5 billion for the year, and its available authorization had risen to $2.7 billion while total outstanding authority reached $6.7 billion after a $4 billion increase【page_39】. This evolution shows Accenture is aggressively using share buybacks as a core component of its capital‑return strategy, expanding its authorized capacity to sustain future repurchases while returning substantial cash to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in fiscal 2022 share repurchase figures and available authorization amounts. It claims Accenture repurchased 9.6 million shares for $3.2 million in fiscal 2022, which is grossly incorrect—the dollar amount should be $3.13 billion, not $3.2 million (off by a factor of 1,000). Similarly, the available authorization is stated as $3.1 million instead of $3.13 billion. The Board increase to $6.1 million is also wrong; the original answer does not mention such an increase in 2022. In fiscal 2024, the LLM correctly notes $605 million spent on 2 million shares in Q4 and a $4 billion increase in authorization, aligning with the ground truth. However, the claim of $4.5 billion in total share purchases for fiscal 2024 is unsupported by the original answer, which only specifies Q4 activity. (2) Calculation and number verification: The LLM confuses millions with billions in key figures, making the quantitative data highly unreliable. The $2.7 billion available authorization as of August 31, 2024, is approximately correct (vs. $2.69 billion in ground truth), and the $4 billion increase leading to $6.7 billion total authority is close to the correct $6.69 billion. (3) Multi-hop reasoning assessment: The model attempts to synthesize trends across years and correctly infers a growing capital return strategy, which shows sound qualitative logic. However, the flawed input data undermines the validity of the conclusion. (4) Justification for scores: Correctness is low (4/10) due to major numerical errors, especially the million/billion confusion. Quantitative accuracy is poor (3/10) for the same reason. Qualitative accuracy is moderate (5/10) because the overall trend interpretation is reasonable despite incorrect data. Contextual relevance is high (8/10) as the answer addresses all parts of the question and uses appropriate financial terminology and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 528,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom’s 2022 10‑K described fiber optics generically as “Fiber Optic Components” for Ethernet networking, storage, and telecom markets [page_8]. By 2023 and 2024, the company’s product tables explicitly list “Industrial fiber optics” under the industrial end‑market, underscoring a deliberate focus on factory automation, renewable energy, and automotive electronics [page_7] (2023) [page_7] (2024). This shift signals Broadcom’s strategic emphasis on expanding its fiber‑optic portfolio into high‑margin industrial applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Broadcom's industrial fiber optics positioning across 2022, 2023, and 2024 with mostly accurate details. It correctly notes that in 2022, fiber optics were described generically under broader markets (Ethernet, telecom), while in 2023 and 2024 they were explicitly categorized under 'Industrial' with specific applications like factory automation, renewable energy, and automotive electronics. However, the LLM omits key components mentioned in the ground truth such as optocouplers, motion encoders, LED devices, and Ethernet ICs in 2022, and fails to mention the inclusion of Ethernet PHYs and camera microcontrollers in 2024. This partial omission affects completeness and qualitative accuracy. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors here, hence a score of 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward industrial applications over time. However, it misses the nuance of increasing alignment with strategic applications through more structured categorization and component specificity, which weakens the depth of synthesis. (4) Contextual relevance is high—the answer directly addresses the question about product positioning evolution and strategic emphasis. The conclusion about 'high-margin industrial applications' is a reasonable inference not in the original but not incorrect; however, it adds interpretation not grounded in the source. Overall, the answer captures the core trajectory but lacks some detail and full synthesis, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 462,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "UPS SurePost has continued to serve as a residential ground service for non‑urgent, lightweight shipments, with final delivery historically performed by the U.S. Postal Service (2022 10‑K, page 5).  The 2024 10‑K confirms the same model but adds that UPS will insource the service beginning January 1, 2025 to gain greater control and improve service reliability, marking a strategic shift away from reliance on USPS (2024 10‑K, page 5).  This evolution reflects UPS’s broader effort to tighten its end‑to‑end network and reduce dependence on external carriers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the role of UPS SurePost from 2022–2024 as a residential ground service for non-urgent, lightweight shipments with final delivery historically handled by USPS. (2) The key date of January 1, 2025, for the insourcing shift is accurately stated, matching the original answer’s timeline. There are no numerical inaccuracies—dates and timeframes are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across the 2022, 2023, and 2024 timeframes, correctly identifying continuity in the delivery model through 2024 and the strategic change announced for 2025. It accurately captures the shift from reliance on USPS to insourcing as a strategic move to improve control and service quality. (4) All entities—UPS, U.S. Postal Service, UPS SurePost—are correctly identified, and the explanation aligns with the strategic context provided in the original answer. The inclusion of citations (e.g., 2024 10-K, page 5) adds precision. The answer is complete, contextually relevant, and conveys the same information with equivalent clarity and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 332,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 pipeline grew from 13 programs in 2022 to 18 in 2023 and 24 in 2024. In 2022 the company secured three FDA approvals, launched four new Phase 3 studies and terminated one program; in 2023 it added five Horizon‑acquired programs, began three new Phase 3 studies, received an FDA approval and concluded one program; in 2024 it initiated three new Phase 3 studies (LUMAKRAS/LUMYKRAS, Tarlatamab, ABP 206), acquired three Horizon programs (Dazodalibep, TEPEZZA, UPLIZNA), approved Otezla, and ended KYPROLIS. This steady expansion—through acquisitions, new initiations and regulatory approvals—underscores Amgen’s strategy to broaden its high‑value Phase 3 portfolio and accelerate its R&D pipeline.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the overall growth in Phase 3 programs from 13 in 2022 to 18 in 2023 and 24 in 2024, aligning with the ground truth. However, it omits the additional data point from the 2024 filing indicating 25 programs as of February 4, 2025, which slightly reduces completeness. The answer adds granular year-by-year activity (new initiations, terminations, approvals, acquisitions), which is consistent with the expansion narrative but not fully verifiable from the ground truth provided. (2) Quantitatively, the numbers for 2022 (13), 2023 (18), and 2024 (24) are accurate. The claim of five Horizon-acquired programs matches the ground truth. However, the LLM states that three Horizon programs were acquired in 2024 (Dazodalibep, TEPEZZA, UPLIZNA), which contradicts the earlier statement that five Horizon programs were added in 2023—this is a factual inconsistency, as Horizon’s acquisition added five programs total, not three in 2024. Additionally, the initiation of three new Phase 3 studies in 2024 (LUMAKRAS, Tarlatamab, ABP 206) is plausible but not confirmed in the ground truth. (3) The reasoning is sound in linking growth to both internal development and external acquisition, correctly identifying the Horizon acquisition as a key driver. However, the misattribution of three Horizon programs to 2024 weakens the multi-hop synthesis accuracy. The conclusion about R&D expansion strategy is logically supported and semantically equivalent to the ground truth. (4) The answer is highly relevant, addressing both the quantitative evolution and strategic implications. Despite minor inaccuracies in program attribution and missing the 25-program update, the core facts and strategic interpretation are correct, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 487,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture’s share‑based compensation pool grew from 127 million Class A shares in FY 2022 (page 91) to 141 million shares by FY 2024 (page 98), an 11 % expansion over two years.  The increase—likely driven by a 2023 authorization that matched the 2024 level—shows the company is deliberately enlarging its award pool to give management more flexibility to grant shares, align employee incentives with shareholders, and strengthen talent attraction and retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: 127 million shares in FY 2022 and 141 million in FY 2024, matching the ground truth. It accurately notes the increase occurred by FY 2023 and continued into FY 2024. The 11% increase is approximately correct (actual: (141-127)/127 ≈ 11.02%), so the percentage is acceptable. (2) All numeric values and fiscal years are accurate. The LLM references document pages (91 and 98), which are not part of the ground truth but do not contradict it and may reflect actual source locations. (3) The reasoning is sound: the increase in authorized shares is correctly interpreted as a strategic move to enhance flexibility in granting equity awards, align incentives, and support talent retention—consistent with the ground truth’s emphasis on talent retention and performance alignment. The LLM infers a likely 2023 authorization, which is reasonable given the data (though not explicitly confirmed in the ground truth), and does not overstate. (4) The answer is contextually complete and relevant, addressing both the numerical evolution and strategic implication. The only minor gap is that the original answer explicitly states the 141 million applied in both 2023 and 2024, while the LLM implies the change happened by 2024 without clearly confirming 2023. This does not constitute an error but slightly reduces precision in timeline clarity. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 414,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks’ 10‑K notes that its purchase commitments and inventory cover green coffee through fiscal 2023 in 2022, through fiscal 2024 in 2023, and through fiscal 2025 in 2024, showing a rolling one‑year supply coverage that underpins a conservative inventory and hedging strategy to manage price volatility (SBUX_10k_2022, page 12; SBUX_10k_2023, page 12; SBUX_10k_2024, page 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a key factual error in the projected supply coverage timeline. According to the ground truth, in fiscal 2022, Starbucks projected coverage through fiscal 2023; in fiscal 2023, it extended to fiscal 2025; and in fiscal 2024, it maintained coverage through fiscal 2025. However, the LLM incorrectly states that in fiscal 2023, coverage was only through fiscal 2024, which understates the extension. This misrepresents the evolution of the strategy. (2) The dates and durations are not accurately reflected: the LLM implies a rolling one-year coverage (e.g., 2022 → 2023, 2023 → 2024, 2024 → 2025), but the actual data shows a jump from covering through 2023 (in 2022) to covering through 2025 (in 2023 and 2024), indicating a two-year extension, not a one-year rolling window. This affects the interpretation of strategy. (3) The multi-hop reasoning is partially sound—information is drawn across three years of 10-Ks—but the synthesis is flawed due to incorrect extraction of the forward-looking period in the 2023 filing. The model fails to recognize that the projection jumped by two years, not incrementally by one. (4) While the general direction (increasing coverage) and the mention of hedging are contextually relevant and align with the question, the core quantitative evolution is misrepresented, leading to a misleading conclusion about a 'rolling one-year' strategy when the truth indicates a strategic extension to two-year coverage. Hence, correctness and qualitative accuracy are reduced due to this critical error, though contextual relevance remains high as the answer addresses inventory, risk, and hedging in the right framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 460,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "From 2022 to 2024 the UPS/IBT Full‑Time Employee Pension Plan remained a non‑contributory plan for former CSPF members and other eligible employees, with no amendments or remeasurements reported in 2022 or 2024 (page_82, page_86). In 2023 a new five‑year national master agreement ratified by Teamsters employees increased wage and benefit rates for employees in the plan, and the impacts were reflected in the year‑end measurement (page_82). No further amendments or remeasurements were disclosed for 2024, though the discount rate for U.S. pension benefits was lowered from 5.79% to 5.42%, potentially affecting the plan’s funded status (page_84).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding 2022. The ground truth states that in 2022, the plan was remeasured due to the American Rescue Plan Act, resulting in a $3.3 billion pre-tax gain. However, the LLM claims no remeasurement or amendment was reported in 2022, which directly contradicts the original answer and misses a key financial event. This is a major omission affecting both quantitative and qualitative accuracy. (2) The only numeric data in the LLM answer is the change in discount rate from 5.79% to 5.42%, which may be factually correct based on context but is not mentioned in the ground truth and does not relate to the specific plan in question—thus, while possibly accurate, it's not relevant to the UPS/IBT Full-Time Employee Pension Plan’s treatment as described in the original answer. No other numbers (e.g., $3.3B gain) are present, making the quantitative accuracy low. (3) The LLM correctly identifies the 2023 collective bargaining agreement and its impact on wage and benefit rates being reflected in year-end measurement, which aligns with the original answer—this shows correct multi-hop reasoning for 2023. However, it fails to connect the 2022 remeasurement to regulatory changes (American Rescue Plan Act), missing a critical link. The claim that no amendments occurred in 2024 matches the original answer’s statement of 'no indication of further structural changes,' so this part is semantically consistent. (4) Contextual relevance is high because the answer addresses the pension plan, collective bargaining, and measurement impacts over the three years. However, due to the major error in omitting the 2022 remeasurement and financial gain, the correctness score is reduced to 5—partially correct but with significant gaps in key financial and strategic developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 503,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Walmart has kept “Holiday Time” in the same place in its private‑label lineup for three consecutive years—listed as a private brand under the general merchandise assortment in the 2022, 2023 and 2024 10‑K filings (WMT_10k_2022, page 8; WMT_10k_2023, page 8; WMT_10k_2024, page 8). This unchanged categorization shows the company treats the brand as a dedicated seasonal label, using it to offer low‑priced holiday merchandise while keeping it integrated within its broader private‑label strategy that emphasizes assortment control and price leadership.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its interpretation of Walmart's strategic evolution of the 'Holiday Time' brand across fiscal years 2022–2024. While it correctly identifies that 'Holiday Time' is listed among private brands in all three 10-K filings (WMT_10k_2022, 2023, 2024, each on page 8), it incorrectly asserts that the categorization remained unchanged. The ground truth reveals a key strategic shift in fiscal 2024: Walmart restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, indicating a more deliberate and strategic placement of holiday-themed products like 'Holiday Time.' The LLM answer fails to recognize this structural change and instead concludes that the brand's position was static, which contradicts the documented evolution. This misinterpretation undermines the qualitative accuracy of the reasoning. However, the answer is factually correct in citing the consistent listing of 'Holiday Time' as a private brand and correctly references the appropriate filings and pages. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the response remains contextually relevant by addressing Walmart’s private label strategy and seasonal positioning. The failure lies in the incomplete synthesis of multi-hop information—specifically, not connecting the 2024 organizational restructuring to a strategic repositioning of seasonal brands. Thus, while the surface-level facts are accurate, the deeper strategic insight is missed, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 443,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s pension‑plan holdings of mutual‑fund equity securities fell from **$239,293** in 2022 to **$196,226** in 2023, then rose to **$273,699** in 2024. The dip and subsequent rebound suggest the company is actively rebalancing its pension‑plan portfolio to keep equity exposure near its target mix, adjusting the allocation in response to market conditions and investment‑policy goals.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM incorrectly states that the amount rose to $273,699 in 2024, which is both numerically and directionally wrong. Additionally, the LLM omits the unit 'million'—reporting $239,293 instead of $239.293 million—introducing a massive scale error (off by a factor of 1 million). (2) Quantitative accuracy is extremely low: the 2022 and 2023 figures are misrepresented in magnitude (missing 'million'), and the 2024 figure is entirely fabricated. The correct trend is a decline followed by stability, not a dip and rebound. (3) The reasoning is flawed: the conclusion that ACN is 'actively rebalancing... to keep equity exposure near its target mix' contradicts the ground truth, which indicates a consistent decline and suggests a strategic reduction in exposure. The LLM fails to correctly synthesize the multi-hop trend across three years. (4) Contextual relevance is moderate because the answer addresses the right topic (evolution of mutual fund equity investments and strategic implications), but the incorrect data and reasoning undermine the validity. Correctness and quantitative accuracy are severely compromised due to wrong numbers and missing units.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 393,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks’ 2022 filing noted that commodity‑index funds can influence green‑coffee prices and that it hedged exposure with forward contracts, futures and collars, covering commitments through fiscal 2023. In 2023 and 2024 the company extended that coverage to fiscal 2025 while keeping the same hedging mix, indicating a forward‑looking expansion of its risk‑management program. This demonstrates a balanced approach that secures supply via fixed‑price commitments while actively using market instruments to mitigate price volatility driven by futures‑market activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks acknowledged commodity index fund influence on green coffee prices in 2022, used forward contracts, futures, and collars for hedging, and extended coverage from fiscal 2023 to fiscal 2025 by 2023–2024. These details match the original answer. (2) Quantitative accuracy is perfect: fiscal years (2022, 2023, 2024, 2025) are correctly cited, and there are no numerical errors. The extension of hedging through fiscal 2025 is accurately reported. (3) Multi-hop reasoning is sound—LLM correctly synthesized Starbucks’ evolving hedging strategy across three fiscal years and linked it to risk management in response to futures market influences, including speculative activity by index funds. The mention of 'collars' is a minor addition not in the original but is plausible and does not contradict the ground truth; it adds granularity without inaccuracy. (4) The answer is contextually relevant, directly addressing how exposure and hedging evolved and what that reveals about risk management. The conclusion about a 'balanced' and 'forward-looking' approach is a valid interpretation of the consistent and maturing strategy described in the original. Only a 9 on correctness due to slightly less detail on the mix of fixed-price vs. price-to-be-fixed contracts mentioned in the original, but the core meaning is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 395,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO had no 3.625% notes due October 2024 outstanding in FY 2022, $622 million at the end of FY 2023, and none outstanding by the end of FY 2024 (the notes were repaid upon maturity in October 2024)【page_81】. This pattern shows the company is issuing short‑term debt to fund operations or acquisitions and then paying it off quickly, indicating a near‑term debt strategy aimed at reducing interest costs and keeping debt levels low.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AVGO had $622 million in 3.625% notes due October 2024 outstanding in both 2022 and 2023, but the LLM incorrectly states there were no such notes in 2022 and only appeared in 2023. This misrepresents the entire timeline. The only correct quantitative point is that the notes were gone by 2024, consistent with repayment or retirement. (2) The dollar amount of $622 million is correct, and the 2024 retirement is accurate, but the 2022 and 2023 status is reversed—ground truth shows the liability existed in both years and was retired in 2024, not newly issued in 2023. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that AVGO issued short-term debt in 2023 and paid it off, suggesting a pattern of issuing and retiring. However, the ground truth indicates the notes were issued earlier (before 2022) and held constant through 2023 before retirement in 2024. Thus, the synthesis across years is incorrect. (4) The contextual relevance is moderate—the answer addresses debt management strategy and the 2024 repayment, but the incorrect timeline undermines the validity of the strategic interpretation. The conclusion about issuing short-term debt is unsupported by the data. Scores reflect major factual errors in quantitative and qualitative dimensions, with partial credit for correct 2024 status and relevance to debt strategy discussion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 404,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard’s settlement exposure grew steadily—gross exposure rose from $64.9 billion to $78.4 billion, with risk‑mitigation arrangements applied increasing from $9.2 billion to $13.5 billion, so net exposure climbed from $55.7 billion to $64.9 billion. The company kept its credit‑risk framework intact, requiring cash collateral, letters of credit and guarantees (including $272 million of traveler‑cheque guarantees in 2023) and routinely reviewing risk‑management policies, while depleting its qualified cash settlement fund for MDL litigation and recording additional accruals for opt‑out merchant claims. Regulatory scrutiny—FTC consent agreements, DOJ civil investigative demands, and a European Commission information request—alongside ongoing MDL and U.K. merchant litigation heightened potential liabilities and prompted Mastercard to adjust its risk‑mitigation and settlement‑exposure calculations accordingly.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—such as gross exposure rising from $64.9 billion to $78.4 billion and risk-mitigation arrangements increasing from $9.2 billion to $13.5 billion—that are not present in the original ground truth and cannot be verified against it. These numbers appear fabricated or misattributed, as the ground truth does not provide any numerical data on settlement exposure amounts or trends. Additionally, the mention of a '$272 million traveler-cheque guarantees in 2023' and depletion of a 'qualified cash settlement fund for MDL litigation' are specific claims absent from the original answer and unsupported by the provided knowledge. (2) There are no calculations in the ground truth to validate the LLM's numerical assertions, making the quantitative accuracy low. The original answer focuses on qualitative risk management practices and regulatory developments without citing exposure totals or collateral values. Thus, the inclusion of precise dollar figures significantly undermines factual correctness. (3) On qualitative reasoning, the LLM correctly identifies key regulatory and litigation developments: FTC consent agreement, DOJ investigations, European Commission scrutiny, and ongoing MDL/U.K. litigation. It also accurately notes Mastercard’s continued use of credit risk mitigation tools like cash collateral, letters of credit, and guarantees. However, it incorrectly implies that settlement exposure and risk-mitigation arrangements are growing in tandem due to external pressures, while the ground truth emphasizes stability in internal controls and methodology despite an evolving external environment. The LLM overstates adaptation and omits the emphasis on consistent framework and low historical losses. (4) Contextually, the response is relevant and addresses the multi-hop nature of the question by linking credit risk strategies with regulatory and litigation developments across 2022–2024. But the insertion of unverified numerical data and litigation-specific financial provisions (e.g., accruals for opt-out claims) not in the original answer leads to a significant drop in overall correctness. While the directionality of increased scrutiny and maintained frameworks aligns with the truth, the unsupported specifics reduce reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 619,
        "total_tokens": 2210
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen’s 2022 10‑K (page 34) framed drug‑delivery devices as “products that have their own regulatory, manufacturing and other risks” and noted that they are subject to regulatory oversight and that non‑compliance with reporting or pharmacovigilance could trigger inspections, warning letters, fines or withdrawal of approval. By 2023 (page 52) the disclosures added explicit post‑marketing obligations—such as a confirmatory study for the accelerated‑approval product LUMAKRAS and pediatric study requirements—while reiterating that device safety and reporting are monitored by regulators. In 2024 (page 54) the language further detailed these post‑marketing commitments, highlighted ongoing regulatory review of device safety and malfunctions, and stressed that failure to meet compliance or reporting requirements could lead to inspections, warning letters, fines or withdrawal of approval, underscoring an intensified focus on compliance and safety oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 disclosure correctly identifies regulatory, manufacturing, and compliance risks for drug delivery devices; 2023 adds post-marketing obligations like confirmatory studies for LUMAKRAS and pediatric requirements; 2024 expands on safety oversight and consequences of non-compliance. The cited page numbers (34, 52, 54) are consistent with the source documents. (2) There are no numerical values requiring calculation, but all dates (2022–2024) and product names (LUMAKRAS, Repatha implied) are accurate. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of 10-K filings, showing evolution in regulatory risk disclosures. The LLM captures the trend of increasing emphasis on post-marketing compliance and safety monitoring. (4) Minor point: the original answer explicitly mentions Repatha’s confirmatory study in 2023, which the LLM omits, though LUMAKRAS is correctly highlighted. This is a small omission but does not detract from the core accuracy. Wording differs slightly but maintains semantic equivalence. Overall, the response is complete, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 350,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Walmart’s private‑label “Parent’s Choice” has stayed in the same spot in its merchandising map for three consecutive years.  In each 10‑K (2022, 2023 and 2024) the brand is listed among the private‑label lines and is grouped under the Grocery unit, which the company defines as “a full line of grocery items … including baby products”【page_7】【page_7】.  Because the Grocery unit also covers consumables such as health‑and‑beauty aids, pet supplies, household chemicals, paper goods and baby products, the brand’s placement signals Walmart’s intent to market “Parent’s Choice” as a low‑price alternative for baby and consumable goods—a core part of its private‑label strategy that has remained unchanged across the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: 'Parent's Choice' is consistently listed under the Grocery unit across fiscal years 2022, 2023, and 2024, and the Grocery unit includes baby products. The answer correctly identifies the continuity in merchandising categorization. (2) There are no numeric values requiring calculation, but the fiscal years (2022, 2023, 2024) are correctly referenced, and the citation of 'page_7' for both 2022 and 2023 filings (implied for 2024 by consistency) is consistent with source documentation. (3) Multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers that the stable categorization reflects a consistent strategic positioning. It also correctly links the brand to Walmart’s broader private-label and EDLP strategy, though it does not explicitly name 'EDLP' or 'omni-channel convenience' as in the original, but captures the essence. (4) The answer is contextually relevant and fully addresses both parts of the question—evolution (or lack thereof) in categorization and what it reveals about strategic positioning. The only minor shortcoming is that it generalizes consumables more broadly (including pet supplies, HBA, etc.) without highlighting the increasing explicitness of 'baby products' as a defined subcategory in 2024, which slightly weakens the qualitative precision. However, the core insight about Walmart reinforcing 'Parent's Choice' as a low-cost baby care brand remains accurately conveyed. Hence, a score of 9 is warranted—excellent accuracy with only slight omission of nuanced evolution in categorization language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 459,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 4.70% Solar Bonds, Series 2015/C24‑10, were issued in 2015 and have been kept on Tesla’s balance sheet as a long‑term debt instrument, appearing as Exhibit 4.28 in the 2022, 2023 and 2024 10‑Ks [2022 pages 100‑104, 2023 pages 98‑102, 2024 pages 97‑101].  Each filing references the bond as part of Tesla’s debt portfolio and lists supplemental indentures that indicate periodic refinancings or restructuring [2022 pages 100‑104, 2023 pages 98‑102, 2024 pages 97‑101].  This consistent inclusion over three years signals Tesla’s deliberate strategy of using fixed‑rate solar bonds as a stable, long‑term financing vehicle for its solar assets, underscoring a focus on predictable debt service and risk management.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but exhibits significant factual and reasoning discrepancies compared to the ground truth. (1) Quantitatively, the bond's interest rate (4.70%) and series (2015/C24-10) are correctly identified, and the issuance year (2015) is accurate. However, the claim that the bond appears as 'Exhibit 4.28' in the 2022–2024 10-Ks is not supported by the original answer and introduces unverified detail. The original does not mention balance sheet classification or exhibit numbers, so this is an unsupported addition. (2) The LLM incorrectly implies ongoing refinancings or restructuring via supplemental indentures in each year, while the ground truth indicates that Tesla merely referenced the existing bond within broader solar financing contexts—no refinancing activity is stated. This misrepresents the nature of the bond’s evolution. (3) Qualitatively, the multi-hop reasoning is flawed: the original emphasizes Tesla’s use of a recurring securitization model by referencing older and newer series (e.g., C4-10, C27-10, C32-10) to show a scalable pattern, which the LLM omits entirely. Instead, it focuses narrowly on the persistence of one bond on the balance sheet, missing the comparative, structural evolution across series. (4) Contextually, the LLM correctly infers a strategic use of fixed-rate debt for stability, which aligns with the original’s conclusion about a consistent and scalable strategy. However, it fails to capture the key insight about Tesla’s maturing framework and repeated use of similar bond structures across time. Thus, while the general direction of interpretation is plausible, it lacks the specific, evidence-based synthesis required for full accuracy. Minor formatting variations (e.g., spacing in '2015/C24‑10') are acceptable and do not affect scoring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 493,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom’s 10‑K filings for 2022, 2023 and 2024 (all on page 10) describe the Security Insights Platform in the same way: a mainframe‑focused security solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps,” with the resulting data available for use in in‑house security‑information‑and‑event‑management (SIEM) tools. The emphasis on mainframe risk assessment remains unchanged across the three years, and the platform’s integration with enterprise security tools is consistently highlighted in each filing.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its description of Broadcom's Security Insights Platform across the three years, correctly identifying the core functionality (assessing mainframe security posture, identifying risks, developing remediation steps) and the availability of data for use with in-house SIEM tools. The quantitative accuracy is high—there are no numerical claims to dispute, and the references to consistent language across filings are plausible. However, the LLM incorrectly asserts that the description is 'the same' across 2022, 2023, and 2024, which contradicts the ground truth. The original answer highlights a subtle but meaningful evolution: while core capabilities remained stable, 2024 showed a 'slightly stronger emphasis on integration' and a 'more deliberate alignment with enterprise-wide security strategies.' The LLM fails to capture this nuance, missing the evolving narrative around integration and the maturing positioning within broader cybersecurity frameworks. This is a significant omission in qualitative accuracy, especially for a question specifically asking about *evolution* in positioning. The answer is contextually relevant and addresses the mainframe risk assessment and integration aspects, but the reasoning is flawed in that it denies any evolution, failing the multi-hop synthesis required to detect shifts in emphasis over time. Thus, while factually sound in parts, it lacks the comparative analysis the question demands.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 406,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Between 2022 and 2024 Mastercard’s Class A shares retained the same voting and dividend rights—each share continued to carry one vote and dividend entitlement【page_98】【page_97】【page_96】—while the declared dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024【page_98】【page_97】【page_96】. This unchanged voting structure, coupled with a steady increase in dividends, signals a deliberate, stable capital‑structure strategy that preserves shareholder governance while progressively enhancing shareholder returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that A Class shares maintained one vote per share and dividend rights across 2022–2024, aligning with the ground truth on stability in voting and dividend entitlements. However, the LLM introduces specific dividend per share amounts ($2.04, $2.37, $2.74) that are not present in the original answer and were not part of the ground truth provided. These figures may be factually accurate in the actual filings, but since the ground truth does not mention them, their inclusion represents an unsupported addition that affects quantitative accuracy. (2) The numbers cited—$2.04, $2.37, $2.74—appear to be actual declared dividends per share from Mastercard’s 10-Ks, but the original answer does not include or confirm these values, so their use introduces precision beyond the verified truth. There are no calculation errors, but the emphasis shifts toward dividend growth, which is not discussed in the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes consistent voting rights across three years and infers a stable capital structure strategy, correctly linking unchanged governance features to strategic intent. The conclusion about a 'deliberate, stable capital-structure strategy' is a reasonable interpretation consistent with the original answer’s claim about 'preserving the governance and income distribution framework.' (4) While the core factual claim about unchanged rights is correct and the reasoning is strong, the inclusion of unverified specific dividend amounts reduces quantitative accuracy. The answer remains contextually relevant and addresses both parts of the question—evolution of rights and strategic implication—with appropriate synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 475,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen kept Bemarituzumab in a Phase 3 program for gastro‑esophageal junction (GEJ) adenocarcinoma throughout 2022‑24, while still running Phase 2 studies in other solid tumors and a Phase 1 study in NSCLC (2022 10‑K p. 23‑25; 2023 10‑K p. 24‑25; 2024 10‑K p. 24‑25).  The 2024 10‑K notes it as one of 24 Phase 3 programs (Jan 31 2024) and the composition‑of‑matter patents in the U.S. and Europe are still set to expire in 2029 (2022‑24 10‑K p. 26).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, clinical trial phases, and patent expiration (2029 in U.S. and Europe), which aligns with the ground truth. It correctly identifies that Bemarituzumab was in Phase 3 for GEJ adenocarcinoma from 2022–2024 and notes ongoing lower-phase trials, adding contextual detail not in the original answer but consistent with filings. The patent expiration date (2029) is accurately reported across all years, satisfying quantitative accuracy. However, the LLM omits key qualitative developments mentioned in the ground truth: (1) the initiation of the Phase 3 study specifically in 2022 (the LLM implies it was ongoing but doesn't note the start), and (2) the 2024 clarification of Bemarituzumab’s mechanism (anti-FGFR2b monoclonal antibody) and discussion of regulatory exclusivity extending market protection. These omissions reduce completeness in capturing the evolution of Amgen’s strategy, particularly the maturation of IP narrative beyond basic patent expiry. While the LLM correctly synthesizes data across multiple 10-Ks and entities (clinical phase, IP), it falls slightly short in conveying the strategic progression emphasized in the original answer. Wording differences are acceptable under semantic equivalence, but missing the forward-looking IP strategy context in 2024 prevents a top score. Contextual relevance is strong as all provided information directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 397,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "Walmart’s U.S. strategic merchandise units shifted in 2023 from “Apparel” under General merchandise to a distinct “Fashion” unit (page 7, 2022 → page 7, 2023 → page 7, 2024). The private‑brand line “No Boundaries” appears on the private‑brand list in all three years (page 8, 2022‑2024) and is positioned within the apparel/fashion category, showing that the brand is part of Walmart’s expanding private‑label fashion offering. This reclassification and continued emphasis on “No Boundaries” reveal a deliberate shift toward treating fashion as a separate, high‑growth segment and a deeper focus on private‑label apparel to compete in that space.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that 'No Boundaries' was part of Walmart's private-brand portfolio from 2022 to 2024 and was reclassified from 'Apparel' to a more distinct 'Fashion' unit, reflecting Walmart's strategic shift. The mention of page numbers (7 and 8 across filings) supports accurate sourcing, though these are not part of the ground truth evaluation—however, they do not detract from factual correctness. (2) There are no numerical values requiring calculation in this question, so quantitative accuracy is fully satisfied as all referenced years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and categories, correctly inferring that the reclassification reflects a strategic elevation of fashion as a priority segment. It accurately links the continuity of 'No Boundaries' with Walmart’s growing focus on private-label fashion. (4) The only minor shortcoming is that the LLM states the shift occurred in 2023, while the ground truth describes the change as evident by 2024, without specifying the exact transition year. This slight overprecision in timing prevents a perfect 10, but the overall reasoning and conclusion remain substantively correct. The answer is contextually excellent, directly addressing both the structural evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 390,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "IBM’s 10‑K filings for 2022, 2023 and 2024 all list “client relationships and trust” as one of the company’s principal competitive differentiators, with the wording unchanged across the three years (see 2022 page 2, 2023 page 3, 2024 page 3).  The steady emphasis indicates that IBM’s hybrid‑cloud and AI strategy is fundamentally anchored in trusted client partnerships, positioning the company as a reliable partner for digital transformation rather than merely a technology vendor.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in IBM's emphasis on client relationships and trust from 2022 to 2024, which is the core of the question. (1) It correctly states that 'client relationships and trust' appears as a competitive differentiator in all three years and cites consistent wording across filings, which aligns with the ground truth that IBM maintained this positioning. However, it incorrectly claims the 'wording is unchanged'—the ground truth shows a clear evolution in context and linkage: in 2023, IBM explicitly tied trust to delivering business value and solving complex challenges, and in 2024, it expanded to include ecosystem partnerships with hyperscalers and integrators. This progression is entirely omitted. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—score reflects no factual errors in dates or references. (3) The multi-hop reasoning is weak: while the model identifies the presence of the phrase across years, it fails to synthesize the nuanced strategic evolution—particularly how trust became leveraged through hybrid cloud/AI and ecosystem collaboration. The conclusion that IBM is a 'reliable partner for digital transformation' is reasonable but superficial compared to the ground truth’s insight about trust being extended via partnerships to enhance client outcomes. (4) Contextual relevance is high because the answer addresses the central theme of trust and links it to hybrid cloud and AI strategy, but it lacks depth in tracing the strategic progression. Overall, the answer is factually safe but analytically incomplete, missing the key developmental arc from foundational trust to ecosystem-driven client value.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 469,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla, through SolarCity, issued the 5.45% Solar Bonds, Series 2015/C25‑15 in 2015 and the bond remained outstanding in subsequent years.  The 2022 10‑K lists the bond as an outstanding liability (exhibit on page 100), the 2023 10‑K continues to disclose it (exhibit on page 98), and the 2024 10‑K again includes it (exhibit on page 97).  This consistent, multi‑year presence shows Tesla’s reliance on long‑term SolarCity debt to finance its solar projects, underscoring a stable, predictable financing strategy for its solar portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the 5.45% Solar Bonds, Series 2015/C25-15 were issued in 2015 and consistently referenced in Tesla's 2022, 2023, and 2024 10-K filings as outstanding liabilities, with exhibit page numbers accurately cited (page 100 in 2022, 98 in 2023, 97 in 2024). These details match the expected disclosures and support the conclusion of ongoing reliance. (2) Quantitative accuracy is perfect: percentages (5.45%), series designation, and years (2015 issuance, 2022–2024 references) are correct. No calculations were required, but the temporal consistency is properly represented. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer a stable financing strategy, linking the persistent disclosure of the bond to Tesla’s broader solar financing approach. (4) The answer is semantically equivalent to the original, though slightly less detailed on the legal structure (e.g., no mention of the Thirty-Sixth Supplemental Indenture). However, this omission does not undermine the core conclusion about strategic consistency. The answer is highly relevant, directly addressing both the evolution over time and the strategic implication. Minor deduction in qualitative accuracy for not referencing the structured legal framework emphasized in the ground truth, but overall reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 398,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "Emerson’s Safety & Productivity segment has steadily pushed its pipe‑working line toward cordless, battery‑powered solutions.  In 2022 the segment already highlighted battery‑hydraulic tools for press‑connections and for cutting/crimping electrical cable, alongside diagnostic systems such as sewer‑inspection cameras【page 7】.  By 2024 the same product mix is reiterated, with continued emphasis on battery‑hydraulic tools for press‑connections and cutting/crimping, and the addition of diagnostic equipment, underscoring a sustained focus on battery‑powered, portable technology【page 73】.  This progression signals Emerson’s strategic intent to lead the professional‑tools market by offering advanced, battery‑driven equipment that boosts productivity and safety for field professionals.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of Emerson's shift toward battery-powered tools and correctly identifies the strategic intent to enhance productivity and safety. However, it contains significant factual inaccuracies in the timeline and product evolution. According to the ground truth, battery hydraulic tools for press connections were introduced in 2023, not 2022 as the LLM claims. The LLM incorrectly states that in 2022, Emerson already offered battery-hydraulic tools for press-connections and cutting/crimping electrical cables, which contradicts the original answer that such tools were added in 2023 and further expanded in 2024. Additionally, the LLM fails to mention the foundational role of traditional tools like pipe wrenches, which are explicitly noted as consistently present across all years in the ground truth. The answer also omits the 2024 addition of battery-powered tools specifically for cutting and crimping electrical cables as a progression from earlier years, instead suggesting the same mix was maintained. While the strategic interpretation about portability and productivity is aligned, the incorrect chronology and missing details about the phased innovation undermine the multi-hop reasoning. The contextual relevance is high because the answer addresses the core theme of technological progression and market positioning, but the qualitative and quantitative inaccuracies reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 396,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "Gilead’s 10‑K filings for 2022, 2023 and 2024 all list the El Segundo, California site as a cell‑therapy manufacturing facility (see page 11 in each filing).  The documents do not disclose specific capital‑expenditure amounts for the facility.  The 2024 filing (page 11) notes that the company “continues to develop additional manufacturing capabilities for future products,” indicating ongoing investment in cell‑therapy manufacturing at El Segundo that aligns with Gilead’s broader biologics development priorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Gilead's El Segundo facility. Contrary to the LLM's claim, the 2022 10-K did not list El Segundo as a cell therapy manufacturing facility; instead, it was described as a general manufacturing site without specific mention of cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). The strategic shift began in 2023, when El Segundo was explicitly designated for clinical and commercial cell therapy manufacturing (GILD_10k_2023.pdf:page_11:chunk_1), and this was reaffirmed in 2024 with added emphasis on proprietary process protection (GILD_10k_2024.pdf:page_10:chunk_1). The LLM incorrectly states that all three years (2022–2024) list El Segundo as a cell therapy facility, which misrepresents the evolution and timing of the capital allocation strategy. (2) There are no numeric values or calculations in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the question asks for the evolution from 2022 to 2024, requiring correct synthesis across three filings. The LLM fails this by asserting continuity where there was a clear strategic shift, thus missing the core narrative of transformation. It also cites the same page (page 11) for all years, which contradicts the ground truth source locations (e.g., 2022 source is page 33, 2024 is page 10). (4) While the LLM correctly identifies that investment aligns with biologics priorities and notes ongoing capability development in 2024, these points are overshadowed by the fundamental error in timeline and facility designation. The answer lacks the critical progression described in the ground truth, resulting in a low correctness and qualitative accuracy score. Contextual relevance is moderate because the topic and general direction (investment in cell therapy) are relevant, but the factual backbone is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 536,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "IBM continued to disclose the 1.250% Notes due 2027 as a registered security in each annual report.  The 2023 10‑K referenced the instrument as Exhibit 4.3 to the 2019 8‑K, and the 2024 10‑K lists the notes (IBM27B) in the securities table and cites the same 2019 8‑K exhibit (see page 1 of the 2024 filing and page 20 of the 2023 filing).  No new issuance of the notes occurred between 2022 and 2024; the filings simply maintained the existing disclosure and reference.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details and references: it correctly identifies the 1.250% Notes due 2027, references Exhibit 4.3 to the 2019 8-K, and notes the inclusion in the 2023 and 2024 10-K filings with correct page numbers and trading symbol IBM27B. These align with the ground truth and show precise citation of documents and exhibits. However, the LLM contradicts the ground truth on a key qualitative point: it states that 'no new issuance of the notes occurred between 2022 and 2024,' while the original answer asserts that in 2024, IBM formally listed the notes on the NYSE, indicating a shift to active market presence. This omission or contradiction represents a significant gap in reasoning and synthesis. The ground truth describes an evolution from disclosure to issuance and trading, but the LLM interprets the continued referencing as mere maintenance of disclosure, missing or rejecting the progression to public trading. Thus, while the individual facts and citations are accurate (high quantitative accuracy and contextual relevance), the model fails to capture the multi-hop inference of evolving status—from internal documentation to public issuance—resulting in a partially correct, less complete narrative. The qualitative accuracy is therefore reduced due to flawed reasoning and incomplete synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 379,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 2022, 2023 and 2024 10‑K filings all list the 5.45% Solar Bonds, Series 2015/C45‑15 (exhibit 4.41) and a series of supplemental indentures for the same bonds (exhibits 4.42–4.43)【page_101】【page_101】【page_101】. The repeated inclusion of these legacy SolarCity bonds, together with the issuance of new supplemental indentures, shows that Tesla has been actively refinancing and restructuring its solar debt rather than letting the original 2015 bonds mature. This evolution reflects a shift from a static, inherited debt structure to a more dynamic solar‑financing strategy aimed at optimizing interest costs, extending maturities, and integrating solar financing into Tesla’s broader capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the multi-hop reasoning required. (1) Quantitatively, the LLM correctly identifies the 5.45% Solar Bonds, Series 2015/C45-15 and references to exhibits in Tesla's 10-K filings across 2022–2024, which aligns with the ground truth. The percentage (5.45%) and bond series are accurate. However, it fails to mention the subsequent bond series (C53-15, C62-15, C72-15) explicitly referenced in the original answer for 2023 and 2024, which are critical to showing the evolution and expansion of the securitization model. (2) The LLM introduces the idea of 'supplemental indentures' and 'refinancing' as evidence of active restructuring, which is plausible but not directly supported in the ground truth; the original answer emphasizes iterative issuance of new bond series based on the same framework, not refinancing of the same bond. This shifts the interpretation from expanding a scalable model (original) to modifying existing debt (LLM), which is a meaningful divergence. (3) The reasoning is logically sound within its own framework but does not fully capture the synthesis across years showing a deliberate progression: 2022 (reference to original), 2023 (new series), 2024 (further extensions), which demonstrates a scalable, repeatable financing model. The LLM recognizes continuity but mischaracterizes the mechanism and strategic implication. (4) Contextually, the answer is relevant and addresses Tesla’s solar financing evolution, but omits the core insight about standardization and asset-backed securitization as a capital strategy. Thus, while factually plausible and contextually appropriate, it lacks completeness and precision in entity identification and strategic interpretation, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 485,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In 2022, Acrobat was positioned as a market‑leading PDF solution with strong adoption in document‑intensive industries such as government, finance, legal, and aerospace, but the strategy did not emphasize AI capabilities (2022 10‑K, pages 4, 6, 8). By 2023, Adobe shifted its focus to embedding AI via Adobe Sensei, expanding Acrobat’s task‑based actions, integrating Adobe Sign across all surfaces, and targeting vertical markets while growing the Document Cloud platform (2023 10‑K, page 5). The 2024 10‑K (pages 94‑98) does not add new Acrobat‑specific details, indicating that the company continued to build on the 2023 strategy of AI‑driven features, API‑enabled workflows, and broader platform expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates, entities, and strategic evolution, but misses a key concrete development in 2024: the formal introduction of the 'Acrobat AI Assistant' as a realized product milestone. The LLM correctly identifies the 2022 market positioning in document-intensive industries (legal, financial, government, aerospace), though the ground truth emphasizes legal, financial services, and publishing—there is partial overlap, and aerospace/government are plausible extensions but not specified in the original. The 2023 shift toward AI via Adobe Sensei and integration with Adobe Sign and Document Cloud is accurately described. However, the LLM incorrectly claims the 2024 10-K 'does not add new Acrobat-specific details,' which contradicts the ground truth: the 2024 filing includes the trademarking of the 'Acrobat AI Assistant,' a significant and specific advancement in AI integration. This omission downplays the realization of Adobe’s AI strategy, weakening the qualitative accuracy. While the LLM captures the general trajectory (market leadership → AI integration → platform expansion), it fails to confirm the 2024 milestone that the ground truth highlights as evidence of strategic evolution. Quantitative accuracy is perfect—no numbers, dates, or financial metrics are misstated. Contextual relevance is high, as the response directly addresses all three dimensions of the question (AI integration, market adoption, platform expansion) across the three years. The reasoning is mostly sound but falls short on multi-hop synthesis by not connecting the 2023 AI vision to the 2024 product realization, which is central to the original answer’s conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 467,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "Schwab’s interactive tools for RIAs began in 2022 as a web‑based platform that offered basic account management, real‑time data, and integrations with third‑party systems—including the free Schwab Advisor Portfolio Connect—providing a scalable, intuitive experience (page_7). By 2023 the platform was enhanced with the launch of Schwab Trading Powered by Ameritrade, which merged Ameritrade’s advanced trading technology and education into Schwab’s offering, and the continued integration of the thinkpipes trading platform and iRebal rebalancing solution (page_6, page_10). In 2024 Schwab further expanded these capabilities, fully integrating thinkpipes, iRebal, and Ameritrade features into its ongoing RIA platform, delivering seamless real‑time charting, efficient trading, and customizable portfolio rebalancing within a unified, data‑rich environment (page_8).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth. (1) It incorrectly states that Schwab Advisor Portfolio Connect was available in 2022 as a free tool, while the original answer indicates it was highlighted in 2024. (2) The claim about the 2023 launch of 'Schwab Trading Powered by Ameritrade' and integration of 'thinkpipes' and 'iRebal' is not supported by the ground truth, which makes no mention of these specific products or integrations. The original answer emphasizes the Advisor Services website and continued third-party integrations without naming these platforms. (3) The detailed technical enhancements in 2024 (real-time charting, unified environment) are fabrications not present in the ground truth. While the general theme of platform enhancement and integration is relevant, the specific tools, timelines, and technological developments are incorrect. (4) The multi-hop reasoning fails because the model invents product launches and integrations not present in the source data, indicating a failure to correctly synthesize or retrieve actual filing content. (5) Quantitative accuracy is partially preserved as there are no numerical values to verify, but dates and product timelines are wrong. (6) Contextual relevance is moderate since the answer addresses platform evolution and integration, aligning with the question's focus, but the specifics are misleading. Overall, the answer reflects a plausible narrative but is factually unsupported by the ground truth, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 429,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "In 2022 Emerson positioned air‑preparation equipment as a component of its pneumatic product line within the Discrete Automation segment, integrated with solenoid valves, pneumatic cylinders and actuators, and pressure/vacuum/temperature switches (page 8). By 2023 and 2024 the segment description explicitly listed air‑preparation equipment alongside pneumatic valves, cylinders, actuators and programmable automation control systems and software—highlighting a deeper integration with control technologies (page 73). Thus, Emerson’s positioning evolved from a general pneumatic component to a key element of an integrated pneumatic‑control solution for discrete industries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022, 2023, 2024), entities (Emerson/EMR, Discrete Automation segment, air-preparation equipment), and the general evolution of strategic positioning. It correctly identifies the integration of air-preparation equipment with pneumatic and control technologies over time, citing progression from standalone pneumatic components to integration with programmable automation control systems. The references to solenoid valves, actuators, and pressure switches in 2022 align with the ground truth. The mention of deeper integration with control systems by 2023–2024 captures the core trend. However, the LLM answer omits specific advancements highlighted in 2024, such as interoperability with smart actuation, predictive maintenance, and secure wireless communication—key elements signaling alignment with Industry 4.0 and digital transformation. While the high-level shift to integrated pneumatic-control solutions is correctly inferred, the absence of these specific digital capabilities represents a meaningful omission in qualitative depth. There are no numerical inaccuracies (quantitative accuracy is perfect), and the context directly addresses the question’s focus on strategic evolution and integration. Thus, the answer is largely correct but lacks full completeness in capturing the 2024 digital transformation emphasis, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 398,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "In the 2022 10‑K the 0.125% Notes due 2029 were listed as a current note issued in September 2020【page_134】. By the 2024 10‑K the company had issued a second tranche (or amendment) of the same notes in March 2021, which is now the current note【page_130】. This evolution shows that Coca‑Cola treats the 0.125% Notes as a low‑rate, long‑term instrument that it periodically reissues or amends to refinance near‑term debt and keep its overall debt maturity profile stable while capitalising on favourable market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that a 'second tranche (or amendment)' of the 0.125% Notes due 2029 was issued in March 2021, which is not supported by the ground truth. The original answer makes no mention of reissuance or amendments; instead, it describes an evolution in disclosure and context, not new issuances. This misrepresents the core factual development. (2) The dates (March 2021, September 2020) and interest rate (0.125%) are factually plausible but are used in a misleading context. The ground truth does not confirm a second issuance or amendment, so the quantitative details, while numerically accurate in isolation, are applied incorrectly. There are no calculations in the response, but the use of dates and issuance events is factually unsound. (3) The multi-hop reasoning is flawed. The LLM infers active reissuance or amendment of the 0.125% Notes, whereas the ground truth indicates a shift in disclosure format and the introduction of higher-yielding, long-term debt (e.g., 5.000% Notes due 2034) in 2024. The correct inference is a strategic pivot toward longer-term financing, not recycling the same low-rate note. The LLM fails to mention the introduction of higher-yielding instruments, a key element of the company's strategy. (4) The contextual relevance is moderate—the response addresses the 0.125% Notes and near-term debt management—but the incorrect mechanism (reissuance) undermines the conclusion. The suggestion that Coca-Cola 'periodically reissues or amends' the note is unsupported and contradicts the ground truth, which shows a move away from such instruments. Thus, while the intent aligns with the question, the factual foundation is incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 482,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor disclosures (2022 p. 5, 2023 p. 4, 2024 p. 4) consistently state that the company’s ability to return capital to shareholders—including dividends and share repurchases—is subject to U.S. banking laws and regulations, particularly capital‑planning rules and Delaware law, and that failure to pay full, timely dividends on preferred stock could further limit those returns. The wording and scope of this regulatory constraint remained unchanged across the three filings, indicating no evolution in the exposure to capital‑planning and dividend‑return restrictions during that period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of regulatory constraints and correctly identifies the consistent presence of disclosures about U.S. banking laws, capital planning, and preferred stock obligations across 2022–2024. It also accurately references Delaware law and the impact of preferred stock dividends, and page numbers cited (2022 p.5, 2023 p.4, 2024 p.4) align with typical disclosure locations, earning high marks for quantitative and contextual accuracy. However, the core of the question asks about the *evolution* of BNY Mellon’s exposure and how its framing of regulatory constraints changed over time. The LLM incorrectly asserts that 'the wording and scope... remained unchanged,' which directly contradicts the ground truth showing a clear evolution from general caution in 2022 to more structured, specific references to 'well capitalized' status and capital adequacy rules in 2024. This misrepresents the trend of increasing specificity and formalization. The model fails to perform the required multi-hop reasoning across years to detect nuanced changes in language and emphasis, leading to a significant qualitative inaccuracy. While entities, years, and legal references are correct, the conclusion about no evolution is wrong, undermining the overall correctness despite accurate individual components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 371,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "McDonald’s 10‑K filings from 2022, 2023, and 2024 all list McGriddles as a breakfast sandwich in the “Products” section of the menu‑innovation disclosures, with identical wording in 2022 and 2023 and only a minor expansion in 2024 that added hash browns to the list (2022 p. 7; 2023 p. 6; 2024 p. 6). This steady presentation shows that McDonald’s breakfast strategy has remained largely unchanged, treating McGriddles as a core, stable offering rather than a focal point of menu innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that McGriddles were consistently listed in the 10-K filings from 2022 to 2024 as part of the core breakfast offerings, with no significant innovation details—matching the original answer's claim of 'remarkable consistency.' The mention of identical wording in 2022 and 2023 and a minor expansion in 2024 (adding hash browns) is consistent with the source documents and does not contradict the ground truth. (2) All dates and page numbers (2022 p.7, 2023 p.6, 2024 p.6) are correct, and there are no numerical inaccuracies. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the stable portrayal reflects a consistent breakfast strategy. It slightly underemphasizes the contrast between broader innovation language (e.g., 'continuous evolution' in 2023, 'testing new products' in 2024) and the static treatment of McGriddles, which the original answer highlights to strengthen the conclusion. This nuance is missing but not misrepresented. (4) The answer is contextually relevant, directly addressing both parts of the question—evolution of portrayal and implications for breakfast strategy—and supports its conclusion with evidence. The only reason for not scoring a 10 is the omission of the specific strategic contrast emphasized in the ground truth, which slightly weakens the depth of the qualitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 410,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe’s 10‑K filings show that free online self‑service learning has remained a core part of its Digital Learning Services portfolio. In 2022 and 2023, the free courses were hosted on **learning.adobe.com** as a large number of self‑service options. By 2024 the same emphasis persisted but the portal was moved to **www.training.adobe.com**, reflecting a platform update while keeping the free learning positioned within Adobe Digital Learning Services.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timeline and platform URLs. According to the ground truth, in 2022, free self-service learning was hosted on www.training.adobe.com, and in 2023 it moved to learning.adobe.com. However, the LLM incorrectly states that in 2022 and 2023 the platform was learning.adobe.com and that in 2024 it moved back to www.training.adobe.com, which is the reverse of the actual evolution. This inversion of the migration direction is a major factual error. (2) There are no numerical values to verify, but the chronological sequence and domain usage are incorrect, undermining quantitative accuracy related to time-series data. (3) The multi-hop reasoning fails because the model misidentifies the progression across years and platforms, which is central to the question. It also omits key aspects such as the strategic rebranding, centralization, and deeper integration into Adobe’s broader learning ecosystem in 2024. (4) While the answer correctly identifies that free self-service learning remains a core part of Adobe Digital Learning Services, it misrepresents the platform evolution and thus conveys an incorrect narrative about Adobe's strategic trajectory. Contextual relevance is moderate because the topic and general theme are addressed, but factual correctness is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 381,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "In 2022 Emerson grouped commercial vacuums under its Tools & Home Products segment, describing them as part of “other professional tools” alongside water jetters, wet‑dry vacuums and hand tools (page 9). By 2024 the segment was renamed Safety & Productivity, with the same product mix but a clearer emphasis on safety and productivity for professionals and homeowners, positioning commercial vacuums alongside pipe‑working and electrical tools (page 73). Thus, the product categorization stayed consistent while the strategic focus shifted to a safety‑and‑productivity narrative and the alignment with professional tools was reinforced under the new segment name.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies regarding the evolution of Emerson's segment structure and product categorization. It incorrectly states that the segment was renamed Safety & Productivity by 2024, when in fact the reclassification of Commercial Vacuums into the Safety & Productivity segment occurred in 2023, not 2024. Additionally, the LLM claims the product mix remained the same and that categorization stayed consistent, which directly contradicts the ground truth: Commercial Vacuums moved from Tools & Home Products in 2022 to Safety & Productivity in 2023, indicating a clear change in categorization. The strategic emphasis shift is partially captured, but the LLM fails to note the 2023 transition and the 2024 evolution toward integration with advanced industrial systems like programmable automation controls. (2) There are no numeric values, dates, or calculations in the answer that are factually wrong per se—dates mentioned (2022, 2024) are within range, though 2023 is omitted incorrectly—but the timeline synthesis is flawed. (3) The multi-hop reasoning is weak: the model fails to recognize the three-year progression (2022 → 2023 → 2024) and incorrectly assumes continuity where there was a structural shift in 2023. It also misattributes the strategic shift to a mere renaming rather than a repositioning involving deeper alignment with industrial productivity tools. (4) While the answer addresses product categorization, strategic emphasis, and alignment with professional tools as required, it does so with significant factual errors in the evolution narrative, warranting a mid-range correctness score. Contextual relevance is high because it attempts all aspects of the question, but qualitative accuracy is low due to incorrect synthesis across years and segments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 493,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site has continued to serve as a commercial manufacturing and processing hub for its cell‑therapy products with no change in its role from 2022 through 2024.  In each filing the facility is described simply as “used for commercial manufacturing and processing of our cell‑therapy products” (2023 page 11; 2024 page 10).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its reasoning and completeness. (1) It correctly identifies that the Hoofddorp facility was used for commercial manufacturing and processing of cell therapy products in 2023 and 2024, and cites appropriate document pages. However, it incorrectly states that there was 'no change in its role from 2022 through 2024'. According to the ground truth, in 2022 the facility was only identified as a 'principal manufacturing site' without explicit mention of cell therapy — that specific designation emerged in 2023. This omission misrepresents the evolution of the facility’s utilization, which the question specifically asks about. (2) There are no numeric values to verify, so quantitative accuracy is not applicable — the score reflects absence of numerical errors. (3) The multi-hop reasoning is flawed: the model fails to recognize the progression from a general principal site in 2022 to a specifically designated cell therapy facility in 2023 and 2024. This evolution is central to the question and was accurately captured in the original answer but missed in the LLM response. (4) While the answer is contextually relevant and uses correct entities (GILD, Hoofddorp, cell therapy, correct years), it lacks the nuanced, fact-based progression required for full accuracy. Thus, the correctness and qualitative accuracy scores are moderate due to a critical omission in the temporal evolution of the facility's role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 411,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s 10‑Ks from 2022‑24 all list the 1.000% Notes due 2028 (Exhibit 4.26 on pages 134, 136, 128 and 132), underscoring the company’s continued reliance on a low‑cost, long‑term debt base.  In the 2024 filing the company also added higher‑yield instruments—5.000% Notes due 2034 and 5.400% Notes due 2064 (Exhibit 4.39 and 4.41 on page 130)—signaling a deliberate shift to diversify maturities and accept higher interest costs for longer horizons, thereby adjusting its capital‑structure mix and financing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All numeric values—1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064—are correctly stated, and the years (2022–2024 filings) match the original. The inclusion of exhibit numbers and page references adds precision, though these were not required for correctness. (2) Quantitative accuracy is perfect: percentages and maturities are correct, and no calculations were needed. (3) The multi-hop reasoning is sound: the model correctly synthesizes the persistent presence of low-cost debt with the 2024 introduction of higher-yield notes, inferring a strategic shift in capital structure. It captures the core idea of balancing low-cost debt with new, costlier long-term instruments. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'recalibration' or 'diversifying to fund strategic initiatives' as in the original, slightly reducing qualitative depth. However, the conclusion about adjusting capital-structure mix and financing strategy is semantically equivalent. The answer is fully contextually relevant, directly addressing the evolution in financing costs and capital structure management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 342,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s 2022 Tools & Home Products segment listed pipe cutters as part of a conventional mechanical lineup, with no mention of battery power (page_9, page_10).  By 2023 the Safety & Productivity portfolio expanded to include battery‑hydraulic tools for press connections and diagnostic systems such as sewer‑inspection cameras (page_73), and the 2024 description continued to highlight these battery‑powered, diagnostic‑integrated tools (page_74).  This evolution signals a deliberate shift toward electrified, tech‑enabled plumbing solutions, positioning Emerson as a forward‑looking, technology‑driven leader in the professional plumbing tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Emerson's pipe cutters were part of a conventional mechanical lineup in 2022 with no battery-powered or diagnostic features; in 2023, the company introduced battery-hydraulic technology and diagnostic systems like sewer inspection cameras; by 2024, these advanced features were emphasized, showing a clear evolution. The years (2022, 2023, 2024) and technological progression are correctly identified. (2) There are no numeric values requiring calculation, but the temporal sequence and qualitative metrics (e.g., 'battery-hydraulic', 'diagnostic-integrated') are accurately reported. Format variations (e.g., page references) do not affect accuracy. (3) The multi-hop reasoning is sound—information is synthesized across three years and linked to a strategic shift. The LLM correctly infers that the integration of battery power and diagnostics reflects a broader strategic pivot toward technology-enhanced tools. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'electrified, tech-enabled plumbing solutions' vs. 'technology-enhanced tools'), the meaning matches the original. The only minor gap is that the LLM does not explicitly mention 'portability' or 'productivity and safety' as outcomes, which are present in the ground truth, slightly reducing qualitative accuracy. However, the core strategic positioning as a 'technology-driven leader' captures the essence. Contextual relevance is perfect—the response directly addresses the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 444,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024 Gilead has consistently listed its Santa Monica, California site as a **clinical‑manufacturing and processing hub for cell‑therapy products** (2022 p. 11; 2023 p. 11; 2024 p. 10).  The unchanged description shows the facility remains a dedicated clinical manufacturing node, underscoring its strategic role as a core part of Gilead’s cell‑therapy network that supports early‑stage production while other sites handle commercial manufacturing.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of GILD's Santa Monica facility. According to the ground truth, in 2022 the facility was part of the R&D and manufacturing network but was *not* specifically highlighted for cell therapy processing. However, the LLM claims that from 2022 through 2024, the facility was consistently described as a 'clinical-manufacturing and processing hub for cell-therapy products,' which contradicts the ground truth. This misrepresents the key evolution — that Santa Monica *transitioned* into a dedicated cell therapy site starting in 2023. While the LLM correctly identifies the facility’s role in 2023 and 2024, it fails to capture the change over time, which is central to the question. There are no numerical errors (hence high quantitative accuracy), and the response is contextually relevant, but the qualitative reasoning is flawed due to incorrect synthesis across years. The multi-hop aspect — tracking changes across filings — is poorly executed, leading to an inaccurate conclusion about continuity rather than evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 310,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In 2022 Frame.io was positioned as a post‑production collaboration tool integrated with Premiere Pro and After Effects, supporting video, still images, design files, PDFs and camera‑to‑cloud uploads. By 2023 Adobe broadened Frame.io’s cross‑app integration to Photoshop, Lightroom and Workfront, added support for video beyond post‑production, still images, design files, PDFs and camera‑to‑cloud, and bundled it with Express and Firefly Services in Adobe G enStudio (see 2023 p. 12‑13). In 2024 the core integration remained with Premiere Pro and After Effects, but the platform continued to offer real‑time upload, review, approval, frame‑accurate commenting and annotations for still images, design files, PDFs and camera‑to‑cloud, reinforcing its role as a collaborative asset hub across the Creative Cloud ecosystem (see 2024 p. 12‑13).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of accurate and inaccurate information, with significant factual discrepancies in the timeline and integration details. (1) Correct elements: The mention of Frame.io's integration with Premiere Pro and After Effects, support for still images, design files, PDFs, and camera-to-cloud uploads, and its inclusion in Adobe GenStudio are factually aligned with the evolution. The cross-application collaboration features like frame-accurate commenting and real-time review are contextually appropriate. (2) Quantitative accuracy is mostly correct—dates (2022–2024) are used appropriately, and no numerical calculations are required. However, the LLM incorrectly attributes expanded integrations (Photoshop, Lightroom, Workfront) and broader video use cases (casting, location scouting) to 2023, while the ground truth states these developments occurred in 2024. Conversely, the 2023 description in the LLM answer includes features that were not yet present that year. (3) Multi-hop reasoning is partially sound—the model attempts to synthesize evolution across years and applications, but misaligns the progression: in 2022, Frame.io was only listed in trademarks, not functionally integrated as a post-production tool with full media support as claimed. The 2022 LLM description anticipates capabilities that emerged later. The 2024 summary downplays the expanded use cases (marketing, scouting) and overemphasizes continuity rather than evolution. (4) Contextual relevance is strong—the answer addresses media types and cross-app collaboration as asked, but the misplacement of features across years undermines the qualitative accuracy. The reference to 'Adobe G enStudio' appears to be a typo for 'Adobe GenStudio'. Overall, the answer captures the general direction of integration but fails on precise temporal alignment and feature rollout sequence, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 516,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "Emerson has kept electrical distribution equipment as a core element of its Discrete Automation portfolio, embedding it within a broader suite of discrete‑industry solutions that include solenoid valves, pneumatic valves, valve‑position indicators, pneumatic cylinders and actuators, air‑preparation equipment, pressure and temperature switches, electric linear‑motion solutions, programmable automation control systems and software, and materials‑joining solutions【page_73】.  The 2024 filing reiterates this positioning, underscoring the integration of electrical distribution equipment with programmable automation control systems and software and highlighting an expanded product scope that now spans a wider array of discrete‑industry components【page_73】.  Thus, from 2022 to 2024 Emerson’s strategy evolved by deepening the automation‑technology integration around its electrical distribution offerings while broadening the segment’s discrete‑industry product mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Emerson's strategic positioning of Electrical Distribution Equipment from 2022 to 2024, noting its deepening integration with automation technologies and expansion in product scope. While the LLM does not explicitly break down the progression year-by-year as in the original answer, it accurately summarizes the overall strategic shift across the period. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only qualitative descriptions of product positioning—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and segments, correctly identifying the integration of electrical distribution equipment with programmable automation control systems (highlighted in 2023) and its broader inclusion with electric linear motion and materials joining solutions (2024). The mention of specific product categories (e.g., solenoid valves, pneumatic cylinders, etc.) adds contextual richness and supports the claim of product scope expansion. (4) The answer is semantically equivalent to the original, though slightly less granular in its year-by-year articulation. It effectively conveys that EMR evolved its strategy to embed electrical distribution equipment as a core part of intelligent, integrated automation solutions. One minor shortcoming is the lack of explicit reference to the 2022 positioning within Industrial Solutions, which slightly weakens the longitudinal narrative. However, the overall conclusion about strategic evolution remains correct and well-supported. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 502,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed unsecured senior debt carried **$24.1 billion** at year‑end 2022 and grew to **$27.2 billion** in 2023, before easing slightly to **$26.9 billion** in 2024 (Table 8.1, 2023/2022; Table 9.1, 2024/2023).  The weighted‑average interest rate was **4.45 %** in both 2022 and 2023, but rose to **4.84 %** in 2024 (same tables).  This trend shows the company is keeping debt levels roughly flat while taking on newer, longer‑dated debt at higher rates, reflecting a strategy of refinancing in a tightening rate environment to preserve liquidity and extend maturities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), which is a substantial difference (~$4.1 billion overstatement). The 2023 and 2024 values are approximately correct ($27.2 billion vs. $27,168 million and $26.9 billion vs. $26,930 million), with minor rounding acceptable. However, the interest rate for 2022 is stated as 4.45%, which is incorrect—the ground truth is 2.91%. The LLM repeats 4.45% for both 2022 and 2023, whereas the correct progression is 2.91% → 4.45% → 4.84%. This misrepresents the magnitude and timing of the rate increase. (2) Calculations: The year-over-year increases and trends are not accurately reflected due to wrong base values. The interest rate change from 2.91% to 4.45% is a key indicator of response to rising rates, but this is erased in the LLM answer. (3) Multi-hop reasoning: While the LLM attempts to synthesize a strategy—refinancing in a tightening environment, extending maturities—the reasoning is based on flawed data. The conclusion that debt levels are 'roughly flat' ignores the significant 35% increase from 2022 to 2023 in the ground truth. The actual strategy of proactively locking in debt amid rising rates is misrepresented because the rate increase is shown to have started earlier (2022) than it actually did. (4) Despite incorrect numbers, the answer addresses all parts of the question (evolution of carrying value and rate, strategic implication), and the final strategic interpretation is directionally plausible, though based on wrong inputs. Hence, partial credit is given for structure and relevance, but major deductions for factual accuracy, especially on critical financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 486,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s carrying amount of liabilities for performance and operating‑cost guarantees fell from $1,109 million at December 31 2022 to $993 million at December 31 2024 (a net decline of $116 million, or $164 million from Jan 1 2022).  The liability decreased each year—$48 million in 2022, $18 million in 2023, and $98 million in 2024—reflecting that settlements consistently outpaced new issuances and indicating a gradual reduction in the company’s exposure to long‑term product‑performance risks in its commercial aerospace business【page_102】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, RTX's liabilities for performance and operating cost guarantees were $120 million in both 2022 and 2023, and slightly decreased to $101 million in 2024—indicating stability. However, the LLM claims the liability was $1,109 million in 2022 and dropped to $993 million by 2024, with annual decreases of $48M, $18M, and $98M—none of which align with the correct figures. These numbers are off by nearly an order of magnitude, suggesting a possible confusion with another metric or company. (2) The quantitative inaccuracies are severe: the correct values are ~$120M (stable), not ~$1.1B declining. The claimed net decline of $116M from end-of-2022 to end-of-2024 contradicts the actual slight decrease from $120M to $101M (a $19M drop). Additionally, the LLM’s breakdown of annual changes has no basis in the ground truth, which reports no change in 2023 and only a small decrease in 2024. (3) The multi-hop reasoning is flawed: while the LLM attempts to interpret the trend (decreasing liabilities = reduced risk), this conclusion is based on fabricated data. The correct reasoning should emphasize stability in liabilities, reflecting consistent risk exposure and reliable accrual practices, not a reduction. (4) Contextual relevance is moderate—the answer addresses the right topic (liabilities related to performance guarantees and their implications), uses appropriate financial language, and attempts trend analysis. However, due to catastrophic failures in factual accuracy and calculation, the qualitative and correctness scores are very low. The answer misrepresents the core data and thus leads to an incorrect business interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 479,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "Coca‑Cola’s 10‑K notes for 2022 (Note 4, page 41), 2023 (Note 4, page 76), and 2024 (Note 4, page 78) all state that for non‑public investments it uses “discounted cash flows, estimates of sales proceeds, and appraisals” as valuation methods—no wording change is evident over the three years.  This unchanged reliance shows that the company has maintained a stable valuation framework, while the notes increasingly emphasize the difficulty of forecasting cash flows in emerging markets, indicating a continued, cautious approach to fair‑value assessment in those regions.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that there was 'no wording change' in Coca-Cola's disclosures from 2022 to 2024. The ground truth shows a clear evolution: from 'disclosure of use' in 2022, to 'explicit reliance' in 2023, to 'continued use with increased caution' in 2024. The LLM incorrectly asserts that the wording remained unchanged across the three years, which contradicts the documented progression in the company's language and strategic emphasis. (2) Quantitatively, the answer is accurate—correctly citing Note 4 in each year and page numbers (41, 76, 78), which aligns with typical 10-K structure. There are no numerical errors, and the valuation methods listed (discounted cash flows, estimates of sales proceeds, appraisals) are factually present in the disclosures. (3) The multi-hop reasoning is flawed: while the model synthesizes information across three years, it fails to detect the nuanced but critical shift in language and strategic posture—'discloses use' vs. 'relies on' vs. 'uses with caution'—which is central to the question. This misreading undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the right documents, sections, and valuation methods, and correctly notes increasing caution around cash flow forecasts in emerging markets. However, the failure to capture the evolution in reliance on 'estimates of sales proceeds' as a methodology—specifically the shift from passive disclosure to active reliance to cautious integration—results in a low correctness and qualitative accuracy score. The answer presents stability where there was actually strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 459,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor disclosures have consistently stated that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The wording has not materially changed over the three years, underscoring a persistent regulatory constraint that caps the company’s flexibility in shareholder distributions while still leaving room for Board discretion when conditions allow.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent disclosure language from 2022 to 2024 regarding BNY Mellon's capital return limitations under U.S. banking laws, Delaware law, and preferred stock dividend obligations, which aligns with the ground truth. All entities (BNY Mellon, U.S. banking laws, Delaware law, preferred stock) and time periods (2022–2024) are accurate, and there are no numerical or date inaccuracies—quantitative accuracy is perfect. The answer also correctly infers that this consistency reflects persistent regulatory constraints on shareholder distributions, which is contextually relevant and logically sound. However, the LLM omits a key qualitative development noted in the original answer: the 2024 addition emphasizing the Parent’s reliance on dividends from subsidiaries and credit extensions from its IHC to fund share repurchases and dividends. This omission weakens the multi-hop synthesis, as the evolution in internal capital flow dependencies—a critical nuance in strategic flexibility—is not addressed. While the core facts are correct, the incomplete treatment of the 2024 disclosure limits the depth of reasoning and prevents full credit for qualitative accuracy. The answer remains semantically close but lacks the full progression analysis required for a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 363,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 2022 filing (page 37) listed the loss or modification of tax and tariff exemptions as one of many political, legal and economic risks in foreign operations. In 2023 (page 40) the same risk was reiterated, now explicitly linked to trade‑protection measures and import/export licensing requirements, reflecting heightened trade tensions. By 2024 (page 40) the risk is framed within an expanded set of global regulatory challenges—including sanctions and export‑control revisions against Russia, Belarus and Ukraine—showing that AMD’s exposure has broadened and the regulatory environment has become increasingly complex and dynamic.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: AMD consistently reported the risk of losing tax and tariff exemptions from 2022 to 2024, with increasing contextual detail each year. The 2022 mention as one of many risks, the 2023 linkage to trade protections and licensing, and the 2024 expansion to include sanctions and export controls (especially related to Russia, Belarus, and Ukraine) are all factually supported and correctly sequenced. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 since no numbers were misstated. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, showing an evolution in risk disclosure that reflects increasing regulatory complexity. The only minor shortcoming is that the original answer includes additional geopolitical context—such as China-Taiwan tensions and the Ukraine conflict’s direct impact on regulatory shifts—which the LLM mentions only indirectly via sanctions. This slight omission in depth prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution of AMD’s exposure and what it suggests about regulatory complexity. Wording differs but semantic meaning matches. Overall, this is a strong, factually correct response with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 413,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024, while long‑term debt declined from $49.3 billion in 2022 to $49.3 billion in 2023 and further to $44.99 billion in 2024. The concurrent elimination of floating‑unsecured senior debt—from $1.6 billion in 2022 to $349 million in 2023 and to zero in 2024—shows a deliberate shift toward fixed‑rate, longer‑term debt, thereby reducing the bank’s exposure to interest‑rate volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. It reports short-term borrowings as $883M (2022), $538M (2023), and $562M (2024), whereas the ground truth shows total short-term borrowings and long-term debt combined were $43.086B, $49.856B, and $45.551B respectively—indicating the LLM misrepresents both magnitude and scope. The LLM incorrectly states long-term debt was $49.3B in both 2022 and 2023, contradicting the ground truth increase from $43.086B to $49.856B. The floating unsecured senior debt is reported as $1.6B in 2022 vs. the correct $1.709B, and omits the sharp rise to $349M in 2023 being part of a larger debt increase. (2) Calculations are flawed: the LLM implies total debt decreased steadily, but truth shows an increase then decrease. The floating-rate debt drop to zero is correct, but context is missing—its elimination occurred after a rate surge to 6.75%, which the LLM omits. Fixed-rate debt trend is entirely missing, including its rise from $21.045B to $27.168B to $26.930B and interest rate increase to 4.84%. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift to fixed-rate debt to reduce rate volatility, which aligns with the ground truth’s conclusion. However, it lacks synthesis of full debt composition changes and interest rate trends, weakening the logic. (4) Scores reflect major quantitative errors (3/10), partial qualitative accuracy in interpretation (6/10), high relevance to question theme (8/10), and overall partial correctness due to wrong numbers despite correct directional insight—hence 4/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 450,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program share interest in International Aero Engines AG (IAE) stayed at **57 %** from 2022 through 2024 (2022: 57 %【page_108】, 2023: 57 %【page_101】, 2024: 57 %【page_102】). This unchanged stake confirms RTX’s continued role as the primary beneficiary and majority stakeholder in the V2500 engine program collaboration, preserving its influence over the program’s economics and decision‑making.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding RTX's net program share interest in IAE. The ground truth states that RTX's interest was 61% in 2022 and decreased to 57% in 2023 and 2024. However, the LLM claims the share was 57% in all three years, missing the 61% figure for 2022 entirely. This error fundamentally misrepresents the trend and direction of change. (2) Quantitative accuracy is severely compromised: the 2022 percentage is wrong (57% vs. correct 61%), and no change is reported when there was a clear 4-percentage-point decrease. The cited pages (108, 101, 102) may contain data, but the synthesis is incorrect. (3) The multi-hop reasoning fails because the model did not detect the change over time, leading to an erroneous conclusion that the stake was 'unchanged' and that RTX maintained stable control. In reality, the reduction from 61% to 57% indicates a strategic dilution of economic exposure, which the LLM completely overlooks. (4) Contextual relevance is moderate because the answer addresses the right entities (RTX, IAE, V2500 program) and attempts to interpret strategic implications, but the incorrect data leads to a misleading interpretation. The conclusion about 'continued role as primary beneficiary' is plausible in isolation but invalid given the factual error. Overall, major factual and reasoning flaws result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 387,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Cascade remains a key brand in P&G’s Fabric & Home Care segment, which has grown its share of net sales from 35 % in 2022 to 36 % in 2023 and 2024, and its share of net earnings from 31 % to 34 %.  The major‑brand list—Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer—has stayed unchanged across the three filings, underscoring Cascade’s steady importance while the segment’s overall weight in the home‑care portfolio has risen.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cascade is consistently positioned within P&G's Fabric & Home Care segment, which accounted for 35% of net sales and 31% of net earnings in 2022, rising to 36% of net sales and 34% of net earnings in both 2023 and 2024. These figures match the original answer exactly. (2) Quantitative accuracy is perfect: percentages for net sales and earnings across the three years are correctly reported, and no calculation errors are present. (3) The reasoning is sound—by noting that the list of major brands remains unchanged across filings, the LLM correctly infers Cascade’s stable strategic importance. It also accurately observes the segment’s growing weight in P&G’s portfolio. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'Home Care sub-category' as the specific portfolio layer where Cascade resides, though it correctly situates Cascade within the broader Fabric & Home Care segment. This slight omission in granularity prevents a perfect 10 on qualitative accuracy, but the core multi-hop synthesis—linking Cascade’s consistent branding status with segment-level financial trends across three 10-Ks—is well executed. The answer is fully contextually relevant and addresses the evolution of Cascade’s positioning as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 378,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "From 2022 to 2023, BNY Mellon listed its Directors’ Code of Conduct at a relative path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑ofconduct.pdf ) under the bny.com domain, with no fully‑qualified URL in the 10‑K. By 2024 the code was moved to a branded, fully‑qualified HTTPS URL on the bnymellon.com domain ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ) and the file name was hyphenated. The 2024 filing also more explicitly tied the code to the broader corporate‑governance framework—linking it to the employee Code of Conduct, the “Corporate Governance” section, and a commitment to disclose amendments on the website.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) URL/domain timeline is reversed: the ground truth states that in 2022 and 2023, BNY Mellon used the 'bnymellon.com' domain with slight path variations (not 'bny.com'), and only in 2024 did they transition to 'bny.com'—but the LLM claims the opposite, stating that 'bny.com' was used in 2022–2023 and 'bnymellon.com' in 2024. This is a fundamental error in both domain branding and chronological evolution. (2) The LLM incorrectly claims that in 2022–2023 the URL was under 'investor-relations', but the ground truth shows it was under '/in relations/' (2022) and '/inv relations/' (2023), which are malformed and likely internal silos, not the properly hyphenated 'investor-relations' path that only appears in 2024. (3) The LLM falsely states that the 2024 version moved back to 'bnymellon.com', when in fact the 2024 shift was to 'bny.com'—a key branding evolution that the LLM completely misrepresents. (4) While the LLM correctly notes increased integration with corporate governance in 2024 (linking to employee Code of Conduct, governance section, etc.), this partial qualitative insight does not compensate for the core factual errors in domain, URL path, and timeline. (5) Multi-hop reasoning fails because the model misaligns data across years and domains, leading to an inverted narrative. Despite addressing the question’s themes (URL structure, branding, integration), the answer is factually inverted on critical points, warranting a low correctness score. Minor points are given for attempting to discuss integration and file naming, but overall accuracy is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 457,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across 2022, 2023, and 2024, AMD’s 10‑K filings consistently protected AIB manufacturers’ inventory from price reductions and continued to stress that system integrators use discrete graphics solutions to differentiate and add value to their board‑level products. The identical wording in each filing indicates a steady, unchanged strategic approach rather than an evolution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures the consistent inventory protection policies across 2022–2024 and correctly identifies the ongoing strategic role of discrete graphics solutions in differentiating system integrators' offerings. The statement about 'identical wording in each filing' supports the conclusion of a stable strategy, which is consistent with the original answer’s emphasis on continuity. There are no errors in entities, years, or financial terms (though no specific numbers like dollar amounts are present, the qualitative claims are accurate). The reasoning is sound and reflects proper multi-hop synthesis across the three years. The only minor shortcoming is the use of 'identical wording'—while illustrative, this detail is not present in the ground truth and slightly overreaches without direct citation; however, it does not undermine the factual correctness. Overall, the answer conveys semantic equivalence and demonstrates strong understanding of AMD's strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 302,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "McDonald’s 2022 10‑K (page 7) lists the Egg McMuffin as a core breakfast sandwich and ties its quality and consistency to rigorous supply‑chain and food‑safety standards (page 6). The 2023 filing (pages 7 and 6) repeats that emphasis, underscoring ongoing menu evolution and supplier collaboration but adding no new detail. By 2024, the breakfast‑menu description remains unchanged (page 7), while the supply‑chain section (page 6) adds a digital‑transformation effort to use data for continuous quality monitoring, further reinforcing the Egg McMuffin’s role as a benchmark for meeting customer expectations for quality and consistency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Egg McMuffin is consistently referenced as a core breakfast item, and the evolution from general quality assurance to a more integrated supply chain and digital approach is accurately captured. The 2024 addition of a digital transformation project for data-driven quality and food safety monitoring is correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but dates (2022–2024) and document references (page numbers) are appropriately cited and consistent with the expected disclosures. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression in narrative focus—from menu quality in 2022, to supplier collaboration in 2023, to digital transformation in 2024—while maintaining the Egg McMuffin as a consistent benchmark for quality and consistency. (4) The only minor shortcoming is that the LLM understates the 2023 disclosure slightly by stating it 'adds no new detail,' whereas the original answer notes a meaningful expansion in narrative around innovation and the role of the Global Chief Supply Chain Officer. This omission slightly affects completeness but does not distort the overall evolution. Wording differs but semantic equivalence is preserved. Contextual relevance is excellent, directly addressing the question’s focus on disclosure evolution, supply chain, and customer expectations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 426,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "Oracle lists the 4.30% Note due 2034 in Exhibit 4.11 on page 111 of each filing (2022, 2023, and 2024) (2022 page 111; 2023 page 111; 2024 page 111). This persistent disclosure shows that the note remains a core, long‑term debt instrument, reflecting Oracle’s strategy of maintaining a diversified, fixed‑rate debt mix and preserving predictable interest costs over time. The consistency across reporting periods indicates a deliberate focus on stable, long‑term financing rather than short‑term debt rollover.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—Oracle, the 4.30% Note due 2034, and the reporting years 2022–2024—are correctly identified. The percentage (4.30%), maturity year (2034), and consistent disclosure across three years are all correct. (2) Quantitative accuracy is perfect: no calculations are required, and all numerical values (interest rate, years) match the original answer exactly. (3) The reasoning is sound: the LLM correctly infers that the persistent disclosure indicates the note is a stable, core component of Oracle’s long-term debt, reflecting a strategy of predictable financing and diversified fixed-rate obligations. It accurately captures the strategic implication of avoiding reliance on short-term rollover. (4) While the LLM does not mention specific comparative instruments (e.g., the 3.625% Note due 2023 or 2.950% Notes due 2024) as in the ground truth, it still conveys the essential qualitative conclusion about Oracle’s financing priorities and debt structure stability. This omission slightly reduces completeness in multi-hop synthesis but does not undermine the core correctness. The answer remains semantically equivalent in intent and factual content, with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 355,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s valuation approach for net derivative assets/liabilities has stayed the same from 2022 through 2024: the firm uses vendor‑based models that rely on observable market inputs for Level 2 instruments and on unobservable inputs (primarily swap rates) for Level 3 instruments, with credit‑risk adjustments applied to all fair‑value calculations (2024 § 218; 2023 § 208).  The fair‑value amounts of the Level 3 net derivative position grew from $5 million at 12/31/2022 to $58 million at 12/31/2023 and to $69 million at 12/31/2024 (2024 § 217; 2023 § 206; 2022 § 206), while the unobservable input range (swap rates 3‑5 %) and weighted average (≈4 %) remained essentially unchanged (2024 § 217; 2023 § 206; 2022 § 206).  Thus, the company’s exposure to unobservable market inputs has increased in dollar terms, reflecting a larger derivative portfolio, but the sensitivity of those inputs has stayed stable over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, $58 million in 2023, and remained $58 million in 2024. However, the LLM claims the values were $5 million (2022), $58 million (2023), and $69 million (2024), which misrepresents the actual trend and magnitude. The $5 million figure for 2022 directly contradicts the ground truth of $19 million, and the $69 million in 2024 contradicts the stable $58 million reported. Additionally, the ground truth notes a net unrealized loss of $20 million in 2022, which the LLM omits entirely. (2) The unobservable inputs are partially correct: the LLM correctly identifies swap rates (3–5%) as a key input in 2023–2024, but fails to mention the highly unusual default rates (53–163%) cited in 2023, which are a critical red flag and part of the evolution in methodology. The claim that swap rates were used in 2022 is not supported by the ground truth, which only mentions unobservable inputs becoming structured in 2023. (3) The reasoning is partially sound in identifying increasing reliance on unobservable inputs, but the conclusion that exposure increased due to portfolio size is speculative and not supported by the ground truth, which emphasizes methodological stabilization and transparency rather than portfolio growth. The LLM incorrectly implies consistency in methodology across all three years, while the ground truth shows a shift from mixed realized/unrealized positions in 2022 to structured unobservable inputs in 2023–2024. (4) Despite these errors, the answer is contextually relevant and attempts to address the evolution of methodology and exposure to unobservable inputs. It correctly cites swap rates as a recurring unobservable input and references Level 3 instruments, showing some understanding of fair value hierarchy. However, the quantitative inaccuracies severely undermine the correctness score, especially given the importance of precise financial figures in SEC filings analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 567,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s V2500‑flight‑hour obligation to Rolls‑Royce has remained a contingent payment tied to each hour flown through June 2027.  In 2022 the company described the payments as being capitalized as collaboration intangible assets and amortized to cost of sales (page 112), a treatment that the 2023 and 2024 filings repeat (page 114, page 73).  The 2024 commitments table (page 103) shows the same flight‑hour payments spread through 2029, indicating that the payment structure and amortization strategy (amortizing the intangible over the term of the underlying economic benefit) did not materially change from 2022 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core concept that RTX's financial obligations to Rolls-Royce are tied to V2500 flight hours through June 2027 and that payments are capitalized as collaboration intangible assets and amortized to cost of sales. This aligns with the ground truth for 2023 and 2024. However, there are key inaccuracies: (1) The LLM claims the 2024 commitments table shows payments spreading through 2029, which contradicts the ground truth stating the obligation runs through June 2027. This is a critical error in date accuracy. (2) The LLM implies the accounting treatment was explicitly stated in 2022 as capitalization and amortization, but the ground truth clarifies that in 2022, these were described as contingent liabilities to be capitalized as payments were made—meaning the full accounting policy was not yet fully articulated. The LLM retroactively applies the 2023–2024 clarity to 2022, which overstates the consistency. (3) The dollar amount of $14.1 billion in total commitments for 2024 is omitted, reducing quantitative completeness. While the LLM correctly identifies the amortization strategy and links it to economic benefit, it fails to note the evolution in transparency over time, a key qualitative point in the original answer. The reasoning is partially sound but misses the nuance of policy clarification over time. Contextually, the answer is highly relevant and addresses the payment structure and amortization, but the incorrect end date (2029 vs 2027) and missing commitment value reduce factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 422,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 10‑K (page 55) disclosed that the FDA had been evaluating the Neulasta Onpro kit and that the company had already implemented device‑ and labeling‑enhancements to address user complaints, and that it continues to monitor complaints and adverse events and add further enhancements as needed. The 2023 10‑K repeated the same statement, underscoring ongoing monitoring and continuous improvement. By 2024, Amgen reiterated the device‑enhancement and monitoring approach while adding broader operational‑resilience details—such as backup generators and power‑outage contingency plans for its Puerto Rico manufacturing facility—to mitigate supply disruptions that could affect the kit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen implemented device- and labeling-enhancements in response to user complaints, referenced the FDA evaluation (implied from 2017, though not explicitly dated in the LLM answer), and maintained ongoing monitoring through 2023. In 2024, operational resilience measures—specifically backup generators and power-outage contingency plans in Puerto Rico—were added to disclosures. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but dates (2022, 2023, 2024) are used correctly and contextually. The mention of a December 31, 2024 island-wide outage in the ground truth is not included in the LLM answer, which omits the specific date and event but still correctly captures the broader point about repeated reliance on backup generators due to grid instability. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures, correctly identifying the evolution from device-focused risk mitigation to include operational resilience. The connection between production stability and indirect impact on user complaints is implied in both answers. (4) The only minor shortcoming is the lack of explicit mention of the December 31, 2024 outage and the phrase 'operational resilience' being slightly underdeveloped compared to the original, but the core meaning and factual progression are preserved. Wording differences do not affect semantic equivalence. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 455,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s 10‑K filings from 2022 through 2024 all contain identical wording in Item 14, stating that the ratification of KPMG LLP is incorporated by reference and that KPMG’s PCAOB firm number is 185 (BK_10k_2022, p. 14; BK_10k_2023, p. 14; BK_10k_2024, p. 14). The unchanged language across the three years indicates that BK has retained the same auditor and that its audit‑governance framework has remained stable, underscoring continuity in its oversight structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BK consistently disclosed KPMG LLP as principal accountant in 2022, 2023, and 2024 filings; the PCAOB firm number 185 is correctly cited across all years; and the conclusion about audit governance continuity is sound. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly reported, and the years (2022–2024) match the ground truth. Page references (p. 14 in each filing) add precision and are consistent with the source structure. (3) The multi-hop reasoning is strong—linking identical disclosure language across three years to infer stability in audit governance demonstrates correct synthesis. The only minor omission is not explicitly stating that there were 'no substantive changes in the structure or framing' beyond identical wording, which slightly reduces qualitative completeness. Also, the ground truth mentions 'institutional trust,' a subtle interpretive point the LLM omits, but this does not detract from core accuracy. (4) The answer is fully contextually relevant, directly addressing both the evolution (or lack thereof) in disclosure and the implication of the consistent PCAOB number. Overall, the response is factually correct, well-supported, and semantically equivalent to the original answer with only negligible depth differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 383,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s maximum‑potential exposure to commercial‑aerospace customer‑financing guarantees fell from **$304 million in 2022** to **$288 million in 2023** and **$274 million in 2024** (Note 16, pages 100‑102).  Correspondingly, the share of those guarantees attributable to collaboration partners declined from **$142 million (2022)** to **$135 million (2023)** and **$131 million (2024)** (Note 16, pages 100‑102).  This steady contraction shows the company is actively trimming guarantee exposure—likely through renegotiated terms, hedging, or shifting risk to partners—to limit potential liabilities and reinforce a more conservative risk‑management posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures from the ground truth: the collaboration partners' share of guarantees is accurately stated as $142M in 2022, $135M in 2023, and $131M in 2024. These values match the original answer exactly and are properly contextualized as declining over time. While the LLM introduces additional data—RTX’s total maximum-potential exposure ($304M, $288M, $274M)—this information is consistent with the trend and does not contradict the ground truth; it adds context without introducing error. (2) All numbers are quantitatively accurate, and the year-over-year decreases (e.g., $142M → $135M → $131M) are correctly represented. The LLM correctly identifies the downward trend, and no calculation errors are present. Format variations (e.g., $142 million vs $142M) are acceptable and handled appropriately. (3) The multi-hop reasoning is sound: the model synthesizes the trend in partner-shared guarantees and links it to RTX’s risk management strategy, concluding that the decline reflects active risk limitation through renegotiation or risk shifting. This aligns with the original answer’s interpretation of a 'strategic reduction in shared financial risk.' The only minor gap is that the LLM does not mention RTX’s assertion about fair market values of guaranteed assets equalling or exceeding guarantees net of reserves—a point included in the ground truth that reinforces confidence in asset quality. This omission slightly reduces completeness but does not undermine the core accuracy. (4) The answer is highly contextually relevant, directly addressing both parts of the question: the evolution of exposure and the implication for risk management. The added detail about total exposure enhances relevance without straying off-topic. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth due to one omitted nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 521,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "From 2022 through 2024, P&G kept the Always brand in the same place in its portfolio: it remains a core brand in the Baby, Feminine & Family Care segment, under the “Feminine Care (Adult Incontinence + Menstrual Care)” sub‑category.  The company continues to list Always, Always Discreet and Tampax Bounty as the key feminine‑care brands, with Always and Tampax consistently highlighted as the top menstrual‑care products, while other feminine‑hygiene brands (e.g., Charmin, Puffs) stay in the broader family‑care sub‑category.  Thus, the product categorization and relative brand emphasis for Always did not shift materially over the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly identifies Always as a core brand in the Feminine Care segment, it incorrectly states that the segment name 'Baby, Feminine & Family Care' was in place throughout 2022–2024. According to the original answer, the segment was called 'Feminine Care' in 2022 and was only renamed in 2023. This is a factual error in entity and timeline accuracy. Additionally, the LLM claims Always has remained in the same sub-category throughout, but the ground truth notes a structural evolution in naming and formatting, particularly the 2023 rebranding and 2024 streamlining of category presentation—details entirely missing from the LLM response. (2) Quantitatively, the LLM omits the net sales percentages (25% in 2022, 24% in 2023 and 2024) that are central to the original answer, which undermines quantitative accuracy. These figures are critical for assessing the segment’s relative importance and are not mentioned at all. (3) The multi-hop reasoning is partially sound—the model correctly infers consistent strategic emphasis on Always—but fails to synthesize the evolution across years as required by the question. It overlooks the renaming of the segment and the integration of Always Discreet into the same grouping only from 2023 onward. Furthermore, the mention of 'Tampax Bounty' appears to be a hallucination, conflating Tampax with Bounty (a paper towel brand), which is a serious entity error. Charmin and Puffs are incorrectly labeled as feminine hygiene brands in the LLM answer, when they are not part of that category. (4) Despite these issues, the answer is contextually relevant and captures the high-level idea of stability in Always’ positioning. However, due to missing quantitative data, incorrect timeline representation, and entity confusion, the correctness score is reduced to 6—partially correct but with significant factual and structural errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 535,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "AMD has consistently warned that protecting its intellectual property in foreign jurisdictions is difficult, a risk that appears in every filing.  In the 2022 10‑K the risk was framed broadly as a challenge in overseas operations, while the 2023 10‑K explicitly linked it to the company’s growing global footprint and its reliance on third‑party wafer foundries in China, Malaysia and Taiwan.  By 2024 the filing emphasized that 66 % of revenue is international and highlighted geopolitical tensions between China and Taiwan—along with sanctions—as factors that could further jeopardize IP protection for its Asia‑based manufacturing partners.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the evolution of AMD's IP protection risks from 2022 to 2024, noting the broad framing in 2022, the increased focus on third-party manufacturing in Asia in 2023 (specifically naming China, Malaysia, and Taiwan), and the added geopolitical concerns in 2024. (2) The only minor discrepancy is in the percentage of international revenue: the LLM states '66%' in 2024, while the original answer cites '65%' in 2023. This is a negligible difference in value and timing—likely a rounding or reporting variation—and does not constitute a material error. All other entities (countries, years, risk factors) are correctly identified. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, connects expanding international operations and third-party manufacturing to IP risks, and incorporates the emerging geopolitical dimension involving China and Taiwan. (4) The answer is contextually excellent, directly addressing the question’s focus on the evolution of IP risks in relation to international expansion and Asian manufacturing. Wording differs slightly but maintains semantic equivalence. No major omissions or inaccuracies—just a minor numerical variance—warranting a high score but not perfect due to the slight mismatch in revenue percentage attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 387,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first issued the 2.300 % Notes due 2028 in a 2021 offering (March 24 2021, Exhibit 4.14).  The same notes are still listed in the 2023 and 2024 10‑K exhibits (Exhibit 4.14, pages 111 and 110) as part of a tranche that includes notes with maturities from 2026 to 2061, while the coupon and maturity of the 2.300 % notes themselves did not change.  This continuity, together with the addition of higher‑coupon 2028 notes in 2023 (Exhibit 4.16, page 110), illustrates Oracle’s laddered, diversified debt strategy—issuing long‑term notes at multiple coupon rates to spread refinancing risk and manage interest‑rate exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 2.300% Notes due 2028 were first issued on March 24, 2021, under Exhibit 4.14, which aligns with the ground truth's reference to March 2021 issuance. The note's continued inclusion in 2023 and 2024 filings (Exhibit 4.14) is accurately reported, though the LLM cites page numbers (111 and 110) not present in the ground truth—this is a minor detail and does not affect factual correctness. However, the LLM introduces a claim not supported by the ground truth: that higher-coupon 2028 notes were added in 2023 (citing Exhibit 4.16, page 110). The original answer makes no mention of new 2028 notes issued in 2023, only that newer notes from late 2022 and early 2023 were disclosed alongside the 2.300% Notes. This addition introduces a potentially incorrect inference about Oracle issuing *additional* 2028-maturity notes in 2023, which is not confirmed in the ground truth. (2) Quantitative accuracy is high: the coupon (2.300%), maturity year (2028), and issuance date (March 2021) are correct. The exhibit numbers (4.14 in 2023 and 2024) match, though the 2022 exhibit number in the ground truth is 4.16, while the LLM does not mention 2022 exhibit details—this is a minor omission. (3) The multi-hop reasoning is largely sound: the LLM correctly infers a laddered debt strategy from the persistence of long-term notes with varying maturities. The conclusion about spreading refinancing risk and managing interest-rate exposure is a reasonable qualitative extension of the data, consistent with the ground truth’s interpretation of a 'diverse maturity profile' and 'stable, deliberate approach.' However, the unsupported claim about new 2028 notes slightly undermines the reasoning chain. (4) Scores reflect high factual accuracy and strong contextual relevance. The answer addresses both the evolution and strategic implication. The 8 on correctness accounts for the unverified claim about new 2028 notes; otherwise, the response is comprehensive and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 551,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "From 2022 through 2024, Boeing’s private‑equity strategy remained focused on U.S. and non‑U.S. limited‑partnership vehicles that target leveraged buyout, venture‑capital, growth and special‑situation strategies (2022: page 108; 2023: page 92; 2024: page 99).  The firm raised its target allocation from 4 % in 2022 to 7 % in 2023 and kept that target in 2024, while the actual allocation climbed from 8 % to 9 % (2022: page 110; 2023: page 92; 2024: page 99).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces Boeing (BA likely interpreted as Boeing) and cites specific pages, but the original answer refers to a firm 'BA' whose investment strategy evolves in private equity vehicles. However, the ground truth does not mention Boeing, nor does it include any data about target allocations (4% in 2022, 7% in 2023) or actual allocations (8% to 9%). These percentages are entirely absent from the original answer and appear to be fabricated or misattributed. Thus, the quantitative claims are incorrect and unsupported by the ground truth. (2) There is no mention in the original answer of allocation percentages or changes in target/actual allocations, so the numerical data in the LLM response fails verification. The original focuses on geographic scope (U.S. and non-U.S.) and strategic focus evolution (e.g., expansion into real assets like energy, farmland, infrastructure, and use of derivatives), none of which are addressed in the LLM answer. (3) The multi-hop reasoning is flawed: while the LLM identifies a consistent focus on U.S. and non-U.S. strategies, it fails to capture the strategic evolution—particularly the 2023 expansion into global real assets and the 2024 use of derivatives and performance transfer mechanisms. These key qualitative shifts are omitted, breaking the chain of reasoning required by the question. (4) The contextual relevance is moderate because the answer discusses limited partnership investments in private equity across years and geographies, which aligns with the question’s scope. However, due to significant factual inaccuracies (invented percentages), missing core developments, and failure to synthesize the actual strategic evolution, the overall correctness is low. The answer is partially on-topic but factually divergent from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 495,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen began phase 3 trials of Bemarituzumab for gastro‑esophageal junction adenocarcinoma in 2022, and the 2023 and 2024 10‑K filings confirm the program remains in phase 3 with no status change (see the “Phase 3 programs” tables in each filing).  The composition‑of‑matter patents for Bemarituzumab are projected to expire in 2029 in both the United States and Europe, a date that has not shifted across the 2022‑2024 filings (see the “Phase 3 Product Candidate Patent Information” tables).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen initiated a phase 3 trial for Bemarituzumab in GEJ adenocarcinoma in 2022, the drug remained in phase 3 through 2023–2024, and composition-of-matter patents are set to expire in 2029 in both the U.S. and Europe—this matches the original answer’s timeline and patent expiration data. (2) Quantitative accuracy is perfect: the years (2022, 2023, 2024, 2029) are correctly cited, and no calculations are required. (3) Multi-hop reasoning is sound—the LLM synthesizes information across multiple years of 10-K filings to confirm consistent trial phase and patent expiry, demonstrating proper cross-document inference. (4) The only minor shortcoming is that the LLM omits the detail about Bemarituzumab being a monoclonal antibody targeting FGFR2b and the mention of regulatory exclusivity in 2024, which adds scientific and strategic context present in the original answer. While not critical to the core facts, this nuance slightly reduces qualitative completeness. However, the omission does not detract from factual correctness or the main progression and IP timelines. Overall, the answer is precise, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 351,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn stayed listed as a major brand in P&G’s Fabric & Home Care segment throughout 2022‑2024, with the segment’s earnings contribution rising from 31 % of net earnings in 2022 to 34 % in 2023 and remaining at 34 % in 2024【page_19】【page_18】【page_18】. The unchanged brand lineup—Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer—shows Dawn’s consistent prominence while the segment’s growing profitability underscores its strengthened positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Dawn remained a listed brand in the Fabric & Home Care segment from 2022 to 2024 and accurately reports the segment’s earnings contribution increasing from 31% in 2022 to 34% in 2023 and 2024. However, the ground truth specifies the 34% figure for 2024, not 2023, and does not confirm 2023 earnings data—thus the LLM slightly misattributes the timing of the increase. All other numbers (stable net sales at 35%-36%) are not mentioned in the LLM answer, leading to a minor omission. (2) The earnings percentages (31%, 34%) are factually correct in value but partially misassigned across years. The brand list is accurately reproduced, confirming Dawn’s consistent inclusion. (3) The reasoning correctly infers that Dawn’s ongoing presence in the segment and rising earnings contribution reflect strengthened positioning, which aligns with the multi-hop logic of combining brand listing stability with segment performance trends. However, the LLM omits the nuance about stable sales percentage (35%-36%), which supports the conclusion of strategic stability despite earnings growth. (4) The answer is highly relevant, directly addressing Dawn’s positioning evolution through both brand listing and segment performance. The minor error in year attribution and omission of sales stability details prevent a perfect score, but core facts and synthesis are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 391,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "Schwab’s margin‑lending program grew between 2022 and 2024, with the fair value of client securities available to be pledged rising from $84.0 B in 2020 to $120.3 B in 2021 (and the amount pledged to third parties increasing from $23.0 B to $31.4 B) 【page_108】. By 2024, the company’s IDA balances—client cash swept into deposit accounts—fell from $97.5 B in 2023 to $87.6 B (page 100), yet the continued use of client securities for collateral and margin lending indicates that Schwab’s exposure to client‑held assets remains substantial and has expanded in terms of pledged securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) The numbers cited—$84.0B in 2020 and $120.3B in 2021—are completely incorrect in the context of the question, which asks about 2022–2024. These figures do not align with the ground truth and appear to misrepresent data from unrelated years. There is no mention in the ground truth of specific dollar amounts for pledged securities, so providing such precise but incorrect figures reduces credibility. (2) The answer references IDA balances declining from $97.5B to $87.6B between 2023 and 2024, which may be accurate internally but is irrelevant to the core question about the use and pledging of client securities for margin lending and collateral obligations. (3) The ground truth emphasizes evolving accounting practices (ASC 326), regulatory compliance, and specific use cases like options clearing and securities lending—none of which are mentioned in the LLM response. Instead, the model focuses on margin loan growth using fabricated data, failing to capture the nuanced evolution described in the original answer. (4) Multi-hop reasoning is weak: the model does not synthesize information across years regarding policy changes, regulatory alignment, or operational sophistication. It incorrectly implies a continuous upward trend based on outdated data and fails to explain what the trend indicates about exposure to client-held assets beyond a superficial claim of 'substantial exposure.' While the general theme of increased pledging is partially aligned, the lack of accurate details, wrong time frame, and absence of key qualitative developments result in a mostly incorrect answer. Minor credit is given for recognizing that Schwab uses client securities for collateral, which is contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 490,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN’s 2023 target allocation for Non‑U.S. plans was 48 % debt, 27 % equity, 4 % cash, 11 % insurance contracts and 10 % other, shifting in 2025 to 36 % debt, 28 % equity, 7 % cash, 21 % insurance and 8 % other (U.S. plans remained at 100 % debt). The weighted‑average plan‑asset mix as of Aug 31 2022–2024 shows a gradual move toward that 2025 mix: debt fell from 50 % (2022) to 43 % (2023) to 42 % (2024); equity dipped to 19 % in 2023 then rose to 23 % in 2024; cash rose to 6 % in 2023 then 5 % in 2024; insurance climbed to 22 % in 2023 then 21 % in 2024; and other fell to 9 % in 2024. For U.S. plans, debt stayed above 94 % and cash increased from 3 % to 6 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to match the ground truth on key factual and quantitative dimensions. (1) The numbers provided are factually wrong: the ground truth states that ACN's weighted-average plan asset allocations were 55% fixed income / 45% equities in 2022 (fiscal 2023), 58/42 in 2023 (fiscal 2024), and 61/39 in 2024 (fiscal 2025). The LLM instead reports debt (fixed income) falling from 50% to 42%, which contradicts the actual upward trend from 55% to 61%. Equity allocations are also wrong—LLM says equity dropped to 19% in 2023 and rose to 23% in 2024, whereas ground truth shows a decline from 45% to 39%. (2) The LLM introduces a breakdown by U.S. and Non-U.S. plans not present in the original question or answer, including categories like 'insurance contracts' and 'other' that are not in the ground truth. It also claims U.S. plans were 100% debt, which is unsupported. These details appear fabricated or misattributed. (3) The multi-hop reasoning is flawed: the question asks for evolution based on disclosed weighted-average allocations as of August 31 in 2022, 2023, and 2024—three data points showing a clear de-risking trend. The LLM fails to report these correctly and instead invents a narrative about shifting toward a '2025 mix' that does not align with the actual disclosed trend. (4) The conclusion that debt decreased is the opposite of the truth—ACN increased fixed income exposure each year. While the answer attempts to describe a trend over time and references the correct time frame (Aug 31, 2022–2024), the core data and direction of change are incorrect, leading to a very low correctness score. Minor credit is given for addressing the general topic and time frame.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 466,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023 and then declined to $44.9 billion in 2024. Over the three years the company shifted from a mix that included $349 million of floating unsecured senior debt in 2022 to virtually all fixed‑rate debt by 2024, and the weighted‑average interest rate on long‑term debt climbed from 3.48 % to 4.84 %, reflecting a more fixed‑rate structure and a higher cost of borrowing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports short-term borrowings as $883M, $538M, and $562M, and long-term debt as $47.8B, $49.3B, and $44.9B—these do not align with the total debt figures in the original answer. The LLM appears to have split and misrepresented the components rather than reporting the correct aggregated or itemized values. (2) The weighted-average interest rate on long-term debt is completely wrong: the LLM claims it rose from 3.48% to 4.84%, while the ground truth shows an increase from 1.51% (2022) to 3.01% (2023) to 3.48% (2024). The LLM has reversed the starting and ending rates. Additionally, the floating unsecured senior debt is reported as $349M in 2022 by the LLM, but the ground truth states $1,597M in 2023 and $0 in 2024—another mismatch in both amount and timing. (3) The multi-hop reasoning is partially sound in that the LLM identifies a shift toward fixed-rate debt and rising borrowing costs, which is consistent with the trend in the original answer. However, because the underlying data is incorrect, the conclusions are not well-supported. The synthesis across years and debt types is conceptually appropriate but based on false inputs. (4) The contextual relevance is fair—the answer addresses debt evolution, structure, and interest rate exposure as asked—but due to severe quantitative errors and incorrect entity values, the correctness score is low. Minor credit is given for identifying a strategic shift in debt structure, though even this is based on inaccurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 479,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Boeing’s fleet‑support costs have stayed at roughly **1 % of total consolidated costs** each year from 2022 through 2024 (see the 2023 and 2024 10‑K notes on fleet support).  In contrast, abnormal production costs for the 787 program climbed to **$2.7 billion in 2023** (page 36), and reach‑forward losses for the 777X program rose to **$2.608 million in Q3 2024 and $891 million in Q4 2024** (page 39).  The stable fleet‑support expense underscores that the company’s operating losses are driven by program‑specific cost overruns rather than support‑service costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that Boeing's fleet support services costs remained at approximately 1% of total consolidated costs from 2022 to 2024, which matches the ground truth. It also correctly notes the $2.7 billion in abnormal production costs for the 787 program in 2023. However, there is a critical error in the 777X reach-forward loss amount: the LLM states '$2.608 million' in Q3 2024, but the ground truth reports '$2,608 million' (i.e., $2.608 billion). This is a significant magnitude error—off by a factor of 1,000—making the quantitative accuracy substantially flawed. The Q4 2024 loss of $891 million is correct.\n\n2) Number verification: \n   - 1% fleet support cost ratio (2022–2024): Correct ✅\n   - $2.7 billion 787 abnormal costs (2023): Correct ✅\n   - $2,608 million (not million) 777X Q3 2024 loss: Incorrect ❌ (LLM says $2.608 million)\n   - $891 million 777X Q4 2024 loss: Correct ✅\n   This error undermines the financial magnitude interpretation.\n\n3) Multi-hop reasoning is sound: the LLM correctly contrasts stable fleet support costs with rising program-specific losses, inferring that financial strain stems from production issues, not service costs. It synthesizes across cost categories and programs appropriately, showing good qualitative understanding.\n\n4) Despite the major numerical error, the overall structure, entity identification (Boeing, 787, 777X, fleet support), time periods, and logical conclusion are accurate and relevant. The answer addresses both parts of the question and draws the correct implication. The correctness score is reduced due to the severe quantitative inaccuracy in the 777X loss figure, but not to a failing level because most elements are right and the core reasoning holds. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 484,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie’s balance sheet shows a clear shift in its short‑term asset mix: money‑market funds and time deposits fell from **$21 million in 2022** (page 79) to **$10 million in 2023** (page 79) and remained at **$10 million in 2024** (page 84). This decline and subsequent plateau indicate a deliberate move to hold more cash in liquid cash and equivalents rather than short‑term market instruments, reflecting a conservative liquidity strategy that prioritizes immediate availability and minimal market‑risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. According to the ground truth, AbbVie's allocation was $12M in 2022, $21M in 2023, and $10M in 2024. The LLM incorrectly states $21M in 2022, $10M in 2023, and $10M in 2024—reversing the trend and misrepresenting the data. This includes a complete inversion of the 2022 and 2023 figures and omission of the 2023 increase. (2) Quantitative accuracy is severely compromised: the correct sequence shows an increase then decrease, while the LLM reports a decrease and plateau. No calculations are required, but the comparisons are invalid due to incorrect inputs. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the year-over-year changes across the three years. The conclusion about a 'deliberate move to hold more cash' and 'conservative liquidity strategy' may seem plausible but is based on incorrect data, undermining the validity of the interpretation. (4) Contextual relevance is moderate—the answer addresses short-term liquidity strategy and references the correct type of instruments and time frame—but the incorrect data renders the analysis misleading. The mention of specific pages suggests source grounding, but the numbers do not align with the ground truth. Overall, major factual inaccuracies result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 383,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "Accenture repurchased **$4.111 billion** of shares in fiscal 2022, with a remaining authorization of **$6.129 million** (page 94–95).  In fiscal 2024 the company bought **$4.5 billion** of shares and the board approved an additional **$4 million** of authority, raising total outstanding authorization to **$6.694 million** (page 39–40).  The steady rise in both repurchase volume and available authority shows Accenture is deliberately expanding its capital‑return program to deliver greater value to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that Accenture repurchased $4.111 billion in fiscal 2022 and had a remaining authorization of $6.129 million, while the ground truth reports $3,129,296 thousand ($3.129 billion) in available authorization at the end of fiscal 2022—not repurchases made. The $6.129 million figure appears to be a misreading of the data (possibly confusing dollars with thousands). Similarly, the claim of $4.5 billion in repurchases in fiscal 2024 is unsupported by the ground truth, which does not specify annual repurchase amounts but focuses on authorization changes. The additional $4 million (not $4 billion) is also wrong—the correct figure is $4,000 million ($4 billion). The final total authorization of $6,694 million is correct for fiscal 2024, but the path to get there is factually flawed. (2) Quantitative accuracy is severely compromised: repurchase volumes are fabricated or misread, remaining authorizations are off by orders of magnitude (millions vs. billions), and the increase in authorization is understated by a factor of 1,000. (3) The multi-hop reasoning is partially sound in intent—recognizing a trend of increasing authorization and linking it to capital return strategy—but fails because it is based on incorrect data. The synthesis across years is attempted but invalid due to input errors. (4) Contextual relevance is moderate: the answer addresses the question’s theme and attempts to interpret strategic implications. However, due to severe numerical inaccuracies and missing correct data points (e.g., cumulative $50.1 billion by 2023), the qualitative and correctness scores are low. The conclusion about expanding capital return is directionally correct but not well-supported by the cited (incorrect) figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 494,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s amended and restated certificate of incorporation has consistently included a clause that “stockholders may only remove directors for cause.” The same language appears in the 2022 filing (see page 46), the 2023 filing (page 27), and the 2024 filing (page 27). By maintaining this restriction year after year, AbbVie is deliberately entrenching its board—limiting shareholder power to replace directors and thereby strengthening its long‑term defense against hostile takeover attempts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie maintained the 'removal for cause only' provision in its governance documents across 2022, 2023, and 2024, citing the consistent language in each year's 10-K filing. The page numbers referenced (2022: p.46, 2023: p.27, 2024: p.27) are specific and plausible, though not independently verifiable from the knowledge graph; however, their inclusion does not contradict the ground truth. (2) There are no numerical values requiring calculation, so quantitative accuracy pertains to correct referencing of years and document locations, which are accurate. (3) The reasoning correctly infers that the consistent retention of this provision reflects a deliberate board entrenchment strategy and strengthens takeover defenses—this is a sound multi-hop synthesis across three years of filings and aligns with the broader context of anti-takeover mechanisms. (4) The LLM omits mention of related provisions like staggered boards, special meeting restrictions, and supermajority requirements, which were included in the original answer and provide fuller context for the takeover defense strategy. This makes the answer slightly less complete but does not detract from the core factual accuracy or main conclusion. Overall, the answer is semantically equivalent in substance and correctly interprets the strategic implication, warranting a high score with only minor room for added contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 412,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo lists the 4.000 % Senior Note due 2047 in the exhibits section of every 10‑K.  In the 2022 filing (page 127, line 4.16), the note is described as “Form of 4.000 % Senior Note due 2047, incorporated herein by reference to Exhibit 4.5 to PepsiCo, Inc.’s Current Report on Form 8‑K filed on May 2 2017.”  The same wording appears unchanged in the 2023 filing (page 127, line 4.16) and again in the 2024 filing (page 127, line 4.16).  \n\nThe unaltered, repeated disclosure indicates that the note is a long‑standing, fixed‑rate debt instrument that PepsiCo continues to hold as a core component of its long‑term capital structure, reflecting a strategy of maintaining a stable, diversified mix of senior notes to support financing needs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 4.000% Senior Note due 2047 is correctly identified, and the disclosure in each year (2022, 2023, 2024) consistently references Exhibit 4.5 from the May 2, 2017 8-K filing—this matches the ground truth exactly. The inclusion of specific page (127) and line (4.16) details adds precision beyond the ground truth but does not introduce error. (2) Quantitative accuracy is perfect: the interest rate (4.000%), maturity year (2047), and filing date (May 2, 2017) are all correct and consistently reported. No calculations are required, but the repetition across years is accurately noted. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three annual 10-K filings and infers the strategic implication—that the unmodified disclosure reflects stability in PepsiCo’s long-term capital structure. (4) The conclusion about the note being a 'core component' and reflecting a strategy of maintaining a stable, diversified debt portfolio aligns with the ground truth’s interpretation of the note as a 'stable, long-term component' with no changes since issuance. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 367,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle issued the 4.30% Note due 2034 in 2014, and it has been continuously disclosed in the company’s Form 10‑K as Exhibit 4.09 in both the 2023 and 2024 filings (see page 110 of each filing).  The 2022 10‑K pages we examined (111‑115) do not list the note as a separate exhibit, indicating it was not a new issuance that year but remains a standing liability.  This steady, long‑term disclosure pattern shows Oracle’s strategy of locking in fixed‑rate debt with extended maturities to manage interest costs and maintain a diversified, multi‑decade debt portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly the claim that Oracle issued the 4.30% Note due 2034 in 2014, which directly contradicts the ground truth stating it was first disclosed in 2022. This is a major error in date and event chronology. Additionally, the ground truth does not mention Exhibit 4.09 or specific page numbers (e.g., page 110), which appear to be fabricated or overly specific unsupported details. However, the LLM correctly identifies the note's continued disclosure in 2023 and 2024, aligning with the ground truth’s emphasis on consistent reporting. (2) The quantitative inaccuracies include the incorrect issuance year (2014 vs. 2022) and the unsupported claim about exhibit numbers and pages, undermining the answer's reliability. While the interest rate (4.30%) and maturity year (2034) are correct, the erroneous issuance date leads to flawed reasoning about the note’s history. (3) The multi-hop reasoning is partially sound—the LLM attempts to infer Oracle’s long-term debt strategy from disclosure patterns across years, concluding Oracle uses fixed-rate, long-term debt for stability and diversification. This aligns semantically with the ground truth’s interpretation of a stable, diversified debt strategy. However, the faulty premise (issuance in 2014) weakens the logical foundation. (4) Despite the factual error, the answer remains contextually relevant by addressing all parts of the question: evolution across years and strategic implications. It synthesizes information across 2022–2024 disclosures and draws a reasonable conclusion about debt strategy, albeit based on incorrect origins. Thus, the correctness score is 5 due to partial accuracy with a major factual flaw, quantitative accuracy is low (4), qualitative reasoning is moderate (6), and relevance is high (8).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 501,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "In FY 2022 the Amended 2010 SIP authorized 127 million Class A shares (page 91), a level that remained unchanged in FY 2023 (no change disclosed). By FY 2024 the authorization had increased to 141 million shares (page 98). This incremental expansion shows Accenture’s deliberate strategy to broaden its share‑based incentive pool, giving it greater flexibility to reward employees and align their interests with shareholders over the long term.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline of share authorization changes. It states that the 127 million shares remained unchanged in FY 2023 and then increased to 141 million in FY 2024, which contradicts the ground truth: the increase from 127M to 141M occurred between FY 2022 and FY 2023, and the level remained at 141M in FY 2024. This misplacement of the increase by one fiscal year undermines the quantitative and logical accuracy. (2) While the numeric values (127 million and 141 million) are correct and properly formatted, the assignment to fiscal years is incorrect. The calculation of a 14 million share increase is implied but attributed to the wrong period. (3) The multi-hop reasoning is partially sound—recognizing a strategic expansion in share-based compensation capacity—but fails because it misaligns the timing of the change, leading to flawed synthesis across years. The conclusion about long-term strategy is reasonable but based on incorrect temporal progression. (4) Contextual relevance is high as the answer addresses both the evolution of shares and the strategic implication. However, due to the key error in fiscal year alignment, the correctness, quantitative, and qualitative scores are significantly reduced despite accurate raw numbers and relevant interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 373,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo first issued the 2.750% Senior Note due 2051 in an 8‑K filing on Oct. 21, 2021, which the 2022 and 2023 10‑Ks incorporated as Exhibit 4.3 (page 128; page 129). The 2024 10‑K adds a board resolution authorizing the note’s terms and re‑incorporates it as Exhibit 4.3 (page 130), indicating a reaffirmation or new issuance. The coupon rate of 2.750 % and maturity of 2051 remained unchanged across the filings, underscoring PepsiCo’s disciplined long‑term debt strategy and its consistent, transparent documentation to support capital‑structure stability.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the 2.750% Senior Note due 2051 was first issued in an 8-K filing on October 21, 2021, and incorporated in the 2022 and 2023 10-Ks as Exhibit 4.3. However, the ground truth states that the note was first introduced in 2022 in Exhibit 4.60 as part of a Board resolution, not in 2021, and not as Exhibit 4.3. The exhibit numbers and years are therefore incorrect. The 2024 10-K reference to Exhibit 4.3 is also inconsistent with the ground truth, which reports Exhibit 4.48 in 2024 (not 4.3), and shows a progression from 4.60 (2022) to 4.51 (2023) to 4.48 (2024), indicating evolving exhibit numbering, not reuse of the same exhibit. (2) Quantitative accuracy is low: the date (Oct 21, 2021) is incorrect—ground truth shows no mention in 2021; the exhibit numbers (4.3 across all years) are wrong—truth shows 4.60, 4.51, 4.48; only the coupon rate (2.750%) and maturity (2051) are correct. (3) Multi-hop reasoning is flawed: the LLM fails to trace the actual evolution of documentation (authorization → formal form → consistency), instead asserting repeated incorporation of the same exhibit, which contradicts the phased progression shown in the ground truth. It misses the strategic implication of moving from board resolution to dedicated form to stable documentation. (4) Contextual relevance is moderate—the answer addresses long-term debt strategy and consistency in terms, but the incorrect timeline and exhibits undermine the validity of the conclusion about PepsiCo’s strategy. The reasoning is based on false premises, leading to an incorrect interpretation of the filing pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 456,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "In 2022, American Express was the fourth‑largest general‑purpose card network, competing with Visa, Mastercard and UnionPay while emphasizing premium and cobrand relationships (see page 12). By 2024, heightened regulatory scrutiny—particularly around interchange‑fee caps, network routing and merchant‑fee structures—has increased compliance costs and eroded discount revenue, prompting the company to exit licensing activities in the EU and Australia (page 34). At the same time, the rapid expansion of alternative payment mechanisms such as digital wallets, open‑banking and buy‑now‑pay‑later has intensified competition, forcing AmEx to invest more heavily in technology and differentiated value propositions to maintain its competitive position (pages 12, 34, 35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest general-purpose card network from 2022 to 2024, behind China UnionPay, Visa, and Mastercard. The emphasis on premium offerings, cobrand relationships, and loyalty systems in 2022–2023 is accurately reflected. (2) There are no numeric inaccuracies—though no specific dollar amounts or percentages appear in either answer, the temporal references (2022, 2024) and regulatory developments are correctly cited. The mention of exits from EU and Australia aligns with the original answer’s reference to market exits due to EU regulatory pressure (minor expansion to Australia is plausible context not contradicted by ground truth). (3) Multi-hop reasoning is sound: the LLM synthesizes competitive positioning, regulatory trends, and alternative payment growth across time. It correctly links regulatory scrutiny (interchange fees, routing practices) to strategic consequences (exits, compliance costs), and identifies competitive pressure from digital wallets, open banking, and BNPL—consistent with Alipay, PayPal, and similar platforms in the original. (4) The only minor gap is that the original specifies regulatory focus on cobrand arrangements in the EU, which the LLM omits, instead generalizing to licensing activities. This is a slight loss in precision but does not undermine the overall correctness. Wording differs but semantic equivalence is strong. The answer fully addresses the evolution in competitive positioning in light of regulation and alternative payments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 443,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing’s 2024 10‑K (page 5) still lists “upgrades and conversions” as a core offering of its Global Services segment, the same wording used in the 2022 10‑K (page 5).  The unchanged emphasis indicates that the company’s services strategy remains focused on life‑cycle support and modernization, positioning upgrades and conversions as a key driver of recurring revenue and customer loyalty.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key strategic developments from 2023 to 2024 that are central to the question. (1) It correctly identifies that 'upgrades and conversions' remained listed in both 2022 and 2024 10-K filings, which aligns with the ground truth. However, it fails to note the shift in emphasis toward 'modifications' in 2023 and the introduction of 'data analytics and digital services' in 2024 as complementary to upgrades—critical elements showing strategic evolution. (2) There are no numeric inaccuracies since the answer avoids quantitative claims, so quantitative accuracy is high. (3) The reasoning is flawed in terms of multi-hop synthesis: the model does not connect changes across years or interpret the implications of evolving language in the filings. Instead, it concludes that 'unchanged wording' implies unchanged strategy, which contradicts the ground truth showing a progressive strategic shift despite similar categorization. (4) Contextual relevance is strong because the answer addresses Boeing's services strategy and ties upgrades to recurring revenue, but it lacks depth in analyzing the transformation toward technology-enabled, high-value services. Overall, the answer captures surface-level consistency but misses the nuanced, forward-looking strategic shift documented in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 373,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo’s 5.50% Senior Note due 2035 (Series A) was issued in 2018 and is cited in the 2022 and 2023 Form 10‑K as Exhibit 4.4 to a prior Form 8‑K. In the 2024 10‑K the note appears twice – still as Exhibit 4.4 to the 8‑K and also as Exhibit 4.6 to the 2018 registration statement – reflecting a re‑issuance or amendment and an updated regulatory filing. This consistent, multi‑year disclosure shows PepsiCo’s disciplined long‑term debt strategy, ensuring transparency, regulatory compliance, and a stable, diversified debt mix over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. The exhibit numbers cited (Exhibit 4.4) do not match the ground truth (Exhibit 4.31 in 2022, 4.25 in 2023, 4.23 in 2024), and the claim that the note appears twice in the 2024 10-K with a new exhibit (4.6) tied to a 2018 registration statement is unsupported by the original answer. The ground truth states the note was consistently referenced in one exhibit per year, all pointing back to the same November 8, 2018 8-K filing, with no evidence of re-issuance or amendment. The LLM incorrectly infers a 're-issuance or amendment' based on non-existent documentation, which is a significant factual error. (2) The issuance date (2018) and interest rate (5.50%) are correct, and the due date (2035) is accurate. However, the exhibit numbers and filing details (e.g., Exhibit 4.6 to a 2018 registration statement) are incorrect or fabricated. There is no mention in the ground truth of a registration statement filing or dual exhibits in 2024. (3) The multi-hop reasoning is partially sound in that the model recognizes the importance of tracking the note across years and linking it to long-term debt strategy. However, it draws an incorrect conclusion about re-issuance due to flawed document references, undermining the reasoning. The original answer emphasizes stability and lack of modification, while the LLM suggests active re-filing or amendment, which contradicts the evidence. (4) The contextual relevance is high—the answer addresses the evolution across years and attempts to interpret strategic implications. However, due to key factual and document-level errors, the correctness and qualitative accuracy scores are moderate. The answer conveys a plausible narrative but misrepresents the actual filing pattern, leading to an incorrect inference about PepsiCo’s actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 501,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "From 2022 through 2024, BNY Mellon’s risk‑factor disclosures have consistently stated that its ability to return capital to shareholders is “subject to the discretion of the Board and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The identical wording on page 5 of each 10‑K shows that the regulatory constraints on capital‑return policies have remained unchanged, underscoring that banking supervision continues to impose a persistent limitation on the company’s dividend and share‑repurchase decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that BNY Mellon's capital return policies from 2022 to 2024 are constrained by U.S. banking laws, Delaware law, and preferred stock dividend obligations, with consistent language across the 10-K filings. This matches the original answer’s core claim about persistent regulatory constraints. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years and correctly infers that unchanged wording in the 10-Ks (specifically on page 5) indicates stable regulatory constraints, which supports the conclusion of ongoing prudential oversight. The only minor shortcoming is that the LLM does not explicitly mention the 2024 emphasis on maintaining 'well capitalized' status, a small but relevant detail in the evolution of risk disclosure. (4) Despite this omission, the answer captures the essential continuity and regulatory context, making it semantically equivalent in intent and meaning. The answer is fully relevant, directly addressing the evolution and implications of regulatory constraints on capital planning and shareholder returns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 369,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in 2021 at a 2.300% coupon (Exhibit 4.14, page 111) and the company did not amend or re‑issue those notes through 2024, as no changes appear in the 2023 or 2024 10‑Ks (pages 111–112). In 2023 Oracle issued new 4.500% Notes due 2028 (Exhibit 4.16, page 111), showing an opportunistic shift to higher‑rate debt as market rates rose and illustrating Oracle’s flexible fixed‑income strategy that balances low‑rate opportunities with cost‑of‑capital considerations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 2.300% coupon rate, the 2021 issuance (via Officers' Certificate filed in 2022 10-K), and the 2023 issuance of 4.500% Notes due 2028 are all factually correct and properly cited to exhibit numbers and pages. The absence of amendments to the 2.300% Notes through 2024 is correctly noted. (2) The LLM correctly identifies that no changes were made to the original 2.300% Notes in 2023 or 2024, which matches the ground truth's assertion of stable terms. It also accurately reports Oracle’s new 4.500% issuance in 2023, reflecting a shift toward higher-cost debt as rates rose. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 to 2024 filings), identifies the lack of changes to existing notes, and contrasts this with new issuance activity, correctly inferring a strategic response to rising interest rates. (4) The only minor omission is that the ground truth mentions the broader multi-tiered offering context (e.g., 2.875% and 3.950% tranches), which adds depth to Oracle’s fixed-rate financing strategy. While the LLM captures the core strategic insight—opportunistic use of low rates and adaptation to higher rates—it doesn’t fully elaborate on the 2021 multi-tranche structure, slightly reducing qualitative completeness. However, the central conclusion about Oracle’s flexible, rate-environment-responsive strategy is semantically equivalent and well-supported. Wording differences do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 438,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "IBM’s 10‑K filings for 2022, 2023, and 2024 all list “client relationships and trust” as a key competitive differentiator (IBM_10k_2022 p.3; IBM_10k_2023 p.3; IBM_10k_2024 p.3), with no change in wording or relative emphasis. This steady focus signals that IBM views deep, trusted client relationships as foundational to its hybrid‑cloud and AI strategy, reinforcing its positioning as a trusted partner in a highly competitive market. By consistently highlighting this factor, IBM underscores that client trust is a core pillar for differentiating its hybrid‑cloud and AI offerings amid intense competition.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that IBM consistently listed 'client relationships and trust' as a competitive differentiator in its 10-K filings from 2022 to 2024, and the citations (IBM_10k_2022 p.3, etc.) align with the source structure. There are no numerical inaccuracies, so quantitative accuracy is perfect. However, the LLM fails to capture the evolution and nuance described in the ground truth: it claims there was 'no change in wording or relative emphasis,' which contradicts the original answer that outlines a clear progression—expanding from a broader strategy in 2022, reinforcing incumbency and innovation in 2023, and broadening strategic partnerships (e.g., Palo Alto Networks) in 2024. This lack of recognition of strategic evolution undermines the qualitative accuracy, as the multi-hop reasoning across years is oversimplified. The answer is contextually relevant and correctly identifies the strategic importance of trust in hybrid cloud and AI, but misses the key insight about increasing sophistication and contextualization of trust as a differentiator over time. Thus, while the core fact is correct, the synthesis and progression analysis are incomplete, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 345,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s average yield on foreign‑government bonds and obligations rose from 3.5 % in 2022 to 5.9 % in 2023 and 6.1 % in 2024 (Taxable investment securities, Non‑U.S., page 176).  The upward trend reflects a modest shift toward higher‑yielding sovereign debt as global rates climbed, yet the yields remain modest, indicating a conservative investment strategy that keeps interest‑rate risk exposure moderate.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, there is no mention of a 3.5% yield in 2022—instead, the original answer does not specify a yield for 2022 at all, only the dollar amounts and maturity distribution. The LLM incorrectly states yields for 2022 (3.5%), 2023 (5.9%), and 2024 (6.1%), whereas the ground truth reports a 6.45% yield in 2023 and 5.85% in 2024—contradicting the LLM's upward trend with an actual decrease. Additionally, the LLM cites a source 'Taxable investment securities, Non-U.S., page 176' not present in the original answer, introducing unverified data. (2) The dollar amounts and maturity distributions from the ground truth are completely omitted: $630M total in 2022, $628M maturing in one year, and the shift in 2024 to 2.03% maturing between 1–5 years are all missing or misrepresented. The LLM fails to report the key structural shift in maturity profile, which is central to the original answer’s conclusion. (3) The multi-hop reasoning is flawed: the original answer infers a strategic shift from ultra-short-duration to a more diversified maturity structure to manage interest rate risk. The LLM instead infers a conservative strategy based on 'modest' yields, which contradicts the ground truth’s indication of a tactical shift toward slightly longer durations in 2024. The LLM mischaracterizes the trend (upward vs actual decline from 6.45% to 5.85%) and thus draws an incorrect conclusion about risk exposure. (4) Despite incorrect facts and reasoning, the LLM attempts to address the question’s core themes—yield evolution and interest rate risk—giving it moderate contextual relevance. However, due to major quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 482,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s 2024 10‑K shows that government grant assistance used to offset capital expenditures for diagnostics testing grew from **$87 million in 2022 to $136 million in 2023 and $198 million in 2024** (with offset operating‑expense assistance of $49 M, $51 M, and $43 M, respectively)【page_70】.  The steady rise in grant‑backed cap‑ex reflects the company’s expanding investment in diagnostics‑testing capacity—primarily funded by BARDA and other agencies—and signals that diagnostics testing is becoming a key growth engine within Danaher’s broader health‑care portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for government grant funding used to offset capital expenditures in diagnostics testing technologies: $87 million in 2022, $136 million in 2023, and $198 million in 2024—matching the ground truth exactly. It also includes additional context (operating expense assistance) not required by the question but factually consistent. (2) All numbers are accurate and correctly attributed to the respective years; no calculation errors are present. The upward trend is correctly identified and quantified. (3) The multi-hop reasoning is sound: the model synthesizes data across years and correctly infers the strategic importance of diagnostics testing within Danaher’s healthcare portfolio based on increasing grant funding, aligning with the ground truth’s interpretation. Mention of BARDA adds contextual accuracy supported by typical funding sources in this domain. (4) The answer is semantically equivalent to the original, with slightly more detail but no factual deviation. All aspects of the question—evolution of investment, grant funding for cap-ex, and strategic implications—are fully addressed with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 340,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "BK’s disclosure of KPMG LLP’s PCAOB firm identification number stayed the same over the three years – the number “185” appears in the 2022, 2023, and 2024 filings.  In each filing the ratification is referenced in the Proxy as “Item 3 – Ratification of KPMG LLP,” with identical wording and placement, indicating no evolution in the presentation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the PCAOB identification number is correctly stated as '185' for all three years (2022, 2023, 2024), and the disclosure's placement under 'Item 3 – Ratification of KPMG LLP' in the Proxy materials is accurately described. (2) Quantitative accuracy is perfect—there are no calculations, but the repeated identification number is correctly cited across all years with no discrepancies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three fiscal years and confirms consistency in both content (PCAOB number) and structure (placement and wording in Proxy), demonstrating an accurate cross-temporal comparison. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in disclosure practices, and correctly concludes that there was no change in either the identification number or presentation format. Minor wording differences (e.g., 'stayed the same' vs. 'no change') do not affect factual equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 327,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "From 2022 through 2024, American Express continued to record discount revenue from third‑party merchant acquirers at the time of each card‑member transaction, with network‑rate fees treated as discount revenue (2022–23 notes [page_103], [page_104]). Contracts with merchants remained structured the same: small‑ and mid‑size merchants had no fixed term, while large merchants signed 3‑ to 7‑year fixed‑term agreements with auto‑renewal (2022–23 notes [page_103], [page_104]). The 2024 filing’s risk‑factor discussion confirms the company’s ongoing strategic goal of expanding global merchant coverage by leveraging third‑party acquirers, aggregators and processors (2024 risk factors [page_93], [page_94]).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details and correctly cites specific pages from the filings (e.g., 2022–23 notes [page_103], [page_104]; 2024 risk factors [page_93], [page_94]), with no errors in dates, revenue recognition timing, or contract terms. It correctly identifies that discount revenue was recognized at transaction time and accurately describes contractual structures for small/mid vs. large merchants. The mention of strategic expansion goals in 2024 via third-party acquirers, aggregators, and processors aligns with the ground truth. However, the LLM answer omits a key qualitative evolution highlighted in the original answer: the shift in 2023 to a broader 'Processed Revenue' model that includes royalties, fees, and structured network partnerships. This represents a significant strategic and accounting evolution from a transactional to a more integrated revenue-sharing framework, which the LLM fails to mention. While the LLM confirms ongoing reliance and strategic use of third-party acquirers, it does not capture the deepening structural integration and formalization of relationships in 2023. Thus, while all stated facts are correct (hence high quantitative accuracy and contextual relevance), the answer lacks completeness in conveying the full multi-hop evolution across revenue recognition structure and contractual depth. The reasoning is sound but incomplete, limiting qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 399,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2025 human‑capital targets were set in FY 2022 and repeated unchanged in FY 2023 and FY 2024: a 15 % increase in women in leadership, a 15 % increase in under‑represented‑minority (URM) leaders, and a 20 % increase in overall URM representation.  In each year the HR and Compensation Committee tied executive bonus payouts to progress on those goals, applying a non‑financial performance modifier that could adjust the bonus by a multiplier of 0.9 – 1.1.  Thus, from FY 2022 through FY 2024 the diversity targets and the bonus‑modifier framework remained the same.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 15% increase for women and URM in leadership, 20% overall URM representation target, and the 0.9–1.1 non-financial performance modifier for executive bonuses are all correctly stated and consistent with the ground truth across FY 2022–2024. These numbers are repeated accurately, and the linkage to executive compensation is correctly described each year. However, the LLM answer omits qualitative developments noted in the original answer for FY 2023 and FY 2024, such as Qualcomm’s recognition in multiple regions, participation in the Reboot Representation Tech Coalition, and the expansion of global engagement, wellness, and development programs. While the core structure of the compensation modifier remained unchanged, the original answer emphasizes an evolving, deepening integration of human capital metrics into corporate strategy—nuance that the LLM answer does not capture. This makes the response factually correct but less complete in conveying the evolution beyond static target repetition. The multi-hop reasoning is sound in linking compensation to diversity goals over time, but the synthesis of broader strategic integration is missing. Hence, full credit for quantitative accuracy and contextual relevance, minor deduction for completeness and qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 375,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar’s dealer network for EMD‑branded products contracted in 2023 and then rebounded in 2024.  In 2022 the company operated 44 U.S. and 116 non‑U.S. dealers that served 193 countries (page 76, 2022).  In 2023 the network shrank to 41 U.S. and 111 non‑U.S. dealers, covering 187 countries (page 66, 2023).  By 2024 it had returned to 44 U.S. and 116 non‑U.S. dealers and again served 193 countries (page 76, 2024).  The brief contraction followed by a full recovery indicates Caterpillar is fine‑tuning its dealer footprint for efficiency while reaffirming its commitment to a broad global distribution network.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numerical claims. According to the ground truth, Caterpillar's EMD-branded product distribution decreased from 193 countries in 2022 to 191 in 2023 and further to 187 in 2024. However, the LLM claims a drop to 187 in 2023 and a rebound to 193 in 2024, which directly contradicts the truth. The dealer numbers (e.g., 44 U.S. and 116 non-U.S. dealers) are not part of the ground truth and appear fabricated or misattributed. (2) The quantitative inaccuracies are severe: the LLM misreports both the country counts and their trend over time. It incorrectly states that coverage rebounded to 193 in 2024, when the truth shows a continued decline to 187. The cited page numbers and dealer counts introduce false precision and misleading sourcing. (3) The multi-hop reasoning is flawed because the LLM infers a contraction-and-recovery narrative, while the actual data shows a consistent downward trend. This leads to an incorrect strategic interpretation—instead of suggesting consolidation or challenges, the LLM posits a temporary adjustment followed by recovery, which is unsupported. (4) Despite the factual errors, the answer is contextually relevant, addressing the question's focus on geographic reach and strategic implications. However, due to major quantitative and qualitative inaccuracies, the correctness score is low. The answer fails on the primary metric of factual accuracy, especially in numbers and trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 412,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The repeated listing of Palmolive as a principal global trademark in the 2022‑2024 10‑Ks (pages 79, 77, 77) shows that the brand remains a core pillar of Colgate‑Palmolive’s Oral, Personal and Home Care portfolio. It signals that Palmolive continues to drive a substantial share of sales and brand equity in that segment, and that the company treats it as a strategic anchor for growth and market presence.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Palmolive has been consistently listed as a principal global trademark in Colgate's 10-K filings from 2022 to 2024, and correctly infers its strategic importance in the Oral, Personal and Home Care segment. The citation of specific page numbers (79, 77, 77) aligns with typical disclosure locations, and no numeric inaccuracies are present—dates and years are correct. The answer captures the core implication: Palmolive remains a strategic anchor for growth and brand equity. However, it lacks the detailed year-by-year synthesis found in the ground truth, such as the mention of Ajax and Darlie, or the specific product categories (liquid hand soap, dishwashing detergents, household cleaners) that ground the brand’s strategic role. While the reasoning is sound and contextually relevant, it does not fully reflect the multi-hop depth of the original answer, which tracks positional consistency and competitive context across three years. Thus, while semantically aligned and factually accurate, it omits key supporting details that demonstrate complete synthesis across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 320,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K projected that the IoT installed base would more than double by 2026, positioning edge‑networking (mobile broadband and wireless access points) as a key growth driver within its IoT portfolio, which it categorizes into consumer, edge‑networking, and industrial segments (page_8). In 2023 and 2024 the company maintained that emphasis, but IoT revenue fell from $7.35 B in 2022 to $5.94 B and $5.42 B, reflecting a shift toward mature markets and a focus on high‑margin equipment sales that are recognized at a point in time, with additional revenue from sales‑based royalties and unearned performance‑obligation balances (page_73). The revenue‑recognition structure for QCT IoT products remained point‑in‑time for equipment sales, while QTL licensing revenue is recognized over time and previously satisfied performance obligations and unearned revenue are disclosed (page_73).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies Qualcomm's IoT growth projection (more than doubling by 2026) and the role of Edge Networking as a key growth driver in 2022, tied to mobile broadband and wireless access points. It also correctly notes the product categorization into consumer, edge-networking, and industrial segments. However, it introduces revenue figures for IoT ($7.35B in 2022, $5.94B in 2023, $5.42B in 2024) that are not present in the original answer and contradict the ground truth, which does not mention any specific IoT revenue declines or dollar amounts. These numbers appear to be hallucinated or pulled from an external source not aligned with the provided ground truth. (2) Quantitative accuracy is low because the dollar amounts and implied revenue trend are factually unsupported in the original answer. The ground truth makes no mention of IoT revenue figures or declines, so these numbers are incorrect. There are no calculations in the original to verify, but the introduction of unsupported financial data significantly undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly tracks the continuity of Edge Networking’s strategic emphasis from 2022 to 2024 and links it to IoT and product categorization. It also correctly identifies the point-in-time revenue recognition for equipment sales and over-time recognition for licensing, which aligns with the QCT segment structure. However, it misrepresents the evolution by framing it around declining revenue, which distorts the strategic narrative of embedding Edge Networking as a structural pillar. The mention of 'unearned performance-obligation balances' and detailed revenue recognition mechanics, while plausible in a 10-K context, are not part of the original answer and add unsupported detail. (4) Despite the hallucinated revenue figures, the answer captures key qualitative elements: the 2026 IoT projection, the 2022 positioning of Edge Networking, the 2023–2024 continuity in categorization, and high-level revenue recognition structure. This prevents a lower score. Contextual relevance is high because the response stays focused on the question’s dimensions—positioning, product categorization, IoT role, and revenue recognition—though it adds extraneous detail. The correctness score is 5 due to significant factual errors in numbers that impact interpretation, even though some core strategic points are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 668,
        "total_tokens": 2185
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s 2022 10‑K (page 23) explained that currency‑exchange risk from its global operations was mitigated with hedging instruments and also warned of additional risks from exchange controls and currency devaluations. The 2023 (page 19) and 2024 (page 19) filings repeated the same hedging language—hedges protect against adverse moves but may forego upside—without mentioning exchange controls or devaluations. Thus, the company’s exposure and hedging strategy remained essentially unchanged, continuing to use hedges to dampen earnings volatility from its international activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its qualitative assessment of Caterpillar's disclosures from 2022 to 2024. While it correctly identifies that Caterpillar used hedging instruments to mitigate currency-exchange risk and that hedges protect against adverse moves but limit upside (a point consistent across years), it incorrectly states that the 2023 and 2024 filings did not mention exchange controls or currency devaluations. The ground truth confirms that in 2023, Caterpillar expanded its discussion to include risks from exchange controls and devaluations—particularly in emerging markets—and reiterated these concerns in 2024 with increased emphasis on macroeconomic volatility. The LLM falsely claims this language was absent in 2023 and 2024, which contradicts the original answer. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the years (2022, 2023, 2024) and page numbers cited (23, 19) are plausible and do not contradict the ground truth, so no numerical errors are present. (3) The multi-hop reasoning is flawed: the question asks for an evolution of risk management over time, but the LLM concludes that the strategy 'remained essentially unchanged,' missing the key progression in Caterpillar’s risk narrative—specifically, the growing concern over geopolitical and macroeconomic factors and the explicit mention of exchange controls and devaluation risks in later years. This represents a failure to synthesize the evolving qualitative disclosures across filings. (4) Contextual relevance is high because the answer addresses currency risk, hedging, international operations, and earnings volatility—all relevant themes. However, due to the incorrect characterization of the temporal evolution and omission of critical developments in 2023 and 2024, the qualitative accuracy and overall correctness are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 529,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "In 2022, 40 % of the U.S. pension plan’s fixed‑income portfolio was invested in Treasury or agency securities (page_102); this dropped to roughly 30 % in 2023 (page_100) and stayed at 30 % in 2024 (page_98). The decline and subsequent plateau suggest Colgate‑Palmolive is intentionally trimming its duration‑sensitive Treasury exposure and moving toward a more diversified fixed‑income mix to better manage interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the starting percentage and year. The original answer states that the allocation was 50% as of December 31, 2020 (disclosed in the 2022 filing), then dropped to 40% as of December 31, 2021, and further to 30% as of December 31, 2022. However, the LLM claims the 40% allocation was in 2022, which conflates the reporting year with the measurement date. This misalignment leads to an incorrect timeline. The LLM correctly reports the 30% allocation for 2023 and 2024, consistent with the ground truth. (2) The quantitative inaccuracies stem from misattributing the 40% figure to 2022 instead of 2021, effectively shifting the timeline backward by one year. While the 30% figures for 2023 and 2024 are correct, the evolution is misrepresented—there is no mention of the 50% starting point or the two-year decline. (3) The reasoning about strategic rebalancing and interest rate risk management is sound and aligns with the original interpretation. The conclusion about reducing duration-sensitive exposure and diversifying the portfolio is logically consistent with the trend, even if the timeline is off. The model correctly infers intent from the data pattern. (4) Despite the timeline error, the answer addresses both parts of the question—evolution of allocation and implications for interest rate risk—and uses appropriate financial reasoning. The contextual relevance is high, and the qualitative logic is strong, warranting a score of 7 for correctness. The quantitative accuracy is penalized due to the incorrect assignment of percentages to years, but not severely, as the latter data points are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 457,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "Pfizer disclosed BPA grant activity in both the 2022 and 2023 10‑Ks (page 99 of each filing), but the 2024 10‑K noted that no BPAs were granted and none were outstanding as of December 31, 2024 (page 94), although vesting from prior grants still occurred (page 96). Across 2022‑2024 the company consistently valued BPAs using the intrinsic‑value method based on the closing price of common stock at grant date and amortized over the vesting term, with no change in methodology (page 96 of the 2024 10‑K and page 99 of the 2023 10‑K). The 2024 disclosure simply reflected the absence of new grants, maintaining transparency while updating the status of BPA activity (page 94).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the evolution of Pfizer's BPA program from 2022 to 2024, leading to a low correctness score. (1) Quantitatively, the LLM incorrectly states that BPA grants were disclosed in the 2023 10-K and that no BPAs were granted or outstanding as of December 31, 2024—however, the ground truth confirms that no BPAs were granted in 2023 and none were outstanding as of December 31, 2023, not 2024. The LLM reverses the timeline: it claims grants occurred in 2022 and 2023, but the truth is that grants occurred only in 2022 (1,165 thousand shares), with no grants in 2023, and the program reappeared in 2024 with new valuation disclosures. The specific numbers (e.g., 1,165k shares, $38.73 intrinsic value, 859k nonvested) from 2022 are entirely omitted. (2) The valuation methodology claim is partially correct—the intrinsic value method was used—but the LLM asserts there was 'no change in methodology' across years, contradicting the ground truth that 2024 introduced a more dynamic framework including performance probability adjustments and stock price changes, indicating an evolution in valuation approach. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the three-year trajectory—active (2022), suspended (2023), then revived with enhanced transparency (2024)—and instead implies continuity. It incorrectly attributes vesting of prior grants in 2024 as evidence of ongoing activity, missing that the program was dormant in 2023. (4) Contextual relevance is moderate because the answer discusses the right topic (BPAs, valuation, disclosures) and cites correct filing pages, but the factual inaccuracies and reversed timeline severely undermine its validity. Overall, the answer misstates key facts, omits critical data, and presents an incorrect narrative of continuity rather than evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 505,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "Schwab’s RIA platform consistently offered the free Schwab Advisor Portfolio Connect and third‑party integrations for CRM, portfolio, trade‑order, and planning systems across 2022‑24 (2022, p. 7; 2023, p. 7; 2024, p. 7). Each year the firm deepened its portfolio‑management toolkit by embedding Ameritrade’s thinkpipes trading platform and iRebal rebalancing engine, adding real‑time charting, efficient trading/allocation, and customizable rebalancing to the RIA suite (2022, p. 8; 2023, p. 8; 2024, p. 8). Thus, while the core interactive tools remained stable, portfolio‑management capabilities expanded through the progressive integration of thinkpipes and iRebal, giving RIAs more advanced analytics and automated rebalancing.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) While it correctly identifies Schwab Advisor Portfolio Connect and third-party integrations as consistent offerings from 2022–2024, it fabricates key details about the integration of 'thinkpipes' (a non-existent platform; likely confusing TD Ameritrade’s thinkorswim) and 'iRebal' as embedded tools, which are not mentioned in the original answer or supported by the knowledge graph. These specific platform names and functionalities (real-time charting, customizable rebalancing via iRebal) are incorrect and unsupported. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not heavily penalized, but the citation of non-existent page numbers (e.g., '2022, p.8') undermines credibility. (3) The multi-hop reasoning is flawed: the original answer traces an evolution in platform usability and emphasis (e.g., document archiving in 2023, modern UX in 2024), but the LLM invents a technical evolution based on false integrations. It fails to mention the increased emphasis on the Advisor Services website or multi-year document archiving in 2023, and omits the 2024 focus on intuitive modern experience. (4) Contextual relevance is moderate because the answer addresses RIA tools and third-party integrations, but the incorrect technical details and fabricated enhancements severely undermine factual correctness. The core stability of tools is correctly noted, but the claimed 'progressive integration' of non-existent platforms makes the answer largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 448,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Texas Instruments has reiterated the same framing in each filing: its “strategic focus is on analog and embedded‑processing products, with embedded‑processing highlighted as a key growth engine—especially in industrial and automotive markets” (2022 p. 19; 2023 p. 19; 2024 p. 19).  The company also describes its business model as “focused on analog and embedded‑processing products” and lists embedded‑processing as one of the four sustainable competitive advantages that drive cash‑flow (2022 p. 18; 2023 p. 18; 2024 p. 18).  This unchanging emphasis signals TI’s long‑term positioning as a leader in high‑margin, long‑lived analog and embedded‑processing segments that underpin its cash‑flow generation and competitive edge in the semiconductor market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, citing the same framing in each year's filing and referencing specific page numbers (p. 18 and p. 19), which supports the claim of consistency. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification—only qualitative assertions about strategic focus—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the repeated emphasis reflects a long-term positioning strategy centered on high-margin, long-lived products that support cash flow. It accurately links embedded processing to TI’s sustainable competitive advantages and cash-flow generation, matching the core logic of the original answer. (4) While the LLM slightly rephrases the strategic pillar (e.g., calling embedded processing a 'key growth engine' and emphasizing industrial and automotive markets, which is plausible but not explicitly confirmed in the ground truth), it does not contradict the original. The ground truth emphasizes the 'broad portfolio' as part of a dual focus with analog, while the LLM highlights embedded processing more prominently as a growth driver. This is a minor interpretive difference but does not undermine factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 444,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s fleet‑support expense has remained essentially flat, consistently about 1 % of total consolidated product and service costs (see pages 40‑44 of the 2022 10‑K and pages 39‑44 of the 2024 10‑K).  Abnormal production costs for the 787 program were very high in 2023 ($2.7 B, page 36) but dropped sharply to $256 M in 2024 (page 39) as rework was completed and production rates began to recover.  Despite the cost‑control gains, delivery delays persisted—787 deliveries were slowed to below five per month in 2024 because of supply‑chain constraints and rework inventory, with the program expected to resume deliveries gradually in 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: fleet support services consistently ~1% of total costs (pages cited match context), abnormal production costs were $2.7B cumulative through 2023 and $256M in 2024, both figures matching the original answer. The drop from $2.7B to $256M is correctly interpreted as a sharp decline due to rework completion. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and years are correct. The $2.7B is properly described as cumulative through 2023 (not annual), and $256M as 2024 expense, consistent with ground truth. (3) Multi-hop reasoning is sound—LLM synthesizes data across 2022–2024 filings, correctly infers cost trend, links rework completion to cost reduction, and acknowledges ongoing delivery delays despite improvement. (4) Minor omission: the original answer notes that 25 inventoried aircraft were involved and that most rework was completed by 2024; this detail is missing in the LLM response, slightly reducing completeness. Also, the LLM implies $2.7B is for 2023 alone, though it's cumulative (though the phrasing 'in 2023' could be interpreted as 'reported in 2023'). However, this does not materially misrepresent the data. Overall, the answer captures the evolution accurately and remains semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 378,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold Meridian in 2021 for about $51 million in cash, recording a $167 million net loss.  After the sale, the company entered into transitional‑service agreements (TSAs) and a manufacturing‑supply agreement (MSA) that continued through 2023, with the TSAs completed by December 31 2023 and the MSA covering a three‑year post‑sale period with a two‑year extension option.  In 2022 and 2023 the amounts recorded under these arrangements were not material to Pfizer’s operations, and the MSA remains in effect through 2024, sustaining the post‑sale relationship【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Pfizer's relationship with Meridian from 2022 through 2024. (1) Quantitatively, the $167 million net loss is correct per the original answer. However, the $51 million cash sale price is not mentioned in the ground truth and appears to be an addition not supported by the provided knowledge graph, which only states the sale occurred on December 31, 2021, and the loss recognized. This introduces a minor factual inaccuracy. All other dates (TSA completion by December 31, 2023), the three-year MSA with a two-year extension option, and the non-material financial impact in 2022 and 2023 are correctly reported. (2) The answer correctly identifies the key contractual arrangements (TSAs and MSA) and their timelines, aligning with the multi-hop requirement across years. (3) Entity accuracy is strong: 'Meridian Medical Technologies, Inc.' is correctly referenced in context, and the agreements are properly named. (4) Reasoning is sound—LLM traces the transition from ownership to supplier relationship, notes diminishing financial impact, and correctly infers ongoing relevance via the MSA in 2024. The only gap is the unsupported $51 million figure; otherwise, the answer is semantically equivalent to the ground truth and fully addresses financial implications and contractual arrangements. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 385,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "From 2022 through 2024, Colgate‑Palmolive has kept the “hello” brand within its Oral, Personal and Home Care segment, consistently listing it among the company’s global trademarks. The 10‑K filings for 2022, 2023 and 2024 show no change in the brand’s strategic positioning relative to core brands such as Colgate and Palmolive, indicating a stable integration into the broader product portfolio. [page_79] [page_80] [page_81]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that from 2022 to 2024, Colgate-Palmolive consistently included 'hello' in its Oral, Personal and Home Care segment as a global trademark, maintaining its strategic positioning relative to core brands like Colgate and Palmolive. The answer correctly reflects the multi-year consistency in brand positioning, which is the central point of the original answer. It references the 10-K filings for all three years and correctly identifies the stability in 'hello's integration, which matches the ground truth's conclusion of sustained strategic emphasis. While the original answer adds contextual nuance—such as the introduction of Darlie in 2023 and the implication of continued prioritization—the LLM answer captures the essential facts and reasoning without introducing errors. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Colgate-Palmolive, 'hello', Oral/Personal/Home Care segment, years 2022–2024) are correct. The reasoning is sound and synthesizes information across years, though slightly less detailed than the original. Semantic equivalence is maintained. Minor deduction in qualitative accuracy due to omission of the Darlie addition context, but core multi-hop logic is intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 369,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "Texas Industries’ Non‑Qualified Defined Benefit Pension Plan has stayed unfunded and closed to new participants through 2022‑2024, with no new entrants or significant participant‑contributions reported in the filings【page_46】.  Because the plan remains unfunded and no additional employees are enrolling, the company’s long‑term pension liability for this plan is not being reduced and employee participation trends have stayed flat, indicating that TI is not actively addressing this obligation and may face unchanged or growing pension exposure in the future.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omissions. It incorrectly refers to 'Texas Industries' instead of 'Texas Instruments', which is a critical entity error. The answer fails to include any of the quantitative data provided in the ground truth—specifically the number of shares held in defined contribution plans (6M, 5M, 5M), their values ($940M, $873M, $852M), dividends ($28M, $27M, $26M), and defined contribution expenses ($70M, $75M, $76M). These numbers are central to the multi-year progression and trend analysis requested. (2) There are no correct numerical values reported, and no calculations or trends based on actual data. The claim that 'no additional employees are enrolling' is partially correct (the plan is closed), but the answer mischaracterizes the implications by suggesting the company is not addressing the obligation, whereas the ground truth shows a strategic shift toward funding defined contribution plans instead. (3) The multi-hop reasoning is flawed: the model fails to connect the unfunded status of the defined benefit plan with the increasing investment in and spending on defined contribution plans, which is the key insight indicating a strategic shift. Instead, it draws an incorrect conclusion about 'unchanged or growing pension exposure' without acknowledging the company's active management via contribution plan growth. (4) The contextual relevance is moderate because it addresses the funding status and participation, but the lack of data and incorrect reasoning severely limits usefulness. The qualitative accuracy is low due to entity and reasoning errors, and quantitative accuracy is nearly absent. Correctness is severely compromised by missing core data and misrepresenting the company's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 485,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term private‑equity holdings at cost declined from $800 million in 2022 to $755 million in 2023 and to $719 million in 2024, a cumulative drop of $81 million (≈10 %). This modest downward trend indicates the company is gradually trimming its private‑equity exposure, likely reallocating capital toward other assets or reducing risk in that segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. The LLM incorrectly states the 2022 value as $800 million (should be $623 million), leading to a false narrative of continuous decline. This error invalidates the quantitative and qualitative conclusions. (2) The calculation of a $81 million (≈10%) drop is based on incorrect starting figures and is therefore inaccurate. The actual change from 2022 to 2024 is an increase of $96 million ($719M - $623M), despite the 2023–2024 decrease. The LLM also fails to note the significant year-over-year increase in 2023, which is a key part of the trajectory. (3) The multi-hop reasoning is flawed because the model did not correctly synthesize the three-year trend: it missed the strategic increase in 2023 and misrepresented the overall direction. The conclusion that Pfizer is 'gradually trimming' exposure contradicts the ground truth showing a net increase over the period. (4) While the answer addresses the question's structure and discusses strategic allocation, the severe numerical inaccuracies and resulting incorrect interpretation of strategy severely undermine correctness. Contextual relevance is moderate because the response attempts the right analysis but on a false foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 401,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "Under the 2019 IDA agreement, Schwab could migrate up to $10 billion of IDA balances each year but only floating‑rate balances, and it had to keep a $50 billion minimum IDA balance and at least 80 % of balances as fixed‑rate; Schwab exercised this option in 2022. The 2023 IDA agreement replaced those terms, eliminating the 80 % fixed‑rate requirement but imposing new minimum/maximum limits ($30 billion above the total unmatured fixed‑rate obligations through Sept 10 2025, then $60 billion minimum and $90 billion maximum thereafter) and restricting withdrawals to customer‑initiated amounts, so Schwab did not migrate balances in 2023. Those same 2023 terms continued into 2024, with Schwab again unable to move IDA balances to its balance sheet and still required to maintain the prescribed minimum/maximum balances, have sufficient capital, and limit withdrawals.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. While it correctly states that Schwab did not migrate IDA balances in 2023 and 2024 under the 2023 agreement, it incorrectly claims that in 2022 Schwab migrated balances under a $10 billion annual cap on floating-rate balances only — the ground truth does not specify a floating-rate restriction, nor does it mention a $50 billion minimum IDA balance or an 80% fixed-rate requirement in the 2019 agreement. These constraints are fabricated and contradict the original answer. The LLM also invents tiered post-September 2025 limits of $60B minimum and $90B maximum, which are not present in the ground truth. (2) Quantitative accuracy is low: the $50B minimum, 80%, $60B/$90B thresholds are all incorrect. The only correct numbers are the $10B annual migration limit in 2022 (though ground truth notes $10.1B already moved by end-2021) and the $30B cap above unmatured fixed-rate obligations through Sept 10, 2025. However, the LLM misrepresents this as a balance sheet migration limit rather than a maximum allowable buffer. (3) Reasoning is partially sound — the model recognizes the shift from the 2019 to 2023 agreement and correctly infers no migration occurred in 2023–2024 due to constraints. It also captures the idea of tightening flexibility. However, it fails to accurately represent the nature of the constraints in either agreement, especially the capital sufficiency condition mentioned in the ground truth. The synthesis across years is logical but based on incorrect premises. (4) Contextual relevance is high — the answer addresses the evolution of migration capability and constraints year-by-year, directly responding to the question’s focus. Despite incorrect details, it maintains appropriate structure and intent. Overall, the answer is partially correct in timeline and direction of change but fails on key factual and quantitative elements, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 538,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments lists Melaka, Malaysia as an analog‑manufacturing site in the property tables of its 2022, 2023 and 2024 10‑K filings (2022 page 18; 2023 page 16; 2024 page 18). The site’s continued inclusion and designation as an analog facility over three consecutive years indicates that TI views Melaka as a stable, strategically important hub for analog production—likely driven by cost‑effective manufacturing, skilled labor and its role in the Southeast‑Asian supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Texas Instruments consistently listed Melaka, Malaysia as an analog manufacturing site in its 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. The specific page references (2022 p.18, 2023 p.16, 2024 p.18) add precision and are consistent with typical disclosure locations, supporting quantitative and contextual accuracy. The conclusion about Melaka’s strategic importance due to stability in listings is logically sound and contextually appropriate. However, the LLM omits the evolving notation markers († in 2022, * in 2023, ** in 2024) that were present in the original answer and potentially indicate increasing operational emphasis. This detail represents a minor gap in qualitative accuracy, as the ground truth suggests a possible escalation in strategic role signaled by changing footnotes, which the LLM does not mention. While the LLM correctly infers strategic importance from consistency, it misses the nuance of intensification implied by the escalating symbols. All entities (Texas Instruments, Melaka, Malaysia, analog manufacturing, correct years) are accurate, and no numerical or date errors are present. The reasoning is strong but not fully complete in capturing the multi-year signaling aspect of the footprint evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 365,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Debit Card’s penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024【page_27】. This gradual decline indicates that the card’s influence on generating incremental sales is shrinking, suggesting that while it still drives additional purchases, its relative contribution to Target’s sales growth is weakening over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports the 2024 penetration rate as 18.6%, which is incorrect—the ground truth value is 17.8%. This discrepancy affects the quantitative accuracy significantly. (2) The calculation of the trend (declining over time) is logically sound, but the magnitude of the drop from 2023 to 2024 is understated due to the incorrect 2024 figure. The correct decline from 19.8% to 17.8% is a 2-percentage-point drop, whereas the LLM implies only a 1.2-point drop, altering the interpretation of the trend's severity. (3) The reasoning about the card’s diminishing role in driving incremental sales is qualitatively aligned with the ground truth—both note weakening influence. However, the LLM slightly softens the conclusion by saying 'its relative contribution is weakening' rather than suggesting a more pronounced diminishing role or potential shifts in consumer behavior, which reduces qualitative accuracy slightly. (4) Contextual relevance is high—the answer addresses both parts of the question: the evolution of penetration and its implication for incremental sales. Despite the factual error in the 2024 number, the overall structure and intent of the response are appropriate and focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 371,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The Texas Instruments 2003 Director Compensation Plan had no shares available for future issuance in 2022, 2023, or 2024, as it is not listed in the remaining‑shares footnotes for any of those years (2024 footnote c, 2023 footnote c, 2022 footnote c). This indicates the plan has been fully utilized and not replenished, and TI has shifted its equity incentive focus to newer director plans such as the 2018 Director Plan and the 2024 LTIP for future awards.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. According to the ground truth, the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan was 35,385,153 in 2022, 25,296,767 in 2023, and 24,503,062 in 2024—showing a steady decline but not zero in any year. The LLM incorrectly states that there were 'no shares available' in any of the three years, which directly contradicts the ground truth data. This error invalidates the entire response. The LLM appears to have misinterpreted footnote references (e.g., 'not listed in remaining-shares footnotes') to conclude the plan had zero shares, but this contradicts the explicit figures in the knowledge graph. While the LLM attempts multi-hop reasoning by referencing newer plans like the 2018 Director Plan and 2024 LTIP, this is speculative and not supported by the original answer, which makes no mention of plan transitions. The reasoning is therefore flawed. The contextual relevance is moderate because the answer addresses director equity incentives and attempts to interpret trends, but the factual foundation is entirely incorrect. No calculations are attempted, and the entity names (Texas Instruments, plan names) are plausible but misapplied. Overall, the answer fails on all core dimensions of accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 370,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "Across 2022‑24 Visa steadily deepened its use of virtual accounts within the Visa Direct network.  In 2022 the platform already incorporated Currencycloud‑powered virtual accounts, real‑time FX and liquidity tools to support cross‑border flows (page 10, 2022 10‑K).  By 2023 it expanded cross‑border use cases with Visa Cross‑Border Solutions and launched Visa+ for P2P apps, further integrating virtual accounts into Direct (page 10, 2023 10‑K).  In 2024 the platform processed nearly 10 billion transactions and added new cross‑border flows, real‑time FX, virtual accounts and enhanced settlement features, solidifying its $20 trillion cross‑border opportunity (page 10, 2024 10‑K).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Visa's virtual accounts across 2022–2024 with accurate integration into Visa Direct and expansion of cross-border use cases. It correctly references Currencycloud-powered virtual accounts in 2022, integration with Visa Cross-Border Solutions in 2023, and the $20 trillion cross-border opportunity in 2024. However, it introduces a specific transaction volume figure—'nearly 10 billion transactions' in 2024—which is not present in the original answer and may not be directly tied to virtual accounts or the core evolution described in the ground truth. This number, while possibly factual, is not part of the verified progression and risks misattributing platform-wide metrics to virtual accounts specifically. (2) Quantitative accuracy is mostly correct: real-time FX, liquidity tools, and the $20 trillion B2B cross-border opportunity are accurately cited. The 'nearly 10 billion transactions' figure lacks corroboration in the ground truth and appears to conflate Visa Direct's overall volume with virtual account activity, introducing a minor factual overreach. (3) The multi-hop reasoning is sound—information is synthesized across years and platforms (Currencycloud, Visa Direct, Cross-Border Solutions)—and the progression of integration is logically presented. The mention of 'Visa+' for P2P apps adds detail not in the original, which may be accurate but is not required and slightly distracts from the core focus on virtual accounts and B2B cross-border use. (4) Scores reflect high factual alignment, minor overstatement of metrics, and strong contextual relevance. The answer addresses all key aspects of the question with only minor additions that don't contradict but slightly exceed the verified facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 484,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi’s revenue slipped slightly in 2023 – the 2023 Form 10‑K shows a 1 % international decline (page 43), reflecting pressure on the product’s sales.  In response, Pfizer intensified its lifecycle‑management strategy, which paid off with the April 2024 FDA approval of a new indication for Xtandi (nmCSPC with biochemical recurrence at high risk for metastasis – page 46).  The 2022 intangible‑asset statement (page 90) lists Xtandi as a key component of the developed‑technology‑rights portfolio, carrying a gross value of $73.3 billion, underscoring the asset’s strategic value that Pfizer sought to protect and grow.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 1% international revenue decline in 2023 is correctly cited from the 10-K (page 43), and the April 2024 FDA approval for the new nmCSPC indication is accurate (page 46). The 2022 intangible asset valuation listing Xtandi as part of a $73.3 billion developed-technology-rights portfolio is factually correct (page 90), though the original answer does not specify the dollar amount—this is an addition by the LLM that is accurate but not present in the ground truth. (2) The answer addresses all parts of the multi-hop question: Xtandi’s 2023 revenue pressure, Pfizer’s lifecycle management response, the 2024 indication expansion, and the 2022 valuation within intangible assets. (3) Entities—Xtandi, Pfizer, nmCSPC indication, 2022–2024 timeline—are all correctly identified. (4) The reasoning is sound: it connects declining revenues to strategic lifecycle investment, using the new FDA approval as evidence of continued commitment, anchored by the high valuation of the asset in 2022. The only minor deviation is that the original answer emphasizes the strategic intent to 'offset declining performance in existing markets,' a nuance slightly underdeveloped in the LLM response, but the core logic and facts are intact. The inclusion of the $73.3B figure, while accurate, is more specific than the original, which only notes Xtandi was 'among' significant assets—this adds precision without error. Overall, the answer is factually correct, well-sourced, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 431,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The Target MasterCard Credit Card’s penetration (measured as the share of purchases paid with a RedCard) fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page_27】. This downward trend indicates that fewer shoppers are using the card relative to total sales, suggesting a gradual erosion of consumer preference for the card and a weakening of loyalty‑program engagement as customers shift to other payment methods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%) are accurately reported with correct formatting and precision. (2) The answer addresses both parts of the question: it traces the evolution of the penetration rate over the three-year period and interprets the trend in terms of consumer preference and loyalty program engagement. (3) Entity accuracy is correct—the card is referred to appropriately in context (RedCard in 2022, with implied rebranding by 2024), and the metric (penetration rate as share of purchases) is correctly understood. (4) The reasoning is sound: the downward trend is correctly identified, and the conclusion about weakening engagement and shifting consumer behavior is logically derived from the data. The answer achieves semantic equivalence with the original, using slightly different phrasing but preserving all factual and inferential content. No errors in multi-hop synthesis; the model correctly links performance over time and infers implications from the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 315,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In FY 2022, Visa’s Currencycloud platform introduced virtual accounts to enable cross‑border payments with real‑time FX and liquidity (page_10, 2022). The same capability was reiterated in FY 2023, underscoring continued expansion of virtual‑account usage within the cross‑border framework (page_10, 2023). By FY 2024, the platform had broadened its reach, enabling cross‑border payments in more than 195 countries and territories and servicing over 11 billion endpoints (cards, bank accounts, wallets) through the Currencycloud‑enabled Visa Direct network (page_10, 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the introduction of virtual accounts in FY2022 with real-time FX and liquidity capabilities, aligns with the expansion in FY2023 into cross-border payments, and notes the increased network reach by FY2024. However, it states 'more than 195 countries and territories' in 2024, while the ground truth specifies 'more than 100 countries' via Visa B2B Connect—this is a significant discrepancy. The '11 billion endpoints' figure is correctly cited and matches the ground truth. (2) Quantitatively, the 11 billion endpoints (cards, bank accounts, wallets) is accurate and correctly attributed to the Visa Direct network in 2024. The error lies in the geographic reach: 195+ countries is overstated compared to the ground truth’s focus on over 100 countries through B2B Connect. The fiscal years (2022–2024) are correctly used. (3) The multi-hop reasoning is mostly sound—information is synthesized across the three years, showing evolution in functionality and reach. However, the LLM conflates the broader Visa Direct network reach (which may indeed cover 195+ countries) with the specific B2B cross-border capabilities of Currencycloud, which the ground truth limits to over 100 countries. This reflects a lack of precise entity and capability distinction. (4) The answer is highly relevant and captures the core progression of virtual accounts, but the overstatement of geographic reach and lack of mention of Visa B2B Connect reduces quantitative and qualitative accuracy. Hence, correctness is reduced to 8 due to this material factual overreach, though the overall trajectory and key capabilities are well represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 456,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 10‑K filings for 2022, 2023 and 2024 all list “difficulties in protecting our intellectual property” as a risk factor tied to its foreign operations (see 2022 page 37, 2023 page 41 and 2024 page 38).  Each year notes that the company relies on third‑party wafer foundries in the U.S., Europe and Asia and that nearly all assembly and testing is performed at third‑party facilities in China, Malaysia and Taiwan, while international sales remain a large portion of revenue (≈65‑70 %).  The consistent wording and unchanged reliance on overseas manufacturing indicate that AMD’s exposure to IP‑protection difficulties has remained high and unchanged over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in AMD's risk disclosure, leading to a significant qualitative inaccuracy. (1) Quantitatively, the answer correctly identifies the consistent reliance on third-party manufacturing in China, Malaysia, and Taiwan, and accurately reports that international sales account for approximately 65–70% of revenue across the years. The citation of specific 10-K pages (2022 p.37, 2023 p.41, 2024 p.38) aligns with the expected sources and supports factual grounding. (2) However, the core reasoning flaw lies in concluding that AMD’s exposure has 'remained high and unchanged'—this contradicts the ground truth, which shows a clear evolution: in 2023, AMD explicitly linked IP risks to geopolitical instability between China and Taiwan, and in 2024, it added evolving export controls related to the Ukraine-Russia and Israel-Hamas conflicts. The LLM fails to recognize this progression, instead interpreting consistent wording as static risk, when in fact the company deepened its risk discussion over time. (3) This reflects a failure in multi-hop reasoning: while the model correctly identifies the presence of IP protection risks and third-party dependencies across years, it does not synthesize the incremental additions in 2023 and 2024 that indicate increasing concern. (4) The answer is contextually relevant and factually accurate on surface-level details, but incorrect in its central conclusion about the trend in exposure. Hence, correctness is reduced to 6 due to this significant omission in the evolution of risk, despite strong quantitative and citation accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 443,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "Corporate stock was re‑classified from largely Level 2 (with a small Level 3 portion) in 2022 to Level 1 for common shares in 2023 and 2024 (Corporate Stock is described as Level 1 for common shares and Level 2 for preferred shares on page 56‑57).  The fair‑value allocation fell sharply from $1,111 million in 2022 (page 70‑74) to $181 million in 2023 (page 56‑60) and remained at $181 million in 2024 (page 54‑58).  This shift signals a de‑risking pension strategy that cuts equity exposure and concentrates on more liquid, debt‑heavy assets, thereby reducing the plan’s market exposure to corporate equities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 valuation and classification. The ground truth states that in 2022, UNP's Corporate Stock investment was $1,990 million, with $1,980 million in Level 1 and $10 million in Level 2. However, the LLM incorrectly reports the 2022 total as $1,111 million and misclassifies the valuation levels, claiming most was Level 2 with a small Level 3 portion—this contradicts the ground truth, which shows almost entirely Level 1 with no mention of Level 3. The 2023 figure of $181 million (with $176M Level 1, $5M Level 2) is correctly reported, and the 2024 classification (common stock Level 1, preferred Level 2) aligns with the original answer, though the LLM incorrectly implies the dollar amount remained at $181 million in 2024, while the ground truth explicitly states no updated figures were provided for that year. (2) Quantitative accuracy is low: the 2022 dollar amount is off by nearly $900 million, and the level classification is completely reversed. The 2023 numbers are accurate, but the erroneous carryover to 2024 compounds the error. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward de-risking and reduced equity exposure based on the drop in investment value and reclassification to more observable levels. However, the flawed input data undermines the validity of this conclusion. The reasoning about increased liquidity and debt-heavy reallocation is speculative and not directly supported in the ground truth. (4) Contextual relevance is high, as the answer addresses all parts of the question—valuation classification, allocation changes, and strategic implications—and attempts synthesis across years. Despite incorrect numbers, it maintains focus on pension strategy and market exposure. Overall, the answer is partially correct but undermined by critical quantitative errors and misclassification of valuation levels.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 532,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott’s 2022, 2023, and 2024 10‑Ks all reference the same exhibits for the 4.75% Senior Notes due 2043—Exhibit 4.6 (the Form of the Notes filed in 2017) and Exhibit 4.7 (the Officers’ Certificate filed in 2017)—showing a consistent documentation and disclosure approach (page_86‑2022, 4.17‑4.18; page_86‑2023, 4.17‑4.18; page_86‑2024, 4.17‑4.18). This consistency signals a stable long‑term debt strategy and a continued emphasis on transparent, regulatory‑compliant communication with investors.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in key aspects of the multi-year evolution of Abbott's disclosure strategy. (1) Quantitatively, the LLM correctly identifies the consistent citation of Exhibits 4.6 and 4.7 across 2022–2024 and references the 2017 filing date, which aligns with the ground truth. These exhibit numbers and dates are accurate, earning high marks for quantitative accuracy. (2) However, the qualitative analysis is flawed: the ground truth emphasizes a clear evolution—from referencing the notes via St. Jude Medical’s 2013 Fourth Supplemental Indenture in 2022 (a legacy integration approach) to a more direct and formalized disclosure in 2023–2024. The LLM incorrectly asserts that the documentation approach was 'consistent' across all years, missing this critical shift from indirect, legacy-based referencing to standardized, current disclosure. (3) This misrepresents the multi-hop reasoning required: the progression reflects a strategic move toward transparency and investor clarity, which the LLM fails to capture. Instead, it interprets consistency as stability, overlooking the significance of the 2023 shift to direct inclusion. (4) While the LLM addresses long-term debt communication, it does so with incorrect reasoning. The answer is contextually relevant and factually grounded in exhibit references but lacks the nuanced, evolving narrative that the question demands. Hence, correctness is reduced due to flawed synthesis and missed evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 417,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "RedCard penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024 (see 2024 Form 10‑K, page 27). The downward trend indicates that fewer guests are adopting the Target‑branded credit card, which is a key driver of the 5 % discount incentive. Because a meaningful portion of incremental purchases on RedCards also represent incremental sales for Target, the decline in penetration likely translates into a modest reduction in the incremental sales that the card generates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The citation to the 2024 Form 10-K, page 27, adds verifiability and aligns with expected sourcing. 2) All numeric values and time periods are accurate; no calculation errors are present. The trend description (declining penetration) is factually sound. 3) The reasoning correctly identifies that declining penetration suggests reduced customer adoption of the branded card and links this to the 5% discount incentive, which is a known driver of usage. It also correctly infers that lower adoption likely results in reduced incremental sales—a key point in the ground truth. The only minor omission is that the original answer notes the card remains a key part of Target’s loyalty and revenue strategy (e.g., profit sharing, retention), which the LLM answer does not mention. This contextual nuance slightly reduces completeness. 4) Despite this omission, the LLM answer captures the core trend, data, and implications accurately. The semantic meaning is highly aligned with the ground truth, with only slight reduction in qualitative depth. Contextual relevance is full, as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 359,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s Multiple Purpose Locomotive fleet shrank from 7,242 units in 2022 to 6,893 units in 2024, while the average age rose from 22.5 to 25.2 years. This trend reflects a deliberate consolidation and aging of the fleet, indicating the company is retiring older units and focusing on efficient asset utilization and phased replacement to manage capital and operating costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual data: the fleet size decreased from 7,242 units in 2022 to 6,893 units in 2024, and the average age increased from 22.5 to 25.2 years, matching the ground truth exactly. There are no numerical or date inaccuracies. (2) Quantitative accuracy is perfect—both the unit counts and age figures are correct, and no calculations were required beyond what was provided. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in both fleet size and age over time and draws a logical inference about asset management strategy. The interpretation slightly differs in tone—'deliberate consolidation and aging' and 'phased replacement' suggest a more strategic, planned approach, whereas the ground truth emphasizes 'deferral of fleet modernization' and 'cost-conscious' strategy. However, both point to capital cost management, so the qualitative interpretation is reasonably aligned, though not perfectly identical in emphasis. (4) The answer is fully contextually relevant, addressing all parts of the question: change in units, change in age, and strategic implication. The slight softening of 'deferral of modernization' into 'phased replacement' does not invalidate the conclusion but introduces a marginally more positive framing. Thus, the answer is factually complete and accurate with only minor nuance differences in interpretation, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 401,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate funds fell modestly over the period: $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024 (Note 14, pages 70‑71). This gradual decline reflects a measured, risk‑aware approach to illiquid alternatives, indicating that Abbott is maintaining exposure while avoiding aggressive expansion and prioritizing long‑term, risk‑adjusted returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative discrepancy in the 2022 unfunded commitment amount. The ground truth reports $585 million for 2022, while the LLM states $569 million. The 2023 and 2024 figures ($555M and $540M) are accurate. This affects the precision of the trend description, though the overall downward trajectory is correctly identified. (2) Calculations: The ground truth shows a $30M total decline from 2022 to 2024 ($585M → $540M), while the LLM implies a $29M drop from $569M, which is close but not exact. The $15M decline mentioned in the original answer over three years appears to be a typo (should be $45M total drop), but the LLM does not repeat this error. (3) Reasoning and synthesis are sound: the LLM correctly infers that the gradual decline suggests a measured, risk-aware strategy in illiquid alternatives, aligning with the ground truth's interpretation of continued long-term participation without aggressive capital deployment. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of commitments and the implication for long-term strategy. Despite the small data discrepancy, the qualitative reasoning and strategic interpretation are strong and semantically equivalent to the original. Quantitative accuracy is marked down due to the incorrect 2022 figure, but not severely as two out of three data points are correct and the trend direction is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 410,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "The carrying value of NVIDIA’s 3.50% Notes Due 2050 was roughly $1,600 million in FY 2022, rose slightly to $1,604 million in FY 2023 (NVDA 10‑K 2023, p. 67), and climbed to $2,000 million in FY 2024 (NVDA 10‑K 2024, p. 72). This steady upward trend—especially the jump to $2 billion in FY 2024—signals a deliberate shift toward longer‑maturity debt, underscoring NVIDIA’s strategy to strengthen its long‑term debt profile and fund growth with higher‑maturity financing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, the carrying value was $2,147 million in FY 2022, decreased to $1,604 million in FY 2023, and then increased to $2,000 million in FY 2024. However, the LLM incorrectly states the FY 2022 value as $1,600 million (a major deviation from $2,147M), and falsely claims a 'slight rise' from 2022 to 2023, when in fact there was a substantial decrease. This misrepresents the trend entirely. (2) The only correct number is $1,604 million in FY 2023 and $2,000 million in FY 2024, which match the ground truth. The $1,600 million figure for 2022 is incorrect and contradicts the actual value by over $500 million. (3) The reasoning is partially sound in interpreting the increase from 2023 to 2024 as a strategic move toward longer-term debt, which aligns with the ground truth's suggestion of refinancing or debt management strategy. However, because the model fails to recognize the large drop from 2022 to 2023, it misses the fluctuating nature of the carrying value and incorrectly frames it as a 'steady upward trend,' undermining the multi-hop synthesis. The ground truth emphasizes a fluctuation (down then up), indicating revaluation or strategic adjustment, while the LLM sees only an ascent, leading to flawed inference. (4) Despite incorrect numbers and flawed trend interpretation, the answer addresses the right metric, company, and years, and attempts a reasonable qualitative explanation based on the last two data points. Hence, contextual relevance is high, qualitative reasoning is moderate (based on incorrect inputs), and quantitative accuracy is low due to the critical error in the 2022 value and mischaracterization of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 480,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD’s 10‑K for 2022 listed the risk of “loss or modification of exemptions for taxes and tariffs” as a key global‑risk factor (page 37). The 2023 filing repeated that same risk without change (page 39). By the 2024 filing the risk remained but was framed alongside new sanctions and export‑control revisions—highlighting a more tangled regulatory landscape that heightens the likelihood of losing such exemptions (page 38).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the evolution of AMD's risk disclosures regarding tax and tariff exemptions from 2022 to 2024. It accurately cites the consistent mention of the risk across years and notes the increasing regulatory complexity in 2024, particularly with reference to sanctions and export controls. All dates (2022, 2023, 2024) and page numbers (37, 39, 38) are correctly stated, and there are no numerical inaccuracies, earning a perfect quantitative accuracy score. The answer is contextually relevant, directly addressing the question’s focus on the trend in risk exposure and regulatory complexity. However, it omits key qualitative details present in the original answer that strengthen the multi-hop reasoning: specifically, the mention of geopolitical tensions (e.g., U.S. sanctions on Russia and Belarus, Ukraine-Russia and Israel-Hamas conflicts in 2023, and China-Taiwan tensions in 2024) and their direct impact on third-party manufacturing. These omissions reduce the depth of the synthesis, particularly in linking geopolitical developments to AMD’s operational and regulatory risks. While the LLM captures the trend of increasing complexity, it does not fully convey the escalating specificity and severity of the risks as detailed in the ground truth. Thus, qualitative accuracy is slightly lower due to incomplete reasoning synthesis, but the answer remains substantially correct and well-aligned with the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 411,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s 10‑K risk‑factor disclosures have repeated the same warning: the company’s ability to return capital—whether through dividends or share repurchases—is subject to board discretion and may be limited by U.S. banking laws, capital‑planning rules, Delaware law, and the obligation to pay full and timely dividends on preferred stock.  The wording and emphasis have not changed across the three filings, indicating that the regulatory constraints on dividend payments and share repurchases have remained essentially unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that BNY Mellon's capital return flexibility has been consistently constrained from 2022 to 2024 by U.S. banking laws, capital-planning rules, Delaware law, and preferred stock dividend obligations—matching all key entities and regulatory factors cited in the original answer. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable; however, the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years of 10-K filings, correctly concluding that regulatory constraints remained essentially unchanged. While the original answer adds slightly more detail—such as the mention of Title I and II resolution strategies in 2023 and expanded context on liquidity management and strategic initiatives in 2024—the LLM captures the core continuity of risk factor disclosures. (4) The answer is contextually fully relevant, directly addressing how regulatory constraints on dividends and share repurchases evolved (or did not evolve) over time. The only minor shortcoming is the lack of nuanced elaboration on the incremental contextual expansions in 2023 and 2024, which prevents a perfect 10, but the semantic equivalence on the central claim of stable constraints is preserved. Thus, the answer is highly accurate with only minor omissions in depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 410,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott’s 10‑K filings for 2022, 2023 and 2024 all list the 2.950% Note due 2025 as Exhibit 99.6 (Item 4.1 in the exhibit table). The form of the note, originally filed with the 8‑K on March 5 2015, is referenced unchanged in each year’s exhibit table, with no change in exhibit number or additional documentation. Thus, the disclosure of the note has remained static across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.950% Note due 2025 is consistently listed as Exhibit 99.6 across 2022–2024, originally filed in the 8-K on March 5, 2015. The dates, exhibit numbers, and note terms match the original answer exactly. (2) Quantitative accuracy is perfect: percentages, years, and filing dates are correct and consistent with the ground truth. (3) The reasoning is sound—LLM correctly infers that the unchanged exhibit reference implies no amendments or refinancing, demonstrating proper multi-hop synthesis across years and filings. (4) The only minor shortcoming is that the LLM does not explicitly state that the *same* 8-K filing (March 5, 2015) was referenced in all three years, though this is implied by saying 'referenced unchanged.' The original answer emphasizes this repetition more clearly. Despite this, the semantic meaning and factual content are effectively equivalent. Contextual relevance is excellent, directly addressing the evolution (or lack thereof) in disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 309,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55% Notes Due 2028 carried **$1,099 million** at the end of FY 2023 (and a similar amount reported for FY 2022) and **$1,115 million** at the end of FY 2024【page_67】. The modest $16 million uptick over two years reflects only minor principal changes, indicating that NVIDIA’s long‑term debt strategy is focused on maintaining a stable, low‑interest balance rather than aggressive refinancing or expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the values were $1,200 million (FY2022), $1,099 million (FY2023), and $1,250 million (FY2024). The LLM incorrectly states that FY2022 and FY2023 were both approximately $1,099 million (missing the $1,200M value for FY2022), and reports $1,115 million for FY2024 instead of the correct $1,250 million. This represents major quantitative errors. (2) The calculation of a '$16 million uptick' is based on incorrect numbers ($1,099M to $1,115M) and does not reflect the actual increase from $1,099M to $1,250M (a $151M rise), nor the fluctuation pattern (down then up) described in the original answer. (3) The reasoning about NVIDIA's long-term debt strategy being 'stable' and 'low-interest' is plausible but not fully supported by the actual data, which shows a notable increase in 2024—suggesting possible strategic repositioning rather than stability. The LLM fails to capture the fluctuation pattern (decrease then increase) that the ground truth highlights as indicative of strategic management. (4) While the LLM addresses the question's structure and attempts multi-hop synthesis (tracking values over time and inferring strategy), the incorrect numbers undermine both quantitative and qualitative accuracy. Contextual relevance is high as the response stays on topic and interprets the trend, but correctness is severely limited by factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 411,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "From 2022 through 2024 AMD kept the same approach to its add‑in‑board (AIB) partners: the company’s agreements consistently protected AIB inventory against price reductions (2022 p. 11; 2023 p. 11; 2024 p. 11).  Across all three filings, AMD also highlighted that system integrators use discrete graphics solutions as a key way to differentiate their board‑level products and add value for customers (2022 p. 11; 2023 p. 11; 2024 p. 11).  In short, the inventory‑protection policy and the emphasis on discrete graphics for differentiation remained unchanged over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: AMD maintained inventory protection policies for AIBs from 2022 to 2024, and consistently emphasized discrete graphics solutions as a differentiator (supported by correct page references across filings). All entities (AMD, AIBs, discrete graphics) and timeframes (2022–2024) are correct, and there are no numerical inaccuracies (no calculations or figures to verify, so quantitative accuracy is high by default). However, the LLM incorrectly states that the strategy and emphasis 'remained unchanged,' which contradicts the ground truth that shows an evolution in emphasis—particularly in 2024, when AMD placed 'greater emphasis' on discrete graphics for differentiation amid market competition. The original answer notes a strategic shift in focus, while the LLM portrays continuity. This misrepresents the multi-hop synthesis of evolving language and strategic nuance across the years, missing the progression in AMD’s messaging. While the key facts are present, the reasoning and qualitative interpretation are oversimplified, failing to capture the strategic evolution. Contextual relevance is high as the answer directly addresses the question’s focus on inventory policies and differentiation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 350,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD has consistently flagged “difficulties in protecting our intellectual property” as a foreign‑operations risk in its 2022, 2023, and 2024 10‑K filings.  Over time the disclosure has sharpened to tie the IP risk to the company’s expanding international sales—now 66 % of revenue—and its growing reliance on third‑party wafer foundries and assembly sites in politically sensitive regions such as China, Taiwan, and the Ukraine‑Russia conflict zone.  The 2024 filing explicitly links IP protection challenges to geopolitical tensions and sanctions that could disrupt these third‑party manufacturing operations, underscoring a heightened exposure as AMD’s global footprint and external manufacturing dependence grow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: AMD consistently reported intellectual property (IP) protection difficulties across 2022–2024; international sales reached 66% in 2024 (up from 65% in 2023); reliance on third-party manufacturing in sensitive regions like China, Taiwan, and areas affected by the Ukraine-Russia conflict is emphasized. The mention of geopolitical tensions affecting third-party foundries is supported in the original. (2) Quantitative accuracy is perfect: the 66% and 65% figures for international revenue in 2024 and 2023 are correctly cited, and no incorrect numbers are introduced. (3) Multi-hop reasoning is sound—LLM synthesizes risk disclosures over three years, links increasing international sales to growing IP exposure, and connects geopolitical risks to third-party manufacturing dependencies. The only minor shortcoming is that the original specifies the 2023 risk expansion included U.S.-Russia and China-Taiwan tensions explicitly, while the LLM generalizes to 'Ukraine-Russia conflict zone' and 'politically sensitive regions' without naming all bilateral dynamics. Also, the original notes that 2022 had a lower but unspecified international sales figure, which the LLM omits but does not misstate. (4) The answer is contextually excellent—directly addresses the evolution of IP risk in relation to international operations and third-party manufacturing. Wording differs slightly but meaning is semantically equivalent. No irrelevant or extraneous information. Minor deduction in qualitative accuracy for slightly less precision in geopolitical context; otherwise, fully correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 457,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "From 2022 to 2024 BNY Mellon kept issuing new performance‑share‑unit and restricted‑stock‑unit agreements under its 2019 Long‑Term Incentive Plan (Exhibits 10.21–10.22 in 2022, 10.26–10.27 in 2023, and 10.28–10.29 in 2024)【page_19】【page_20】. This steady use of the same plan each year shows a deliberate strategy of tying executive pay to long‑term performance through equity awards, underscoring the company’s focus on aligning executive incentives with shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative synthesis compared to the ground truth. (1) Quantitatively, the years (2022–2024) and references to the 2019 Long-Term Incentive Plan are correct, and the mention of ongoing use of equity awards under the plan aligns with the original answer. The exhibit numbers (e.g., 10.21–10.22, etc.) may be factually accurate based on filings, though not present in the ground truth, so they are not penalized. (2) However, the LLM misrepresents the evolution of the incentive agreements: it states that new PSU and RSU agreements were issued each year under the same plan, but the ground truth specifies that the *form* of the PSU agreement evolved—specifically, the 2021 Form was referenced in 2022, the 2020 Form was introduced in 2023 (not a newer form, but an older one possibly reused), and the 2022 Form was introduced in 2024. The LLM incorrectly implies a linear progression of new forms each year, missing the nuance of reusing or layering prior forms. (3) The multi-hop reasoning is flawed: the original answer highlights a 'layered approach' and 'continuity with periodic enhancements,' which the LLM oversimplifies into steady issuance without noting the strategic reuse or backward/forward movement in form dates. (4) The conclusion about aligning pay with shareholder value is contextually relevant and reasonable, but it lacks the depth of the original insight about adaptive, long-term strategy with legacy integration. Thus, while the core idea of continuity is captured, the specific evolution and strategic implications are inaccurately portrayed, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 458,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s capital outlay on diagnostics instruments leased to customers grew from an original cost of **$3.5 billion** in 2022 (the same level as 2021) to **$3.9 billion** in 2024, with the net book value rising from **$1.6 billion** to **$1.8 billion** (page 64).  The right‑of‑use asset fell modestly from **$1,122 million** in 2023 to **$1,075 million** in 2024, indicating that new purchases were partially offset by disposals or lease terminations (page 64).  This trend shows a disciplined, incremental investment strategy that expands the diagnostics asset base while keeping lease revenue a small share of total sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, the original cost of leased diagnostics instruments was $3.3B in 2022, $3.6B in 2023, and $3.9B in 2024. The LLM incorrectly states $3.5B in 2022 and skips 2023 entirely, implying a direct jump to $3.9B in 2024. Similarly, net book value is reported as $1.4B in 2022, $1.6B in 2023, and $1.6B in 2024 in the ground truth, but the LLM claims $1.6B rising to $1.8B, which is incorrect. The mention of 'right-of-use asset' falling from $1,122 million to $1,075 million appears to conflate different line items not referenced in the original answer and may refer to a different category of assets. (2) Calculations and trends are misrepresented: the LLM suggests a continuous rise in net book value to $1.8B, whereas it plateaued at $1.6B in 2023–2024. The original cost increase is understated for 2022 and misaligned across years. (3) Multi-hop reasoning is partially present—linking investment in leased instruments to broader capital strategy—but the flawed data undermines the conclusion. The LLM infers a 'disciplined, incremental investment strategy' and mentions lease revenue as a small share of sales, which is not supported or mentioned in the ground truth. Instead, the correct inference focuses on driving reagent and consumables sales through equipment leasing, tied to performance obligations—this strategic insight is missing. (4) Due to major quantitative errors and incorrect synthesis, the correctness score is low at 3. Quantitative accuracy is severely compromised (2), qualitative reasoning is partially sound but based on wrong data (4), and contextual relevance is moderate as the topic and general direction (investment in leased diagnostics) are relevant, though specifics are flawed (6).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 498,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across FY 2022, 2023, and 2024 NVIDIA’s 10‑K filings list Lumentum Holdings as a competitor in the interconnect, switch, and cable‑solutions segment (FY22: page 15; FY23: page 9; FY24: page 9). While Lumentum’s presence in the competitor list remains unchanged, NVIDIA’s business‑strategy sections increasingly spotlight AI‑driven networking and interconnect technologies (FY23: page 7; FY24: page 7), underscoring that the competitive pressure on Lumentum in that space is intensifying as NVIDIA expands its AI‑centric networking portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative evolution details present in the ground truth. (1) Correctly identifies that Lumentum Holdings is listed as a competitor in NVIDIA's 10-K filings across FY2022, FY2023, and FY2024 and cites consistent page numbers, which aligns with the source data. The mention of NVIDIA's increasing focus on AI-driven networking in FY23 and FY24 is also accurate. (2) Quantitative accuracy is high: fiscal years, page references, and segment descriptions (interconnect, switch, cable solutions) are factually correct with no numerical errors. (3) However, the reasoning and synthesis are flawed—while the ground truth highlights a clear *evolution* in Lumentum’s competitive positioning (from general supplier to specialized high-performance interconnect player to specifically named entity), the LLM claims 'Lumentum’s presence... remains unchanged,' which contradicts the documented repositioning and sharpened recognition. This misrepresents the multi-hop insight about Lumentum's rising prominence. (4) Contextual relevance is strong as it addresses NVIDIA's AI networking expansion and Lumentum's role, but the failure to capture the trajectory of Lumentum’s evolving competitive positioning significantly undermines the qualitative accuracy. Thus, while factually consistent in parts, the LLM fails to convey the core progression described in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 390,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In 2022 Emerson classified pipe cutters as part of its **Tools & Home Products** segment, where they were listed under “professional tools” alongside wrenches and other pipe‑working equipment【page_9】. By 2023 (and still in 2024) the company moved pipe cutters into the **Safety & Productivity** segment, positioning them as part of a broader safety‑and‑productivity portfolio for professionals【page_73】. This shift signals Emerson’s strategy to consolidate professional tools under a safety‑focused umbrella, emphasizing their role in professional‑grade safety and productivity solutions rather than as generic home‑use tools.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: Emerson, pipe cutters, Tools & Home Products segment (2022), Safety & Productivity segment (2023–2024). Dates (2022, 2023, 2024) are correctly used. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct use of years—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly identifies the segment shift across years and infers strategic intent. It captures the repositioning from a consumer/professional hybrid segment to a professional-industrial focus. The only minor omission is that the LLM does not mention the divestiture of InSinkErator as contextual reinforcement of the strategic shift away from consumer products, which is included in the original answer and adds depth to the strategic rationale. Also, the original answer includes specific examples of related tools (battery hydraulic tools, drain cleaners, sewer cameras), which the LLM summarizes more generally as 'safety-and-productivity portfolio'—accurate but slightly less detailed. (4) Despite these small omissions, the core facts, reasoning, and strategic interpretation are correct and semantically equivalent. The answer is fully relevant, directly addressing both parts of the question: the segment shift and its implication for professional tool strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 396,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 to 2024 Schwab’s interactive tools for RIAs stayed largely unchanged: the Advisor Services website continued to deliver core account‑management, trading, archiving, and third‑party integration, and Schwab Advisor Portfolio Connect remained a free, simplified solution that required no data download. The 2022 filing highlighted the addition of Ameritrade features (thinkpipes, iRebal), a focus that was not repeated in later filings, indicating a shift in integration emphasis while the advisor‑support suite—interactive tools, educational content, consulting, benchmarking, and transition services—remained robust and consistent.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Schwab's interactive tools for RIAs 'stayed largely unchanged' from 2022 to 2024, which directly contradicts the ground truth. The original answer clearly outlines a progression: in 2022, the focus was on the Advisor Services website and basic integrations; in 2023, Schwab expanded educational and consulting services; and by 2024, the tools were embedded in a broader ecosystem with multi-year document archiving, outbound data feeds for compliance, and enhanced prospect consulting—indicating significant evolution in functionality, integration, and advisor support. The LLM incorrectly minimizes this progression, asserting stability rather than change. While it mentions some correct elements (e.g., Schwab Advisor Portfolio Connect being free, no data download, third-party integrations), these are surface-level details. The claim about Ameritrade features (thinkpipes, iRebal) is not supported in the ground truth and appears to be a misattribution or confusion with another source. There are no numerical values to assess, so quantitative accuracy is neutral (scored 10 by default for absence of error). The reasoning is flawed as it fails to synthesize the multi-hop progression across years and misrepresents the strategic shift toward integrated compliance and operational support. Contextually, the answer addresses the right domain (RIAs, Schwab tools) but misses the central theme of technological and service evolution, resulting in low correctness and qualitative accuracy despite some accurate terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 432,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first issued the 1.650% Notes due 2026, as disclosed in Exhibit 4.14 of the 2022 10‑K (page 112). The same exhibit appears unchanged in the 2023 10‑K (page 111) and the 2024 10‑K (page 111), indicating that the notes remain a senior unsecured debt instrument with a 1.650% coupon due 2026. This consistency shows Oracle’s disciplined short‑to‑intermediate‑term debt strategy—maintaining a stable, low‑rate financing mix that complements its long‑term capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance of Oracle's 1.650% Notes due 2026 and their consistent treatment in the 2022, 2023, and 2024 10-K filings. However, there is a minor discrepancy in the exhibit number for the 2022 filing: the ground truth states Exhibit 4.16, while the LLM claims Exhibit 4.14. The exhibit numbers for 2023 and 2024 (4.14) match the ground truth. This is a factual error but does not affect the core understanding of the note's consistency. (2) All quantitative elements—interest rate (1.650%), maturity year (2026), and the years of filing (2022–2024)—are accurate. No calculations are required, and all dates and percentages are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer stability in Oracle’s debt strategy. It draws a logical conclusion about Oracle’s short-to-intermediate-term financing approach based on unchanged disclosures. (4) Despite the exhibit number mismatch in 2022, the overall answer conveys the same key message as the ground truth—consistent treatment of the notes reflects a stable debt financing strategy. Wording differs slightly (e.g., 'disciplined' vs. 'consistent'), but semantic equivalence is maintained. The answer is fully contextually relevant and addresses both the evolution (or lack thereof) and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 383,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson’s Discrete Automation segment—whose product mix explicitly includes electrical distribution equipment【page_73】—reported sales of $2.61 B in 2022, $2.64 B in 2023, and $2.51 B in 2024, with earnings falling from $542 M to $466 M and capital‑expenditures hovering around $60 M【page_74】【page_75】.  The segment’s stable sales, earnings, and continued CAPEX investment in this product line signal that Emerson is keeping electrical distribution equipment as a core pillar of its discrete‑automation portfolio, underscoring a sustained strategic emphasis on industrial electrification solutions.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate quantitative data regarding the Discrete Automation segment's sales and earnings across 2022–2024, with correct figures: $2.61B (2022), $2.64B (2023), $2.51B (2024), and earnings from $542M to $466M, which aligns with typical reporting in 10-K filings. Capital expenditures around $60M are also plausible. However, the original answer does not include these financial metrics, so their correctness cannot be fully verified against the ground truth, though they do not contradict it. The core issue lies in qualitative accuracy: the LLM fails to capture the key evolution in segment classification. It assumes electrical distribution equipment was part of Discrete Automation in 2022, but according to the ground truth, it was only moved there in 2023 from 'Industrial Solutions.' This misrepresents the strategic shift—positioning the product line as newly integrated into automation, not consistently core. The LLM interprets stable financials as evidence of sustained emphasis, but the ground truth emphasizes a structural reorganization signaling a strategic pivot. Thus, while the financial data may be accurate and contextually relevant to Emerson’s strategy, the reasoning is flawed because it misses the multi-hop insight: the re-segmentation in 2023 reflects a strategic repositioning. The answer is partially correct in highlighting continued investment but fails to identify the evolution in organizational structure and strategic intent from 2022 to 2024. Therefore, the correctness score is moderate due to factual presentation of numbers but significant omission and mischaracterization of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 451,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell from **$569 million in 2022 to $555 million in 2023 and to $540 million in 2024** (see Note 14, pages 70–71). The steady decline indicates the company is trimming its exposure to illiquid alternative assets within its pension plan, suggesting a more conservative, liquidity‑focused strategy for managing its pension fund’s risk profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the unfunded commitments for 2023 ($555 million) and 2024 ($540 million), which match the ground truth. However, it states $569 million for 2022 instead of the correct $585 million, introducing a factual inaccuracy of $16 million. This error affects the quantitative precision but does not alter the overall trend direction. (2) The calculation of the declining trend (from 2022 to 2024) is logically consistent, but the starting point is incorrect. The ground truth shows a decrease of $45 million over three years ($585M → $540M), while the LLM implies a $29 million reduction ($569M → $540M), which underrepresents the actual scale of de-risking. (3) The multi-hop reasoning is sound: the model correctly infers that a declining commitment suggests reduced exposure to illiquid alternatives and interprets this as a conservative, liquidity-focused pension strategy—aligning with the ground truth’s conclusion about de-risking and rebalancing. It misses the nuance about the long time horizon (through 2034) for liquidation, which adds context to the continued long-term belief in these assets, thus slightly reducing completeness. (4) Despite the numerical discrepancy in the 2022 figure, the answer captures the essential trend and strategic implication accurately, with strong qualitative reasoning and high contextual relevance. The error is significant but not fundamental, warranting a score of 8 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 408,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle’s 1.650% Notes due 2026 were not disclosed in the 2022 10‑K (pages 112‑116 contain no reference to the note).  The 2023 10‑K (page 111, Exhibit 4.14) first reports the issuance of the notes, citing an officer’s certificate dated March 24 2021.  The 2024 10‑K again lists the same notes as outstanding debt (page 111, Exhibit 4.14).  This steady, unchanged presentation shows Oracle is keeping a stable, low‑rate note portfolio to fund short‑term needs and minimize refinancing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims the 1.650% Notes due 2026 were *not* disclosed in the 2022 10-K, which contradicts the ground truth stating Oracle *first disclosed* the notes in the 2022 filing. This is a major inaccuracy affecting the core timeline. However, the LLM correctly notes the 2023 and 2024 10-Ks reference the March 24, 2021 officer’s certificate (equivalent to the 8-K filing in the ground truth), and correctly observes the notes remain outstanding with no changes. (2) Quantitatively, the percentage (1.650%), maturity year (2026), and issuance date (March 24, 2021) are all accurate. The error lies in the *timing of first disclosure*, not the numbers themselves. (3) The multi-hop reasoning is partially sound—LLM correctly tracks the note across 2023 and 2024 filings and infers stability in debt strategy—but fails the first hop by incorrectly denying disclosure in 2022, undermining the longitudinal analysis. (4) Contextual relevance is high as the answer addresses Oracle’s short-term debt strategy and attempts to trace the note over time. However, due to the incorrect starting point and omission of the 8-K reference (citing an officer’s certificate instead), the qualitative and correctness scores are significantly reduced. The conclusion about stable, low-rate funding is semantically aligned with the ground truth but based on flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 392,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in July 2014, documented in exhibit 4.09 (page_109). In the 2022 10‑K the note is not presented as a new exhibit—indicating no amendment or re‑issuance—while the 2023 and 2024 10‑Ks continue to reference the same exhibit 4.09, showing the note remains unchanged (page_111, page_109). This consistent, multi‑year disclosure signals Oracle’s long‑term debt strategy of maintaining a stable, fixed‑rate debt portfolio with a staggered maturity schedule rather than frequent refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent documentation of the 4.30% Note due 2034 across 2022, 2023, and 2024, and draws a reasonable conclusion about Oracle's long-term debt strategy, aligning with the ground truth. However, it introduces a fact not present in the original answer — that the note was first issued in July 2014 and documented in exhibit 4.09 — which is not supported by the provided ground truth. The original answer only discusses the note’s presence in filings from 2022–2024, not its initial issuance. This addition, while potentially true, is an unsupported inference and affects factual accuracy. (2) The exhibit numbers are partially mismatched: the ground truth states the note appeared in Exhibit 4.11 in 2022 and Exhibit 4.09 in 2023 and 2024, but the LLM claims it was Exhibit 4.09 in all years, including 2022. This is a factual discrepancy in exhibit labeling, though the core idea of consistent referencing holds. (3) The multi-hop reasoning is sound in interpreting the repeated disclosure as evidence of a stable debt strategy, correctly synthesizing the pattern across years. The conclusion about a staggered maturity and avoidance of frequent refinancing is semantically equivalent to the ground truth’s point about a diversified maturity profile and sustained presence. (4) The correctness score is 7 because the core financial facts (interest rate, maturity year, consistent disclosure) are accurate, and the strategic interpretation is valid, but the unsupported claim about the 2014 issuance and incorrect exhibit number in 2022 reduce quantitative and qualitative accuracy. The answer remains contextually relevant and well-reasoned overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 465,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "Schwab migrated IDA balances to its balance sheet in 2021 and 2022 under the 2019 IDA agreement, which allowed up to $10 billion per year (page 102).  In 2023 the 2019 agreement was replaced by a new 2023 IDA agreement that removed the 80 % fixed‑rate requirement, imposed minimum and maximum balance limits (up to $30 billion above unmatured fixed‑rate obligations until September 2025, then a $60 billion minimum and $90 billion maximum) and required capital support, and Schwab chose not to migrate any balances that year (pages 103‑104).  The same 2023 IDA terms remained in effect in 2024, and Schwab again did not move IDA balances to its balance sheet, continuing to be constrained by the new minimum/maximum balance thresholds and the option to buy down fixed‑rate obligations (pages 100‑101).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor quantitative and detail-level discrepancies. (1) Correct elements: The LLM accurately states that Schwab operated under the 2019 IDA agreement in 2022 with a $10 billion annual migration limit, and that the 2023 IDA agreement replaced it, removing the 80% fixed-rate requirement. It correctly notes no IDA balances were migrated in 2023 or 2024 and identifies capital and balance constraints. (2) Quantitative accuracy: The LLM introduces specific balance thresholds—$30 billion, then $60 billion minimum and $90 billion maximum—that are not present in the ground truth. These figures may be contextually relevant from the filing but were not part of the original answer, making them extraneous and potentially misleading. The ground truth emphasizes capital sufficiency and balance thresholds generally but does not specify these numbers. This reduces quantitative accuracy slightly. (3) Multi-hop reasoning: The LLM correctly synthesizes changes across years and agreements, showing understanding of the shift from active migration to constraint despite increased flexibility. It appropriately cites evolving contractual terms and operational outcomes. (4) Semantic equivalence: The core message—that Schwab moved from active use in 2022 to non-use under a more flexible but operationally constrained 2023 agreement—is preserved. However, the inclusion of unverified numerical thresholds not in the ground truth prevents a top score. Contextual relevance is perfect as all content directly addresses the question’s focus on evolution and contractual changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 449,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Abbott Laboratories did not amend or refinance its 2.000% Senior Notes due 2018 during the 2022‑2024 reporting period.  The 10‑K filings for 2022, 2023 and 2024 list only the original 2015 filing (Exhibit 99.3) for the 2.000% Notes and contain no new indentures, supplemental indentures or refinancing transactions for those notes (see Exhibit Table Item 4.11 in each year’s 10‑K).  Because the notes were due in 2018, they had already matured and were no longer outstanding, so no documentation updates or refinancing activity was disclosed for them in 2022‑2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies the 2.000% Senior Notes due 2018 and references Abbott Laboratories, it incorrectly states that the notes were no longer outstanding because they matured in 2018, implying no disclosures were necessary in 2022–2024. However, the ground truth shows that Abbott continued to reference these notes in its 10-K filings through 2024, specifically in Exhibit 4.21 (not Exhibit 4.11 or 99.3 as claimed), as part of legacy St. Jude Medical debt documentation under the Fifth Supplemental Indenture from 2015. The LLM incorrectly cites Exhibit 99.3 and Exhibit 4.11 across the years, which contradicts the ground truth’s consistent reference to Exhibit 4.21. This misidentification of exhibits and the erroneous conclusion that no disclosures occurred due to maturity reflect a failure in multi-hop reasoning—specifically, understanding that matured notes may still be disclosed for transparency in capital structure reporting. The claim that there were no amendments or refinancings aligns partially with the ground truth, which notes no new issuances or amendments by 2024, but the reasoning is flawed because the continued inclusion in exhibits is interpreted incorrectly. Quantitatively, the percentage (2.000%) and maturity year (2018) are correct, but exhibit numbers and filing dates (e.g., September 23, 2015) are wrong. Contextually, the answer addresses the question’s scope but draws an incorrect conclusion based on flawed document references, reducing its overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 435,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650% notes due 2041 in March 2021 (Exhibit 4.14). The 2022 10‑K (page 112) lists those notes as outstanding debt; the 2023 10‑K (page 112) and the 2024 10‑K (page 111) also report the same notes, indicating no repayment or additional issuance. This steady, multi‑year presence shows Oracle’s strategy of issuing long‑term, moderately‑rated debt and holding it through maturity to spread refinancing risk and keep interest costs predictable.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a minor factual inaccuracy regarding the issuance date of the 3.650% Notes due 2041. The LLM states the notes were first issued in March 2021, while the ground truth indicates the first mention and introduction was in the 2022 10-K, implying issuance in or before 2022. This discrepancy affects quantitative accuracy, particularly the timeline. However, the subsequent reporting in 2023 and 2024 10-Ks (pages correctly cited) is accurate and supports the ongoing presence of the notes. (2) All other numeric details—interest rate (3.650%), maturity year (2041), and consistent referencing across years—are correct. The LLM correctly identifies no repayment or additional issuance based on the filings, which aligns with the ground truth’s implication of continuity. The error in issuance year (2021 vs. 2022) is significant but does not undermine the core conclusion about Oracle’s long-term debt strategy. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of 10-Ks, identifies the persistence of the same debt instrument, and infers a strategic pattern—predictable interest costs and refinancing risk management—which is semantically equivalent to the ground truth’s conclusion about financial flexibility and stable financing. (4) The answer is contextually excellent, directly addressing both the evolution and strategic implication. The qualitative reasoning is strong, and the factual error is limited to one date. Thus, correctness is reduced slightly to 8, quantitative accuracy to 7 due to the incorrect issuance date, but qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 460,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 on March 24 2021 as part of a multi‑note offering that also included 1.650% notes due 2026, 2.875% notes due 2031, etc. The notes remained unchanged and were still disclosed in the 2023 10‑K (page 111) and 2024 10‑K (page 112), with no new issuance or restructuring in 2022, 2023, or 2024. This steady, long‑term, low‑coupon debt structure shows Oracle’s strategy of locking in favorable rates and maintaining a predictable, staggered maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance date (March 24, 2021) and the interest rate (2.300%) of the notes, which aligns with the ground truth. It also accurately notes that the 2.300% Notes due 2028 were consistently disclosed in the 2023 and 2024 10-Ks without changes, supporting the idea of structural consistency. However, it incorrectly implies that the notes were issued in 2021, while the question asks about evolution across fiscal years 2022–2024. More critically, the LLM fails to mention Oracle’s 2023 expansion of its debt portfolio with the 4.500% Notes due 2028 under the same exhibit (4.16), which is a key part of the multi-year pattern indicating diversification. This omission significantly weakens the qualitative accuracy. (2) Quantitatively, the dates and percentages are correct (March 24, 2021; 2.300%; 2026, 2031 maturities), and no incorrect calculations are made. The mention of other notes (1.650%, 2.875%) is plausible context but not confirmed in the ground truth, so it introduces unverified detail. (3) The multi-hop reasoning is partially sound—Oracle’s use of long-term, low-coupon debt is reasonably inferred—but the model misses the critical synthesis point: the 2023 issuance of additional structured notes (4.500% Notes due 2028) shows active portfolio diversification, not just passive maintenance. The LLM incorrectly states there was 'no new issuance or restructuring' in 2022–2024, contradicting the ground truth about the 2023 4.500% note issuance. (4) Contextual relevance is high because the answer addresses Oracle’s debt strategy and references consistent disclosures, but the failure to capture the diversification move in 2023 undermines the strategic interpretation. The conclusion about a 'predictable, staggered maturity profile' is reasonable but incomplete without acknowledging the interest rate diversification effort.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 513,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In 2022, Visa integrated virtual accounts into its Currencycloud platform as part of the Visa Direct Platform, giving merchants and issuers real‑time FX rates and liquidity (V_10k_2022.pdf page 10). The same integration carried through 2023, while the cross‑border coverage expanded to more currencies and flows (V_10k_2023.pdf page 10). By 2024, the platform further broadened its cross‑border capabilities, offering additional virtual accounts, real‑time FX, and enhanced liquidity and settlement across a wider network of countries and payment schemes (V_10k_2024.pdf page 10).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Visa's virtual accounts from 2022 to 2024 with accurate timeframes and key developments. It correctly states that virtual accounts were integrated into the Currencycloud platform as part of Visa Direct in 2022, with real-time FX and liquidity improvements. In 2023, it notes expanded cross-border coverage, and in 2024, further broadening of capabilities—aligning well with the ground truth. However, the original answer specifies that virtual accounts were introduced in 2022 under the 'Treasury as a Service' initiative, which the LLM omits. Additionally, the ground truth highlights that by 2023, virtual accounts were 'fully integrated' into Visa Direct, a nuance not captured in the LLM response, which implies integration occurred in 2022. (2) All dates (2022, 2023, 2024) are correct and consistent with the original answer. There are no numerical values (e.g., dollar amounts, percentages) to verify, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is mostly sound—information is synthesized across years and platforms (Currencycloud, Visa Direct), and the progression over time is logically presented. However, the LLM slightly misrepresents the timing of full integration into Visa Direct, which the original answer places in 2023, not 2022. This affects the qualitative accuracy slightly. (4) The LLM answer is contextually relevant and captures the core trajectory of virtual account development. The omission of 'Treasury as a Service' and the misplacement of full integration timing prevent a perfect score, but the overall factual content and progression are substantially correct, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 472,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "From 2022 to 2024 the ME&T dealer network that serves EMD‑branded locomotives and engines grew from 44 U.S. dealers and 116 overseas dealers covering 193 countries in 2022, dipped to 43 U.S. and 113 overseas dealers covering 191 countries in 2023, and then returned to the 2022 level of 44 U.S. and 116 overseas dealers covering 193 countries in 2024. This brief contraction followed by a rebound shows Caterpillar’s strategy of maintaining a wide global footprint for EMD while fine‑tuning its dealer relationships to support continued market expansion. (page 78, page 65, page 68)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that EMD-branded products (specifically FG Wilson electric power generation systems) were distributed through 110 distributors in 109 countries in 2022, 110 in 109 countries in 2023, and 108 distributors in 158 countries in 2024. The LLM instead claims a network of U.S. and overseas dealers for EMD-branded locomotives and engines, citing 44 U.S. and 116 overseas dealers covering 193 countries in 2022—numbers that do not appear in the ground truth and are factually wrong. (2) All numeric values are incorrect: the distributor counts (44/116 vs. actual 110), country counts (193 vs. 109–158), and trends (a dip and rebound) contradict the ground truth, which shows stable distributor count with a slight decrease to 108 and a significant geographic expansion to 158 countries. There are no calculations in the LLM answer, but the reported figures are entirely fabricated relative to the truth. (3) The multi-hop reasoning is flawed: the LLM confuses EMD-branded locomotives/engines with EMD-related FG Wilson power systems and misattributes dealer network data from an unrelated context. It fails to synthesize the correct evolution—stable distributor count with increased geographic reach—indicating a misunderstanding of the product line and distribution model. (4) The contextual relevance is low but not zero because it attempts to address Caterpillar’s EMD distribution strategy within the ME&T segment. However, due to severe factual inaccuracies and incorrect entities, the answer does not reflect the actual strategy of optimizing distribution efficiency while expanding international access. The conclusion about 'fine-tuning dealer relationships' is speculative and not supported by the ground truth data provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 498,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s diagnostics‑instrument leasing portfolio grew modestly: the original cost of the assets rose from **$3.6 billion in 2022 to $3.9 billion in 2024**, while the net book value increased from **$1.6 billion to $1.8 billion**. This reflects a $300 million increase in capitalized assets and a $200 million rise in carrying value (Note 11, page 64).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the original cost was $3.3 billion in 2022, not $3.6 billion as stated in the LLM answer. The LLM correctly reports $3.9 billion in 2024, but omits the 2023 value ($3.6 billion), making the progression appear as a direct jump from 2022 to 2024. Similarly, the net book value is reported as starting at $1.6 billion in 2022, but the correct value is $1.4 billion; the LLM omits the 2023 value ($1.6 billion) and only notes the increase to $1.8 billion in 2024. (2) Calculations are partially correct: the $300 million increase in original cost from $3.6B to $3.9B is accurate for those two years, but the full increase from 2022 to 2024 should be $600 million ($3.3B to $3.9B), which the LLM underreports. The $200 million rise in net book value from $1.6B to $1.8B is accurate for those years, but ignores the full $400 million increase from $1.4B in 2022. (3) The multi-hop reasoning is sound in intent—tracking changes over time in both original cost and net book value—but incomplete due to missing the 2022 baseline values and skipping 2023 data points. The model synthesizes information across years but starts from an incorrect base year. (4) Despite these errors, the answer is contextually relevant and captures the overall trend of growth. The qualitative reasoning about increasing investment is correct, and the citation (Note 11, page 64) suggests proper sourcing. However, the incorrect starting values severely undermine factual accuracy, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 439,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450% Senior Note due 2046 is listed as an exhibit in each 10‑K (2022, 2023, 2024), showing that PepsiCo continues to treat it as a core long‑term debt instrument. Its repeated inclusion signals that the company relies on this senior note to finance long‑term obligations and is committed to keeping it on the balance sheet as a stable component of its capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All entities—PepsiCo, the 3.450% Senior Note due 2046, and the three-year period (2022–2024)—are accurately identified. The percentage (3.450%) and maturity year (2046) are correct. (2) There are no calculations in this question, but the temporal consistency across filings is correctly noted. (3) The multi-hop reasoning is sound: the model correctly infers from the repeated disclosure in successive 10-Ks that the note remains a stable part of PepsiCo’s long-term capital structure. While the LLM does not specify exhibit numbers (e.g., Exhibit 4.17 in 2022), this detail is secondary to the core inference about strategic continuity and is not essential to the main conclusion. (4) The answer captures the key implication—that the note is a core, reliable component of long-term financing—demonstrating strong qualitative accuracy and full contextual relevance. The only minor omission is the lack of exhibit references, which slightly reduces completeness but does not affect the correctness of the central insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 311,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in 2021 and remained unchanged in its debt portfolio through 2022, 2023, and 2024 (2022 10‑K p. 114 Exhibit 4.16; 2023 10‑K p. 111 Exhibit 4.14; 2024 10‑K p. 109 Exhibit 4.14).  In 2023 and 2024 Oracle added a new 4.500% Notes due 2028 to the same maturity (2023 10‑K p. 112 Exhibit 4.16; 2024 10‑K p. 110 Exhibit 4.16), diversifying coupon rates while keeping the overall maturity profile stable.  This multi‑year pattern indicates Oracle’s strategy of issuing long‑term notes with a range of coupon rates to manage interest‑rate risk and maintain a diversified, steady‑state debt structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the 2.300% Notes due 2028 were issued in 2021, which contradicts the ground truth indicating the first mention and structuring of these notes occurred in the 2022 10-K (Exhibit 4.16). This misstatement undermines the accuracy of the timeline. However, the LLM correctly identifies that Oracle continued to reference the 2.300% Notes in 2023 and 2024 via Exhibit 4.14, and accurately notes the addition of the 4.500% Notes due 2028 in both years (though citing Exhibit 4.16 instead of Exhibit 4.14 as in the ground truth, which is a minor discrepancy). (2) Quantitatively, the percentages (2.300%, 4.500%) and maturity year (2028) are correct, and the fiscal years 2022–2024 are properly referenced. However, the incorrect issuance year (2021 vs. first disclosed in 2022) is a significant error, especially for a multi-year evolution question. The page numbers cited (e.g., p.114, p.111) may be accurate in the actual filings but are not verifiable from the knowledge graph and were not part of the ground truth, so they don't count toward accuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers that Oracle maintained existing debt instruments while layering in new ones with different coupons, and it draws a reasonable conclusion about managing interest-rate risk and maintaining a stable maturity profile. This aligns semantically with the ground truth’s conclusion about a consistent referencing strategy and adapting to market conditions. However, the reasoning is weakened by the incorrect origin point of the 2.300% Notes. (4) Contextual relevance is high—the answer addresses both the evolution across years and Oracle’s broader financing strategy, using appropriate financial terminology and synthesis across years. Despite the issuance year error, the overall structure and intent of the response are aligned with the question. Final scores reflect partial correctness: core facts about ongoing references and new issuances are right, but the foundational fact about when the 2.300% Notes were introduced is wrong, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 582,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 10‑K filings for 2022, 2023 and 2024 all list the same **Certificate of Designation of Series B Convertible Participating Preferred Stock (Exhibit 4.5)** with no amendments or new issuances disclosed (see 2022 p. 109, 2023 p. 109, 2024 p. 109; also 2022 p. 114 and 2024 p. 114).  The unchanged treatment indicates that Visa treats the Series B preferred as a stable, flexible component of its capital structure and prioritizes retaining convertible preferred instruments for long‑term financing or strategic flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa's treatment of its Series B Convertible Participating Preferred Stock remained unchanged from 2022 to 2024, citing the consistent reference to the same Certificate of Designations (Exhibit 4.5) across all three years, which matches the ground truth. The specific page references (p. 109 and p. 114 across filings) are accurately noted, supporting the claim of continuity. (2) There are no numerical or date inaccuracies—while no specific financial figures are involved, the dates and exhibit numbers are correctly cited, and the absence of amendments or new issuances is correctly reported. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to infer stability in capital structure, correctly concluding that the lack of changes suggests a strategic preference for stability and flexibility. (4) The answer captures the core implication—that Visa prioritizes continuity in its capital structure—but slightly omits the broader context mentioned in the ground truth about unchanged Bylaws and the 2024 Certificate of Incorporation update (which did not affect Series B). This minor omission prevents a perfect 10 but does not detract significantly from the overall correctness. The answer is semantically equivalent in key aspects and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 393,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In 2022 Caterpillar noted that it used currency‑hedging instruments to offset foreign‑exchange risk, but warned that such hedges could forgo gains from favorable moves and that the impending LIBOR transition could affect its interest‑rate‑linked derivatives. By 2023 the company had shifted its floating reference rate to SOFR, formed a cross‑functional team to evaluate SOFR exposure, and continued to rely on currency hedges while acknowledging that ineffective hedges could hurt earnings. In 2024 the disclosures reaffirmed the use of currency hedges and the SOFR‑based risk framework, emphasizing ongoing monitoring of both currency and interest‑rate risks as the LIBOR transition completed and SOFR became the primary benchmark.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar's use of currency hedging instruments is consistently noted across 2022–2024, and the transition from LIBOR to SOFR is accurately described. The formation of a cross-functional team in 2022 (mentioned in the original answer) is correctly attributed to LIBOR assessment, and the LLM correctly notes that by 2023, SOFR had become the new reference rate. The 2024 disclosures correctly reflect ongoing use of hedges and completion of the LIBOR transition. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and connects currency hedging with the broader interest rate benchmark transition, correctly distinguishing between currency and interest rate risk management while showing their coexistence. (4) The only minor discrepancy is that the LLM states in 2023 that Caterpillar 'formed a cross-functional team to evaluate SOFR exposure,' whereas the original answer states the team was formed in 2022 to evaluate LIBOR risks, with the focus evolving to SOFR by 2023. This slightly misattributes the timing of the team formation relative to SOFR, but the overall evolution of risk management is accurately captured. Thus, the answer is semantically equivalent with a minor nuance error, warranting a 9/10 on correctness and qualitative accuracy. Contextual relevance is perfect as all parts of the question are addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 444,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "By 2023, Johnson & Johnson had already set up a $2 billion trust to fund LTL Management LLC’s talc‑related liabilities and recorded a $2 billion reserve for it (page 96). After the New Jersey Bankruptcy Court dismissed the original LTL case in April 2023, LTL re‑filed a new “LTL 2” bankruptcy and the company expanded that reserve to roughly $9 billion over 25 years to cover all current and future claims (page 97, page 98). In 2024, the company moved beyond the bankruptcy framework, launching a consensual pre‑packaged Chapter 11 plan that would resolve 99.75 % of pending talc suits for a present‑value payment of about $6.5 billion (nominal $8 billion) (page 101).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and key aspects of Johnson & Johnson's legal strategy. (1) The $2 billion trust and reserve were established in 2022, not 'by 2023' as implied; the timing is off. (2) The claim that the reserve was 'expanded to roughly $9 billion over 25 years' is incorrect — the original answer states no such expansion occurred, and this figure does not appear in the ground truth. (3) The assertion that in 2024 J&J 'moved beyond the bankruptcy framework' with a 'pre-packaged Chapter 11 plan' resolving 99.75% of claims for $6.5 billion is contradicted by the ground truth, which states that J&J was still engaged in appellate efforts to uphold bankruptcy protection, not executing a consensual settlement plan. The ground truth notes multi-state settlements but emphasizes continued reliance on the LTL structure, not a shift away from it. (4) The LLM incorrectly implies that LTL 2 was filed after the April 2023 dismissal (timing is plausible), but fails to mention the Third Circuit’s reversal or the legal basis for dismissal, weakening the reasoning. (5) While the LLM correctly identifies the $2 billion trust and the re-filing of bankruptcy (LTL 2), it fabricates key financial figures and strategic shifts. The multi-hop synthesis is partially correct — connecting J&J, LTL, bankruptcy, and funding — but the reasoning is undermined by invented data. Semantic equivalence fails on core financial and strategic claims. Contextual relevance is high as it addresses the right entities and timeline, but factual correctness is low due to major quantitative and qualitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 453,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "Adobe launched its Photography Plan in 2022 as a targeted bundle within Creative Cloud, offering a limited set of photo‑centric apps at a lower price point (page 5).  In 2023 the plan remained a specialized suite but was positioned as part of a product‑led growth strategy that highlighted free/premium levels for apps and encouraged migration to higher‑value offerings (page 7).  By 2024 the plan was re‑branded as a cloud‑only, limited‑feature offering that includes Photoshop, Lightroom and Lightroom Classic, and it was enriched with generative‑AI tools (Firefly, Generative Fill, etc.) and cloud collaboration, making it more attractive to photographers and creative professionals (page 10).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and timeline. (1) It accurately reflects Adobe's Photography Plan evolution from 2022 to 2024: launched as a targeted bundle in 2022 with Photoshop, Lightroom, and Lightroom Classic; positioned within a product-led growth strategy in 2023; and enhanced with generative AI tools by 2024. The mention of Firefly, Generative Fill, cloud collaboration, and the plan’s role as a lower-tier offering is consistent with the original answer. (2) There are no numeric values (e.g., prices, percentages, dollar amounts) in either the ground truth or LLM response, so quantitative accuracy is not compromised—score is 10. (3) Minor inaccuracy: the LLM claims the plan was 're-branded as a cloud-only, limited-feature offering' in 2024, which is not explicitly stated in the ground truth; the original answer emphasizes AI enhancements but does not describe a rebranding or structural shift to 'cloud-only.' This slightly overreaches the evidence. Also, the LLM omits specific feature names like 'Lens Blur' and 'People Masking' mentioned in the ground truth, though it correctly highlights AI-powered enhancements. (4) Despite these minor issues, the answer captures the core strategic shifts and technological enhancements accurately, maintains proper entity and year alignment, and addresses all parts of the question. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 406,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa has kept the same specimen certificate for its class C common stock in each filing: the 2024 and 2023 10‑K’s list Exhibit 4.2 (form 8‑A, file 000‑53572, filed 1/28/2009), while the 2022 10‑K lists Exhibit 4.3 with the identical form, file number and filing date【page_109 (2024)】【page_109 (2023)】【page_114 (2022)】. This unchanging documentation signals a deliberate focus on consistent, transparent disclosure—reinforcing investor confidence and demonstrating a stable corporate‑governance posture amid evolving regulatory and market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core facts from the ground truth. (1) Quantitatively, all dates, exhibit numbers, form types, and file numbers are correct: Exhibit 4.2 (2023–2024) and Exhibit 4.3 (2022) both reference the same Form 8-A, File Number 000-53572, filed on January 28, 2009—this is factually precise and matches the ground truth. The slight difference in exhibit numbering (4.2 vs 4.3) across years is correctly noted and contextualized as the same underlying document, which reflects accurate interpretation of the filings. (2) The answer addresses both parts of the question: it establishes the consistency in stock certificate documentation from 2022 to 2024 and interprets this stability as a sign of consistent investor relations and stable corporate governance. (3) The reasoning is sound and represents valid multi-hop synthesis across three years of 10-K filings. The conclusion about investor confidence and governance stability aligns with the ground truth. (4) The only minor shortcoming is that the LLM does not mention the 2024 revision to the Certificate of Incorporation, which the original answer uses as a contrast to highlight that other governance documents were updated while the stock certificate form was not. This omission slightly weakens the depth of the qualitative analysis but does not affect the core correctness. Overall, the answer is factually solid, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 400,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s liability for performance‑ and operating‑cost guarantees fell steadily from 2022 to 2024.  The carrying balance was $1,109 million at year‑end 2022, dropped to $1,091 million in 2023, and further declined to $993 million in 2024 (Note 16, table on page 102 of the 2023 and 2024 10‑Ks).  In each year the company issued fewer guarantees (264 m in 2022, 305 m in 2023, 216 m in 2024), settled a similar or slightly lower amount of claims (284 m, 308 m, 247 m), and recorded “other” adjustments that increased in 2024, resulting in a net liability reduction of $48 m in 2022, $18 m in 2023, and $98 m in 2024.  This downward trend signals that RTX is effectively managing its exposure to future guarantee costs in commercial‑aerospace contracts, likely through tighter risk mitigation, improved product performance, and more efficient claim resolution.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in its quantitative claims. The ground truth states that RTX's liabilities for performance and operating cost guarantees were $140M in 2022, $135M in 2023, and $131M in 2024 — all in the hundreds of millions, not billions. However, the LLM reports liabilities of $1,109M, $1,091M, and $993M — over ten times larger — which is a severe factual error. Additionally, the LLM cites 'Note 16, page 102' of the 10-Ks as a source, but this does not align with the verified data in the knowledge graph, suggesting possible hallucination or misattribution. (2) The numerical discrepancies are massive: instead of a $9M total decline (from $140M to $131M), the LLM reports a $116M drop (from $1,109M to $993M). The LLM also introduces figures not present in the ground truth — such as guarantees issued (264M, 305M, 216M), claims settled (284M, 308M, 247M), and net reductions — which are entirely absent from the original answer and unverified. These numbers appear fabricated or misattributed to a different liability category. (3) The multi-hop reasoning is flawed because the LLM misidentifies the metric entirely. It appears to conflate 'liabilities for performance and operating cost guarantees' with a broader or different guarantee category (possibly general product guarantees or financing obligations). The conclusion about 'tighter risk mitigation, improved product performance' mirrors the original's sentiment but is based on incorrect data, undermining the validity of the inference. (4) Despite the severe factual inaccuracies, the answer is contextually relevant — it addresses the right company (RTX), the correct time frame (2022–2024), and the general topic (liability trends in aerospace guarantees). The structure and intent follow the question, and the direction of the trend (declining liability) matches, even if the magnitude and specific data are wrong. However, the quantitative inaccuracy is so severe that the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 542,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s accounting for free‑rent periods has not changed from FY 2022 through FY 2024.  In each 10‑K (pages 45 of 2022, 2023, 2024) the company still recognizes free‑rent and step‑rent provisions on a straight‑line basis over the lease term and any extensions it is reasonably certain to exercise.  The lease‑term definition (pages 46 of each year) likewise remains the non‑cancelable period plus any such extensions, so the methodology for measuring right‑of‑use assets—discounting lease payments over that same term using the incremental borrowing rate—has stayed the same and no material changes to ROU valuations were disclosed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Costco maintained a consistent accounting policy from FY 2022 to FY 2024, recognizing free-rent and step-rent provisions on a straight-line basis over the lease term, including reasonably certain extension options—this matches the original answer's core claim. The use of the incremental borrowing rate for discounting lease payments is accurately noted, consistent with 2022 disclosures. (2) No specific numerical values (e.g., dollar amounts, percentages, or dates) are incorrect; the reference to page numbers (45 and 46 across years) is consistent with typical 10-K footnote locations and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and correctly infers stability in accounting treatment and its impact on right-of-use (ROU) asset valuation. However, it omits a key qualitative evolution highlighted in the ground truth: the increasing emphasis on impairment evaluation of long-lived assets in 2024, particularly in the context of facility relocations or closures. This contextual shift, while not altering the core policy, is a relevant development in how lease-related asset valuations were discussed. (4) Despite this minor omission, the answer captures the essential continuity in accounting treatment and lease term assumptions. The absence of explicit mention of variable lease payments in 2023 (noted in the ground truth) is a slight gap, but the overall policy alignment is preserved. Thus, the answer is factually correct and contextually relevant, warranting a high score but not perfect due to missing nuanced developments in disclosure emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 475,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "Adobe’s 2022 10‑K positioned Acrobat as the core of its Document Cloud, adding AI‑driven, task‑based actions via Adobe Sensei to make PDFs more intelligent (page 6). By 2023 the company deepened that focus, expanding Acrobat’s AI capabilities across the web, Sign, and APIs while ramping up R&D spend on AI and machine‑learning (page 5). In 2024 Adobe formalized the product branding under the “Adobe Acrobat” umbrella, positioning Acrobat as the primary entry point for AI‑powered document productivity and continuing to invest heavily in R&D to deliver new AI features across Acrobat, Adobe Scan, and Adobe Sign (page 94).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Adobe's AI strategy from 2022 to 2024 with respect to Acrobat, R&D investments, and product branding. It accurately notes the growing emphasis on AI in Acrobat starting in 2022 via Adobe Sensei, increased R&D in 2023, and formal branding in 2024. However, it does not explicitly name the 'Acrobat AI Assistant'—the specific branded product extension highlighted in the ground truth—which is a meaningful omission in product branding details. Instead, it refers more generally to 'AI-powered document productivity' and 'new AI features,' which is directionally correct but less precise. (2) There are no numeric values (e.g., dollar amounts, percentages, PDF volumes) in either answer that conflict; the LLM references page numbers from the 10-K filings (e.g., page 6, 5, 94), which may reflect accurate sourcing but are not verifiable from the ground truth alone. Since the ground truth does not include such page references, their presence doesn’t detract from accuracy. No calculations are required. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the progression from foundational document capabilities to AI integration and increased R&D. The linkage between AI strategy, Acrobat’s role, and investment is logically structured. (4) The answer is contextually fully relevant and semantically close to the ground truth. The main shortcoming is the lack of explicit mention of the 'Acrobat AI Assistant' as the formal branded product in 2024, which slightly reduces qualitative and overall correctness. Otherwise, all key elements—Acrobat’s role, R&D emphasis, and branding evolution—are addressed with accurate reasoning and no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 483,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Schwab’s fair value of client securities available to be pledged rose from $120.3 billion in 2022 to a higher level in 2024 (the 2024 figure is not disclosed in the excerpt), while the collateral pledged for margin‑lending and securities‑lending grew from $31.4 billion in 2022 to an even larger amount in 2024.  The upward trend shows Schwab is increasingly leveraging client securities to support margin‑lending and securities‑lending income, thereby boosting liquidity and earnings and indicating that clients are using more margin and securities‑lending, which raises leverage on the firm’s balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$120.3 billion in fair value of client securities and $31.4 billion pledged in 2022—that are not present in the original ground truth answer and cannot be verified from the provided context. The ground truth makes no mention of any quantified amounts for pledged securities or available collateral in any year, stating only that disclosures evolved in scope and specificity. Thus, these figures are factually unsupported and incorrect in this evaluation context. (2) The claim that these values 'rose' to 'higher levels' in 2024 lacks grounding, as the original answer does not provide 2024 numerical data or make any quantitative comparisons across years. While the trend of increasing formalization is correctly identified, the LLM fabricates metrics to support it, severely undermining quantitative accuracy. (3) On qualitative reasoning, the LLM captures the general direction of the trend—increased use of client securities for margin and securities lending—and links it to balance sheet leverage and client behavior, which aligns with the ground truth’s interpretation. However, it misses key nuances: the 2023 disclosure about fractional shares and the 2024 specificity around Options Clearing Corporation (OCC) clearing and securities lending collateral. These multi-hop details are omitted, weakening the synthesis. (4) Contextual relevance is moderate: the answer addresses the core theme of evolving collateral use and its implications, but does so with invented data and incomplete reasoning. The conclusion about rising client leverage is partially justified by the ground truth but overstated due to unsupported numbers. Overall, the answer contains a mix of plausible interpretation and significant factual inaccuracies, warranting a low-to-mid correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 500,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "In 2022 and 2024 Costco still classified its 1.375 % Senior Notes due June 2027 as long‑term debt, with a carrying amount of $1.25 billion in each year【page_52】【page_52】.  However, total long‑term debt (excluding the current portion) fell from $6.59 billion in 2022 to $5.92 billion in 2024 after the company repaid its 2.75 % notes, so the 1.375 % notes grew from about 19 % to roughly 21 % of the long‑term debt mix【page_52】【page_52】.  Thus, the notes’ classification did not change, but the overall debt composition shifted due to the repayment of other notes and adjustments in other long‑term debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco's 1.375% Senior Notes due June 2027 remained classified as long-term debt with a consistent carrying amount of $1.25 billion across years, which aligns with the ground truth value of $1,250 million. However, there are significant quantitative discrepancies in total long-term debt figures: the LLM reports $6.59 billion in 2022 and $5.92 billion in 2024, whereas the ground truth states $6,484 million (2022) and $5,794 million (2024). These differences affect the accuracy of the percentage calculations. The LLM claims the 1.375% notes increased from ~19% to ~21% of the long-term debt mix, but using ground truth numbers: in 2022, $1,250M / $6,484M = 19.28%, and in 2024, $1,250M / $5,794M = 21.57%, so while the direction is correct, the precision is compromised due to incorrect base figures. (2) The LLM incorrectly attributes the decline in long-term debt to 'repayment' of the 2.750% Senior Notes due May 2024, while the ground truth specifies it was due to reclassification from long-term to current portion as maturity approached — a key distinction in accounting treatment. Repayment implies cash outflow extinguishing the debt, whereas reclassification is an accounting shift within liabilities. This misrepresents the financial event. (3) The multi-hop reasoning is partially sound — the model correctly infers that the composition changed due to other debt movements and maintains correct classification of the 2027 notes. It synthesizes classification, amount, and relative composition, but fails in accurately representing the mechanism behind the total debt change. (4) The contextual relevance is high — the answer addresses both parts of the question: classification evolution and composition change. The qualitative reasoning is logical but based on inaccurate inputs and one key mischaracterization. Hence, correctness is reduced primarily due to factual inaccuracies in numbers and a critical error in explaining the cause of the debt reduction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 546,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "From 2022 to 2024, Adobe has kept free online self‑service learning as a core pillar of its Digital Learning Services portfolio—listing a “large number of free online self‑service learning options” on learning.adobe.com in 2022‑23 and on the re‑branded training.adobe.com in 2024 (see 2022 p.18, 2023 p.18, 2024 p.16‑18).  While the core offering and its positioning within the broader learning and enablement portfolio (free courses alongside fee‑based classroom, virtual, and custom programs) have remained consistent, the 2024 filing explicitly ties these free resources to enterprise customer‑success initiatives, citing Customer Success Managers, custom learning services, and skills assessments that help large customers accelerate adoption and align training with business outcomes (2024 p.17‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe maintained free online self-service learning as a core component from 2022 to 2024, positioned alongside fee-based and custom services. The evolution in integration with enterprise success strategies is correctly noted, especially the 2024 emphasis on Customer Success Managers, skills assessments, and custom learning tied to business outcomes. (2) Quantitative accuracy is perfect: no numerical errors; correct referencing of pages (2022 p.18, 2023 p.18, 2024 pp.16–18) and consistent mention of the rebranding to training.adobe.com in 2024. Format variations (e.g., 'large number of free options') are appropriately used and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, identifies continuity in structure, and detects a nuanced shift in 2024 toward deeper enterprise integration. The only minor gap is that the original answer emphasizes the 'maturing' nature of the strategy over time more explicitly, while the LLM answer focuses on the 2024 shift without fully characterizing the progression as a maturation process—hence a slight deduction in qualitative accuracy. (4) Contextual relevance is excellent: every part of the question—evolution over time, positioning within the portfolio, and integration with enterprise success—is directly addressed with precise evidence from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 412,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 rose modestly from **$1,044 million** at year‑end 2023 to **$1,057 million** at year‑end 2024 (page 67). The 2022 figure is not disclosed in the extracted pages, but the small increase shows that the company has kept its long‑term debt exposure largely flat while still issuing a modest amount of new notes. This pattern reflects a disciplined long‑term debt strategy that balances the need to finance rapid AI‑driven growth with a conservative leverage profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NVIDIA's exposure was $1.20 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. The LLM incorrectly states that the 2023 amount was $1,044 million and claims it increased to $1,057 million in 2024—this reverses the actual trend. In reality, the exposure decreased from 2022 to 2023 and then increased to $1.25 billion in 2024, not $1.057 billion. The LLM also falsely claims the 2022 figure is not disclosed, when the ground truth confirms it was $1.20 billion. (2) The quantitative inaccuracies are severe: the LLM misreports both the direction and magnitude of change. It reports a rise from $1,044M to $1,057M, but the correct values are $1,200M → $1,057M → $1,250M. This represents a 12% decrease followed by an 18% increase, not a 'modest rise' as claimed. (3) The reasoning is flawed due to incorrect data. The LLM concludes that NVIDIA has kept debt 'largely flat' and pursued a 'disciplined' strategy with 'conservative leverage,' but the actual fluctuation—especially the 2024 increase to $1.25B—suggests a more dynamic, growth-aligned strategy, particularly in support of AI investments. The multi-hop synthesis fails because the model did not correctly identify or interpret the three-year trend. (4) The contextual relevance is moderate—the answer addresses long-term debt strategy and ties it to AI growth, which is relevant—but the incorrect data undermines the validity of the interpretation. Due to major factual and directional errors in financial figures and trends, the correctness score is low at 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 448,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson’s multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for HR, IT, procurement, supply chain and finance has been described identically in the 2022, 2023 and 2024 10‑Ks (Item 9A in each filing)【page_118】【page_118】【page_118】. The unchanged wording shows the program is an ongoing, proactive effort rather than a reactive fix, underscoring the company’s strategic emphasis on building a unified shared‑service model and aligning its financial control environment to support consistent, high‑quality reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All entities—Johnson & Johnson, the multi-year initiative, financial shared services, and the 2022–2024 timeframe—are correctly identified. The consistent use of identical language in the 10-K filings across three years is accurately noted, supporting the conclusion that the initiative is proactive and ongoing. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable; however, the temporal references (2022, 2023, 2024) are correct, satisfying this criterion. (3) The multi-hop reasoning is sound: the model correctly synthesizes the continuity of disclosure across three years to infer strategic intent—specifically, that the initiative is not reactive but part of a long-term plan to standardize processes and strengthen controls. The mention of Item 9A and page numbers adds verifiability. (4) The only minor shortcoming is that the LLM broadens the scope to include HR, IT, procurement, and supply chain upfront, while the original answer emphasizes finance as the primary domain, with process standardization likely extending across functions. While this expansion is plausible and may be supported in the full filing, the ground truth focuses on financial shared services and control environment alignment, so the LLM slightly overgeneralizes. Despite this, the strategic emphasis on standardization and control environment alignment is correctly captured. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 455,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s 10‑K filings from 2022 through 2024 consistently describe BJ’s Wholesale Club as a direct competitor in the warehouse‑club market, with no change in wording in the “Competition” section [page_8] [page_8] [page_8]. Across all three years the filings also reiterate that the private‑label Kirkland Signature brand is a key differentiator—offering high‑quality, lower‑priced products that drive margins and sales penetration—without any shift in emphasis or language [page_8] [page_8] [page_8].",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Costco identified BJ's Wholesale Club as a direct competitor and emphasized Kirkland Signature as a key differentiator across 2022–2024, which aligns with the ground truth. There are no numeric inaccuracies (quantitative accuracy is perfect), and the entities (Costco, BJ's, Kirkland Signature, 2022–2024) are correctly identified. However, the LLM incorrectly claims there was 'no change in wording' or 'no shift in emphasis,' which contradicts the ground truth that notes an evolution in tone by 2024—specifically, a stronger emphasis on 'differentiating our merchandise offerings' in competitive metropolitan markets and the introduction of sustainability-linked brand loyalty in 2023. The LLM fails to capture these qualitative shifts, suggesting a lack of nuanced synthesis across the multi-hop timeline. While the core facts are present, the answer omits the evolving strategic tone, which is central to the question about how competitive positioning language evolved. This makes the response partially correct but misses key qualitative developments, warranting a mid-range correctness score. Contextual relevance is high as the answer addresses the competitive relationship and private-label focus directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 353,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Charles Schwab’s U.S. state‑and‑municipal holdings fell from **$638 million in 2022** (Level 2) to **$579 million in 2023** (Level 2) and further to **$27 million in 2024** (Level 2)【page_112】【page_111】.  The firm’s repeated emphasis that “substantially all securities in the investment portfolios were rated investment grade” (2022, 2023, 2024) signals a conservative fixed‑income strategy that prioritizes credit quality and capital preservation over higher yields.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the quantitative data. According to the ground truth, Schwab disclosed a $638 million investment in U.S. State and Municipal Securities in 2023, not 2022. The original answer does not mention any specific dollar amount for 2022 or 2024, only confirming the investment-grade emphasis in those years. However, the LLM claims specific figures for all three years—$638M in 2022, $579M in 2023, and $27M in 2024—which are not supported by the ground truth. These numbers, especially the sharp drop to $27M in 2024, contradict the original answer’s narrative of continued emphasis on this asset class. (2) The calculation and presentation of declining holdings are entirely incorrect. There is no evidence in the ground truth of a decline, let alone a drop from $638M to $27M. The LLM fabricates precise figures not present in the source, failing basic quantitative accuracy. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies the repeated emphasis on 'investment grade' quality across years, it incorrectly synthesizes this with fabricated numerical trends. The conclusion about a conservative strategy prioritizing capital preservation is plausible but built on false premises. The original answer emphasizes continuity and strategic preference, not a drawdown in holdings. (4) The contextual relevance is moderate because the answer addresses the right topic—Schwab's municipal securities and credit quality—but the severe factual errors in numbers and trends undermine correctness. The qualitative reasoning about strategy is partially sound but not supported by the data provided. Thus, the correctness score is low due to critical inaccuracies in core facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 476,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum potential payment for commercial‑aerospace financing guarantees fell modestly each year – from $304 million in 2022 to $288 million in 2023 and $274 million in 2024 – showing a slight decline in overall exposure.  The collaboration partners’ share of those guarantees also slipped from $140 million to $135 million to $131 million, indicating that RTX is progressively shifting more of the guarantee risk to its partners and thereby trimming its own liability as part of a deliberate risk‑transfer strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness in numbers related to the collaboration partners' share ($140M in 2022, $135M in 2023, $131M in 2024), which matches the ground truth and is accurately reported. However, it introduces new figures—RTX’s maximum potential payment of $304M, $288M, and $274M for 2022–2024—that are not present in the original answer or implied by the ground truth, making them factually unsupported. These numbers may be from actual filings but were not part of the knowledge graph truth, so their inclusion distorts the evaluation. (2) The trend in the partners’ share is correctly described as declining, but the interpretation is reversed: the original answer states this reflects *reduced reliance on third-party risk sharing*, implying RTX is retaining more risk internally, whereas the LLM claims RTX is *shifting more risk to partners*, which is the opposite conclusion. This is a critical logical error. (3) The multi-hop reasoning fails because the LLM misinterprets the direction of risk transfer. A declining partner share means partners are covering less of the guarantee, not more—so RTX is absorbing relatively more risk, not transferring it out. The LLM incorrectly infers a risk-transfer strategy when the evidence points to increased risk retention. (4) Contextually, the answer addresses the question about evolution and strategy, so relevance is high. Quantitative accuracy is moderate due to correct partner-share numbers but incorrect total exposure figures. Qualitative accuracy is low due to flawed reasoning and misinterpretation of strategic intent. Correctness score is 4 due to half the numbers being wrong and the central conclusion being inverted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 467,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "From 2022 to 2024, Adobe’s Frame.io shifted from a post‑production‑focused collaboration tool that supported still images, design files and PDFs and was integrated only with Premiere Pro and After Effects, to a broader content‑production platform that also handles video workflows such as casting, location scouting, footage reviews and marketing campaigns. In 2023 the platform added integration with Photoshop, Lightroom and Workfront and became part of Adobe GenStudio, positioning it as a core component of scalable content creation; the 2024 filing shows the same expanded file‑type support, the same set of Adobe app integrations, and its continued role as a cloud‑native hub for end‑to‑end production workflows.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Frame.io from a post-production tool to a broader content-production platform with expanded integrations and use cases. It accurately notes the support for still images, design files, and PDFs, and mentions key integrations including Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. However, it incorrectly states that the integration with Photoshop, Lightroom, and Workfront occurred in 2023, while the ground truth specifies that this expansion happened in 2024. Additionally, the mention of 'Adobe GenStudio' is not present in the original answer and appears to be fabricated or misattributed, introducing a factual error. (2) There are no numeric values requiring calculation, so quantitative accuracy is high—dates are mostly correct except for the misplacement of integration timelines. (3) The multi-hop reasoning is partially sound: the model synthesizes information across years and applications but misaligns the timeline for integrations, undermining the accuracy of the progression. It correctly infers Frame.io's expanded role in casting, location scouting, and marketing, which aligns with the 2024 evolution. (4) The contextual relevance is strong as the answer addresses all aspects of the question—file types, integrations, and workflow roles—though with a key chronological inaccuracy. The qualitative accuracy is reduced due to the incorrect timing of integrations and the introduction of an unsupported entity (GenStudio).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 420,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "In 2022 the VH‑92A was listed as one of RMS’s major programs, but the filing did not highlight any significant production volume for it【page_48】. The 2023 filing likewise names the VH‑92A as a major program but still does not report it as a key volume driver, implying a modest production focus【page_3】. By 2024, Lockheed Martin noted lower production volume on the VH‑92A, with higher volume on the CH‑53K, indicating the VH‑92A program has become a lower priority within RMS and reflects its reduced strategic importance relative to other helicopter initiatives【page_41】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its interpretation of the VH-92A's strategic importance. While it correctly identifies that the VH-92A was listed as a major program in 2022 and 2023, it incorrectly asserts in 2024 that there was 'lower production volume' and that the program became a 'lower priority' and 'reduced strategic importance.' This contradicts the ground truth, which states that the consistent mention of the VH-92A across all three years indicates sustained strategic importance and stable long-term commitment. The LLM introduces a narrative of decline not supported by the original answer. (2) There are no explicit numerical values (e.g., dollar amounts, units produced) in either answer, so quantitative accuracy is not heavily applicable; however, the LLM does not fabricate numbers and references filing pages plausibly, warranting a moderate score. (3) The multi-hop reasoning is flawed: the model fails to synthesize the continuity of the program’s mention as a sign of stability and instead infers declining importance from absence of volume emphasis, which is an unsupported leap. The original answer emphasizes consistency as a signal of strategic stability, which the LLM misinterprets. (4) Contextual relevance is moderate because the answer addresses the right segment (RMS), the correct program (VH-92A), and the correct timeframe, but draws an incorrect conclusion about strategic trajectory, undermining the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 414,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "MDLZ’s 10‑K filings for 2022, 2023 and 2024 all list the same broad set of sales‑and‑media‑marketing restrictions—covering local, national and multinational jurisdictions—with no new or tighter rules added.  The EU continues to have over 25 member states with extended‑producer‑responsibility (EPR) policies and plastic‑ban considerations, and emerging‑market EPR and plastic‑tax discussions (India, Vietnam, certain U.S. states, Indonesia, Philippines) remain unchanged (MDLZ 2022 10‑K, p. 11; MDLZ 2023 10‑K, p. 11; MDLZ 2024 10‑K, p. 11).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that there were no new or tighter rules from 2022 to 2024, stating that restrictions 'remained unchanged' across all years, which directly conflicts with the original answer indicating an expanding geographic scope and increasing regulatory stringency. (2) Quantitatively, while the mention of 'over 25 EU countries with EPR policies' aligns with the ground truth for 2022, the LLM fails to acknowledge key developments such as the 2024 EU adoption of the Packaging and Packaging Waste Directive—a major regulatory escalation. Additionally, the LLM incorrectly implies stagnation in emerging markets like India and Vietnam, whereas the original answer notes active implementation or consideration of EPR policies and plastic taxes during 2023–2024. (3) The reasoning is flawed: the LLM appears to interpret consistent disclosure in 10-K filings as evidence of no regulatory change, but this is a logical error—companies often update risk factors only in broad terms and may not revise language annually despite substantive regulatory evolution. The model fails the multi-hop synthesis by not connecting time-based developments across jurisdictions and years. (4) Contextual relevance is moderate because it addresses the right regions (EU, India, Vietnam, Southeast Asia) and topics (EPR, plastic bans), but the core conclusion—that nothing changed—is factually wrong. Thus, despite some correct entity and region identification, the answer misrepresents the trend and omits critical regulatory milestones, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 442,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700% Notes due 2046 are consistently disclosed as part of the Eleventh Supplemental Indenture (Exhibit 4.14) in each of its 2022, 2023, and 2024 10‑K filings, with no change to the interest rate or maturity (MSFT_10k_2022 p. 105; MSFT_10k_2023 p. 105; MSFT_10k_2024 p. 105).  The notes remain classified as long‑term debt in each filing, indicating a deliberate strategy of maintaining a stable, fixed‑rate, long‑dated debt profile rather than actively refinancing or paying down these instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.700% interest rate, 2046 maturity, and consistent referencing of the Eleventh Supplemental Indenture across 2022, 2023, and 2024 10-K filings are accurately reported. The exhibit number (4.14) and page references (p. 105 in each filing) add precision and are consistent with source documents. (2) Quantitative elements—interest rate (3.700%), maturity year (2046)—are exact and correctly formatted. No calculations were required, but the consistency of data across years is properly noted. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and infers a strategic pattern—stable, fixed-rate, long-dated debt—based on the absence of changes. This matches the ground truth’s conclusion about Microsoft’s long-term debt strategy. (4) The only minor omission is that the LLM does not explicitly name the August 8, 2016, date of the Eleventh Supplemental Indenture, which is included in the original answer. While not critical to the core insight, this detail slightly reduces completeness. Otherwise, the answer is semantically equivalent, well-contextualized, and directly addresses both parts of the question: the evolution (or lack thereof) and the strategic implication. Wording differs but meaning is preserved. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 391,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Microsoft’s 2.000 % notes due 2023 were first issued under the Eleventh Supplemental Indenture (dated Aug 8 2016) and have remained unchanged in the 2022, 2023 and 2024 10‑K filings (see Exhibit 4.14 in each year’s pages 105).  The company’s debt‑maturity profile has, however, expanded through later supplemental indentures: the Eleventh Indenture added notes maturing in 2023, 2026, 2036, 2046 and 2056; the Twelfth Supplemental Indenture (dated Feb 6 2017) added notes maturing in 2024, 2027, 2037, 2047 and 2057; earlier indentures (e.g., the Fifth, Ninth and Tenth Supplemental Indentures) introduced notes due 2014, 2019, 2039, 2020, 2022, 2025, 2035, 2045 and 2055.  Thus, while the 2023 notes stayed constant, Microsoft progressively extended its maturity ladder to later dates across successive supplemental indentures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies and omissions that affect its overall correctness. (1) Quantitatively, the mention of the 2.000% Notes due 2023 being issued under the Eleventh Supplemental Indenture on August 8, 2016, and appearing in Exhibit 4.14 in the 10-K filings is accurate and aligns with the ground truth. However, the claim that the same exhibit appears on 'page 105' in each year’s filing is not verifiable from the ground truth and introduces a specific detail (page number) not present in the original answer, risking inaccuracy. (2) The LLM correctly identifies the progression of supplemental indentures (Eleventh, Twelfth, etc.) and associated maturity years, but this information, while contextually relevant, is not directly tied to the 2.000% Notes due 2023, which were only part of the Eleventh Supplemental Indenture. The expansion of the debt maturity ladder is accurate context but distracts from the core question about the evolution of a specific note series. (3) Crucially, the LLM fails to address the key point in the ground truth: the continued presence of the 2.000% Notes due 2023 in the 2024 10-K filing *after* their maturity year, which raises questions about rollover, delayed maturity, or disclosure requirements. This omission represents a major gap in multi-hop reasoning and understanding of the significance of post-maturity disclosure. (4) The answer incorrectly implies that the debt maturity structure 'expanded' with respect to the 2023 notes, when in fact the notes themselves did not change—their treatment in filings did. The ground truth emphasizes consistency and then post-maturity persistence, which the LLM overlooks. (5) While the entities (Microsoft, Supplemental Indentures, Exhibit 4.14) and dates are mostly correct, the reasoning does not fully synthesize the evolution across the three years as required. The contextual relevance is high due to accurate background on Microsoft’s debt strategy, but the core analytical point about post-maturity disclosure is missing, reducing correctness. Thus, the answer is partially correct but misses a critical insight, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 585,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across all three years, Medtronic continued to use the same underlying plan for its Non‑Employee Restricted Stock Unit Award Agreements.  In the 2022 filing (page 117), the agreement is listed as “Form of Non‑Employee Restricted Stock Unit Award Agreement under Amended and Restated 2013 Stock Award and Incentive Plan” and cites Exhibit 10.65 to the 2015 Annual Report.  The identical reference appears in the 2023 filing (page 115) and again in the 2024 filing (page 115).  Thus, the underlying plan and exhibit remained unchanged from 2022 through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Medtronic used the same underlying plan—the Amended and Restated 2013 Stock Award and Incentive Plan—for its Non-Employee Restricted Stock Unit Award Agreements across 2022, 2023, and 2024, which aligns with the ground truth. It also accurately notes the continuity in the form of the agreement and references to the same plan, supporting the conclusion of structural stability. However, there are two key inaccuracies: (1) The LLM incorrectly cites Exhibit 10.65 to the 2015 Annual Report as the source in the 2022 filing, while the ground truth specifies Exhibit 10.45 in MDT_10k_2022.pdf—this is a factual error in exhibit number and source document; (2) The LLM implies no change in the foundational plan and omits the nuance that while the form agreement remained consistent, the underlying plan had undergone amendments over time (e.g., effective December 8, 2017), which the original answer highlights as part of the evolution. This missing context reduces the depth of the multi-hop synthesis. Quantitative accuracy is high as no numerical data is misstated, and exhibit numbers are the only discrepancy. Qualitatively, the reasoning is sound in observing continuity but lacks the full evolution narrative—particularly the distinction between form consistency and plan amendments. Contextual relevance is strong as the response directly addresses the question’s focus on plan references and evolution. Minor wording differences are acceptable, but the omission of the plan’s amendment history and incorrect exhibit citation prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 435,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans allocated 17 % of assets to buy‑in annuity policies in 2022, fell to 16 % in 2023, and returned to 17 % in 2024. The modest fluctuation—essentially a stable 16‑17 % level—shows the company is deliberately maintaining a high, consistent exposure to buy‑in annuities as a core tool for hedging and managing its international pension liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024. However, the LLM claims the allocation returned to 17% in 2024, which directly contradicts the ground truth. This misrepresents the entire trend. (2) Quantitatively, the 2022 (17%) and 2023 (16%) figures are correct, but the 2024 figure is wrong—the ground truth states the practice was discontinued, not that it rebounded to 17%. This invalidates any calculation or trend analysis involving 2024. (3) The reasoning is flawed: the LLM concludes that MDLZ is maintaining 'consistent exposure' to buy-in annuities as a core hedging tool, while the actual trend shows a strategic exit from such policies, shifting to fair value estimation methods. This reflects a complete misinterpretation of the company's liability management strategy. The multi-hop synthesis fails because the model did not correctly interpret the discontinuation in 2024 and its implications. (4) Contextual relevance is moderate because the answer addresses the right topic (allocation to buy-in annuities in non-U.S. pension plans) and time frame, and attempts to infer strategy, but the incorrect data leads to an opposite and misleading conclusion. Thus, while the structure and intent are relevant, the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 398,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft first issued the 2.000 % Notes due 2023 in 2022 as part of the Eleventh Supplemental Indenture (4.14)【page_105】【page_105】【page_105】. The same indenture is referenced unchanged in the 2023 and 2024 10‑K filings, indicating the notes remained outstanding through those years without new issuances. This consistency shows Microsoft’s long‑term debt strategy relies on low‑coupon, short‑term notes to keep borrowing costs low while preserving flexibility in its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.000% Notes due in 2023 and their inclusion in Exhibit 4.14 of the Eleventh Supplemental Indenture dated August 8, 2016, as referenced in the 2022, 2023, and 2024 10-K filings. The percentage (2.000%), maturity year (2023), and exhibit number (4.14) are all factually accurate, supporting a high quantitative accuracy score. However, the LLM incorrectly states that Microsoft 'first issued' the notes in 2022, which contradicts the ground truth: the notes were issued in 2016 under the Eleventh Supplemental Indenture, not 2022. This is a significant factual error in entity and temporal accuracy. (2) There are no calculations in this question, but the dates and percentages are mostly correct except for the erroneous issuance year. The note remained outstanding through 2024, which the LLM correctly notes, and the consistency across filings is accurately described. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the presence of the notes across three years and infers stability. However, the conclusion that this reflects a strategy using 'short-term notes' is misleading, as the note in question had a 7-year term (2016–2023), and the ground truth emphasizes consistency and lack of early retirement, not a strategy based on short-term instruments. The LLM overreaches in strategic interpretation. (4) Contextual relevance is high because the answer addresses the evolution across years and attempts to infer strategy. However, due to the incorrect issuance date and flawed strategic characterization, the qualitative accuracy and overall correctness are reduced. The core data is present but misinterpreted, warranting a score of 6 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 472,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Microsoft continued to list its 4.000 % Notes due 2021 in Exhibit 4.6 – the Third Supplemental Indenture dated February 8 2011 – in the 2022, 2023 and 2024 10‑K filings (2022 page 104; 2023 page 104; 2024 page 104).  The indenture and the notes’ classification remained unchanged, keeping the 4.000 % Notes within the same senior‑unsecured debt structure governed by the base indenture and its supplemental indentures (2022 page 104; 2023 page 104; 2024 page 104).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently listed under the Third Supplemental Indenture dated February 8, 2011, and appear in Exhibit 4.6 across all three 10-K filings (2022, 2023, 2024), with page numbers correctly cited as 104 in each year. (2) Quantitative accuracy is perfect: percentages (4.000%), dates (February 8, 2011), and exhibit numbers (4.6) match the original answer exactly. Format variations (e.g., spacing in '4.000 %') do not affect meaning. (3) The reasoning is sound and reflects multi-hop synthesis across three years of filings, correctly identifying consistency in treatment over time. However, the LLM omits a minor but relevant detail from the ground truth: that new debt instruments (e.g., 2.375% Notes due 2023 in 2023, 2.125% Notes due 2022 in 2022) were introduced under subsequent supplemental indentures, which provides context for the broader debt structure evolution. While not central to the question about the 2021 notes, this omission slightly reduces completeness. (4) Despite this, the answer is highly relevant, directly addressing the core question about the treatment of the 4.000% Notes due 2021 and their structural placement across years. Semantic equivalence is strong, and the missing detail does not undermine the correctness of what is stated. Hence, a score of 9 is appropriate—excellent accuracy with a minor gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 408,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K notes for 2022, 2023 and 2024 all state that the company is authorized to issue 40,000 Euro Deferred Shares with a €1.00 par value, but that none have been issued or are outstanding as of the reporting dates (April 29 2022, April 28 2023, April 26 2024)【page_81】. The wording and the zero balances remain unchanged across the three years, indicating that the company deliberately keeps this instrument idle. This consistency shows Medtronic’s capital‑structure strategy focuses on ordinary shares and repurchase programs, avoiding dilution or the complexity of a separate Euro‑denominated equity class.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Medtronic is authorized to issue 40,000 Euro Deferred Shares with a €1.00 par value and that none were issued or outstanding in fiscal years 2022, 2023, and 2024. The reporting dates (April 29, 2022; April 28, 2023; April 26, 2024) are accurate and consistent with typical Medtronic fiscal year-ends. (2) All numeric values—40,000 shares, €1.00 par value, zero issued/outstanding—are factually correct and match the ground truth. No calculations are required, but the consistency across years is accurately noted. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three years and infers strategic intent from the persistent absence of issuance. It correctly identifies that the instrument remains unused and links this to broader capital structure preferences. (4) The only minor shortcoming is that the LLM slightly extends the interpretation by emphasizing 'ordinary shares and repurchase programs' and 'avoiding dilution or complexity,' which, while reasonable, are not explicitly stated in the ground truth. The original answer focuses more neutrally on lack of utilization and possible investor demand or strategic preference without specifying alternative instruments. This small addition does not introduce inaccuracy but adds interpretive detail beyond the source. Overall, the answer is factually precise, contextually relevant, and logically sound, warranting a high score with a minor deduction for slight over-interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 418,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Microsoft consistently disclosed its 4.000% Notes due 2021 in Exhibit 4.6 (the Third Supplemental Indenture) in each of the 2022, 2023, and 2024 10‑K filings, and referenced the same instrument in the notes to the financial statements as long‑term debt (page_104). The unchanged disclosure across the three years indicates that Microsoft treats this debt instrument as a stable, long‑term obligation with no material changes in terms or status over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key factual inaccuracy regarding the status of the debt. Quantitatively, the percentages (4.000% Notes due 2021), exhibit number (4.6), and reference to the Third Supplemental Indenture dated February 8, 2011, are accurate and consistent with the ground truth. The mention of consistent disclosure across 2022–2024 filings is also correct. However, the LLM incorrectly characterizes the debt as a 'long-term obligation' and implies it remains active, while the ground truth states the notes were due in 2021 and had no changes because they were likely matured or fully accounted for—meaning they should not be treated as ongoing obligations. This misrepresents the company's treatment over time. The reasoning is partially sound in noting consistency, but the conclusion about 'stable, long-term obligation' contradicts the implication in the original answer that the lack of change reflects inactivity post-maturity. The answer is contextually relevant and well-structured, but the qualitative error in interpretation reduces its accuracy. Semantic equivalence is close but flawed in a critical detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 323,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s 2021 10‑K reports a single pension‑risk‑transfer transaction that moved $4.9 billion of gross defined‑benefit pension obligations to an insurer (page 60).  The 2022 and 2023 10‑Ks do not disclose any additional GAC purchases, and the 2024 10‑K likewise does not report a new transfer amount (page 47).  The company’s statements in each filing emphasize that it continues to pursue such transactions to reduce PBGC premiums and stabilize pension costs.  This pattern shows a deliberate, ongoing strategy to shift long‑term pension liabilities to third‑party insurers rather than fund them directly.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the $4.9 billion pension risk transfer occurred in 2021 and was the only transaction, while the ground truth indicates a cumulative $11.6 billion transferred since December 2018, disclosed in the 2022 filing. The LLM also claims no additional transfers were disclosed in 2022, 2023, or 2024, which contradicts the original answer stating that Lockheed Martin had transferred $11.6 billion by 2022 and continued to pursue further transactions through 2024. (2) The quantitative inaccuracies are severe: the $4.9 billion figure may reflect a partial transaction but fails to report the full $11.6 billion cumulative amount disclosed by 2022, omitting over $6.7 billion in transferred obligations. There is no mention of the $69 million in annual PBGC premium savings, a key metric in the original answer. The years are also misaligned—the $11.6 billion figure is from the 2022 report, not 2021. (3) The multi-hop reasoning is flawed. While the LLM correctly infers from repeated language in filings that Lockheed Martin has an ongoing strategy, it fails to synthesize the cumulative dollar amount disclosed in 2022 and incorrectly concludes no new transfers occurred. The model does not connect the evolution of the obligation amounts over time as required by the question. (4) Despite incorrect numbers and timeline, the LLM captures the qualitative direction of the strategy—ongoing interest in risk transfers to reduce liabilities and stabilize costs—so some relevance and partial reasoning are preserved, justifying a low but non-zero score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 449,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "The 0.125% Notes due 2029 are consistently disclosed as Exhibit 4.4 in each filing, all referencing the same 2020 8‑K (KO_10k_2022 p. 134, KO_10k_2023 p. 132, KO_10k_2024 p. 130).  The note’s terms—0.125% coupon, maturity 2029, and classification as long‑term debt—remain unchanged across the three years, and the company continues to present it only as an exhibit rather than a separate note in the financial‑statement disclosures.  This uniform treatment demonstrates that Coca‑Cola’s debt‑instrument structuring has been stable and consistent over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth. (1) Quantitatively, all key facts are correct: the 0.125% coupon rate, 2029 maturity, and consistent disclosure across 2022–2024 are accurately stated. The mention of Exhibit 4.4 in each year aligns with the ground truth, and the citation of specific page numbers (e.g., p.134, p.132, p.130) adds precision. (2) The answer correctly identifies that the note is consistently treated as an exhibit and not a separate financial statement note, and that terms remain unchanged—this reflects stable debt structuring. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual filings and correctly infers consistency in disclosure and structuring. (4) The only minor shortcoming is that the ground truth notes the note appeared in Exhibits 4.23 and 4.31 each year, with those citing Exhibit 4.4 from prior 8-Ks—this layer of exhibit hierarchy is omitted in the LLM answer, which simplifies it to direct disclosure as Exhibit 4.4. While not incorrect, it slightly oversimplifies the filing structure. However, the semantic meaning and conclusion about consistency are preserved. Hence, the answer is factually correct and contextually relevant, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 363,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1,109 million** at December 31 2022 to **$1,091 million** at December 31 2023 and further to **$993 million** at December 31 2024 (Note 16, table of changes in carrying amounts). The decline—driven by fewer warranties issued and lower settlements—indicates that the company’s exposure to long‑term product performance risks in its commercial aerospace business is easing, reflecting improved product reliability and risk management.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. It states RTX's total liability for performance and operating-cost guarantees was $1,109 million in 2022, $1,091 million in 2023, and $993 million in 2024. However, the ground truth specifies only the collaboration partners' share of financing guarantees—$141M (2022), $135M (2023), $131M (2024)—not RTX's total liability. The LLM incorrectly presents much larger figures as RTX's total liabilities, which are not supported by the ground truth. These numbers appear to be fabricated or misattributed. (2) The calculation of a declining trend is consistent in both answers, but the magnitude and basis are wrong. The actual decrease is from $141M to $131M (a $10M drop over two years), not over $100M as claimed. The LLM’s figures are an order of magnitude higher and misrepresent the scale of exposure. (3) The multi-hop reasoning is partially sound in structure—assessing trend and inferring risk exposure—but fails at entity and data attribution. The LLM conflates 'collaboration partners’ share of financing guarantees' with RTX’s total liabilities for performance and operating cost guarantees, a critical error in entity accuracy. It also introduces a source 'Note 16, table of changes in carrying amounts' not present in the ground truth, suggesting hallucination. (4) The conclusion about easing exposure and improved reliability contradicts the ground truth, which states liabilities are 'relatively stable' and indicate 'managed but ongoing exposure' with 'stable long-term product performance expectations.' The LLM overinterprets a minor decline as a significant trend. While the answer addresses the question’s structure and attempts inference, the factual foundation is severely flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 494,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic continues to use the Black‑Scholes model for non‑qualified options, but its input assumptions have shifted between 2022 and 2024.  Volatility rose from 23.0 % to 24.3 %, the risk‑free rate jumped from 0.9 % to 4.2 %, and the dividend yield increased from 1.95 % to 3.18 %, while the expected life lengthened slightly from 6.0 to 6.1 years; consequently the weighted‑average fair value of options granted fell from $22.83 million to $18.49 million.  These changes indicate Medtronic is modeling a more volatile, higher‑interest‑rate market and a higher expected dividend environment, leading to a more conservative equity‑compensation risk valuation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual errors. (1) Quantitative Accuracy: The numeric values provided (e.g., volatility rising from 23.0% to 24.3%, risk-free rate from 0.9% to 4.2%, dividend yield from 1.95% to 3.18%, expected life from 6.0 to 6.1 years, and fair value falling from $22.83 million to $18.49 million) are not supported by the ground truth and appear fabricated. The original answer does not mention any specific numerical changes in assumptions or fair values, so these figures are entirely inaccurate. (2) Completeness: While the question asks about the evolution in Medtronic's valuation approach and what it suggests about volatility and risk modeling, the LLM focuses on fabricated quantitative inputs rather than the actual disclosed evolution in methodology—specifically, the refinement in how implied volatility is sourced and disclosed. (3) Entity Accuracy: The company (Medtronic) and the use of the Black-Scholes model are correctly identified, and the time frame (2022–2024) is appropriately referenced. (4) Reasoning: The LLM attempts multi-hop reasoning by linking input changes to valuation outcomes, but since the inputs are false, the logic collapses. The actual evolution involves increased transparency in volatility estimation (use of market-traded options for implied volatility), not changes in the numerical assumptions themselves. (5) Semantic Equivalence: The LLM answer conveys a completely different narrative—focusing on changing parameter values and their impact on fair value—whereas the ground truth emphasizes methodological transparency and improved market alignment in volatility modeling. The conclusion about 'more conservative equity-compensation risk valuation' is unsupported. Overall, the answer fails on factual accuracy and correct synthesis, though it addresses the general topic of valuation assumptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 509,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 1.000% note due 2028 appears as a **current** note in both the 2022 and 2023 10‑K filings (page 134) and is listed again in the 2024 filing as a **new** note (page 136). This consistent presence—first as a current instrument and then as a newly issued one—shows that Coca‑Cola has been steadily issuing or renewing this low‑interest, long‑term debt, suggesting a deliberate strategy to maintain a stable, low‑cost financing base for that maturity.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual inaccuracies. While it correctly identifies the 1.000% Notes due 2028 as being present in the 2022, 2023, and 2024 filings, it mischaracterizes the 2024 reference as a 'new' note, which contradicts the ground truth indicating ongoing acknowledgment rather than a new issuance. The ground truth does not support the claim that the note was 'newly issued' in 2024; instead, it was already outstanding and maintained in the debt structure. (2) Quantitatively, the interest rate (1.000%), maturity year (2028), and years of reference (2022–2024) are correct. However, the claim of being a 'current' note in 2022 and 2023 and 'new' in 2024 introduces a factual error about the nature of the instrument’s classification and timing, which affects interpretation. Page references (134, 136) may be accurate but are not verifiable without source documents and are less critical. (3) The multi-hop reasoning is flawed: the LLM fails to incorporate the key strategic shift highlighted in the ground truth—namely, the introduction of higher-yielding notes (5.000% and 5.300%) in 2024—which is central to understanding Coca-Cola’s evolving debt strategy. By omitting this critical context, the model misses the broader strategic implication that low-cost debt like the 1.000% Notes were maintained while the company began issuing higher-cost debt, suggesting a shift in financing approach. (4) The contextual relevance is moderate because the answer addresses the evolution of the specific instrument, but the reasoning and conclusion are incomplete and slightly misleading. The score reflects partial correctness on facts but significant gaps in synthesis and strategic interpretation required by the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 483,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Microsoft continued to structure its 2.125% Notes due 2022 under the Fourth Supplemental Indenture (Exhibit 4.7) with The Bank of New York Mellon Trust Company, N.A. as trustee in each of the 2022, 2023, and 2024 10‑Ks, and the trustee arrangement remained unchanged (104). Each filing also disclosed the Twelfth Supplemental Indenture (Exhibit 4.15) – which contains 2.400% Notes due 2022 and 2.875% Notes due 2024 – and the Fifteenth Supplemental Indenture (Exhibit 4.18) with the same trustee, indicating that Microsoft’s approach to related debt instruments stayed consistent and no new 2.125% Notes were issued in 2023 or 2024 (106).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly refers to the '2.125% Notes due 2022' and the 'Fourth Supplemental Indenture (Exhibit 4.7)', while the ground truth states the 2.125% Notes were due in 2021 and were governed by the Seventh Supplemental Indenture. This misstates both the maturity year and the correct indenture document. (2) The trustee is correctly identified as The Bank of New York Mellon Trust Company, N.A., which aligns with the ground truth. (3) The LLM introduces unrelated supplemental indentures (Twelfth and Fifteenth) with different note series (2.400% and 2.875%) that are not mentioned in the original answer, adding misleading context. (4) The claim that 'no new 2.125% Notes were issued in 2023 or 2024' is speculative and not supported in the ground truth, which simply states the structure remained unchanged. (5) The core conclusion in the original answer—that the structure and trustee arrangement remained consistent across 2022–2024—is partially echoed in the LLM answer, preserving some contextual relevance. However, due to incorrect note maturity dates, wrong indenture numbers, and references to unrelated debt instruments, the quantitative and qualitative accuracy is severely compromised. The answer fails on key multi-hop synthesis: it does not correctly link the 2.125% Notes due 2021 to the Seventh Supplemental Indenture and misrepresents the continuity of the arrangement. Minor credit is given for identifying the correct trustee and attempting to assess consistency over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 431,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program share interest in the International Aero Engines (IAE) collaboration remained at **57 %** and in the IAE LLC collaboration at **51 %** throughout 2022‑24 (see RTX 10‑K notes on pages 108, 97 and 101).  \nThe unchanged, majority‑stake percentages show that RTX continues to hold a controlling position in both the V2500 (IAE) and PW1100G‑JM (IAE LLC) programs, underscoring its sustained strategic focus and influence in these key commercial‑aircraft engine collaborations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the quantitative evolution of Pratt & Whitney's net program share interest. According to the ground truth, in 2022, the net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as claimed. The decrease to 57% (IAE) and 51% (IAE LLC) occurred in 2023 and remained stable in 2024. The LLM incorrectly states these percentages were unchanged from 2022–2024, contradicting the source data. (2) The numbers cited (57% and 51%) are correct for 2023–2024 but misapplied to 2022, making the temporal trend completely inaccurate. There is no mention of the 2022 figures (61% and 59%), and the key evolution—decline from 2022 to 2023—is omitted. (3) The multi-hop reasoning is flawed: the question asks how the share evolved, requiring comparison across years. The LLM fails to show this progression and instead asserts stability, missing the strategic recalibration indicated by the decline. The conclusion about 'sustained strategic focus' oversimplifies and misrepresents the nuance of a deliberate reduction due to sub-collaborator adjustments. (4) While the answer correctly identifies the entities (IAE, IAE LLC, V2500, PW1100G-JM, RTX) and the general context of strategic positioning, the core factual error in the timeline and percentages severely undermines correctness. The contextual relevance is high as it addresses the right programs and strategic implications, but the reasoning is based on false premises. Quantitative accuracy is low due to incorrect assignment of percentages to years; qualitative accuracy is moderate due to correct entity identification but flawed synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 456,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s company‑contributed expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022 to $468 million in 2023** (a 16 % increase) and then fell to **$443 million in 2024** (about 5 % lower than 2023 but still 10 % above 2022)【page_69】. This pattern shows a generally upward trend in employee‑benefit spending, with a modest dip in 2024 that still reflects a sustained commitment to supporting employee retirement and savings plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 contribution amount: it reports $402 million, whereas the ground truth is $299 million. This is a major quantitative discrepancy (over $100M difference) that affects the validity of the trend interpretation. The 2023 ($468M) and 2024 ($443M) figures are correct. (2) Calculations based on incorrect 2022 data are therefore flawed: the claimed 16% increase from 2022 to 2023 and 10% increase above 2022 in 2024 are inaccurate. The actual increase from 2022 ($299M) to 2023 ($468M) is about 56.5%, which is far more significant. The 2024 figure is still 48% higher than 2022, not 10%. (3) The reasoning and synthesis across years are structurally sound—identifying an increase then a partial decline, and interpreting this as a dynamic but sustained investment in employee benefits. However, due to the incorrect baseline, the characterization of a 'generally upward trend' downplays the true magnitude of the 2023 surge. The conclusion is partially reasonable but based on incorrect inputs. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of contributions and interpretation of spending trajectory) and uses appropriate financial terminology. The qualitative reasoning is logical and well-structured, just anchored on an incorrect starting figure. The citation reference (page_69) suggests a source, but the number still conflicts with ground truth. Overall, the answer is partially correct but undermined by a critical numerical error in the earliest data point, which distorts the entire trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 445,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "In the 2022 10‑K, Coca‑Cola’s 3.000% Notes due 2051 were listed as Exhibit 4.36, showing that the notes were issued in 2021 and remained outstanding through 2022 【page_134】. The 2023 10‑K continues to reference the same 3.000% Notes due 2051 as an exhibit, indicating no new issuance or refinancing of that instrument in 2023 【page_134】. The 2024 10‑K likewise lists the 3.000% Notes due 2051 while adding new long‑term debt with higher coupon rates, underscoring Coca‑Cola’s strategy of keeping a stable, diversified debt base with moderate yields to balance cost and maturity risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.000% Notes due 2051 across 2022, 2023, and 2024, noting their continued presence in disclosures and the addition of higher-coupon debt in 2024. The core facts—continuity of the 3.000% Notes and introduction of higher-yielding instruments—are accurate and align with the ground truth. However, there is a minor discrepancy in the exhibit number: the LLM states Exhibit 4.36 in 2022, while the ground truth specifies Exhibit 4.6 to the May 5, 2021 Form 8-K. This is a factual error, though not material to the overall interpretation. (2) Quantitatively, all percentages (3.000%, 5.000%, 5.300%) and maturities (2051, 2034, 2054) are correctly referenced. The LLM correctly notes no new issuance or refinancing in 2023, which is consistent with the ground truth’s emphasis on continuity. The timeline and numerical data are accurate, warranting a high quantitative score. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly infers that the retention of low-cost debt alongside new higher-cost debt reflects a strategy of diversification and risk management. The conclusion about balancing cost and maturity risk is semantically equivalent to the ground truth’s point about balancing long-term obligations with market rate conditions. (4) Contextually, the answer is fully relevant, addressing both the evolution of the debt instrument and the strategic implication. The minor exhibit number error prevents a perfect score, but the overall factual and conceptual accuracy is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 438,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first issued the 2.875% Notes due 2031 in 2021 (Exhibit 4.14).  In its 2022, 2023, and 2024 10‑K filings the same 2.875% notes remain listed in Exhibit 4.14 with no changes to terms or additional issuances (2022 p. 113; 2023 p. 108; 2024 p. 109).  This steady presence shows Oracle’s long‑term debt strategy of maintaining a diversified mix of fixed‑rate, long‑maturity notes to lock in favorable rates, manage interest‑rate exposure, and preserve liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that Oracle first issued the 2.875% Notes due 2031 in 2021, which contradicts the ground truth that the notes were formally listed in 2022. While the answer correctly notes the continued listing of the notes in 2022, 2023, and 2024 filings, it fails to acknowledge the key evolution highlighted in the ground truth: Oracle's strategic shift in 2024 to include newer, higher-yielding notes (4.500% due 2028 and 4.900% due 2033) alongside the 2.875% Notes. This omission significantly undermines the qualitative accuracy of the response. (2) Quantitatively, the percentages (2.875%) and years (2031) are correct, and the reference to consistent listing across years is accurate. However, the incorrect issuance date (2021 vs. 2022) and lack of mention of the new debt instruments in 2024 reduce quantitative precision. (3) The multi-hop reasoning is partially sound—correctly identifying the continuity of the 2.875% Notes across years—but fails the full synthesis required to compare Oracle’s evolving debt portfolio and infer strategic intent from the addition of higher-cost debt. The answer presents a static view of Oracle’s strategy rather than the dynamic progression described in the ground truth. (4) Contextual relevance is high because the answer addresses Oracle’s long-term debt strategy and references the correct notes and filings, but the failure to capture the strategic shift in 2024 limits its overall correctness. The conclusion about maintaining favorable rates is plausible but incomplete without acknowledging rising borrowing costs reflected in newer, higher-yielding instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 458,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s repeated inclusion of the 2.000 % Notes due 2023 in Exhibit 4.14 of its 2022, 2023 and 2024 10‑K filings shows that the company maintains a stable, predictable debt profile and is disciplined about managing long‑term maturities. The consistent disclosure signals a deliberate strategy to balance coupon costs with a clear repayment schedule, while the repeated reporting demonstrates a commitment to transparency and to keeping investors fully informed of its debt obligations. [page_105]",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 2.000% Notes due 2023 across Microsoft's 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. The interest rate (2.000%) and maturity year (2023) are accurately stated. The mention of Exhibit 4.14 adds specificity, though this detail is not in the original answer; however, it does not contradict it and may reflect actual filing structure. (2) Quantitatively, all numbers—interest rate and maturity year—are correct. There are no calculations required, and the temporal scope (three consecutive filings) is properly referenced. (3) The reasoning is sound but slightly less complete than the ground truth. The LLM captures the transparency and stability aspects but omits key contextual details such as the origin of the notes in the Eleventh Supplemental Indenture dated August 8, 2016, and the fact that the liability structure remained unchanged over the years. This missing multi-hop link reduces qualitative accuracy slightly. (4) The answer is highly contextually relevant, directly addressing Microsoft’s debt management and transparency strategy. While the core conclusion about stable debt management and transparency is supported and semantically equivalent to the original, the lack of specific sourcing and structural continuity details prevents a perfect score. Overall, the answer is factually correct and well-reasoned but lacks some depth in synthesis present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 413,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s total commitments to Rolls‑Royce under the 2012 IAE deal rose from $1.29 billion in 2022 to $1.33 billion in 2024, while the portion attributable to flight‑hour payments (shown in the “Collaboration partners’ share” line) climbed from $665 million in 2022 to $814 million in 2024, even as overall commitments fell slightly in 2024.  These payments are contingent on each hour flown by V2500‑powered aircraft through June 2027, are capitalized as intangible assets and amortized to cost of sales, and the trend shows that RTX’s exposure to Rolls‑Royce remains sizable but will gradually diminish as flight hours accrue and the payment period ends in 2027.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($1.29B, $1.33B, $665M, $814M) that are not present in the original answer (ground truth), and there is no mention in the ground truth of total commitments or their changes over time. These figures appear to be fabricated or misattributed, making the quantitative claims entirely incorrect. (2) The ground truth does not provide any numerical values for RTX's financial obligations—only qualitative descriptions of accounting treatment and categorization. Therefore, all numeric assertions in the LLM answer fail verification. The date (June 2027) is correctly mentioned as the end of the payment period, which aligns with the original answer. (3) While the LLM captures the correct structure of the contingent payments being tied to V2500 flight hours through June 2027 and correctly states that payments are capitalized as intangible assets and amortized to cost of sales (consistent with 2023 and 2024 disclosures), it incorrectly implies a trend analysis based on fabricated numbers. The reasoning about exposure 'gradually diminishing' is speculative and not supported in the original answer, which instead emphasizes 'stable long-term financial exposure'. (4) The contextual relevance is moderate because the LLM addresses the right agreement (2012 IAE), the correct counterparty (Rolls-Royce), the correct aircraft engine (V2500), and the correct accounting treatment in later years. However, the inclusion of false quantitative data severely undermines factual correctness. The qualitative accuracy is partially correct due to accurate terminology and some correct synthesis, but the core financial evolution narrative is based on non-existent data. Correctness score is low due to major factual inaccuracies in numbers and unsupported conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 494,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "The fair value of U.S. equity funds in TMO’s domestic pension plans rose from **$89 million in 2022 to $93 million in 2023, then fell modestly to $91 million in 2024** (page 70). This largely flat 3‑year trend shows that the company is maintaining a steady, low‑to‑moderate domestic‑equity exposure—consistent with its ~10 % target allocation—and is not aggressively shifting its portfolio toward or away from U.S. equities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of allocation changes. According to the ground truth, TMO's U.S. equity fund allocation decreased from $125M in 2022 to $89M in 2023, then slightly increased to $93M in 2024. The LLM incorrectly states it rose from $89M in 2022 to $93M in 2023 and then fell to $91M in 2024—reversing the actual trend and misstating all three values. Only the $93M figure for 2024 is close (ground truth is $93M, LLM says $91M), but still inaccurate. (2) The calculation of change is therefore flawed: the actual 3-year trajectory shows a net decrease of $32M (from $125M to $93M), while the LLM implies a nearly flat trend with a $2M decrease—missing the significant 2022–2023 drop entirely. (3) The multi-hop reasoning is unsound: the LLM fails to correctly identify the starting point of the trend, distorts the intermediate value, and introduces a non-existent stabilization pattern. As a result, its conclusion about a 'largely flat' trend contradicts the ground truth of a cautious reduction with a modest rebound. (4) While the LLM attempts to interpret strategic implications (steady exposure, alignment with target allocation), this reasoning is based on incorrect data and thus invalid. Contextual relevance is moderate because it addresses the right topic (investment strategy in domestic equities) and references a plausible document page, but the factual foundation is so flawed that the analysis is misleading. Quantitative accuracy is very low due to multiple incorrect figures and mischaracterized trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 439,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s 2022 10‑K lists a 1.000 % note due 2041 (Exhibit 4.33) as part of its long‑term debt, and the 2023 10‑K continues to reference the same 1 % note, indicating it remained outstanding. In the 2024 10‑K the company broadened its debt mix by issuing a series of higher‑yielding notes—ranging from 3.125 % to 5.400 % with maturities between 2032 and 2064 (Exhibits 4.39‑4.47)—while still retaining the 1 % note due 2041, reflecting a strategy to diversify maturities and take advantage of favorable market rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the continued presence of the 1.000% Notes due 2041 in all three years (2022–2024) and accurately notes their retention in 2024. It also correctly states that higher-yielding notes were introduced in 2024. However, there is a partial inaccuracy in the specific yields mentioned: the LLM claims notes ranging from 3.125% to 5.400% were issued (Exhibits 4.39–4.47), but the ground truth specifies exact new instruments: 5.000% due 2034, 5.300% due 2054, and 5.400% due 2064. The LLM overgeneralizes the range (e.g., including 3.125%, which is not in the ground truth) and does not specify these exact tranches, leading to a quantitative shortfall. (2) The maturities mentioned (2032–2064) are close but not fully aligned—ground truth starts at 2034, not 2032. The exhibit numbers differ (4.39–4.47 vs. 4.33), which may reflect document structure differences, but the core issue is the imprecision in yield figures. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from low-yield to high-yield instruments over time, noting the coexistence of old and new debt, and contextualizes it as diversification and market rate adaptation—consistent with the ground truth’s interpretation. (4) Scores reflect high correctness due to accurate core narrative and entity identification, minor quantitative inaccuracies in yield ranges and maturities, strong qualitative reasoning, and full contextual relevance to the question about strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 417,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle’s 2023 and 2024 10‑K filings list the 1.650% Notes due 2026 as part of its debt portfolio (Exhibit 4.14, page 111), and the 2022 10‑K also includes the same note, indicating its continued presence in the capital structure over three consecutive fiscal years. By keeping this low‑rate, long‑term debt alongside newer, higher‑rate issues such as the 5.800% Notes due 2025 and 6.150% Notes due 2029 (Exhibit 4.15, page 111), Oracle demonstrates a strategy of anchoring its leverage with inexpensive debt while using higher‑cost notes for targeted financing or refinancing needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor factual discrepancy in the interest rate and maturity of one of the newly issued notes. The LLM correctly identifies the continued inclusion of the 1.650% Notes due 2026 across fiscal years 2022, 2023, and 2024, citing the appropriate exhibit (4.14) and confirming their presence in Oracle's capital structure. It accurately contrasts this low-rate debt with higher-rate instruments, supporting the interpretation of a dual debt strategy. However, the LLM incorrectly references the '6.150% Notes due 2029' as a new instrument, whereas the ground truth specifies the '4.500% Notes due 2028' introduced in 2024. This misstatement affects quantitative accuracy and completeness, as it substitutes a different note not mentioned in the original answer. Despite this, the core reasoning—Oracle maintaining low-cost debt while issuing higher-cost notes—is sound and logically derived from the evidence. The multi-hop synthesis across years and debt instruments is appropriate, and the conclusion reflects a valid interpretation of Oracle's financing strategy. Wording differs but meaning is semantically equivalent on the main strategic point. Contextual relevance is strong, directly addressing the question’s focus on debt strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 369,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s 10‑Ks for 2022, 2023 and 2024 all list the same Third Supplemental Indenture (Exhibit 4.6) that contains the 4.000 % Notes due 2021【page_104】. The unchanged inclusion of that tranche indicates that Microsoft has not re‑issued or refinanced the 2021 notes, instead keeping the original indenture in force and merely updating the documentation to keep it current. This reflects a conservative long‑term debt strategy that prioritizes stability of existing debt over frequent refinancing of that portion of its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Microsoft, 4.000% Notes due 2021, Exhibit 4.6, and the fiscal years 2022–2024 are accurately referenced. The percentage (4.000%) and due year (2021) match exactly. (2) Quantitative accuracy is perfect: no numerical errors, and the consistent listing across years is correctly noted. (3) The reasoning is sound: the LLM correctly infers that the unchanged inclusion of the notes post-due date suggests no refinancing, reflecting a stable, conservative debt strategy. It correctly identifies that the original indenture remains in force. (4) The answer captures the core implication about Microsoft’s long-term debt management—prioritizing documentation continuity and avoiding restructuring of this tranche. One minor omission: the ground truth notes a formatting update to the trustee’s name in 2024 ('The Bank of New York Mellon Trust Company, N.A.'), which the LLM does not mention. While this is a small administrative detail, its absence slightly reduces completeness. However, it does not affect the overall correctness or interpretation of the debt strategy. The answer is semantically equivalent in intent and meaning, with appropriate contextual relevance to the question about documentation updates and refinancing activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 370,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s maximum‑potential payment for commercial‑aerospace financing guarantees fell from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024, with no carrying liability recorded in any of those years.  The collaboration partners’ share of those guarantees declined from roughly $142 million in 2022 to $135 million in 2023 and to $131 million in 2024, indicating a deliberate shift of risk to partners and a gradual reduction of RTX’s own guarantee exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of financing guarantees as $142M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. It also introduces additional data—RTX’s maximum-potential payment amounts ($304M, $288M, $274M)—which are contextually relevant and may come from the same filings, though not part of the original answer. However, the critical error lies in the interpretation: the LLM claims the declining partner share indicates a 'deliberate shift of risk to partners' and 'reduction of RTX’s own guarantee exposure.' This is factually incorrect. A declining partner share means partners are covering less of the risk, implying RTX is retaining more risk directly, not less. Thus, the trend contradicts the LLM's conclusion. (2) All numerical values are accurate and consistently formatted; no calculation errors. The sequence of partner contributions decreasing by $7M (142→135) and $4M (135→131) is correctly represented. (3) The multi-hop reasoning fails: while the model identifies the correct figures across years and entities (RTX, collaboration partners, commercial aerospace financing), it inverts the logical implication of the trend. The original answer correctly infers that RTX may be assuming more direct risk due to reduced partner participation, whereas the LLM incorrectly interprets reduced partner share as risk being shifted away from RTX. This reflects a fundamental misunderstanding of risk allocation in guarantee structures. (4) Despite strong quantitative accuracy and inclusion of relevant context (e.g., no carrying liability), the qualitative reasoning is flawed, severely undermining the correctness. The answer is contextually relevant and well-structured but draws the opposite conclusion from the evidence, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 501,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950 % Notes due 2056 were issued under the Eleventh Supplemental Indenture in 2016 and have remained a component of its long‑term debt portfolio through FY 2022, FY 2023, and FY 2024, as each filing continues to list the Eleventh Supplemental Indenture (Exhibit 4.14) (2022 10‑K p. 105; 2023 10‑K p. 105; 2024 10‑K p. 105). The absence of new issuances or maturities for this instrument over three consecutive years shows Microsoft’s preference for long‑dated, moderate‑rate debt to lock in favorable financing terms and preserve capital‑allocation flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 were issued under the Eleventh Supplemental Indenture in 2016, and they were consistently referenced in Microsoft's 10-K filings for fiscal years 2022, 2023, and 2024. The exhibit number (4.14) and page numbers (p. 105) are correctly cited across all three years, which supports the claim of consistent disclosure. (2) Quantitative accuracy is perfect: the interest rate (3.950%), maturity year (2056), and issuance date (2016) match the ground truth. No calculations were required, but the temporal consistency across fiscal years is correctly observed. (3) The multi-hop reasoning is sound—by synthesizing data across three annual reports, the model correctly infers that the absence of changes indicates a stable long-term capital strategy. The conclusion that Microsoft uses long-dated, moderate-rate debt to lock in favorable terms is a reasonable interpretation of the pattern and aligns with the ground truth’s implication of a steady financing strategy. (4) The only minor gap is that the LLM slightly expands on the strategic interpretation ('preserve capital-allocation flexibility') beyond the more neutral tone of the original answer, but this is a plausible inference and not factually incorrect. Thus, the answer is semantically equivalent and contextually appropriate, warranting high scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 402,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s tactical‑and‑strike‑missile segment (MFC) ramped production each year—volume of LRASM and JASSM grew in 2022, expanded further in 2023, and broadened to include G‑MLRS in 2024—boosting MFC net sales from $11.3 B (2022) to $12.7 B (2024)【page_50】【page_40】.  Yet operating profit collapsed from $1.637 B in 2022 to $413 M in 2024, as 2023 and 2024 recorded $45 M and $1.2 B in losses on classified contracts and lower profit‑booking‑rate adjustments, respectively【page_40】.  The combined effect was a decline in Lockheed Martin’s consolidated operating profit of roughly $1.4 B (≈18 %) over the three‑year period, falling from $7.47 B in 2022 to $6.08 B in 2024【page_50】【page_40】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core trajectory of Lockheed Martin's tactical and strike missile programs from 2022 to 2024, with accurate qualitative and quantitative details on production ramp-up and declining profitability. (1) Correct elements: The answer correctly identifies increasing production volume across the years—LRASM and JASSM in 2022, continued ramp-up in 2023, and inclusion of GMLRS in 2024. It accurately reports the operating profit decline from $1.637B in 2022 to $413M in 2024 and attributes the 2023 and 2024 losses to classified contracts ($45M in 2023, $1.2B in 2024). It also correctly notes the impact on consolidated operating profit, falling from $7.47B to $6.08B—a $1.39B drop (~18%), which aligns closely with the ground truth's implied $1.4B decline. (2) Quantitative verification: The $45M loss in 2023 matches the ground truth. The $1.2B loss in 2024 is slightly off—the ground truth specifies $1.2B in lower profit booking rate adjustments, which included $1.4B in losses on a classified program. The LLM conflates the total adjustment with the classified loss, understating the latter. Also, the ground truth states a $1.1B operating profit drop in 2024 (73%), while the LLM implies a cumulative $1.2B loss over two years, which is not precisely equivalent. (3) Multi-hop reasoning: The LLM successfully synthesizes production trends, financial performance, and consolidated impact across years and programs, demonstrating sound reasoning. It links rising sales to production ramp-up and declining profits to classified program losses, which is consistent with the ground truth. (4) Minor omissions: The answer omits the $215M and $145M production increases in 2022 and 2023, respectively, and does not mention 'precision fires' in 2023. However, it compensates by providing net sales growth ($11.3B to $12.7B), which is contextually relevant. Overall, the answer is factually strong with minor numerical imprecision in loss attribution, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 544,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "Thermo Fisher’s 2022 10‑K listed only the original Executive Change‑In‑Control Retention Agreement (ECI‑CRA) for CEO Marc N. Casper, but also included the 2018 form for other officers (page 47). In 2023 a new, updated officer form was introduced (page 76), replacing the 2018 version. The 2024 filing continues to reference that 2023 officer form and contains no additional amendments to the ECI‑CRA beyond the earlier 2010 and 2018 amendments (page 76).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several inaccuracies that affect factual correctness. First, it incorrectly states that the 2022 10-K included the 2018 form for other officers; the ground truth indicates that in 2022, Thermo Fisher introduced a new Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper), not a carryover of the 2018 version. Second, the LLM claims a 'new, updated officer form was introduced in 2023' as Exhibit 10.7, but the ground truth shows the 2023 filing merely re-filed the form introduced in 2022, not a new version. The mention of '2018 form' and '2010 and 2018 amendments' is unsupported by the original answer and introduces extraneous, unverified details not present in the ground truth. While the LLM correctly identifies that the 2024 filing continues referencing prior forms with no new amendments, this part aligns with the ground truth's indication of consistency. The core structure—tracking evolution across years and inclusion of officers beyond Casper—is addressed, giving it partial credit. However, the incorrect dating of form introductions and references to unmentioned amendments significantly undermine quantitative and qualitative accuracy. Contextual relevance is high as the response stays focused on the question’s scope and attempts multi-hop synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 373,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "Lockheed Martin’s variable‑interest‑rate swap program grew sharply between 2022 and 2024, with the notional amount rising from $500 million in 2021 (disclosed in the 2022 filing) to $1.3 billion in 2023 and staying at that level in 2024【page_66】. The company uses these swaps to convert fixed‑rate borrowings to variable‑rate borrowings as fair‑value hedges, a strategy that expanded in scale to better manage the fair‑value impact of its debt and to align with a variable‑rate borrowing mix【page_66】【page_52】. The sustained $1.3 billion notional amount indicates a deliberate, stable hedging program that matches its debt profile and risk appetite.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the notional amount of $500 million in 2021 (disclosed in the 2022 filing), increase to $1.3 billion in 2023, and maintenance at $1.3 billion in 2024 are accurately reported. Format variations (e.g., $500 million vs $500 million) are acceptable and semantically equivalent. (2) The answer addresses all parts of the question: it describes the evolution of LMT's use of variable interest rate swaps from 2022 through 2024 and interprets the change in notional amounts. (3) Entity accuracy is strong: 'Lockheed Martin' (LMT), 'interest rate swaps', 'notional amount', and correct years are properly identified. (4) Reasoning is sound: the LLM correctly infers that the increase and stabilization reflect a strategic, deliberate hedging approach. It adds valuable context not explicitly in the ground truth—namely, that the swaps are used to convert fixed-rate to variable-rate debt as fair-value hedges, and that this aligns with a variable-rate borrowing mix—likely drawn from cited pages 52 and 66. This enhances qualitative accuracy but slightly diverges from the ground truth’s focus on rising debt and volatile rates. However, the interpretation is plausible and consistent with the data. The only reason for not scoring 10 is that the LLM emphasizes conversion to variable-rate borrowings, while the ground truth emphasizes risk mitigation amid rising rates and debt—slightly different framing, but not contradictory. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 445,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans climbed from **$402 million in 2022 to $468 million in 2023** and then eased to **$443 million in 2024**【page_68】【page_51】. This pattern shows the company maintains a substantial, though somewhat variable, investment in employee benefits—peaking in 2023 likely due to higher participation or contribution rates, and then settling at a level still above the 2022 expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The trend description—increasing from 2022 to 2023 and then decreasing slightly in 2024—is factually accurate. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and no calculations (e.g., differences or growth rates) are misstated. The model correctly notes the increase and subsequent decline without introducing numerical errors. (3) The multi-hop reasoning is sound: the model synthesizes data across years and draws a reasonable interpretation about investment in employee benefits. While the original answer describes the 2024 flatness as 'stabilization or recalibration,' the LLM interprets it as 'easing' to a level 'still above 2022,' which is semantically consistent and adds plausible context (e.g., higher participation or contribution rates). This slight interpretive difference does not reduce factual accuracy. (4) The answer is fully contextually relevant, addressing both the evolution of expenses and the implication for employee benefit investment. The only minor deviation is in the characterization of the 2024 change as 'eased' rather than 'remained flat'—$443M is indeed lower than $468M, so 'eased' is acceptable, though 'slight reduction' would be more precise. Overall, the answer is factually correct, well-reasoned, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 404,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "From 2022 through 2024 Coca‑Cola’s investment note consistently states that fair‑value estimates for non‑public equity holdings are based on “discounted cash flows, estimates of sales proceeds, and appraisals.”  The wording and emphasis did not change, indicating the company has maintained the same reliance on sales‑proceeds estimates as a core valuation tool.  That consistency, coupled with management’s decision in 2022 not to impair its Japan investment—viewing the $87 million excess of carrying over fair value as temporary—shows a strong confidence that the decline is recoverable and that future cash‑flow estimates will eventually reflect a rebound.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in Coca-Cola's valuation approach from 2022 to 2024, which is central to the question. (1) Quantitatively, all numbers are accurate: the $87 million excess of carrying value over fair value in 2022 is correctly cited, and the reference to Coca-Cola Bottlers Japan Holdings Inc. (implied by context) is factually sound. The use of estimates of sales proceeds is accurately described as part of the valuation methodology. (2) However, the LLM incorrectly states that 'the wording and emphasis did not change,' which contradicts the ground truth: in 2023 and 2024, Coca-Cola placed 'increasing emphasis on the assumptions a market participant would use' in evaluating future cash flows, particularly in volatile markets. This shift indicates a qualitative evolution in how estimates of sales proceeds were applied—becoming more aligned with external market perspectives—even if the methodology was not formally changed. (3) The multi-hop reasoning is incomplete: the question asks what the evolution reveals about management’s confidence, especially in light of the Japan impairment. The LLM correctly infers confidence from the 2022 non-impairment decision, but fails to address the growing caution reflected in later disclosures about macroeconomic risks and market participant assumptions. Thus, it presents a static view of confidence, whereas the ground truth shows a nuanced shift—maintained confidence in recovery but with heightened awareness of external risks. (4) While the answer is factually grounded and contextually relevant, the lack of recognition of this evolving emphasis results in a significant qualitative gap, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 469,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle issued the 2.300 % Notes due 2028 as part of a multi‑maturity note issuance on March 24 2021 (Exhibit 4.14). The same terms appear unchanged in the 2022, 2023, and 2024 10‑Ks (pages 113, 109, 111), indicating the note has been held to maturity without refinancing. This consistency reflects Oracle’s broader strategy of issuing long‑dated, moderate‑coupon notes with staggered maturities to manage interest costs and preserve liquidity while maintaining a stable debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. It correctly identifies the 2.300% Notes due 2028 and their presence in Oracle's filings across 2022–2024, and the issuance date of March 24, 2021, is factually accurate. However, the ground truth does not mention this specific issuance date or Exhibit 4.14, so this detail, while potentially accurate, is not verifiable from the provided truth and introduces unconfirmed specificity. (2) Quantitatively, the interest rate (2.300%) and maturity year (2028) are correct, and the years 2022–2024 are properly referenced. However, the LLM fails to mention the critical comparative context from the ground truth: the issuance of higher-interest notes in 2023 (4.500% Notes due 2028) and 2024 (5.800% Notes due 2025), which is central to understanding Oracle’s evolving debt strategy. This omission undermines the quantitative and strategic completeness of the response. (3) The reasoning is flawed in its conclusion: while the LLM suggests Oracle maintained a stable debt profile through long-dated, moderate-coupon notes, it misses the multi-hop insight that Oracle was layering more expensive debt over time amid rising rates. The ground truth emphasizes a strategic mix of older low-cost debt and newer high-cost instruments, indicating refinancing and funding pressures. The LLM instead implies stability and no refinancing activity, which contradicts the implication of the original answer. (4) The contextual relevance is high because the answer addresses the evolution of the 2.300% Notes and Oracle’s debt strategy, but the qualitative accuracy is reduced due to incorrect synthesis and missing comparative data. The correctness score is 4 due to major omissions in strategic context and failure to reflect the multi-year comparative pattern essential to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 515,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple had no floating‑rate notes due 2019 outstanding in fiscal years 2022, 2023, or 2024, because those notes were issued in 2014 and fully matured in 2019 (see the 2014 officer’s certificate listing the Floating Rate Notes due 2019 in the 10‑K exhibits (page 56, 58, 54, 53)). The absence of this short‑term instrument in recent debt schedules shows that Apple has retired the 2019 notes and now relies on longer‑term debt or other financing for its short‑term needs, using floating‑rate debt only when it aligns with liquidity or interest‑rate‑risk management objectives (page 56).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. The ground truth states that Apple consistently disclosed the Floating Rate Notes due 2019 in its 10-K filings for 2022, 2023, and 2024, referencing the May 6, 2014 Officer's Certificate each year, indicating ongoing reporting of the instrument despite its 2019 maturity. The LLM incorrectly asserts that these notes were 'fully matured in 2019' and 'had no...outstanding' balance in 2022–2024, which contradicts the ground truth. This misinterpretation leads to an erroneous conclusion about Apple retiring the debt and shifting strategy. In reality, the consistent disclosure suggests Apple continued to report the notes as part of its debt structure, possibly due to accounting or disclosure requirements, indicating stability rather than retirement. The LLM’s reasoning fails the multi-hop synthesis: it assumes maturity equals removal from financial statements, but the knowledge graph evidence shows continued inclusion. While the mention of Apple’s use of floating-rate debt for liquidity or risk management is plausible context, it is speculative and not supported by the ground truth, which makes no claim about current reliance on other instruments. Quantitative accuracy is low because the key date (2019 maturity) is misapplied—while the note maturity date is correct, the assumption that it implies zero outstanding balance post-2019 is factually wrong per the continued disclosures. Contextual relevance is moderate because the answer addresses debt management strategy, but the conclusion is based on flawed premises. Overall, the answer fails on correctness due to a critical factual and interpretive error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 457,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s repeated inclusion of the 4.000% Senior Note due 2047 in Exhibits 4.17 (2022), 4.16 (2023) and 4.61 (2024) (PEP_10k_2022, p. 128; PEP_10k_2023, p. 128; PEP_10k_2024, p. 129) signals a deliberate long‑term debt strategy that relies on a stable, long‑maturity instrument to underpin its capital structure. In contrast, the 2.150% Senior Note due 2024 (Exhibit 4.18) and the 0.750% Senior Note due 2027 (Exhibit 4.28) are also consistently disclosed (PEP_10k_2022, p. 128; PEP_10k_2023, p. 128; PEP_10k_2024, p. 129) but, because of their shorter maturities, serve as complementary short‑term financing or refinancing tools rather than core long‑term debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 4.000% Senior Note due 2047 and its consistent disclosure across the 2022, 2023, and 2024 10-K filings, including accurate exhibit references and page numbers. The percentages and maturities for the 2.150% note due 2024 and 0.750% note due 2027 are also factually correct, satisfying quantitative accuracy. However, the LLM makes a critical error in claiming that the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027 are 'consistently disclosed' across all three filings. This contradicts the ground truth: the 2.150% note due 2024 would not appear in the 2022 filing (as it likely didn't exist yet or wasn't material), and the 0.750% note due 2027 is introduced in 2024, meaning it should not appear in prior years. The ground truth emphasizes that shorter-dated instruments appear in only one or two filings, reflecting transient financing needs, whereas the LLM incorrectly treats them as consistently reported, undermining the core comparative analysis. This misrepresents PepsiCo’s debt strategy by failing to contrast the persistent long-term note with the dynamic, short-term instruments. The reasoning is therefore flawed in a key multi-hop comparison, which is central to the question. While the general structure and intent of the answer are relevant and well-framed, the incorrect characterization of short-term note disclosures leads to an inaccurate conclusion about PepsiCo’s strategy, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 409,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple continues to list the 0.45% Notes due 2016 in the “Description of Securities” exhibit (Exhibit 4.3) in its 2022, 2023 and 2024 10‑Ks (see page 58 and page 56). Because those notes matured in 2016, their inclusion reflects Apple’s practice of keeping a complete historical record of all debt issuances for transparency and regulatory compliance, rather than an active refinancing or repurchase strategy. This suggests a conservative, transparent approach to legacy debt—maintaining disclosure for investors while acknowledging that the notes are no longer outstanding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 matured in 2016, and Apple continues to disclose them in its 2022, 2023, and 2024 10-K filings. The mention of Exhibit 4.3 and specific page numbers (58 and 56) adds precision and matches known filing structures. (2) Quantitative accuracy is perfect: the interest rate (0.45%), maturity year (2016), and reporting years (2022–2024) are all correct. No calculations are required, but temporal facts are accurate. (3) The reasoning is sound: the LLM correctly infers that continued disclosure reflects a practice of maintaining historical records for transparency and regulatory compliance, not active debt management. It appropriately rules out refinancing or repurchase activity. The answer captures the core insight about conservative and transparent disclosure practices. (4) While the LLM does not explicitly mention the 'Officer's Certificate dated May 3, 2013'—a specific document referenced in the ground truth—this is a minor omission that does not undermine the overall correctness. The answer still conveys the essential strategy: Apple maintains legacy disclosures for completeness and investor clarity. Semantic equivalence is strong, and the response is fully contextually relevant. The score is 9/10 due to this slight lack of detail on the specific documentation, but all key elements are otherwise accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 406,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "Lockheed Martin’s 2022‑2024 filings show a steady strategy of reducing pension obligations through risk‑transfer transactions, but no new GAC purchases were announced in 2022 or 2023.  The company has transferred roughly $11.6 billion of defined‑benefit obligations since 2018 (including a $4.9 billion GAC in 2021) and continues to “look for opportunities to manage our pension liabilities through additional pension risk‑transfer transactions in future years” (2024 10‑K, p. 47; 2023 10‑K, p. 19).  The only material earnings impact from these transactions was the $1.7 billion non‑cash settlement charge recorded in 2021; no such charge appeared in 2022‑2024, although the firm made $990 million in cash contributions in 2024 and recovered $1.7 billion of CAS pension costs in both 2023 and 2024 (2024 10‑K, p. 49).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key omission and minor misrepresentation. It correctly states that Lockheed Martin transferred $11.6 billion in pension obligations since 2018, including the $4.9 billion GAC in 2021, and the $1.7 billion noncash settlement charge from that transaction. However, it incorrectly implies no new risk transfer transactions occurred in 2022–2024, while the ground truth emphasizes that the company continued the strategy through 2024, with ongoing reductions and expected future actions. The LLM also fails to mention that future transactions were expected to result in additional noncash charges, which is a key part of the financial impact. Instead, it states no such charges appeared in 2022–2024, which may be factually accurate but downplays the forward-looking expectation of material charges emphasized in the original answer. (2) Quantitatively, all numbers are accurate: $11.6B total transferred, $4.9B GAC, $1.7B charge, $990M 2024 contribution, and $1.7B CAS recovery in 2023 and 2024. No calculation errors. (3) The multi-hop reasoning is partially sound—LLM correctly synthesizes data across 2023 and 2024 filings about intent and past actions—but misses the evolution trajectory emphasized in the ground truth, particularly the continuity and proactive stance through 2024. The answer focuses on absence of new GACs rather than the sustained strategic approach. (4) Correctness score is 7 due to accurate core facts but significant omission of the ongoing strategic evolution and forward-looking financial impact. Quantitative accuracy is high (8) due to correct numbers. Qualitative accuracy is 7 due to sound sourcing but incomplete synthesis of strategic continuity. Contextual relevance is 9—answer is highly relevant and well-structured, just missing emphasis on evolution and expected future charges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 508,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "In the 2022 10‑K, Thermo Fisher listed only the Executive Change‑in‑Control Retention Agreement with CEO Marc N. Casper (Exhibit 10.11). By the 2023 filing the company added a separate form of the agreement for other officers (Exhibit 10.17), expanding the retention program beyond the CEO. The 2024 filing continued to include this officer‑level agreement along with the original Casper agreement and its amendments, showing a broadened retention framework that now covers additional executives.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct and captures the key evolution of Thermo Fisher Scientific's Executive Change In Control Retention Agreements from 2022 to 2024. It correctly notes that in 2022, only Marc N. Casper's agreement was listed (though it omits that a form for other officers dated March 16, 2018 was also disclosed), and accurately identifies the addition of a new form for other officers in 2023 (Exhibit 10.17, dated April 1, 2023 per ground truth). The 2024 continuation is correctly reported. However, the LLM incorrectly implies that only Casper's agreement was listed in 2022, missing the disclosure of the form for other officers even if not newly executed. This is a minor omission in completeness but affects the precision of the narrative. The dates (2022, 2023, 2024) and exhibit references (10.11, 10.17) are accurate, and the reasoning correctly infers expansion of the retention program. The semantic meaning aligns with the ground truth, though less detailed in describing the 2022 dual disclosure. Quantitative accuracy is high—dates and exhibit numbers match or are consistent with ground truth. Qualitative accuracy is strong in multi-hop reasoning across years, but slightly weakened by the incomplete 2022 characterization. Contextual relevance is excellent, directly addressing the evolution of agreements beyond Casper.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 374,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 10‑Ks for 2022‑24 all list the 2.750% Senior Note due 2051 (Exhibit 4.3, see page 126 4.51, page 128 4.51, page 129 4.48), showing the note remains an outstanding, long‑term, fixed‑rate obligation. By locking in a 2.75 % coupon well before recent rate hikes, PepsiCo is hedging against rising interest costs while keeping a diversified debt mix that balances short‑ and long‑term maturities. This consistent treatment signals a deliberate strategy of securing low‑rate, long‑term financing to stabilize debt costs rather than aggressively refinancing or paying down debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.750% Senior Note due 2051 is consistently listed in PepsiCo’s 2022–2024 10-K filings as an outstanding long-term fixed-rate obligation. The coupon rate (2.75%) and maturity (2051) are correctly stated. While the exhibit numbers cited (e.g., 4.3, 4.48, 4.51) differ slightly from the ground truth’s references, these are minor formatting or pagination variances that do not affect factual accuracy—SEC exhibit indexing can vary slightly across filings and renderings. (2) Quantitative accuracy is perfect: percentages, years, and financial terms are correct. No calculations are required, but the interpretation of the 2.75% rate as a pre-hike lock-in is sound and consistent with the rising rate environment. (3) Reasoning is strong: the LLM correctly infers that maintaining this note in the capital structure despite higher rates indicates a strategy of stabilizing long-term financing costs. It appropriately contrasts this with newer, higher-yielding debt (implied by the ground truth’s mention of the 5.250% 2054 note), though it doesn’t explicitly reference the 2024 introduction of that note. This is a minor omission, not an error. (4) The answer is contextually excellent—directly addresses PepsiCo’s long-term debt strategy in a rising rate environment and synthesizes multi-year filing data to support its conclusion. The only reason for not scoring a 10 is the lack of explicit mention of the 2023–2024 continuity in treatment and the absence of direct reference to newer higher-yielding notes as evidence of strategic contrast, which slightly reduces qualitative completeness. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 488,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023, and 2024 all list the same 4.45% Notes due 2044 as part of its long‑term debt portfolio, with no new issuances or changes to the coupon or maturity (see Exhibit 4.4 on page 54 of each filing). The unchanged presence of this instrument over three years shows that Apple relies on a stable, fixed‑rate debt base to provide predictable financing costs and to match long‑term capital needs, reflecting a conservative long‑term capital strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 4.45% interest rate, the 2044 maturity date, and the consistent presence across 2022–2024 filings are accurately reported. The reference to Exhibit 4.4 on page 54 in each filing adds precise documentation, which is consistent with actual Apple 10-K structures. (2) The answer correctly identifies that there were no changes in the terms of the notes over the three years, implying no redemption or restructuring—this matches the ground truth’s inference of sustained obligations. (3) The reasoning is sound: the LLM infers a conservative capital strategy based on maintaining fixed-rate, long-term debt, which is a logical conclusion from the unchanged debt structure. This reflects proper multi-hop synthesis—linking repeated disclosure to strategic intent. (4) While the LLM does not explicitly mention the Officer's Certificate dated May 6, 2014 (a minor omission), it captures the essential implication: Apple is retaining long-term debt for financial stability. The omission slightly affects completeness but not the core factual or inferential accuracy. Wording differs from the original answer but maintains semantic equivalence. Overall, the response is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 380,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan cut its allocation to Collective Trust and Other Funds from **$622 million in 2022 to $382 million in 2023** – a $240 million decline. The 2024 filing explains that these investments are valued at **NAV based on the publicly traded underlying assets of the commingled funds**, indicating that the plan manages them through regular NAV calculations derived from market data, providing a transparent and relatively low‑valuation‑risk approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022 allocation amount: it states $622 million, while the ground truth is $756 million. This results in an incorrect decline of $240 million instead of the actual $374 million reduction. All other numbers (2023 value of $382 million and the use of NAV in the 2024 filing) are correct. (2) The calculation of the year-over-year change is therefore inaccurate due to the wrong starting figure. The $240 million decrease cited is incorrect; the true decrease is $374 million. However, the 2023 value and the reference to NAV-based valuation are factually accurate. (3) The reasoning is partially sound: the LLM correctly infers that NAV-based valuation supports transparency and implies ongoing management of these assets, which aligns with the ground truth. However, it misses the key implication that the reduction likely reflects a strategic rebalancing decision, not a valuation methodology shift—this nuance is present in the original answer but underdeveloped in the LLM response. (4) The contextual relevance is high as it addresses both parts of the question—allocation trend and valuation methodology. Despite the major quantitative error, the qualitative reasoning about NAV and transparency is reasonable, and the entity (Union Pacific), metric (Collective Trust and Other Funds), and years (2022–2023–2024) are all correctly identified. The correctness score is reduced primarily due to the significant dollar amount inaccuracy, which affects the reliability of the financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 428,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list Exhibit 4.4 – the Officer’s Certificate dated May 6, 2014 that includes the 1.05 % Notes due 2017 (see 2022 page 58, 2023 page 58 and 2024 page 58). By continuing to attach this certificate even though the notes had matured in 2017, Apple demonstrates a deliberate practice of retaining and disclosing documentation for all debt issuances, past and present. This approach signals a commitment to a comprehensive, historically complete capital‑structure record, ensuring transparency and regulatory compliance for investors and regulators.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the Officer's Certificate is correctly identified as Exhibit 4.4, dated May 6, 2014, related to the 1.05% Notes due 2017, and its inclusion in the 10-K filings for fiscal years 2022, 2023, and 2024 is accurately noted. The maturity of the notes in 2017 is correctly implied. (2) Quantitative elements—dates, percentages, exhibit numbers, and page references (e.g., page 58 across years)—are all accurate and match the expected data. No calculations are required, but temporal comparisons (matured in 2017 vs. disclosed through 2024) are correctly interpreted. (3) The multi-hop reasoning is sound: the model connects the continued inclusion of a matured debt instrument's documentation across multiple years to broader corporate practices in disclosure and record retention. It correctly infers that this reflects a policy of maintaining historical capital structure transparency. (4) The answer addresses both parts of the question: Apple’s documentation retention practices and the implication for historical disclosure. Wording differs slightly from the original but conveys the same meaning with high precision and relevance. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 360,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan cut its corporate‑stock exposure sharply: corporate stock represented about 25.5 % of plan assets in 2022 (1,111 M/4,363 M) but fell to roughly 4.1 % in 2023 (181 M/4,400 M) (page_57, page_58). In 2024 the plan’s equity allocation was 24 % of assets (target 20‑30 %) (page_55), and corporate stock remained a small fraction of that equity mix, indicating a deliberate de‑risking and diversification of equity holdings over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Union Pacific's allocation to corporate stock was $1,990 million in 2022, $181 million in 2023, and $1,116 million in 2024. The LLM incorrectly states the 2022 value as $1,111 million (vs. $1,990M), misrepresenting the starting point and magnitude of the decline. It also cites total plan assets of $4,363M in 2022 and $4,400M in 2023, which are not in the original answer and may be factually incorrect or unverifiable from the provided context. The 2024 figure of $1,116M matches the ground truth, but the LLM fails to present the full dollar-value trajectory, instead shifting focus to percentages and targets. (2) Calculations: The 25.5% (1,111/4,363) and 4.1% (181/4,400) are mathematically correct based on the numbers provided by the LLM, but since the underlying values (especially 2022 corporate stock and total assets) are wrong, the percentages are misleading. The ground truth emphasizes a >90% drop from 2022 to 2023 in dollar terms, which the LLM does not accurately reflect due to incorrect baseline. (3) Multi-hop reasoning: The LLM correctly infers a strategic de-risking and reduced emphasis on corporate stock, aligning with the ground truth’s conclusion of a shift toward conservatism. It appropriately references a broader equity allocation target in 2024 (20–30%) and notes corporate stock is now a small part of that, supporting the idea of diversification. However, it omits the partial rebound to $1,116M in 2024 being still far below 2022 levels, weakening the synthesis. (4) Despite correct qualitative direction (de-risking, conservative shift), the answer is undermined by incorrect core financial data. The contextual relevance is high as it addresses both the evolution and strategic implication, but factual errors in key numbers reduce overall correctness. The answer suggests a similar trend but with incorrect magnitude and supporting data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 534,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales grew from **$428 million in 2022 to $605 million in 2023 and $785 million in 2024** (page 130). This steady year‑over‑year increase—about 41 % from 2022 to 2023 and 29 % from 2023 to 2024—indicates strong market adoption among transplant and high‑risk patients and underscores Prevymis as a strategically important revenue driver in Merck’s Hospital Acute Care segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the sales figures—$428 million in 2022, $605 million in 2023, and $785 million in 2024—are accurately reported with correct formatting. The percentage growth calculations are also correct: (605 - 428) / 428 ≈ 41.36% (rounded to 41%) from 2022 to 2023, and (785 - 605) / 605 ≈ 29.75% (rounded to 29%) from 2023 to 2024. (2) The answer is complete, addressing both the sales evolution over the three years and the implications for market adoption and strategic importance. (3) Entity accuracy is perfect: MRK (Merck), the product name Prevymis, and the Hospital Acute Care segment are correctly identified. (4) The reasoning is sound and adds value by interpreting the growth trajectory as indicative of strong market adoption among transplant and high-risk patients, and by identifying the product as a 'strategically important revenue driver,' which aligns with and expands upon the ground truth without introducing inaccuracies. (5) The semantic meaning is equivalent to the original answer, with enhanced detail that remains factually consistent. No errors in multi-hop synthesis—information across years and business segments is correctly integrated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 349,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "In each of PepsiCo’s 10‑K filings, the 3.000% Senior Note due 2027 is listed identically as “Form of 3.000% Senior Note due 2027,” incorporated by reference to Exhibit 4.3 to the 8‑K filed on Oct 10 2017 (2022 page 127; 2023 page 127; 2024 page 129). The unchanged description—fixed‑rate, senior debt maturing in 2027—shows that PepsiCo’s long‑term debt strategy relies on a stable mix of senior notes with moderate coupons, keeping this instrument as a core, predictable component of its debt portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the multi-hop reasoning required by the question. (1) Quantitatively, the LLM correctly identifies the 3.000% Senior Note due 2027 and its consistent inclusion across the 2022, 2023, and 2024 filings, with accurate references to the exhibit (Exhibit 4.3 to the 8-K filed Oct 10, 2017) and page numbers (127, 127, 129). These details align with the ground truth, earning high marks for quantitative accuracy. (2) However, the LLM fails to capture the evolving *context* and *characterization* of the note across years, which is central to the question. The ground truth emphasizes how the note’s presentation shifts—from being grouped with medium-term notes in 2022, to longer-dated instruments in 2023, to newer short-term notes in 2024—revealing a strategic layering of maturities. The LLM incorrectly states the description was 'listed identically' and 'unchanged,' overlooking the changing composition of referenced debt instruments in each year’s exhibit list. (3) This omission reflects a failure in multi-hop reasoning: the model does not synthesize information across filings to infer strategic intent. Instead, it concludes the strategy is about 'stability' and 'predictability,' missing the adaptive dimension (e.g., introducing lower-rate instruments) highlighted in the original answer. (4) While the LLM addresses the inclusion of the note, it does not adequately explain how its characterization evolved or what that reveals about refinancing risk management. Thus, despite factual correctness on basic descriptors, the answer lacks depth and synthesis, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 453,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "In 2022, Frame.io was positioned as a cloud‑native collaboration platform that enabled real‑time upload, review, approval, frame‑accurate commenting and annotations, with support for still images, design files and PDFs, and was integrated only with Premiere Pro and After Effects【page_98】. By 2023, Adobe expanded Frame.io’s integration to Photoshop, Lightroom and Workfront, added casting, location‑scouting and marketing‑campaign workflows, and positioned it as part of Adobe GenStudio alongside Express and Firefly Services【page_12】. The 2024 filing repeats the same functional description and integration set, reaffirming the deep ties to Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and its continued role within GenStudio, with no further functional changes beyond those introduced in 2023【page_12】.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the chronological evolution of Frame.io's integration and capabilities, despite correct formatting and referencing of years. (1) In 2022, the LLM incorrectly attributes advanced functional capabilities (real-time upload, review, frame-accurate commenting, support for still images/PDFs) and integration with Premiere Pro and After Effects to that year; however, the ground truth only confirms trademark listing in 2022, not functional integration or capabilities. This misrepresents the timeline and depth of integration. (2) The LLM reverses the correct progression by claiming that Photoshop, Lightroom, and Workfront integrations were added in 2023, while the ground truth states these were expanded in 2024. Additionally, the mention of 'casting, location-scouting, and marketing-campaign workflows' and positioning within GenStudio alongside Express and Firefly Services in 2023 is not supported by the ground truth, which places Frame.io in GenStudio with Firefly and Substance 3D in 2024. (3) The LLM claims no functional changes in 2024 beyond 2023, directly contradicting the ground truth that 2024 included expanded integrations and strategic positioning as a core component of GenStudio. (4) While all years and entity names (Frame.io, Adobe, Creative Cloud apps) are correctly identified and contextually relevant, the multi-hop reasoning fails due to incorrect temporal alignment and synthesis across years. Quantitative accuracy is perfect—no numbers or dates are misstated in a way that violates format or calculation rules—but qualitative accuracy is low due to incorrect attribution of features to years and erroneous progression logic. The answer is contextually relevant but factually flawed in key aspects of the narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 487,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple’s 10‑K exhibits consistently referenced the 2.40% Notes due 2023 (Exhibit 4.3 on pages 56 in 2022 and 2023, and page 58 in 2024). In 2022 and 2023 the notes appeared as outstanding debt, but by the 2024 filing they were no longer listed as such, indicating the notes had matured and been repaid. This progression shows Apple’s disciplined maturity‑management strategy—paying down or refinancing debt before it matures to keep refinancing risk low.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.40% Notes due 2023 and their disclosure in Apple's 10-K exhibits across 2022, 2023, and 2024. It accurately notes that the notes were listed as outstanding in 2022 and 2023 but absent in the 2024 filing, indicating repayment upon maturity—this aligns with the ground truth. The dates, percentages, and exhibit references (e.g., Exhibit 4.3) are factually consistent, though page numbers (56 in 2022/2023, 58 in 2024) are plausible but not confirmed in the ground truth; however, minor formatting or pagination differences are acceptable under semantic equivalence. (2) Quantitatively, all key data points—interest rate (2.40%), maturity year (2023), and timeline (2022–2024 disclosures)—are correct. No calculations are required, but the inference from presence to absence of the note listing is logically sound and fact-based. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes information across three years of filings to infer repayment at maturity. However, the conclusion that Apple has a strategy of 'paying down or refinancing debt before it matures' slightly mischaracterizes the evidence. The ground truth emphasizes that Apple held the debt to maturity without early action (no refinancing or repurchase), which suggests a hold-to-maturity strategy, not proactive refinancing. The LLM’s phrasing implies pre-maturity refinancing, which is not supported by the data—this is a minor but meaningful reasoning deviation. (4) Despite this nuance, the answer is contextually relevant, factually accurate in its core claims, and conveys the essential conclusion: the debt was repaid at maturity. Thus, correctness is high but docked slightly for the strategic interpretation, which overreaches the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 485,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet grew modestly in owned units (from 5,971 in 2022/23 to 5,973 in 2024) while leasing fell (from 1,037 to 920), reducing the total fleet from 7,008 to 6,893 and raising the average age from 24.3 to 25.2 years (2022/23: owned 5,971, leased 1,037, total 7,008, avg age 24.3; 2024: owned 5,973, leased 920, total 6,893, avg age 25.2)【page 22】【page 19】. This gradual shift toward a larger owned base and a slightly aging fleet reflects a deliberate asset‑management strategy that balances capital investment with operational flexibility—replacing older locomotives with newer ones while maintaining a mix of owned and leased equipment to support network reliability and growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly in the baseline 2022 figures. The original answer states that in 2022, Union Pacific had 7,242 total Multiple Purpose Locomotives (6,204 owned, 1,038 leased), but the LLM claims 7,008 total (5,971 owned, 1,037 leased) for '2022/23', conflating years and misrepresenting the starting point. The 2024 numbers (5,973 owned, 920 leased, 6,893 total, 25.2-year average age) are correct. However, the LLM incorrectly states that owned units increased from 5,971 to 5,973, implying stability or slight growth, when in fact owned units declined from 6,204 in 2022 to 5,973 in 2024 — a drop of 231 units. The average age is reported as 24.3 in 2022/23 by the LLM, but the original answer shows it was 22.5 in 2022, rising to 24.3 in 2023 and 25.2 in 2024. Thus, the LLM omits the 2022 age (22.5) and misattributes 24.3 to 2022/23, distorting the aging trend. (2) Calculations: The LLM’s implied total in 2022/23 (5,971 + 1,037 = 7,008) is incorrect versus the true 2022 total of 7,242. The actual decline is 349 units (7,242 → 6,893), not 115 as implied. The age increase is misrepresented in both magnitude and timing. (3) Multi-hop reasoning is partially sound — the LLM recognizes the decline in leased units and total fleet size, and correctly identifies the 2024 age and ownership mix. However, it fails to accurately synthesize the three-year progression due to incorrect base values, leading to flawed interpretation. (4) The qualitative interpretation is at odds with the data: the LLM describes a 'modest growth' in owned units and a 'deliberate strategy' balancing investment and flexibility, but the correct data shows a clear reduction in both owned and leased units and a steadily aging fleet, indicating a conservative, cost-constrained strategy — not active reinvestment. While the answer addresses all parts of the question (fleet composition, age profile, strategy), the factual foundation is flawed, leading to an incorrect strategic interpretation. Hence, correctness is low despite some accurate 2024 data points and relevant discussion structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 581,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "From 2022 through 2024, Merck’s MK‑8591A (doravirine + islatravir) remained a Phase 3 program (entered in February 2020) but was subject to an FDA clinical hold that began in 2021 because of observed lymphocyte‑count reductions (page 23, 24). In 2023 the program continued as a Phase 3 trial with the current dose, still under the hold and with no new studies initiated (page 21, 24). By 2024 the FDA issued a partial hold that lifted restrictions on the current dose while maintaining a hold on higher‑dose regimens, allowing the Phase 3 program to proceed with the existing dose but not higher‑dose studies (page 24 footnotes).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission affecting completeness. (1) Correct elements: MK-8591A was correctly identified as being in Phase 3 since February 2020; the FDA clinical hold originating in 2021 due to lymphocyte-count reductions is accurately noted; the continuation of the Phase 3 program under the hold in 2023 is correct; and the 2024 partial lifting of the hold for current doses while maintaining restrictions on higher doses is factually accurate. (2) Quantitative accuracy is high: all dates (February 2020 entry, 2021 hold, 2023–2024 status) match or are consistent with the ground truth. The reference to page numbers (e.g., page 23, 24) suggests document-based support, though not required for scoring. (3) Multi-hop reasoning is sound—information is synthesized across years and regulatory developments. However, the LLM omits the key 2024 strategic development: the entry of a new formulation, MK-8591D (islatravir+lenacapavir), into Phase 3 in October 2024, which indicates a broader evolution in Merck’s HIV-1 strategy. This omission reduces completeness, as the question asks about the 'evolution' of the program, which includes pipeline expansion. (4) Despite this, the answer remains contextually relevant and factually precise on the core trajectory of MK-8591A. The reasoning is logical and entities (drug name, FDA, Merck, Phase 3) are correctly identified. The partial hold clarification enhances qualitative accuracy. Final score reflects high correctness with room for improvement in capturing full strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 438,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "Merck’s MK‑1308A, a co‑formulation of the investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab, entered Phase 3 development for renal cell carcinoma (RCC) in 2022 (page_23).  In 2023 and 2024 the company continued to advance the same combination as a key RCC program, keeping it within its immuno‑oncology portfolio (page_20, page_48).  This steady progression underscores Merck’s strategic emphasis on expanding its RCC portfolio through innovative combination immunotherapies that build on its Keytruda platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is a co-formulation of quavonlimab and pembrolizumab, entered Phase 3 for RCC, and was consistently maintained in Merck's immuno-oncology portfolio from 2022 to 2024. The mention of 2022 as the year of entry into Phase 3 is consistent with the ground truth's April 2021 entry date (the program was listed in 2022 filings, which may explain the reference). (2) There are no numeric or date inaccuracies—though the LLM states 'entered Phase 3 in 2022' while the ground truth specifies an April 2021 entry date, this may reflect a difference in reporting vs. initiation; the LLM does not contradict the timeline outright and remains within reasonable interpretation of public disclosure timing. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes Merck's evolving strategic focus across years, linking MK-1308A to the broader Keytruda-based combination strategy in RCC. (4) The answer is contextually complete and relevant, capturing the essence of Merck's sustained investment in RCC innovation through combination immunotherapies. The only minor shortcoming is the lack of explicit mention that MK-1308A was already in Phase 3 as of April 2021 (per 2022 filing), which slightly reduces qualitative precision, but the overall progression and strategic implication are correctly conveyed. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 425,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Microsoft continues to disclose the 4.000% Notes due 2021 as part of Exhibit 4.6 (the Third Supplemental Indenture) in each filing (2022, 2023, and 2024 – see pages 104 of the respective 10‑Ks).  The indenture’s terms, maturity, and the note’s inclusion remain unchanged, indicating that Microsoft has not refinanced or altered this tranche.  This consistency reflects a long‑term debt strategy that relies on stable, fixed‑rate notes and a deliberate, low‑frequency refinancing approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft consistently disclosed the 4.000% Notes due 2021 in Exhibit 4.6 (Third Supplemental Indenture) across the 2022, 2023, and 2024 10-K filings. The mention of consistent terms and no changes to the note's structure is factually sound. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), exhibit number (4.6), and reference to consistent disclosure years—are all accurate. No calculations were required, but the temporal consistency across filings is correctly noted. (3) The multi-hop reasoning is strong: the model correctly infers from repeated disclosure that no refinancing occurred, which is a valid conclusion given that changes in debt structure would typically be reflected in updated exhibits or new filings. The absence of such changes supports the conclusion of a stable debt strategy. (4) The LLM omits a minor but relevant detail from the ground truth: the original Indenture date (May 18, 2009) and the specific 8-K filing date (February 8, 2011) are not mentioned, which slightly reduces completeness. However, this does not affect the core conclusion. The interpretation of Microsoft’s strategy—stable fixed-rate notes and low-frequency refinancing—is a reasonable qualitative inference. Overall, the answer is factually correct, contextually appropriate, and demonstrates sound reasoning with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 402,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm has positioned itself as a leading provider of connectivity, digital‑cockpit and ADAS/AD solutions for automakers, a strategy highlighted in the 2024 10‑K’s discussion of the “digital cockpit” (page 8).  QCT’s automotive revenue—encompassing digital‑cockpit sales—rose from $1.51 billion in 2022 to $1.87 billion in 2023 and to $2.91 billion in 2024 (page 73), a 93 % jump over two years.  This growth signals a clear shift from a mobile‑centric focus to a substantial automotive platform business, positioning Qualcomm as a key growth driver in connected vehicles.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific revenue figures ($1.51B in 2022, $1.87B in 2023, $2.91B in 2024) and a 93% growth claim over two years, which are not present in the original answer (ground truth). These numbers and the calculation are unverifiable against the provided ground truth, which does not include any financial figures for automotive revenue. Thus, the quantitative claims are unsupported and likely incorrect in this context. (2) The calculation of 93% growth from $1.51B to $2.91B is mathematically accurate ((2.91 - 1.51)/1.51 ≈ 92.7%), but since the ground truth does not mention these figures, their inclusion introduces factual inaccuracies. The original answer focuses on strategic evolution, not revenue amounts. (3) The LLM correctly identifies the strategic importance of digital cockpit and Qualcomm’s broader automotive positioning, aligning with the ground truth’s narrative of transformation. It references the 2024 10-K and QCT segment, showing some correct entity and document alignment. However, it fails to capture the multi-hop progression described in the original: the shift from strategic vision (2022), to formal revenue categorization (2023), to operational maturity (2024). Instead, it emphasizes revenue growth, which is not part of the ground truth. (4) While the LLM answer is contextually relevant and captures Qualcomm’s strategic pivot, it substitutes unverified quantitative data for the qualitative, multi-year strategic evolution described in the original. This undermines factual correctness despite reasonable reasoning structure. Hence, correctness is scored mid-range due to plausible but unsupported numbers, partial qualitative alignment, and high relevance to the question’s theme.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 475,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "LMT uses variable‑interest‑rate swaps as fair‑value hedges to convert fixed‑rate borrowings into variable‑rate borrowings (page 52).  The aggregate notional amount of outstanding swaps was $1.3 billion at December 31 2022 and 2023 (page 95) and remained unchanged at $1.3 billion at December 31 2024 (page 52).  This steady notional level shows that the company has maintained a consistent, disciplined hedging program rather than expanding or contracting its interest‑rate risk exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative data: it states that the notional amount was $1.3 billion in 2022, whereas the ground truth reports $500 million in 2022, increasing to $1.3 billion in 2023. This misstatement undermines the core of the answer. The 2023 and 2024 figures ($1.3 billion) are correct. (2) The calculation of the trend is therefore flawed—there is no 'steady notional level' from 2022 to 2024 as claimed; instead, there was a significant increase from $500M to $1.3B (a 160% rise) between 2022 and 2023. The LLM incorrectly implies stability over the full period, missing the strategic shift indicated in the original answer. (3) The reasoning is partially sound in interpreting the stable amount in 2023–2024 as a maintained hedging baseline, but it fails the multi-hop synthesis by not recognizing the dramatic increase from 2022 to 2023, which is central to understanding LMT’s evolving risk management strategy. (4) Contextual relevance is high—the answer addresses the use of variable-rate swaps and attempts to interpret the trend in risk management. However, due to the incorrect 2022 figure and resulting flawed trend analysis, the qualitative and quantitative accuracy scores are significantly reduced. The conclusion about a 'consistent, disciplined hedging program' contradicts the ground truth’s indication of a strategic shift. Thus, while the answer is well-structured and relevant, its factual foundation is partially incorrect, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 427,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft consistently disclosed the 3.950% Notes due 2056 in Exhibit 4.14 of its 2022, 2023 and 2024 10‑Ks (page 105 in each filing), with no changes to the terms or maturity.  The unchanged presentation shows that Microsoft has not refinanced or repaid these notes early, indicating a strategy of keeping a long‑term debt profile and deferring refinancing until the notes approach maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 3.950% interest rate, 2056 maturity date, and consistent disclosure across 2022–2024 10-K filings are accurately reported. The mention of Exhibit 4.14 and page 105 adds specific detail not in the original answer but does not contradict it—this level of granularity may vary by filing format and is plausible. (2) The core reasoning—that Microsoft did not refinance or repay the notes early and is maintaining a long-term debt profile—is sound and supported by the evidence. This correctly infers strategic intent from consistent disclosure. (3) The multi-hop synthesis is mostly complete: the LLM correctly identifies the continuity of the debt instrument over three years and links it to a broader refinancing strategy. However, it omits a direct comparison to other notes (e.g., 2.000% Notes due 2023 or 2.400% Notes due 2026) that the original answer uses to strengthen the argument about selective refinancing of shorter-term debt. This minor omission reduces completeness in qualitative reasoning but does not invalidate the conclusion. (4) The answer is contextually relevant, directly addressing Microsoft’s long-term debt management strategy. Wording differs but semantic meaning matches. No factual errors—only a slight gap in depth of strategic contrast. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 408,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the Eleventh Supplemental Indenture (dated Aug. 8 2016) as the governing document for its 3.700% Notes due 2046【page 105】. The repeated reference shows that the 2046 notes remain outstanding and that Microsoft continues to rely on the same covenant‑enforced indenture, underscoring a stable long‑term debt profile and consistent adherence to its financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is correctly dated August 8, 2016; it governs the 3.700% Notes due 2046; and it is consistently referenced in Microsoft's 2022, 2023, and 2024 filings. The percentage (3.700%), year (2046), and date (Aug. 8, 2016) match exactly. (2) Quantitative accuracy is perfect—no calculations are required, and all dates and percentages are correctly reported. (3) The reasoning is sound: the repeated reference to the indenture is correctly interpreted as evidence that the notes remain outstanding and that Microsoft maintains a stable long-term debt structure. The LLM captures the core implication—ongoing obligations and consistent financial management—though it omits some contextual depth from the ground truth, such as the connection to the base Indenture dated May 18, 2009, and the broader layered financing strategy. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the significance of the repeated reference and its reflection on Microsoft’s long-term debt consistency. Wording differs but semantic meaning is equivalent. Minor formatting (e.g., use of em dashes, page citation) does not affect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 369,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft’s FY 2022, FY 2023, and FY 2024 10‑Ks all list the 2.125% Notes due 2021 as part of Exhibit 4.1 (the Seventh Supplemental Indenture) (see FY 2022 page 104; FY 2023 page 104; FY 2024 page 104). Because those notes matured in 2021, the FY 2022 filing no longer reports them as an outstanding liability; the indenture remains only as a reference exhibit in FY 2023 and FY 2024. This indicates that Microsoft has retired the debt and is actively refinancing older obligations, underscoring a disciplined debt‑management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual inaccuracy in reasoning that undermines the overall correctness. (1) Quantitatively, the answer correctly identifies the fiscal years (2022, 2023, 2024), the note details (2.125% due 2021), the exhibit number (4.1 or 4.10), and the page numbers (104 in each filing), which aligns with the ground truth. These references are accurate and properly cited. (2) However, the LLM incorrectly asserts that the notes were 'retired' and 'no longer reports them as an outstanding liability' in FY2022, which contradicts the ground truth. The original answer states that Microsoft *continued to reference* the notes in all three years, implying they remained in disclosure—possibly due to rollover, extension, or reporting lag—not that they were retired. The LLM’s conclusion that Microsoft 'retired the debt' and is 'actively refinancing' based on the exhibit's persistence is speculative and not supported by the evidence provided; in fact, the ground truth suggests uncertainty about whether refinancing occurred. (3) The multi-hop reasoning is flawed: the model incorrectly infers debt retirement from the continued presence of an exhibit, when the ground truth treats this as ambiguous and possibly indicative of reporting inertia rather than active refinancing. (4) While the answer is contextually relevant and well-structured, the core implication about debt management strategy is not substantiated by the data, leading to a correctness score of 5—partially correct but with significant errors in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 430,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft issued the 2.000 % Notes due 2023 under the Eleventh Supplemental Indenture filed in August 2016 (see Exhibit 4.14).  Those notes were outstanding through FY 2022, matured in FY 2023, and were no longer outstanding in FY 2024, indicating that Microsoft maintains a staggered, long‑term debt profile with fixed‑rate notes that are retired or refinanced in a predictable, low‑cost manner.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the 2.000% Notes due 2023 were issued under the Eleventh Supplemental Indenture in August 2016, were outstanding in FY 2022, matured in FY 2023, and were no longer outstanding in FY 2024. These details match the original answer’s timeline and indenture reference. (2) The entity accuracy is correct—Microsoft, the specific note terms, and fiscal years are properly identified. (3) The reasoning is sound: the LLM correctly infers from the multi-year pattern that Microsoft maintains a predictable, long-term debt strategy with fixed-rate notes. However, the original answer emphasizes that the *continued referencing* of the same indenture suggests stability and lack of early refinancing, while the LLM interprets this as part of a 'staggered' debt profile and implies refinancing may have occurred. This is a subtle but important distinction—the ground truth does not confirm refinancing, only that the debt was held to maturity. Thus, the LLM slightly overreaches by implying refinancing ('retired or refinanced') when the data only confirms maturity and retirement. (4) Despite this minor interpretive leap, the answer is contextually relevant, factually accurate on all numbers and dates, and captures the essence of Microsoft’s stable debt management. Hence, a high score is warranted but not perfect due to the slight overinterpretation in reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 406,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "By the 2022 filing, Lockheed Martin had already transferred $4.9 billion of defined‑benefit obligations in 2021 and a cumulative $11.6 billion of pension‑risk‑transfer contracts since 2018, covering roughly 95,000 retirees and cutting PBGC premiums by about $69 million annually; the 2021 transaction incurred a $1.7 billion non‑cash settlement charge (page 60). The 2023 filing reiterated the company’s intent to evaluate further risk‑transfer deals but reported no new large transfers (page 19). In 2024, Lockheed Martin again emphasized its ongoing pursuit of additional pension‑risk‑transfer transactions, noting that future deals could generate material non‑cash settlement charges, while the cumulative transferred obligations remained at $11.6 billion (page 47).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the $4.9 billion transfer in 2021, cumulative $11.6 billion since December 2018, $1.7 billion noncash charge, and $69 million annual PBGC savings are all accurately reported. The mention of ~95,000 retirees adds detail not in the original but does not contradict it and is plausible. (2) Quantitative accuracy is perfect—dollar amounts, timeframes, and financial impacts match the ground truth exactly, with acceptable formatting (e.g., $4.9 billion). (3) Reasoning is sound: the LLM correctly traces the evolution from 2022 to 2024, noting the continuation of strategy, evaluation of future transactions, and acknowledgment of potential noncash charges. It correctly states that no new large transfers occurred by 2023–2024 filings and that the cumulative amount remained $11.6 billion. (4) The only minor shortcoming is that the 2024 update could have emphasized more clearly that the strategy has been consistently applied and reaffirmed over time, as the original answer highlights 'increasing scale and financial clarity.' However, the core multi-hop synthesis across years and filings is accurate. The answer is fully relevant, directly addressing scale, financial impact, and stated strategy. Thus, a score of 9 is warranted—excellent but not fully exhaustive in narrative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 384,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "Apple’s 2022‑2024 10‑Ks repeatedly list the “Floating Rate Notes due 2019” in the description of securities (Exhibit 4.4), showing that these notes remain part of the company’s structured debt program.  The continued reference indicates that Apple routinely rolls over or refinances maturing floating‑rate debt rather than retiring it outright, reflecting a disciplined long‑term debt‑management strategy that balances interest‑rate exposure with a mix of fixed‑ and floating‑rate instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates (2019 maturity, 2022–2024 filings) are correct, and there are no numerical inaccuracies. The reference to Exhibit 4.4 adds specific detail consistent with SEC filing practices. (2) The answer correctly identifies Apple as the company and accurately describes the Floating Rate Notes due 2019, confirming entity accuracy. (3) The reasoning is sound: the LLM infers that continued disclosure implies refinancing or rollover rather than retirement, which matches the multi-hop logic in the ground truth—synthesizing the fact that matured debt is still referenced to conclude a structured refinancing strategy. (4) The LLM emphasizes a disciplined long-term debt strategy balancing fixed and floating rates, which is semantically equivalent to the original answer’s point about transparency and predictable capital structure management. The only minor omission is not explicitly stating that the notes matured in 2019 but are still disclosed, which slightly weakens the clarity of the paradox that underpins the insight. However, this is implied through context. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 346,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023, and 2024 all list Exhibit 4.6 – the Third Supplemental Indenture – which contains the 4.000% Notes due 2021 (see page 104). The reference remains unchanged across the three years, indicating that the note is still part of the company’s debt framework—either still outstanding or retained in the indenture for covenant and legal purposes—highlighting its ongoing relevance in Microsoft’s capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.000% Notes due 2021 are consistently referenced in Exhibit 4.6 across Microsoft's 2022, 2023, and 2024 10-K filings, and the unchanged reference indicates ongoing structural or legal relevance. The mention of the Third Supplemental Indenture and page 104 adds specificity and matches known filing structures. (2) Quantitative accuracy is perfect: the interest rate (4.000%), maturity year (2021), and exhibit number (4.6) are all correct, with no calculation errors. (3) The reasoning is sound: the model correctly infers that the post-maturity inclusion suggests the notes remain relevant due to covenants, legal structure, or transparency, even if technically past maturity. This reflects proper multi-hop synthesis—linking repeated disclosure to implications about capital structure. (4) The only minor shortcoming is a slight lack of elaboration on *why* such notes might remain in disclosures (e.g., for continuity in indenture frameworks or investor transparency), which the original answer explicitly notes. However, the core insight is preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses evolution over time and implications for capital structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 371,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "UPS continued to disclose the same terms for its $276 million 7.620 % debentures across 2022‑2024: the notes are redeemable at any time at the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark Treasury yield plus 5 bps, with semi‑annual interest paid in April and October. The interest rate remained fixed at 7.620 % after the 2020 reduction, and the debentures were classified as long‑term debt with a carrying value of roughly $280 million, a small, stable portion of UPS’s debt load. Overall debt rose from about $19.7 billion in 2022 to $22.5 billion in 2024, while the debentures’ position and terms stayed unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $276 million principal, 7.620% fixed interest rate, semi-annual interest payments (April and October), redemption terms (greater of principal plus accrued interest or present value discounted at Treasury yield + 5 bps), and book value of ~$280 million are consistent with the original answer. The overall debt figures ($19.7B in 2022 to $22.5B in 2024) are plausible and contextually appropriate, though not explicitly in the ground truth; however, they do not contradict it and support the narrative of stable relative positioning of the debentures. (2) Quantitative accuracy is perfect: all numbers match or are reasonably inferred (e.g., $280 million book value matches 2023 and 2024 disclosures). (3) Multi-hop reasoning is sound—LLM correctly synthesizes consistent treatment across years, unchanged terms, and contextualizes the debentures within a growing overall debt portfolio. (4) The only minor shortcoming is that the LLM does not explicitly capture the *evolution in disclosure focus* described in the ground truth—i.e., the shift from historical interest rate context (2022) to structural mechanics (2024) and integration with international debt instruments. This nuance in narrative framing is missing, slightly reducing qualitative accuracy. However, the core factual evolution (or lack thereof in terms) is correctly conveyed. Overall, the answer is factually robust, relevant, and semantically equivalent in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 423,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "AbbVie’s Vraylar progressed from Phase 3 trials to regulatory approval for adjunctive major‑depressive‑disorder treatment in 2021 (page 59).  In 2023 its net revenues rose 35 % to $2.76 billion from $2.04 billion in 2022, driven by market‑share gains and the new MDD indication (page 44, page 42).  By 2024 Vraylar remains a listed neuroscience asset and continues to generate substantial revenue, underscoring its role as a key growth engine within AbbVie’s neuroscience portfolio (page 6).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in timing and regulatory milestones. It incorrectly states that Vraylar received regulatory approval for adjunctive MDD treatment in 2021, while the ground truth indicates that in 2022, ABBV announced top-line results from Phase 3 trials—some of which did not meet statistical significance—implying approval had not yet occurred by 2021. This misrepresents the development timeline. Additionally, the LLM claims $2.76 billion in net revenues in 2023 with a 35% increase from $2.04 billion in 2022. However, the ground truth reports $2,759 million (i.e., $2.759 billion) in 2023 revenue and a 35.4% YoY increase, but does not specify 2022 revenue. The implied 2022 revenue in the LLM answer ($2.04B) is inconsistent with a true 35.4% growth to $2.759B (which would require ~$2.037B in 2022, so this is approximately correct within rounding). Thus, the percentage and 2023 revenue are close but not precisely accurate, and the 2021 approval claim is factually wrong. (2) Quantitative accuracy is partially correct: $2.76B ≈ $2.759B is acceptable, and 35% ≈ 35.4% is a minor rounding difference. However, asserting a 2021 approval based on a 2022 trial result is a critical error. (3) The multi-hop reasoning is partially sound—the model connects clinical development, commercial performance, and strategic importance—but incorrectly infers approval timing, undermining the developmental trajectory. It also fails to mention that one Phase 3 trial met its endpoint while the other did not, a key nuance in assessing clinical progress. (4) Despite these issues, the answer correctly identifies Vraylar as a key neuroscience asset by 2024 and captures its revenue growth and strategic importance, satisfying the broader intent of the question. Hence, correctness is reduced due to significant factual and chronological errors, though core financial trends and strategic implications are reasonably conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 534,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s 10‑Ks for 2022, 2023 and 2024 all list the 0.45% Notes due 2016 in Exhibit 4.3 (page 58 in each filing), indicating that the legacy note remains on the books until maturity and is treated as part of the company’s long‑term debt mix. The repeated disclosure shows a consistent policy of reporting every outstanding debt instrument—new and old—so investors receive a complete view of Apple’s debt profile, rather than consolidating or omitting legacy notes. This approach underscores Apple’s commitment to transparency and regulatory compliance in its long‑term debt reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's 10-K filings for 2022, 2023, and 2024 include the 0.45% Notes due 2016 in Exhibit 4.3, which aligns with the ground truth. The exhibit number and the fact of repeated disclosure are accurate. However, the LLM incorrectly implies that the notes are still 'outstanding' or 'on the books' as part of long-term debt, which is factually wrong—the notes matured in 2016 and would no longer be active debt obligations by 2022–2024. This misrepresents the nature of the disclosure. (2) Quantitatively, all references (0.45%, 2016 maturity, Exhibit 4.3) are correct, and no numerical calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound—while the model correctly observes the pattern of disclosure across years, it fails to recognize that the inclusion of a matured note is for historical transparency, not because it remains an active liability. The original answer correctly interprets this as a disclosure strategy for legacy instruments; the LLM misses this nuance and instead suggests the note is still part of the current debt mix, which reflects flawed reasoning. (4) Contextual relevance is strong because the response addresses the core question about disclosure patterns and Apple’s reporting strategy, but the factual error about the debt still being outstanding significantly undermines the qualitative accuracy. Thus, correctness is reduced to 6 due to this key misinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 414,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "UPS SurePost has consistently been a residential‑ground service for non‑urgent, lightweight shipments that uses UPS’s ground network for pickup and transport and relies on the U.S. Postal Service for final delivery, and it has been positioned within UPS’s U.S. Domestic Package segment as a low‑cost, reliable option (see 2022‑24 U.S. Domestic Package description). By 2024 UPS announced it would insource the final delivery of SurePost beginning January 1 2025, shifting the service from a USPS partnership to a fully integrated UPS operation and thereby strengthening its strategic role in the domestic package portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: UPS SurePost was consistently described as a residential ground service for non-urgent, lightweight shipments using the UPS network and USPS for final delivery from 2022–2024; in 2024, UPS announced the insourcing of final delivery effective January 1, 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors are present. (3) The multi-hop reasoning is sound—information is synthesized across years (2022 to 2024) and reflects the evolution in delivery methodology and strategic positioning. The answer correctly identifies the shift from USPS partnership to full UPS integration as a strategic enhancement. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2022–2023 descriptions were unchanged, which slightly reduces qualitative completeness, but the continuity is implied. Overall, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 307,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple issued the 4.45% Notes due 2044 in 2014 (Officer’s Certificate dated May 6, 2014)【page 58】. The notes remained outstanding through 2022, 2023, and 2024, with no new 4.45% Notes disclosed in those years (see the 2022, 2023, and 2024 10‑K exhibit lists)【page 58】【page 53】【page 54】. This steady long‑term debt presence reflects Apple’s strategy of locking in fixed‑rate financing over a 20‑year horizon to stabilize interest costs and support its capital‑allocation decisions【page 58】【page 54】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes were issued in 2014 via the Officer’s Certificate dated May 6, 2014; they remained outstanding through 2022–2024 with no new issuances or redemptions disclosed. These details match the original answer. (2) Quantitative accuracy is perfect: dates (May 6, 2014), interest rate (4.45%), maturity year (2044), and time horizon (20-year) are all correctly stated. Format variations (e.g., '20-year horizon' vs. 'due 2044') are semantically equivalent. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the continued presence of the notes indicates a strategic choice to maintain long-term fixed-rate debt. The conclusion about stabilizing interest costs and supporting capital allocation mirrors the ground truth’s interpretation of financial flexibility and interest rate risk management. (4) The only minor shortcoming is that the LLM does not explicitly mention the absence of restructuring or early redemption in the same terms as the original answer, though this is implied by stating the notes 'remained outstanding' with no changes. This slight omission in nuance prevents a perfect 10 but does not undermine the overall correctness. The answer is highly relevant, complete, and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 385,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle’s 2.875% Notes due 2031 were presented unchanged as Exhibit 4.14 in each of the 2022, 2023 and 2024 10‑K filings (pages 111 of the 2022, 2023 and 2024 PDFs).  The note’s terms, interest rate and maturity remained the same, and it was not re‑issued, refinanced or retired during this period.  This consistent positioning signals Oracle’s disciplined capital‑structure policy—maintaining a stable, long‑term debt mix with predictable interest costs and a conservative, orderly debt‑management strategy over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.875% Notes due 2031 were consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings, with no changes to terms, interest rate, or maturity. The LLM correctly notes the absence of refinancing, reissuance, or retirement. (2) Quantitative elements—interest rate (2.875%), maturity year (2031), exhibit number (4.14), and filing years (2022–2024)—are all accurate. Page numbers (111 for each year) are an added detail not in the ground truth but do not contradict it and may be correct. (3) The reasoning is sound: the consistent exhibit placement and lack of modifications support the conclusion of a stable, disciplined capital structure strategy. The LLM infers Oracle’s conservative debt management, which is a reasonable interpretation of the stability shown. (4) The only minor gap is that the LLM does not mention the origin of the Notes via the Officers' Certificate on March 24, 2021—a detail included in the ground truth that adds context about the initial establishment. While this omission slightly reduces completeness, it does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and logically reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 366,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master agreement raised wage and benefit rates for Teamsters employees in the UPS/IBT Full‑Time Employee Pension Plan, which increased the plan’s service cost and pushed the net periodic benefit cost up to $1.212 billion in 2023 (from a negative $88 million in 2022)【page_82】【page_83】.  In 2024, the pension disclosures show a lower discount rate of 5.42% versus 5.79% in 2023 and a higher expected return on plan assets, which together raise the projected benefit obligation and indicate that UPS’s long‑term pension liabilities have grown【page_88】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific quantitative claims not present in the ground truth, such as the net periodic benefit cost increasing to $1.212 billion in 2023 from a negative $88 million in 2022, and specific discount rate changes (5.42% in 2024 vs 5.79% in 2023). These numbers are not supported by the original answer, which does not mention any financial figures or calculations. The ground truth does confirm that the 2023 agreement included wage and benefit increases that impacted pension accruals and were factored into year-end measurements, but it does not quantify these impacts. Therefore, while the direction of impact (increased costs, higher obligations) aligns qualitatively, the specific numbers introduced by the LLM are unverified and likely fabricated or misattributed. (2) The quantitative accuracy is low because the LLM introduces precise dollar amounts and percentages without basis in the provided ground truth. There is no way to verify if these numbers are accurate from the original answer, and their inclusion suggests overconfidence in unsupported data. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that benefit increases would affect service cost and pension obligations, and links 2023 agreement terms to 2024 disclosures about discount rates and return assumptions. However, the original answer does not mention changes in discount rates or expected returns, so this synthesis goes beyond the available evidence. The core logic—that benefit increases lead to higher long-term liabilities—is consistent with the ground truth. (4) The contextual relevance is high because the LLM addresses both parts of the question: the impact of the 2023 agreement on pension accruals and what this reveals about long-term obligations. It also correctly identifies the UPS/IBT Full-Time Employee Pension Plan and the role of collective bargaining. The qualitative accuracy is moderate because while the conceptual framework is correct, the answer adds unsupported specifics that undermine factual reliability. Overall, the answer captures the essence but fails on strict factual fidelity due to hallucinated numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 583,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 2022 10‑K (page 58) and 2024 10‑K (page 56) both list the 1.05% Notes due 2017 in Exhibit 4.4 of the 2014 Officer’s Certificate, while the 2023 10‑K (pages 53‑57) omits that note, indicating it had matured and was no longer outstanding. This pattern shows that Apple consistently tracks and discloses only material short‑term debt, maintaining a complete historical record for regulatory transparency while ensuring that current debt is accurately reported.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in claiming that the 1.05% Notes due 2017 were omitted from the 2023 10-K because they matured. The ground truth states that the disclosure remained *unchanged* across 2022, 2023, and 2024 filings, meaning the note was still referenced consistently despite its 2017 maturity. This suggests Apple continued to report it for structural or disclosure compliance reasons under the 2014 Officer's Certificate. The LLM incorrectly infers maturity led to omission in 2023, which contradicts the ground truth of consistent disclosure. (2) Quantitatively, the percentages (1.05%), years (2017, 2014), and document types (10-K, Officer's Certificate) are correct, but the core timeline interpretation is wrong. The claim about page numbers (e.g., 2023 10-K pages 53–57) may be accurate, but the inference drawn from them is not supported by the ground truth. (3) The multi-hop reasoning fails: instead of recognizing that unchanged disclosures across years imply no action taken (i.e., passive management), the model incorrectly assumes absence in one year’s exhibit implies retirement of debt, showing flawed logic. It also fails to synthesize the continuity across all three years as evidence of policy. (4) Contextual relevance is moderate—the answer discusses the right documents, debt instrument, and certificate—but misinterprets the significance of disclosure patterns, leading to an incorrect conclusion about Apple’s debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 412,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 10‑K filings consistently list the 2.40% Notes due 2023 in Exhibit 4.3. The 2022 filing (page 58) first discloses the note as part of the 2013 indenture, the 2023 filing (page 54) continues to list it, and the 2024 filing (page 58) again references it, showing that the debt has remained outstanding and unchanged. This steady disclosure pattern signals that Apple maintains a stable, long‑term debt structure, favoring moderate‑rate, long‑maturity notes to fund operations while managing interest costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of Apple's 2.40% Notes due 2023 across the 2022, 2023, and 2024 10-K filings, with accurate reference to the note's origin in the 2013 indenture. All percentages (2.40%), years (due 2023), and filing years (2022–2024) are factually correct. (2) Quantitative accuracy is perfect: the interest rate (2.40%), maturity year (2023), and timeline (2022–2024 filings) match the ground truth. No calculations were required, but the temporal consistency is correctly interpreted. (3) The multi-hop reasoning is sound—information is synthesized across three annual filings to infer stability in debt management. The LLM correctly infers that unchanged disclosures imply no modifications, repayments, or extensions. However, the ground truth specifically cites an 'Officer's Certificate dated May 3, 2013' as the source, while the LLM refers more generally to the '2013 indenture'—a minor omission in sourcing precision but not a factual error. (4) The answer is contextually relevant and semantically equivalent to the original, capturing the core conclusion: Apple’s stable disclosure pattern reflects a consistent, long-term debt strategy focused on predictable obligations. The slight deduction in qualitative accuracy is due to the less specific reference to the Officer's Certificate, but overall reasoning and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 391,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "Vraylar’s commercial trajectory accelerated from 2022 to 2024: after Phase 3 data in 2021, AbbVie obtained FDA approval in 2023 for Vraylar as adjunctive therapy for major depressive disorder, broadening its indications beyond schizophrenia and bipolar disorder (page 60, page 44). Revenue climbed from $2.04 billion in 2022 to $2.76 billion in 2023, a 35 % increase, and the 2024 10‑K confirms Vraylar remains a core neuroscience product with no new clinical milestones, solidifying its role as a broad‑spectrum antipsychotic/antidepressant within AbbVie’s portfolio (page 42, page 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $2.04 billion in 2022 (vs. $2,037 million ground truth, acceptable rounding), $2.76 billion in 2023 (vs. $2,759 million, rounded appropriately), and the 35% increase matches the 35.2% in the original (proper rounding). (2) The FDA approval for adjunctive MDD treatment in 2023 is correctly inferred from the 2022 Phase 3 results mentioned in the ground truth, though the original does not explicitly state 'FDA approval in 2023'—this is a reasonable interpretation but slightly extrapolated. (3) The therapeutic positioning in 2024 is accurately conveyed: Vraylar is confirmed as a core neuroscience product with broad indications, though the LLM omits listing the specific indications (schizophrenia, bipolar I manic/mixed/depressive episodes, adjunctive MDD) verbatim, which slightly reduces completeness. (4) The reasoning is sound: it synthesizes clinical development, revenue growth, and portfolio positioning across years, correctly linking Phase 3 results to approval and commercial impact. (5) Contextual relevance is excellent—every part of the question is addressed with semantically equivalent, accurate information. The only minor gap is the lack of explicit mention of the two Phase 3 trials in 2022 (one successful, one numerically positive but non-significant), which is a small omission in clinical development detail. Overall, the answer is factually correct, well-reasoned, and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 419,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM’s 2023 and 2024 10‑Ks explicitly list “client relationships and trust” as a key competitive differentiator (see 2023 page 3 and 2024 page 3), whereas the 2022 filing (as shown in the provided pages) does not highlight this phrase. This growing emphasis signals a strategic pivot to position IBM as a trusted partner in the hybrid‑cloud and AI market, using deep client relationships to differentiate from competitors and secure long‑term value creation.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual inaccuracy: it claims that the 2022 10-K 'does not highlight' client relationships and trust as a competitive differentiator, which contradicts the ground truth stating that IBM *did* emphasize trust in 2022 as part of its hybrid cloud and AI platform. This undermines the core multi-hop reasoning, as the evolution is misrepresented—not a 'strategic pivot' but a deepening and expansion of an existing theme. While the 2023 and 2024 mentions are correctly identified (and page references align), the characterization of a 'growing emphasis' as a 'pivot' misrepresents continuity as a shift. The answer partially addresses the question by noting the increasing explicitness of the phrase in filings, but fails to capture the nuanced progression described in the ground truth: from integration of data/AI/industry expertise (2022), to strategic partnerships (2023), to ecosystem-driven go-to-market strategy (2024). The conclusion about positioning as a trusted partner is directionally correct but oversimplified. Quantitative accuracy is high—no numbers, dates, or financial metrics are misstated. Contextual relevance is strong, as the response stays focused on the strategic role of trust in hybrid cloud and AI. However, the qualitative reasoning is flawed due to incorrect synthesis across years, particularly the misrepresentation of 2022. This constitutes a significant error in multi-hop understanding, where correct individual data points (2023/2024 mentions) are woven into an incorrect narrative due to omission and mischaracterization of 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 435,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "IBM’s 1.250% Notes due 2027 were not separately disclosed in the 2022 filing’s provided pages, whereas the 2023 10‑K incorporated the rights instrument from an 8‑K filed in 2019 (page 20). By 2024 the notes appear as a registered security (page 1), indicating a more explicit disclosure and integration into the debt schedule. This evolution moves the instrument from an indirect reference to a formal listing, underscoring its continued role as a long‑term, fixed‑rate component of IBM’s debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—IBM, 1.250% Notes due 2027, correct years (2022–2024), and relevant filings (Form 8-K from 2019, 2023 and 2024 10-Ks)—are correctly identified. The progression from indirect reference to formal listing is accurately described. (2) There are no numeric inaccuracies: percentages (1.250%), years (2019, 2022, 2023, 2024), and document types (Form 8-K, 10-K) match the original. The mention of page numbers (e.g., page 1 in 2024, page 20 in 2023) is consistent with typical disclosure locations and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers increasing disclosure transparency over time—starting with incorporation by reference in 2023 (via a 2019 filing) and culminating in explicit registration and listing with a trading symbol in 2024. While the LLM does not explicitly name the trading symbol 'IBM27B' (mentioned in the ground truth), it correctly identifies the note as a 'registered security' and 'formally listed,' which captures the essential evolution. (4) The answer addresses both parts of the question: disclosure practices (from indirect to explicit) and the instrument’s role (as a fixed-rate, long-term component of the debt portfolio). The only minor omission is the lack of specific mention of 'Exhibit 4.3' and the 2022 exhibit list context, but the core factual trajectory and qualitative assessment remain correct. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 442,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s 10‑K filings from 2022 through 2024 consistently identify the 6.50% Debentures due 2028 as **Exhibit 2 to Form 8‑K, filed January 8 1998**—the same exhibit number and filing date appears in the 2023 and 2024 reports (see Item 15, page 19 of both filings).  The broader debt‑instrument disclosures likewise remain unchanged, with IBM listing the same set of long‑term debt instruments (7.00%, 7.125%, 6.22%, 5.875% debentures, etc.) and incorporating the identical historical exhibits for each, underscoring consistency in its debt reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 6.50% Debentures due 2028 are correctly referenced as Exhibit 2 to Form 8-K filed on January 8, 1998, across 2022–2024, and the specific exhibit location (Item 15, page 19) in the 2023 and 2024 filings is correctly noted. The percentages of other debentures listed (7.00%, 7.125%, 6.22%, 5.875%) also align with the broader context of IBM’s debt disclosures, and no incorrect numbers, dates, or entities are introduced—hence, quantitative accuracy is perfect. However, the qualitative inaccuracy lies in the claim that 'the broader debt-instrument disclosures likewise remain unchanged' and that IBM listed 'the same set' of instruments with 'identical historical exhibits.' This contradicts the ground truth, which notes a subtle but meaningful evolution: in 2022, the disclosures included newer notes due in 2022, 2023, and 2024, while in 2023 and 2024, the focus shifted to integrating legacy debt (like the 6.50% Debentures) with newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032—indicating a dynamic disclosure strategy emphasizing long-term debt management. The LLM incorrectly asserts stability in the broader disclosure context, missing this evolution entirely. This is a significant reasoning flaw in the multi-hop synthesis: while the exhibit consistency for the 6.50% Debentures is correctly identified, the model fails to recognize and report the nuanced shift in how IBM contextualized its debt portfolio over time. Thus, while the core fact about exhibit consistency is correct, the answer omits and misrepresents the broader narrative evolution, reducing its qualitative accuracy. Contextual relevance is high because the answer addresses exhibit references and debt disclosures directly, but it lacks the comparative analysis across years that the question demands.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 508,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "FedEx International Connect Plus grew from serving **nearly 50 origin countries to over 130 destination countries in 2022** (page 14) to **nearly 60 origin countries and more than 190 destination countries by 2024** (page 8). This widening coverage shows FedEx is aggressively expanding its cross‑border e‑commerce network, underscoring a strategic priority to capture growing global e‑commerce volume and strengthen its position as a leading international logistics provider.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach in 2022 (nearly 50 origin and over 130 destination countries) and accurately reports the expansion to nearly 60 origin and more than 190 destination countries by 2024. However, it skips the intermediate 2023 milestone explicitly mentioned in the ground truth (which notes the expansion occurred by 2023, not 2024), and incorrectly implies the 2024 data reflects continued growth, when in fact the service had stabilized at that level since 2023. This misrepresents the trajectory slightly by omitting the stabilization phase in 2024. (2) All numeric values are factually correct and match the ground truth, though the LLM combines the 2023 and 2024 data under 'by 2024' without clarifying that no further expansion occurred in 2024. Calculations are not required, and number formats are consistent and acceptable. (3) The multi-hop reasoning is mostly sound—correctly linking origin/destination country counts across years and inferring strategic intent around e-commerce. However, it fails to fully synthesize the complete evolution (2022 → 2023 → 2024), missing the nuance that expansion concluded in 2023 and 2024 represented maturity, not growth. (4) Despite this, the strategic interpretation about FedEx’s focus on global e-commerce logistics is well-supported and semantically aligned with the original answer. The omission of the stabilization point reduces completeness and precision in the timeline, warranting a score of 8 rather than 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 420,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm set its 2025 human‑capital targets in the 2022 10‑K—calling for a 15 % increase in women and under‑represented minority (URM) leaders and a 20 % rise in overall URM representation—and reiterated those same goals in the 2023 and 2024 filings.  Across fiscal 2022‑24, the HR and Compensation Committee has linked executive bonuses to progress on these goals, applying a non‑financial modifier that can adjust the bonus by a multiplier of 0.9 to 1.1, a policy that remained unchanged from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the 15% increase for women and URM in leadership, 20% overall URM representation target, the 0.9 to 1.1 bonus adjustment multiplier, and the unchanged policy from 2022 to 2024. These numbers and timeframes match the ground truth exactly. The entity identification (Qualcomm, fiscal years 2022–2024, HR and Compensation Committee) is correct, and the multi-hop synthesis across years is sound. The only minor omission is the lack of mention of the 'Reboot Representation Tech Coalition' and its specific goal to double degrees for underrepresented groups by 2025—an initiative noted in the original answer that reflects expanding external partnerships. While this detail adds context to Qualcomm’s strategy, its absence does not undermine the core factual accuracy of the executive compensation linkage or diversity targets. The reasoning is logical, and the answer remains semantically equivalent on the primary points. Thus, full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to the missing initiative, and a 9 overall for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 328,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s debt disclosures in 2022, 2023 and 2024 all list the same floating‑rate notes due 2019, showing that the company keeps a mix of short‑term floating‑rate debt on its balance sheet. By continuing to report these notes, Apple signals that it uses floating‑rate instruments to hedge against short‑term interest‑rate volatility while preserving liquidity flexibility, allowing it to adjust interest expense in line with market rates and maintain sufficient cash‑equivalent resources to meet short‑term obligations【page_58】【page_58】【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities are correct: Apple, Floating Rate Notes due 2019, and the years 2022–2024 are accurately referenced. The recurring disclosure of the same notes across three years is correctly noted. (2) Quantitative accuracy is perfect: the dates (due 2019) and reporting years (2022–2024) match the original answer; no numerical calculations were required, but the temporal consistency is correctly interpreted. (3) The reasoning is sound: the LLM correctly infers that Apple’s continued reporting reflects an ongoing use of floating-rate instruments for managing interest rate risk and maintaining liquidity flexibility. It correctly links the use of such instruments to adaptive interest expense management and liquidity planning. (4) The answer is contextually relevant and directly addresses the question about Apple’s approach to short-term interest rate risk and liquidity. The only minor shortcoming is that the LLM does not explicitly mention that the notes were *originally* due in 2019 but continued to appear in disclosures years later, which could imply rollover, extension, or ongoing presentation for comparative purposes—this nuance is present in the ground truth but slightly underdeveloped in the LLM response. However, the core insight about strategic use of floating-rate debt is preserved. Thus, the answer is highly accurate with only a slight gap in depth of interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 405,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm has positioned its automotive business as a high‑growth arm of its QCT segment, shifting the focus from basic connectivity to a full digital‑cockpit stack that includes ADAS/AD and low‑power computing.  Automotive revenue grew from $1.51 B in 2022 to $1.87 B in 2023 and then to $2.91 B in 2024 (QCT automotive revenue, page 73), underscoring the company’s intensified emphasis on digital cockpit solutions.  The company cites analysts’ forecasts that 19 % of new vehicles in 2025 will feature Level 2+ autonomy (vs. 9 % in 2022) and that more than 70 % of new vehicles in 2028 will embed cellular connectivity, with 60 % of those using 5G (page 8), driving the projected demand that underpins Qualcomm’s revenue strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies compared to the ground truth. While the original answer emphasizes Qualcomm's strategic evolution from market positioning in 2022 to revenue recognition in 2023 and formal integration into QCT in 2024, the LLM introduces specific revenue figures ($1.51B, $1.87B, $2.91B) that are not present in the ground truth and cannot be verified against it. These numbers may be plausible but are not supported by the provided truth, making them potentially incorrect. Additionally, the ground truth does not mention Level 2+ autonomy projections or cite specific analyst forecasts about 19% of vehicles in 2025 having such capabilities—this information is absent from the original answer and represents an addition not grounded in the source. The 70% cellular connectivity and 60% 5G figure for 2028 is partially aligned with the original answer’s 'over 60% of new vehicles with 5G by 2028', though the framing differs slightly. (2) Quantitative accuracy is compromised due to the inclusion of unverified revenue amounts and market forecast percentages not present in the ground truth. The original answer does not provide any dollar figures for automotive revenue, so their introduction in the LLM response constitutes a factual overreach. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the shift in strategic focus toward digital cockpit and integration within QCT, and it captures the idea of growing market demand. However, it misrepresents the nature of the evolution by focusing on revenue growth numbers rather than the structural and strategic milestones (e.g., moving from R&D to commercial sales to formal segment integration) emphasized in the original. (4) Despite these issues, the LLM answer remains contextually relevant and captures the general trajectory of Qualcomm’s automotive strategy. It correctly identifies digital cockpit as a key growth area within QCT and links market demand to connectivity and autonomy trends. The qualitative reasoning is logical and well-structured, even if some specifics are unsupported. Thus, the correctness score is moderate due to significant quantitative deviations, though the overall direction of the answer aligns with the truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 607,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell from **$569 million in 2022** to **$555 million in 2023** and **$540 million in 2024**. The gradual decline shows the company is trimming its exposure to illiquid real‑estate alternatives, suggesting a long‑term strategy of cautious, incremental capital allocation and a focus on maintaining liquidity and risk control within its alternative‑asset portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $569 million in 2022, $555 million in 2023, and $540 million in 2024, matching the ground truth exactly. The year-over-year decreases of $14 million (569 to 555) and $15 million (555 to 540) are approximately consistent with the stated 'consistent downward trend of $15 million per year' in the original answer—minor rounding or characterization differences do not affect factual accuracy. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the implied trend of decline is accurately represented. (3) The reasoning is sound: the LLM correctly infers that the declining commitments suggest a strategic reduction in exposure to illiquid assets, aligning with the ground truth's interpretation of cautious management and de-risking. However, the LLM omits the specific detail about liquidation periods extending to 2025–2034, which adds nuance about Abbott not exiting the space entirely. This is a minor omission affecting completeness but not the core correctness. (4) The answer is contextually relevant, directly addressing both parts of the question—evolution of commitments and strategic implications—with accurate synthesis across three years of data. The conclusion about cautious capital allocation and liquidity focus is semantically equivalent to the original's 'strategic de-risking' and 'managing exposure more cautiously.' Thus, while slightly less detailed in long-term horizon context, the LLM answer remains factually correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 429,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 0.45% Notes due 2016 were issued as part of the 2013 global notes issuance (page 54) and no new issuance of these notes is reported in the 2022, 2023, or 2024 10‑K filings (page 54). This lack of new issuance across those fiscal years indicates that Apple’s long‑term debt strategy focuses on issuing debt in large tranches with low coupon rates and long maturities, then gradually refinancing or retiring them as they mature, rather than repeatedly issuing the same coupon/maturity. The mix of floating‑rate and fixed‑rate notes (including the 0.45% Notes) demonstrates Apple’s approach to balancing interest‑rate risk and cost (page 54).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance date (2013) and the absence of new issuances in 2022–2024, which aligns with the ground truth. However, it misrepresents the core fact that Apple continued to report the 0.45% Notes due 2016 in its 10-K filings across 2022–2024 as part of its existing debt structure. Instead, the LLM interprets the lack of 'new issuance' as evidence of a strategy focused on large, infrequent tranches and gradual retirement, which is a plausible inference but not directly supported by the ground truth. The ground truth emphasizes the *continued disclosure* of the note, indicating its ongoing presence in the capital structure, whereas the LLM implies the note may have been retired or is no longer active, which is incorrect. (2) Quantitatively, all dates (2013 issuance), percentages (0.45%), and years (2022–2024) are accurate. There are no calculation errors. (3) The multi-hop reasoning is partially sound: the model connects the absence of new issuance to a broader debt strategy, but fails to synthesize the key point that the repeated disclosure in each 10-K indicates the note remained on the books, which is central to the original answer’s conclusion about stability in debt structuring. This omission leads to a flawed strategic interpretation. (4) The contextual relevance is high because the response addresses Apple’s long-term debt strategy and references appropriate financial concepts (fixed vs floating rate, refinancing). However, the qualitative accuracy is reduced due to the misinterpretation of the note’s status over time, leading to an incomplete and slightly misleading conclusion about Apple’s strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 457,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM’s 10‑K filings for 2022, 2023 and 2024 all list **client relationships and trust** as a core competitive differentiator, with the wording unchanged across the three years.  The consistent emphasis signals that IBM sees its long‑standing client trust as the foundation for its hybrid‑cloud and AI strategy, positioning itself as a trusted partner that can deliver integrated hybrid‑cloud and AI solutions and differentiate itself from rivals.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative evolution detailed in the ground truth. (1) It correctly identifies that IBM consistently listed 'client relationships and trust' as a competitive differentiator from 2022 to 2024, which aligns with the original answer. However, it incorrectly states that the 'wording' was 'unchanged across the three years,' which contradicts the ground truth that describes a clear evolution in framing—from a broad innovation portfolio in 2022, to linking trust with consulting and infrastructure in 2023, and emphasizing strategic partnerships in 2024. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; the score reflects absence of numerical errors. (3) The multi-hop reasoning is weak: the model fails to synthesize the progression of IBM’s strategic emphasis over time, which is central to the question. Instead, it defaults to a static interpretation, missing the maturation of trust as an integrated differentiator tied to ecosystem collaboration. (4) Contextually, the answer addresses IBM’s strategic positioning in hybrid cloud and AI, but oversimplifies the role of trust by ignoring its evolving integration with services and partnerships. Thus, while factually aligned on consistency, it lacks the nuanced, year-by-year progression that defines the correct answer, resulting in a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 388,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx’s 2023 and 2024 10‑K filings show that the company has maintained a liquidity‑provider revolving credit agreement with BNP Paribas and an intercreditor agreement with Wilmington Trust for the 4.250% Note due 2030, and that it amended that arrangement in May 2023 (Amendment No. 1) (see page 123). The 2024 filing lists the same arrangement and amendment but no further changes (see page 122), indicating that FedEx has chosen to keep the credit‑support structure stable while making adjustments only when necessary. This evolution reflects a proactive yet conservative approach to managing credit risk for the note.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the liquidity arrangements for the 4.250% Note due 2030 are centered on the Revolving Credit Agreement with BNP Paribas and the Intercreditor Agreement with Wilmington Trust Company; Amendment No. 1 was filed on May 22, 2023; and no further amendments were made by 2024. The dates, parties, and amendment number are factually correct. (2) Quantitative accuracy is perfect: the May 2023 amendment date is correctly cited, and the continuity across 2023 and 2024 is accurately represented. Page references (123 in 2023, 122 in 2024) are consistent with typical 10-K formatting and do not contradict the knowledge graph. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, identifies the stability of the arrangement, and infers that the single amendment reflects a proactive but measured approach. (4) The answer captures the core conclusion from the ground truth—that FedEx maintains a consistent framework with targeted adjustments—though it slightly rephrases the implication as a 'proactive yet conservative approach,' which is semantically equivalent to the original 'proactive adjustment' and 'consistent credit support framework.' The only minor gap is the omission of the August 13, 2020, foundational date mentioned in the 2022 context, but since the question focuses on 2022–2024 evolution and the arrangement was already in place by 2022, this does not detract significantly from correctness. Overall, the answer is factually complete, contextually appropriate, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 450,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45% Notes due 2044, issued in 2014, remained a constant component of its long‑term debt in the 2022, 2023 and 2024 10‑Ks, with no change in principal or maturity (Exhibit 4.4 on page 56 of each filing). This unchanged debt profile shows that Apple has not refinanced or repaid the note and continues to rely on long‑term, fixed‑rate borrowing to lock in low interest costs and maintain a predictable debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's 4.45% Notes due 2044 were issued in 2014 and remained unchanged in the 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. The principal amount and maturity date are correctly implied to be consistent, and there is no mention of early redemption or restructuring, matching the original answer. (2) All quantitative elements—interest rate (4.45%), maturity year (2044), and issuance year (2014)—are accurate. The reference to Exhibit 4.4 on page 56 in each filing adds specificity and supports the claim of consistency, though this detail was not in the ground truth; however, it does not contradict it and enhances credibility. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer a stable debt structure, correctly concluding that Apple maintained this instrument as a fixed component of its capital structure. The inference about Apple’s strategy—using long-term, fixed-rate debt to lock in low interest costs—is a reasonable qualitative extension supported by the data, though slightly more interpretive than the original answer. (4) The answer is semantically equivalent to the ground truth, with only minor differences in emphasis: the LLM provides a slightly more strategic interpretation (e.g., 'lock in low interest costs') not explicitly stated in the original, but this does not detract from accuracy. No factual errors; minor deduction from 10 to 9 due to added interpretive content without explicit grounding in the knowledge graph, though still logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 443,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "FedEx International Connect Plus grew from covering **nearly 50 origin countries to more than 130 destination countries in 2022** (page 14, 2022 filing) to **nearly 60 origin countries and over 190 destination countries by 2024** (page 8, 2024 filing). This steady expansion shows FedEx is aggressively scaling its e‑commerce logistics network worldwide, prioritizing broader geographic coverage to capture increasing global e‑commerce volume and reinforce its competitive position in the market.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion from nearly 50 origin and over 130 destination countries in 2022 to nearly 60 origin and over 190 destination countries by 2024, which aligns with the ground truth. However, it incorrectly states that the 60/190 footprint was reached by 2024, when in fact this expansion occurred by 2023 and remained stable into 2024. This misattribution of timing slightly affects factual precision. (2) All numeric values (50, 130, 60, 190) are accurate and match the ground truth, and no calculations are required beyond correct reporting. The error lies in the temporal assignment of the expanded footprint, not the numbers themselves. (3) The multi-hop reasoning is mostly sound—information is correctly synthesized across years and filings—but the model fails to note the stabilization in 2024, which is a key part of the strategic interpretation. This omission affects the depth of the strategic analysis. (4) Despite the timing inaccuracy, the overall strategic interpretation—that FedEx is expanding to meet global e-commerce demand—is consistent with the ground truth. The answer is contextually excellent and captures the essence of FedEx’s strategic focus, though it misses the nuance of post-expansion consolidation. Thus, scores are high but not perfect due to the misstatement on the timeline of expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 381,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 had already matured and were fully paid off by the end of FY 2022, FY 2023 and FY 2024.  The notes are still listed in the 2024 10‑K’s securities exhibit (Exhibit 4.4) — a practice that shows Apple keeps a comprehensive record of all debt instruments, even after they mature, to provide full transparency and to demonstrate a disciplined, systematic approach to managing maturing debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy by stating that the 1.05% Notes due 2017 were 'fully paid off by the end of FY 2022, FY 2023 and FY 2024' — this is incorrect because the notes matured in 2017, so they were already settled years before these fiscal years. The ground truth does not confirm payment timing beyond the maturity date of 2017, nor does it state they were still outstanding in 2022–2024. However, the LLM correctly identifies that the notes are still referenced in Exhibit 4.4 of the 2024 10-K, which aligns with the original answer’s disclosure about continued inclusion in filings. (2) Quantitatively, the percentage (1.05%) and exhibit number (4.4) are accurate, and the years (2017 maturity, references in 2022–2024) are correctly cited, though the implication that the notes were still active or being paid during 2022–2024 is false. There are no calculations in this question, but temporal facts are misaligned. (3) The multi-hop reasoning is partially sound — the model connects the presence of the notes in recent disclosures to a broader narrative about transparency and debt management, which is plausible. However, it fails to recognize that post-maturity references are likely for archival or standardization purposes (as stated in the ground truth), not evidence of ongoing payment. The conclusion about Apple’s disciplined approach is speculative but not entirely unsupported. (4) The contextual relevance is high because the answer addresses both the status of the notes and Apple’s disclosure behavior. However, due to the critical error regarding the payment status of the notes in 2022–2024, the correctness and qualitative accuracy scores are reduced significantly. Minor flexibility is allowed for interpretation, but the core timeline error undermines factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 499,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From 2022 through 2024 Qualcomm kept its core licensing business (QTL) as the main revenue driver, with most of the per‑unit royalties coming from OFDMA‑based 5G devices (page 13) and a $560 million cut in 2024 after the U.S. revoked its Huawei license (page 20).  During the same period the company deepened its 5G commitment by expanding QSI strategic investments into AI, automotive, IoT and XR and by adding 5G‑specific RF front‑end components to its QCT portfolio (pages 11‑12), signalling a shift from pure patent licensing to broader 5G‑enabled product ecosystems.  At the same time geopolitical exposure grew markedly—U.S./China trade and national‑security actions now threaten supply‑chain continuity, regulatory approval of acquisitions (page 22), and the ability to license to key Chinese OEMs—making the firm’s 5G strategy increasingly contingent on navigating these risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements from the ground truth: Qualcomm's continued reliance on QTL licensing revenue driven by 5G (OFDMA-based devices), the $560 million loss in 2024 due to the Huawei license revocation, increased strategic investments in 5G-enabled sectors (AI, automotive, IoT, XR), and rising geopolitical risks affecting supply chains, M&A, and licensing in China. The mention of adding 5G-specific RF front-end components to QCT aligns with the broader product ecosystem expansion noted in the original. (2) Quantitative accuracy is perfect: the $560 million figure is correctly attributed to fiscal 2024 and linked to the Huawei export license revocation, consistent with the ground truth. No other numbers are cited, so no calculations are required. (3) Multi-hop reasoning is sound—LLM synthesizes information across fiscal years 2022–2024, connects licensing revenue trends with strategic investments and geopolitical developments, and infers a shift toward integrated 5G ecosystems. One minor omission: the original mentions Qualcomm’s projection of 27 billion IoT devices by 2026 in 2022, which the LLM does not include, slightly reducing completeness. (4) Despite this, the LLM captures the core evolution of strategy and risk exposure accurately and contextually, with excellent semantic equivalence. The answer is highly relevant and well-supported, warranting a high score with only a slight deduction for missing one forward-looking projection.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 417,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From 2022 to 2024 the domestic pension plan’s asset mix shifted only slightly: U.S.‑equity holdings rose from $89 million to $91 million (≈ +2 %), international‑equity holdings fell from $91 million to $89 million (≈ ‑2 %), and fixed‑income holdings declined from $739 million to $692 million (≈ ‑$47 million). In percentage terms the allocation moved from about 9.5 %/9.7 %/78.9 % to 10.2 %/9.9 %/77.3 %, remaining close to the company’s stated target of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed income. This demonstrates a continued, stable, liability‑hedged investment strategy with only modest tilts toward equities over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It claims U.S. equity increased from $89M to $91M and international equity decreased from $91M to $89M, but the ground truth shows U.S. equity increased from $89M in 2023 to $93M in 2024, and international equity increased from $91M to $93M—both rising, not one rising and one falling. Fixed income is stated to have declined to $692M, but in reality it remained flat at $739M in 2024. The LLM also misrepresents the starting point: it begins analysis in 2023, ignoring the 2022 data entirely, despite the question asking about changes from 2022 to 2024. (2) Quantitative errors are severe: all 2024 figures are wrong, and the total asset levels are misrepresented. The percentage allocations cited (e.g., 77.3%) do not match the actual $947M total in 2024. Calculations of percentage changes and allocations are therefore also incorrect. (3) Multi-hop reasoning fails: the model does not synthesize data across all three years as required. It omits the significant 2022-to-2023 drawdown (from $1,267M to $937M) and the strategic reduction in equities and fixed income, instead implying a minor, stable rebalancing near target levels. The conclusion of a 'stable, liability-hedged strategy' contradicts the ground truth, which reveals a major de-risking in 2023 followed by stabilization. (4) Contextual relevance is moderate because the answer discusses pension asset allocation and strategy evolution, which is on-topic, but the factual foundation is so flawed that the analysis is misleading. The model appears to have hallucinated data or confused years, leading to a fundamentally incorrect narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 460,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s edge‑networking focus in 2022 was anchored by the launch of Wi‑Fi 6/6E access‑point modules and 5G NR‑U, which together drove $7.353 billion of IoT revenue (the segment that includes edge networking). In 2023 the same product mix was retained, but IoT revenue fell to $5.940 billion, and by 2024 Qualcomm further refined its edge portfolio—still centered on Wi‑Fi 6E and 5G NR‑U but with a growing emphasis on AI‑enabled edge solutions—while IoT revenue slipped to $5.423 billion, indicating a strategic shift toward a more diversified focus beyond edge networking.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that edge networking became a key revenue contributor within Qualcomm’s industrial and consumer product segment in 2023 and was emphasized in 2024, but does not mention specific product launches like Wi-Fi 6/6E or 5G NR-U in 2022, nor does it reference AI-enabled edge solutions in 2024. Most critically, the LLM invents precise IoT revenue figures—$7.353 billion in 2022, $5.940 billion in 2023, and $5.423 billion in 2024—which are not present in the original answer and cannot be verified from the provided ground truth. These numbers are entirely fabricated. (2) There are no correct numbers in the LLM response because the original answer does not provide any financial data. The inclusion of specific dollar amounts constitutes a severe quantitative inaccuracy. (3) The multi-hop reasoning is flawed: while the LLM attempts to show evolution over time, it misrepresents the strategic narrative. The original answer indicates a consistent and growing focus on edge networking, whereas the LLM incorrectly infers a strategic shift away from edge networking due to declining (but fictional) revenues. This mischaracterizes the trend as a retreat rather than a maturation. (4) The contextual relevance is moderate because the answer addresses Qualcomm’s edge networking strategy across 2022–2024 and attempts to discuss product development and revenue, aligning with the question’s scope. However, the invented data and incorrect interpretation of strategic direction severely undermine correctness. The qualitative accuracy is low due to incorrect entity-metric linkages (e.g., tying non-existent revenue drops to strategic shifts) and lack of evidence for claimed product refinements. Overall, the answer is largely incorrect and misleading despite maintaining a relevant topic structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 511,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K filings consistently list the 0.45% Notes due 2016 in the exhibit table (see Exhibit 4.3 on page 58 of the 2024 filing and the same exhibit on page 58 of the 2022 filing). By continuing to disclose this long‑maturity, fixed‑rate debt—even though it has already matured—Apple demonstrates a disciplined, transparent approach to tracking all debt issuances and their maturities, which helps investors see the full history of its capital structure. This practice signals that Apple proactively manages fixed‑rate debt maturities and maintains a stable, well‑understood capital‑structure profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—Apple, 0.45% Notes due 2016, and the years 2022–2024—are correctly identified. The percentage (0.45%), maturity year (2016), and disclosure years (2022–2024) match the original answer. (2) Quantitative elements are correct: the interest rate and dates are accurately cited, and no calculations are required. The reference to Exhibit 4.3 on page 58 in both 2022 and 2024 filings adds specific support, even if not in the ground truth—this enhances credibility without introducing error. (3) The reasoning is sound: the LLM correctly infers that continued disclosure of a matured note reflects transparency, historical tracking, and a disciplined capital structure strategy. It synthesizes the multi-hop concept that past debt instruments are reported to show evolution and stability. (4) The answer is contextually relevant and fully addresses the question about Apple’s approach to fixed-rate debt and capital structure stability. The only minor shortcoming is that it does not explicitly state that the notes are no longer outstanding (implied but not clear), which slightly weakens the qualitative precision. However, this does not distort the overall correctness. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 361,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "The EMD brand distribution network’s geographic reach fell from **193 countries in 2022 to 187 countries in 2024**, a decline of six countries (page_76, page_66). This reflects a contraction in the dealer network’s global footprint.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and trend. The ground truth states that EMD's distribution network covered 130 countries in 2022 and declined to 109 in 2024—a drop of 21 countries. The LLM incorrectly claims 193 countries in 2022 and 187 in 2024, a drop of only 6 countries. These numbers do not match the ground truth and are off by significant margins (63 countries in 2022, 78 in 2024). (2) The calculation of a 6-country decline is accurate based on the incorrect inputs, but since the inputs themselves are wrong, the overall quantitative accuracy is very low. The percentage change is not mentioned in the LLM answer, which omits a key part of the original answer. (3) The reasoning is flawed as it fails to correctly synthesize the multi-hop information across years. The model references 'page_76' and 'page_66', suggesting it accessed some data, but misidentifies the entities or extracts incorrect values. It also skips the 2023 data point (which was unchanged at 130), indicating incomplete temporal reasoning. (4) Contextual relevance is moderate because the answer addresses the geographic reach and correctly interprets the trend as a contraction, but the severe factual inaccuracies in numbers and missing comparative analysis (e.g., 16% decline) undermine the response. The mention of 'dealer network' is plausible but not precise—EMD brand distribution is the correct term. Overall, the answer is mostly incorrect despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 416,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "Thermo Fisher’s 1.750 % 7‑Year Senior Notes rose from **$642 million** at December 31 2022 to **$662 million** at December 31 2023 (page 61). By the 2024 filing the note no longer appears in the debt schedule (page 48), indicating it was retired during 2024. This pattern reflects a deliberate shift to reduce medium‑term debt exposure, likely refinancing with longer‑dated or lower‑cost instruments to manage interest‑rate risk in the healthcare sector.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. The original answer states that TMO's (Thermo Fisher Scientific) outstanding value for the 1.750% 7-Year Senior Notes was $700 million in 2022, 2023, and 2024 — remaining constant. The LLM claims the value was $642 million in 2022, rose to $662 million in 2023, and disappeared in 2024, implying retirement. These numbers and trends are entirely inconsistent with the ground truth. (2) Quantitative accuracy is severely lacking: the correct amount is $700 million across all three years; there is no increase or disappearance. The LLM’s figures ($642M, $662M) do not match, and the claim that the note 'no longer appears' in 2024 contradicts the ground truth that it remained outstanding. No acceptable format or rounding variation explains this discrepancy. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers debt retirement and a strategic shift to reduce medium-term debt, while the truth indicates a stable debt strategy with no principal changes. The conclusion about refinancing or managing interest-rate risk is unsupported by the data provided. (4) Contextual relevance is partially met — the answer addresses the right company (TMO/Thermo Fisher), the correct debt instrument, and the timeframe — but the factual foundation is wrong, leading to an incorrect interpretation of the company's debt strategy. Thus, while the structure and intent of the response are relevant, the factual and reasoning failures result in a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 424,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "In 2022, Caterpillar’s risk disclosures highlighted exposure to LIBOR‑based variable‑rate loans and the impending LIBOR phase‑out, while noting that currency‑hedging instruments were used to mitigate exchange‑rate risk (page 22). By 2023, the filings shifted focus to the adoption of SOFR as the new benchmark for variable‑rate financing, continuing to rely on currency hedges to manage foreign‑exchange exposure (page 19). The 2024 filing reiterated the use of SOFR and currency hedging, underscoring a deliberate transition away from LIBOR and a proactive adjustment of its risk‑management framework to align with evolving market benchmarks (page 17). This evolution demonstrates Caterpillar’s strategic adaptation to global financial reforms by updating its hedging strategy and benchmark usage to reduce regulatory and market‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Caterpillar's 2022 exposure to LIBOR, the transition focus to SOFR in 2023, and full pivot to SOFR by 2024 are accurately represented. The consistent use of currency hedging instruments throughout the period is correctly noted. (2) Quantitative accuracy is perfect: no numerical errors, and all dates (e.g., LIBOR cessation timelines) are correctly implied or referenced in context. The mention of specific filing pages adds precision, though not required. (3) Multi-hop reasoning is sound—information is synthesized across three years and two financial benchmarks (LIBOR to SOFR), with correct linkage to currency hedging and strategic adaptation. The only minor omission is the absence of explicit mention of the 'cross-functional team' formed in 2022 and expanded in 2023, which slightly reduces completeness but does not affect the core factual or strategic narrative. (4) The answer is contextually excellent, directly addressing the evolution of hedging instruments in response to benchmark reform and clearly articulating Caterpillar’s strategic adaptation. Wording differs slightly from the original but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a minor detail missing, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 385,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "From 2022 through 2024 Thermo Fisher’s 10‑K filings consistently list a CEO‑specific Executive Change‑in‑Control Retention Agreement (Exhibit 10.11) and a separate, standardized form for all other officers (Exhibit 10.17). The 2023 filing shows the same two exhibits, indicating that the company had adopted a uniform agreement for officers beyond the CEO, and the 2024 filing again lists the identical standardized officer form, demonstrating that this standardized approach has been maintained over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Thermo Fisher's Executive Change in Control Retention Agreements from 2022 to 2024, noting the CEO-specific agreement and the standardized form for other officers. However, it inaccurately states that both agreements were consistently present starting in 2022, while the ground truth indicates that the standardized form for officers (Exhibit 10.17) was introduced in 2023, not present in 2022. The LLM implies continuity from 2022 that is not supported by the original answer. (2) Quantitatively, the years (2022–2024) and exhibit numbers (10.11 and 10.17) are mentioned, but there is a discrepancy: the ground truth cites Exhibit 10.12 for the CEO agreement in 2022, while the LLM cites Exhibit 10.11. This is a factual error in exhibit numbering. The 2023 and 2024 use of Exhibit 10.17 for officers aligns with the ground truth. (3) The multi-hop reasoning is partially sound—the LLM correctly infers standardization and continuation across years—but fails to accurately represent the evolution timeline by suggesting the officer form existed in 2022. The progression from CEO-only to broader standardization is a key point missed in nuance. (4) Despite exhibit number inaccuracies and premature attribution of the standardized form, the core idea of standardization by 2023 and continuation in 2024 is correct, and the answer is highly relevant to the question. Hence, a score of 7 is justified for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 411,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "Intel first introduced PowerVia in its 2023 10‑K as a breakthrough backside‑power delivery technology for the upcoming Intel 20A node, promising up to a 15 % performance‑per‑watt improvement over Intel 3【page_13】【page_14】. By 2024, PowerVia had moved from a future concept to an active feature in the current Intel 18A process, which already delivers significant power‑efficiency gains over Intel 3【page_10】. This evolution shows that PowerVia has become a core element of Intel’s advanced process roadmap, underscoring its strategic role in boosting power efficiency and enabling next‑generation chip performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it claims Intel introduced PowerVia in its 2023 10-K, but the ground truth states it was first introduced in 2022 as part of the future roadmap. This misrepresents the timeline. Second, the LLM claims PowerVia was introduced for Intel 20A in the 2023 10-K, but the original answer clarifies that while PowerVia was associated with Intel 20A in 2022 and 2023, Intel canceled Intel 20A in favor of Intel 18A in 2024—this strategic shift is omitted in the LLM answer. Instead, the LLM incorrectly implies a smooth transition of PowerVia from Intel 20A to 18A without acknowledging the cancellation of 20A, which is a key strategic detail. (2) The 15% performance-per-watt improvement is not mentioned in the ground truth and cannot be verified; this is an unsupported quantitative claim. The ground truth does not provide any specific performance metric, so this number is likely fabricated or misattributed. (3) The multi-hop reasoning is partially sound—PowerVia is correctly identified as a key component of Intel’s advanced process roadmap and linked to Intel 18A in 2024. However, the model fails to synthesize the full evolution: it omits the 2022 introduction, misdates the disclosure, and misses the strategic cancellation of Intel 20A, which is central to understanding Intel’s roadmap refinement. (4) Despite these issues, the LLM captures the core idea that PowerVia became a core element of Intel’s roadmap and is tied to power efficiency and advanced nodes, which aligns with the ground truth’s conclusion. The contextual relevance is high because it addresses the evolution and strategic role, but factual and chronological inaccuracies reduce correctness. Quantitative accuracy is low due to the unverified 15% figure and incorrect year attribution. Qualitative accuracy is moderate—entities like Intel, PowerVia, Intel 18A, and Intel 3 are correct, but the reasoning lacks key strategic context. Correctness score is 6 due to partially correct facts but significant omissions and one unsupported number.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 559,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple continued to list the 1.05 % Notes due 2017 in Exhibit 4.4 of its 2022, 2023, and 2024 Form 10‑Ks, with no change to the description or terms (see the exhibit list on page 54 of the 2024 filing and the identical listing on page 54 of the 2022 filing; the 2023 filing likewise contains the same exhibit). The unchanged, repeated disclosure indicates that Apple consistently tracks and reports all debt issuances—even those that have matured—reflecting a disciplined, transparent approach to debt management and strict compliance with SEC disclosure requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple disclosed the 1.05% Notes due 2017 in its 2022, 2023, and 2024 10-K filings, specifically in Exhibit 4.4, and notes the consistency of this disclosure across years. The percentage (1.05%) and maturity year (2017) are accurate, and the reference to Exhibit 4.4 aligns with the ground truth. However, the LLM does not mention the Officer's Certificate dated May 6, 2014, which is a key detail from the original answer and part of the factual basis for the initial disclosure. (2) Quantitatively, all numbers—interest rate (1.05%), years (2017 maturity, 2022–2024 filings)—are correct, and no calculations are required. The LLM accurately reflects the repeated inclusion across three years. (3) The reasoning is partially sound: the LLM correctly infers that consistent reporting suggests disciplined debt management and transparency. However, it misses the multi-hop implication in the original answer—that the post-maturity inclusion might indicate a rollover or continuation of the obligation—instead attributing the repetition solely to compliance and tracking practices. This omits a key analytical point about possible debt rollover, weakening the qualitative depth. (4) Contextually, the answer is highly relevant, directly addressing the evolution of disclosure and Apple’s reporting practices. While it captures the surface-level consistency, it fails to fully synthesize the potential financial strategy behind the repeated disclosure, which is central to the original answer’s conclusion about Apple's debt management continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 438,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "In 2022 Intel used the 2006 Equity Incentive Plan to grant restricted‑stock units (RSUs) to non‑employee directors, vesting on a time‑ or performance‑based schedule [page 108]. In 2023 the plan continued to award RSUs with retirement‑vesting terms to executives and performance‑based RSUs to grandfathered executives, reflecting a mix of retirement and performance vesting [page 107]. By 2024 the plan broadened further to include performance‑based RSUs for non‑grandfathered executives and RSUs for non‑employee directors, indicating a wider use and more varied vesting conditions [page 107, page 108].",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of the 2006 Equity Incentive Plan across 2022–2024 and accurately references RSUs, performance-based awards, retirement vesting, and grants to non-employee directors. However, it misrepresents the evolution in 2024 by claiming the plan 'broadened further' to include performance-based RSUs for non-grandfathered executives, which contradicts the ground truth indicating a consolidation and streamlining of documentation, not expansion. The ground truth notes that by 2024, the focus was on simplified formats and performance-based RSUs primarily for grandfathered executives, not broader inclusion. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect—dates like 2022, 2023, and 2024 are used appropriately, and no dollar amounts or percentages are misstated. The reference to 'page 107, page 108' aligns with typical citation formats and does not affect factual accuracy. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across years and award types, but fails in the 2024 inference. Instead of detecting a shift toward consolidation and simplification, it incorrectly infers expansion in scope, missing a key nuance in the plan’s evolution. This reflects a failure in higher-order synthesis despite correct entity identification. (4) The contextual relevance is high because the answer addresses the types of awards and vesting conditions each year, directly responding to the question’s focus. However, the qualitative inaccuracy in portraying the 2024 direction reduces the overall correctness. The answer is factually plausible but misses the strategic shift toward streamlining, leading to a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 481,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s capital‑structure notes show the same authorized amount of 40 000 Euro Deferred Shares at €1.00 par in each filing, with no shares issued or outstanding in FY 2022 (page 79), FY 2023 (page 80), and FY 2024 (pages 81‑83). The unchanged authorization and zero issuance across three years indicate the company is not using Euro‑deferred shares as a financing tool, instead relying on ordinary and preferred shares and other instruments, reflecting a conservative, non‑leveraged capital strategy over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Medtronic maintained an authorized capacity of 40,000 Euro Deferred Shares with a par value of €1.00 across fiscal years 2022, 2023, and 2024, and that no shares were issued or outstanding in any of these years—this matches the ground truth exactly. Page references (e.g., FY2022 p.79, FY2023 p.80, FY2024 pp.81–83) are consistent with typical 10-K footnote disclosures and add precision without contradicting the source. (2) All numeric and structural details—40,000 shares, €1.00 par value, zero issuance—are factually accurate and correctly repeated across the three-year period. No calculations were required, but the consistency check across years is properly reflected. (3) The reasoning correctly infers that the persistent lack of issuance suggests non-use of Euro Deferred Shares as a financing tool. The LLM extends this to conclude Medtronic relies on other instruments like ordinary and preferred shares and implies a conservative capital strategy—this is a reasonable interpretation aligned with the ground truth’s mention of preference for repurchases and dividends. However, the LLM slightly diverges by not explicitly referencing share repurchases or dividend policy, which are key elements in the original answer’s explanation of capital allocation strategy. This omission slightly weakens the qualitative accuracy but does not invalidate the overall logic. (4) The answer is fully contextually relevant, directly addressing both the evolution (or lack thereof) in disclosures and the strategic implication of zero issuance. The minor deduction in qualitative accuracy reflects the absence of specific reference to repurchases/dividends, but the core multi-hop synthesis—linking unchanged authorization, zero issuance, and strategic preference—is sound. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth with only slight variation in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 531,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "Intel’s advanced‑packaging strategy remained a core focus from 2022‑24, but execution risks intensified: in 2022 the company spent $17.5 B on R&D and warned that its disaggregated design and novel packaging added complexity and could delay launches (page_54). By 2023 R&D fell to $16 B, yet packaging delays could erode competitiveness and inventory‑related charges rose to $922 M (page_35). In 2024 R&D rose to $16.5 B and the firm recorded $3.1 B in impairment charges tied to its Intel 7 node, underscoring the high cost and risk of advanced packaging and the financial hit from under‑utilized capacity (page_34).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's strategic positioning and execution risks in Advanced Packaging from 2022 to 2024, aligning well with the ground truth in terms of narrative arc—initial strategic focus, technical progress, and growing financial/operational strain. Key elements like the $3.1 billion impairment in 2024 tied to Intel 7 are accurately reported. However, the R&D figures—$17.5B in 2022, $16B in 2023, and $16.5B in 2024—are not present in the original answer and are therefore unverifiable against the ground truth. While these numbers may be factually correct in external sources, their inclusion introduces quantitative claims not supported by the provided knowledge graph, which does not specify annual R&D amounts. (2) The $922M inventory-related charge in 2023 and $3.1B impairment in 2024 are specific and match the direction of the original answer’s financial impact narrative, though the original does not cite the $922M figure—this may be contextually relevant but is not confirmed in the ground truth. (3) The multi-hop reasoning is strong: the LLM synthesizes risks across years, connects R&D trends to execution challenges, and links financial charges to underutilized capacity, reflecting sound logic and entity accuracy (Intel, Intel 7, advanced packaging, 2022–2024 timeline). (4) Contextual relevance is excellent—the answer directly addresses strategic positioning, R&D investment, manufacturing complexity, and financial impact as required. The score is reduced slightly due to unsupported R&D figures, but the core narrative, entity usage, and qualitative analysis are accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 456,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "In 2022 Intel positioned PowerVia as a breakthrough backside‑power delivery technology for the Intel 20A node, targeting up to a 15 % performance‑per‑watt improvement over Intel 3. The 2023 roadmap shifted focus to the Intel 18A node, where PowerVia would now be part of a second‑generation process expected to add an additional ~10 % performance‑per‑watt over 20A, underscoring its role as a key enabler of density and power scaling. By 2024 Intel disclosed that PowerVia is integrated into the Intel 18A design and that high‑volume manufacturing of 18A‑based processors (Panther Lake) is slated to begin in 2025, marking the transition from concept to production readiness.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of PowerVia and correctly identifies its integration into Intel's advanced process nodes and the 2025 high-volume manufacturing timeline, which aligns with the ground truth. However, there are significant factual inaccuracies that impact correctness. First, the LLM incorrectly states that PowerVia was initially targeted at the Intel 20A node in 2022; the ground truth specifies that in 2022, PowerVia was introduced conceptually as part of the future roadmap without specifying 20A at that stage. The 2023 update did confirm Intel 20A as the initial target, not a shift to 18A. Then in 2024, the shift was disclosed—to move PowerVia from 20A to 18A. The LLM misrepresents this evolution by suggesting a 2023 shift to 18A and a second-generation improvement of ~10% over 20A, which is not supported by the ground truth. The ground truth states PowerVia was expected to deliver up to 15% performance-per-watt improvement over Intel 3 with 20A, but the LLM incorrectly attributes an additional ~10% gain to 18A, which is not mentioned in the original. The 2024 update correctly notes integration into 18A and HVM in 2025, which the LLM gets right. While the overall narrative of progression from concept to production is accurate, the misrepresentation of timing, node assignments, and unverified performance metrics reduces quantitative and qualitative accuracy. The contextual relevance is high as the answer addresses the strategic positioning and evolution across years as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 418,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic has not revised its U.S. employee restricted‑stock‑unit award agreement between FY2022 and FY2024 – all three filings (FY2022, FY2023 and FY2024) continue to reference the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (exhibit 10.54)【page_115 (FY2022)】【page_115 (FY2023)】【page_115 (FY2024)】. This consistency indicates a deliberate choice to keep a stable, long‑term equity‑compensation framework for U.S. employees, emphasizing continuity and alignment with shareholder interests rather than frequent plan changes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Medtronic did not update its U.S. employee restricted stock unit agreements between FY2022 and FY2024, consistently referencing the same Form of Restricted Stock Unit Award Agreement under the 2013 Stock Award and Incentive Plan. (2) No numerical values (e.g., dates, dollar amounts) are incorrect—while the specific filing date (August 27, 2013) and File No. 001-07707 are omitted, these are not critical to the core factual claim and do not affect correctness; the key point—the agreement’s continuity—is preserved. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three fiscal years (FY2022–FY2024) and draws a valid conclusion about Medtronic’s equity compensation strategy. (4) The conclusion about a stable, long-term equity framework emphasizing continuity and alignment with shareholder interests matches the original answer’s interpretation. Minor differences in wording (e.g., 'deliberate choice' vs. 'stable and consistent') do not affect factual accuracy. All aspects of the question are addressed: update status and strategic implication. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 344,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "In 2022 Intel’s 2006 Equity Incentive Plan used a single performance‑based RSU grant structure for all executives. By 2024 the plan had been split into two distinct grant agreements—Exhibit 10.1.5 for grandfathered executives and a new Exhibit 10.1.6 for non‑grandfathered executives—showing a move to a more granular, differentiated incentive structure【page 107】【page 108】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures part of the truth but contains significant inaccuracies in reasoning and completeness. (1) It correctly identifies that Intel used the 2006 Equity Incentive Plan for performance-based RSUs and references a structural change by 2024 involving separate agreements for grandfathered and non-grandfathered executives, citing Exhibits 10.1.5 and 10.1.6. These details align with the 2023 10-K filing, supporting partial factual accuracy. (2) Quantitatively, there are no explicit numbers (e.g., grant amounts, dates of filings) in the LLM answer to verify, but it references a September 26, 2023 S-8 filing and May 11, 2023 amendment indirectly through context—dates not mentioned in the LLM response, so no direct error. However, the claim that in 2022 there was a 'single' structure is not fully supported; the original answer notes use of the plan for grants on or after Feb 1, 2019, but does not state all executives were under one structure. (3) The multi-hop reasoning is flawed: the LLM implies an evolution from a unified to a split structure between 2022 and 2024, but the ground truth indicates that by 2023—before 2024—the plan already had separate agreements, and the 2024 filing reaffirmed continued use, not a new structural change. Thus, the timeline of evolution is misrepresented. (4) The answer misses key elements: it omits Intel’s reaffirmation of the amended plan in 2024 via S-8 registration and fails to mention the continuity from 2022 through 2024, undermining the 'consistent strategic focus' narrative. While the differentiation in agreements is correct, the characterization of evolution is oversimplified and partially incorrect. Hence, correctness is reduced to 6 due to incomplete and slightly misleading synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 477,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s R&D spend on process‑and‑packaging technology stayed high through the period – $17.5 billion in 2022, $16.0 billion in 2023, and $16.5 billion in 2024 (page 32).  In 2023 the company secured five new AI‑focused design wins and demonstrated its Universal Chiplet Interconnect Express standard in silicon, underscoring a tangible advance in its advanced‑packaging capability (page 33, page 36).  These milestones show Intel is scaling investment in advanced packaging to support its disaggregated design strategy and is gaining traction in the AI‑driven semiconductor market (page 35, page 56).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly notes Intel's $16.5 billion R&D spend in 2024 and mentions the UCIe demonstration in 2023, it incorrectly reports R&D spending as $17.5B in 2022 and $16.0B in 2023, which contradicts the ground truth that only specifies $16.5B in 2024 without breaking out prior years' totals for packaging-specific or overall R&D. The original answer does not provide full-year R&D figures for 2022 and 2023, so the LLM's specific numbers appear fabricated or misattributed. Additionally, the LLM omits the critical negative developments in 2024 — specifically the $3.1 billion in non-cash impairment charges tied to manufacturing assets including Intel 7 — which is a major factual gap. This omission significantly undermines the assessment of Intel’s execution risks. (2) The quantitative inaccuracies are severe: the LLM assigns precise R&D figures for 2022 and 2023 that are not present in the ground truth and may not be accurate. The only confirmed number is $16.5B in 2024, which matches. The mention of 'five new AI-focused design wins' is not present in the ground truth and cannot be verified, suggesting potential hallucination. (3) The multi-hop reasoning is partially sound — the LLM correctly links UCIe silicon demonstration to progress in advanced packaging and ties this to AI market competitiveness. However, it fails to synthesize the full trajectory, especially the setback in 2024, resulting in an overly optimistic and incomplete narrative. It does not reflect the tension between progress and execution risk emphasized in the original answer. (4) Despite these issues, the answer is contextually relevant and captures part of the positive progression in 2023. The qualitative reasoning is logical where information is present, but the lack of balance and key financial setbacks reduces its accuracy. Hence, correctness is scored at 6 due to partial factual alignment but major omissions and questionable numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 549,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel continued to use the 2006 Equity Incentive Plan for RSU grants, adding a grant agreement for non‑employee directors in 2022 (May 12 2022)【108】. The 2023 filing shows no new grant agreements or amendments to the plan, and the 2024 filing likewise contains no additional amendments or grant agreements under the plan【107‑108】. Thus, the plan’s use remained largely unchanged, with the only new grant agreement disclosed being the 2022 director‑RSU agreement.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly states that there were no amendments or new grant agreements in 2023, when the original answer confirms Intel filed an amended and restated version of the 2006 Equity Incentive Plan effective May 11, 2023. This is a major factual error. (2) The LLM claims the only new grant agreement was for non-employee directors in 2022, but the ground truth indicates multiple types of grant agreements (including for executives and performance-based awards) were referenced in 2022, not just one new type. (3) The LLM asserts no new agreements in 2024, while the original answer notes ongoing use of standardized RSU agreements and notices of grant, implying continued operational use, not stagnation. (4) The reasoning is flawed: it concludes the plan’s use remained 'largely unchanged,' which contradicts the ground truth narrative of evolution and formal structural updates in 2023. (5) The date May 12, 2022, is mentioned by the LLM but not in the original answer, introducing an unsupported detail. While the general context of continued RSU use under the 2006 plan is relevant, the specific facts about amendments, types of agreements, and evolution are incorrect. Quantitative accuracy is partially preserved (dates are in the right ballpark), but the critical 2023 amendment date (May 11, 2023) is omitted. The model fails the multi-hop synthesis by not connecting the 2023 amendment to the broader evolution of the plan across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 421,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm kept wireless access points in the same revenue bucket – the IoT stream under the “edge networking” sub‑category – in both 2022 and 2024 (see QCT revenue tables on page 73).  However, its strategic narrative shifted from a focus on Wi‑Fi 6/6E to foregrounding the upcoming Wi‑Fi 7 standard and the role of access points in replacing last‑mile wired broadband, positioning Qualcomm as a leader in next‑generation edge‑networking solutions (page 8 and page 10).  The IoT revenue that includes wireless access points fell from $7.35 bn in 2022 to $5.42 bn in 2024, reflecting a market‑demand shift while the classification stayed unchanged (page 73).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that wireless access points were explicitly categorized under edge networking in 2023, implying a formal classification shift, but the LLM claims they were in the same IoT/edge networking bucket in both 2022 and 2024, contradicting the evolution described in the original answer. Additionally, the LLM introduces specific revenue figures—$7.35 billion in 2022 and $5.42 billion in 2024 for IoT revenue including wireless access points—which are not present in the ground truth and cannot be verified against it; more critically, the original answer explicitly states that 'exact revenue figures for wireless access points alone are not disclosed,' making the LLM’s precise numbers factually incorrect. (2) The quantitative accuracy is low because the dollar amounts and implied trends (a decline in revenue) are unsupported by the ground truth, which makes no mention of revenue changes. There is no basis for claiming a drop in financial performance, which misrepresents the situation. (3) The qualitative reasoning is partially sound in identifying a strategic narrative shift toward Wi-Fi 7 and positioning in edge networking, which aligns with the idea of evolving market positioning. However, the multi-hop synthesis fails because it misrepresents the timeline of financial categorization: the original answer emphasizes a key change in 2023 when wireless access points were formally included in edge networking, whereas the LLM implies no change in classification over the period. This undermines the core of the financial categorization evolution. (4) Contextual relevance is moderate—the answer addresses revenue classification and strategic emphasis as asked, and introduces relevant concepts like Wi-Fi standards and market positioning, but the inclusion of fabricated revenue data and misrepresentation of the categorization timeline significantly reduce its factual reliability. Overall, the answer gets the general domain right but fails on key facts and numbers, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 566,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "MRK’s Prevymis sales climbed steadily, rising from **$428 million in 2022** to **$605 million in 2023** and **$785 million in 2024** (Hospital Acute Care segment totals)【page_130】. The year‑over‑year growth of roughly 41 % (2022‑23) and 29 % (2023‑24) indicates that the CMV‑prophylaxis is gaining traction and solidifying its position as a key product within the hospital acute‑care portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the reported sales figures. According to the ground truth, MRK's Prevymis sales were $370 million in 2022 and $428 million in 2023, but the LLM incorrectly reports $428 million in 2022 and $605 million in 2023. Only the 2024 figure ($785 million) is correct. This leads to incorrect year-over-year growth rates: the LLM claims ~41% (2022–2023) and ~29% (2023–2024), whereas the correct growth is approximately 15.7% (from $370M to $428M) and 83.4% (from $428M to $785M). The compound growth rate over 2022–2024 is stated as ~46% in the ground truth, which the LLM fails to mention or compute correctly. (2) The quantitative inaccuracies are severe, especially in the foundational 2022 and 2023 numbers, which are swapped and inflated. Even allowing for format variation, the values are factually wrong. The cited page reference (page_130) does not align with the truth data, raising concerns about source fidelity. (3) While the LLM correctly identifies the product (Prevymis), company (MRK), indication (CMV prophylaxis), and segment (Hospital Acute Care), and draws a reasonable qualitative conclusion about market positioning, the reasoning is based on incorrect data. The multi-hop synthesis—linking sales trends to market positioning—is conceptually sound but undermined by inaccurate inputs. (4) The answer is contextually relevant and addresses both parts of the question (sales evolution and market positioning), but the incorrect numbers severely compromise factual correctness. A score of 4 reflects partial credit for correct 2024 value and logical structure, but major deductions for core data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 453,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "In 2022 Intel positioned advanced packaging as a core IDM 2.0 enabler, adopting a disaggregated design approach to combine components across nodes while noting that manufacturing delays and capital constraints limited progress (page 56, page 55). By 2023 the company secured multiple design wins and packaging revenue rose $483 million, yet still posted operating losses because of heavy R&D and capital outlays (page 35, page 36, page 38). In 2024 Intel continues to market advanced packaging as a unique advantage—highlighting new standards such as the Universal Chiplet Interconnect Express and ongoing partnerships—while acknowledging construction delays and the need for alternative financing, underscoring that IDM 2.0 execution remains challenged by persistent manufacturing lag and capital‑intensive demands (page 32‑36).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic evolution of Intel's advanced packaging and IDM 2.0 positioning from 2022 to 2024, correctly identifying key themes such as disaggregated design, UCIe, and persistent execution challenges. However, it introduces a significant factual error: the $483 million increase in packaging revenue in 2023 is not present in the ground truth and is unsupported by the original answer. The ground truth mentions no such revenue figure or design wins with financial impact. Additionally, the LLM claims R&D and capital outlays led to operating losses in 2023, which is not stated in the original. While the 2024 discussion aligns thematically (delays, financing challenges), it omits the critical $3.1 billion non-cash impairment in Q3 2024 and misrepresents Intel 7 as a construction delay rather than a process node delay. The $16.5 billion R&D investment in 2024 is also missing from the LLM response. (2) Quantitative accuracy is low: the $483 million figure is fabricated; no correct numbers from the ground truth (e.g., $3.1B impairment, $16.5B R&D) are included. Format variations are not the issue—missing or invented data is. (3) Multi-hop reasoning is partially sound: the model connects packaging strategy to IDM 2.0 and recognizes delays and capital constraints across years. However, it fails to accurately synthesize financial and technical data from each year, especially in 2024, weakening the conclusion. (4) Contextual relevance is high—the answer addresses the multi-year trajectory and strategic implications as asked. Qualitative accuracy is moderate due to correct framing but flawed support. Correctness score is 6 due to correct strategic narrative but major quantitative inaccuracies and omissions of key facts that alter the factual basis of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 496,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM has consistently cited client relationships and trust as a core competitive differentiator in its 2022, 2023, and 2024 10‑K filings (the phrase appears in the competition section on page 4 of each filing). Over time the company has increasingly tied this trust to its hybrid‑cloud platform and AI strategy, stressing that the platform and AI technology enable clients to realize digital transformations while building confidence. This progression signals IBM’s intent to position itself as a trusted partner in the hybrid‑cloud and AI market, using client trust to differentiate from competitors and drive adoption of its hybrid‑cloud and AI solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies IBM's consistent emphasis on client relationships and trust as a competitive differentiator from 2022 to 2024, and correctly links this to its hybrid cloud and AI strategy. The claim that the phrase appears on page 4 of each 10-K filing is consistent with the knowledge graph data, though this specific page detail was not in the original answer—this is a minor addition, not a factual error. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in the traditional sense; however, the years 2022–2024 are correctly referenced, earning full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes IBM’s evolving strategic framing across three years and ties it to hybrid cloud and AI positioning. However, it omits the specific 2024 detail about the strategic partnership with Palo Alto Networks, which is a meaningful omission in the evolution of trust-based collaboration. This weakens the completeness of the progression narrative. (4) Despite this omission, the LLM captures the core strategic intent—positioning IBM as a trusted partner to drive adoption of hybrid cloud and AI solutions—making the answer contextually relevant and semantically close to the original. The answer is slightly less detailed in the 2023 and 2024 developments but maintains factual correctness overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 405,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "IBM did not issue any new 0.950% Notes between 2022 and 2024; the notes were originally issued in 2017.  In the 2023 10‑K, IBM disclosed the terms of the 0.950% Notes through Exhibits 4.1 and 4.2 to a 2017 8‑K filing (page 20), whereas the 2024 10‑K lists the notes as a registered security (IBM25B) under Section 12(b) of the Act, consolidating the disclosure within the annual report (page 1).  This shift from separate 8‑K exhibits to a fully integrated 10‑K disclosure reflects IBM’s disciplined debt‑management approach that prioritizes regulatory compliance, transparency, and a stable, diversified debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were originally issued in 2017, not newly issued between 2022–2024; IBM continued referencing the 2017 Form 8-K (Exhibits 4.1 and 4.2) in its 2023 disclosures; and by 2024, the notes were listed as a registered security under IBM25B on the NYSE, consistent with Section 12(b) of the Exchange Act. (2) Quantitative elements—dates (2017 issuance), percentages (0.950%), and trading symbol (IBM25B)—are all factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022–2024), identifies the evolution from external exhibit referencing to integrated disclosure, and infers a broader debt management strategy focused on transparency and stability. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2022 disclosure behavior (referencing the 2017 8-K), which was included in the original answer, though it implies continuity. The conclusion about a disciplined, transparent, and stable debt strategy is well-supported and semantically equivalent to the ground truth. Wording differs slightly but meaning is preserved. No calculation errors. Fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 357,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "In 2022 Intel announced PowerVia as a future backside‑power technology for its upcoming 20A node (INTC_10k_2022.pdf: page 9). By 2023 the company positioned PowerVia as the first high‑volume commercial implementation in the 18A node—eliminating front‑side power routing—and noted that 20A would also incorporate it (INTC_10k_2023.pdf: pages 10 & 14). The 2024 filings (INTC_10k_2024.pdf: pages 8‑12) no longer treat PowerVia as a future technology, implying it has moved into production, underscoring Intel’s roadmap that backside power delivery will be a core differentiator in its next‑generation advanced process nodes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel's PowerVia strategy and correctly identifies its role in backside power delivery, with accurate references to the 20A and 18A nodes and the progression from concept to production. However, it contains a key factual error: it states that in 2023, PowerVia was positioned as part of the 18A node and that 20A would also incorporate it, which contradicts the ground truth. According to the original answer, Intel canceled the productization of 20A in favor of 18A in 2024, meaning 18A (not 20A) is the node where PowerVia is being commercialized. The LLM incorrectly implies that 20A remained in the roadmap and that 18A was already the commercial node in 2023, which misrepresents the timeline and strategic pivot. The 2022 and 2024 descriptions are mostly accurate—PowerVia was introduced as a future technology and later implied to be in production—but the misattribution of node timelines and the erroneous claim that 18A was the first commercial node in 2023 (rather than 2024) undermines the multi-hop reasoning. Quantitative accuracy is high as there are no numerical errors, only timeline and entity placement issues. Contextual relevance is strong, as the answer addresses the evolution and strategic significance. However, due to the incorrect synthesis of node roadmaps across years, the qualitative accuracy and overall correctness are reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 388,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 2022‑, 2023‑ and 2024‑10 K filings all reference the same 2021 Medtronic plc Long‑Term Incentive Plan RSU award agreements (exhibits 10.78‑10.81 in each year).  The vesting schedule—100 % on the third anniversary or ratably over four years—remains unchanged, and the underlying Amended and Restated 2013 Stock Award and Incentive Plan has not been materially altered.  This consistency indicates a stable U.S. equity‑compensation strategy across the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Medtronic's 2022–2024 10-K filings reference the '2021 Medtronic plc Long-Term Incentive Plan RSU award agreements' and cites exhibits 10.78–10.81, which contradicts the ground truth. The original answer confirms that the correct exhibit is 10.54, referencing the August 27, 2013 filing, not 2021. This misidentification of the plan, year, and exhibit number undermines the factual foundation of the response. (2) Quantitative accuracy is low: the dates (2021 vs. 2013), exhibit numbers (10.78–10.81 vs. 10.54), and plan name are all incorrect. While the vesting schedule description (100% on third anniversary or ratably over four years) may align with typical RSU terms, it is not corroborated in the ground truth and thus cannot be verified as consistently documented across the period. (3) The multi-hop reasoning is partially sound—the model correctly infers that consistency in documentation implies strategic stability in equity compensation. However, this logic is applied to incorrect source documents, leading to a valid conclusion based on false premises. (4) Contextual relevance is high because the answer addresses the core question about equity compensation stability and attempts to support it with filing references and vesting terms. Despite the correct direction of reasoning, the use of inaccurate entities and documentation severely limits factual correctness, warranting a moderate score of 4/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 424,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "In 2022 Intel positioned advanced packaging as a key differentiator of its IDM 2.0 strategy, but execution was hampered by 10 nm and 7 nm node delays, a delayed 4th‑Gen Xeon, and capital constraints that postponed facility expansions, while the newly‑adopted disaggregated design approach added logistical and packaging complexity. By 2023 the company secured several Intel 18A design wins and saw packaging revenue rise, yet continued to incur operating losses from aggressive R&D and capital spending, and the disaggregated strategy still exposed it to supply‑chain and yield risks. In 2024 advanced‑packaging revenue grew further, but capital constraints remained—evidenced by joint‑investment penalties and delayed Fab 34 construction—while the disaggregated design approach continued to create execution challenges, underscoring the trade‑off between pursuing cutting‑edge packaging and managing cost and schedule risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Intel's strategic positioning and execution challenges around advanced packaging from 2022 to 2024, aligning well with the ground truth in terms of narrative arc—acknowledging delays, capital constraints, and the role of disaggregated design. However, it misses the specific $3.1 billion impairment charge in 2024, a key quantitative fact from the original answer, and incorrectly references '10 nm' delays in 2022 when the ground truth emphasizes 'Intel 4 (formerly 7nm)' as the critical delay. It also introduces details not in the original, such as 'packaging revenue rise', 'joint-investment penalties', and 'Fab 34 construction delays', which, while plausible, are not supported by the ground truth. (2) Quantitative accuracy is partially compromised: the $3.1B impairment charge—a major financial indicator of execution failure in 2024—is omitted. The LLM mentions 'operating losses' and 'capital constraints' but lacks precise figures, reducing factual precision. The reference to '4th-Gen Xeon delay' is contextually relevant but not explicitly in the ground truth. (3) Multi-hop reasoning is sound: the LLM correctly links advanced packaging to the disaggregated design approach, connects capital constraints to delayed expansions, and traces the evolution across years. It also correctly identifies UCIe-adjacent strategic moves (e.g., design wins) even if not naming UCIe directly. However, it fails to explicitly mention UCIe or Intel 7 node underutilization, which are key elements in the 2024 challenges. (4) The answer is contextually relevant and well-structured, addressing all time periods and strategic themes. The qualitative reasoning is strong, but the absence of specific financial figures and some conflation of technical nodes (10nm vs Intel 4/7nm) reduces factual fidelity. Hence, correctness is downgraded to 7 due to missing key facts and minor inaccuracies, despite strong overall alignment in theme and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 539,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Across 2022‑24 Accenture kept a heavily fixed‑income focus.  In 2022 the U.S. plans were 100 % debt, while non‑U.S. plans were 48 % debt and 27 % equity (page 88).  By 2023 the U.S. mix shifted to 95 % debt (5 % cash) and non‑U.S. plans to 43 % debt/19 % equity (page 95).  In 2024 the U.S. mix was 94 % debt (6 % cash) and non‑U.S. plans 42 % debt/23 % equity (page 95).  The modest swing—down in equity in 2023 and a slight rebound in 2024—shows the company’s willingness to adjust equity exposure in response to market conditions while preserving a conservative, risk‑adjusted return strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The Original Answer (ground truth) describes Accenture's *target asset allocation strategy* in qualitative, strategic terms across fiscal years 2022–2024, emphasizing duration matching, flexibility, and risk-adjusted returns. In contrast, the LLM Answer fabricates specific numerical allocations (e.g., 'U.S. plans were 100% debt', '48% debt and 27% equity') that do not appear in the ground truth and are not supported by the question or context. There is no mention in the ground truth of U.S. vs. non-U.S. plan breakdowns or exact percentages for equities and fixed income. (2) The cited percentages (100%, 95%, 43%, etc.) are entirely absent from the Original Answer and cannot be verified. The LLM incorrectly presents these as factual with page references (e.g., 'page 88', 'page 95'), which are not part of the input and suggest hallucination. No calculations are performed in the LLM answer, but the use of precise numbers where none exist in the ground truth severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about the *evolution of the target strategy*, not specific portfolio weights. The LLM misinterprets the task by focusing on granular, nonexistent data instead of synthesizing the strategic shift toward flexibility and risk management described in the Original Answer. It fails to capture the core narrative of increasing adaptability in asset allocation decisions from 2022 to 2024. (4) While the LLM attempts to infer a trend (slight equity rebound in 2024), this is based on false data. The concluding remark about 'conservative, risk-adjusted return strategy' aligns loosely with the ground truth’s theme, providing minimal qualitative overlap. However, due to pervasive factual inaccuracies and hallucinated data, the correctness score is low. The answer is contextually relevant in topic but incorrect in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 535,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s repeated mention of the 1.05% Notes due 2017 in its 2023 and 2024 10‑Ks (Exhibit 4.4) shows a disciplined, consistent disclosure policy that keeps investors apprised of all outstanding debt, even older maturities. In contrast, the company’s broader debt‑issuance strategy over 2022‑24 has been to issue new, higher‑yield notes (e.g., the 4.421% Notes due 2026 in 2024, Exhibit 4.28) to fund share repurchases and other corporate purposes, reflecting a proactive, diversified debt‑raising approach while maintaining full transparency on legacy obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. The ground truth references Apple issuing notes such as Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024, but the LLM incorrectly cites a '4.421% Notes due 2026 in 2024'—a specific instrument not mentioned in the ground truth and outside the 2022–2024 issuance window emphasized in the question. Additionally, the maturity year of the legacy note is correctly stated as 2017, but its continued disclosure is not about 'outstanding debt' (it is long matured), so the characterization is factually wrong. (2) The LLM misrepresents the nature of the 1.05% Notes' disclosure: these are not outstanding, so stating that Apple discloses 'all outstanding debt' is incorrect. The ground truth emphasizes transparency in maintaining historical records post-maturity, not current obligations. (3) The multi-hop reasoning is partially sound: the model correctly infers that consistent disclosure reflects a transparency policy and contrasts it with active new issuances. However, the synthesis fails because the new debt examples provided are not aligned with the ground truth data, undermining the comparison. (4) Despite factual inaccuracies in specific instruments and maturities, the answer captures the broader theme of transparent historical disclosure versus active debt management, earning moderate scores in qualitative accuracy and high relevance. The core reasoning is on track but built on incorrect factual premises, leading to a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 430,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "Accenture repurchased 12.2 million shares for $4.1 million in fiscal 2022, and its remaining authorization rose to $6.129 million after a $3 million increase (page 94). In fiscal 2023 the company bought roughly $3.5 billion in shares and had about $6.3 million left in authorization (intermediate year). By fiscal 2024 it had returned $4.5 billion to shareholders and its total authorization had grown to $6.694 million (page 39 and page 40). This steady rise in both buy‑back volume and authorized capacity signals a disciplined, expanding capital‑return strategy that balances shareholder payouts with a flexible buy‑back pool.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains numerous factual inaccuracies. It claims Accenture repurchased 12.2 million shares for $4.1 million in fiscal 2022, which is grossly incorrect—$4.1 million for over 12 million shares implies a price of ~$0.34 per share, which is nonsensical for Accenture. The ground truth states that in fiscal 2022, Accenture had $3.13 billion in available authorization, not $6.129 million as claimed. The LLM also states remaining authorization 'rose to $6.129 million' after a $3 million increase, which is off by a factor of nearly 1,000 (should be billions, not millions). In fiscal 2023, the LLM claims $3.5 billion in share buys and $6.3 million in remaining authorization—again confusing millions with billions. By fiscal 2024, it claims $4.5 billion returned to shareholders and total authorization of $6.694 million (should be $6.69 billion), again mixing units. The only partially correct figure is the $6.69 billion total authorization in 2024, but even that is misstated as $6.694 million. (2) Calculations and comparisons are entirely flawed due to unit errors and invented numbers. The ground truth states Accenture purchased over $605 million in shares in fiscal 2024, not $4.5 billion. The $4.0 billion new authorization in September 2024 is not mentioned in the LLM answer, nor is the decrease in available authorization from $3.13B to $2.69B despite new approvals. (3) Multi-hop reasoning is superficial and incorrect. The LLM fabricates a 'steady rise in buy-back volume' when the ground truth shows measured, not expanding, repurchases. It fails to note the key point that available authorization decreased despite new approvals, indicating repurchases are being executed but not at an accelerating pace. (4) The contextual relevance is moderate because the answer attempts to address share repurchases and capital return strategy, but the qualitative conclusion of an 'expanding' strategy contradicts the ground truth's 'measured' and 'sustained but flexible' interpretation. Due to pervasive numerical errors and flawed reasoning, the correctness score is very low at 2, quantitative accuracy is 1, qualitative accuracy is 3 (for attempting the right structure), and contextual relevance is 6 (topic is addressed but with severe inaccuracies).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 611,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "BMS issued the $1 billion 4.350 % Senior Notes due 2047 in 2019 and the notes have remained unchanged through the 2022, 2023 and 2024 Form 10‑Ks.  Each filing lists the notes in the supplemental‑indenture exhibit (4jj) and in the debt schedule, with no change to the coupon or maturity (2022 10‑K p. 137; 2023 10‑K p. 132; 2024 10‑K p. 134‑138).  The steady presence of this long‑term instrument across three years signals BMS’s strategy of locking in a moderate, fixed‑rate debt for a long horizon to manage refinancing risk and keep a stable, diversified debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent presence of the 4.350% Senior Notes due 2047 in BMY's (Bristol-Myers Squibb, referred to as BMS) debt portfolio across 2022, 2023, and 2024, and accurately notes that the coupon and maturity remained unchanged. However, it incorrectly states that the notes were issued in 2019 for $1 billion, which is not confirmed in the ground truth—while the Eleventh Supplemental Indenture was dated November 22, 2019, the original answer does not specify the issuance amount or confirm $1 billion. This is a factual overreach not supported by the provided truth. (2) The quantitative accuracy is partially compromised due to the unsupported $1 billion figure; all other numbers (4.350%, 2047 maturity) are correct. The ground truth does not mention the issuance size, so introducing $1 billion reduces precision. (3) The reasoning is sound: the LLM correctly infers that the persistent listing of the notes indicates a strategy of maintaining fixed-rate, long-term debt to manage refinancing risk and ensure stability and diversification. It aligns well with the ground truth’s conclusion about staggered maturities and a diversified liability structure. (4) Contextual relevance is perfect—the response directly addresses the evolution (or lack thereof) in the debt instrument and interprets the strategic implication over the three-year period. Despite the unsupported dollar amount, the core facts and strategic interpretation are consistent with the ground truth, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 428,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple’s 10‑K filings show a consistent disclosure of the 2.40 % Notes due 2023.  In each year (2022, 2023, and 2024) Apple included Exhibit 4.3 – the officer’s certificate that lists the 2.40 % Notes – and the notes were also presented in the “Notes to Consolidated Financial Statements.”  No substantive change in detail or presentation is evident as the notes approached maturity; Apple simply continued to disclose them in the same manner across the three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—Apple, the 2.40% Notes due 2023, Exhibit 4.3, the Officer's Certificate, and the years 2022–2024—are correctly identified. (2) Quantitative elements are accurate: the interest rate (2.40%), the years of disclosure (2022, 2023, 2024), and the exhibit number (4.3) match the original answer. No calculations were required, but the consistency across filings is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes disclosure practices across three years and correctly infers that Apple maintained a consistent approach despite the notes nearing and reaching maturity. (4) The answer conveys semantic equivalence to the ground truth—while it omits the specific date of the Officer's Certificate (May 3, 2013), this is a minor detail that does not affect the core conclusion about disclosure consistency. The LLM correctly emphasizes the unchanging format and placement in both Exhibit 4.3 and the Notes to Financial Statements. The omission prevents a perfect 10, but the answer remains highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 319,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "In FY 2022 Accenture authorized **127 million** Class A shares for the Amended 2010 Share Incentive Plan (SIP)【page_91】. That authorization remained unchanged in FY 2023, and by FY 2024 it had risen to **141 million** shares【page_98】. The 14‑million‑share increase reflects a deliberate expansion of the share‑based compensation pool, giving the company greater flexibility to reward and retain talent over the long term and to align employee incentives more closely with shareholder value.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the timeline of share authorizations. According to the ground truth, the number of shares was 127 million in FY2022, increased to 141 million in FY2023, and remained at 141 million in FY2024. However, the LLM incorrectly states that the amount remained unchanged in FY2023 and only increased to 141 million in FY2024, which misrepresents the actual progression. This error affects both the quantitative accuracy and the reasoning. (2) While the numeric values of 127 million and 141 million are correctly cited (allowing for format variation), the assignment of these figures to the wrong fiscal years invalidates the calculation and timeline. The 14-million-share increase is accurate (141M - 127M = 14M), but it occurred from FY2022 to FY2023, not FY2023 to FY2024 as implied. (3) The multi-hop reasoning is partially sound in that the model recognizes the increase and infers strategic intent behind expanding the share pool for talent retention and incentives. However, because the temporal evolution is incorrect, the synthesis across years is flawed. The conclusion about long-term strategy is reasonable but based on incorrect timing. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of shares and strategic implications—and uses appropriate terminology. However, due to the critical error in year-to-year progression, the correctness and quantitative accuracy scores are significantly reduced. A score of 4 reflects partial correctness with major factual inaccuracies in the core data sequence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 444,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "Intel first announced PowerVia in its 2022 20A roadmap as a breakthrough backside‑power technology, and reiterated its role in 2023 as a key performance‑per‑watt improvement. By 2024 the technology had moved from a future concept to a high‑volume commercial implementation in the 18A node, which is slated for Panther Lake processors and delivers an additional 10 % performance‑per‑watt gain over 20A. This evolution shows that PowerVia is a core enabler of Intel’s next‑generation process nodes, underscoring its strategic importance for density and power‑efficiency in the advanced roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution and strategic importance of PowerVia from 2022 to 2024. (1) It correctly identifies PowerVia's introduction in 2022 as part of the 20A roadmap, its reinforcement in 2023, and its transition to high-volume implementation in the 18A node for Panther Lake—aligning with the ground truth. (2) The claim of a '10% performance-per-watt gain over 20A' is not explicitly stated in the ground truth, which notes performance-per-watt improvements but does not quantify them. This is a minor addition not contradicted by the original but not verifiable from it—hence a slight deduction in quantitative accuracy. (3) The reasoning is sound: the LLM correctly synthesizes the multi-hop progression—PowerVia moving from concept (2022) to 20A (2023) to 18A (2024)—and infers its strategic importance in Intel's roadmap. It accurately reflects the cancellation of 20A's productization (implied by shift to 18A) even if not explicitly stated. (4) The answer is contextually excellent, directly addressing the evolution and strategic significance. Minor lack of explicit mention of 'backside power delivery' as an 'industry-first' slightly reduces qualitative precision, but the core technical and strategic points are preserved. Overall, the answer is factually strong, well-reasoned, and semantically equivalent with only minor embellishment on performance gain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 389,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s pension‑plan assets allocated to mutual‑fund equity securities fell from **$239,293** in fiscal 2022 to **$196,226** in fiscal 2023, then rose sharply to **$273,699** in fiscal 2024 (see page 89 for 2022 and page 96 for 2023‑24). This 3‑year trajectory shows a dip in 2023 followed by a sizable rebound in 2024, indicating a strategic shift toward greater equity exposure in its pension portfolio and a willingness to pursue higher equity‑based returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative data. While it correctly reports the $239,293 million allocation for fiscal year 2022 and $196,226 million for 2023, it incorrectly states that the allocation rose to $273,699 million in 2024. The ground truth confirms the amount remained at $196,226 million in 2024, showing no increase. This error fundamentally misrepresents the trend. (2) The calculation and comparison of values are therefore incorrect: instead of a 'sharp rise' or 'rebound', the actual trajectory shows a decrease followed by stability, not recovery. The claimed $273,699 figure has no basis in the ground truth and introduces a false upward trend. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the data across the three years. It incorrectly infers a strategic shift toward greater equity exposure, while the actual data indicates a strategic reduction or rebalancing away from mutual fund equity securities. The conclusion about 'willingness to pursue higher equity-based returns' is unsupported and contradicts the stable-to-lower allocation. (4) Despite the incorrect numbers and reasoning, the answer is contextually relevant in that it addresses Accenture's allocation to mutual fund equity securities over the three fiscal years and attempts to interpret strategic positioning. However, due to the critical error in the 2024 figure and the resulting false trend analysis, the overall correctness is very low. Minor note: the dollar amounts are presented without 'million' but contextually imply thousands of millions, which is acceptable formatting; the core issue is the wrong value for 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 462,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck has kept the $145 million net carrying value of Dificid’s intangible asset unchanged, with no impairment disclosed in 2023 or 2024 (page 115). The drug remains positioned as a hospital‑acute‑care antibiotic for Clostridioides difficile infection (page 3). Its global sales rose from $263 million in 2022 to $302 million in 2023 and $340 million in 2024, a modest but steady increase in its contribution to the pharmaceutical segment (page 130).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in financial figures compared to the ground truth. While it correctly states Dificid's $145 million intangible asset value in 2022 and the $340 million global sales in 2024, it incorrectly reports $263 million in 2022 sales and $302 million in 2023 sales—these figures are not supported by the ground truth, which does not provide 2022 or 2023 revenue data. The ground truth only specifies 2024 revenue ($340M: $303M U.S. + $37M international), so the LLM's inclusion of prior-year sales figures introduces fabricated data. (2) The quantitative accuracy is compromised due to these unsupported numbers; although the $340M 2024 revenue and $145M asset value are correct, the incremental sales progression is not verifiable and contradicts the original answer’s lack of 2022–2023 revenue disclosure. (3) Qualitatively, the LLM correctly identifies Dificid’s therapeutic positioning in hospital acute care and its status as a marketed product within Merck’s pharmaceutical segment, aligning with the 2023 and 2024 strategic emphasis. It also correctly notes no impairment of the intangible asset, consistent with continued valuation. However, it fails to mention the shift from a balance sheet item to a strategically highlighted product, missing part of the evolution narrative. (4) Contextually, the answer remains highly relevant, addressing asset valuation, therapeutic positioning, and revenue trends as asked. Despite incorrect sales figures, the overall direction of growth and strategic importance is plausibly conveyed. The main failure is in quantitative fidelity, particularly the invention of 2022 and 2023 revenue numbers not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 469,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "Intel’s IDM 2.0 strategy has pushed it to invest heavily in advanced‑packaging and disaggregated‑design R&D—$17.5 billion in 2022, $16.0 billion in 2023, and $16.5 billion in 2024—while still grappling with delays in 10 nm and 7 nm process rollouts and a 4th‑Gen Xeon launch shift (page 34).  The company kept high R&D spend and secured new advanced‑packaging wins, yet continued implementation lags exposed it to financial risk, as shown by a $922 million inventory charge for AI accelerators (page 35), a $3.1 billion impairment tied to the Intel 7 node (page 34), and a $755 million penalty for Ireland construction delays (page 36).  These delays and associated costs highlight the growing risk that capital‑intensive advanced‑packaging projects may not deliver the expected returns under Intel’s IDM 2.0 strategy (page 34).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several incorrect numerical values not present in the ground truth. Specifically, it claims R&D investments of $17.5B in 2022, $16.0B in 2023, and $16.5B in 2024—these figures are not supported by the original answer and are factually inaccurate based on the provided ground truth, which does not specify exact R&D dollar amounts. Additionally, the LLM introduces a $922 million inventory charge for AI accelerators and a $755 million penalty for Ireland construction delays, neither of which are mentioned in the ground truth. While the $3.1 billion impairment charge is correctly cited and aligns with the original answer, the context (tied to Intel 7 node) adds detail not confirmed in the ground truth. (2) The quantitative inaccuracies are significant and unsupported. The original answer makes no mention of specific R&D spending figures or the two additional charges, making these hallucinations. The only correct number is the $3.1 billion impairment, which matches the ground truth. (3) The reasoning is partially sound: the LLM correctly identifies the strategic importance of advanced packaging within IDM 2.0, acknowledges implementation delays, and links them to financial risks—this reflects the multi-hop synthesis required. It captures the evolution from investment to execution challenges and financial strain, aligning with the trajectory described in the original answer. However, the use of fabricated numbers undermines the credibility of the analysis. (4) The contextual relevance is high—the answer addresses R&D investment, implementation delays, and financial risk exposure across 2022–2024, directly responding to the question’s scope. The qualitative reasoning is logical and follows the same narrative arc as the ground truth, despite factual inaccuracies in specifics. Thus, while the structure and intent are correct, the inclusion of false quantitative data reduces the correctness score significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 531,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "Merck’s MK‑8591A, a doravirine/islatravir once‑daily oral combination, entered Phase 3 in February 2020 but was placed on a clinical hold in 2022 due to observed lymphocyte and CD4‑T‑cell declines (page 24). The 2023 filing notes that the hold remained in place while a Phase 3 program was slated to begin that year (page 21), and the 2024 filing still lists the drug under a full FDA clinical hold with a partial hold for higher doses (page 22). This steady, cautious progression reflects Merck’s long‑term commitment to HIV therapy while prioritizing safety and regulatory compliance, indicating a measured, risk‑managed strategy rather than an accelerated push.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the regulatory status of MK-8591A. It incorrectly states that a clinical hold was placed in 2022, while the ground truth indicates that the FDA lifted a clinical hold on December 4, 2024 — a critical reversal not reflected in the LLM response. Instead, the LLM claims the drug remained under a 'full FDA clinical hold' in 2024, which contradicts the original answer stating the hold was lifted (though partially maintained for higher doses). This misrepresents the trajectory as stagnant or negative when it was actually progressing positively by late 2024. (2) The Phase 3 entry date of February 2020 is correctly cited, and the mention of lymphocyte and CD4-T-cell declines aligns with known safety concerns, but the attribution of the hold to 2022 is unsupported by the ground truth, which does not specify when the hold occurred — only that it was resolved in December 2024. The use of 'page 24', 'page 21', etc., suggests document references but does not compensate for factual errors. (3) The multi-hop reasoning is partially sound — the model attempts to synthesize development phase, safety issues, and regulatory status across years — but fails in the key synthesis point: the evolution from hold to partial resolution. This undermines the conclusion about the drug’s progression. (4) While the strategic interpretation of Merck showing commitment to HIV therapy is consistent with both answers, the flawed factual basis reduces the validity of the reasoning. The LLM’s portrayal of a 'steady, cautious progression' under continuous hold contradicts the actual lifting of the hold in 2024, leading to an inaccurate overall assessment. Quantitative accuracy is moderate due to correct dates but incorrect event timing; qualitative accuracy suffers from incorrect event sequence; contextual relevance is high as the answer addresses all question components with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 531,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "In 2022, Merck described MK‑1308A as a co‑formulation of its investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab, targeting renal cell carcinoma (RCC) and other advanced solid tumors【page_23】【page_25】. The 2023 filing reiterated the same RCC/advanced‑solid‑tumor focus and combination strategy, with no new regulatory milestones reported【page_21】【page_23】. The 2024 10‑K pages provided contain no mention of MK‑1308A, indicating that no further clinical or regulatory progress was disclosed for that program during 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a critical factual error regarding the 2024 status of MK-1308A. While it correctly states that in 2022 and 2023, MK-1308A was a co-formulation of quavonlimab and pembrolizumab targeting RCC and advanced solid tumors, it incorrectly claims that the 2024 10-K contains no mention of MK-1308A. The ground truth states that in 2024, MK-1308A remained a key immuno-oncology candidate in Phase 3 development for RCC with continued strategic emphasis—indicating it was still under active development and mentioned in disclosures. The LLM’s conclusion that 'no further clinical or regulatory progress was disclosed' due to absence in the provided 2024 pages is an overreach; absence from excerpted pages does not equate to absence from the full filing or public development. (2) Quantitatively, all dates (2022, 2023, 2024) and drug names (quavonlimab, pembrolizumab) are accurate, and no numerical claims are made that contradict the ground truth. (3) The multi-hop reasoning is flawed: the model fails to maintain consistency in the developmental trajectory, incorrectly inferring discontinuation or lack of progress in 2024 when the ground truth confirms ongoing Phase 3 evaluation. This breaks the synthesis across years. (4) Contextually, the answer addresses clinical focus, combination therapies, and regulatory progress as asked, but the erroneous 2024 conclusion undermines the overall correctness. The answer is well-structured and relevant but factually incomplete in a significant way.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 427,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "Accenture’s share‑repurchase program grew sharply from fiscal 2022 to fiscal 2024: in 2022 it bought 12.2 million Class A shares for $4.1 million, while in 2024 it purchased $4.5 billion of shares (2.07 million in Q4 alone) as part of a $4.5 billion total share‑purchase program.  The Board’s available authorization rose from $3.13 million at the start of 2022 to $6.694 billion by September 2024 (after a $4.0 billion boost), giving the company a large, flexible pool to fund future repurchases.  This multi‑year trend shows Accenture’s commitment to a robust, shareholder‑friendly capital‑return strategy that relies heavily on both dividends and a scalable, open‑market share‑buyback program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It claims Accenture bought 12.2 million shares for $4.1 million in fiscal 2022, which is grossly inaccurate—the ground truth does not specify 2022 repurchase volume or value, only that $3.13 billion in authorization was available. The $4.1 million figure is off by orders of magnitude (should be billions, not millions). In fiscal 2024, the LLM states $4.5 billion in share purchases, but the ground truth reports only $605 million in open-market repurchases. The claim of '2.07 million shares in Q4 alone' is unsupported by the data. The available authorization is misrepresented: it says $3.13 million (not billion) in 2022, when it should be $3.13 billion. While it correctly notes a $4.0 billion increase in authority in September 2024 and a resulting $6.694 billion total, this is partially correct but built on incorrect prior values. (2) Calculations and number usage are severely flawed: mixing millions and billions, inventing repurchase volumes not in the source, and misrepresenting authorization balances. The only correct quantitative elements are the $4.0 billion new authorization and the resulting $6.694 billion total outstanding authority. (3) Multi-hop reasoning is weak: the model fails to accurately track the evolution of share repurchases and authorization across years. It fabricates 2022 repurchase activity and mischaracterizes 2024 activity. It also omits key details like the 2,000,308 shares and $605 million spent in fiscal 2024, and the employee-related share acquisitions. The inference about a 'robust, shareholder-friendly strategy' is plausible but based on incorrect data. (4) The answer is contextually relevant—addressing share repurchases, authorization changes, and capital return strategy—but the severe quantitative inaccuracies and invented figures drastically undermine correctness. The qualitative reasoning is partially sound in structure but built on false premises. Correctness score is low due to fundamental errors in numbers and missing accurate multi-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 561,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "Bristol‑Myers Squibb has continued to list the $750 million 2.350 % Notes due 2040 in its capital‑structure disclosures in 2022, 2023 and 2024 (see 4ll on pages 137, 133 and 134).  The note’s persistence shows the company’s deliberate use of long‑term, fixed‑rate debt to lock in a low borrowing cost, match long‑term cash‑flow expectations and reduce refinancing risk, reflecting a broader strategy of maintaining a diversified maturity profile and stable financing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million 2.350% Notes due 2040 are correctly identified, and their presence in capital structure filings for 2022, 2023, and 2024 is accurately stated. The dollar amount is correctly rendered as $750 million (equivalent to $750,000,000), and the interest rate and maturity year match. (2) Quantitative accuracy is perfect—no calculations are required, but all numeric values (amount, rate, years) are correct and consistently reported. (3) The reasoning is sound: the LLM correctly infers that the persistence of the notes reflects a strategy to lock in low fixed-rate debt, reduce refinancing risk, and stabilize financing costs—key elements in the ground truth. It also adds value by referencing a diversified maturity profile, which is consistent with BMY’s broader strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention that the continued inclusion indicates no refinancing or retirement despite market fluctuations—a nuance present in the original answer. However, this is implied in 'deliberate use' and 'reduce refinancing risk.' The citation of specific pages (137, 133, 134) adds precision, though not required. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight omission of emphasis on strategic retention amid market changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 401,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Bristol‑Myers Squibb first issued the 4.350% Senior Notes due 2047 in 2019 (see Exhibit 4.19 on page 136 and page 134).  The coupon rate of 4.350 % has remained unchanged in later filings (2022, 2023, 2024), with no subsequent amendment or re‑issuance at a different rate.  This consistency shows the company’s preference for stable, fixed‑rate long‑term debt, locking in moderate borrowing costs and maintaining a predictable interest‑expense profile over a multi‑decade horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all key facts are correct: the 4.350% interest rate, the issuance year (2019), and the consistency across 2022, 2023, and 2024 filings. The reference to the 2019 issuance aligns with the ground truth's mention of the Form 8-K from November 22, 2019. While the LLM cites Exhibit 4.19 and specific page numbers not mentioned in the ground truth, these do not contradict the known facts and may reflect document formatting details. (2) The core calculation—unchanged interest rate over time—is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data across multiple years and correctly infers that no changes to the rate occurred, supporting a conclusion about long-term debt strategy. (4) The qualitative analysis accurately reflects the company's stable, transparent approach to long-term financing, emphasizing predictability and fixed-rate commitments. The only minor shortcoming is the absence of specific supplemental indenture details (Twelfth, Fourteenth) and exact exhibit evolution (4bbb → 4ff), which are present in the ground truth but not critical to the overall meaning. These omissions reduce completeness slightly but do not affect factual correctness. The answer remains semantically equivalent in intent and substance, with excellent contextual relevance to the question about interest rate evolution and debt financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 409,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "Nike first listed FlyEase in its 2022 Form 10‑K as one of the technologies that “typifies” its product innovation.  In the 2024 filing the same technology is still mentioned in the product‑research section, but the report now pairs that mention with detailed manufacturing data that shows the scale at which FlyEase‑enabled footwear is produced.  For fiscal 2024 Nike Brand footwear was manufactured by 15 contract manufacturers in 11 countries, with factories in Vietnam, Indonesia and China producing roughly 50 %, 27 % and 18 % of total footwear, and four manufacturers each contributing more than 10 % of production—quantitative evidence that FlyEase is being produced at scale and integrated into Nike’s global manufacturing network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 2024 manufacturing distribution (50% Vietnam, 27% Indonesia, 18% China) matches the original answer exactly, and the mention of 15 contract manufacturers in 11 countries is consistent with Nike's disclosed supply chain scale. (2) The LLM correctly identifies the evolution of FlyEase reporting: introduced in 2022 as a representative innovation, and by 2024 integrated with production data, indicating maturity. (3) The reasoning is sound—linking the continued mention of FlyEase in R&D with detailed manufacturing footprints demonstrates logical multi-hop synthesis across years and sections of filings. (4) The only minor omission is that the original answer notes FlyEase was grouped with Nike Air and Dri-FIT in 2023, showing progressive integration, which the LLM does not mention. However, this does not undermine the core conclusion about scale and integration in 2024. The addition of 'four manufacturers each contributing more than 10%' is not in the ground truth but is plausible and contextually supportive without being contradictory. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 348,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "RedCard penetration fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page 27 of 2023 10‑K】【page 27 of 2024 10‑K】. The steady decline shows that while the loyalty‑driven payment program still captures a sizable share of Target purchases, its incremental growth is slowing—likely reflecting market saturation or diminishing marginal lift from the 5 % discount incentive.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rate for 2022 (20.5%) and 2023 (19.8%), which matches the ground truth. However, it incorrectly reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This is a significant quantitative error that affects the trend interpretation. (2) The calculation of the trend—a steady decline—is logically consistent with falling percentages, but the magnitude of decline is misrepresented due to the incorrect 2024 figure. The actual drop from 19.8% to 17.8% (a 1 percentage point decline) is more severe than the implied drop to 18.6% (a 1.2-point drop from 20.3%, but only a 1.2-point drop from 19.8% to 18.6%). While the direction of the trend is correct, the rate of decline is understated. (3) The multi-hop reasoning across the 2023 and 2024 10-K filings is appropriately executed, and the synthesis of RedCard penetration over time is sound in structure. The conclusion about slowing growth and possible market saturation is plausible but differs in tone from the ground truth, which suggests a 'weakening effectiveness' and potential competitive pressures. The LLM’s interpretation is somewhat softer and misses the stronger implication of declining strategy effectiveness. (4) The contextual relevance is high—the answer addresses both parts of the question: the evolution of penetration and the strategic implication. The qualitative reasoning is logical and entity identification (Target, RedCard, years) is accurate. However, the quantitative inaccuracy in the 2024 figure reduces confidence in the conclusion, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 451,
        "total_tokens": 1669
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 6.47,
    "average_quantitative_accuracy": 7.15,
    "average_qualitative_accuracy": 6.76,
    "average_contextual_relevance": 8.68,
    "score_distribution": {
      "excellent": 283,
      "good": 140,
      "fair": 241,
      "poor": 136
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 40196.73,
    "timestamp": "2026-02-03T12:13:51.017221"
  }
}